17,20-lyase deficiency, isolated, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17A1
17,20-lyase deficiency, isolated, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17
17,20-lyase deficiency, isolated, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	P450C17
17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17A1
17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	CYP17
17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3)	CYP17A1, CYP17, P450C17	609300	10q24.32	P450C17
17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	HSD17B10
17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	HADH2
17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	ERAB
17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	MRXS10
2-aminoadipic 2-oxoadipic aciduria, 204750 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	DHTKD1
2-aminoadipic 2-oxoadipic aciduria, 204750 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	KIAA1630
2-aminoadipic 2-oxoadipic aciduria, 204750 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	AMOXAD
2-aminoadipic 2-oxoadipic aciduria, 204750 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	CMT2Q
2-methylbutyrylglycinuria, 610006 (3)	ACADSB, SBCAD	600301	10q26.13	ACADSB
2-methylbutyrylglycinuria, 610006 (3)	ACADSB, SBCAD	600301	10q26.13	SBCAD
3-M syndrome 1, 273750 (3)	CUL7, 3M1	609577	6p21.1	CUL7
3-M syndrome 1, 273750 (3)	CUL7, 3M1	609577	6p21.1	3M1
3-M syndrome 2, 612921 (3)	OBSL1, KIAA0657, 3M2	610991	2q35	OBSL1
3-M syndrome 2, 612921 (3)	OBSL1, KIAA0657, 3M2	610991	2q35	KIAA0657
3-M syndrome 2, 612921 (3)	OBSL1, KIAA0657, 3M2	610991	2q35	3M2
3-M syndrome 3, 614205 (3)	CCDC8, 3M3	614145	19q13.32	CCDC8
3-M syndrome 3, 614205 (3)	CCDC8, 3M3	614145	19q13.32	3M3
3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	MCCC1, MCCA	609010	3q27.1	MCCC1
3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)	MCCC1, MCCA	609010	3q27.1	MCCA
3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	MCCC2, MCCB	609014	5q13.2	MCCC2
3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)	MCCC2, MCCB	609014	5q13.2	MCCB
3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HADHSC
3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)	HADHSC, SCHAD, HHF4	601609	4q25	SCHAD
3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HHF4
3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)	HIBCH	610690	2q32.2	HIBCH
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	SERAC1, MEGDEL	614725	6q25.3	SERAC1
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3)	SERAC1, MEGDEL	614725	6q25.3	MEGDEL
3-methylglutaconic aciduria, type I, 250950 (3)	AUH	600529	9q22.31	AUH
3-methylglutaconic aciduria, type III, 258501 (3)	OPA3, MGA3	606580	19q13.32	OPA3
3-methylglutaconic aciduria, type III, 258501 (3)	OPA3, MGA3	606580	19q13.32	MGA3
3-methylglutaconic aciduria, type V, 610198 (3)	DNAJC19, TIM14	608977	3q26.33	DNAJC19
3-methylglutaconic aciduria, type V, 610198 (3)	DNAJC19, TIM14	608977	3q26.33	TIM14
3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	CLPB, SKD3, MEGCANN, MGCA7	616254	11q13.4	CLPB
3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	CLPB, SKD3, MEGCANN, MGCA7	616254	11q13.4	SKD3
3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	CLPB, SKD3, MEGCANN, MGCA7	616254	11q13.4	MEGCANN
3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3)	CLPB, SKD3, MEGCANN, MGCA7	616254	11q13.4	MGCA7
3MC syndrome 1, 257920 (3)	MASP1, CRARF, 3MC1	600521	3q27.3	MASP1
3MC syndrome 1, 257920 (3)	MASP1, CRARF, 3MC1	600521	3q27.3	CRARF
3MC syndrome 1, 257920 (3)	MASP1, CRARF, 3MC1	600521	3q27.3	3MC1
3MC syndrome 2, 265050 (3)	COLEC11, CLK1, 3MC2	612502	2p25.3	COLEC11
3MC syndrome 2, 265050 (3)	COLEC11, CLK1, 3MC2	612502	2p25.3	CLK1
3MC syndrome 2, 265050 (3)	COLEC11, CLK1, 3MC2	612502	2p25.3	3MC2
3p- syndrome (4)	DEL3pterp25, C3DELpterp25	613792	3pter-p25	DEL3pterp25
3p- syndrome (4)	DEL3pterp25, C3DELpterp25	613792	3pter-p25	C3DELpterp25
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRY
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	TDF
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	TDY
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRXX1
46XX sex reversal 1, 400045 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRXY1
46XX sex reversal 2 (4)	SRXX2, DUP17q24.3	278850	17q24.3-q25.1	SRXX2
46XX sex reversal 2 (4)	SRXX2, DUP17q24.3	278850	17q24.3-q25.1	DUP17q24.3
46XX sex reversal 3 (4)	SRXX3	300833	Xq26.3	SRXX3
46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	DHH
46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	SRXY7
46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	GDXYM
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRY
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	TDF
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	TDY
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRXX1
46XY sex reversal 1, 400044 (3)	SRY, TDF, TDY, SRXX1, SRXY1	480000	Yp11.2	SRXY1
46XY sex reversal 10 (4)	SRXY10	616425	17q24	SRXY10
46XY sex reversal 2, dosage-sensitive, 300018 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	DAX1
46XY sex reversal 2, dosage-sensitive, 300018 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	AHC
46XY sex reversal 2, dosage-sensitive, 300018 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	AHX
46XY sex reversal 2, dosage-sensitive, 300018 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	NR0B1
46XY sex reversal 2, dosage-sensitive, 300018 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	SRXY2
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	NR5A1
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZF1
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZ1
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SF1
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	AD4BP
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	POF7
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SRXY3
46XY sex reversal 3, 612965 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SPGF8
46XY sex reversal 4 (4)	DEL9p24.3, C9DELp24.3, SRXY4	154230	9p24.3	DEL9p24.3
46XY sex reversal 4 (4)	DEL9p24.3, C9DELp24.3, SRXY4	154230	9p24.3	C9DELp24.3
46XY sex reversal 4 (4)	DEL9p24.3, C9DELp24.3, SRXY4	154230	9p24.3	SRXY4
46XY sex reversal 6, 613762 (3)	MAP3K1, MEKK1, MEKK, SRXY6	600982	5q11.2	MAP3K1
46XY sex reversal 6, 613762 (3)	MAP3K1, MEKK1, MEKK, SRXY6	600982	5q11.2	MEKK1
46XY sex reversal 6, 613762 (3)	MAP3K1, MEKK1, MEKK, SRXY6	600982	5q11.2	MEKK
46XY sex reversal 6, 613762 (3)	MAP3K1, MEKK1, MEKK, SRXY6	600982	5q11.2	SRXY6
46XY sex reversal 7, 233420 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	DHH
46XY sex reversal 7, 233420 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	SRXY7
46XY sex reversal 7, 233420 (3)	DHH, SRXY7, GDXYM	605423	12q13.12	GDXYM
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	AKR1C2
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	DDH2
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	DD2
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	HAKRD
46XY sex reversal 8, 614279 (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	SRXY8
46XY sex reversal 9, 616067 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
46XY sex reversal 9, 616067 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	FOG2
46XY sex reversal 9, 616067 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	DIH3
46XY sex reversal 9, 616067 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	SRXY9
5-fluorouracil toxicity, 274270 (3)	DPYD, DPD	612779	1p21.3	DPYD
5-fluorouracil toxicity, 274270 (3)	DPYD, DPD	612779	1p21.3	DPD
5-oxoprolinase deficiency, 260005 (3)	OPLAH, OPLAHD	614243	8q24.3	OPLAH
5-oxoprolinase deficiency, 260005 (3)	OPLAH, OPLAHD	614243	8q24.3	OPLAHD
?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	NADK2, C5orf33, DECRD	615787	5p13.2	NADK2
?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	NADK2, C5orf33, DECRD	615787	5p13.2	C5orf33
?2,4-dienoyl-CoA reductase deficiency, 616034 (3)	NADK2, C5orf33, DECRD	615787	5p13.2	DECRD
?46XY sex reversal 5, 613080 (3)	CBX2, M33, SRXY5	602770	17q25.3	CBX2
?46XY sex reversal 5, 613080 (3)	CBX2, M33, SRXY5	602770	17q25.3	M33
?46XY sex reversal 5, 613080 (3)	CBX2, M33, SRXY5	602770	17q25.3	SRXY5
?ACAT2 deficiency, 614055 (1)	ACAT2	100678	6q25.3	ACAT2
?Abruzzo-Erickson syndrome, 302905 (3)	TBX22, CPX, ABERS	300307	Xq21.1	TBX22
?Abruzzo-Erickson syndrome, 302905 (3)	TBX22, CPX, ABERS	300307	Xq21.1	CPX
?Abruzzo-Erickson syndrome, 302905 (3)	TBX22, CPX, ABERS	300307	Xq21.1	ABERS
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
?Advanced sleep phase syndrome, familial, 3, 616882 (3)	PER3, FASPS3	603427	1p36.23	PER3
?Advanced sleep phase syndrome, familial, 3, 616882 (3)	PER3, FASPS3	603427	1p36.23	FASPS3
?Agammaglobulinemia 5, 613506 (3)	LRRC8A, KIAA1437, AGM5	608360	9q34.11	LRRC8A
?Agammaglobulinemia 5, 613506 (3)	LRRC8A, KIAA1437, AGM5	608360	9q34.11	KIAA1437
?Agammaglobulinemia 5, 613506 (3)	LRRC8A, KIAA1437, AGM5	608360	9q34.11	AGM5
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	GRB1
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	AGM7
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	SHORT
?Agammaglobulinemia 7, autosomal recessive, 615214 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	IMD36
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	HLS2
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	ACLS
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	JBTS12
?Al-Gazali-Bakalinova syndrome, 607131 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	AGBK
?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	RBM28, ANES	612074	7q32.1	RBM28
?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)	RBM28, ANES	612074	7q32.1	ANES
?Amelogenesis imperfecta, type IE, X-linked 2 (2)	AI1E2, AIH3	301201	Xq22-q28	AI1E2
?Amelogenesis imperfecta, type IE, X-linked 2 (2)	AI1E2, AIH3	301201	Xq22-q28	AIH3
?Amyloidosis, familial visceral, 105200 (3)	B2M, IMD43	109700	15q21.1	B2M
?Amyloidosis, familial visceral, 105200 (3)	B2M, IMD43	109700	15q21.1	IMD43
?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SIGMAR1
?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SRBP
?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	ALS16
?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	DSMA2
?Anal canal carcinoma (2)	ANC	105580	11q22-qter	ANC
?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	STEAP3, TSAP6, AHMIO2	609671	2q14.2	STEAP3
?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	STEAP3, TSAP6, AHMIO2	609671	2q14.2	TSAP6
?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3)	STEAP3, TSAP6, AHMIO2	609671	2q14.2	AHMIO2
?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	ITPR2, ANHD	600144	12p11.23	ITPR2
?Anhidrosis, isolated, with normal sweat glands, 106190 (3)	ITPR2, ANHD	600144	12p11.23	ANHD
?Aniridia, 106210 (3)	ELP4, PAX6NEB, AN	606985	11p13	ELP4
?Aniridia, 106210 (3)	ELP4, PAX6NEB, AN	606985	11p13	PAX6NEB
?Aniridia, 106210 (3)	ELP4, PAX6NEB, AN	606985	11p13	AN
?Antiphospholipid syndrome, familial (2)	ATPLS	107320	6p21.3	ATPLS
?Aplasia cutis congenita, nonsyndromic, 107600 (3)	BMS1, BMS1L, KIAA0187, ACC	611448	10q11.21	BMS1
?Aplasia cutis congenita, nonsyndromic, 107600 (3)	BMS1, BMS1L, KIAA0187, ACC	611448	10q11.21	BMS1L
?Aplasia cutis congenita, nonsyndromic, 107600 (3)	BMS1, BMS1L, KIAA0187, ACC	611448	10q11.21	KIAA0187
?Aplasia cutis congenita, nonsyndromic, 107600 (3)	BMS1, BMS1L, KIAA0187, ACC	611448	10q11.21	ACC
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NERCC1
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	LCCS10
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	APUG
?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NC
?Arthrogryposis, mental retardation, and seizures, 615553 (3)	SLC35A3, AMRS	605632	1p21.2	SLC35A3
?Arthrogryposis, mental retardation, and seizures, 615553 (3)	SLC35A3, AMRS	605632	1p21.2	AMRS
?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	DNAJC3, PRKRI, P58, ACPHD	601184	13q32.1	DNAJC3
?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	DNAJC3, PRKRI, P58, ACPHD	601184	13q32.1	PRKRI
?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	DNAJC3, PRKRI, P58, ACPHD	601184	13q32.1	P58
?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3)	DNAJC3, PRKRI, P58, ACPHD	601184	13q32.1	ACPHD
?Ataxia-telangiectasia-like disorder, 615919 (3)	PCNA, ATLD2	176740	20p12.3	PCNA
?Ataxia-telangiectasia-like disorder, 615919 (3)	PCNA, ATLD2	176740	20p12.3	ATLD2
?Atrial fibrillation 15, 615770 (3)	NUP155, KIAA0791, ATFB15	606694	5p13.2	NUP155
?Atrial fibrillation 15, 615770 (3)	NUP155, KIAA0791, ATFB15	606694	5p13.2	KIAA0791
?Atrial fibrillation 15, 615770 (3)	NUP155, KIAA0791, ATFB15	606694	5p13.2	ATFB15
?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	MCH5
?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	ALPS2B
?Bardet-Biedl syndrome 11, 615988 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	TRIM32
?Bardet-Biedl syndrome 11, 615988 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	HT2A
?Bardet-Biedl syndrome 11, 615988 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	LGMD2H
?Bardet-Biedl syndrome 11, 615988 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	BBS11
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	KIAA0373
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	3H11AG
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	JBTS5
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	SLSN6
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	LCA10
?Bardet-Biedl syndrome 14, 615991 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	BBS14
?Bardet-Biedl syndrome 15, 615992 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	WDPCP
?Bardet-Biedl syndrome 15, 615992 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	C2orf86
?Bardet-Biedl syndrome 15, 615992 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	BBS15
?Bardet-Biedl syndrome 15, 615992 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	CHDTHP
?Bardet-Biedl syndrome 18, 615995 (3)	BBIP1, NCRNA00081, BBIP10, BBS18	613605	10q25.2	BBIP1
?Bardet-Biedl syndrome 18, 615995 (3)	BBIP1, NCRNA00081, BBIP10, BBS18	613605	10q25.2	NCRNA00081
?Bardet-Biedl syndrome 18, 615995 (3)	BBIP1, NCRNA00081, BBIP10, BBS18	613605	10q25.2	BBIP10
?Bardet-Biedl syndrome 18, 615995 (3)	BBIP1, NCRNA00081, BBIP10, BBS18	613605	10q25.2	BBS18
?Bardet-Biedl syndrome 19, 615996 (3)	IFT27, RABL4, BBS19	615870	22q12.3	IFT27
?Bardet-Biedl syndrome 19, 615996 (3)	IFT27, RABL4, BBS19	615870	22q12.3	RABL4
?Bardet-Biedl syndrome 19, 615996 (3)	IFT27, RABL4, BBS19	615870	22q12.3	BBS19
?Bile acid synthesis defect, congenital, 5, 616278 (3)	ABCD3, PXMP1, PMP70, CBAS5	170995	1p21.3	ABCD3
?Bile acid synthesis defect, congenital, 5, 616278 (3)	ABCD3, PXMP1, PMP70, CBAS5	170995	1p21.3	PXMP1
?Bile acid synthesis defect, congenital, 5, 616278 (3)	ABCD3, PXMP1, PMP70, CBAS5	170995	1p21.3	PMP70
?Bile acid synthesis defect, congenital, 5, 616278 (3)	ABCD3, PXMP1, PMP70, CBAS5	170995	1p21.3	CBAS5
?Bleeding disorder, platelet-type, 18, 615888 (3)	RASGRP2, CDC25L	605577	11q13.1	RASGRP2
?Bleeding disorder, platelet-type, 18, 615888 (3)	RASGRP2, CDC25L	605577	11q13.1	CDC25L
?Bleeding disorder, platelet-type, 19, 616176 (3)	PRKACG, BDPLT19	176893	9q21.11	PRKACG
?Bleeding disorder, platelet-type, 19, 616176 (3)	PRKACG, BDPLT19	176893	9q21.11	BDPLT19
?Brachydactyly-syndactyly syndrome, 610713 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
?Brachydactyly-syndactyly syndrome, 610713 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOX4I
?Brachydactyly-syndactyly syndrome, 610713 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	SPD1
?Brachydactyly-syndactyly syndrome, 610713 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	BDSD
?Breast cancer, type 3 (2)	BRCA3, BRCAX	605365	13q21	BRCA3
?Breast cancer, type 3 (2)	BRCA3, BRCAX	605365	13q21	BRCAX
?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	PTPRF, LAR, BNAH2	179590	1p34.2	PTPRF
?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	PTPRF, LAR, BNAH2	179590	1p34.2	LAR
?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3)	PTPRF, LAR, BNAH2	179590	1p34.2	BNAH2
?CHARGE syndrome, 214800 (3)	SEMA3E, SEMAH, KIAA0331	608166	7q21.11	SEMA3E
?CHARGE syndrome, 214800 (3)	SEMA3E, SEMAH, KIAA0331	608166	7q21.11	SEMAH
?CHARGE syndrome, 214800 (3)	SEMA3E, SEMAH, KIAA0331	608166	7q21.11	KIAA0331
?Camptosynpolydactyly, complex, 607539 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHA9
?Camptosynpolydactyly, complex, 607539 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHF42
?Camptosynpolydactyly, complex, 607539 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	MSSD
?Camptosynpolydactyly, complex, 607539 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	CCSPD
?Candidiasis, familial, 5, autosomal recessive, 613953 (3)	IL17RA, IL17R, CANDF5	605461	22q11.1	IL17RA
?Candidiasis, familial, 5, autosomal recessive, 613953 (3)	IL17RA, IL17R, CANDF5	605461	22q11.1	IL17R
?Candidiasis, familial, 5, autosomal recessive, 613953 (3)	IL17RA, IL17R, CANDF5	605461	22q11.1	CANDF5
?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	IL17F, ML1, CANDF6	606496	6p12.2	IL17F
?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	IL17F, ML1, CANDF6	606496	6p12.2	ML1
?Candidiasis, familial, 6, autosomal dominant, 613956 (3)	IL17F, ML1, CANDF6	606496	6p12.2	CANDF6
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	TRAF3IP2
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf5
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	ACT1
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	CIKS
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf4
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf6
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	PSORS13
?Candidiasis, familial, 8, 615527 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	CANDF8
?Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	TNNI3K, CCDD	613932	1p31.1	TNNI3K
?Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3)	TNNI3K, CCDD	613932	1p31.1	CCDD
?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	COA5, C2orf64, PET191, CEMCOX3	613920	2q11.2	COA5
?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	COA5, C2orf64, PET191, CEMCOX3	613920	2q11.2	C2orf64
?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	COA5, C2orf64, PET191, CEMCOX3	613920	2q11.2	PET191
?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3)	COA5, C2orf64, PET191, CEMCOX3	613920	2q11.2	CEMCOX3
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CSRP3
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CRP3
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CLP
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CMD1M
?Cardiomyopathy, dilated, 1M, 607482 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CMH12
?Cardiomyopathy, dilated, 1T, 613740 (3)	TMPO, LAP2, CMD1T	188380	12q23.1	TMPO
?Cardiomyopathy, dilated, 1T, 613740 (3)	TMPO, LAP2, CMD1T	188380	12q23.1	LAP2
?Cardiomyopathy, dilated, 1T, 613740 (3)	TMPO, LAP2, CMD1T	188380	12q23.1	CMD1T
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMH7
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD2A
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	RCM1
?Cardiomyopathy, dilated, 2A, 611880 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD1FF
?Cardiomyopathy, dilated, 2B, 614672 (3)	GATAD1, ODAG, CMD2B	614518	7q21.2	GATAD1
?Cardiomyopathy, dilated, 2B, 614672 (3)	GATAD1, ODAG, CMD2B	614518	7q21.2	ODAG
?Cardiomyopathy, dilated, 2B, 614672 (3)	GATAD1, ODAG, CMD2B	614518	7q21.2	CMD2B
?Cardiomyopathy, hypertrophic, 19, 613875 (3)	CALR3, CRT2, CMH19	611414	19p13.11	CALR3
?Cardiomyopathy, hypertrophic, 19, 613875 (3)	CALR3, CRT2, CMH19	611414	19p13.11	CRT2
?Cardiomyopathy, hypertrophic, 19, 613875 (3)	CALR3, CRT2, CMH19	611414	19p13.11	CMH19
?Carnitine acetyltransferase deficiency (1)	CRAT, CAT1	600184	9q34.11	CRAT
?Carnitine acetyltransferase deficiency (1)	CRAT, CAT1	600184	9q34.11	CAT1
?Cataract 30, pulverulent, 116300 (3)	VIM, CTRCT30	193060	10p13	VIM
?Cataract 30, pulverulent, 116300 (3)	VIM, CTRCT30	193060	10p13	CTRCT30
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFRS
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA6
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA14
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA38
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFSL
?Cataract 41, 116400 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	CTRCT41
?Cataract 42, 115900 (3)	CRYBA2, CTRCT42	600836	2q35	CRYBA2
?Cataract 42, 115900 (3)	CRYBA2, CTRCT42	600836	2q35	CTRCT42
?Cataract 43, 616279 (3)	UNC45B, SMUNC45, CTRCT43	611220	17q12	UNC45B
?Cataract 43, 616279 (3)	UNC45B, SMUNC45, CTRCT43	611220	17q12	SMUNC45
?Cataract 43, 616279 (3)	UNC45B, SMUNC45, CTRCT43	611220	17q12	CTRCT43
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	SIPA1L3
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	SPAL3
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	SPAR3
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	KIAA0545
?Cataract 45, 616851 (3)	SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45	616655	19q13.1-q13.2	CTRCT45
?Cataract, congenital (2)	SORD, SORD1	182500	15q21.1	SORD
?Cataract, congenital (2)	SORD, SORD1	182500	15q21.1	SORD1
?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	IARS2, CAGSSS	612801	1q41	IARS2
?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3)	IARS2, CAGSSS	612801	1q41	CAGSSS
?Caudal duplication anomaly, 607864 (3)	AXIN1, AXIN	603816	16p13.3	AXIN1
?Caudal duplication anomaly, 607864 (3)	AXIN1, AXIN	603816	16p13.3	AXIN
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	ATP8A2, ATPIB, CAMRQ4	605870	13q12.13	ATP8A2
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	ATP8A2, ATPIB, CAMRQ4	605870	13q12.13	ATPIB
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3)	ATP8A2, ATPIB, CAMRQ4	605870	13q12.13	CAMRQ4
?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	GAD1, SCP, CPSQ1	605363	2q31.1	GAD1
?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	GAD1, SCP, CPSQ1	605363	2q31.1	SCP
?Cerebral palsy, spastic quadriplegic, 1, 603513 (3)	GAD1, SCP, CPSQ1	605363	2q31.1	CPSQ1
?Ceroid lipofuscinosis, neuronal, 12, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	ATP13A2
?Ceroid lipofuscinosis, neuronal, 12, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	PARK9
?Ceroid lipofuscinosis, neuronal, 12, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	KRPPD
?Ceroid lipofuscinosis, neuronal, 12, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	CLN12
?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	PDK3, CMTX6	300906	Xp22.11	PDK3
?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3)	PDK3, CMTX6	300906	Xp22.11	CMTX6
?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	JPH1, JP1, CMT2K	605266	8q21.11	JPH1
?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	JPH1, JP1, CMT2K	605266	8q21.11	JP1
?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3)	JPH1, JP1, CMT2K	605266	8q21.11	CMT2K
?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	DHTKD1
?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	KIAA1630
?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	AMOXAD
?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3)	DHTKD1, KIAA1630, AMOXAD, CMT2Q	614984	10p14	CMT2Q
?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	NAGLU
?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	MPS3B
?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	CMT2V
?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	KARS
?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	CMTRIB
?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	DFNB89
?Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
?Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A
?Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A1
?Charcot-Marie-Tooth disease, type 2A1, 118210 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	NBLST1
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	MED25
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	PTOV2
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	ARC92
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	CMT2B2
?Charcot-Marie-Tooth disease, type 2B2, 605589 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	BVSYS
?Chilblain lupus 2, 614415 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	SAMHD1
?Chilblain lupus 2, 614415 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	AGS5
?Chilblain lupus 2, 614415 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	DCIP
?Chilblain lupus 2, 614415 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	CHBL2
?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	HDAC6, CPBHM	300272	Xp11.23	HDAC6
?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3)	HDAC6, CPBHM	300272	Xp11.23	CPBHM
?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	GPR88, STRG, COCPMR	607468	1p21.2	GPR88
?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	GPR88, STRG, COCPMR	607468	1p21.2	STRG
?Chorea, childhood-onset, with psychomotor retardation, 616939 (3)	GPR88, STRG, COCPMR	607468	1p21.2	COCPMR
?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	COQ7, CLK1, COQ10D8	601683	16p12.3	COQ7
?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	COQ7, CLK1, COQ10D8	601683	16p12.3	CLK1
?Coenzyme Q10 deficiency, primary, 8, 616733 (3)	COQ7, CLK1, COQ10D8	601683	16p12.3	COQ10D8
?Cognitive impairment with or without cerebellar ataxia, 614306 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	SCN8A
?Cognitive impairment with or without cerebellar ataxia, 614306 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	CIAT
?Cognitive impairment with or without cerebellar ataxia, 614306 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	EIEE13
?Coloboma, ocular, autosomal recessive, 216820 (3)	SALL2, HSAL2, COLB	602219	14q11.2	SALL2
?Coloboma, ocular, autosomal recessive, 216820 (3)	SALL2, HSAL2, COLB	602219	14q11.2	HSAL2
?Coloboma, ocular, autosomal recessive, 216820 (3)	SALL2, HSAL2, COLB	602219	14q11.2	COLB
?Combined oxidative phosphorylation deficiency 16, 615395 (3)	MRPL44, COXPD16	611849	2q36.1	MRPL44
?Combined oxidative phosphorylation deficiency 16, 615395 (3)	MRPL44, COXPD16	611849	2q36.1	COXPD16
?Combined oxidative phosphorylation deficiency 19, 615595 (3)	LYRM4, ISD11, C6orf149, COXPD19	613311	6p25.1	LYRM4
?Combined oxidative phosphorylation deficiency 19, 615595 (3)	LYRM4, ISD11, C6orf149, COXPD19	613311	6p25.1	ISD11
?Combined oxidative phosphorylation deficiency 19, 615595 (3)	LYRM4, ISD11, C6orf149, COXPD19	613311	6p25.1	C6orf149
?Combined oxidative phosphorylation deficiency 19, 615595 (3)	LYRM4, ISD11, C6orf149, COXPD19	613311	6p25.1	COXPD19
?Combined oxidative phosphorylation deficiency 21, 615918 (3)	TARS2, COXPD21	612805	1q21.2	TARS2
?Combined oxidative phosphorylation deficiency 21, 615918 (3)	TARS2, COXPD21	612805	1q21.2	COXPD21
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A1
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATPM
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ORM
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	MC5DN4
?Combined oxidative phosphorylation deficiency 22, 616045 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	COXPD22
?Combined oxidative phosphorylation deficiency 25, 616430 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	MARS2
?Combined oxidative phosphorylation deficiency 25, 616430 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	SPAX3
?Combined oxidative phosphorylation deficiency 25, 616430 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	COXPD25
?Combined oxidative phosphorylation deficiency 29, 616811 (3)	TXN2, TRX2, MTRX, COXPD29	609063	22q12.3	TXN2
?Combined oxidative phosphorylation deficiency 29, 616811 (3)	TXN2, TRX2, MTRX, COXPD29	609063	22q12.3	TRX2
?Combined oxidative phosphorylation deficiency 29, 616811 (3)	TXN2, TRX2, MTRX, COXPD29	609063	22q12.3	MTRX
?Combined oxidative phosphorylation deficiency 29, 616811 (3)	TXN2, TRX2, MTRX, COXPD29	609063	22q12.3	COXPD29
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	BF
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	GBG
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	AHUS4
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	ARMD14
?Complement factor B deficiency, 615561 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFBD
?Cone-rod dystrophy (3)	UNC119, HRG4, IMD13	604011	17q11.2	UNC119
?Cone-rod dystrophy (3)	UNC119, HRG4, IMD13	604011	17q11.2	HRG4
?Cone-rod dystrophy (3)	UNC119, HRG4, IMD13	604011	17q11.2	IMD13
?Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	ALG2
?Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CDGII
?Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CMSTA3
?Congenital disorder of glycosylation, type Ii, 607906 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CMS14
?Congenital disorder of glycosylation, type Ir, 614507 (3)	DDOST, OST, OST48, CDG1R	602202	1p36.12	DDOST
?Congenital disorder of glycosylation, type Ir, 614507 (3)	DDOST, OST, OST48, CDG1R	602202	1p36.12	OST
?Congenital disorder of glycosylation, type Ir, 614507 (3)	DDOST, OST, OST48, CDG1R	602202	1p36.12	OST48
?Congenital disorder of glycosylation, type Ir, 614507 (3)	DDOST, OST, OST48, CDG1R	602202	1p36.12	CDG1R
?Congenital disorder of glycosylation, type Iw, 615596 (3)	STT3A, ITM1, TMC	601134	11q24.2	STT3A
?Congenital disorder of glycosylation, type Iw, 615596 (3)	STT3A, ITM1, TMC	601134	11q24.2	ITM1
?Congenital disorder of glycosylation, type Iw, 615596 (3)	STT3A, ITM1, TMC	601134	11q24.2	TMC
?Congenital disorder of glycosylation, type Ix, 615597 (3)	STT3B, SIMP, CDG1X	608605	3p23	STT3B
?Congenital disorder of glycosylation, type Ix, 615597 (3)	STT3B, SIMP, CDG1X	608605	3p23	SIMP
?Congenital disorder of glycosylation, type Ix, 615597 (3)	STT3B, SIMP, CDG1X	608605	3p23	CDG1X
?Congenital disorder of glycosylation, type Iy, 300934 (3)	SSR4, TRAPD, CDG1Y	300090	Xq28	SSR4
?Congenital disorder of glycosylation, type Iy, 300934 (3)	SSR4, TRAPD, CDG1Y	300090	Xq28	TRAPD
?Congenital disorder of glycosylation, type Iy, 300934 (3)	SSR4, TRAPD, CDG1Y	300090	Xq28	CDG1Y
?Congenital disorder of glycosylation, type Iz, 616457 (3)	CAD, CDG1Z	114010	2p23.3	CAD
?Congenital disorder of glycosylation, type Iz, 616457 (3)	CAD, CDG1Z	114010	2p23.3	CDG1Z
?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	WDPCP
?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	C2orf86
?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	BBS15
?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3)	WDPCP, C2orf86, BBS15, CHDTHP	613580	2p15	CHDTHP
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	NLRP1
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	NALP1
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	KIAA0926
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	DEFCAP
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	CARD7
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	SLEV1
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	VAMAS1
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia, 615225 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	CIDED
?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	FRMD4A, KIAA1294, CCAFCA	616305	10p13	FRMD4A
?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	FRMD4A, KIAA1294, CCAFCA	616305	10p13	KIAA1294
?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3)	FRMD4A, KIAA1294, CCAFCA	616305	10p13	CCAFCA
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	SRTD5
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	ATD5
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	NPHP13
?Cranioectodermal dysplasia 4, 614378 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	CED4
?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	VSX1
?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	RINX
?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	KTCN1
?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	CAASDS
?Craniofacioskeletal syndrome (2)	CFSS	300712	Xq26-q27	CFSS
?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	ATR
?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	FRP1
?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	SCKL1
?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	FCTCS
?Deafness, X-linked 6, 300914 (3)	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	303631	Xq22.3	COL4A6
?Deafness, X-linked 6, 300914 (3)	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	303631	Xq22.3	DELXq22.3
?Deafness, X-linked 6, 300914 (3)	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	303631	Xq22.3	CXDELq22.3
?Deafness, X-linked 6, 300914 (3)	COL4A6, DELXq22.3, CXDELq22.3, DFNX6	303631	Xq22.3	DFNX6
?Deafness, autosomal dominant 44, 607453 (3)	CCDC50, C3orf6, DFNA44	611051	3q28	CCDC50
?Deafness, autosomal dominant 44, 607453 (3)	CCDC50, C3orf6, DFNA44	611051	3q28	C3orf6
?Deafness, autosomal dominant 44, 607453 (3)	CCDC50, C3orf6, DFNA44	611051	3q28	DFNA44
?Deafness, autosomal dominant 66, 616969 (3)	CD164, DFNA66	603356	6q21	CD164
?Deafness, autosomal dominant 66, 616969 (3)	CD164, DFNA66	603356	6q21	DFNA66
?Deafness, autosomal dominant 68, 616707 (3)	HOMER2, HOMER2B, HOMER2A, DFNA68	604799	15q25.2	HOMER2
?Deafness, autosomal dominant 68, 616707 (3)	HOMER2, HOMER2B, HOMER2A, DFNA68	604799	15q25.2	HOMER2B
?Deafness, autosomal dominant 68, 616707 (3)	HOMER2, HOMER2B, HOMER2A, DFNA68	604799	15q25.2	HOMER2A
?Deafness, autosomal dominant 68, 616707 (3)	HOMER2, HOMER2B, HOMER2A, DFNA68	604799	15q25.2	DFNA68
?Deafness, autosomal dominant 70, 616968 (3)	MCM2, CDCL1, DFNA70	116945	3q21.3	MCM2
?Deafness, autosomal dominant 70, 616968 (3)	MCM2, CDCL1, DFNA70	116945	3q21.3	CDCL1
?Deafness, autosomal dominant 70, 616968 (3)	MCM2, CDCL1, DFNA70	116945	3q21.3	DFNA70
?Deafness, autosomal recessive 101, 615837 (3)	GRXCR2, DFNB101	615762	5q32	GRXCR2
?Deafness, autosomal recessive 101, 615837 (3)	GRXCR2, DFNB101	615762	5q32	DFNB101
?Deafness, autosomal recessive 102, 615974 (3)	EPS8, DFNB102	600206	12p12.3	EPS8
?Deafness, autosomal recessive 102, 615974 (3)	EPS8, DFNB102	600206	12p12.3	DFNB102
?Deafness, autosomal recessive 103, 616042 (3)	CLIC5, DFNB103	607293	6p21.1	CLIC5
?Deafness, autosomal recessive 103, 616042 (3)	CLIC5, DFNB103	607293	6p21.1	DFNB103
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	FAM65B
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	C6orf32
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	KIAA0386
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	PL48
?Deafness, autosomal recessive 104, 616515 (3)	FAM65B, C6orf32, KIAA0386, PL48, DFNB104	611410	6p22.3	DFNB104
?Deafness, autosomal recessive 44, 610154 (3)	ADCY1, DFNB44	103072	7p12.3	ADCY1
?Deafness, autosomal recessive 44, 610154 (3)	ADCY1, DFNB44	103072	7p12.3	DFNB44
?Deafness, autosomal recessive 61, 613865 (3)	SLC26A5, PRES, DFNB61	604943	7q22.1	SLC26A5
?Deafness, autosomal recessive 61, 613865 (3)	SLC26A5, PRES, DFNB61	604943	7q22.1	PRES
?Deafness, autosomal recessive 61, 613865 (3)	SLC26A5, PRES, DFNB61	604943	7q22.1	DFNB61
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	DCDC2
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	RU2
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	KIAA1154
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	NPHP19
?Deafness, autosomal recessive 66, 610212 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	DFNB66
?Deafness, autosomal recessive 88, 615429 (3)	ELMOD3, RBED1, DFNB88	615427	2p11.2	ELMOD3
?Deafness, autosomal recessive 88, 615429 (3)	ELMOD3, RBED1, DFNB88	615427	2p11.2	RBED1
?Deafness, autosomal recessive 88, 615429 (3)	ELMOD3, RBED1, DFNB88	615427	2p11.2	DFNB88
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	SERPINB6
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	PI6
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	PTI
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	SPI3
?Deafness, autosomal recessive 91, 613453 (3)	SERPINB6, PI6, PTI, SPI3, DFNB91	173321	6p25.2	DFNB91
?Deafness, autosomal recessive 97, 616705 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
?Deafness, autosomal recessive 97, 616705 (3)	MET, DFNB97, OSFD	164860	7q31.2	DFNB97
?Deafness, autosomal recessive 97, 616705 (3)	MET, DFNB97, OSFD	164860	7q31.2	OSFD
?Deafness, congenital heart defects, and posterior embryotoxon (3)	JAG1, AGS, AHD	601920	20p12.2	JAG1
?Deafness, congenital heart defects, and posterior embryotoxon (3)	JAG1, AGS, AHD	601920	20p12.2	AGS
?Deafness, congenital heart defects, and posterior embryotoxon (3)	JAG1, AGS, AHD	601920	20p12.2	AHD
?Diabetes mellitus, insulin-dependent, neonatal (2)	PBCA	600089	6p21.3	PBCA
?Diamond-Blackfan anemia 11, 614900 (3)	RPL26, DBA11	603704	17p13.1	RPL26
?Diamond-Blackfan anemia 11, 614900 (3)	RPL26, DBA11	603704	17p13.1	DBA11
?Diamond-Blackfan anemia 12, 615550 (3)	RPL15, DBA12	604174	3p24.2	RPL15
?Diamond-Blackfan anemia 12, 615550 (3)	RPL15, DBA12	604174	3p24.2	DBA12
?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	TSR2, WGG1, DBA14	300945	Xp11.22	TSR2
?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	TSR2, WGG1, DBA14	300945	Xp11.22	WGG1
?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3)	TSR2, WGG1, DBA14	300945	Xp11.22	DBA14
?Diarrhea 7, 615863 (3)	DGAT1, ARGP1, DIAR7	604900	8q24.3	DGAT1
?Diarrhea 7, 615863 (3)	DGAT1, ARGP1, DIAR7	604900	8q24.3	ARGP1
?Diarrhea 7, 615863 (3)	DGAT1, ARGP1, DIAR7	604900	8q24.3	DIAR7
?Dyskeratosis congenita, autosomal dominant 6, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	ACD
?Dyskeratosis congenita, autosomal dominant 6, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	PTOP
?Dyskeratosis congenita, autosomal dominant 6, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	PIP1
?Dyskeratosis congenita, autosomal dominant 6, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	TINT1
?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	ACD
?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	PTOP
?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	PIP1
?Dyskeratosis congenita, autosomal recessive 7, 616553 (3)	ACD, PTOP, PIP1, TINT1	609377	16q22.1	TINT1
?Dystonia 23, 614860 (3)	CACNA1B, CACNL1A5, DYT23	601012	9q34.3	CACNA1B
?Dystonia 23, 614860 (3)	CACNA1B, CACNL1A5, DYT23	601012	9q34.3	CACNL1A5
?Dystonia 23, 614860 (3)	CACNA1B, CACNL1A5, DYT23	601012	9q34.3	DYT23
?Dystonia, juvenile-onset, 607371 (3)	ACTB, BRWS1	102630	7p22.1	ACTB
?Dystonia, juvenile-onset, 607371 (3)	ACTB, BRWS1	102630	7p22.1	BRWS1
?EEC syndrome-1 (2)	EEC1	129900	7q11.2-q21.3	EEC1
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	K6IRS4
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT6IRS4
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HTSS2
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HYPT3
?Ectodermal dysplasia 7, hair/nail type, 614929 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	ADWH
?Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	DSE, SART2, EDSMC2	605942	6q22.1	DSE
?Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	DSE, SART2, EDSMC2	605942	6q22.1	SART2
?Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3)	DSE, SART2, EDSMC2	605942	6q22.1	EDSMC2
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLTN
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBS1
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	LGMD2Q
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSOG
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSPA
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSMD
?Epidermolysis bullosa simplex with nail dystrophy, 616487 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSND
?Epilepsy, familial temporal lobe, 8, 616461 (3)	GAL, GALN, GLNN, ETL8	137035	11q13.2	GAL
?Epilepsy, familial temporal lobe, 8, 616461 (3)	GAL, GALN, GLNN, ETL8	137035	11q13.2	GALN
?Epilepsy, familial temporal lobe, 8, 616461 (3)	GAL, GALN, GLNN, ETL8	137035	11q13.2	GLNN
?Epilepsy, familial temporal lobe, 8, 616461 (3)	GAL, GALN, GLNN, ETL8	137035	11q13.2	ETL8
?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	CNTN2, TAX, TAX1, FAME5	190197	1q32.1	CNTN2
?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	CNTN2, TAX, TAX1, FAME5	190197	1q32.1	TAX
?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	CNTN2, TAX, TAX1, FAME5	190197	1q32.1	TAX1
?Epilepsy, myoclonic, familial adult, 5, 615400 (3)	CNTN2, TAX, TAX1, FAME5	190197	1q32.1	FAME5
?Epilepsy, progressive myoclonic, 10, 616640 (3)	PRDM8, EPM10	616639	4q21.21	PRDM8
?Epilepsy, progressive myoclonic, 10, 616640 (3)	PRDM8, EPM10	616639	4q21.21	EPM10
?Epilepsy, progressive myoclonic, 8, 616230 (3)	CERS1, LASS1, UOG1, EPM8	606919	19p13.11	CERS1
?Epilepsy, progressive myoclonic, 8, 616230 (3)	CERS1, LASS1, UOG1, EPM8	606919	19p13.11	LASS1
?Epilepsy, progressive myoclonic, 8, 616230 (3)	CERS1, LASS1, UOG1, EPM8	606919	19p13.11	UOG1
?Epilepsy, progressive myoclonic, 8, 616230 (3)	CERS1, LASS1, UOG1, EPM8	606919	19p13.11	EPM8
?Epilepsy, progressive myoclonic, 9, 616540 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMNB2
?Epilepsy, progressive myoclonic, 9, 616540 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMN2
?Epilepsy, progressive myoclonic, 9, 616540 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	EPM9
?Epileptic encephalopathy, early infantile, 21, 615833 (3)	NECAP1, EIEE21	611623	12p13.31	NECAP1
?Epileptic encephalopathy, early infantile, 21, 615833 (3)	NECAP1, EIEE21	611623	12p13.31	EIEE21
?Epileptic encephalopathy, early infantile, 40, 617065 (3)	GUF1, EF4, EIEE40	617064	4p12	GUF1
?Epileptic encephalopathy, early infantile, 40, 617065 (3)	GUF1, EF4, EIEE40	617064	4p12	EF4
?Epileptic encephalopathy, early infantile, 40, 617065 (3)	GUF1, EF4, EIEE40	617064	4p12	EIEE40
?Epiphyseal dysplasia, multiple, 6, 614135 (3)	COL9A1, EDM6, STL4	120210	6q13	COL9A1
?Epiphyseal dysplasia, multiple, 6, 614135 (3)	COL9A1, EDM6, STL4	120210	6q13	EDM6
?Epiphyseal dysplasia, multiple, 6, 614135 (3)	COL9A1, EDM6, STL4	120210	6q13	STL4
?Exercise intolerance, riboflavin-responsive, 616839 (3)	SLC25A32, MFT, RREI	610815	8q22.3	SLC25A32
?Exercise intolerance, riboflavin-responsive, 616839 (3)	SLC25A32, MFT, RREI	610815	8q22.3	MFT
?Exercise intolerance, riboflavin-responsive, 616839 (3)	SLC25A32, MFT, RREI	610815	8q22.3	RREI
?Exudative vitreoretinopathy 6, 616468 (3)	ZNF408, EVR6, RP72	616454	11p11.2	ZNF408
?Exudative vitreoretinopathy 6, 616468 (3)	ZNF408, EVR6, RP72	616454	11p11.2	EVR6
?Exudative vitreoretinopathy 6, 616468 (3)	ZNF408, EVR6, RP72	616454	11p11.2	RP72
?Facial clefting, oblique, 1, 600251 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	SPECC1L
?Facial clefting, oblique, 1, 600251 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	KIAA0376
?Facial clefting, oblique, 1, 600251 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	OBLFC1
?Facial clefting, oblique, 1, 600251 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	GBBB2
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	NLRC4
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	CARD12
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	CLAN
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	IPAF
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	AIFEC
?Familial cold autoinflammatory syndrome 4, 616115 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	FCAS4
?Fanconi renotubular syndrome 3, 615605 (3)	EHHADH, PBFE, LBFP, FRTS3	607037	3q27.2	EHHADH
?Fanconi renotubular syndrome 3, 615605 (3)	EHHADH, PBFE, LBFP, FRTS3	607037	3q27.2	PBFE
?Fanconi renotubular syndrome 3, 615605 (3)	EHHADH, PBFE, LBFP, FRTS3	607037	3q27.2	LBFP
?Fanconi renotubular syndrome 3, 615605 (3)	EHHADH, PBFE, LBFP, FRTS3	607037	3q27.2	FRTS3
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	GPR98
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	MASS1
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	VLGR1
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	KIAA0686
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	FEB4
?Febrile seizures, familial, 4, 604352 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	USH2C
?Fetal akinesia deformation sequence, 208150 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	DOK7
?Fetal akinesia deformation sequence, 208150 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	C4orf25
?Fetal akinesia deformation sequence, 208150 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	CMS10
?Fetal hydantoin syndrome (1)	EPHX1	132810	1q42.12	EPHX1
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	SOS1
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	GINGF
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	GF1
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	HGF
?Fibromatosis, gingival, 1, 135300 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	NS4
?Frontonasal dysplasia 3, 613456 (3)	ALX1, CART1, FND3	601527	12q21.31	ALX1
?Frontonasal dysplasia 3, 613456 (3)	ALX1, CART1, FND3	601527	12q21.31	CART1
?Frontonasal dysplasia 3, 613456 (3)	ALX1, CART1, FND3	601527	12q21.31	FND3
?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	DCAF8, WDR42A, GAN2	615820	1q23.2	DCAF8
?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	DCAF8, WDR42A, GAN2	615820	1q23.2	WDR42A
?Giant axonal neuropathy 2, autosomal dominant, 610100 (3)	DCAF8, WDR42A, GAN2	615820	1q23.2	GAN2
?Glycogen storage disease XIII, 612932 (3)	ENO3, GSD13	131370	17p13.2	ENO3
?Glycogen storage disease XIII, 612932 (3)	ENO3, GSD13	131370	17p13.2	GSD13
?Glycogen storage disease XV, 613507 (3)	GYG1, GSD15	603942	3q24	GYG1
?Glycogen storage disease XV, 613507 (3)	GYG1, GSD15	603942	3q24	GSD15
?Glycoprotein Ia deficiency, 614200 (1)	ITGA2, CD49B, BR, BDPLT9	192974	5q11.2	ITGA2
?Glycoprotein Ia deficiency, 614200 (1)	ITGA2, CD49B, BR, BDPLT9	192974	5q11.2	CD49B
?Glycoprotein Ia deficiency, 614200 (1)	ITGA2, CD49B, BR, BDPLT9	192974	5q11.2	BR
?Glycoprotein Ia deficiency, 614200 (1)	ITGA2, CD49B, BR, BDPLT9	192974	5q11.2	BDPLT9
?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	NCF4, P40PHOX, CGD3	601488	22q12.3	NCF4
?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	NCF4, P40PHOX, CGD3	601488	22q12.3	P40PHOX
?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3)	NCF4, P40PHOX, CGD3	601488	22q12.3	CGD3
?Growth restriction, severe, with distinctive facies, 616489 (3)	IGF2, GRDF	147470	11p15.5	IGF2
?Growth restriction, severe, with distinctive facies, 616489 (3)	IGF2, GRDF	147470	11p15.5	GRDF
?Hairy ears, Y-linked (2)	HEY	425500	Yq	HEY
?Hemochromatosis, type 5, 615517 (3)	FTH1, FTHL6, HFE5	134770	11q12.3	FTH1
?Hemochromatosis, type 5, 615517 (3)	FTH1, FTHL6, HFE5	134770	11q12.3	FTHL6
?Hemochromatosis, type 5, 615517 (3)	FTH1, FTHL6, HFE5	134770	11q12.3	HFE5
?Hepatocellular carcinoma (1)	LCO	165320	2q14-q21	LCO
?Hermansky-Pudlak syndrome 10, 617050 (3)	AP3D1, HPS10	607246	19p13.3	AP3D1
?Hermansky-Pudlak syndrome 10, 617050 (3)	AP3D1, HPS10	607246	19p13.3	HPS10
?Heterotaxy, visceral, 3, autosomal (2)	HTX3	606325	6q21	HTX3
?Hip dysplasia, Beukes type, 142669 (3)	UFSP2, C4orf20, BHD	611482	4q35.1	UFSP2
?Hip dysplasia, Beukes type, 142669 (3)	UFSP2, C4orf20, BHD	611482	4q35.1	C4orf20
?Hip dysplasia, Beukes type, 142669 (3)	UFSP2, C4orf20, BHD	611482	4q35.1	BHD
?Hydrocephalus, autosomal dominant (2)	HDCPH1	123155	8q12.2-q21.2	HDCPH1
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	HLS2
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	ACLS
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	JBTS12
?Hydrolethalus syndrome 2, 614120 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	AGBK
?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	LARS2
?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	PRLTS4
?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	HLASA
?Hydroxykynureninuria, 236800 (3)	KYNU, KYNUU	605197	2q22.2	KYNU
?Hydroxykynureninuria, 236800 (3)	KYNU, KYNUU	605197	2q22.2	KYNUU
?Hyperimmunoglobulin G1 syndrome (2)	IGHR	144120	14q32.33	IGHR
?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	BCAT1, BCT1	113520	12p12.1	BCAT1
?Hyperleucinemia-isoleucinemia or hypervalinemia (1)	BCAT1, BCT1	113520	12p12.1	BCT1
?Hyperphosphatasia with mental retardation syndrome 5, 616025 (3)	PIGW, HPMRS5	610275	17q12	PIGW
?Hyperphosphatasia with mental retardation syndrome 5, 616025 (3)	PIGW, HPMRS5	610275	17q12	HPMRS5
?Hyperprolactinemia, 615555 (3)	PRLR, MFAB, HPRL	176761	5p13.2	PRLR
?Hyperprolactinemia, 615555 (3)	PRLR, MFAB, HPRL	176761	5p13.2	MFAB
?Hyperprolactinemia, 615555 (3)	PRLR, MFAB, HPRL	176761	5p13.2	HPRL
?Hypertension, salt-resistant (1)	NPR3, ANPRC	108962	5p13.3	NPR3
?Hypertension, salt-resistant (1)	NPR3, ANPRC	108962	5p13.3	ANPRC
?Hypertrichosis universalis congenita, Ambras type (2)	HTC1	145701	8q22	HTC1
?Hypervalinemia or hyperleucine-isoleucinemia (1)	BCAT2, BCT2	113530	19q13.33	BCAT2
?Hypervalinemia or hyperleucine-isoleucinemia (1)	BCAT2, BCT2	113530	19q13.33	BCT2
?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	GNRH1, LNRH, HH12	152760	8p21.2	GNRH1
?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	GNRH1, LNRH, HH12	152760	8p21.2	LNRH
?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3)	GNRH1, LNRH, HH12	152760	8p21.2	HH12
?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	KISS1, HH13	603286	1q32.1	KISS1
?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3)	KISS1, HH13	603286	1q32.1	HH13
?Hypotrichosis 13, 615896 (3)	KRT71, K6IRS1, KRT6IRS1, HYPT13	608245	12q13.13	KRT71
?Hypotrichosis 13, 615896 (3)	KRT71, K6IRS1, KRT6IRS1, HYPT13	608245	12q13.13	K6IRS1
?Hypotrichosis 13, 615896 (3)	KRT71, K6IRS1, KRT6IRS1, HYPT13	608245	12q13.13	KRT6IRS1
?Hypotrichosis 13, 615896 (3)	KRT71, K6IRS1, KRT6IRS1, HYPT13	608245	12q13.13	HYPT13
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	K6IRS4
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT6IRS4
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HTSS2
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HYPT3
?Hypotrichosis 3, 613981 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	ADWH
?Hypotrichosis and recurrent skin vesicles, 613102 (3)	DSC3, DSC4	600271	18q12.1	DSC3
?Hypotrichosis and recurrent skin vesicles, 613102 (3)	DSC3, DSC4	600271	18q12.1	DSC4
?Immunodeficiency 13, 615518 (3)	UNC119, HRG4, IMD13	604011	17q11.2	UNC119
?Immunodeficiency 13, 615518 (3)	UNC119, HRG4, IMD13	604011	17q11.2	HRG4
?Immunodeficiency 13, 615518 (3)	UNC119, HRG4, IMD13	604011	17q11.2	IMD13
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	TNFRSF4
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	TXGP1L
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	OX40
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	ACT35
?Immunodeficiency 16, 615593 (3)	TNFRSF4, TXGP1L, OX40, ACT35, IMD16	600315	1p36.33	IMD16
?Immunodeficiency 22, 615758 (3)	LCK, IMD22	153390	1p35.2	LCK
?Immunodeficiency 22, 615758 (3)	LCK, IMD22	153390	1p35.2	IMD22
?Immunodeficiency 25, 610163 (3)	CD247, CD3Z, TCRZ, IMD25	186780	1q24.2	CD247
?Immunodeficiency 25, 610163 (3)	CD247, CD3Z, TCRZ, IMD25	186780	1q24.2	CD3Z
?Immunodeficiency 25, 610163 (3)	CD247, CD3Z, TCRZ, IMD25	186780	1q24.2	TCRZ
?Immunodeficiency 25, 610163 (3)	CD247, CD3Z, TCRZ, IMD25	186780	1q24.2	IMD25
?Immunodeficiency 37, 616098 (3)	BCL10, IMD37	603517	1p22.3	BCL10
?Immunodeficiency 37, 616098 (3)	BCL10, IMD37	603517	1p22.3	IMD37
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7A
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7B
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7C
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IRF7H
?Immunodeficiency 39, 616345 (3)	IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39	605047	11p15.5	IMD39
?Immunodeficiency 45, 616669 (3)	IFNAR2, IMD45	602376	21q22.11	IFNAR2
?Immunodeficiency 45, 616669 (3)	IFNAR2, IMD45	602376	21q22.11	IMD45
?Immunodeficiency, common variable, 11, 615767 (3)	IL21, CVID11	605384	4q27	IL21
?Immunodeficiency, common variable, 11, 615767 (3)	IL21, CVID11	605384	4q27	CVID11
?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	HNRPA2B1, IBMPFD2	600124	7p15.2	HNRPA2B1
?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)	HNRPA2B1, IBMPFD2	600124	7p15.2	IBMPFD2
?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	HNRNPA1
?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	IBMPFD3
?Inclusion body myopathy with early-onset Paget disease without frontotemporal dementia 3, 615424 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	ALS20
?Infantile liver failure syndrome 1, 615438 (3)	LARS, LFIS, ILFS1	151350	5q32	LARS
?Infantile liver failure syndrome 1, 615438 (3)	LARS, LFIS, ILFS1	151350	5q32	LFIS
?Infantile liver failure syndrome 1, 615438 (3)	LARS, LFIS, ILFS1	151350	5q32	ILFS1
?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	ADAM17, TACE, NISBD1	603639	2p25.1	ADAM17
?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	ADAM17, TACE, NISBD1	603639	2p25.1	TACE
?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3)	ADAM17, TACE, NISBD1	603639	2p25.1	NISBD1
?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
?Inflammatory skin and bowel disease, neonatal, 2, 616069 (3)	EGFR, NISBD2	131550	7p11.2	NISBD2
?Isolated growth hormone deficiency due to defect in GHRF (1)	GHRH, GHRF	139190	20q11.23	GHRH
?Isolated growth hormone deficiency due to defect in GHRF (1)	GHRH, GHRF	139190	20q11.23	GHRF
?Joubert syndrome 22, 615665 (3)	PDE6D, JBTS22	602676	2q37.1	PDE6D
?Joubert syndrome 22, 615665 (3)	PDE6D, JBTS22	602676	2q37.1	JBTS22
?Joubert syndrome 26, 616784 (3)	KATNIP, KIAA0556	616650	16p12.1	KATNIP
?Joubert syndrome 26, 616784 (3)	KATNIP, KIAA0556	616650	16p12.1	KIAA0556
?Juvenile myelomonocytic leukemia, 607785 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL
?Juvenile myelomonocytic leukemia, 607785 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL2
?Juvenile myelomonocytic leukemia, 607785 (3)	CBL, CBL2, NSLL	165360	11q23.3	NSLL
?Keratoderma, palmoplantar, punctate type 3 (2)	PPKP3	101850	2p25-p12	PPKP3
?Lacrimal duct defect, 149700 (3)	IGSF3, LCDD	603491	1p13.1	IGSF3
?Lacrimal duct defect, 149700 (3)	IGSF3, LCDD	603491	1p13.1	LCDD
?Laryngeal adductor paralysis (2)	LAP	150270	6p21.3-p21.2	LAP
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTE
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	SPG39
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTEMND
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	BNHS
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	LNMS
?Laurence-Moon syndrome, 245800 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	OMCS
?Leigh syndrome, 256000 (3)	NDUFA10	603835	2q37.3	NDUFA10
?Lethal congenital contracture syndrome 6, 616248 (3)	ZBTB42, ZNF925, LCCS6	613915	14q32.33	ZBTB42
?Lethal congenital contracture syndrome 6, 616248 (3)	ZBTB42, ZNF925, LCCS6	613915	14q32.33	ZNF925
?Lethal congenital contracture syndrome 6, 616248 (3)	ZBTB42, ZNF925, LCCS6	613915	14q32.33	LCCS6
?Lethal congenital contracture syndrome 8, 616287 (3)	ADCY6, LCCS8	600294	12q13.12	ADCY6
?Lethal congenital contracture syndrome 8, 616287 (3)	ADCY6, LCCS8	600294	12q13.12	LCCS8
?Leukemia, acute myeloid, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBPA
?Leukemia, acute myeloid, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBP
?Lichtenstein-Knorr syndrome, 616291 (3)	SLC9A1, NHE1, APNH, LIKNS	107310	1p36.11	SLC9A1
?Lichtenstein-Knorr syndrome, 616291 (3)	SLC9A1, NHE1, APNH, LIKNS	107310	1p36.11	NHE1
?Lichtenstein-Knorr syndrome, 616291 (3)	SLC9A1, NHE1, APNH, LIKNS	107310	1p36.11	APNH
?Lichtenstein-Knorr syndrome, 616291 (3)	SLC9A1, NHE1, APNH, LIKNS	107310	1p36.11	LIKNS
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	BSCL3
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CGL3
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	PPH3
?Lipodystrophy, congenital generalized, type 3, 612526 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	LCCNS
?Lipodystrophy, familial partial, type 5, 615238 (3)	CIDEC, FSP27, CIDE3, FPLD5	612120	3p25.3	CIDEC
?Lipodystrophy, familial partial, type 5, 615238 (3)	CIDEC, FSP27, CIDE3, FPLD5	612120	3p25.3	FSP27
?Lipodystrophy, familial partial, type 5, 615238 (3)	CIDEC, FSP27, CIDE3, FPLD5	612120	3p25.3	CIDE3
?Lipodystrophy, familial partial, type 5, 615238 (3)	CIDEC, FSP27, CIDE3, FPLD5	612120	3p25.3	FPLD5
?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	CDK5, LIS7	123831	7q36.1	CDK5
?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3)	CDK5, LIS7	123831	7q36.1	LIS7
?Long QT syndrome-11, 611820 (3)	AKAP9, YOTIAO, AKAP450	604001	7q21.2	AKAP9
?Long QT syndrome-11, 611820 (3)	AKAP9, YOTIAO, AKAP450	604001	7q21.2	YOTIAO
?Long QT syndrome-11, 611820 (3)	AKAP9, YOTIAO, AKAP450	604001	7q21.2	AKAP450
?Lysosomal acid phosphatase deficiency, 200950 (1)	ACP2	171650	11p11.2	ACP2
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAX2
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAXL1
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	QRX
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	CORD11
?Macular degeneration, age-related, 6, 613757 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	ARMD6
?Male infertility (1)	UBE2B, RAD6B	179095	5q31.1	UBE2B
?Male infertility (1)	UBE2B, RAD6B	179095	5q31.1	RAD6B
?Male infertility due to acrosin deficiency (2)	ACR	102480	22q13.33	ACR
?Maple syrup urine disease, mild variant, 615135 (3)	PPM1K, PP2CM, PTMP, MSUDMV	611065	4q22.1	PPM1K
?Maple syrup urine disease, mild variant, 615135 (3)	PPM1K, PP2CM, PTMP, MSUDMV	611065	4q22.1	PP2CM
?Maple syrup urine disease, mild variant, 615135 (3)	PPM1K, PP2CM, PTMP, MSUDMV	611065	4q22.1	PTMP
?Maple syrup urine disease, mild variant, 615135 (3)	PPM1K, PP2CM, PTMP, MSUDMV	611065	4q22.1	MSUDMV
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	PIEZO2
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	FAM38B
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA5
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA3
?Marden-Walker syndrome, 248700 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	MWKS
?Meckel syndrome 12, 616258 (3)	KIF14, KIAA0042, MKS12	611279	1q32.1	KIF14
?Meckel syndrome 12, 616258 (3)	KIF14, KIAA0042, MKS12	611279	1q32.1	KIAA0042
?Meckel syndrome 12, 616258 (3)	KIF14, KIAA0042, MKS12	611279	1q32.1	MKS12
?Meckel syndrome 8, 613885 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TCTN2
?Meckel syndrome 8, 613885 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TECT2
?Meckel syndrome 8, 613885 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	MKS8
?Meckel syndrome 8, 613885 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	JBTS24
?Meckel syndrome 9, 614209 (3)	B9D1, MKSR1, MKS9	614144	17p11.2	B9D1
?Meckel syndrome 9, 614209 (3)	B9D1, MKSR1, MKS9	614144	17p11.2	MKSR1
?Meckel syndrome 9, 614209 (3)	B9D1, MKSR1, MKS9	614144	17p11.2	MKS9
?Meier-Gorlin syndrome 5, 613805 (3)	CDC6, CDC18L, MGORS5	602627	17q21.2	CDC6
?Meier-Gorlin syndrome 5, 613805 (3)	CDC6, CDC18L, MGORS5	602627	17q21.2	CDC18L
?Meier-Gorlin syndrome 5, 613805 (3)	CDC6, CDC18L, MGORS5	602627	17q21.2	MGORS5
?Melkersson-Rosenthal syndrome (2)	MROS	155900	9p11	MROS
?Mental retardation, X-linked 100, 300923 (3)	KIF4A, KIF4, MRX100	300521	Xq13.1	KIF4A
?Mental retardation, X-linked 100, 300923 (3)	KIF4A, KIF4, MRX100	300521	Xq13.1	KIF4
?Mental retardation, X-linked 100, 300923 (3)	KIF4A, KIF4, MRX100	300521	Xq13.1	MRX100
?Mental retardation, X-linked 101, 300928 (3)	MID2, MRX101	300204	Xq22.3	MID2
?Mental retardation, X-linked 101, 300928 (3)	MID2, MRX101	300204	Xq22.3	MRX101
?Mental retardation, X-linked 91, 300577 (3)	ZDHHC15, MRX91	300576	Xq13.3	ZDHHC15
?Mental retardation, X-linked 91, 300577 (3)	ZDHHC15, MRX91	300576	Xq13.3	MRX91
?Mental retardation, X-linked syndromic 10, 300220 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	HSD17B10
?Mental retardation, X-linked syndromic 10, 300220 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	HADH2
?Mental retardation, X-linked syndromic 10, 300220 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	ERAB
?Mental retardation, X-linked syndromic 10, 300220 (3)	HSD17B10, HADH2, ERAB, MRXS10	300256	Xp11.22	MRXS10
?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	RBMX, MRXS11	300199	Xq26.3	RBMX
?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3)	RBMX, MRXS11	300199	Xq26.3	MRXS11
?Mental retardation, X-linked, syndromic 12 (2)	MRXS12	309545	Xp11	MRXS12
?Mental retardation, X-linked, syndromic 32, 300886 (3)	CLIC2, XAP121, MRXS32	300138	Xq28	CLIC2
?Mental retardation, X-linked, syndromic 32, 300886 (3)	CLIC2, XAP121, MRXS32	300138	Xq28	XAP121
?Mental retardation, X-linked, syndromic 32, 300886 (3)	CLIC2, XAP121, MRXS32	300138	Xq28	MRXS32
?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6AP2
?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6M8-9
?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	XMRE
?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	MRXSH
?Mental retardation, X-linked, syndromic, Hedera type, 300423 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	XPDS
?Mental retardation, autosomal dominant 11, 614257 (3)	EPB41L1, MRD11	602879	20q11.23	EPB41L1
?Mental retardation, autosomal dominant 11, 614257 (3)	EPB41L1, MRD11	602879	20q11.23	MRD11
?Mental retardation, autosomal dominant 22, 612337 (3)	ZBTB18, ZNF238, RP58, MRD22	608433	1q44	ZBTB18
?Mental retardation, autosomal dominant 22, 612337 (3)	ZBTB18, ZNF238, RP58, MRD22	608433	1q44	ZNF238
?Mental retardation, autosomal dominant 22, 612337 (3)	ZBTB18, ZNF238, RP58, MRD22	608433	1q44	RP58
?Mental retardation, autosomal dominant 22, 612337 (3)	ZBTB18, ZNF238, RP58, MRD22	608433	1q44	MRD22
?Mental retardation, autosomal recessive 43, 615817 (3)	KIAA1033, SWIP, MRT43	615748	12q23.3	KIAA1033
?Mental retardation, autosomal recessive 43, 615817 (3)	KIAA1033, SWIP, MRT43	615748	12q23.3	SWIP
?Mental retardation, autosomal recessive 43, 615817 (3)	KIAA1033, SWIP, MRT43	615748	12q23.3	MRT43
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	FBXO31
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	FBX31
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	FBXO14
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	FBX14
?Mental retardation, autosomal recessive 45, 615979 (3)	FBXO31, FBX31, FBXO14, FBX14, MRT45	609102	16q24.2	MRT45
?Mental retardation, autosomal recessive 49, 616281 (3)	GPT2, ALT2, MRT49	138210	16q11.2	GPT2
?Mental retardation, autosomal recessive 49, 616281 (3)	GPT2, ALT2, MRT49	138210	16q11.2	ALT2
?Mental retardation, autosomal recessive 49, 616281 (3)	GPT2, ALT2, MRT49	138210	16q11.2	MRT49
?Mental retardation, autosomal recessive 50, 616460 (3)	EDC3, YJDC, MRT50	609842	15q24.1	EDC3
?Mental retardation, autosomal recessive 50, 616460 (3)	EDC3, YJDC, MRT50	609842	15q24.1	YJDC
?Mental retardation, autosomal recessive 50, 616460 (3)	EDC3, YJDC, MRT50	609842	15q24.1	MRT50
?Mental retardation, autosomal recessive 55, 617051 (3)	PUS3, MRT55	616283	11q24.2	PUS3
?Mental retardation, autosomal recessive 55, 617051 (3)	PUS3, MRT55	616283	11q24.2	MRT55
?Mental retardation, autosomal recessive, 37, 615493 (3)	ANK3, MRT37	600465	10q21.2	ANK3
?Mental retardation, autosomal recessive, 37, 615493 (3)	ANK3, MRT37	600465	10q21.2	MRT37
?Mental retardation, autosomal recessive, 52, 616887 (3)	LMAN2L, VIPL, MRT52	609552	2q11.2	LMAN2L
?Mental retardation, autosomal recessive, 52, 616887 (3)	LMAN2L, VIPL, MRT52	609552	2q11.2	VIPL
?Mental retardation, autosomal recessive, 52, 616887 (3)	LMAN2L, VIPL, MRT52	609552	2q11.2	MRT52
?Microcephaly 10, primary, autosomal recessive, 615095 (3)	ZNF335, NIF1, NIF2, MCPH10	610827	20q13.12	ZNF335
?Microcephaly 10, primary, autosomal recessive, 615095 (3)	ZNF335, NIF1, NIF2, MCPH10	610827	20q13.12	NIF1
?Microcephaly 10, primary, autosomal recessive, 615095 (3)	ZNF335, NIF1, NIF2, MCPH10	610827	20q13.12	NIF2
?Microcephaly 10, primary, autosomal recessive, 615095 (3)	ZNF335, NIF1, NIF2, MCPH10	610827	20q13.12	MCPH10
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	PHC1
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	EDR1
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	HPH1
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	RAE28
?Microcephaly 11, primary, autosomal recessive, 615414 (3)	PHC1, EDR1, HPH1, RAE28, MCPH11	602978	12p13.31	MCPH11
?Microcephaly 12, primary, autosomal recessive, 616080 (3)	CDK6, PLSTIRE, MCPH12	603368	7q21.2	CDK6
?Microcephaly 12, primary, autosomal recessive, 616080 (3)	CDK6, PLSTIRE, MCPH12	603368	7q21.2	PLSTIRE
?Microcephaly 12, primary, autosomal recessive, 616080 (3)	CDK6, PLSTIRE, MCPH12	603368	7q21.2	MCPH12
?Microcephaly 13, primary, autosomal recessive, 616051 (3)	CENPE, MCPH13	117143	4q24	CENPE
?Microcephaly 13, primary, autosomal recessive, 616051 (3)	CENPE, MCPH13	117143	4q24	MCPH13
?Microcephaly 14, primary, autosomal recessive, 616402 (3)	SASS6, SAS6, MCPH14	609321	1p21.2	SASS6
?Microcephaly 14, primary, autosomal recessive, 616402 (3)	SASS6, SAS6, MCPH14	609321	1p21.2	SAS6
?Microcephaly 14, primary, autosomal recessive, 616402 (3)	SASS6, SAS6, MCPH14	609321	1p21.2	MCPH14
?Microcephaly 16, primary, autosomal recessive, 616681 (3)	ANKLE2, LEM4, KIAA0692, MCPH16	616062	12q24.33	ANKLE2
?Microcephaly 16, primary, autosomal recessive, 616681 (3)	ANKLE2, LEM4, KIAA0692, MCPH16	616062	12q24.33	LEM4
?Microcephaly 16, primary, autosomal recessive, 616681 (3)	ANKLE2, LEM4, KIAA0692, MCPH16	616062	12q24.33	KIAA0692
?Microcephaly 16, primary, autosomal recessive, 616681 (3)	ANKLE2, LEM4, KIAA0692, MCPH16	616062	12q24.33	MCPH16
?Microcephaly 8, primary, autosomal recessive, 614673 (3)	CEP135, KIAA0635, MCPH8	611423	4q12	CEP135
?Microcephaly 8, primary, autosomal recessive, 614673 (3)	CEP135, KIAA0635, MCPH8	611423	4q12	KIAA0635
?Microcephaly 8, primary, autosomal recessive, 614673 (3)	CEP135, KIAA0635, MCPH8	611423	4q12	MCPH8
?Microhydranencephaly, 605013 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NDE1
?Microhydranencephaly, 605013 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NUDE
?Microhydranencephaly, 605013 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	LIS4
?Microhydranencephaly, 605013 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	MHAC
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NAA10
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	ARD1A
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	ARD1
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	TE2
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NATD
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	OGDNS
?Microphthalmia, syndromic 1, 309800 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	MCOPS1
?Microphthalmia, syndromic 11, 614402 (3)	VAX1, MCOPS11	604294	10q25.3	VAX1
?Microphthalmia, syndromic 11, 614402 (3)	VAX1, MCOPS11	604294	10q25.3	MCOPS11
?Microphthalmia, syndromic 13, 300915 (3)	HMGB3, HMG4, HMG2A, MCOPS13	300193	Xq28	HMGB3
?Microphthalmia, syndromic 13, 300915 (3)	HMGB3, HMG4, HMG2A, MCOPS13	300193	Xq28	HMG4
?Microphthalmia, syndromic 13, 300915 (3)	HMGB3, HMG4, HMG2A, MCOPS13	300193	Xq28	HMG2A
?Microphthalmia, syndromic 13, 300915 (3)	HMGB3, HMG4, HMG2A, MCOPS13	300193	Xq28	MCOPS13
?Microphthalmia, syndromic 4 (2)	MCOPS4, ANOP1	301590	Xq27-q28	MCOPS4
?Microphthalmia, syndromic 4 (2)	MCOPS4, ANOP1	301590	Xq27-q28	ANOP1
?Microtia with or without hearing impairment (AD), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	HOXA2
?Microtia with or without hearing impairment (AD), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	MCOHI
?Microtia, hearing impairment, and cleft palate (AR), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	HOXA2
?Microtia, hearing impairment, and cleft palate (AR), 612290 (3)	HOXA2, MCOHI	604685	7p15.2	MCOHI
?Mirror movements 3, 616059 (3)	DNAL4, MRMV3	610565	22q13.1	DNAL4
?Mirror movements 3, 616059 (3)	DNAL4, MRMV3	610565	22q13.1	MRMV3
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NTG
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NPG
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	BERHS
?Mitochondrial DNA depletion syndrome 14 (encephalocardiomyopathic type), 616896 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	MTDPS14
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A1
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATPM
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ATP5A
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	ORM
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	MC5DN4
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4, 615228 (3)	ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22	164360	18q21.1	COXPD22
?Mitochondrial complex I deficiency, 252010 (3)	NDUFB9, UQOR22	601445	8q24.13	NDUFB9
?Mitochondrial complex I deficiency, 252010 (3)	NDUFB9, UQOR22	601445	8q24.13	UQOR22
?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	UQCC2, C6orf126, M19	614461	6p21.31	UQCC2
?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	UQCC2, C6orf126, M19	614461	6p21.31	C6orf126
?Mitochondrial complex III deficiency, nuclear type 7, 615824 (3)	UQCC2, C6orf126, M19	614461	6p21.31	M19
?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	UQCC3, C11orf83, MC3DN9	616097	11q12.3	UQCC3
?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	UQCC3, C11orf83, MC3DN9	616097	11q12.3	C11orf83
?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3)	UQCC3, C11orf83, MC3DN9	616097	11q12.3	MC3DN9
?Mitochondrial complex IV deficiency, 220110 (3)	COX14, C12orf62	614478	12q13.12	COX14
?Mitochondrial complex IV deficiency, 220110 (3)	COX14, C12orf62	614478	12q13.12	C12orf62
?Mitochondrial complex IV deficiency, 220110 (3)	COX8A	123870	11q13.1	COX8A
?Mitochondrial complex IV deficiency, 220110 (3)	FASTKD2, KIAA0971	612322	2q33.3	FASTKD2
?Mitochondrial complex IV deficiency, 220110 (3)	FASTKD2, KIAA0971	612322	2q33.3	KIAA0971
?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	ATP5E, MC5DN3	606153	20q13.32	ATP5E
?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3)	ATP5E, MC5DN3	606153	20q13.32	MC5DN3
?Mitochondrial myopathy with lactic acidosis, 251950 (3)	PNPLA8, MMLA	612123	7q31.1	PNPLA8
?Mitochondrial myopathy with lactic acidosis, 251950 (3)	PNPLA8, MMLA	612123	7q31.1	MMLA
?Moebius syndrome (2)	MBS, MBS1	157900	13q12.2-q13	MBS
?Moebius syndrome (2)	MBS, MBS1	157900	13q12.2-q13	MBS1
?Monilethrix, 158000 (3)	KRT83, KRTHB3, HB3	602765	12q13.13	KRT83
?Monilethrix, 158000 (3)	KRT83, KRTHB3, HB3	602765	12q13.13	KRTHB3
?Monilethrix, 158000 (3)	KRT83, KRTHB3, HB3	602765	12q13.13	HB3
?Morning glory disc anomaly, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
?Morning glory disc anomaly, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
?Morning glory disc anomaly, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
?Morning glory disc anomaly, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
?Mucopolysaccharidosis type IX, 601492 (3)	HYAL1, MPS9	607071	3p21.31	HYAL1
?Mucopolysaccharidosis type IX, 601492 (3)	HYAL1, MPS9	607071	3p21.31	MPS9
?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	IBA57
?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	C1orf69
?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	MMDS3
?Multiple mitochondrial dysfunctions syndrome 3, 615330 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	SPG74
?Multiple synostoses syndrome 3, 612961 (3)	FGF9, SYNS3	600921	13q12.11	FGF9
?Multiple synostoses syndrome 3, 612961 (3)	FGF9, SYNS3	600921	13q12.11	SYNS3
?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	TRIP4
?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	ASC1
?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	SMABF1
?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	MDCDC
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	CMD1I
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	MFM1
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	SCPNK
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVD7
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVC7
?Muscular dystrophy, limb-girdle, type 2R, 615325 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	LGMD2R
?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	BVES, HBVES, POPDC1, LGMD2X	604577	6q21	BVES
?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	BVES, HBVES, POPDC1, LGMD2X	604577	6q21	HBVES
?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	BVES, HBVES, POPDC1, LGMD2X	604577	6q21	POPDC1
?Muscular dystrophy, limb-girdle, type 2X, 616812 (3)	BVES, HBVES, POPDC1, LGMD2X	604577	6q21	LGMD2X
?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	POMK
?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	SGK196
?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	MDDGA12
?Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 12, 616094 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	MDDGC12
?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3)	ALG14, CMS15	612866	1p21.3	ALG14
?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3)	ALG14, CMS15	612866	1p21.3	CMS15
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	MEGF7
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CLSS
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	SOST2
?Myasthenic syndrome, congenital, 17, 616304 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CMS17
?Myasthenic syndrome, congenital, 18, 616330 (3)	SNAP25, CMS18	600322	20p12.2	SNAP25
?Myasthenic syndrome, congenital, 18, 616330 (3)	SNAP25, CMS18	600322	20p12.2	CMS18
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CHRNB1
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	ACHRB
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	SCCMS
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CMS2A
?Myasthenic syndrome, congenital, 2C, associated with acetylcholine receptor deficiency, 616314 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CMS2C
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	ACHRD
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	SCCMS
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3A
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3B
?Myasthenic syndrome, congenital, 3A, slow-channel, 616321 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3C
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	ACHRD
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	SCCMS
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3A
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3B
?Myasthenic syndrome, congenital, 3C, associated with acetylcholine receptor deficiency, 616323 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3C
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CADASIL1
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CASIL
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	IMF2
?Myofibromatosis, infantile 2, 615293 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	LMNS
?Myopathy, congenital, Compton-North, 612540 (3)	CNTN1, MYPCN	600016	12q12	CNTN1
?Myopathy, congenital, Compton-North, 612540 (3)	CNTN1, MYPCN	600016	12q12	MYPCN
?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	FTDALS2
?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	SMAJ
?Myopathy, isolated mitochondrial, autosomal dominant, 616209 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	IMMD
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ASMA
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	NEM3
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	CFTD1
?Myopathy, scapulohumeroperoneal, 616852 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	SHPM
?Myosclerosis, congenital, 255600 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
?Myosclerosis, congenital, 255600 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	BTHLM1
?Myosclerosis, congenital, 255600 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	UCMD1
?N-acetylaspartate deficiency, 614063 (3)	NAT8L, CML3, NACED	610647	4p16.3	NAT8L
?N-acetylaspartate deficiency, 614063 (3)	NAT8L, CML3, NACED	610647	4p16.3	CML3
?N-acetylaspartate deficiency, 614063 (3)	NAT8L, CML3, NACED	610647	4p16.3	NACED
?Narcolepsy 1, 161400 (3)	HCRT, OX, NRCLP1	602358	17q21.2	HCRT
?Narcolepsy 1, 161400 (3)	HCRT, OX, NRCLP1	602358	17q21.2	OX
?Narcolepsy 1, 161400 (3)	HCRT, OX, NRCLP1	602358	17q21.2	NRCLP1
?Narcolepsy 7, 614250 (3)	MOG, NRCLP7	159465	6p22.1	MOG
?Narcolepsy 7, 614250 (3)	MOG, NRCLP7	159465	6p22.1	NRCLP7
?Nephrolithiasis, calcium oxalate, 167030 (3)	SLC25A1, SAT1, CAON	610130	4p16.3	SLC25A1
?Nephrolithiasis, calcium oxalate, 167030 (3)	SLC25A1, SAT1, CAON	610130	4p16.3	SAT1
?Nephrolithiasis, calcium oxalate, 167030 (3)	SLC25A1, SAT1, CAON	610130	4p16.3	CAON
?Nephronophthisis 9, 613824 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NEK8
?Nephronophthisis 9, 613824 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	JCK
?Nephronophthisis 9, 613824 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NPHP9
?Nephronophthisis 9, 613824 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	RHPD2
?Nephrotic syndrome, type 13, 616893 (3)	NUP205, C7orf14, KIAA0225, NPHS13	614352	7q33	NUP205
?Nephrotic syndrome, type 13, 616893 (3)	NUP205, C7orf14, KIAA0225, NPHS13	614352	7q33	C7orf14
?Nephrotic syndrome, type 13, 616893 (3)	NUP205, C7orf14, KIAA0225, NPHS13	614352	7q33	KIAA0225
?Nephrotic syndrome, type 13, 616893 (3)	NUP205, C7orf14, KIAA0225, NPHS13	614352	7q33	NPHS13
?Neuroblastoma (1)	TP73	601990	1p36.32	TP73
?Neurodegeneration with optic atrophy, childhood onset, 615491 (3)	UCHL1, PARK5, NDGOA	191342	4p13	UCHL1
?Neurodegeneration with optic atrophy, childhood onset, 615491 (3)	UCHL1, PARK5, NDGOA	191342	4p13	PARK5
?Neurodegeneration with optic atrophy, childhood onset, 615491 (3)	UCHL1, PARK5, NDGOA	191342	4p13	NDGOA
?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	HSPB3, HSPL27, HMN2C, DHMN2C	604624	5q11.2	HSPB3
?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	HSPB3, HSPL27, HMN2C, DHMN2C	604624	5q11.2	HSPL27
?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	HSPB3, HSPL27, HMN2C, DHMN2C	604624	5q11.2	HMN2C
?Neuronopathy, distal hereditary motor, type IIC, 613376 (3)	HSPB3, HSPL27, HMN2C, DHMN2C	604624	5q11.2	DHMN2C
?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	REEP1
?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	C2ORF23
?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	SPG31
?Neuronopathy, distal hereditary motor, type VB, 614751 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	HMN5B
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DST
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	BPAG1
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DMH
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	D6S1101
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	HSAN6
?Neuropathy, hereditary sensory and autonomic, type VI, 614653 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	EBSB2
?Neutrophil chemotactic response, abnormal (2)	NM, NCR	162820	7q22-qter	NM
?Neutrophil chemotactic response, abnormal (2)	NM, NCR	162820	7q22-qter	NCR
?Night blindness, congenital stationary, type 1G, 616389 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	GNAT1
?Night blindness, congenital stationary, type 1G, 616389 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	CSNBAD3
?Night blindness, congenital stationary, type 1G, 616389 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	CSNB1G
?Obesity, hyperphagia, and developmental delay, 613886 (3)	NTRK2, TRKB	600456	9q21.33	NTRK2
?Obesity, hyperphagia, and developmental delay, 613886 (3)	NTRK2, TRKB	600456	9q21.33	TRKB
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	S2P
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	IFAP
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	KFSDX
?Olmsted syndrome, X-linked, 300918 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	OLMSX
?Optic atrophy 9, 616289 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ACO2
?Optic atrophy 9, 616289 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ICRD
?Optic atrophy 9, 616289 (3)	ACO2, ICRD, OPA9	100850	22q13.2	OPA9
?Orofacial cleft 15, 616788 (3)	DLX4, DLX7, DLX8, OFC15	601911	17q21.33	DLX4
?Orofacial cleft 15, 616788 (3)	DLX4, DLX7, DLX8, OFC15	601911	17q21.33	DLX7
?Orofacial cleft 15, 616788 (3)	DLX4, DLX7, DLX8, OFC15	601911	17q21.33	DLX8
?Orofacial cleft 15, 616788 (3)	DLX4, DLX7, DLX8, OFC15	601911	17q21.33	OFC15
?Orofaciodigital syndrome XIV, 615948 (3)	C2CD3, OFD14	615944	11q13.4	C2CD3
?Orofaciodigital syndrome XIV, 615948 (3)	C2CD3, OFD14	615944	11q13.4	OFD14
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH1
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH2
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	PPROM
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	CBP2
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	CBP1
?Osteogenesis imperfecta, type X, 613848 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	OI10
?Osteogenesis imperfecta, type XII, 613849 (3)	SP7, OSX, OI12	606633	12q13.13	SP7
?Osteogenesis imperfecta, type XII, 613849 (3)	SP7, OSX, OI12	606633	12q13.13	OSX
?Osteogenesis imperfecta, type XII, 613849 (3)	SP7, OSX, OI12	606633	12q13.13	OI12
?Osteoporosis, involutional, 166710 (1)	VDR	601769	12q13.11	VDR
?Otofaciocervical syndrome 2, 615560 (3)	PAX1, OFC2	167411	20p11.22	PAX1
?Otofaciocervical syndrome 2, 615560 (3)	PAX1, OFC2	167411	20p11.22	OFC2
?Otofaciocervical syndrome, 166780 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
?Otofaciocervical syndrome, 166780 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOR
?Otofaciocervical syndrome, 166780 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOS1
?Otofaciocervical syndrome, 166780 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	OFC1
?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	TRPV3
?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	OLMS
?Palmoplantar keratoderma, nonepidermolytic, focal 2, 616400 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	FNEPPK2
?Pancreatic endocrine tumors (1)	ST11, PETS1	602011	3p25	ST11
?Pancreatic endocrine tumors (1)	ST11, PETS1	602011	3p25	PETS1
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6AP2
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	ATP6M8-9
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	XMRE
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	MRXSH
?Parkinsonism with spasticity, X-linked, 300911 (3)	ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS	300556	Xp11.4	XPDS
?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PIGT
?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	NDAP
?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PNH2
?Paroxysmal nocturnal hemoglobinuria 2, 615399 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	MCAHS3
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	BSCL3
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CGL3
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	PPH3
?Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome, 606721 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	LCCNS
?Peeling skin syndrome 3, 616265 (3)	CHST8, GALNAC4ST1, PSS3	610190	19q13.11	CHST8
?Peeling skin syndrome 3, 616265 (3)	CHST8, GALNAC4ST1, PSS3	610190	19q13.11	GALNAC4ST1
?Peeling skin syndrome 3, 616265 (3)	CHST8, GALNAC4ST1, PSS3	610190	19q13.11	PSS3
?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	MYH14
?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	KIAA2034
?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	DFNA4A
?Peripheral neuropathy, myopathy, hoarseness, and hearing loss, 614369 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	PNMHH
?Periventricular nodular heterotopia 6, 615544 (3)	ERMARD, C6orf70, PVNH6	615532	6q27	ERMARD
?Periventricular nodular heterotopia 6, 615544 (3)	ERMARD, C6orf70, PVNH6	615532	6q27	C6orf70
?Periventricular nodular heterotopia 6, 615544 (3)	ERMARD, C6orf70, PVNH6	615532	6q27	PVNH6
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	HARS2
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	HARSL
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	HARSR
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	HO3
?Perrault syndrome 2, 614926 (3)	HARS2, HARSL, HARSR, HO3, PRLTS2	600783	5q31.3	PRLTS2
?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680 (1)	PCK1	614168	20q13.31	PCK1
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT1
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	EPIP
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSATD
?Phosphoserine aminotransferase deficiency, 610992 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	NLS2
?Polydactyly, postaxial, type A6, 615226 (3)	ZNF141, D4S90, PAPA6	194648	4p16.3	ZNF141
?Polydactyly, postaxial, type A6, 615226 (3)	ZNF141, D4S90, PAPA6	194648	4p16.3	D4S90
?Polydactyly, postaxial, type A6, 615226 (3)	ZNF141, D4S90, PAPA6	194648	4p16.3	PAPA6
?Polyendocrine-polyneuropathy syndrome, 616113 (3)	DMXL2, RC3, KIAA0856, PEPNS	612186	15q21.2	DMXL2
?Polyendocrine-polyneuropathy syndrome, 616113 (3)	DMXL2, RC3, KIAA0856, PEPNS	612186	15q21.2	RC3
?Polyendocrine-polyneuropathy syndrome, 616113 (3)	DMXL2, RC3, KIAA0856, PEPNS	612186	15q21.2	KIAA0856
?Polyendocrine-polyneuropathy syndrome, 616113 (3)	DMXL2, RC3, KIAA0856, PEPNS	612186	15q21.2	PEPNS
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	KIAA0274
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	SAC3
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	ALS11
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	YVS
?Polymicrogyria, bilateral temporooccipital, 612691 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	BTOP
?Pontocerebellar hypoplasia type 2C, 612390 (3)	TSEN34, PCH2C, LENG5, SEN34	608754	19q13.42	TSEN34
?Pontocerebellar hypoplasia type 2C, 612390 (3)	TSEN34, PCH2C, LENG5, SEN34	608754	19q13.42	PCH2C
?Pontocerebellar hypoplasia type 2C, 612390 (3)	TSEN34, PCH2C, LENG5, SEN34	608754	19q13.42	LENG5
?Pontocerebellar hypoplasia type 2C, 612390 (3)	TSEN34, PCH2C, LENG5, SEN34	608754	19q13.42	SEN34
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	SEN54
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH2A
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH4
?Pontocerebellar hypoplasia type 5, 610204 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH5
?Pontocerebellar hypoplasia, type 3, 608027 (3)	PCLO, PCH3	604918	7q21.11	PCLO
?Pontocerebellar hypoplasia, type 3, 608027 (3)	PCLO, PCH3	604918	7q21.11	PCH3
?Preauricular fistulae, congenital (2)	PAFC	128700	8q11.1-q13.3	PAFC
?Precocious puberty, central, 1, 176400 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	KISS1R
?Precocious puberty, central, 1, 176400 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	GPR54
?Precocious puberty, central, 1, 176400 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	HH8
?Precocious puberty, central, 1, 176400 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	CPPB1
?Premature ovarian failure 10, 612885 (3)	MCM8, POF10	608187	20p12.3	MCM8
?Premature ovarian failure 10, 612885 (3)	MCM8, POF10	608187	20p12.3	POF10
?Premature ovarian failure 12, 616947 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SYCE1
?Premature ovarian failure 12, 616947 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	POF12
?Premature ovarian failure 12, 616947 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SPGF15
?Progesterone resistance, 264080 (2)	PGR	607311	11q22.1	PGR
?Prune belly syndrome, 100100 (3)	CHRM3, PBS, EGBRS	118494	1q43	CHRM3
?Prune belly syndrome, 100100 (3)	CHRM3, PBS, EGBRS	118494	1q43	PBS
?Prune belly syndrome, 100100 (3)	CHRM3, PBS, EGBRS	118494	1q43	EGBRS
?Ptosis, congenital, 178300 (2)	ZFHX4, ZFH4	606940	8q21.13	ZFHX4
?Ptosis, congenital, 178300 (2)	ZFHX4, ZFH4	606940	8q21.13	ZFH4
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
?Ragweed sensitivity (2)	RWS	179450	6p21.3	RWS
?Renal hypodysplasia/aplasia 2, 615721 (3)	FGF20, RHDA2	605558	8p22	FGF20
?Renal hypodysplasia/aplasia 2, 615721 (3)	FGF20, RHDA2	605558	8p22	RHDA2
?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NEK8
?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	JCK
?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	NPHP9
?Renal-hepatic-pancreatic dysplasia 2, 615415 (3)	NEK8, JCK, NPHP9, RHPD2	609799	17q11.2	RHPD2
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	POREN1
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	HANAC
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	ICH
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	BSVD
?Retinal arteries, tortuosity of, 180000 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	RATOR
?Retinal cone dystrophy-1 (2)	RCD1	180020	6q25-q26	RCD1
?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	MIR204, MIRN204, RDICC	610942	9q21.12	MIR204
?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	MIR204, MIRN204, RDICC	610942	9q21.12	MIRN204
?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3)	MIR204, MIRN204, RDICC	610942	9q21.12	RDICC
?Retinal dystrophy and obesity, 616188 (3)	TUB, RDOB	601197	11p15.4	TUB
?Retinal dystrophy and obesity, 616188 (3)	TUB, RDOB	601197	11p15.4	RDOB
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	BRI
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ABRI
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	FBD
?Retinal dystrophy with inner retinal dysfunction and ganglion cell abnormalities, 616079 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	RDGCA
?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	RDH11, PSDR1, RALR1, RDJCSS	607849	14q24.1	RDH11
?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	RDH11, PSDR1, RALR1, RDJCSS	607849	14q24.1	PSDR1
?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	RDH11, PSDR1, RALR1, RDJCSS	607849	14q24.1	RALR1
?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3)	RDH11, PSDR1, RALR1, RDJCSS	607849	14q24.1	RDJCSS
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	CXorf5
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	SGBS2
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	JBTS10
?Retinitis pigmentosa 23, 300424 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	RP23
?Retinitis pigmentosa 51, 613464 (3)	TTC8, BBS8, RP51	608132	14q31.3	TTC8
?Retinitis pigmentosa 51, 613464 (3)	TTC8, BBS8, RP51	608132	14q31.3	BBS8
?Retinitis pigmentosa 51, 613464 (3)	TTC8, BBS8, RP51	608132	14q31.3	RP51
?Retinitis pigmentosa 55, 613575 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
?Retinitis pigmentosa 55, 613575 (3)	ARL6, BBS3, RP55	608845	3q11.2	BBS3
?Retinitis pigmentosa 55, 613575 (3)	ARL6, BBS3, RP55	608845	3q11.2	RP55
?Retinitis pigmentosa 66, 615233 (3)	RBP3, RP66	180290	10q11.22	RBP3
?Retinitis pigmentosa 66, 615233 (3)	RBP3, RP66	180290	10q11.22	RP66
?Retinitis pigmentosa 67, 615565 (3)	NEK2, RP67	604043	1q32.3	NEK2
?Retinitis pigmentosa 67, 615565 (3)	NEK2, RP67	604043	1q32.3	RP67
?Retinitis pigmentosa 9, 180104 (3)	RP9, PAP1	607331	7p14.3	RP9
?Retinitis pigmentosa 9, 180104 (3)	RP9, PAP1	607331	7p14.3	PAP1
?Retinitis pigmentosa, X-linked recessive, 6 (2)	RP6	312612	Xp21.3-p21.2	RP6
?Reynolds syndrome, 613471 (3)	LBR, PHA	600024	1q42.12	LBR
?Reynolds syndrome, 613471 (3)	LBR, PHA	600024	1q42.12	PHA
?Ribose 5-phosphate isomerase deficiency, 608611 (3)	RPIA, RPI, RPIAD	180430	2p11.2	RPIA
?Ribose 5-phosphate isomerase deficiency, 608611 (3)	RPIA, RPI, RPIAD	180430	2p11.2	RPI
?Ribose 5-phosphate isomerase deficiency, 608611 (3)	RPIA, RPI, RPIAD	180430	2p11.2	RPIAD
?Roifman-Chitayat syndrome (2)	RCHTS	613328	15q11-q21.1	RCHTS
?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	SRPX2, SRPUL, RESDX	300642	Xq22.1	SRPX2
?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	SRPX2, SRPUL, RESDX	300642	Xq22.1	SRPUL
?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)	SRPX2, SRPUL, RESDX	300642	Xq22.1	RESDX
?Sarcoma, synovial, 300813 (3)	SSX1, SSRC	312820	Xp11.23	SSX1
?Sarcoma, synovial, 300813 (3)	SSX1, SSRC	312820	Xp11.23	SSRC
?Sarcoma, synovial, 300813 (3)	SSX2	300192	Xp11.22	SSX2
?Seckel syndrome 4, 613676 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CENPJ
?Seckel syndrome 4, 613676 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CPAP
?Seckel syndrome 4, 613676 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	MCPH6
?Seckel syndrome 4, 613676 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	SCKL4
?Seckel syndrome 6, 614728 (3)	CEP63, SCKL6	614724	3q22.2	CEP63
?Seckel syndrome 6, 614728 (3)	CEP63, SCKL6	614724	3q22.2	SCKL6
?Seckel syndrome 7, 614851 (3)	NIN, KIAA1565, SCKL7	608684	14q22.1	NIN
?Seckel syndrome 7, 614851 (3)	NIN, KIAA1565, SCKL7	608684	14q22.1	KIAA1565
?Seckel syndrome 7, 614851 (3)	NIN, KIAA1565, SCKL7	608684	14q22.1	SCKL7
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2L
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	KIAA0083
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	PEOA6
?Seckel syndrome 8, 615807 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	SCKL8
?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	EXT2, SSMS	608210	11p11.2	EXT2
?Seizures, scoliosis, and macrocephaly syndrome, 616682 (3)	EXT2, SSMS	608210	11p11.2	SSMS
?Sertoli-cell-only syndrome (1)	DAZ	400003	Yq11.223	DAZ
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	SRTD5
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	ATD5
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	NPHP13
?Short-rib thoracic dysplasia 5 with or without polydactyly, 614376 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	CED4
?Slowed nerve conduction velocity, AD, 608236 (3)	ARHGEF10, KIAA0294, SNCV	608136	8p23.3	ARHGEF10
?Slowed nerve conduction velocity, AD, 608236 (3)	ARHGEF10, KIAA0294, SNCV	608136	8p23.3	KIAA0294
?Slowed nerve conduction velocity, AD, 608236 (3)	ARHGEF10, KIAA0294, SNCV	608136	8p23.3	SNCV
?Sneddon syndrome, 182410 (3)	CECR1, PAN, SNEDS	607575	22q11.1	CECR1
?Sneddon syndrome, 182410 (3)	CECR1, PAN, SNEDS	607575	22q11.1	PAN
?Sneddon syndrome, 182410 (3)	CECR1, PAN, SNEDS	607575	22q11.1	SNEDS
?Spastic paraplegia 41, autosomal dominant (2)	SPG41	613364	11p14.1-p11.2	SPG41
?Spastic paraplegia 43, autosomal recessive, 615043 (3)	C19orf12, NBIA4, SPG43	614297	19q12	C19orf12
?Spastic paraplegia 43, autosomal recessive, 615043 (3)	C19orf12, NBIA4, SPG43	614297	19q12	NBIA4
?Spastic paraplegia 43, autosomal recessive, 615043 (3)	C19orf12, NBIA4, SPG43	614297	19q12	SPG43
?Spastic paraplegia 57, autosomal recessive, 615658 (3)	TFG, HMSNP, SPG57	602498	3q12.2	TFG
?Spastic paraplegia 57, autosomal recessive, 615658 (3)	TFG, HMSNP, SPG57	602498	3q12.2	HMSNP
?Spastic paraplegia 57, autosomal recessive, 615658 (3)	TFG, HMSNP, SPG57	602498	3q12.2	SPG57
?Spastic paraplegia 61, autosomal recessive, 615685 (3)	ARL6IP1, KIAA0069, SPG61	607669	16p12.3	ARL6IP1
?Spastic paraplegia 61, autosomal recessive, 615685 (3)	ARL6IP1, KIAA0069, SPG61	607669	16p12.3	KIAA0069
?Spastic paraplegia 61, autosomal recessive, 615685 (3)	ARL6IP1, KIAA0069, SPG61	607669	16p12.3	SPG61
?Spastic paraplegia 63, 615686 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	AMPD2
?Spastic paraplegia 63, 615686 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	SPG63
?Spastic paraplegia 63, 615686 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	PCH9
?Spastic paraplegia 72, autosomal dominant, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	REEP2
?Spastic paraplegia 72, autosomal dominant, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	C5orf19
?Spastic paraplegia 72, autosomal dominant, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	SPG72
?Spastic paraplegia 72, autosomal recessive, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	REEP2
?Spastic paraplegia 72, autosomal recessive, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	C5orf19
?Spastic paraplegia 72, autosomal recessive, 615625 (3)	REEP2, C5orf19, SPG72	609347	5q31.2	SPG72
?Spastic paraplegia 73, autosomal dominant, 616282 (3)	CPT1C, SPG73	608846	19q13.33	CPT1C
?Spastic paraplegia 73, autosomal dominant, 616282 (3)	CPT1C, SPG73	608846	19q13.33	SPG73
?Spastic paraplegia 74, autosomal recessive, 616451 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	IBA57
?Spastic paraplegia 74, autosomal recessive, 616451 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	C1orf69
?Spastic paraplegia 74, autosomal recessive, 616451 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	MMDS3
?Spastic paraplegia 74, autosomal recessive, 616451 (3)	IBA57, C1orf69, MMDS3, SPG74	615316	1q42.13	SPG74
?Spastic paraplegia 77, autosomal recessive, 617046 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS2
?Spastic paraplegia 77, autosomal recessive, 617046 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS1
?Spastic paraplegia 77, autosomal recessive, 617046 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	COXPD14
?Spastic paraplegia 77, autosomal recessive, 617046 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	SPG77
?Spermatogenic failure 13, 615841 (3)	TAF4B, TAF2C2, TAFII105, SPGF13	601689	18q11.2	TAF4B
?Spermatogenic failure 13, 615841 (3)	TAF4B, TAF2C2, TAFII105, SPGF13	601689	18q11.2	TAF2C2
?Spermatogenic failure 13, 615841 (3)	TAF4B, TAF2C2, TAFII105, SPGF13	601689	18q11.2	TAFII105
?Spermatogenic failure 13, 615841 (3)	TAF4B, TAF2C2, TAFII105, SPGF13	601689	18q11.2	SPGF13
?Spermatogenic failure 14, 615842 (3)	ZMYND15, SPGF14	614312	17p13.2	ZMYND15
?Spermatogenic failure 14, 615842 (3)	ZMYND15, SPGF14	614312	17p13.2	SPGF14
?Spermatogenic failure 15, 616950 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SYCE1
?Spermatogenic failure 15, 616950 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	POF12
?Spermatogenic failure 15, 616950 (3)	SYCE1, POF12, SPGF15	611486	10q26.3	SPGF15
?Spermatogenic failure 6, 102530 (3)	SPATA16, SPGF6	609856	3q26.31	SPATA16
?Spermatogenic failure 6, 102530 (3)	SPATA16, SPGF6	609856	3q26.31	SPGF6
?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	ASCC1, p50, SMABF2	614215	10q22.1	ASCC1
?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	ASCC1, p50, SMABF2	614215	10q22.1	p50
?Spinal muscular atrophy with congenital bone fractures 2, 616867 (3)	ASCC1, p50, SMABF2	614215	10q22.1	SMABF2
?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SIGMAR1
?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	SRBP
?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	ALS16
?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3)	SIGMAR1, SRBP, ALS16, DSMA2	601978	9p13.3	DSMA2
?Spinocerebellar ataxia 26, 609306 (3)	EEF2, EF2, SCA26	130610	19p13.3	EEF2
?Spinocerebellar ataxia 26, 609306 (3)	EEF2, EF2, SCA26	130610	19p13.3	EF2
?Spinocerebellar ataxia 26, 609306 (3)	EEF2, EF2, SCA26	130610	19p13.3	SCA26
?Spinocerebellar ataxia 30 (2)	SCA30	613371	4q34.3-q35.1	SCA30
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ADMD
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD2
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD3
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ISQMR
?Spinocerebellar ataxia 34, 133190 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	SCA34
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	CCDC88C
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	HKRP2
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	DAPLE
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	KIAA1509
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	HYC
?Spinocerebellar ataxia 40, 616053 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	SCA40
?Spinocerebellar ataxia 41, 616410 (3)	TRPC3, TRP3, SCA41	602345	4q27	TRPC3
?Spinocerebellar ataxia 41, 616410 (3)	TRPC3, TRP3, SCA41	602345	4q27	TRP3
?Spinocerebellar ataxia 41, 616410 (3)	TRPC3, TRP3, SCA41	602345	4q27	SCA41
?Spinocerebellar ataxia, X-linked 1, 302500 (3)	ATP2B3, PMCA3, SCAX1	300014	Xq28	ATP2B3
?Spinocerebellar ataxia, X-linked 1, 302500 (3)	ATP2B3, PMCA3, SCAX1	300014	Xq28	PMCA3
?Spinocerebellar ataxia, X-linked 1, 302500 (3)	ATP2B3, PMCA3, SCAX1	300014	Xq28	SCAX1
?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	RUBCN, RUBICON, KIAA0226, SCAR15	613516	3q29	RUBCN
?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	RUBCN, RUBICON, KIAA0226, SCAR15	613516	3q29	RUBICON
?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	RUBCN, RUBICON, KIAA0226, SCAR15	613516	3q29	KIAA0226
?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3)	RUBCN, RUBICON, KIAA0226, SCAR15	613516	3q29	SCAR15
?Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	CWF19L1, C19L1, SCAR17	616120	10q24.31	CWF19L1
?Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	CWF19L1, C19L1, SCAR17	616120	10q24.31	C19L1
?Spinocerebellar ataxia, autosomal recessive 17, 616127 (3)	CWF19L1, C19L1, SCAR17	616120	10q24.31	SCAR17
?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	VWA3B, SCAR22	614884	2q11.2	VWA3B
?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3)	VWA3B, SCAR22	614884	2q11.2	SCAR22
?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	DLX5, SHFM1D	600028	7q21.3	DLX5
?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3)	DLX5, SHFM1D	600028	7q21.3	SHFM1D
?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	LFNG, SCDO3	602576	7p22.3	LFNG
?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)	LFNG, SCDO3	602576	7p22.3	SCDO3
?Spondylocostal dysostosis 6, 616566 (3)	RIPPLY2, C6orf59, SCDO6	609891	6q14.2	RIPPLY2
?Spondylocostal dysostosis 6, 616566 (3)	RIPPLY2, C6orf59, SCDO6	609891	6q14.2	C6orf59
?Spondylocostal dysostosis 6, 616566 (3)	RIPPLY2, C6orf59, SCDO6	609891	6q14.2	SCDO6
?Steel syndrome, 615155 (3)	COL27A1, KIAA1870, STLS	608461	9q32	COL27A1
?Steel syndrome, 615155 (3)	COL27A1, KIAA1870, STLS	608461	9q32	KIAA1870
?Steel syndrome, 615155 (3)	COL27A1, KIAA1870, STLS	608461	9q32	STLS
?Stickler syndrome, type V, 614284 (3)	COL9A2, EDM2, STL5	120260	1p34.2	COL9A2
?Stickler syndrome, type V, 614284 (3)	COL9A2, EDM2, STL5	120260	1p34.2	EDM2
?Stickler syndrome, type V, 614284 (3)	COL9A2, EDM2, STL5	120260	1p34.2	STL5
?Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	SHROOM4, KIAA1202, SDSX	300579	Xp11.22	SHROOM4
?Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	SHROOM4, KIAA1202, SDSX	300579	Xp11.22	KIAA1202
?Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)	SHROOM4, KIAA1202, SDSX	300579	Xp11.22	SDSX
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	ASD2
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	VSD1
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TACHD
?Testicular anomalies with or without congenital heart disease, 615542 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TOF
?Tetra-amelia syndrome, 273395 (3)	WNT3, INT4, TETAMS	165330	17q21.31-q21.32	WNT3
?Tetra-amelia syndrome, 273395 (3)	WNT3, INT4, TETAMS	165330	17q21.31-q21.32	INT4
?Tetra-amelia syndrome, 273395 (3)	WNT3, INT4, TETAMS	165330	17q21.31-q21.32	TETAMS
?Thrombocytopenia 6, 616937 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC
?Thrombocytopenia 6, 616937 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	ASV
?Thrombocytopenia 6, 616937 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC1
?Thrombocytopenia 6, 616937 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	THC6
?Thrombocytopenia, Paris-Trousseau type (4)	TCPT	188025	11q23	TCPT
?Thrombocytopenia-2, 188000 (3)	MASTL, FLJ14813, GWL, THC2	608221	10p12.1	MASTL
?Thrombocytopenia-2, 188000 (3)	MASTL, FLJ14813, GWL, THC2	608221	10p12.1	FLJ14813
?Thrombocytopenia-2, 188000 (3)	MASTL, FLJ14813, GWL, THC2	608221	10p12.1	GWL
?Thrombocytopenia-2, 188000 (3)	MASTL, FLJ14813, GWL, THC2	608221	10p12.1	THC2
?Thrombophilia due to decreased release of tissue plasminogen (1)	THPH9	612348	8p12	THPH9
?Thromboxane synthase deficiency, 614158 (1)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	TBXAS1
?Thromboxane synthase deficiency, 614158 (1)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	GHOSAL
?Thromboxane synthase deficiency, 614158 (1)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	CYP5
?Thromboxane synthase deficiency, 614158 (1)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	BDPLT14
?Tibial hemimelia (2)	THM	275220	8q24.1	THM
?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	RNF113A, ZNF183, TTD5	300951	Xq24	RNF113A
?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	RNF113A, ZNF183, TTD5	300951	Xq24	ZNF183
?Trichothiodystrophy 5, nonphotosensitive, 300953 (3)	RNF113A, ZNF183, TTD5	300951	Xq24	TTD5
?Trichotillomania, 613229 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	SLITRK1
?Trichotillomania, 613229 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	KIAA1910
?Trichotillomania, 613229 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	TTM
?Ullrich congenital muscular dystrophy 2, 616470 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	COL12A1
?Ullrich congenital muscular dystrophy 2, 616470 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	UCMD2
?Ullrich congenital muscular dystrophy 2, 616470 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	BTHLM2
?Urocanase deficiency, 276880 (3)	UROC1, UROCD	613012	3q21.3	UROC1
?Urocanase deficiency, 276880 (3)	UROC1, UROCD	613012	3q21.3	UROCD
?Waisman syndrome, 311510 (3)	RAB39B, MRX72, WSMN	300774	Xq28	RAB39B
?Waisman syndrome, 311510 (3)	RAB39B, MRX72, WSMN	300774	Xq28	MRX72
?Waisman syndrome, 311510 (3)	RAB39B, MRX72, WSMN	300774	Xq28	WSMN
?Webb-Dattani syndrome, 615926 (3)	ARNT2, WEDAS	606036	15q25.1	ARNT2
?Webb-Dattani syndrome, 615926 (3)	ARNT2, WEDAS	606036	15q25.1	WEDAS
?Winchester syndrome, 277950 (3)	MMP14, WNCHRS	600754	14q11.2	MMP14
?Winchester syndrome, 277950 (3)	MMP14, WNCHRS	600754	14q11.2	WNCHRS
?Wiskott-Aldrich syndrome 2, 614493 (3)	WIPF1, WASPIP, WIP, WAS2	602357	2q31.1	WIPF1
?Wiskott-Aldrich syndrome 2, 614493 (3)	WIPF1, WASPIP, WIP, WAS2	602357	2q31.1	WASPIP
?Wiskott-Aldrich syndrome 2, 614493 (3)	WIPF1, WASPIP, WIP, WAS2	602357	2q31.1	WIP
?Wiskott-Aldrich syndrome 2, 614493 (3)	WIPF1, WASPIP, WIP, WAS2	602357	2q31.1	WAS2
?XFE progeroid syndrome, 610965 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
?XFE progeroid syndrome, 610965 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XPF
?XFE progeroid syndrome, 610965 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	FANCQ
?XFE progeroid syndrome, 610965 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XFEPS
?[Birbeck granule deficiency], 613393 (3)	CD207, LANGERIN, CLEC4K	604862	2p13.3	CD207
?[Birbeck granule deficiency], 613393 (3)	CD207, LANGERIN, CLEC4K	604862	2p13.3	LANGERIN
?[Birbeck granule deficiency], 613393 (3)	CD207, LANGERIN, CLEC4K	604862	2p13.3	CLEC4K
?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	NEFH, CMT2CC	162230	22q12.2	NEFH
?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	NEFH, CMT2CC	162230	22q12.2	CMT2CC
?{Autism susceptibility 16}, 613410 (3)	SLC9A9, AUTS16	608396	3q24	SLC9A9
?{Autism susceptibility 16}, 613410 (3)	SLC9A9, AUTS16	608396	3q24	AUTS16
?{Parkinson disease 5, susceptibility to}, 613643 (3)	UCHL1, PARK5, NDGOA	191342	4p13	UCHL1
?{Parkinson disease 5, susceptibility to}, 613643 (3)	UCHL1, PARK5, NDGOA	191342	4p13	PARK5
?{Parkinson disease 5, susceptibility to}, 613643 (3)	UCHL1, PARK5, NDGOA	191342	4p13	NDGOA
ABCD syndrome, 600501 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
ABCD syndrome, 600501 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	HSCR2
ABCD syndrome, 600501 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	ABCDS
ABCD syndrome, 600501 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	WS4A
ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	ARMC5, AIMAH2	615549	16p11.2	ARMC5
ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3)	ARMC5, AIMAH2	615549	16p11.2	AIMAH2
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
ACTH-independent macronodular adrenal hyperplasia, 219080 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
ADULT syndrome, 103285 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
AICA-ribosiduria due to ATIC deficiency, 608688 (3)	ATIC, PURH, AICAR	601731	2q35	ATIC
AICA-ribosiduria due to ATIC deficiency, 608688 (3)	ATIC, PURH, AICAR	601731	2q35	PURH
AICA-ribosiduria due to ATIC deficiency, 608688 (3)	ATIC, PURH, AICAR	601731	2q35	AICAR
Aarskog-Scott syndrome, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGD1
Aarskog-Scott syndrome, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGDY
Aarskog-Scott syndrome, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	AAS
Aarskog-Scott syndrome, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	MRXS16
Abdominal obesity-metabolic syndrome (2)	AOMS2	605572	17p12	AOMS2
Abdominal obesity-metabolic syndrome 1 (2)	AOMS1, SYNX	605552	3q27	AOMS1
Abdominal obesity-metabolic syndrome 1 (2)	AOMS1, SYNX	605552	3q27	SYNX
Abdominal obesity-metabolic syndrome 3, 615812 (3)	DYRK1B, MIRK, AOMS3	604556	19q13.2	DYRK1B
Abdominal obesity-metabolic syndrome 3, 615812 (3)	DYRK1B, MIRK, AOMS3	604556	19q13.2	MIRK
Abdominal obesity-metabolic syndrome 3, 615812 (3)	DYRK1B, MIRK, AOMS3	604556	19q13.2	AOMS3
Abetalipoproteinemia, 200100 (3)	MTP	157147	4q23	MTP
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	DERMO1
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	SETLSS
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	FFDD3
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	BBRSAY
Ablepharon-macrostomia syndrome, 200110 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	AMS
Acampomelic campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Acampomelic campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	CMD1
Acampomelic campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SRA1
Acatalasemia, 614097 (3)	CAT	115500	11p13	CAT
Acetyl-CoA carboxylase deficiency, 613933 (1)	ACACA, ACAC, ACC1, ACACAD	200350	17q12	ACACA
Acetyl-CoA carboxylase deficiency, 613933 (1)	ACACA, ACAC, ACC1, ACACAD	200350	17q12	ACAC
Acetyl-CoA carboxylase deficiency, 613933 (1)	ACACA, ACAC, ACC1, ACACAD	200350	17q12	ACC1
Acetyl-CoA carboxylase deficiency, 613933 (1)	ACACA, ACAC, ACC1, ACACAD	200350	17q12	ACACAD
Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	AAAS, AAA	605378	12q13.13	AAAS
Achalasia-addisonianism-alacrimia syndrome, 231550 (3)	AAAS, AAA	605378	12q13.13	AAA
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Acheiropody, 200500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
Achondrogenesis Ib, 600972 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Achondrogenesis, type IA, 200600 (3)	TRIP11, TRIP230, CEV14, ACG1A	604505	14q32.12	TRIP11
Achondrogenesis, type IA, 200600 (3)	TRIP11, TRIP230, CEV14, ACG1A	604505	14q32.12	TRIP230
Achondrogenesis, type IA, 200600 (3)	TRIP11, TRIP230, CEV14, ACG1A	604505	14q32.12	CEV14
Achondrogenesis, type IA, 200600 (3)	TRIP11, TRIP230, CEV14, ACG1A	604505	14q32.12	ACG1A
Achondrogenesis, type II or hypochondrogenesis, 200610 (3)	COL2A1	120140	12q13.11	COL2A1
Achondroplasia, 100800 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Achondroplasia, 100800 (3)	FGFR3, ACH	134934	4p16.3	ACH
Achromatopsia 6, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	PDE6H
Achromatopsia 6, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	RCD3
Achromatopsia 6, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	ACHM6
Achromatopsia 7, 616517 (3)	ATF6, ACHM7	605537	1q23.3	ATF6
Achromatopsia 7, 616517 (3)	ATF6, ACHM7	605537	1q23.3	ACHM7
Achromatopsia-2, 216900 (3)	CNGA3, CNG3, ACHM2	600053	2q11.2	CNGA3
Achromatopsia-2, 216900 (3)	CNGA3, CNG3, ACHM2	600053	2q11.2	CNG3
Achromatopsia-2, 216900 (3)	CNGA3, CNG3, ACHM2	600053	2q11.2	ACHM2
Achromatopsia-3, 262300 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	CNGB3
Achromatopsia-3, 262300 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	ACHM3
Achromatopsia-3, 262300 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	ACHM1
Achromatopsia-4, 613856 (3)	GNAT2, ACHM4	139340	1p13.3	GNAT2
Achromatopsia-4, 613856 (3)	GNAT2, ACHM4	139340	1p13.3	ACHM4
Acid-labile subunit, deficiency of, 615961 (3)	IGFALS, ALS, ACLSD	601489	16p13.3	IGFALS
Acid-labile subunit, deficiency of, 615961 (3)	IGFALS, ALS, ACLSD	601489	16p13.3	ALS
Acid-labile subunit, deficiency of, 615961 (3)	IGFALS, ALS, ACLSD	601489	16p13.3	ACLSD
Acne inversa, familial, 1, 142690 (3)	NCSTN	605254	1q23.2	NCSTN
Acne inversa, familial, 2, 613736 (3)	PSENEN, PEN2	607632	19q13.12	PSENEN
Acne inversa, familial, 2, 613736 (3)	PSENEN, PEN2	607632	19q13.12	PEN2
Acne inversa, familial, 3, 613737 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Acne inversa, familial, 3, 613737 (3)	PSEN1, AD3	104311	14q24.2	AD3
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	HLS2
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	ACLS
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	JBTS12
Acrocallosal syndrome, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	AGBK
Acrocapitofemoral dysplasia, 607778 (3)	IHH, BDA1	600726	2q35	IHH
Acrocapitofemoral dysplasia, 607778 (3)	IHH, BDA1	600726	2q35	BDA1
Acrodermatitis enteropathica, 201100 (3)	SLC39A4, ZIP4	607059	8q24.3	SLC39A4
Acrodermatitis enteropathica, 201100 (3)	SLC39A4, ZIP4	607059	8q24.3	ZIP4
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	TSE1
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CNC1
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CAR
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PPNAD1
Acrodysostosis 1, with or without hormone resistance, 101800 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	ACRDYS1
Acrodysostosis 2, with or without hormone resistance, 614613 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	PDE4D
Acrodysostosis 2, with or without hormone resistance, 614613 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	DPDE3
Acrodysostosis 2, with or without hormone resistance, 614613 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	STRK1
Acrodysostosis 2, with or without hormone resistance, 614613 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	ACRDYS2
Acrofacial dysostosis 1, Nager type, 154400 (3)	SF3B4, SF3B49, SAP49, AFD1	605593	1q21.2	SF3B4
Acrofacial dysostosis 1, Nager type, 154400 (3)	SF3B4, SF3B49, SAP49, AFD1	605593	1q21.2	SF3B49
Acrofacial dysostosis 1, Nager type, 154400 (3)	SF3B4, SF3B49, SAP49, AFD1	605593	1q21.2	SAP49
Acrofacial dysostosis 1, Nager type, 154400 (3)	SF3B4, SF3B49, SAP49, AFD1	605593	1q21.2	AFD1
Acrofacial dysostosis, Cincinnati type, 616462 (3)	POLR1A, RPA194, AFDCIN	616404	2p11.2	POLR1A
Acrofacial dysostosis, Cincinnati type, 616462 (3)	POLR1A, RPA194, AFDCIN	616404	2p11.2	RPA194
Acrofacial dysostosis, Cincinnati type, 616462 (3)	POLR1A, RPA194, AFDCIN	616404	2p11.2	AFDCIN
Acrokeratosis verruciformis, 101900 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2A2
Acrokeratosis verruciformis, 101900 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2B
Acrokeratosis verruciformis, 101900 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	DAR
Acromegaloid features, overgrowth, cleft palate, and hernia (2)	AOCH	606049	Chr.11	AOCH
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Acromegaly, somatic, 102200 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Acromelic frontonasal dysostosis, 603671 (3)	ZSWIM6, KIAA1577, AFND	615951	5q12.1	ZSWIM6
Acromelic frontonasal dysostosis, 603671 (3)	ZSWIM6, KIAA1577, AFND	615951	5q12.1	KIAA1577
Acromelic frontonasal dysostosis, 603671 (3)	ZSWIM6, KIAA1577, AFND	615951	5q12.1	AFND
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	ALK6
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	AMDD
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA2
Acromesomelic dysplasia, Demirhan type, 609441 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA1D
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ANPRB
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	AMDM
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ECDM
Acromesomelic dysplasia, Maroteaux type, 602875 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	SNSK
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Acromicric dysplasia, 102370 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Acropectoral syndrome (2)	ACRPS	605967	7q36	ACRPS
Acropectorovertebral dysplasia (2)	ACRPV	102510	2q36	ACRPV
Acute insulin response (2)	AIR	601676	1p31	AIR
Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	ACADM, MCAD	607008	1p31.1	ACADM
Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)	ACADM, MCAD	607008	1p31.1	MCAD
Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	ACADS, SCAD	606885	12q24.31	ACADS
Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)	ACADS, SCAD	606885	12q24.31	SCAD
Adams-Oliver syndrome 1, 100300 (3)	ARHGAP31, CDGAP, KIAA1204, AOS1	610911	3q13.32-q13.33	ARHGAP31
Adams-Oliver syndrome 1, 100300 (3)	ARHGAP31, CDGAP, KIAA1204, AOS1	610911	3q13.32-q13.33	CDGAP
Adams-Oliver syndrome 1, 100300 (3)	ARHGAP31, CDGAP, KIAA1204, AOS1	610911	3q13.32-q13.33	KIAA1204
Adams-Oliver syndrome 1, 100300 (3)	ARHGAP31, CDGAP, KIAA1204, AOS1	610911	3q13.32-q13.33	AOS1
Adams-Oliver syndrome 2, 614219 (3)	DOCK6, KIAA1395, AOS2	614194	19p13.2	DOCK6
Adams-Oliver syndrome 2, 614219 (3)	DOCK6, KIAA1395, AOS2	614194	19p13.2	KIAA1395
Adams-Oliver syndrome 2, 614219 (3)	DOCK6, KIAA1395, AOS2	614194	19p13.2	AOS2
Adams-Oliver syndrome 3, 614814 (3)	RBPJ, RBPSUH, IGKJRB1, AOS3	147183	4p15.2	RBPJ
Adams-Oliver syndrome 3, 614814 (3)	RBPJ, RBPSUH, IGKJRB1, AOS3	147183	4p15.2	RBPSUH
Adams-Oliver syndrome 3, 614814 (3)	RBPJ, RBPSUH, IGKJRB1, AOS3	147183	4p15.2	IGKJRB1
Adams-Oliver syndrome 3, 614814 (3)	RBPJ, RBPSUH, IGKJRB1, AOS3	147183	4p15.2	AOS3
Adams-Oliver syndrome 4, 615297 (3)	EOGT, EOGT1, C3orf64, AOS4	614789	3p14.1	EOGT
Adams-Oliver syndrome 4, 615297 (3)	EOGT, EOGT1, C3orf64, AOS4	614789	3p14.1	EOGT1
Adams-Oliver syndrome 4, 615297 (3)	EOGT, EOGT1, C3orf64, AOS4	614789	3p14.1	C3orf64
Adams-Oliver syndrome 4, 615297 (3)	EOGT, EOGT1, C3orf64, AOS4	614789	3p14.1	AOS4
Adams-Oliver syndrome 5, 616028 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	NOTCH1
Adams-Oliver syndrome 5, 616028 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	TAN1
Adams-Oliver syndrome 5, 616028 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	AOS5
Adams-Oliver syndrome 5, 616028 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	AOVD1
Adams-Oliver syndrome 6, 616589 (3)	DLL4, AOS6	605185	15q15.1	DLL4
Adams-Oliver syndrome 6, 616589 (3)	DLL4, AOS6	605185	15q15.1	AOS6
Adenine phosphoribosyltransferase deficiency, 614723 (3)	APRT, APRTD	102600	16q24.3	APRT
Adenine phosphoribosyltransferase deficiency, 614723 (3)	APRT, APRTD	102600	16q24.3	APRTD
Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
Adenocarcinoma of lung, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	NISBD2
Adenocarcinoma of lung, somatic, 211980 (3)	BRAF, NS7	164757	7q34	BRAF
Adenocarcinoma of lung, somatic, 211980 (3)	BRAF, NS7	164757	7q34	NS7
Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NGL
Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NEU
Adenocarcinoma of lung, somatic, 211980 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	HER2
Adenocarcinoma of lung, somatic, 211980 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Adenocarcinoma of lung, somatic, 211980 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PARK2
Adenocarcinoma of lung, somatic, 211980 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PDJ
Adenocarcinoma of lung, somatic, 211980 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	LPRS2
Adenocarcinoma, colonic, somatic (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
Adenocarcinoma, colonic, somatic (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HR54
Adenocarcinoma, colonic, somatic (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HRAD54
Adenocarcinoma, ovarian, somatic, 167000 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Adenocarcinoma, ovarian, somatic, 167000 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PARK2
Adenocarcinoma, ovarian, somatic, 167000 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PDJ
Adenocarcinoma, ovarian, somatic, 167000 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	LPRS2
Adenoma, periampullary, somatic (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Adenoma, periampullary, somatic (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Adenoma, periampullary, somatic (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Adenoma, periampullary, somatic (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Adenomas, multiple colorectal, 608456 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Adenomas, multiple colorectal, 608456 (3)	MUTYH, MYH	604933	1p34.1	MYH
Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	PLAG1, SGPA, PSA	603026	8q12.1	PLAG1
Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	PLAG1, SGPA, PSA	603026	8q12.1	SGPA
Adenomas, salivary gland pleomorphic, somatic, 181030 (3)	PLAG1, SGPA, PSA	603026	8q12.1	PSA
Adenomatous polyposis coli, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Adenomatous polyposis coli, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Adenomatous polyposis coli, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Adenomatous polyposis coli, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Adenosine deaminase deficiency, partial, 102700 (3)	ADA	608958	20q13.12	ADA
Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	PKLR, PK1	609712	1q22	PKLR
Adenosine triphosphate, elevated, of erythrocytes, 102900 (3)	PKLR, PK1	609712	1q22	PK1
Adenylosuccinase deficiency, 103050 (3)	ADSL	608222	22q13.1	ADSL
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	612761	4q22.3	SMARCAD1
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	612761	4q22.3	KIAA1122
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	612761	4q22.3	ETL1
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	612761	4q22.3	HEL1
Adermatoglyphia, 136000 (3)	SMARCAD1, KIAA1122, ETL1, HEL1, ADERM	612761	4q22.3	ADERM
Adiponectin deficiency, 612556 (3)	ADIPOQ, APM1, GBP28, ADIPQTL1	605441	3q27.3	ADIPOQ
Adiponectin deficiency, 612556 (3)	ADIPOQ, APM1, GBP28, ADIPQTL1	605441	3q27.3	APM1
Adiponectin deficiency, 612556 (3)	ADIPOQ, APM1, GBP28, ADIPQTL1	605441	3q27.3	GBP28
Adiponectin deficiency, 612556 (3)	ADIPOQ, APM1, GBP28, ADIPQTL1	605441	3q27.3	ADIPQTL1
Adrenal adenoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Adrenal cortical carcinoma, 202300 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Adrenal cortical carcinoma, 202300 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Adrenal cortical carcinoma, 202300 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Adrenal cortical carcinoma, 202300 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	CYP11B1
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	P450C11
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency, 202010 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	FHI
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21A2
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CA21H
Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3)	HSD3B2	613890	1p12	HSD3B2
Adrenal hypoplasia, congenital, 300200 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	DAX1
Adrenal hypoplasia, congenital, 300200 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	AHC
Adrenal hypoplasia, congenital, 300200 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	AHX
Adrenal hypoplasia, congenital, 300200 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	NR0B1
Adrenal hypoplasia, congenital, 300200 (3)	DAX1, AHC, AHX, NR0B1, SRXY2	300473	Xp21.2	SRXY2
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	CYP11A1, P450SCC	118485	15q24.1	CYP11A1
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)	CYP11A1, P450SCC	118485	15q24.1	P450SCC
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	NR5A1
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZF1
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZ1
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SF1
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	AD4BP
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	POF7
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SRXY3
Adrenocortical insufficiency (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SPGF8
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	TSE1
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CNC1
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CAR
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PPNAD1
Adrenocortical tumor, somatic, (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	ACRDYS1
Adrenocorticotropic hormone deficiency, 201400 (3)	TBX19	604614	1q24.2	TBX19
Adrenoleukodystrophy, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ABCD1
Adrenoleukodystrophy, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ALD
Adrenoleukodystrophy, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	AMN
Adrenomyeloneuropathy, adult, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ABCD1
Adrenomyeloneuropathy, adult, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	ALD
Adrenomyeloneuropathy, adult, 300100 (3)	ABCD1, ALD, AMN	300371	Xq28	AMN
Adult i phenotype without cataract, 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
Adult i phenotype without cataract, 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	Ii
Adult i phenotype without cataract, 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	CTRCT13
Advanced sleep phase syndrome, familial, 1, 604348 (3)	PER2, FASPS1, KIAA0347	603426	2q37.3	PER2
Advanced sleep phase syndrome, familial, 1, 604348 (3)	PER2, FASPS1, KIAA0347	603426	2q37.3	FASPS1
Advanced sleep phase syndrome, familial, 1, 604348 (3)	PER2, FASPS1, KIAA0347	603426	2q37.3	KIAA0347
Advanced sleep-phase syndrome, familial, 2, 615224 (3)	CSNK1D, ASPS, FASPS2	600864	17q25.3	CSNK1D
Advanced sleep-phase syndrome, familial, 2, 615224 (3)	CSNK1D, ASPS, FASPS2	600864	17q25.3	ASPS
Advanced sleep-phase syndrome, familial, 2, 615224 (3)	CSNK1D, ASPS, FASPS2	600864	17q25.3	FASPS2
Afibrinogenemia, congenital, 202400 (3)	FGA	134820	4q31.3	FGA
Afibrinogenemia, congenital, 202400 (3)	FGB	134830	4q31.3	FGB
Afibrinogenemia, congenital, 202400 (3)	FGG	134850	4q32.1	FGG
Agammaglobulinemia 1, 601495 (3)	IGHM, MU, AGM1	147020	14q32.33	IGHM
Agammaglobulinemia 1, 601495 (3)	IGHM, MU, AGM1	147020	14q32.33	MU
Agammaglobulinemia 1, 601495 (3)	IGHM, MU, AGM1	147020	14q32.33	AGM1
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	IGLL1
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	IGO
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	IGL5
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	VPREB2
Agammaglobulinemia 2, 613500 (3)	IGLL1, IGO, IGL5, VPREB2, AGM2	146770	22q11.23	AGM2
Agammaglobulinemia 3, 613501 (3)	CD79A, IGA	112205	19q13.2	CD79A
Agammaglobulinemia 3, 613501 (3)	CD79A, IGA	112205	19q13.2	IGA
Agammaglobulinemia 4, 613502 (3)	BLNK, SLP65, AGM4	604515	10q24.1	BLNK
Agammaglobulinemia 4, 613502 (3)	BLNK, SLP65, AGM4	604515	10q24.1	SLP65
Agammaglobulinemia 4, 613502 (3)	BLNK, SLP65, AGM4	604515	10q24.1	AGM4
Agammaglobulinemia 6, 612692 (3)	CD79B, IGB, B29, AGM6	147245	17q23.3	CD79B
Agammaglobulinemia 6, 612692 (3)	CD79B, IGB, B29, AGM6	147245	17q23.3	IGB
Agammaglobulinemia 6, 612692 (3)	CD79B, IGB, B29, AGM6	147245	17q23.3	B29
Agammaglobulinemia 6, 612692 (3)	CD79B, IGB, B29, AGM6	147245	17q23.3	AGM6
Agammaglobulinemia 8, autosomal dominant, 616941 (3)	TCF3, E2A, AGM8	147141	19p13.3	TCF3
Agammaglobulinemia 8, autosomal dominant, 616941 (3)	TCF3, E2A, AGM8	147141	19p13.3	E2A
Agammaglobulinemia 8, autosomal dominant, 616941 (3)	TCF3, E2A, AGM8	147141	19p13.3	AGM8
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	BTK
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	AGMX1
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	IMD1
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	XLA
Agammaglobulinemia and isolated hormone deficiency, 307200 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	AT
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	BTK
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	AGMX1
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	IMD1
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	XLA
Agammaglobulinemia, X-linked 1, 300755 (3)	BTK, AGMX1, IMD1, XLA, AT	300300	Xq22.1	AT
Agammaglobulinemia, X-linked 2 (2)	AGMX2, XLA2, IMD6	300310	Xp22	AGMX2
Agammaglobulinemia, X-linked 2 (2)	AGMX2, XLA2, IMD6	300310	Xp22	XLA2
Agammaglobulinemia, X-linked 2 (2)	AGMX2, XLA2, IMD6	300310	Xp22	IMD6
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	SLC12A6
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	KCC3A
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	KCC3B
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	KCC3
Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3)	SLC12A6, KCC3A, KCC3B, KCC3, ACCPN	604878	15q14	ACCPN
Agnathia-otocephaly complex, 202650 (3)	PRRX1, PMX1, PHOX1, AGOTC	167420	1q24.2	PRRX1
Agnathia-otocephaly complex, 202650 (3)	PRRX1, PMX1, PHOX1, AGOTC	167420	1q24.2	PMX1
Agnathia-otocephaly complex, 202650 (3)	PRRX1, PMX1, PHOX1, AGOTC	167420	1q24.2	PHOX1
Agnathia-otocephaly complex, 202650 (3)	PRRX1, PMX1, PHOX1, AGOTC	167420	1q24.2	AGOTC
Aicardi syndrome (2)	AIC	304050	Xp22	AIC
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	AGS1
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	CRV
Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	HERNS
Aicardi-Goutieres syndrome 2, 610181 (3)	RNASEH2B, DLEU8, FLJ11712, AGS2	610326	13q14.3	RNASEH2B
Aicardi-Goutieres syndrome 2, 610181 (3)	RNASEH2B, DLEU8, FLJ11712, AGS2	610326	13q14.3	DLEU8
Aicardi-Goutieres syndrome 2, 610181 (3)	RNASEH2B, DLEU8, FLJ11712, AGS2	610326	13q14.3	FLJ11712
Aicardi-Goutieres syndrome 2, 610181 (3)	RNASEH2B, DLEU8, FLJ11712, AGS2	610326	13q14.3	AGS2
Aicardi-Goutieres syndrome 3, 610329 (3)	RNASEH2C, AYP1, FLJ20974, AGS3	610330	11q13.1	RNASEH2C
Aicardi-Goutieres syndrome 3, 610329 (3)	RNASEH2C, AYP1, FLJ20974, AGS3	610330	11q13.1	AYP1
Aicardi-Goutieres syndrome 3, 610329 (3)	RNASEH2C, AYP1, FLJ20974, AGS3	610330	11q13.1	FLJ20974
Aicardi-Goutieres syndrome 3, 610329 (3)	RNASEH2C, AYP1, FLJ20974, AGS3	610330	11q13.1	AGS3
Aicardi-Goutieres syndrome 4, 610333 (3)	RNASEH2A, RNHIA, AGS4	606034	19p13.13	RNASEH2A
Aicardi-Goutieres syndrome 4, 610333 (3)	RNASEH2A, RNHIA, AGS4	606034	19p13.13	RNHIA
Aicardi-Goutieres syndrome 4, 610333 (3)	RNASEH2A, RNHIA, AGS4	606034	19p13.13	AGS4
Aicardi-Goutieres syndrome 5, 612952 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	SAMHD1
Aicardi-Goutieres syndrome 5, 612952 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	AGS5
Aicardi-Goutieres syndrome 5, 612952 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	DCIP
Aicardi-Goutieres syndrome 5, 612952 (3)	SAMHD1, AGS5, DCIP, CHBL2	606754	20q11.23	CHBL2
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	ADAR
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DRADA
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DSH
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DSRAD
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	IFI4
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	G1P1
Aicardi-Goutieres syndrome 6, 615010 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	AGS6
Aicardi-Goutieres syndrome 7, 615846 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	IFIH1
Aicardi-Goutieres syndrome 7, 615846 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	MDA5
Aicardi-Goutieres syndrome 7, 615846 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	AGS7
Aicardi-Goutieres syndrome 7, 615846 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	SGMRT1
Al-Raqad syndrome, 616459 (3)	DCPS, HINT5, DCS1, ARS	610534	11q24.2	DCPS
Al-Raqad syndrome, 616459 (3)	DCPS, HINT5, DCS1, ARS	610534	11q24.2	HINT5
Al-Raqad syndrome, 616459 (3)	DCPS, HINT5, DCS1, ARS	610534	11q24.2	DCS1
Al-Raqad syndrome, 616459 (3)	DCPS, HINT5, DCS1, ARS	610534	11q24.2	ARS
Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	GMPPA, AAMR	615495	2q35	GMPPA
Alacrima, achalasia, and mental retardation syndrome, 615510 (3)	GMPPA, AAMR	615495	2q35	AAMR
Alagille syndrome 2, 610205 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	NOTCH2
Alagille syndrome 2, 610205 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	AGS2
Alagille syndrome 2, 610205 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	HJCYS
Alagille syndrome, 118450 (3)	JAG1, AGS, AHD	601920	20p12.2	JAG1
Alagille syndrome, 118450 (3)	JAG1, AGS, AHD	601920	20p12.2	AGS
Alagille syndrome, 118450 (3)	JAG1, AGS, AHD	601920	20p12.2	AHD
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CORDX3
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2A
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	AIED
Aland Island eye disease, 300600 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	OA2
Alazami syndrome, 615071 (3)	LARP7, PIP7S, ALAZS	612026	4q25	LARP7
Alazami syndrome, 615071 (3)	LARP7, PIP7S, ALAZS	612026	4q25	PIP7S
Alazami syndrome, 615071 (3)	LARP7, PIP7S, ALAZS	612026	4q25	ALAZS
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	P
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	PED
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	D15S12
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	BOCA
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	EYCL3
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	HCL3
Albinism, brown oculocutaneous, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	SHEP1
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
Albinism, oculocutaneous, type IA, 203100 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
Albinism, oculocutaneous, type IB, 606952 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	P
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	PED
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	D15S12
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	BOCA
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	EYCL3
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	HCL3
Albinism, oculocutaneous, type II, 203200 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	SHEP1
Albinism, oculocutaneous, type III, 203290 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	TYRP1
Albinism, oculocutaneous, type III, 203290 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	CAS2
Albinism, oculocutaneous, type III, 203290 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	GP75
Albinism, oculocutaneous, type III, 203290 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	SHEP11
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	MATP
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	AIM1
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SHEP5
Albinism, oculocutaneous, type IV, 606574 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	OCA4
Albinism, oculocutaneous, type V (2)	OCA5	615312	4q24	OCA5
Albinism, oculocutaneous, type VI, 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SLC24A5
Albinism, oculocutaneous, type VI, 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	NCKX5
Albinism, oculocutaneous, type VI, 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SHEP4
Albinism, oculocutaneous, type VI, 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	OCA6
Albinism, oculocutaneous, type VII, 615179 (3)	C10orf11, OCA7	614537	10q22.2-q22.3	C10orf11
Albinism, oculocutaneous, type VII, 615179 (3)	C10orf11, OCA7	614537	10q22.2-q22.3	OCA7
Albinism-deafness syndrome (2)	ADFN, ALDS	300700	Xq24-q26	ADFN
Albinism-deafness syndrome (2)	ADFN, ALDS	300700	Xq24-q26	ALDS
Alcohol sensitivity, acute, 610251 (3)	ALDH2	100650	12q24.12	ALDH2
Aldosterone to renin ratio raised (3)	CYP11B2	124080	8q24.3	CYP11B2
Aldosteronism, glucocorticoid-remediable, 103900 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	CYP11B1
Aldosteronism, glucocorticoid-remediable, 103900 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	P450C11
Aldosteronism, glucocorticoid-remediable, 103900 (3)	CYP11B1, P450C11, FHI	610613	8q24.3	FHI
Alexander disease, 203450 (3)	GFAP, ALXDRD	137780	17q21.31	GFAP
Alexander disease, 203450 (3)	GFAP, ALXDRD	137780	17q21.31	ALXDRD
Alkaptonuria, 203500 (3)	HGD, AKU	607474	3q13.33	HGD
Alkaptonuria, 203500 (3)	HGD, AKU	607474	3q13.33	AKU
Allan-Herndon-Dudley syndrome, 300523 (3)	SLC16A2, DXS128, XPCT	300095	Xq13.2	SLC16A2
Allan-Herndon-Dudley syndrome, 300523 (3)	SLC16A2, DXS128, XPCT	300095	Xq13.2	DXS128
Allan-Herndon-Dudley syndrome, 300523 (3)	SLC16A2, DXS128, XPCT	300095	Xq13.2	XPCT
Alopecia areata 1 (2)	AA1	104000	18p11.3-p11.2	AA1
Alopecia areata 2 (2)	AA2	610753	16q11-q22	AA2
Alopecia universalis, 203655 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Alopecia universalis, 203655 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	AU
Alopecia universalis, 203655 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	MUHH1
Alopecia universalis, 203655 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HYPT4
Alopecia, androgenetic, 1 (2)	AFA1, MPB	109200	3q26	AFA1
Alopecia, androgenetic, 1 (2)	AFA1, MPB	109200	3q26	MPB
Alopecia, androgenetic, 2 (2)	AGA2	300710	Xq11-q12	AGA2
Alopecia, androgenetic, 3 (2)	AGA3	612421	20p11.22	AGA3
Alopecia-mental retardation syndrome 1 (2)	APMR1	203650	3q26.3-q27.3	APMR1
Alopecia-mental retardation syndrome 2 (2)	APMR2	610422	3q26.2-q26.31	APMR2
Alopecia-mental retardation syndrome 3 (2)	APMR3	613930	18q11.2-q12.2	APMR3
Alpha-1-antichymotrypsin deficiency (3)	SERPINA3, AACT, ACT	107280	14q32.13	SERPINA3
Alpha-1-antichymotrypsin deficiency (3)	SERPINA3, AACT, ACT	107280	14q32.13	AACT
Alpha-1-antichymotrypsin deficiency (3)	SERPINA3, AACT, ACT	107280	14q32.13	ACT
Alpha-2-macroglobulin deficiency, 614036 (1)	A2M , A2MD	103950	12p13.31	A2M
Alpha-2-macroglobulin deficiency, 614036 (1)	A2M , A2MD	103950	12p13.31	A2MD
Alpha-2-plasmin inhibitor deficiency, 262850 (3)	PLI, SERPINF2	613168	17p13.3	PLI
Alpha-2-plasmin inhibitor deficiency, 262850 (3)	PLI, SERPINF2	613168	17p13.3	SERPINF2
Alpha-fetoprotein deficiency, 615969 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFP
Alpha-fetoprotein deficiency, 615969 (3)	AFP, HPAFP, AFPD	104150	4q13.3	HPAFP
Alpha-fetoprotein deficiency, 615969 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFPD
Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)	OGDH	613022	7p13	OGDH
Alpha-methylacetoacetic aciduria, 203750 (3)	ACAT1	607809	11q22.3	ACAT1
Alpha-methylacyl-CoA racemase deficiency, 614307 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACR
Alpha-methylacyl-CoA racemase deficiency, 614307 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	CBAS4
Alpha-methylacyl-CoA racemase deficiency, 614307 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACRD
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XH2
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XNP
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SHS
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SFM1
Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	MRXHF1
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XH2
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XNP
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SHS
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SFM1
Alpha-thalassemia/mental retardation syndrome, 301040 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	MRXHF1
Alpha-thalassemia/mental retardation syndrome, type 1 (4)	HBHR, ATR1	141750	16pter-p13.3	HBHR
Alpha-thalassemia/mental retardation syndrome, type 1 (4)	HBHR, ATR1	141750	16pter-p13.3	ATR1
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)	RAG1	179615	11p12	RAG1
Alport syndrome, 301050 (3)	COL4A5, ATS, ASLN	303630	Xq22.3	COL4A5
Alport syndrome, 301050 (3)	COL4A5, ATS, ASLN	303630	Xq22.3	ATS
Alport syndrome, 301050 (3)	COL4A5, ATS, ASLN	303630	Xq22.3	ASLN
Alport syndrome, autosomal dominant, 104200 (3)	COL4A3	120070	2q36.3	COL4A3
Alport syndrome, autosomal recessive, 203780 (3)	COL4A3	120070	2q36.3	COL4A3
Alport syndrome, autosomal recessive, 203780 (3)	COL4A4	120131	2q36.3	COL4A4
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	AMMEC, DELXq22.3, CXDELq22.3	300194	Xq22.3	AMMEC
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	AMMEC, DELXq22.3, CXDELq22.3	300194	Xq22.3	DELXq22.3
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis (4)	AMMEC, DELXq22.3, CXDELq22.3	300194	Xq22.3	CXDELq22.3
Alstrom syndrome, 203800 (3)	ALMS1, ALSS, KIAA0328	606844	2p13.1	ALMS1
Alstrom syndrome, 203800 (3)	ALMS1, ALSS, KIAA0328	606844	2p13.1	ALSS
Alstrom syndrome, 203800 (3)	ALMS1, ALSS, KIAA0328	606844	2p13.1	KIAA0328
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	DYT12
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	RDP
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	AHC2
Alternating hemiplegia of childhood 2, 614820 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	CAPOS
Alternating hemiplegia of childhood, 104290 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Alternating hemiplegia of childhood, 104290 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	FHM2
Alternating hemiplegia of childhood, 104290 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	MHP2
Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	FOXF1, FKHL5, ACDMPV	601089	16q24.1	FOXF1
Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	FOXF1, FKHL5, ACDMPV	601089	16q24.1	FKHL5
Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3)	FOXF1, FKHL5, ACDMPV	601089	16q24.1	ACDMPV
Alveolar soft-part sarcoma, 606243 (3)	ASPSCR1, RCC17, ASPL, ASPS	606236	17q25.3	ASPSCR1
Alveolar soft-part sarcoma, 606243 (3)	ASPSCR1, RCC17, ASPL, ASPS	606236	17q25.3	RCC17
Alveolar soft-part sarcoma, 606243 (3)	ASPSCR1, RCC17, ASPL, ASPS	606236	17q25.3	ASPL
Alveolar soft-part sarcoma, 606243 (3)	ASPSCR1, RCC17, ASPL, ASPS	606236	17q25.3	ASPS
Alzheimer disease 1, familial, 104300 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	APP
Alzheimer disease 1, familial, 104300 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	AAA
Alzheimer disease 1, familial, 104300 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	CVAP
Alzheimer disease 1, familial, 104300 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	AD1
Alzheimer disease 17 (2)	AD17	615080	6p21.2	AD17
Alzheimer disease 6 (2)	AD6	605526	10q24	AD6
Alzheimer disease 8 (2)	AD8	607116	20p	AD8
Alzheimer disease, type 3, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease, type 3, 607822 (3)	PSEN1, AD3	104311	14q24.2	AD3
Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease, type 3, with spastic paraparesis and apraxia, 607822 (3)	PSEN1, AD3	104311	14q24.2	AD3
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques, 607822 (3)	PSEN1, AD3	104311	14q24.2	AD3
Alzheimer disease-10 (2)	AD10	609636	7q36	AD10
Alzheimer disease-11 (2)	AD11	609790	9p22.1	AD11
Alzheimer disease-2, 104310 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Alzheimer disease-2, 104310 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
Alzheimer disease-2, 104310 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
Alzheimer disease-2, 104310 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
Alzheimer disease-4, 606889 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	PSEN2
Alzheimer disease-4, 606889 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	AD4
Alzheimer disease-4, 606889 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	STM2
Alzheimer disease-4, 606889 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	CMD1V
Alzheimer disease-5 (2)	AD5	602096	12p11.23-q13.12	AD5
Alzheimer disease-7 (2)	AD7	606187	10p13	AD7
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AMELX
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AMG
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AIH1
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AMGX
Amelogenesis imperfecta, type 1E, 301200 (3)	AMELX, AMG, AIH1, AMGX, AI1E	300391	Xp22.2	AI1E
Amelogenesis imperfecta, type IA, 104530 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Amelogenesis imperfecta, type IA, 104530 (3)	LAMB3, AI1A	150310	1q32.2	AI1A
Amelogenesis imperfecta, type IB, 104500 (3)	ENAM, AIH2, AI1C	606585	4q13.3	ENAM
Amelogenesis imperfecta, type IB, 104500 (3)	ENAM, AIH2, AI1C	606585	4q13.3	AIH2
Amelogenesis imperfecta, type IB, 104500 (3)	ENAM, AIH2, AI1C	606585	4q13.3	AI1C
Amelogenesis imperfecta, type IC, 204650 (3)	ENAM, AIH2, AI1C	606585	4q13.3	ENAM
Amelogenesis imperfecta, type IC, 204650 (3)	ENAM, AIH2, AI1C	606585	4q13.3	AIH2
Amelogenesis imperfecta, type IC, 204650 (3)	ENAM, AIH2, AI1C	606585	4q13.3	AI1C
Amelogenesis imperfecta, type IF, 616270 (3)	AMBN, AI1F	601259	4q13.3	AMBN
Amelogenesis imperfecta, type IF, 616270 (3)	AMBN, AI1F	601259	4q13.3	AI1F
Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	FAM20A, AIGFS, AI1G	611062	17q24.2	FAM20A
Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	FAM20A, AIGFS, AI1G	611062	17q24.2	AIGFS
Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3)	FAM20A, AIGFS, AI1G	611062	17q24.2	AI1G
Amelogenesis imperfecta, type IH, 616221 (3)	ITGB6, AI1H	147558	2q24.2	ITGB6
Amelogenesis imperfecta, type IH, 616221 (3)	ITGB6, AI1H	147558	2q24.2	AI1H
Amelogenesis imperfecta, type IIA1, 204700 (3)	KLK4, EMSP1, PRSS17, AI2A1	603767	19q13.41	KLK4
Amelogenesis imperfecta, type IIA1, 204700 (3)	KLK4, EMSP1, PRSS17, AI2A1	603767	19q13.41	EMSP1
Amelogenesis imperfecta, type IIA1, 204700 (3)	KLK4, EMSP1, PRSS17, AI2A1	603767	19q13.41	PRSS17
Amelogenesis imperfecta, type IIA1, 204700 (3)	KLK4, EMSP1, PRSS17, AI2A1	603767	19q13.41	AI2A1
Amelogenesis imperfecta, type IIA2, 612529 (3)	MMP20, AI2A2	604629	11q22.2	MMP20
Amelogenesis imperfecta, type IIA2, 612529 (3)	MMP20, AI2A2	604629	11q22.2	AI2A2
Amelogenesis imperfecta, type IIA3, 613211 (3)	WDR72, AI2A3	613214	15q21.3	WDR72
Amelogenesis imperfecta, type IIA3, 613211 (3)	WDR72, AI2A3	613214	15q21.3	AI2A3
Amelogenesis imperfecta, type IIA4, 614832 (3)	C4orf26, AI2A4	614829	4q21.1	C4orf26
Amelogenesis imperfecta, type IIA4, 614832 (3)	C4orf26, AI2A4	614829	4q21.1	AI2A4
Amelogenesis imperfecta, type IIA5, 615887 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
Amelogenesis imperfecta, type IIA5, 615887 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	NCKX4
Amelogenesis imperfecta, type IIA5, 615887 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SHEP6
Amelogenesis imperfecta, type IIA5, 615887 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	AI2A5
Amelogenesis imperfecta, type III, 130900 (3)	FAM83H, AI3	611927	8q24.3	FAM83H
Amelogenesis imperfecta, type III, 130900 (3)	FAM83H, AI3	611927	8q24.3	AI3
Amelogenesis imperfecta, type IV, 104510 (3)	DLX3, TDO, AI4	600525	17q21.33	DLX3
Amelogenesis imperfecta, type IV, 104510 (3)	DLX3, TDO, AI4	600525	17q21.33	TDO
Amelogenesis imperfecta, type IV, 104510 (3)	DLX3, TDO, AI4	600525	17q21.33	AI4
Aminoacylase 1 deficiency, 609924 (3)	ACY1, ACY1D	104620	3p21.2	ACY1
Aminoacylase 1 deficiency, 609924 (3)	ACY1, ACY1D	104620	3p21.2	ACY1D
Amish infantile epilepsy syndrome, 609056 (3)	SIAT9, ST3GALV	604402	2p11.2	SIAT9
Amish infantile epilepsy syndrome, 609056 (3)	SIAT9, ST3GALV	604402	2p11.2	ST3GALV
Amyloidosis, 3 or more types, 105200 (3)	APOA1	107680	11q23.3	APOA1
Amyloidosis, Finnish type, 105120 (3)	GSN	137350	9q33.2	GSN
Amyloidosis, familial visceral, 105200 (3)	FGA	134820	4q31.3	FGA
Amyloidosis, hereditary, transthyretin-related, 105210 (3)	TTR, PALB	176300	18q12.1	TTR
Amyloidosis, hereditary, transthyretin-related, 105210 (3)	TTR, PALB	176300	18q12.1	PALB
Amyloidosis, primary localized cutaneous, 1, 105250 (3)	OSMR, OSMRB, PLCA1	601743	5p13.1	OSMR
Amyloidosis, primary localized cutaneous, 1, 105250 (3)	OSMR, OSMRB, PLCA1	601743	5p13.1	OSMRB
Amyloidosis, primary localized cutaneous, 1, 105250 (3)	OSMR, OSMRB, PLCA1	601743	5p13.1	PLCA1
Amyloidosis, primary localized cutaneous, 2, 613955 (3)	IL31RA, GLMR, GPL, PLCA2	609510	5q11.2	IL31RA
Amyloidosis, primary localized cutaneous, 2, 613955 (3)	IL31RA, GLMR, GPL, PLCA2	609510	5q11.2	GLMR
Amyloidosis, primary localized cutaneous, 2, 613955 (3)	IL31RA, GLMR, GPL, PLCA2	609510	5q11.2	GPL
Amyloidosis, primary localized cutaneous, 2, 613955 (3)	IL31RA, GLMR, GPL, PLCA2	609510	5q11.2	PLCA2
Amyloidosis, renal, 105200 (3)	LYZ	153450	12q15	LYZ
Amyotrophic lateral sclerosis 1, 105400 (3)	SOD1, ALS1	147450	21q22.11	SOD1
Amyotrophic lateral sclerosis 1, 105400 (3)	SOD1, ALS1	147450	21q22.11	ALS1
Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TARDBP
Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TDP43
Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	ALS10
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	KIAA0274
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	SAC3
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	ALS11
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	YVS
Amyotrophic lateral sclerosis 11, 612577 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	BTOP
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	GLC1E
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	FIP2
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	HYPL
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	NRP
Amyotrophic lateral sclerosis 12, 613435 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	ALS12
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	IBMPFD1
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	ALS14
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	CMT2Y
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	UBQLN2, PLIC2, CHAP1, ALS15	300264	Xp11.21	UBQLN2
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	UBQLN2, PLIC2, CHAP1, ALS15	300264	Xp11.21	PLIC2
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	UBQLN2, PLIC2, CHAP1, ALS15	300264	Xp11.21	CHAP1
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3)	UBQLN2, PLIC2, CHAP1, ALS15	300264	Xp11.21	ALS15
Amyotrophic lateral sclerosis 17, 614696 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	CHMP2B
Amyotrophic lateral sclerosis 17, 614696 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	DMT1
Amyotrophic lateral sclerosis 17, 614696 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	VPS2B
Amyotrophic lateral sclerosis 17, 614696 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	ALS17
Amyotrophic lateral sclerosis 18, 614808 (3)	PFN1, ALS18	176610	17p13.2	PFN1
Amyotrophic lateral sclerosis 18, 614808 (3)	PFN1, ALS18	176610	17p13.2	ALS18
Amyotrophic lateral sclerosis 19, 615515 (3)	ERBB4, HER4, ALS19	600543	2q34	ERBB4
Amyotrophic lateral sclerosis 19, 615515 (3)	ERBB4, HER4, ALS19	600543	2q34	HER4
Amyotrophic lateral sclerosis 19, 615515 (3)	ERBB4, HER4, ALS19	600543	2q34	ALS19
Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALSJ
Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	PLSJ
Amyotrophic lateral sclerosis 2, juvenile, 205100 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	IAHSP
Amyotrophic lateral sclerosis 20, 615426 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	HNRNPA1
Amyotrophic lateral sclerosis 20, 615426 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	IBMPFD3
Amyotrophic lateral sclerosis 20, 615426 (3)	HNRNPA1, IBMPFD3, ALS20	164017	12q13.13	ALS20
Amyotrophic lateral sclerosis 21, 606070 (3)	MATR3, MPD2, ALS21	164015	5q31.2	MATR3
Amyotrophic lateral sclerosis 21, 606070 (3)	MATR3, MPD2, ALS21	164015	5q31.2	MPD2
Amyotrophic lateral sclerosis 21, 606070 (3)	MATR3, MPD2, ALS21	164015	5q31.2	ALS21
Amyotrophic lateral sclerosis 22 with or without frontotemoral dementia, 616208 (3)	TUBA4A, TUBA1, ALS22	191110	2q35	TUBA4A
Amyotrophic lateral sclerosis 22 with or without frontotemoral dementia, 616208 (3)	TUBA4A, TUBA1, ALS22	191110	2q35	TUBA1
Amyotrophic lateral sclerosis 22 with or without frontotemoral dementia, 616208 (3)	TUBA4A, TUBA1, ALS22	191110	2q35	ALS22
Amyotrophic lateral sclerosis 3 (2)	ALS3	606640	18q21	ALS3
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SETX
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SCAR1
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	AOA2
Amyotrophic lateral sclerosis 4, juvenile, 602433 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	ALS4
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	KIAA1840
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	FLJ21439
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	ALS5
Amyotrophic lateral sclerosis 5, juvenile, 602099 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	CMT2X
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	FUS
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	TLS
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	ALS6
Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	ETM4
Amyotrophic lateral sclerosis 7 (2)	ALS7	608031	20p13	ALS7
Amyotrophic lateral sclerosis 8, 608627 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPB
Amyotrophic lateral sclerosis 8, 608627 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPC
Amyotrophic lateral sclerosis 8, 608627 (3)	VAPB, VAPC, ALS8	605704	20q13.32	ALS8
Amyotrophic lateral sclerosis 9, 611895 (3)	ANG, RNASE5, ALS9	105850	14q11.2	ANG
Amyotrophic lateral sclerosis 9, 611895 (3)	ANG, RNASE5, ALS9	105850	14q11.2	RNASE5
Amyotrophic lateral sclerosis 9, 611895 (3)	ANG, RNASE5, ALS9	105850	14q11.2	ALS9
Amyotrophy, hereditary neuralgic, 162100 (3)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Amyotrophy, hereditary neuralgic, 162100 (3)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF
Amyotrophy, hereditary neuralgic, 162100 (3)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF1
Amyotrophy, hereditary neuralgic, 162100 (3)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	NAPB
Analbuminemia, 616000 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ALB
Analbuminemia, 616000 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ANALBA
Analbuminemia, 616000 (3)	ALB, ANALBA, FDAH	103600	4q13.3	FDAH
Anauxetic dysplasia, 607095 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Anauxetic dysplasia, 607095 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRPR
Anauxetic dysplasia, 607095 (3)	RMRP, RMRPR, CHH	157660	9p13.3	CHH
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	HHIRK1
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KIR2.1
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	IRK1
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	LQT7
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	SQT3
Andersen syndrome, 170390 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	ATFB9
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	DHTR
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	TFM
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SBMA
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	KD
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SMAX1
Androgen insensitivity, 300068 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	HYSP1
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	DHTR
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	TFM
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SBMA
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	KD
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SMAX1
Androgen insensitivity, partial, with or without breast cancer, 312300 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	HYSP1
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GF1
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	ERYF1
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	NFE1
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTDA
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTT
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLANP
Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	RHAG, RH50A, OHST	180297	6p12.3	RH50A
Anemia, hemolytic, Rh-null, regulator type, 268150 (3)	RHAG, RH50A, OHST	180297	6p12.3	OHST
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3A, NT5C3, UMPH1, PSN1	606224	7p14.3	NT5C3A
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3A, NT5C3, UMPH1, PSN1	606224	7p14.3	NT5C3
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3A, NT5C3, UMPH1, PSN1	606224	7p14.3	UMPH1
Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)	NT5C3A, NT5C3, UMPH1, PSN1	606224	7p14.3	PSN1
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	SLC11A2
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	NRAMP2
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	DCT1
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	DMT1
Anemia, hypochromic microcytic, with iron overload 1, 206100 (3)	SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1	600523	12q13.12	AHMIO1
Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPH2
Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	EL3
Anemia, neonatal hemolytic, fatal and near-fatal (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	HS2
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ALAS2
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ANH1
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ASB
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	XLEPP
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	XLSA
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ANH1
Anemia, sideroblastic, 1, 300751 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	SIDBA1
Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	SLC25A38, SIDBA2	610819	3p22.1	SLC25A38
Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3)	SLC25A38, SIDBA2	610819	3p22.1	SIDBA2
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	GLRX5
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	C14orf87
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	PRO1238
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	FLB4739
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	PRSA
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	SIDBA3
Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	SPAHGC
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9B
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	MOT2
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	GRP75
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	EVPLS
Anemia, sideroblastic, 4, 182170 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	SIDBA4
Anemia, sideroblastic, with ataxia, 301310 (3)	ABCB7, ABC7, ASAT	300135	Xq13.3	ABCB7
Anemia, sideroblastic, with ataxia, 301310 (3)	ABCB7, ABC7, ASAT	300135	Xq13.3	ABC7
Anemia, sideroblastic, with ataxia, 301310 (3)	ABCB7, ABC7, ASAT	300135	Xq13.3	ASAT
Aneurysm, intracranial berry, 1 (2)	ANIB1	105800	7q11.2	ANIB1
Aneurysm, intracranial berry, 11 (2)	ANIB11	614252	8p22	ANIB11
Aneurysm, intracranial berry, 2 (2)	ANIB2	608542	19q13	ANIB2
Aneurysm, intracranial berry, 3 (2)	ANIB3	609122	1p36.13-p34.3	ANIB3
Aneurysm, intracranial berry, 4 (2)	ANIB4	610213	5p15.2-p14.3	ANIB4
Aneurysm, intracranial berry, 5 (2)	ANIB5	300870	Xp22	ANIB5
Aneurysm, intracranial berry, 7 (2)	ANIB7	612161	11q24-q25	ANIB7
Aneurysm, intracranial berry, 8 (2)	ANIB8	612162	14q23	ANIB8
Aneurysmal bone cysts (2)	ANBC	606179	16q22	ANBC
Angelman syndrome, 105830 (3)	UBE3A, ANCR	601623	15q11.2	UBE3A
Angelman syndrome, 105830 (3)	UBE3A, ANCR	601623	15q11.2	ANCR
Angio serpiginosum (2)	AGSPX	300652	Xp11.3-q12	AGSPX
Angioedema, hereditary, type III, 610618 (3)	F12, HAF, HAE3	610619	5q35.3	F12
Angioedema, hereditary, type III, 610618 (3)	F12, HAF, HAE3	610619	5q35.3	HAF
Angioedema, hereditary, type III, 610618 (3)	F12, HAF, HAE3	610619	5q35.3	HAE3
Angioedema, hereditary, types I and II, 106100 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	C1NH
Angioedema, hereditary, types I and II, 106100 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	HAE1
Angioedema, hereditary, types I and II, 106100 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	HAE2
Angioedema, hereditary, types I and II, 106100 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	SERPING1
Angiofibroma, somatic (3)	MEN1	613733	11q13.1	MEN1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	POREN1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	HANAC
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	ICH
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	BSVD
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	RATOR
Aniridia, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Aniridia, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Aniridia, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Aniridia, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Anisomastia (2)	ANMA	605746	16q13-q21	ANMA
Anonychia congenita, 206800 (3)	RSPO4, CRISTIN4	610573	20p13	RSPO4
Anonychia congenita, 206800 (3)	RSPO4, CRISTIN4	610573	20p13	CRISTIN4
Anosmia, isolated congenital (2)	ANIC	107200	18p11.23-q12.2	ANIC
Anterior segment anomalies with or without cataract, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Anterior segment anomalies with or without cataract, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOR
Anterior segment anomalies with or without cataract, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOS1
Anterior segment anomalies with or without cataract, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	OFC1
Anterior segment mesenchymal dysgenesis, 107250 (3)	FOXE3, FKHL12, ASMD	601094	1p33	FOXE3
Anterior segment mesenchymal dysgenesis, 107250 (3)	FOXE3, FKHL12, ASMD	601094	1p33	FKHL12
Anterior segment mesenchymal dysgenesis, 107250 (3)	FOXE3, FKHL12, ASMD	601094	1p33	ASMD
Anterior segment mesenchymal dysgenesis, 107250 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	PITX3
Anterior segment mesenchymal dysgenesis, 107250 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTPP4
Anterior segment mesenchymal dysgenesis, 107250 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTRCT11
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3)	POR	124015	7q11.23	POR
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Aortic aneurysm, ascending, and dissection (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Aortic aneurysm, familial abdominal 1 (2)	AAA1, AAA	100070	19q13	AAA1
Aortic aneurysm, familial abdominal 1 (2)	AAA1, AAA	100070	19q13	AAA
Aortic aneurysm, familial abdominal 2 (2)	AAA2	609782	4q31	AAA2
Aortic aneurysm, familial abdominal, 4 (2)	AAA4	614375	12q13.3	AAA4
Aortic aneurysm, familial thoracic 1 (2)	AAT1, FAA1	607086	11q23.3-q24	AAT1
Aortic aneurysm, familial thoracic 1 (2)	AAT1, FAA1	607086	11q23.3-q24	FAA1
Aortic aneurysm, familial thoracic 2 (2)	AAT2, FAA2	607087	5q13-q14	AAT2
Aortic aneurysm, familial thoracic 2 (2)	AAT2, FAA2	607087	5q13-q14	FAA2
Aortic aneurysm, familial thoracic 4, 132900 (3)	MYH11, AAT4, FAA4	160745	16p13.11	MYH11
Aortic aneurysm, familial thoracic 4, 132900 (3)	MYH11, AAT4, FAA4	160745	16p13.11	AAT4
Aortic aneurysm, familial thoracic 4, 132900 (3)	MYH11, AAT4, FAA4	160745	16p13.11	FAA4
Aortic aneurysm, familial thoracic 6, 611788 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Aortic aneurysm, familial thoracic 6, 611788 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTSA
Aortic aneurysm, familial thoracic 6, 611788 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	AAT6
Aortic aneurysm, familial thoracic 6, 611788 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	MYMY5
Aortic aneurysm, familial thoracic 7, 613780 (3)	MYLK, MLCK, AAT7	600922	3q21.1	MYLK
Aortic aneurysm, familial thoracic 7, 613780 (3)	MYLK, MLCK, AAT7	600922	3q21.1	MLCK
Aortic aneurysm, familial thoracic 7, 613780 (3)	MYLK, MLCK, AAT7	600922	3q21.1	AAT7
Aortic aneurysm, familial thoracic 8, 615436 (3)	PRKG1, PRKG1B, PRKGR1B, AAT8	176894	10q11.2-q21.1	PRKG1
Aortic aneurysm, familial thoracic 8, 615436 (3)	PRKG1, PRKG1B, PRKGR1B, AAT8	176894	10q11.2-q21.1	PRKG1B
Aortic aneurysm, familial thoracic 8, 615436 (3)	PRKG1, PRKG1B, PRKGR1B, AAT8	176894	10q11.2-q21.1	PRKGR1B
Aortic aneurysm, familial thoracic 8, 615436 (3)	PRKG1, PRKG1B, PRKGR1B, AAT8	176894	10q11.2-q21.1	AAT8
Aortic aneurysm, familial thoracic 9, 616166 (3)	MFAP5, MAGP2, AAT9	601103	12p13.31	MFAP5
Aortic aneurysm, familial thoracic 9, 616166 (3)	MFAP5, MAGP2, AAT9	601103	12p13.31	MAGP2
Aortic aneurysm, familial thoracic 9, 616166 (3)	MFAP5, MAGP2, AAT9	601103	12p13.31	AAT9
Aortic valve disease 1, 109730 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	NOTCH1
Aortic valve disease 1, 109730 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	TAN1
Aortic valve disease 1, 109730 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	AOS5
Aortic valve disease 1, 109730 (3)	NOTCH1, TAN1, AOS5, AOVD1	190198	9q34.3	AOVD1
Aortic valve disease 2, 614823 (3)	SMAD6, MADH6, AOVD2	602931	15q22.31	SMAD6
Aortic valve disease 2, 614823 (3)	SMAD6, MADH6, AOVD2	602931	15q22.31	MADH6
Aortic valve disease 2, 614823 (3)	SMAD6, MADH6, AOVD2	602931	15q22.31	AOVD2
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Apert syndrome, 101200 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Aphakia, congenital primary, 610256 (3)	FOXE3, FKHL12, ASMD	601094	1p33	FOXE3
Aphakia, congenital primary, 610256 (3)	FOXE3, FKHL12, ASMD	601094	1p33	FKHL12
Aphakia, congenital primary, 610256 (3)	FOXE3, FKHL12, ASMD	601094	1p33	ASMD
Aphasia, primary progressive, 607485 (3)	GRN, CLN11	138945	17q21.31	GRN
Aphasia, primary progressive, 607485 (3)	GRN, CLN11	138945	17q21.31	CLN11
Aplasia of lacrimal and salivary glands, 180920 (3)	FGF10	602115	5p12	FGF10
Aplastic anemia, 609135 (3)	NBN, NBS1	602667	8q21.3	NBN
Aplastic anemia, 609135 (3)	NBN, NBS1	602667	8q21.3	NBS1
Aplastic anemia, 609135 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Aplastic anemia, 609135 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	HPLH2
Aplastic anemia, 609135 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	FLH2
Apnea, postanesthetic (3)	BCHE, CHE1	177400	3q26.1	BCHE
Apnea, postanesthetic (3)	BCHE, CHE1	177400	3q26.1	CHE1
ApoA-I and apoC-III deficiency, combined (3)	APOA1	107680	11q23.3	APOA1
Apolipoprotein A-II deficiency (3)	APOA2	107670	1q23.3	APOA2
Apolipoprotein C-III deficiency, 614028 (3)	APOC3, HALP2	107720	11q23.3	APOC3
Apolipoprotein C-III deficiency, 614028 (3)	APOC3, HALP2	107720	11q23.3	HALP2
Apparent mineralocorticoid excess, 218030 (3)	HSD11B2, HSD11K, AME	614232	16q22.1	HSD11B2
Apparent mineralocorticoid excess, 218030 (3)	HSD11B2, HSD11K, AME	614232	16q22.1	HSD11K
Apparent mineralocorticoid excess, 218030 (3)	HSD11B2, HSD11K, AME	614232	16q22.1	AME
Argininemia, 207800 (3)	ARG1	608313	6q23.2	ARG1
Argininosuccinic aciduria, 207900 (3)	ASL	608310	7q11.21	ASL
Aromatase deficiency, 613546 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19A1
Aromatase deficiency, 613546 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19
Aromatase deficiency, 613546 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	ARO
Aromatase excess syndrome, 139300 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19A1
Aromatase excess syndrome, 139300 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	CYP19
Aromatase excess syndrome, 139300 (3)	CYP19A1, CYP19, ARO	107910	15q21.2	ARO
Aromatic L-amino acid decarboxylase deficiency, 608643 (3)	DDC	107930	7p12.2-p12.1	DDC
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	TGFB3
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	ARVD1
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	RNHF
Arrhythmogenic right ventricular dysplasia 1, 107970 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	LDS5
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	DSG2
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	ARVD10
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	ARVC10
Arrhythmogenic right ventricular dysplasia 10, 610193 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	CMD1BB
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC2
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC3
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	ARVD11
Arrhythmogenic right ventricular dysplasia 11, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC2
Arrhythmogenic right ventricular dysplasia 11, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	DSC3
Arrhythmogenic right ventricular dysplasia 11, 610476 (3)	DSC2, DSC3, ARVD11	125645	18q12.1	ARVD11
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	JUP
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	DP3
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	PDGB
Arrhythmogenic right ventricular dysplasia 12, 611528 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	ARVD12
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	RYR2
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	VTSIP
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	ARVD2
Arrhythmogenic right ventricular dysplasia 2, 600996 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	ARVC2
Arrhythmogenic right ventricular dysplasia 3 (2)	ARVD3	602086	14q12-q22	ARVD3
Arrhythmogenic right ventricular dysplasia 4 (2)	ARVD4	602087	2q32.1-q32.3	ARVD4
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	TMEM43
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	ARVD5
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	ARVC5
Arrhythmogenic right ventricular dysplasia 5, 604400 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	EDMD7
Arrhythmogenic right ventricular dysplasia 6 (2)	ARVD6	604401	10p14-p12	ARVD6
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Arrhythmogenic right ventricular dysplasia 8, 607450 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	PKP2, ARVD9	602861	12p11.21	PKP2
Arrhythmogenic right ventricular dysplasia 9, 609040 (3)	PKP2, ARVD9	602861	12p11.21	ARVD9
Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	CTNNA3, ARVD13	607667	10q21.3	CTNNA3
Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3)	CTNNA3, ARVD13	607667	10q21.3	ARVD13
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PDNP1
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	NPPS
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	M6S1
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PCA1
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ARHR2
Arterial calcification, generalized, of infancy, 1, 208000 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	COLED
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ARA
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABC34
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	MLP1
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	PXE
Arterial calcification, generalized, of infancy, 2, 614473 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	GACI2
Arterial tortuosity syndrome, 208050 (3)	SLC2A10, GLUT10, ATS	606145	20q13.12	SLC2A10
Arterial tortuosity syndrome, 208050 (3)	SLC2A10, GLUT10, ATS	606145	20q13.12	GLUT10
Arterial tortuosity syndrome, 208050 (3)	SLC2A10, GLUT10, ATS	606145	20q13.12	ATS
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TMSB
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	AMCD1
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA1
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA2B
Arthrogryposis multiplex congenita, distal, type 1, 108120 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	NEM4
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	TNNI2
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	AMCD2B
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	DA2B
Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)	TNNI2, AMCD2B, DA2B, FSSV	191043	11p15.5	FSSV
Arthrogryposis multiplex congenita, neurogenic (2)	AMCN, AMCN1	208100	5q35	AMCN
Arthrogryposis multiplex congenita, neurogenic (2)	AMCN, AMCN1	208100	5q35	AMCN1
Arthrogryposis, distal, type 10 (2)	DA10	187370	2q31.3-q32.1	DA10
Arthrogryposis, distal, type 1B, 614335 (3)	MYBPC1, LCCS4	160794	12q23.2	MYBPC1
Arthrogryposis, distal, type 1B, 614335 (3)	MYBPC1, LCCS4	160794	12q23.2	LCCS4
Arthrogryposis, distal, type 2A, 193700 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, type 2A, 193700 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2A
Arthrogryposis, distal, type 2A, 193700 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2B
Arthrogryposis, distal, type 2A, 193700 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA8
Arthrogryposis, distal, type 2B, 601680 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, type 2B, 601680 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2A
Arthrogryposis, distal, type 2B, 601680 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2B
Arthrogryposis, distal, type 2B, 601680 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA8
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TMSB
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	AMCD1
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA1
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA2B
Arthrogryposis, distal, type 2B, 601680 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	NEM4
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	PIEZO2
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	FAM38B
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA5
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA3
Arthrogryposis, distal, type 3, 114300 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	MWKS
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	PIEZO2
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	FAM38B
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA5
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	DA3
Arthrogryposis, distal, type 5, 108145 (3)	PIEZO2, FAM38B, DA5, DA3, MWKS	613629	18p11.22-p11.21	MWKS
Arthrogryposis, distal, type 5D, 615065 (3)	ECEL1, XCE, DA5D	605896	2q37.1	ECEL1
Arthrogryposis, distal, type 5D, 615065 (3)	ECEL1, XCE, DA5D	605896	2q37.1	XCE
Arthrogryposis, distal, type 5D, 615065 (3)	ECEL1, XCE, DA5D	605896	2q37.1	DA5D
Arthrogryposis, distal, type 8, 178110 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	MYH3
Arthrogryposis, distal, type 8, 178110 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2A
Arthrogryposis, distal, type 8, 178110 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA2B
Arthrogryposis, distal, type 8, 178110 (3)	MYH3, DA2A, DA2B, DA8	160720	17p13.1	DA8
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1L
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	LCCS
Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	LCCS1
Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)	VPS33B	608552	15q26.1	VPS33B
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	VIPAS39, VIPAR, SPE39, C14orf133	613401	14q24.3	VIPAS39
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	VIPAS39, VIPAR, SPE39, C14orf133	613401	14q24.3	VIPAR
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	VIPAS39, VIPAR, SPE39, C14orf133	613401	14q24.3	SPE39
Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)	VIPAS39, VIPAR, SPE39, C14orf133	613401	14q24.3	C14orf133
Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	WISP3
Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	PPAC
Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	PPD
Arthyrgryposis, distal, type 2B, 601680 (3)	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	TNNT3
Arthyrgryposis, distal, type 2B, 601680 (3)	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	AMCD2B
Arthyrgryposis, distal, type 2B, 601680 (3)	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	DA2B
Arthyrgryposis, distal, type 2B, 601680 (3)	TNNT3, AMCD2B, DA2B, FSSV	600692	11p15.5	FSSV
Arts syndrome, 301835 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Arts syndrome, 301835 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	CMTX5
Arts syndrome, 301835 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFNX1
Arts syndrome, 301835 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFN2
Asparagine synthetase deficiency, 615574 (3)	ASNS, ASNSD	108370	7q21.3	ASNS
Asparagine synthetase deficiency, 615574 (3)	ASNS, ASNSD	108370	7q21.3	ASNSD
Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	GOT1, ASTQTL1	138180	10q24.2	GOT1
Aspartate aminotransferase, serum level of, QTL1, 614419 (3)	GOT1, ASTQTL1	138180	10q24.2	ASTQTL1
Aspartylglucosaminuria, 208400 (3)	AGA	613228	4q34.3	AGA
Asplenia, isolated congenital, 271400 (3)	RPSA, LAMR1, LAMBR, ICAS	150370	3p22.1	RPSA
Asplenia, isolated congenital, 271400 (3)	RPSA, LAMR1, LAMBR, ICAS	150370	3p22.1	LAMR1
Asplenia, isolated congenital, 271400 (3)	RPSA, LAMR1, LAMBR, ICAS	150370	3p22.1	LAMBR
Asplenia, isolated congenital, 271400 (3)	RPSA, LAMR1, LAMBR, ICAS	150370	3p22.1	ICAS
Asthma and nasal polyps, 208550 (3)	TBX21, TBET	604895	17q21.32	TBX21
Asthma and nasal polyps, 208550 (3)	TBX21, TBET	604895	17q21.32	TBET
Ataxia with isolated vitamin E deficiency, 277460 (3)	TTPA, TTP1, AVED	600415	8q12.3	TTPA
Ataxia with isolated vitamin E deficiency, 277460 (3)	TTPA, TTP1, AVED	600415	8q12.3	TTP1
Ataxia with isolated vitamin E deficiency, 277460 (3)	TTPA, TTP1, AVED	600415	8q12.3	AVED
Ataxia, cerebellar, Cayman type, 601238 (3)	ATCAY, CLAC, KIAA1872	608179	19p13.3	ATCAY
Ataxia, cerebellar, Cayman type, 601238 (3)	ATCAY, CLAC, KIAA1872	608179	19p13.3	CLAC
Ataxia, cerebellar, Cayman type, 601238 (3)	ATCAY, CLAC, KIAA1872	608179	19p13.3	KIAA1872
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	APTX, AOA, AOA1	606350	9p21.1	APTX
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	APTX, AOA, AOA1	606350	9p21.1	AOA
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3)	APTX, AOA, AOA1	606350	9p21.1	AOA1
Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	FLVCR1, AXPC1, PCARP	609144	1q32.3	FLVCR1
Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	FLVCR1, AXPC1, PCARP	609144	1q32.3	AXPC1
Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)	FLVCR1, AXPC1, PCARP	609144	1q32.3	PCARP
Ataxia, sensory, 1, autosomal dominant, 608984 (3)	RNF170, SNAX1	614649	8p11.21	RNF170
Ataxia, sensory, 1, autosomal dominant, 608984 (3)	RNF170, SNAX1	614649	8p11.21	SNAX1
Ataxia, spastic, 4, 613672 (3)	MTPAP, PAPD1, SPAX4	613669	10p11.23	MTPAP
Ataxia, spastic, 4, 613672 (3)	MTPAP, PAPD1, SPAX4	613669	10p11.23	PAPD1
Ataxia, spastic, 4, 613672 (3)	MTPAP, PAPD1, SPAX4	613669	10p11.23	SPAX4
Ataxia, spastic, 5, autosomal recessive, 614487 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	AFG3L2
Ataxia, spastic, 5, autosomal recessive, 614487 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	SCA28
Ataxia, spastic, 5, autosomal recessive, 614487 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	SPAX5
Ataxia-oculomotor apraxia 3, 615217 (3)	PIK3R5, p101	611317	17p13.1	PIK3R5
Ataxia-oculomotor apraxia 3, 615217 (3)	PIK3R5, p101	611317	17p13.1	p101
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	PNKP
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	PNK
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	MCSZ
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	EIEE10
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	MCSZ
Ataxia-oculomotor apraxia 4, 616267 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	AOA4
Ataxia-pancytopenia syndrome, 159550 (3)	SAMD9L, ATXPC	611170	7q21.2	SAMD9L
Ataxia-pancytopenia syndrome, 159550 (3)	SAMD9L, ATXPC	611170	7q21.2	ATXPC
Ataxia-telangiectasia, 208900 (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Ataxia-telangiectasia, 208900 (3)	ATM, ATA, AT1	607585	11q22.3	ATA
Ataxia-telangiectasia, 208900 (3)	ATM, ATA, AT1	607585	11q22.3	AT1
Ataxia-telangiectasia-like disorder, 604391 (3)	MRE11A, MRE11, ATLD	600814	11q21	MRE11A
Ataxia-telangiectasia-like disorder, 604391 (3)	MRE11A, MRE11, ATLD	600814	11q21	MRE11
Ataxia-telangiectasia-like disorder, 604391 (3)	MRE11A, MRE11, ATLD	600814	11q21	ATLD
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
Atelosteogenesis II, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Atelosteogenesis, type I, 108720 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Atelosteogenesis, type I, 108720 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	SCT
Atelosteogenesis, type I, 108720 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	AOI
Atelosteogenesis, type I, 108720 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	LRS1
Atelosteogenesis, type III, 108721 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Atelosteogenesis, type III, 108721 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	SCT
Atelosteogenesis, type III, 108721 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	AOI
Atelosteogenesis, type III, 108721 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	LRS1
Athabaskan brainstem dysgenesis syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOXA1
Athabaskan brainstem dysgenesis syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOX1F
Athabaskan brainstem dysgenesis syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	BSAS
Atopy, 147050 (3)	SPINK5, LEKTI	605010	5q32	SPINK5
Atopy, 147050 (3)	SPINK5, LEKTI	605010	5q32	LEKTI
Atransferrinemia, 209300 (3)	TF, TFQTL1	190000	3q22.1	TF
Atransferrinemia, 209300 (3)	TF, TFQTL1	190000	3q22.1	TFQTL1
Atrial fibrillation, familial, 1 (2)	ATFB1	608583	10q22-q24	ATFB1
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Atrial fibrillation, familial, 10, 614022 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Atrial fibrillation, familial, 11, 614049 (3)	GJA5, CX40, ATFB11	121013	1q21.2	GJA5
Atrial fibrillation, familial, 11, 614049 (3)	GJA5, CX40, ATFB11	121013	1q21.2	CX40
Atrial fibrillation, familial, 11, 614049 (3)	GJA5, CX40, ATFB11	121013	1q21.2	ATFB11
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	SUR2
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CMD1O
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ATFB12
Atrial fibrillation, familial, 12, 614050 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CANTU
Atrial fibrillation, familial, 13, 615377 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	SCN1B
Atrial fibrillation, familial, 13, 615377 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	GEFSP1
Atrial fibrillation, familial, 13, 615377 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	BRGDA5
Atrial fibrillation, familial, 13, 615377 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	ATFB13
Atrial fibrillation, familial, 14, 615378 (3)	SCN2B, ATFB14	601327	11q23.3	SCN2B
Atrial fibrillation, familial, 14, 615378 (3)	SCN2B, ATFB14	601327	11q23.3	ATFB14
Atrial fibrillation, familial, 16, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCN3B
Atrial fibrillation, familial, 16, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCNB3
Atrial fibrillation, familial, 16, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	BRGDA7
Atrial fibrillation, familial, 16, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	ATFB16
Atrial fibrillation, familial, 17, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	SCN4B
Atrial fibrillation, familial, 17, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	LQT10
Atrial fibrillation, familial, 17, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	ATFB17
Atrial fibrillation, familial, 2 (2)	ATFB2	608988	6q14-q16	ATFB2
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNA9
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	LQT1
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KVLQT1
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	ATFB3
Atrial fibrillation, familial, 3, 607554 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	SQT2
Atrial fibrillation, familial, 4, 611493 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	KCNE2
Atrial fibrillation, familial, 4, 611493 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	MIRP1
Atrial fibrillation, familial, 4, 611493 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	LQT6
Atrial fibrillation, familial, 4, 611493 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	ATFB4
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	NPPA
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	PND
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ANP
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ATFB6
Atrial fibrillation, familial, 6, 612201 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ATRST2
Atrial fibrillation, familial, 7, 612240 (3)	KCNA5, ATFB7	176267	12p13.32	KCNA5
Atrial fibrillation, familial, 7, 612240 (3)	KCNA5, ATFB7	176267	12p13.32	ATFB7
Atrial fibrillation, familial, 8 (2)	ATFB8	613055	16q22	ATFB8
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	HHIRK1
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KIR2.1
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	IRK1
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	LQT7
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	SQT3
Atrial fibrillation, familial, 9, 613980 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	ATFB9
Atrial septal defect 1 (2)	ASD1	108800	5p	ASD1
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	ASD2
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	VSD1
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TACHD
Atrial septal defect 2, 607941 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TOF
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	ASD3
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYHCA
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMD1EE
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMH14
Atrial septal defect 3, 614089 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	SSS3
Atrial septal defect 4, 611363 (3)	TBX20, ASD4	606061	7p14.2	TBX20
Atrial septal defect 4, 611363 (3)	TBX20, ASD4	606061	7p14.2	ASD4
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMD1R
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMH11
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ASD5
Atrial septal defect 5, 612794 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	LVNC4
Atrial septal defect 6, 613087 (3)	TLL1, TLL, ASD6	606742	4q32.3	TLL1
Atrial septal defect 6, 613087 (3)	TLL1, TLL, ASD6	606742	4q32.3	TLL
Atrial septal defect 6, 613087 (3)	TLL1, TLL, ASD6	606742	4q32.3	ASD6
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Atrial septal defect 7, with or without AV conduction defects, 108900 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	CITED2
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	MRG1
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	P35SRJ
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	VSD2
Atrial septal defect 8, 614433 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	ASD8
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	GATA6
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	ASD9
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Atrial septal defect 9, 614475 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	PACHD
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	NPPA
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	PND
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ANP
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ATFB6
Atrial standstill 2, 615745 (3)	NPPA, PND, ANP, ATFB6, ATRST2	108780	1p36.22	ATRST2
Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	GJA5, CX40, ATFB11	121013	1q21.2	GJA5
Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	GJA5, CX40, ATFB11	121013	1q21.2	CX40
Atrial standstill, digenic (GJA5/SCN5A), 108770 (3)	GJA5, CX40, ATFB11	121013	1q21.2	ATFB11
Atrichia with papular lesions, 209500 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Atrichia with papular lesions, 209500 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	AU
Atrichia with papular lesions, 209500 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	MUHH1
Atrichia with papular lesions, 209500 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HYPT4
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Atrioventricular septal defect 3, 600309 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	ASD2
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	VSD1
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TACHD
Atrioventricular septal defect 4, 614430 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TOF
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	GATA6
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	ASD9
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Atrioventricular septal defect 5, 614474 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	PACHD
Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	CRELD1
Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	AVSD2
Au-Kline syndrome, 616580 (3)	HNRNPK, HNRPK, AUKS	600712	9q21.32	HNRNPK
Au-Kline syndrome, 616580 (3)	HNRNPK, HNRPK, AUKS	600712	9q21.32	HNRPK
Au-Kline syndrome, 616580 (3)	HNRNPK, HNRPK, AUKS	600712	9q21.32	AUKS
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	DIAPH3
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	DIA2
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	DRF3
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	AUNA1
Auditory neuropathy, autosomal dominant, 1, 609129 (3)	DIAPH3, DIA2, DRF3, AUNA1, NSDAN	614567	13q21.2	NSDAN
Auditory neuropathy, autosomal recessive, 1, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	OTOF
Auditory neuropathy, autosomal recessive, 1, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	DFNB9
Auditory neuropathy, autosomal recessive, 1, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	NSRD9
Auditory neuropathy, autosomal recessive, 1, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	AUNB1
Aural atresia, congenital, 607842 (3)	TSHZ1, TSH1, CAA	614427	18q22.3	TSHZ1
Aural atresia, congenital, 607842 (3)	TSHZ1, TSH1, CAA	614427	18q22.3	TSH1
Aural atresia, congenital, 607842 (3)	TSHZ1, TSH1, CAA	614427	18q22.3	CAA
Auriculocondylar syndrome 1, 602483 (3)	GNAI3, ARCND1	139370	1p13.3	GNAI3
Auriculocondylar syndrome 1, 602483 (3)	GNAI3, ARCND1	139370	1p13.3	ARCND1
Auriculocondylar syndrome 2, 614669 (3)	PLCB4, ARCND2	600810	20p12.3-p12.2	PLCB4
Auriculocondylar syndrome 2, 614669 (3)	PLCB4, ARCND2	600810	20p12.3-p12.2	ARCND2
Auriculocondylar syndrome 3, 615706 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
Auriculocondylar syndrome 3, 615706 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	ARCND3
Auriculocondylar syndrome 3, 615706 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	QME
Auriculocondylar syndrome 3, 615706 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	HDLCQ7
Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	STAT3
Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	APRF
Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	HIES
Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	ADMIO1
Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ZAP70
Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	SRK
Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ADMIO2
Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	IMD48
Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	ITCH, AIP4, NAPP1, ADMFD	606409	20q11.22	ITCH
Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	ITCH, AIP4, NAPP1, ADMFD	606409	20q11.22	AIP4
Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	ITCH, AIP4, NAPP1, ADMFD	606409	20q11.22	NAPP1
Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3)	ITCH, AIP4, NAPP1, ADMFD	606409	20q11.22	ADMFD
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	TNFRSF6
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	APT1
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	CD95
Autoimmune lymphoproliferative syndrome, type IA, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	ALPS1A
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASLG
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	TNFSF6
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	APT1LG1
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASL
Autoimmune lymphoproliferative syndrome, type IB, 601859 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	ALPS1B
Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	MCH4
Autoimmune lymphoproliferative syndrome, type II, 603909 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	ALPS2
Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	PRKCD, CVID9, ALPS3	176977	3p21.1	PRKCD
Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	PRKCD, CVID9, ALPS3	176977	3p21.1	CVID9
Autoimmune lymphoproliferative syndrome, type III, 615559 (3)	PRKCD, CVID9, ALPS3	176977	3p21.1	ALPS3
Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	IDDM12
Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CELIAC3
Autoimmune lymphoproliferative syndrome, type V, 616100 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	ALPS5
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	AIRE, APECED, APS1	607358	21q22.3	AIRE
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	AIRE, APECED, APS1	607358	21q22.3	APECED
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3)	AIRE, APECED, APS1	607358	21q22.3	APS1
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	NLRC4
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	CARD12
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	CLAN
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	IPAF
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	AIFEC
Autoinflammation with infantile enterocolitis, 616050 (3)	NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4	606831	2p22.3	FCAS4
Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	PLCG2
Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	FCAS3
Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	APLAID
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	PSMB8
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	LMP7
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	RING10
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	JMP
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	NKJO
Autoinflammation, lipodystrophy, and dermatosis syndrome, 256040 (3)	PSMB8, LMP7, RING10, JMP, NKJO, ALDD	177046	6p21.32	ALDD
Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	TNFAIP3, A20, OTUD7C, AISBL	191163	6q23.3	TNFAIP3
Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	TNFAIP3, A20, OTUD7C, AISBL	191163	6q23.3	A20
Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	TNFAIP3, A20, OTUD7C, AISBL	191163	6q23.3	OTUD7C
Autoinflammatory syndrome, familial, Behcet-like, 616744 (3)	TNFAIP3, A20, OTUD7C, AISBL	191163	6q23.3	AISBL
Autonomic nervous system dysfunction (3)	DRD4	126452	11p15.5	DRD4
Avascular necrosis of the femoral head, 608805 (3)	COL2A1	120140	12q13.11	COL2A1
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	PITX2
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IDG2
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RIEG1
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RGS
Axenfeld-Rieger syndrome, type 1, 180500 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IGDS2
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FOXC1
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FKHL7
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FREAC3
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	IRID1
Axenfeld-Rieger syndrome, type 3, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	RIEG3
Ayme-Gripp syndrome, 601088 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	MAF
Ayme-Gripp syndrome, 601088 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	CCA4
Ayme-Gripp syndrome, 601088 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	CTRCT21
Ayme-Gripp syndrome, 601088 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	AYGRP
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	CARD11
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	CARMA1
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	BIMP3
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	PPBL
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	BENTA
B-cell expansion with NFKB and T-cell anergy, 616452 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	IMD11
B-cell non-Hodgkin lymphoma, high-grade (3)	BCL7A, BCL7	601406	12q24.31	BCL7A
B-cell non-Hodgkin lymphoma, high-grade (3)	BCL7A, BCL7	601406	12q24.31	BCL7
Bainbridge-Ropers syndrome, 615485 (3)	ASXL3, KIAA1713, BRPS	615115	18q12.1	ASXL3
Bainbridge-Ropers syndrome, 615485 (3)	ASXL3, KIAA1713, BRPS	615115	18q12.1	KIAA1713
Bainbridge-Ropers syndrome, 615485 (3)	ASXL3, KIAA1713, BRPS	615115	18q12.1	BRPS
Baller-Gerold syndrome, 218600 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
Baller-Gerold syndrome, 218600 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RTS
Baller-Gerold syndrome, 218600 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQ4
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FOXE1
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FKHL15
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	TITF2
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	TTF2
Bamforth-Lazarus syndrome, 241850 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	NMTC4
Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)	OCLN, BLCPMG	602876	5q13.2	OCLN
Band-like calcification with simplified gyration and polymicrogyria, 251290 (3)	OCLN, BLCPMG	602876	5q13.2	BLCPMG
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Bannayan-Riley-Ruvalcaba syndrome, 153480 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Baraitser-Winter syndrome 1, 243310 (3)	ACTB, BRWS1	102630	7p22.1	ACTB
Baraitser-Winter syndrome 1, 243310 (3)	ACTB, BRWS1	102630	7p22.1	BRWS1
Baraitser-Winter syndrome 2, 614583 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	ACTG1
Baraitser-Winter syndrome 2, 614583 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	DFNA20
Baraitser-Winter syndrome 2, 614583 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	DFNA26
Baraitser-Winter syndrome 2, 614583 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	BRWS2
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	DERMO1
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	SETLSS
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	FFDD3
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	BBRSAY
Barber-Say syndrome, 209885 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	AMS
Bardet-Biedl syndrome 1, 209900 (3)	BBS1	209901	11q13.2	BBS1
Bardet-Biedl syndrome 10, 615987 (3)	BBS10, C12orf58, FLJ23560	610148	12q21.2	BBS10
Bardet-Biedl syndrome 10, 615987 (3)	BBS10, C12orf58, FLJ23560	610148	12q21.2	C12orf58
Bardet-Biedl syndrome 10, 615987 (3)	BBS10, C12orf58, FLJ23560	610148	12q21.2	FLJ23560
Bardet-Biedl syndrome 12, 615989 (3)	BBS12, FLJ35630, C4orf24	610683	4q27	BBS12
Bardet-Biedl syndrome 12, 615989 (3)	BBS12, FLJ35630, C4orf24	610683	4q27	FLJ35630
Bardet-Biedl syndrome 12, 615989 (3)	BBS12, FLJ35630, C4orf24	610683	4q27	C4orf24
Bardet-Biedl syndrome 13, 615990 (3)	MKS1, MKS, BBS13	609883	17q22	MKS1
Bardet-Biedl syndrome 13, 615990 (3)	MKS1, MKS, BBS13	609883	17q22	MKS
Bardet-Biedl syndrome 13, 615990 (3)	MKS1, MKS, BBS13	609883	17q22	BBS13
Bardet-Biedl syndrome 16, 615993 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SDCCAG8
Bardet-Biedl syndrome 16, 615993 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	CCCAP
Bardet-Biedl syndrome 16, 615993 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SLSN7
Bardet-Biedl syndrome 16, 615993 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	BBS16
Bardet-Biedl syndrome 17, 615994 (3)	LZTFL1, BBS17	606568	3p21.31	LZTFL1
Bardet-Biedl syndrome 17, 615994 (3)	LZTFL1, BBS17	606568	3p21.31	BBS17
Bardet-Biedl syndrome 2, 615981 (3)	BBS2, RP74	606151	16q13	BBS2
Bardet-Biedl syndrome 2, 615981 (3)	BBS2, RP74	606151	16q13	RP74
Bardet-Biedl syndrome 3, 600151 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
Bardet-Biedl syndrome 3, 600151 (3)	ARL6, BBS3, RP55	608845	3q11.2	BBS3
Bardet-Biedl syndrome 3, 600151 (3)	ARL6, BBS3, RP55	608845	3q11.2	RP55
Bardet-Biedl syndrome 4, 615982 (3)	BBS4	600374	15q24.1	BBS4
Bardet-Biedl syndrome 5, 615983 (3)	BBS5	603650	2q31.1	BBS5
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKKS
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	HMCS
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	KMS
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKS
Bardet-Biedl syndrome 6, 605231 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	BBS6
Bardet-Biedl syndrome 7, 615984 (3)	BBS7	607590	4q27	BBS7
Bardet-Biedl syndrome 8, 615985 (3)	TTC8, BBS8, RP51	608132	14q31.3	TTC8
Bardet-Biedl syndrome 8, 615985 (3)	TTC8, BBS8, RP51	608132	14q31.3	BBS8
Bardet-Biedl syndrome 8, 615985 (3)	TTC8, BBS8, RP51	608132	14q31.3	RP51
Bardet-Biedl syndrome 9, 615986 (3)	PTHB1, BBS9	607968	7p14.3	PTHB1
Bardet-Biedl syndrome 9, 615986 (3)	PTHB1, BBS9	607968	7p14.3	BBS9
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, TAP1, RING4, PSF1	170260	6p21.32	TAP1
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, TAP1, RING4, PSF1	170260	6p21.32	ABCB2
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, TAP1, RING4, PSF1	170260	6p21.32	TAP1
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, TAP1, RING4, PSF1	170260	6p21.32	RING4
Bare lymphocyte syndrome, type I, 604571 (3)	TAP1, ABCB2, TAP1, RING4, PSF1	170260	6p21.32	PSF1
Bare lymphocyte syndrome, type I, 604571 (3)	TAPBP, TPSN	601962	6p21.32	TAPBP
Bare lymphocyte syndrome, type I, 604571 (3)	TAPBP, TPSN	601962	6p21.32	TPSN
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	TAP2
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	ABCB3
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	PSF2
Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	RING11
Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)	MHC2TA, C2TA	600005	16p13.13	MHC2TA
Bare lymphocyte syndrome, type II, complementation group A, 209920 (3)	MHC2TA, C2TA	600005	16p13.13	C2TA
Bare lymphocyte syndrome, type II, complementation group C, 209920 (3)	RFX5	601863	1q21.3	RFX5
Bare lymphocyte syndrome, type II, complementation group D, 209920 (3)	RFXAP	601861	13q13.3	RFXAP
Bare lymphocyte syndrome, type II, complementation group E, 209920 (3)	RFX5	601863	1q21.3	RFX5
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	ASCC1, p50, SMABF2	614215	10q22.1	ASCC1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	ASCC1, p50, SMABF2	614215	10q22.1	p50
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	ASCC1, p50, SMABF2	614215	10q22.1	SMABF2
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	CTHRC1	610635	8q22.3	CTHRC1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	MSR1, SCARA1, SRA	153622	8p22	MSR1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	MSR1, SCARA1, SRA	153622	8p22	SCARA1
Barrett esophagus/esophageal adenocarcinoma, 614266 (3)	MSR1, SCARA1, SRA	153622	8p22	SRA
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Bart-Pumphrey syndrome, 149200 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	TAZ
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	EFE2
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	BTHS
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	CMD3A
Barth syndrome, 302060 (3)	TAZ, EFE2, BTHS, CMD3A, LVNCX	300394	Xq28	LVNCX
Bartter syndrome, type 1, 601678 (3)	SLC12A1, NKCC2	600839	15q21.1	SLC12A1
Bartter syndrome, type 1, 601678 (3)	SLC12A1, NKCC2	600839	15q21.1	NKCC2
Bartter syndrome, type 2, 241200 (3)	KCNJ1, ROMK1	600359	11q24.3	KCNJ1
Bartter syndrome, type 2, 241200 (3)	KCNJ1, ROMK1	600359	11q24.3	ROMK1
Bartter syndrome, type 3, 607364 (3)	CLCNKB	602023	1p36.13	CLCNKB
Bartter syndrome, type 4a, 602522 (3)	BSND	606412	1p32.3	BSND
Bartter syndrome, type 4b, digenic, 613090 (3)	CLCNKA	602024	1p36.13	CLCNKA
Bartter syndrome, type 4b, digenic, 613090 (3)	CLCNKB	602023	1p36.13	CLCNKB
Bartter syndrome, type 5, antenatal, transient, 300971 (3)	MAGED2, MAGED, BARTS5	300470	Xp11.21	MAGED2
Bartter syndrome, type 5, antenatal, transient, 300971 (3)	MAGED2, MAGED, BARTS5	300470	Xp11.21	MAGED
Bartter syndrome, type 5, antenatal, transient, 300971 (3)	MAGED2, MAGED, BARTS5	300470	Xp11.21	BARTS5
Basal cell carcinoma, somatic, 605462 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Basal cell carcinoma, somatic, 605462 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	NBCCS
Basal cell carcinoma, somatic, 605462 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	BCNS
Basal cell carcinoma, somatic, 605462 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	HPE7
Basal cell carcinoma, somatic, 605462 (3)	PTCH2	603673	1p34.1	PTCH2
Basal cell carcinoma, somatic, 605462 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Basal cell carcinoma, somatic, 605462 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	GAP
Basal cell carcinoma, somatic, 605462 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	CMAVM
Basal cell carcinoma, somatic, 605462 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	PKWS
Basal cell carcinoma, somatic, 605462 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMOH
Basal cell carcinoma, somatic, 605462 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMO
Basal cell carcinoma, somatic, 605462 (3)	SMOH, SMO, CRJS	601500	7q32.1	CRJS
Basal cell nevus syndrome, 109400 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Basal cell nevus syndrome, 109400 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	NBCCS
Basal cell nevus syndrome, 109400 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	BCNS
Basal cell nevus syndrome, 109400 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	HPE7
Basal cell nevus syndrome, 109400 (3)	PTCH2	603673	1p34.1	PTCH2
Basal cell nevus syndrome, 109400 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFU
Basal cell nevus syndrome, 109400 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUXL
Basal cell nevus syndrome, 109400 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUH
Basal ganglia calcification, idiopathic, 1, 213600 (3)	SLC20A2, MLVAR, GLVR2, IBGC1	158378	8p11.21	SLC20A2
Basal ganglia calcification, idiopathic, 1, 213600 (3)	SLC20A2, MLVAR, GLVR2, IBGC1	158378	8p11.21	MLVAR
Basal ganglia calcification, idiopathic, 1, 213600 (3)	SLC20A2, MLVAR, GLVR2, IBGC1	158378	8p11.21	GLVR2
Basal ganglia calcification, idiopathic, 1, 213600 (3)	SLC20A2, MLVAR, GLVR2, IBGC1	158378	8p11.21	IBGC1
Basal ganglia calcification, idiopathic, 2 (2)	IBGC2	606656	2q37	IBGC2
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFR
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IBGC4
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IMF1
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PENTT
Basal ganglia calcification, idiopathic, 4, 615007 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	KOGS
Basal ganglia calcification, idiopathic, 5, 615483 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Basal ganglia calcification, idiopathic, 5, 615483 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	SIS
Basal ganglia calcification, idiopathic, 5, 615483 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	IBGC5
Basal ganglia calcification, idiopathic, 6, 616413 (3)	XPR1, SYG1, IBGC6	605237	1q25.3	XPR1
Basal ganglia calcification, idiopathic, 6, 616413 (3)	XPR1, SYG1, IBGC6	605237	1q25.3	SYG1
Basal ganglia calcification, idiopathic, 6, 616413 (3)	XPR1, SYG1, IBGC6	605237	1q25.3	IBGC6
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HF1
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HUS
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	ARMD4
Basal laminar drusen, 126700 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	AHUS1
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	MED25
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	PTOV2
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	ARC92
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	CMT2B2
Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3)	MED25, PTOV2, ARC92, CMT2B2, BVSYS	610197	19q13.33	BVSYS
Bazex syndrome (2)	BZX	301845	Xq24-q27	BZX
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Beare-Stevenson cutis gyrata syndrome, 123790 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Beaulieu-Boycott-Innes syndrome, 613680 (3)	THOC6, FSAP35, BBIS	615403	16p13.3	THOC6
Beaulieu-Boycott-Innes syndrome, 613680 (3)	THOC6, FSAP35, BBIS	615403	16p13.3	FSAP35
Beaulieu-Boycott-Innes syndrome, 613680 (3)	THOC6, FSAP35, BBIS	615403	16p13.3	BBIS
Becker muscular dystrophy, 300376 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Becker muscular dystrophy, 300376 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	BMD
Becker muscular dystrophy, 300376 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	CMD3B
Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	CDKN1C
Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	KIP2
Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	BWS
Beckwith-Wiedemann syndrome, 130650 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	IMAGE
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	D11S813E
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	ASM1
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	BWS
Beckwith-Wiedemann syndrome, 130650 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	WT2
Beckwith-Wiedemann syndrome, 130650 (3)	ICR1	616186	11p15.5	ICR1
Beckwith-Wiedemann syndrome, 130650 (3)	KCNQ1OT1, LIT1	604115	11p15.5	KCNQ1OT1
Beckwith-Wiedemann syndrome, 130650 (3)	KCNQ1OT1, LIT1	604115	11p15.5	LIT1
Beckwith-Wiedemann syndrome, 130650 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	NSD1
Beckwith-Wiedemann syndrome, 130650 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	ARA267
Beckwith-Wiedemann syndrome, 130650 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	STO
Beckwith-Wiedemann syndrome, 130650 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	SOTOS1
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NTG
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NPG
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	BERHS
Behr syndrome, 210000 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	MTDPS14
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Bent bone dysplasia syndrome, 614592 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BSS
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT1
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	VWDP
Bernard-Soulier syndrome, type A1 (recessive), 231200 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT3
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BSS
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT1
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	VWDP
Bernard-Soulier syndrome, type A2 (dominant), 153670 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT3
Bernard-Soulier syndrome, type B, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	GP1BB
Bernard-Soulier syndrome, type B, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	BS
Bernard-Soulier syndrome, type B, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	BDPLT1
Bernard-Soulier syndrome, type C, 231200 (3)	GP9	173515	3q21.3	GP9
Bestrophinopathy, autosomal recessive, 611809 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Bestrophinopathy, autosomal recessive, 611809 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Bestrophinopathy, autosomal recessive, 611809 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Bestrophinopathy, autosomal recessive, 611809 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Beta-2-adrenoreceptor agonist, reduced response to (3)	ADRB2	109690	5q32	ADRB2
Beta-ureidopropionase deficiency, 613161 (3)	UPB1, BUP1	606673	22q11.23	UPB1
Beta-ureidopropionase deficiency, 613161 (3)	UPB1, BUP1	606673	22q11.23	BUP1
Bethlem myopathy 1, 158810 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	COL6A1
Bethlem myopathy 1, 158810 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	BTHLM1
Bethlem myopathy 1, 158810 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	UCHMD1
Bethlem myopathy 1, 158810 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
Bethlem myopathy 1, 158810 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	BTHLM1
Bethlem myopathy 1, 158810 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	UCMD1
Bethlem myopathy 1, 158810 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Bethlem myopathy 1, 158810 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	DYT27
Bethlem myopathy 1, 158810 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	BTHLM1
Bethlem myopathy 1, 158810 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	UCMD1
Bethlem myopathy 2, 616471 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	COL12A1
Bethlem myopathy 2, 616471 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	UCMD2
Bethlem myopathy 2, 616471 (3)	COL12A1, UCMD2, BTHLM2	120320	6q13-q14	BTHLM2
Bietti crystalline corneoretinal dystrophy, 210370 (3)	CYP4V2, BCD	608614	4q35.1-q35.2	CYP4V2
Bietti crystalline corneoretinal dystrophy, 210370 (3)	CYP4V2, BCD	608614	4q35.1-q35.2	BCD
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	C9orf154
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	BNAR
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	MOTA
Bifid nose with or without anorectal and renal anomalies, 608980 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	TRIGNO2
Bile acid malabsorption, primary, 613291 (3)	SLC10A2, NTCP2, PBAM	601295	13q33.1	SLC10A2
Bile acid malabsorption, primary, 613291 (3)	SLC10A2, NTCP2, PBAM	601295	13q33.1	NTCP2
Bile acid malabsorption, primary, 613291 (3)	SLC10A2, NTCP2, PBAM	601295	13q33.1	PBAM
Bile acid synthesis defect, congenital, 1, 607765 (3)	HSD3B7, CBAS1	607764	16p11.2	HSD3B7
Bile acid synthesis defect, congenital, 1, 607765 (3)	HSD3B7, CBAS1	607764	16p11.2	CBAS1
Bile acid synthesis defect, congenital, 2, 235555 (3)	AKR1D1, SRD5B1, CBAS2	604741	7q33	AKR1D1
Bile acid synthesis defect, congenital, 2, 235555 (3)	AKR1D1, SRD5B1, CBAS2	604741	7q33	SRD5B1
Bile acid synthesis defect, congenital, 2, 235555 (3)	AKR1D1, SRD5B1, CBAS2	604741	7q33	CBAS2
Bile acid synthesis defect, congenital, 3, 613812 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CYP7B1
Bile acid synthesis defect, congenital, 3, 613812 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CBAS3
Bile acid synthesis defect, congenital, 3, 613812 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	SPG5A
Bile acid synthesis defect, congenital, 4, 214950 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACR
Bile acid synthesis defect, congenital, 4, 214950 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	CBAS4
Bile acid synthesis defect, congenital, 4, 214950 (3)	AMACR, CBAS4, AMACRD	604489	5p13.2	AMACRD
Biliary cirrhosis, primary, 1 (2)	PBC1	109720	3p12-q13.2	PBC1
Biliary cirrhosis, primary, 4 (2)	PBC4	614220	7q32	PBC4
Biliary cirrhosis, primary, 5 (2)	PBC5	614221	17q12	PBC5
Biotinidase deficiency, 253260 (3)	BTD	609019	3p25.1	BTD
Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	KCNK9, TASK3	605874	8q24.3	KCNK9
Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)	KCNK9, TASK3	605874	8q24.3	TASK3
Birt-Hogg-Dube syndrome, 135150 (3)	FLCN, BHD	607273	17p11.2	FLCN
Birt-Hogg-Dube syndrome, 135150 (3)	FLCN, BHD	607273	17p11.2	BHD
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	FLNMS
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	GRACILE
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BJS
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	PTD
Bjornstad syndrome, 262000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	MC3DN1
Bladder cancer, somatic, 109800 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Bladder cancer, somatic, 109800 (3)	FGFR3, ACH	134934	4p16.3	ACH
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Bladder cancer, somatic, 109800 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Bladder cancer, somatic, 109800 (3)	RB1	614041	13q14.2	RB1
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	NOD2
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CARD15
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	IBD1
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CD
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	ACUG
Blau syndrome, 186580 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	PSORAS1
Bleeding disorder due to P2RX1 defect, somatic, 609821 (3)	P2RX1, P2X1	600845	17p13.2	P2RX1
Bleeding disorder due to P2RX1 defect, somatic, 609821 (3)	P2RX1, P2X1	600845	17p13.2	P2X1
Bleeding disorder, east Texas type (2)	BDET	605913	1q23	BDET
Bleeding disorder, platelet-type, 11, 614201 (3)	GP6, GPIV, BDPLT11	605546	19q13.42	GP6
Bleeding disorder, platelet-type, 11, 614201 (3)	GP6, GPIV, BDPLT11	605546	19q13.42	GPIV
Bleeding disorder, platelet-type, 11, 614201 (3)	GP6, GPIV, BDPLT11	605546	19q13.42	BDPLT11
Bleeding disorder, platelet-type, 15, 615193 (3)	ACTN1, BDPLT15	102575	14q24.1	ACTN1
Bleeding disorder, platelet-type, 15, 615193 (3)	ACTN1, BDPLT15	102575	14q24.1	BDPLT15
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GP2B
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	CD41B
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GT
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT2
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT16
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GP3A
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GT
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT2
Bleeding disorder, platelet-type, 16, autosomal dominant, 187800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT16
Bleeding disorder, platelet-type, 17, 187900 (3)	GFI1B, BDPLT17	604383	9q34.13	GFI1B
Bleeding disorder, platelet-type, 17, 187900 (3)	GFI1B, BDPLT17	604383	9q34.13	BDPLT17
Bleeding disorder, platelet-type, 20, 616913 (3)	SLFN14, BDPLT20	614958	17q12	SLFN14
Bleeding disorder, platelet-type, 20, 616913 (3)	SLFN14, BDPLT20	614958	17q12	BDPLT20
Bleeding disorder, platelet-type, 8, 609821 (3)	P2RY12, P2Y12, BDPLT8	600515	3q25.1	P2RY12
Bleeding disorder, platelet-type, 8, 609821 (3)	P2RY12, P2Y12, BDPLT8	600515	3q25.1	P2Y12
Bleeding disorder, platelet-type, 8, 609821 (3)	P2RY12, P2Y12, BDPLT8	600515	3q25.1	BDPLT8
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES1
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	PFRK
Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	POF3
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES1
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	PFRK
Blepharophimosis, epicanthus inversus, and ptosis, type 2, 110100 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	POF3
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	EKLF
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	INLU
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	HBFQTL6
Blood group--Lutheran inhibitor, 111150 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	CDAN4
Bloom syndrome, 210900 (3)	RECQL3, RECQ2, BLM, BS	604610	15q26.1	RECQL3
Bloom syndrome, 210900 (3)	RECQL3, RECQ2, BLM, BS	604610	15q26.1	RECQ2
Bloom syndrome, 210900 (3)	RECQL3, RECQ2, BLM, BS	604610	15q26.1	BLM
Bloom syndrome, 210900 (3)	RECQL3, RECQ2, BLM, BS	604610	15q26.1	BS
Blue cone monochromacy, 303700 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	OPN1LW
Blue cone monochromacy, 303700 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	RCP
Blue cone monochromacy, 303700 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	CBP
Blue cone monochromacy, 303700 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	CBBM
Blue cone monochromacy, 303700 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	OPN1MW
Blue cone monochromacy, 303700 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	GCP
Blue cone monochromacy, 303700 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	CBD
Blue cone monochromacy, 303700 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	CBBM
Bohring-Opitz syndrome, 605039 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	ASXL1
Bohring-Opitz syndrome, 605039 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	KIAA0978
Bohring-Opitz syndrome, 605039 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	BOPS
Bohring-Opitz syndrome, 605039 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	MDS
Bone marrow failure syndrome 1, 614675 (3)	SRP72, BMFS1	602122	4q12	SRP72
Bone marrow failure syndrome 1, 614675 (3)	SRP72, BMFS1	602122	4q12	BMFS1
Bone marrow failure syndrome 2, 615715 (3)	ERCC6L2, RAD26L, BMFS2	615667	9q22.32	ERCC6L2
Bone marrow failure syndrome 2, 615715 (3)	ERCC6L2, RAD26L, BMFS2	615667	9q22.32	RAD26L
Bone marrow failure syndrome 2, 615715 (3)	ERCC6L2, RAD26L, BMFS2	615667	9q22.32	BMFS2
Bone marrow failure syndrome 3, 617052 (3)	DNAJC21, DNAJA5, BMFS3	617048	5p13.2	DNAJC21
Bone marrow failure syndrome 3, 617052 (3)	DNAJC21, DNAJA5, BMFS3	617048	5p13.2	DNAJA5
Bone marrow failure syndrome 3, 617052 (3)	DNAJC21, DNAJA5, BMFS3	617048	5p13.2	BMFS3
Bone mineral density QTL18, osteoporosis, 300910 (3)	PLS3, BMND18	300131	Xq23	PLS3
Bone mineral density QTL18, osteoporosis, 300910 (3)	PLS3, BMND18	300131	Xq23	BMND18
Boomerang dysplasia, 112310 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Boomerang dysplasia, 112310 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	SCT
Boomerang dysplasia, 112310 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	AOI
Boomerang dysplasia, 112310 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	LRS1
Bor-Duane hydrocephalus contiguous gene syndrome (4)	DEL8q12q21, C8DELq12q21	600257	8q12.2-q21.2	DEL8q12q21
Bor-Duane hydrocephalus contiguous gene syndrome (4)	DEL8q12q21, C8DELq12q21	600257	8q12.2-q21.2	C8DELq12q21
Borjeson-Forssman-Lehmann syndrome, 301900 (3)	PHF6, BFLS	300414	Xq26.2	PHF6
Borjeson-Forssman-Lehmann syndrome, 301900 (3)	PHF6, BFLS	300414	Xq26.2	BFLS
Bornholm eye disease (2)	BED	300843	Xq28	BED
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	NR2F1
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	TFCOUP1
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	ERBAL3
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	EAR3
Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3)	NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS	132890	5q15	BBSOAS
Bosley-Salih-Alorainy syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOXA1
Bosley-Salih-Alorainy syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	HOX1F
Bosley-Salih-Alorainy syndrome, 601536 (3)	HOXA1, HOX1F, BSAS	142955	7p15.2	BSAS
Bothnia retinal dystrophy, 607475 (3)	RLBP1	180090	15q26.1	RLBP1
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTE
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	SPG39
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTEMND
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	BNHS
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	LNMS
Boucher-Neuhauser syndrome, 215470 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	OMCS
Bowen-Conradi syndrome, 211180 (3)	EMG1, NEP1, C2F, BWCNS	611531	12p13.31	EMG1
Bowen-Conradi syndrome, 211180 (3)	EMG1, NEP1, C2F, BWCNS	611531	12p13.31	NEP1
Bowen-Conradi syndrome, 211180 (3)	EMG1, NEP1, C2F, BWCNS	611531	12p13.31	C2F
Bowen-Conradi syndrome, 211180 (3)	EMG1, NEP1, C2F, BWCNS	611531	12p13.31	BWCNS
Brachydactyly, type A1, 112500 (3)	IHH, BDA1	600726	2q35	IHH
Brachydactyly, type A1, 112500 (3)	IHH, BDA1	600726	2q35	BDA1
Brachydactyly, type A1, B (2)	BDA1B	607004	5p13.3-p13.2	BDA1B
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Brachydactyly, type A1, C, 615072 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	ALK6
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	AMDD
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA2
Brachydactyly, type A1, D, 616849 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA1D
Brachydactyly, type A2, 112600 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2
Brachydactyly, type A2, 112600 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2A
Brachydactyly, type A2, 112600 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BDA2
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BMPR1B
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	ALK6
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	AMDD
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA2
Brachydactyly, type A2, 112600 (3)	BMPR1B, ALK6, AMDD, BDA2, BDA1D	603248	4q22.3	BDA1D
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Brachydactyly, type A2, 112600 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Brachydactyly, type B1, 113000 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	ROR2
Brachydactyly, type B1, 113000 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	BDB1
Brachydactyly, type B1, 113000 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	BDB
Brachydactyly, type B1, 113000 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	NTRKR2
Brachydactyly, type B2, 611377 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Brachydactyly, type B2, 611377 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYM1
Brachydactyly, type B2, 611377 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYNS1A
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Brachydactyly, type C, 113100 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Brachydactyly, type D, 113200 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Brachydactyly, type D, 113200 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOX4I
Brachydactyly, type D, 113200 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	SPD1
Brachydactyly, type D, 113200 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	BDSD
Brachydactyly, type E, 113300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Brachydactyly, type E, 113300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOX4I
Brachydactyly, type E, 113300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	SPD1
Brachydactyly, type E, 113300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	BDSD
Brachydactyly, type E2, 613382 (3)	PTHLH, BDE2	168470	12p11.22	PTHLH
Brachydactyly, type E2, 613382 (3)	PTHLH, BDE2	168470	12p11.22	BDE2
Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	PAPSS2, ATPSK2, BCYM4	603005	10q23.2-q23.3	PAPSS2
Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	PAPSS2, ATPSK2, BCYM4	603005	10q23.2-q23.3	ATPSK2
Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3)	PAPSS2, ATPSK2, BCYM4	603005	10q23.2-q23.3	BCYM4
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Brachyolmia type 3, 113500 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Bradyopsia, 608415 (3)	RGS9, PERRS	604067	17q24.1	RGS9
Bradyopsia, 608415 (3)	RGS9, PERRS	604067	17q24.1	PERRS
Bradyopsia, 608415 (3)	RGS9BP, R9AP, RGS9, PERRS	607814	19q13.11	RGS9BP
Bradyopsia, 608415 (3)	RGS9BP, R9AP, RGS9, PERRS	607814	19q13.11	R9AP
Bradyopsia, 608415 (3)	RGS9BP, R9AP, RGS9, PERRS	607814	19q13.11	RGS9
Bradyopsia, 608415 (3)	RGS9BP, R9AP, RGS9, PERRS	607814	19q13.11	PERRS
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	POREN1
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	HANAC
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	ICH
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	BSVD
Brain small vessel disease with or without ocular anomalies, 607595 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	RATOR
Brain tumor-polyposis syndrome 2, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Brain tumor-polyposis syndrome 2, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Brain tumor-polyposis syndrome 2, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Brain tumor-polyposis syndrome 2, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	BCKDK, BDK, BCKDKD	614901	16p11.2	BCKDK
Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	BCKDK, BDK, BCKDKD	614901	16p11.2	BDK
Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)	BCKDK, BDK, BCKDKD	614901	16p11.2	BCKDKD
Branchiooculofacial syndrome, 113620 (3)	TFAP2A, AP2TF, BOFS	107580	6p24.3	TFAP2A
Branchiooculofacial syndrome, 113620 (3)	TFAP2A, AP2TF, BOFS	107580	6p24.3	AP2TF
Branchiooculofacial syndrome, 113620 (3)	TFAP2A, AP2TF, BOFS	107580	6p24.3	BOFS
Branchiootic syndrome 1, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Branchiootic syndrome 1, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOR
Branchiootic syndrome 1, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOS1
Branchiootic syndrome 1, 602588 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	OFC1
Branchiootic syndrome 2 (2)	BOS2	120502	1q31	BOS2
Branchiootic syndrome 3, 608389 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	SIX1
Branchiootic syndrome 3, 608389 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	BOS3
Branchiootic syndrome 3, 608389 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	DFNA23
Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	EYA1
Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOR
Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	BOS1
Branchiootorenal syndrome 1, with or without cataracts, 113650 (3)	EYA1, BOR, BOS1, OFC1	601653	8q13.3	OFC1
Branchiootorenal syndrome 2, 610896 (3)	SIX5, DMAHP, BOR2	600963	19q13.32	SIX5
Branchiootorenal syndrome 2, 610896 (3)	SIX5, DMAHP, BOR2	600963	19q13.32	DMAHP
Branchiootorenal syndrome 2, 610896 (3)	SIX5, DMAHP, BOR2	600963	19q13.32	BOR2
Breast cancer (1)	BCPR	113721	17p13.3	BCPR
Breast cancer, 114480 (3)	PPM1D, WIP1	605100	17q23.2	PPM1D
Breast cancer, 114480 (3)	PPM1D, WIP1	605100	17q23.2	WIP1
Breast cancer, 114480 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Breast cancer, 114480 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Breast cancer, 114480 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Breast cancer, 114480 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Breast cancer, 11:22 translocation associated (1)	BRCATA	600048	11q23	BRCATA
Breast cancer, early-onset, 114480 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BRIP1
Breast cancer, early-onset, 114480 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BACH1
Breast cancer, early-onset, 114480 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	FANCJ
Breast cancer, somatic, 114480 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Breast cancer, somatic, 114480 (3)	AKT1, CWS6	164730	14q32.33	CWS6
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Breast cancer, somatic, 114480 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Breast cancer, somatic, 114480 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Breast cancer, somatic, 114480 (3)	RB1CC1, CC1, KIAA0203	606837	8q11.23	RB1CC1
Breast cancer, somatic, 114480 (3)	RB1CC1, CC1, KIAA0203	606837	8q11.23	CC1
Breast cancer, somatic, 114480 (3)	RB1CC1, CC1, KIAA0203	606837	8q11.23	KIAA0203
Breast cancer, somatic, 114480 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Breast cancer, somatic, 114480 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	BWSCR1A
Breast cancer, somatic, 114480 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	IMPT1
Breast cancer, somatic, 114480 (3)	TSG101	601387	11p15.1	TSG101
Brittle cornea syndrome 1, 229200 (3)	ZNF469, KIAA1858, BCS1	612078	16q24.2	ZNF469
Brittle cornea syndrome 1, 229200 (3)	ZNF469, KIAA1858, BCS1	612078	16q24.2	KIAA1858
Brittle cornea syndrome 1, 229200 (3)	ZNF469, KIAA1858, BCS1	612078	16q24.2	BCS1
Brittle cornea syndrome 2, 614170 (3)	PRDM5, BCS2	614161	4q27	PRDM5
Brittle cornea syndrome 2, 614170 (3)	PRDM5, BCS2	614161	4q27	BCS2
Brody myopathy, 601003 (3)	ATP2A1, SERCA1	108730	16p11.2	ATP2A1
Brody myopathy, 601003 (3)	ATP2A1, SERCA1	108730	16p11.2	SERCA1
Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Bronchiectasis with or without elevated sweat chloride 1, 211400 (3)	SCNN1B, BESC1	600760	16p12.2	BESC1
Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	SCNN1A, BESC2	600228	12p13.31	SCNN1A
Bronchiectasis with or without elevated sweat chloride 2, 613021 (3)	SCNN1A, BESC2	600228	12p13.31	BESC2
Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	PHA1
Bronchiectasis with or without elevated sweat chloride 3, 613071 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	BESC3
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CDMT
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	EAC
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	MFT1
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	KIAA0849
Brooke-Spiegler syndrome, 605041 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	BRSS
Brooks-Wisniewski-Brown syndrome (2)	MRXSBWB	300612	Chr.X	MRXSBWB
Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	SLC52A3
Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	C20orf54
Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	RFT2
Brown-Vialetto-Van Laere syndrome 1, 211530 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	BVVLS1
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	SLC52A2
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	GPR172A
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	GPCR41
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	PAR1
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	FLJ11856
Brown-Vialetto-Van Laere syndrome 2, 614707 (3)	SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2	607882	8q24.3	BVVLS2
Bruck syndrome 1, 259450 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP10
Bruck syndrome 1, 259450 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP65
Bruck syndrome 1, 259450 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	OI11
Bruck syndrome 1, 259450 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	BRKS1
Bruck syndrome 2, 609220 (3)	PLOD2, LH2, TLH, BRKS2	601865	3q24	PLOD2
Bruck syndrome 2, 609220 (3)	PLOD2, LH2, TLH, BRKS2	601865	3q24	LH2
Bruck syndrome 2, 609220 (3)	PLOD2, LH2, TLH, BRKS2	601865	3q24	TLH
Bruck syndrome 2, 609220 (3)	PLOD2, LH2, TLH, BRKS2	601865	3q24	BRKS2
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Brugada syndrome 1, 601144 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Brugada syndrome 2, 611777 (3)	GPD1L, KIAA0089	611778	3p22.3	GPD1L
Brugada syndrome 2, 611777 (3)	GPD1L, KIAA0089	611778	3p22.3	KIAA0089
Brugada syndrome 3, 611875 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNA1C
Brugada syndrome 3, 611875 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNL1A1
Brugada syndrome 3, 611875 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CCHL1A1
Brugada syndrome 3, 611875 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	TS
Brugada syndrome 4, 611876 (3)	CACNB2	600003	10p12.33-p12.31	CACNB2
Brugada syndrome 5, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	SCN1B
Brugada syndrome 5, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	GEFSP1
Brugada syndrome 5, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	BRGDA5
Brugada syndrome 5, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	ATFB13
Brugada syndrome 6, 613119 (3)	KCNE3, HOKPP, HYPP	604433	11q13.4	KCNE3
Brugada syndrome 6, 613119 (3)	KCNE3, HOKPP, HYPP	604433	11q13.4	HOKPP
Brugada syndrome 6, 613119 (3)	KCNE3, HOKPP, HYPP	604433	11q13.4	HYPP
Brugada syndrome 7, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCN3B
Brugada syndrome 7, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	SCNB3
Brugada syndrome 7, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	BRGDA7
Brugada syndrome 7, 613120 (3)	SCN3B, SCNB3, BRGDA7, ATFB16	608214	11q24.1	ATFB16
Brugada syndrome 8, 613123 (3)	HCN4, SSS2	605206	15q24.1	HCN4
Brugada syndrome 8, 613123 (3)	HCN4, SSS2	605206	15q24.1	SSS2
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3S
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3L
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	SCA19
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	SCA22
Brugada syndrome 9, 616399 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	BRGDA9
Brunner syndrome, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	MAOA
Brunner syndrome, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	BRNRS
Burkitt lymphoma, 113970 (3)	MYC	190080	8q24.21	MYC
Burn-McKeown syndrome, 608572 (3)	TXNL4A, DIM1, BMKS	611595	18q23	TXNL4A
Burn-McKeown syndrome, 608572 (3)	TXNL4A, DIM1, BMKS	611595	18q23	DIM1
Burn-McKeown syndrome, 608572 (3)	TXNL4A, DIM1, BMKS	611595	18q23	BMKS
Buschke-Ollendorff syndrome, 166700 (3)	LEMD3, MAN1	607844	12q14.3	LEMD3
Buschke-Ollendorff syndrome, 166700 (3)	LEMD3, MAN1	607844	12q14.3	MAN1
C syndrome, 211750 (3)	CD96, TACTILE	606037	3q13.1-q13.2	CD96
C syndrome, 211750 (3)	CD96, TACTILE	606037	3q13.1-q13.2	TACTILE
C1q deficiency, 613652 (3)	C1QA	120550	1p36.12	C1QA
C1q deficiency, 613652 (3)	C1QB	120570	1p36.12	C1QB
C1q deficiency, 613652 (3)	C1QC, C1QG	120575	1p36.12	C1QC
C1q deficiency, 613652 (3)	C1QC, C1QG	120575	1p36.12	C1QG
C1r/C1s deficiency, combined, 216950 (1)	C1R	613785	12p13.31	C1R
C1s deficiency, 613783 (3)	C1S	120580	12p13.31	C1S
C2 deficiency, 217000 (3)	C2, ARMD14	613927	6p21.33	C2
C2 deficiency, 217000 (3)	C2, ARMD14	613927	6p21.33	ARMD14
C3 deficiency, 613779 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
C3 deficiency, 613779 (3)	C3, ARMD9, AHUS5	120700	19p13.3	ARMD9
C3 deficiency, 613779 (3)	C3, ARMD9, AHUS5	120700	19p13.3	AHUS5
C4B deficiency, 614379 (3)	C4B, C4F, C4BD	120820	6p21.33	C4B
C4B deficiency, 614379 (3)	C4B, C4F, C4BD	120820	6p21.33	C4F
C4B deficiency, 614379 (3)	C4B, C4F, C4BD	120820	6p21.33	C4BD
C4a deficiency, 614380 (3)	C4A, C4S, C4AD	120810	6p21.33	C4A
C4a deficiency, 614380 (3)	C4A, C4S, C4AD	120810	6p21.33	C4S
C4a deficiency, 614380 (3)	C4A, C4S, C4AD	120810	6p21.33	C4AD
C5 deficiency, 609536 (3)	C5, C5D, ECLZB	120900	9q33.2	C5
C5 deficiency, 609536 (3)	C5, C5D, ECLZB	120900	9q33.2	C5D
C5 deficiency, 609536 (3)	C5, C5D, ECLZB	120900	9q33.2	ECLZB
C6 deficiency, 612446 (3)	C6	217050	5p13.1	C6
C7 deficiency, 610102 (3)	C7	217070	5p13.1	C7
C8 deficiency, type I, 613790 (3)	C8A	120950	1p32.2	C8A
C8 deficiency, type II, 613789 (3)	C8B	120960	1p32.2	C8B
C9 deficiency, 613825 (3)	C9, C9D, ARMD15	120940	5p13.1	C9
C9 deficiency, 613825 (3)	C9, C9D, ARMD15	120940	5p13.1	C9D
C9 deficiency, 613825 (3)	C9, C9D, ARMD15	120940	5p13.1	ARMD15
CAP myopathy 1, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
CAP myopathy 1, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	NEM1
CAP myopathy 1, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CFTD
CAP myopathy 1, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CAPM1
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TMSB
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	AMCD1
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA1
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA2B
CAP myopathy 2, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	NEM4
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	DYT12
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	RDP
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	AHC2
CAPOS syndrome, 601338 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	CAPOS
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	PRSS11
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	ARMD7
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CARASIL
CARASIL syndrome, 600142 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CADASIL2
CATSHL syndrome, 610474 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
CATSHL syndrome, 610474 (3)	FGFR3, ACH	134934	4p16.3	ACH
CD8 deficiency, familial, 608957 (3)	CD8A	186910	2p11.2	CD8A
CDAGS syndrome (2)	CDAGS	603116	22q12-q13	CDAGS
CHARGE syndrome, 214800 (3)	CHD7, HH5	608892	8q12.2	CHD7
CHARGE syndrome, 214800 (3)	CHD7, HH5	608892	8q12.2	HH5
CHILD syndrome, 308050 (3)	NSDHL	300275	Xq28	NSDHL
CHIME syndrome, 280000 (3)	PIGL, CHIME	605947	17p11.2	PIGL
CHIME syndrome, 280000 (3)	PIGL, CHIME	605947	17p11.2	CHIME
CHOPS syndrome, 616368 (3)	AFF4, AF5Q31, CHOPS	604417	5q31.1	AFF4
CHOPS syndrome, 616368 (3)	AFF4, AF5Q31, CHOPS	604417	5q31.1	AF5Q31
CHOPS syndrome, 616368 (3)	AFF4, AF5Q31, CHOPS	604417	5q31.1	CHOPS
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NLRP3
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	CIAS1
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCU
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCAS1
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NALP3
CINCA syndrome, 607115 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	PYPAF1
CK syndrome, 300831 (3)	NSDHL	300275	Xq28	NSDHL
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
CLOVE syndrome, somatic, 612918 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
COACH syndrome, 216360 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
COACH syndrome, 216360 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	KIAA1345
COACH syndrome, 216360 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	MKS6
COACH syndrome, 216360 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
COACH syndrome, 216360 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	KIAA1005
COACH syndrome, 216360 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	JBTS7
COACH syndrome, 216360 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	MKS5
COACH syndrome, 216360 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
COACH syndrome, 216360 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	MKS3
COACH syndrome, 216360 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	JBTS6
COACH syndrome, 216360 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	NPHP11
CODAS syndrome, 600373 (3)	LONP1, PRSS15, LON, CODASS	605490	19p13.3	LONP1
CODAS syndrome, 600373 (3)	LONP1, PRSS15, LON, CODASS	605490	19p13.3	PRSS15
CODAS syndrome, 600373 (3)	LONP1, PRSS15, LON, CODASS	605490	19p13.3	LON
CODAS syndrome, 600373 (3)	LONP1, PRSS15, LON, CODASS	605490	19p13.3	CODASS
COPD, rate of decline of lung function in, 606963 (3)	MMP1, CLG	120353	11q22.2	MMP1
COPD, rate of decline of lung function in, 606963 (3)	MMP1, CLG	120353	11q22.2	CLG
CPT II deficiency, lethal neonatal, 608836 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
CPT II deficiency, lethal neonatal, 608836 (3)	CPT2, IIAE4	600650	1p32.3	IIAE4
CPT deficiency, hepatic, type IA, 255120 (3)	CPT1A	600528	11q13.3	CPT1A
CPT deficiency, hepatic, type II, 600649 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
CPT deficiency, hepatic, type II, 600649 (3)	CPT2, IIAE4	600650	1p32.3	IIAE4
CR1 deficiency (1)	CR1, C3BR	120620	1q32.2	CR1
CR1 deficiency (1)	CR1, C3BR	120620	1q32.2	C3BR
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
CRASH syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Caffey disease, 114000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Calcification of joints and arteries, 211800 (3)	NT5E, NT5	129190	6q14.3	NT5E
Calcification of joints and arteries, 211800 (3)	NT5E, NT5	129190	6q14.3	NT5
Campomelic dysplasia with autosomal sex reversal, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Campomelic dysplasia with autosomal sex reversal, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	CMD1
Campomelic dysplasia with autosomal sex reversal, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SRA1
Campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SOX9
Campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	CMD1
Campomelic dysplasia, 114290 (3)	SOX9, CMD1, SRA1	608160	17q24.3	SRA1
Camptodactyly 1 (2)	CAMPD1	114200	3q11.2-q13.12	CAMPD1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	PRG4
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	CACP
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	MSF
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	SZP
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)	PRG4, CACP, MSF, SZP, HAPO	604283	1q31.1	HAPO
Camurati-Engelmann disease, 131300 (3)	TGFB1, DPD1, CED	190180	19q13.2	TGFB1
Camurati-Engelmann disease, 131300 (3)	TGFB1, DPD1, CED	190180	19q13.2	DPD1
Camurati-Engelmann disease, 131300 (3)	TGFB1, DPD1, CED	190180	19q13.2	CED
Canavan disease, 271900 (3)	ASPA	608034	17p13.2	ASPA
Candidiasis, familial, 1, autosomal dominant (2)	CANDF1, CMCT	114580	2p22.3-p21	CANDF1
Candidiasis, familial, 1, autosomal dominant (2)	CANDF1, CMCT	114580	2p22.3-p21	CMCT
Candidiasis, familial, 2, autosomal recessive, 212050 (3)	CARD9, CANDF2	607212	9q34.3	CARD9
Candidiasis, familial, 2, autosomal recessive, 212050 (3)	CARD9, CANDF2	607212	9q34.3	CANDF2
Candidiasis, familial, 3 (2)	CANDF3, CANDN1, FCNC	607644	11p13-q12	CANDF3
Candidiasis, familial, 3 (2)	CANDF3, CANDN1, FCNC	607644	11p13-q12	CANDN1
Candidiasis, familial, 3 (2)	CANDF3, CANDN1, FCNC	607644	11p13-q12	FCNC
Candidiasis, familial, 4, autosomal recessive, 613108 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLEC7A
Candidiasis, familial, 4, autosomal recessive, 613108 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLECSF12
Candidiasis, familial, 4, autosomal recessive, 613108 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	DECTIN1
Candidiasis, familial, 4, autosomal recessive, 613108 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CANDF4
Candidiasis, familial, 9, 616445 (3)	IL17RC, IL17RL, CANDF9	610925	3p25.3	IL17RC
Candidiasis, familial, 9, 616445 (3)	IL17RC, IL17RL, CANDF9	610925	3p25.3	IL17RL
Candidiasis, familial, 9, 616445 (3)	IL17RC, IL17RL, CANDF9	610925	3p25.3	CANDF9
Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	GAP
Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	CMAVM
Capillary malformation-arteriovenous malformation, 608354 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	PKWS
Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	GNAQ, SWS, CMC1	600998	9q21.2	GNAQ
Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	GNAQ, SWS, CMC1	600998	9q21.2	SWS
Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)	GNAQ, SWS, CMC1	600998	9q21.2	CMC1
Carbamoylphosphate synthetase I deficiency, 237300 (3)	CPS1, PHN	608307	2q34	CPS1
Carbamoylphosphate synthetase I deficiency, 237300 (3)	CPS1, PHN	608307	2q34	PHN
Carboxylesterase 1 deficiency (3)	CES1, SES1	114835	16q12.2	CES1
Carboxylesterase 1 deficiency (3)	CES1, SES1	114835	16q12.2	SES1
Carboxypeptidase N deficiency, 212070 (3)	CPN1, SCPN, CPN	603103	10q24.2	CPN1
Carboxypeptidase N deficiency, 212070 (3)	CPN1, SCPN, CPN	603103	10q24.2	SCPN
Carboxypeptidase N deficiency, 212070 (3)	CPN1, SCPN, CPN	603103	10q24.2	CPN
Carcinoid tumor of lung (3)	MEN1	613733	11q13.1	MEN1
Carcinoid tumors, intestinal, 114900 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Carcinoid tumors, intestinal, 114900 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Carcinoid tumors, intestinal, 114900 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	ANK2, LQT4	106410	4q25-q26	ANK2
Cardiac arrhythmia, ankyrin-B-related, 600919 (3)	ANK2, LQT4	106410	4q25-q26	LQT4
Cardiac conduction defect, nonspecific, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	SCN1B
Cardiac conduction defect, nonspecific, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	GEFSP1
Cardiac conduction defect, nonspecific, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	BRGDA5
Cardiac conduction defect, nonspecific, 612838 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	ATFB13
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Cardiac valvular dysplasia, X-linked, 314400 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	SCO2
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	CEMCOX1
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	MYP6
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3)	COX15, CEMCOX2	603646	10q24.2	COX15
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3)	COX15, CEMCOX2	603646	10q24.2	CEMCOX2
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	COA6, C1orf31, CEMCOX4	614772	1q42.2	COA6
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	COA6, C1orf31, CEMCOX4	614772	1q42.2	C1orf31
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3)	COA6, C1orf31, CEMCOX4	614772	1q42.2	CEMCOX4
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Cardiofaciocutaneous syndrome 2, 615278 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	MAP2K1
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	PRKMK1
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	MKK1
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	MEK1
Cardiofaciocutaneous syndrome 3, 615279 (3)	MAP2K1, PRKMK1, MKK1, MEK1, CFC3	176872	15q22.31	CFC3
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	MAP2K2
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	PRKMK2
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	MEK2
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	MKK2
Cardiofaciocutaneous syndrome 4, 615280 (3)	MAP2K2, PRKMK2, MEK2, MKK2, CFC4	601263	19p13.3	CFC4
Cardiofaciocutaneous syndrome, 115150 (3)	BRAF, NS7	164757	7q34	BRAF
Cardiofaciocutaneous syndrome, 115150 (3)	BRAF, NS7	164757	7q34	NS7
Cardiomyopathy, dilated 1B (2)	CMD1B, CMPD1, FDC	600884	9q13	CMD1B
Cardiomyopathy, dilated 1B (2)	CMD1B, CMPD1, FDC	600884	9q13	CMPD1
Cardiomyopathy, dilated 1B (2)	CMD1B, CMPD1, FDC	600884	9q13	FDC
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Cardiomyopathy, dilated, 1A, 115200 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	ACTN2
Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	CMD1AA
Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	CMH23
Cardiomyopathy, dilated, 1BB, 612877 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	DSG2
Cardiomyopathy, dilated, 1BB, 612877 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	ARVD10
Cardiomyopathy, dilated, 1BB, 612877 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	ARVC10
Cardiomyopathy, dilated, 1BB, 612877 (3)	DSG2, ARVD10, ARVC10, CMD1BB	125671	18q12.1	CMD1BB
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	ZASP
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CYPHER
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	KIAA01613
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	MFM4
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMD1C
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMH24
Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LVNC3
Cardiomyopathy, dilated, 1CC, 613122 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NEXN
Cardiomyopathy, dilated, 1CC, 613122 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NELIN
Cardiomyopathy, dilated, 1CC, 613122 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	CMD1CC
Cardiomyopathy, dilated, 1CC, 613122 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	CMH20
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMH2
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMD1D
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	RCM3
Cardiomyopathy, dilated, 1D, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	LVNC6
Cardiomyopathy, dilated, 1DD, 613172 (3)	RBM20	613171	10q25.2	RBM20
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Cardiomyopathy, dilated, 1E, 601154 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	ASD3
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYHCA
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMD1EE
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMH14
Cardiomyopathy, dilated, 1EE, 613252 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	SSS3
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	CMD1F, CDCD3, LGMD1D	602067	6q23	CMD1F
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	CMD1F, CDCD3, LGMD1D	602067	6q23	CDCD3
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D (2)	CMD1F, CDCD3, LGMD1D	602067	6q23	LGMD1D
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMH7
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD2A
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	RCM1
Cardiomyopathy, dilated, 1FF, 613286 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD1FF
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Cardiomyopathy, dilated, 1G, 604145 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDH1
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHF
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	CMD1GG
Cardiomyopathy, dilated, 1GG, 613642 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	PGL5
Cardiomyopathy, dilated, 1H (2)	CMD1H	604288	2q14-q22	CMD1H
Cardiomyopathy, dilated, 1HH, 613881 (3)	BAG3, MFM6	603883	10q26.11	BAG3
Cardiomyopathy, dilated, 1HH, 613881 (3)	BAG3, MFM6	603883	10q26.11	MFM6
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	CMD1I
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	MFM1
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	SCPNK
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVD7
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVC7
Cardiomyopathy, dilated, 1I, 604765 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	LGMD2R
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYA2
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTPP2
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CMD1II
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTRCT16
Cardiomyopathy, dilated, 1II, 615184 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	MFM2
Cardiomyopathy, dilated, 1J, 605362 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	EYA4
Cardiomyopathy, dilated, 1J, 605362 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	DFNA10
Cardiomyopathy, dilated, 1J, 605362 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	CMD1J
Cardiomyopathy, dilated, 1JJ, 615235 (3)	LAMA4, LAMA3, CMD1JJ	600133	6q21	LAMA4
Cardiomyopathy, dilated, 1JJ, 615235 (3)	LAMA4, LAMA3, CMD1JJ	600133	6q21	LAMA3
Cardiomyopathy, dilated, 1JJ, 615235 (3)	LAMA4, LAMA3, CMD1JJ	600133	6q21	CMD1JJ
Cardiomyopathy, dilated, 1K (2)	CMD1K	605582	6q12-q16	CMD1K
Cardiomyopathy, dilated, 1KK, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	MYPN
Cardiomyopathy, dilated, 1KK, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMD1DD
Cardiomyopathy, dilated, 1KK, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMH22
Cardiomyopathy, dilated, 1KK, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	RCM4
Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGCD
Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGD
Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	LGMD2F
Cardiomyopathy, dilated, 1L, 606685 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	CMD1L
Cardiomyopathy, dilated, 1LL, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	PRDM16
Cardiomyopathy, dilated, 1LL, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	MEL1
Cardiomyopathy, dilated, 1LL, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	LVNC8
Cardiomyopathy, dilated, 1LL, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	CMD1LL
Cardiomyopathy, dilated, 1MM, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Cardiomyopathy, dilated, 1MM, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMH4
Cardiomyopathy, dilated, 1MM, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMD1MM
Cardiomyopathy, dilated, 1MM, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	LVNC10
Cardiomyopathy, dilated, 1NN, 615916 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
Cardiomyopathy, dilated, 1NN, 615916 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CRAF
Cardiomyopathy, dilated, 1NN, 615916 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	NS5
Cardiomyopathy, dilated, 1NN, 615916 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CMD1NN
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	SUR2
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CMD1O
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ATFB12
Cardiomyopathy, dilated, 1O, 608569 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CANTU
Cardiomyopathy, dilated, 1P, 609909 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLN
Cardiomyopathy, dilated, 1P, 609909 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLB
Cardiomyopathy, dilated, 1P, 609909 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	CMD1P
Cardiomyopathy, dilated, 1P, 609909 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	CMH18
Cardiomyopathy, dilated, 1Q (2)	CMD1Q	609915	7q22.3-q31.1	CMD1Q
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMD1R
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMH11
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ASD5
Cardiomyopathy, dilated, 1R, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	LVNC4
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Cardiomyopathy, dilated, 1S, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Cardiomyopathy, dilated, 1U, 613694 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Cardiomyopathy, dilated, 1U, 613694 (3)	PSEN1, AD3	104311	14q24.2	AD3
Cardiomyopathy, dilated, 1V, 613697 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	PSEN2
Cardiomyopathy, dilated, 1V, 613697 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	AD4
Cardiomyopathy, dilated, 1V, 613697 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	STM2
Cardiomyopathy, dilated, 1V, 613697 (3)	PSEN2, AD4, STM2, CMD1V	600759	1q42.13	CMD1V
Cardiomyopathy, dilated, 1W, 611407 (3)	VCL, CMD1W, CMH15	193065	10q22.2	VCL
Cardiomyopathy, dilated, 1W, 611407 (3)	VCL, CMD1W, CMH15	193065	10q22.2	CMD1W
Cardiomyopathy, dilated, 1W, 611407 (3)	VCL, CMD1W, CMH15	193065	10q22.2	CMH15
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FCMD
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	CMD1X
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	LGMD2M
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGA4
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGB4
Cardiomyopathy, dilated, 1X, 611615 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGC4
Cardiomyopathy, dilated, 1Y, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Cardiomyopathy, dilated, 1Y, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMH3
Cardiomyopathy, dilated, 1Y, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMD1Y
Cardiomyopathy, dilated, 1Y, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	LVNC9
Cardiomyopathy, dilated, 1Z, 611879 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	TNNC1
Cardiomyopathy, dilated, 1Z, 611879 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	CMD1Z
Cardiomyopathy, dilated, 1Z, 611879 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	CMH13
Cardiomyopathy, dilated, 3B, 302045 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Cardiomyopathy, dilated, 3B, 302045 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	BMD
Cardiomyopathy, dilated, 3B, 302045 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	CMD3B
Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Cardiomyopathy, dilated, with woolly hair and keratoderma, 605676 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Cardiomyopathy, familial hypertrophic, 192600 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Cardiomyopathy, familial hypertrophic, 192600 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Cardiomyopathy, familial hypertrophic, 192600 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLN2
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPA
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPL
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MFM5
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MPD4
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	CMH26
Cardiomyopathy, familial hypertrophic, 26 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	RCM5
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Cardiomyopathy, familial hypertrophic, 9, 613765 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLN2
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPA
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPL
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MFM5
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MPD4
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	CMH26
Cardiomyopathy, familial restrictive 5, 617047 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	RCM5
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMH7
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD2A
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	RCM1
Cardiomyopathy, familial restrictive, 1, 115210 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD1FF
Cardiomyopathy, familial restrictive, 2 (2)	RCM2	609578	10q23.3	RCM2
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMH2
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMD1D
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	RCM3
Cardiomyopathy, familial restrictive, 3, 612422 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	LVNC6
Cardiomyopathy, familial restrictive, 4, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	MYPN
Cardiomyopathy, familial restrictive, 4, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMD1DD
Cardiomyopathy, familial restrictive, 4, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMH22
Cardiomyopathy, familial restrictive, 4, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	RCM4
Cardiomyopathy, hypertrophic 6, 600858 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Cardiomyopathy, hypertrophic 6, 600858 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	WPWS
Cardiomyopathy, hypertrophic 6, 600858 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	CMH6
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Cardiomyopathy, hypertrophic, 1, 192600 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	MYLK2, MLCK	606566	20q11.21	MYLK2
Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3)	MYLK2, MLCK	606566	20q11.21	MLCK
Cardiomyopathy, hypertrophic, 10, 608758 (3)	MYL2, CMH10	160781	12q24.11	MYL2
Cardiomyopathy, hypertrophic, 10, 608758 (3)	MYL2, CMH10	160781	12q24.11	CMH10
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMD1R
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMH11
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ASD5
Cardiomyopathy, hypertrophic, 11, 612098 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	LVNC4
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CSRP3
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CRP3
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CLP
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CMD1M
Cardiomyopathy, hypertrophic, 12, 612124 (3)	CSRP3, CRP3, CLP, CMD1M, CMH12	600824	11p15.1	CMH12
Cardiomyopathy, hypertrophic, 13, 613243 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	TNNC1
Cardiomyopathy, hypertrophic, 13, 613243 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	CMD1Z
Cardiomyopathy, hypertrophic, 13, 613243 (3)	TNNC1, CMD1Z, CMH13	191040	3p21.1	CMH13
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	ASD3
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYHCA
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMD1EE
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMH14
Cardiomyopathy, hypertrophic, 14, 613251 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	SSS3
Cardiomyopathy, hypertrophic, 15, 613255 (3)	VCL, CMD1W, CMH15	193065	10q22.2	VCL
Cardiomyopathy, hypertrophic, 15, 613255 (3)	VCL, CMD1W, CMH15	193065	10q22.2	CMD1W
Cardiomyopathy, hypertrophic, 15, 613255 (3)	VCL, CMD1W, CMH15	193065	10q22.2	CMH15
Cardiomyopathy, hypertrophic, 16, 613838 (3)	MYOZ2, CMH16	605602	4q26	MYOZ2
Cardiomyopathy, hypertrophic, 16, 613838 (3)	MYOZ2, CMH16	605602	4q26	CMH16
Cardiomyopathy, hypertrophic, 17, 613873 (3)	JPH2, JP2, CMH17	605267	20q13.12	JPH2
Cardiomyopathy, hypertrophic, 17, 613873 (3)	JPH2, JP2, CMH17	605267	20q13.12	JP2
Cardiomyopathy, hypertrophic, 17, 613873 (3)	JPH2, JP2, CMH17	605267	20q13.12	CMH17
Cardiomyopathy, hypertrophic, 18, 613874 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLN
Cardiomyopathy, hypertrophic, 18, 613874 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	PLB
Cardiomyopathy, hypertrophic, 18, 613874 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	CMD1P
Cardiomyopathy, hypertrophic, 18, 613874 (3)	PLN, PLB, CMD1P, CMH18	172405	6q22.31	CMH18
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMH2
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMD1D
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	RCM3
Cardiomyopathy, hypertrophic, 2, 115195 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	LVNC6
Cardiomyopathy, hypertrophic, 20, 613876 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NEXN
Cardiomyopathy, hypertrophic, 20, 613876 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	NELIN
Cardiomyopathy, hypertrophic, 20, 613876 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	CMD1CC
Cardiomyopathy, hypertrophic, 20, 613876 (3)	NEXN, NELIN, CMD1CC, CMH20	613121	1p31.1	CMH20
Cardiomyopathy, hypertrophic, 21 (2)	CMH21	614676	7p12.1-q21	CMH21
Cardiomyopathy, hypertrophic, 22, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	MYPN
Cardiomyopathy, hypertrophic, 22, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMD1DD
Cardiomyopathy, hypertrophic, 22, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	CMH22
Cardiomyopathy, hypertrophic, 22, 615248 (3)	MYPN, CMD1DD, CMH22, RCM4	608517	10q21.3	RCM4
Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	ACTN2
Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	CMD1AA
Cardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3)	ACTN2, CMD1AA, CMH23	102573	1q43	CMH23
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	ZASP
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CYPHER
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	KIAA01613
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	MFM4
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMD1C
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMH24
Cardiomyopathy, hypertrophic, 24, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LVNC3
Cardiomyopathy, hypertrophic, 25, 607487 (3)	TCAP, LGMD2G, CMH25	604488	17q12	TCAP
Cardiomyopathy, hypertrophic, 25, 607487 (3)	TCAP, LGMD2G, CMH25	604488	17q12	LGMD2G
Cardiomyopathy, hypertrophic, 25, 607487 (3)	TCAP, LGMD2G, CMH25	604488	17q12	CMH25
Cardiomyopathy, hypertrophic, 3, 115196 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Cardiomyopathy, hypertrophic, 3, 115196 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMH3
Cardiomyopathy, hypertrophic, 3, 115196 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMD1Y
Cardiomyopathy, hypertrophic, 3, 115196 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	LVNC9
Cardiomyopathy, hypertrophic, 4, 115197 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Cardiomyopathy, hypertrophic, 4, 115197 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMH4
Cardiomyopathy, hypertrophic, 4, 115197 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMD1MM
Cardiomyopathy, hypertrophic, 4, 115197 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	LVNC10
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	TNNI3
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMH7
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD2A
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	RCM1
Cardiomyopathy, hypertrophic, 7, 613690 (3)	TNNI3, CMH7, CMD2A, RCM1, CMD1FF	191044	19q13.42	CMD1FF
Cardiomyopathy, hypertrophic, 8, 608751 (3)	MYL3, CMH8	160790	3p21.31	MYL3
Cardiomyopathy, hypertrophic, 8, 608751 (3)	MYL3, CMH8	160790	3p21.31	CMH8
Carney complex variant, 608837 (3)	MYH8, DA7	160741	17p13.1	MYH8
Carney complex variant, 608837 (3)	MYH8, DA7	160741	17p13.1	DA7
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	TSE1
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CNC1
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CAR
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PPNAD1
Carney complex, type 1, 160980 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	ACRDYS1
Carney complex, type II (2)	CNC2	605244	2p16	CNC2
Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	SLC22A5
Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	OCTN2
Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	CDSP
Carnitine deficiency, systemic primary, 212140 (3)	SLC22A5, OCTN2, CDSP, SCD	603377	5q31.1	SCD
Carnitine-acylcarnitine translocase deficiency, 212138 (3)	SLC25A20, CACT, CAC	613698	3p21.31	SLC25A20
Carnitine-acylcarnitine translocase deficiency, 212138 (3)	SLC25A20, CACT, CAC	613698	3p21.31	CACT
Carnitine-acylcarnitine translocase deficiency, 212138 (3)	SLC25A20, CACT, CAC	613698	3p21.31	CAC
Carnosinemia (2)	CNSN	212200	18q21.3	CNSN
Carotid intimal medial thickness (2)	CIMT	608447	12q24	CIMT
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
Carotid intimal medial thickness 1, 609338 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
Carpal tunnel syndrome, familial, 115430 (3)	TTR, PALB	176300	18q12.1	TTR
Carpal tunnel syndrome, familial, 115430 (3)	TTR, PALB	176300	18q12.1	PALB
Carpenter syndrome 2, 614976 (3)	MEGF8, EGFL4, CRPT2	604267	19q13.2	MEGF8
Carpenter syndrome 2, 614976 (3)	MEGF8, EGFL4, CRPT2	604267	19q13.2	EGFL4
Carpenter syndrome 2, 614976 (3)	MEGF8, EGFL4, CRPT2	604267	19q13.2	CRPT2
Carpenter syndrome, 201000 (3)	RAB23	606144	6p12.1-p11.2	RAB23
Cartilage-hair hypoplasia, 250250 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Cartilage-hair hypoplasia, 250250 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRPR
Cartilage-hair hypoplasia, 250250 (3)	RMRP, RMRPR, CHH	157660	9p13.3	CHH
Cat eye syndrome (4)	CECR, CES	115470	22q11	CECR
Cat eye syndrome (4)	CECR, CES	115470	22q11	CES
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	GJA8
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	CX50
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	CTRCT1
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	CZP1
Cataract 1, multiple types, 116200 (3)	GJA8, CX50, CTRCT1, CZP1, CAE1	600897	1q21.2	CAE1
Cataract 10, multiple types, 600881 (3)	CRYBA1, CRYB1, CTRCT10	123610	17q11.2	CRYBA1
Cataract 10, multiple types, 600881 (3)	CRYBA1, CRYB1, CTRCT10	123610	17q11.2	CRYB1
Cataract 10, multiple types, 600881 (3)	CRYBA1, CRYB1, CTRCT10	123610	17q11.2	CTRCT10
Cataract 11, multiple types, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	PITX3
Cataract 11, multiple types, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTPP4
Cataract 11, multiple types, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTRCT11
Cataract 11, syndromic, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	PITX3
Cataract 11, syndromic, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTPP4
Cataract 11, syndromic, 610623 (3)	PITX3, CTPP4, CTRCT11	602669	10q24.32	CTRCT11
Cataract 12, multiple types, 611597 (3)	BFSP2, CP49, CP47, CTRCT12	603212	3q22.1	BFSP2
Cataract 12, multiple types, 611597 (3)	BFSP2, CP49, CP47, CTRCT12	603212	3q22.1	CP49
Cataract 12, multiple types, 611597 (3)	BFSP2, CP49, CP47, CTRCT12	603212	3q22.1	CP47
Cataract 12, multiple types, 611597 (3)	BFSP2, CP49, CP47, CTRCT12	603212	3q22.1	CTRCT12
Cataract 13 with adult i phenotype, 116700 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
Cataract 13 with adult i phenotype, 116700 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	Ii
Cataract 13 with adult i phenotype, 116700 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	CTRCT13
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	GJA3
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	CX46
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	CZP3
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	CAE3
Cataract 14, multiple types, 601885 (3)	GJA3, CX46, CZP3, CAE3, CTRCT14	121015	13q12.11	CTRCT14
Cataract 15, multiple types, 615274 (3)	MIP, AQP0, CTRCT15	154050	12q13.3	MIP
Cataract 15, multiple types, 615274 (3)	MIP, AQP0, CTRCT15	154050	12q13.3	AQP0
Cataract 15, multiple types, 615274 (3)	MIP, AQP0, CTRCT15	154050	12q13.3	CTRCT15
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYA2
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTPP2
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CMD1II
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTRCT16
Cataract 16, multiple types, 613763 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	MFM2
Cataract 17, multiple types, 611544 (3)	CRYBB1, CATCN3, CTRCT17	600929	22q12.1	CRYBB1
Cataract 17, multiple types, 611544 (3)	CRYBB1, CATCN3, CTRCT17	600929	22q12.1	CATCN3
Cataract 17, multiple types, 611544 (3)	CRYBB1, CATCN3, CTRCT17	600929	22q12.1	CTRCT17
Cataract 18, autosomal recessive, 610019 (3)	FYCO1, CATC2, CTRCT18	607182	3p21.31	FYCO1
Cataract 18, autosomal recessive, 610019 (3)	FYCO1, CATC2, CTRCT18	607182	3p21.31	CATC2
Cataract 18, autosomal recessive, 610019 (3)	FYCO1, CATC2, CTRCT18	607182	3p21.31	CTRCT18
Cataract 19, multiple types, 615277 (3)	LIM2, MP19, CTRCT19	154045	19q13.41	LIM2
Cataract 19, multiple types, 615277 (3)	LIM2, MP19, CTRCT19	154045	19q13.41	MP19
Cataract 19, multiple types, 615277 (3)	LIM2, MP19, CTRCT19	154045	19q13.41	CTRCT19
Cataract 2, multiple types, 604307 (3)	CRYGC, CRYG3, CTRCT2, CCL	123680	2q33.3	CRYGC
Cataract 2, multiple types, 604307 (3)	CRYGC, CRYG3, CTRCT2, CCL	123680	2q33.3	CRYG3
Cataract 2, multiple types, 604307 (3)	CRYGC, CRYG3, CTRCT2, CCL	123680	2q33.3	CTRCT2
Cataract 2, multiple types, 604307 (3)	CRYGC, CRYG3, CTRCT2, CCL	123680	2q33.3	CCL
Cataract 20, multiple types, 116100 (3)	CRYGS, CRYG8, CTRCT20	123730	3q27.3	CRYGS
Cataract 20, multiple types, 116100 (3)	CRYGS, CRYG8, CTRCT20	123730	3q27.3	CRYG8
Cataract 20, multiple types, 116100 (3)	CRYGS, CRYG8, CTRCT20	123730	3q27.3	CTRCT20
Cataract 21, multiple types, 610202 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	MAF
Cataract 21, multiple types, 610202 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	CCA4
Cataract 21, multiple types, 610202 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	CTRCT21
Cataract 21, multiple types, 610202 (3)	MAF, CCA4, CTRCT21, AYGRP	177075	16q23.2	AYGRP
Cataract 22, autosomal recessive, 609741 (3)	CRYBB3, CRYB3, CATCN2, CTRCT22	123630	22q11.23	CRYBB3
Cataract 22, autosomal recessive, 609741 (3)	CRYBB3, CRYB3, CATCN2, CTRCT22	123630	22q11.23	CRYB3
Cataract 22, autosomal recessive, 609741 (3)	CRYBB3, CRYB3, CATCN2, CTRCT22	123630	22q11.23	CATCN2
Cataract 22, autosomal recessive, 609741 (3)	CRYBB3, CRYB3, CATCN2, CTRCT22	123630	22q11.23	CTRCT22
Cataract 23, 610425 (3)	CRYBA4, CTRCT23	123631	22q12.1	CRYBA4
Cataract 23, 610425 (3)	CRYBA4, CTRCT23	123631	22q12.1	CTRCT23
Cataract 24, anterior polar (2)	CTRCT24, CTAA2	601202	17p13	CTRCT24
Cataract 24, anterior polar (2)	CTRCT24, CTAA2	601202	17p13	CTAA2
Cataract 25 (2)	CTRCT25, CCSSO	605728	15q21-q22	CTRCT25
Cataract 25 (2)	CTRCT25, CCSSO	605728	15q21-q22	CCSSO
Cataract 26, multiple types (2)	CTRCT26, CAAR	605749	9q13-q22	CTRCT26
Cataract 26, multiple types (2)	CTRCT26, CAAR	605749	9q13-q22	CAAR
Cataract 27, nuclear progressive (2)	CTRCT27, CCNP	607304	2p12	CTRCT27
Cataract 27, nuclear progressive (2)	CTRCT27, CCNP	607304	2p12	CCNP
Cataract 29, coralliform (2)	CTRCT29	115800	2pter-p24	CTRCT29
Cataract 3, multiple types, 601547 (3)	CRYBB2, CRYB2, CTRCT3, CCA2	123620	22q11.23	CRYBB2
Cataract 3, multiple types, 601547 (3)	CRYBB2, CRYB2, CTRCT3, CCA2	123620	22q11.23	CRYB2
Cataract 3, multiple types, 601547 (3)	CRYBB2, CRYB2, CTRCT3, CCA2	123620	22q11.23	CTRCT3
Cataract 3, multiple types, 601547 (3)	CRYBB2, CRYB2, CTRCT3, CCA2	123620	22q11.23	CCA2
Cataract 31, multiple types, 605387 (3)	CHMP4B, SNF7, CTPP3, CTRCT31	610897	20q11.22	CHMP4B
Cataract 31, multiple types, 605387 (3)	CHMP4B, SNF7, CTPP3, CTRCT31	610897	20q11.22	SNF7
Cataract 31, multiple types, 605387 (3)	CHMP4B, SNF7, CTPP3, CTRCT31	610897	20q11.22	CTPP3
Cataract 31, multiple types, 605387 (3)	CHMP4B, SNF7, CTPP3, CTRCT31	610897	20q11.22	CTRCT31
Cataract 32, multiple types (2)	CTRCT32, CTAA1, CAP, CTPP5	115650	14q22-q23	CTRCT32
Cataract 32, multiple types (2)	CTRCT32, CTAA1, CAP, CTPP5	115650	14q22-q23	CTAA1
Cataract 32, multiple types (2)	CTRCT32, CTAA1, CAP, CTPP5	115650	14q22-q23	CAP
Cataract 32, multiple types (2)	CTRCT32, CTAA1, CAP, CTPP5	115650	14q22-q23	CTPP5
Cataract 33, 611391 (3)	BFSP1, CP115, CTRCT33	603307	20p12.1	BFSP1
Cataract 33, 611391 (3)	BFSP1, CP115, CTRCT33	603307	20p12.1	CP115
Cataract 33, 611391 (3)	BFSP1, CP115, CTRCT33	603307	20p12.1	CTRCT33
Cataract 34, multiple types (2)	CTRCT34, CATC3	612968	1p34.3-p32.2	CTRCT34
Cataract 34, multiple types (2)	CTRCT34, CATC3	612968	1p34.3-p32.2	CATC3
Cataract 35, congenital nuclear (2)	CTRCT35, CATCN1	609376	19q13	CTRCT35
Cataract 35, congenital nuclear (2)	CTRCT35, CATCN1	609376	19q13	CATCN1
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	TDRD7
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	KIAA1529
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	TRAP
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	CATC4
Cataract 36, 613887 (3)	TDRD7, KIAA1529, TRAP, CATC4, CTRCT36	611258	9q22.33	CTRCT36
Cataract 37, autosomal dominant (2)	CTRCT37, CCA5	614422	12q24.2-q24.3	CTRCT37
Cataract 37, autosomal dominant (2)	CTRCT37, CCA5	614422	12q24.2-q24.3	CCA5
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	AGK
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	MULK
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	MTDPS10
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	CATC5
Cataract 38, autosomal recessive, 614691 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	CTRCT38
Cataract 39, multiple types, autosomal dominant, 615188 (3)	CRYGB, CRYG2, CTRCT39	123670	2q33.3	CRYGB
Cataract 39, multiple types, autosomal dominant, 615188 (3)	CRYGB, CRYG2, CTRCT39	123670	2q33.3	CRYG2
Cataract 39, multiple types, autosomal dominant, 615188 (3)	CRYGB, CRYG2, CTRCT39	123670	2q33.3	CTRCT39
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CRYGD
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CRYG4
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CTRCT4
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CACA
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	CCA3
Cataract 4, multiple types, 115700 (3)	CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC	123690	2q33.3	PCC
Cataract 40, X-linked, 302200 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	NHS
Cataract 40, X-linked, 302200 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	CXN
Cataract 40, X-linked, 302200 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	CTRCT40
Cataract 44, 616509 (3)	LSS, OSC, CTRCT44	600909	21q22.3	LSS
Cataract 44, 616509 (3)	LSS, OSC, CTRCT44	600909	21q22.3	OSC
Cataract 44, 616509 (3)	LSS, OSC, CTRCT44	600909	21q22.3	CTRCT44
Cataract 46, juvenile-onset, 212500 (3)	LEMD2, NET25, CTRCT42	616312	6p21.31	LEMD2
Cataract 46, juvenile-onset, 212500 (3)	LEMD2, NET25, CTRCT42	616312	6p21.31	NET25
Cataract 46, juvenile-onset, 212500 (3)	LEMD2, NET25, CTRCT42	616312	6p21.31	CTRCT42
Cataract 47, juvenile, with microcornea, 612018 (3)	SLC16A12, MCT12, CTRCT47	611910	10q23.31	SLC16A12
Cataract 47, juvenile, with microcornea, 612018 (3)	SLC16A12, MCT12, CTRCT47	611910	10q23.31	MCT12
Cataract 47, juvenile, with microcornea, 612018 (3)	SLC16A12, MCT12, CTRCT47	611910	10q23.31	CTRCT47
Cataract 5, multiple types, 116800 (3)	HSF4, CTM, CTRCT5	602438	16q22.1	HSF4
Cataract 5, multiple types, 116800 (3)	HSF4, CTM, CTRCT5	602438	16q22.1	CTM
Cataract 5, multiple types, 116800 (3)	HSF4, CTM, CTRCT5	602438	16q22.1	CTRCT5
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	EPHA2
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	ECK
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	ARCC2
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	CTPP1
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	CTPA
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	ARCC2
Cataract 6, multiple types, 116600 (3)	EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2, CTRCT6	176946	1p36.13	CTRCT6
Cataract 7 (2)	CTRCT7, CCA1	115660	17q24	CTRCT7
Cataract 7 (2)	CTRCT7, CCA1	115660	17q24	CCA1
Cataract 8, multiple types (2)	CTRCT8, CCV	115665	1pter-p36.13	CTRCT8
Cataract 8, multiple types (2)	CTRCT8, CCV	115665	1pter-p36.13	CCV
Cataract 9, multiple types, 604219 (3)	CRYAA, CRYA1, CTRCT9	123580	21q22.3	CRYAA
Cataract 9, multiple types, 604219 (3)	CRYAA, CRYA1, CTRCT9	123580	21q22.3	CRYA1
Cataract 9, multiple types, 604219 (3)	CRYAA, CRYA1, CTRCT9	123580	21q22.3	CTRCT9
Cataract with late-onset corneal dystrophy, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Cataract with late-onset corneal dystrophy, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Cataract with late-onset corneal dystrophy, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Cataract with late-onset corneal dystrophy, 106210 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Catel-Manzke syndrome, 616145 (3)	TGDS, SDR2E1, CATMANS	616146	13q32.1	TGDS
Catel-Manzke syndrome, 616145 (3)	TGDS, SDR2E1, CATMANS	616146	13q32.1	SDR2E1
Catel-Manzke syndrome, 616145 (3)	TGDS, SDR2E1, CATMANS	616146	13q32.1	CATMANS
Caudal regression syndrome, 600145 (3)	VANGL1, STBM2	610132	1p13.1	VANGL1
Caudal regression syndrome, 600145 (3)	VANGL1, STBM2	610132	1p13.1	STBM2
Cavernous malformations of CNS and retina, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Cavernous malformations of CNS and retina, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CAM
Cavernous malformations of CNS and retina, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	KRIT1
Cavitary optic disc anomalies, 611543 (3)	MMP19, MMP18, CODA	601807	12q13.2	MMP19
Cavitary optic disc anomalies, 611543 (3)	MMP19, MMP18, CODA	601807	12q13.2	MMP18
Cavitary optic disc anomalies, 611543 (3)	MMP19, MMP18, CODA	601807	12q13.2	CODA
Cayler cardiofacial syndrome (2)	ACF	125520	22q11	ACF
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	MEGF7
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CLSS
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	SOST2
Cenani-Lenz syndactyly syndrome, 212780 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CMS17
Central core disease, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Central core disease, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	MHS
Central core disease, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	CCO
Central hypoventilation syndrome, 209880 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
Central hypoventilation syndrome, 209880 (3)	GDNF, HSCR3	600837	5p13.2	HSCR3
Central hypoventilation syndrome, congenital, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASCL1
Central hypoventilation syndrome, congenital, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASH1
Central hypoventilation syndrome, congenital, 209880 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
Central hypoventilation syndrome, congenital, 209880 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BULN2
Central hypoventilation syndrome, congenital, 209880 (3)	BDNF, BULN2, ANON2	113505	11p14.1	ANON2
Central hypoventilation syndrome, congenital, 209880 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
Central hypoventilation syndrome, congenital, 209880 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	WS4B
Central hypoventilation syndrome, congenital, 209880 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	HSCR4
Central hypoventilation syndrome, congenital, 209880 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Central hypoventilation syndrome, congenital, 209880 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
Central hypoventilation syndrome, congenital, 209880 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBPHOX
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PHOX2B
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBLST2
Centronuclear myopathy 5, 615959 (3)	SPEG, APEG1, CNM5	615950	2q35	SPEG
Centronuclear myopathy 5, 615959 (3)	SPEG, APEG1, CNM5	615950	2q35	APEG1
Centronuclear myopathy 5, 615959 (3)	SPEG, APEG1, CNM5	615950	2q35	CNM5
Centrotemporal epilepsy (2)	ECT, BECTS	117100	11p13	ECT
Centrotemporal epilepsy (2)	ECT, BECTS	117100	11p13	BECTS
Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	RNF216, TRIAD3, ZIN, CAHH	609948	7p22.1	RNF216
Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	RNF216, TRIAD3, ZIN, CAHH	609948	7p22.1	TRIAD3
Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	RNF216, TRIAD3, ZIN, CAHH	609948	7p22.1	ZIN
Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3)	RNF216, TRIAD3, ZIN, CAHH	609948	7p22.1	CAHH
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	CA8, CALS, CARP, CAMRQ3	114815	8q12.1	CA8
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	CA8, CALS, CARP, CAMRQ3	114815	8q12.1	CALS
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	CA8, CALS, CARP, CAMRQ3	114815	8q12.1	CARP
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3)	CA8, CALS, CARP, CAMRQ3	114815	8q12.1	CAMRQ3
Cerebellar ataxia, 604290 (3)	CP	117700	3q24-q25	CP
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	DNMT1
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	MCMT
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	HSN1E
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	ADCADN
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3)	WDR81, CAMRQ2	614218	17p13.3	WDR81
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3)	WDR81, CAMRQ2	614218	17p13.3	CAMRQ2
Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	CAMTA1, KIAA0833, CANPMR	611501	1p36.31-p36.23	CAMTA1
Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	CAMTA1, KIAA0833, CANPMR	611501	1p36.31-p36.23	KIAA0833
Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3)	CAMTA1, KIAA0833, CANPMR	611501	1p36.31-p36.23	CANPMR
Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	EMC1, KIAA0090, CAVIPMR	616846	1p36.13	EMC1
Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	EMC1, KIAA0090, CAVIPMR	616846	1p36.13	KIAA0090
Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3)	EMC1, KIAA0090, CAVIPMR	616846	1p36.13	CAVIPMR
Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	VLDLR, CAMRQ1	192977	9p24.2	VLDLR
Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3)	VLDLR, CAMRQ1	192977	9p24.2	CAMRQ1
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	BRF1
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	TAF3C
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	GTF3B
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	TF3B90
Cerebellofaciodental syndrome, 616202 (3)	BRF1, TAF3C, GTF3B, TF3B90, CFDS	604902	14q32.33	CFDS
Cerebral amyloid angiopathy, 105150 (3)	CST3, ARMD11	604312	20p11.21	CST3
Cerebral amyloid angiopathy, 105150 (3)	CST3, ARMD11	604312	20p11.21	ARMD11
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	APP
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	AAA
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	CVAP
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3)	APP, AAA, CVAP, AD1	104760	21q21.3	AD1
Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Cerebral amyloid angiopathy, PRNP-related, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CADASIL1
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CASIL
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	IMF2
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	LMNS
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	PRSS11
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	ARMD7
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CARASIL
Cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 2, 616779 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CADASIL2
Cerebral cavernous malformations 3, 603285 (3)	PDCD10, TFAR15, CCM3	609118	3q26.1	PDCD10
Cerebral cavernous malformations 3, 603285 (3)	PDCD10, TFAR15, CCM3	609118	3q26.1	TFAR15
Cerebral cavernous malformations 3, 603285 (3)	PDCD10, TFAR15, CCM3	609118	3q26.1	CCM3
Cerebral cavernous malformations-1, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Cerebral cavernous malformations-1, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CAM
Cerebral cavernous malformations-1, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	KRIT1
Cerebral cavernous malformations-2, 603284 (3)	C7orf22, CCM2, MGC4067	607929	7p13	C7orf22
Cerebral cavernous malformations-2, 603284 (3)	C7orf22, CCM2, MGC4067	607929	7p13	CCM2
Cerebral cavernous malformations-2, 603284 (3)	C7orf22, CCM2, MGC4067	607929	7p13	MGC4067
Cerebral creatine deficiency syndrome 1, 300352 (3)	SLC6A8, CRTR, CCDS1	300036	Xq28	SLC6A8
Cerebral creatine deficiency syndrome 1, 300352 (3)	SLC6A8, CRTR, CCDS1	300036	Xq28	CRTR
Cerebral creatine deficiency syndrome 1, 300352 (3)	SLC6A8, CRTR, CCDS1	300036	Xq28	CCDS1
Cerebral creatine deficiency syndrome 2, 612736 (3)	GAMT, CCDS2	601240	19p13.3	GAMT
Cerebral creatine deficiency syndrome 2, 612736 (3)	GAMT, CCDS2	601240	19p13.3	CCDS2
Cerebral creatine deficiency syndrome 3, 612718 (3)	GATM, AGAT, CCDS3	602360	15q21.1	GATM
Cerebral creatine deficiency syndrome 3, 612718 (3)	GATM, AGAT, CCDS3	602360	15q21.1	AGAT
Cerebral creatine deficiency syndrome 3, 612718 (3)	GATM, AGAT, CCDS3	602360	15q21.1	CCDS3
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	SNAP29, CEDNIK	604202	22q11.21	SNAP29
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3)	SNAP29, CEDNIK	604202	22q11.21	CEDNIK
Cerebral palsy, ataxic, autosomal recessive (2)	ACP	605388	9p12-q12	ACP
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	KANK1
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	KANK
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	ANKRD15
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	KIAA0172
Cerebral palsy, spastic quadriplegic, 2, 612900 (3)	KANK1, KANK, ANKRD15, KIAA0172, CPSQ2	607704	9p24.3	CPSQ2
Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	ADD3, ADDL, CPSQ3	601568	10q25.1-q25.2	ADD3
Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	ADD3, ADDL, CPSQ3	601568	10q25.1-q25.2	ADDL
Cerebral palsy, spastic quadriplegic, 3, 617008 (3)	ADD3, ADDL, CPSQ3	601568	10q25.1-q25.2	CPSQ3
Cerebral-cerebellar-coloboma syndrome, X-linked (2)	CCCSX	300864	Chr.X	CCCSX
Cerebrocostomandibular syndrome, 117650 (3)	SNRPB, CCMS	182282	20p13	SNRPB
Cerebrocostomandibular syndrome, 117650 (3)	SNRPB, CCMS	182282	20p13	CCMS
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
Cerebrooculofacioskeletal syndrome 1, 214150 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	EM9
Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	XPD
Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	COFS2
Cerebrooculofacioskeletal syndrome 2, 610756 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	TTD1
Cerebrooculofacioskeletal syndrome 3, 616570 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Cerebrooculofacioskeletal syndrome 3, 616570 (3)	ERCC5, XPG, COFS3	133530	13q33.1	XPG
Cerebrooculofacioskeletal syndrome 3, 616570 (3)	ERCC5, XPG, COFS3	133530	13q33.1	COFS3
Cerebrooculofacioskeletal syndrome 4, 610758 (3)	ERCC1, UV20, COFS4	126380	19q13.32	ERCC1
Cerebrooculofacioskeletal syndrome 4, 610758 (3)	ERCC1, UV20, COFS4	126380	19q13.32	UV20
Cerebrooculofacioskeletal syndrome 4, 610758 (3)	ERCC1, UV20, COFS4	126380	19q13.32	COFS4
Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	CTC1, CRMCC, C17orf68, AAF132	613129	17p13.1	CTC1
Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	CTC1, CRMCC, C17orf68, AAF132	613129	17p13.1	CRMCC
Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	CTC1, CRMCC, C17orf68, AAF132	613129	17p13.1	C17orf68
Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3)	CTC1, CRMCC, C17orf68, AAF132	613129	17p13.1	AAF132
Cerebrotendinous xanthomatosis, 213700 (3)	CYP27A1, CYP27, CTX	606530	2q35	CYP27A1
Cerebrotendinous xanthomatosis, 213700 (3)	CYP27A1, CYP27, CTX	606530	2q35	CYP27
Cerebrotendinous xanthomatosis, 213700 (3)	CYP27A1, CYP27, CTX	606530	2q35	CTX
Cerebrovascular disease, occlusive (3)	SERPINA3, AACT, ACT	107280	14q32.13	SERPINA3
Cerebrovascular disease, occlusive (3)	SERPINA3, AACT, ACT	107280	14q32.13	AACT
Cerebrovascular disease, occlusive (3)	SERPINA3, AACT, ACT	107280	14q32.13	ACT
Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	PPT1, CLN1	600722	1p34.2	PPT1
Ceroid lipofuscinosis, neuronal, 1, 256730 (3)	PPT1, CLN1	600722	1p34.2	CLN1
Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	CTSD, CPSD, CLN10	116840	11p15.5	CTSD
Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	CTSD, CPSD, CLN10	116840	11p15.5	CPSD
Ceroid lipofuscinosis, neuronal, 10, 610127 (3)	CTSD, CPSD, CLN10	116840	11p15.5	CLN10
Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	GRN, CLN11	138945	17q21.31	GRN
Ceroid lipofuscinosis, neuronal, 11, 614706 (3)	GRN, CLN11	138945	17q21.31	CLN11
Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	CTSF, CLN13	603539	11q13.2	CTSF
Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3)	CTSF, CLN13	603539	11q13.2	CLN13
Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	TPP1
Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	CLN2
Ceroid lipofuscinosis, neuronal, 2, 204500 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	SCAR7
Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	CLN3, BTS	607042	16p12.1	CLN3
Ceroid lipofuscinosis, neuronal, 3, 204200 (3)	CLN3, BTS	607042	16p12.1	BTS
Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	DNAJC5, DNAJC5A, CSP, CLN4B	611203	20q13.33	DNAJC5
Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	DNAJC5, DNAJC5A, CSP, CLN4B	611203	20q13.33	DNAJC5A
Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	DNAJC5, DNAJC5A, CSP, CLN4B	611203	20q13.33	CSP
Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)	DNAJC5, DNAJC5A, CSP, CLN4B	611203	20q13.33	CLN4B
Ceroid lipofuscinosis, neuronal, 5, 256731 (3)	CLN5	608102	13q22.3	CLN5
Ceroid lipofuscinosis, neuronal, 6, 601780 (3)	CLN6, CLN4A	606725	15q23	CLN6
Ceroid lipofuscinosis, neuronal, 6, 601780 (3)	CLN6, CLN4A	606725	15q23	CLN4A
Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MFSD8
Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MGC33302
Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	CLN7
Ceroid lipofuscinosis, neuronal, 7, 610951 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	CCMD
Ceroid lipofuscinosis, neuronal, 8, 600143 (3)	CLN8, EPMR	607837	8p23.3	CLN8
Ceroid lipofuscinosis, neuronal, 8, 600143 (3)	CLN8, EPMR	607837	8p23.3	EPMR
Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	CLN8, EPMR	607837	8p23.3	CLN8
Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3)	CLN8, EPMR	607837	8p23.3	EPMR
Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	CLN6, CLN4A	606725	15q23	CLN6
Ceroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3)	CLN6, CLN4A	606725	15q23	CLN4A
Cervical cancer, somatic, 603956 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Cervical cancer, somatic, 603956 (3)	FGFR3, ACH	134934	4p16.3	ACH
Cervical carcinoma (2)	ST3	191181	11q13	ST3
Chanarin-Dorfman syndrome, 275630 (3)	ABHD5, CGI58, IECN2, NCIE2	604780	3p21.33	ABHD5
Chanarin-Dorfman syndrome, 275630 (3)	ABHD5, CGI58, IECN2, NCIE2	604780	3p21.33	CGI58
Chanarin-Dorfman syndrome, 275630 (3)	ABHD5, CGI58, IECN2, NCIE2	604780	3p21.33	IECN2
Chanarin-Dorfman syndrome, 275630 (3)	ABHD5, CGI58, IECN2, NCIE2	604780	3p21.33	NCIE2
Char syndrome, 169100 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	TFAP2B
Char syndrome, 169100 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	CHAR
Char syndrome, 169100 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	PDA2
Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	CMTX5
Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFNX1
Charcot-Marie-Tooth disease, X-linked recessive, 5, 311070 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFN2
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNCL
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNECL
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	CMT20
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	MRD13
Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	SMALED1
Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	NEFH, CMT2CC	162230	22q12.2	NEFH
Charcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3)	NEFH, CMT2CC	162230	22q12.2	CMT2CC
Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSPB1
Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSP27
Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	CMT2F
Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HMN2B
Charcot-Marie-Tooth disease, axonal, type 2G (2)	CMT2G	608591	12q12-q13.3	CMT2G
Charcot-Marie-Tooth disease, axonal, type 2H (2)	CMT2H	607731	8q13-q23	CMT2H
Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT4A
Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT2K
Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMTRIA
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HSPB8
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	H11
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	E2IG1
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	DHMN2
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	CMT2L
Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HMN2A
Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDIB
Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDI1
Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMT2M
Charcot-Marie-Tooth disease, axonal, type 2M, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	LCCS5
Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	AARS
Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	CMT2N
Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	EIEE29
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	IGHMBP2
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	SMUBP2
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	CATF1
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	SMARD1
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	HMN6
Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	CMT2S
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T	120520	3q25.2	MME
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T	120520	3q25.2	CD10
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T	120520	3q25.2	CALLA
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T	120520	3q25.2	NEP
Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3)	MME, CD10, CALLA, NEP, CMT2T	120520	3q25.2	CMT2T
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MARS
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MTRNS
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	METRS
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	ILLD
Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	CMT2U
Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	HARS, USH3B, CMT2W	142810	5q31.3	HARS
Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	HARS, USH3B, CMT2W	142810	5q31.3	USH3B
Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3)	HARS, USH3B, CMT2W	142810	5q31.3	CMT2W
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	KIAA1840
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	FLJ21439
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	ALS5
Charcot-Marie-Tooth disease, axonal, type 2X, 616668 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	CMT2X
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	MORC2
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	ZCW3
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	ZCWCC1
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	KIAA0852
Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3)	MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z	616661	22q12.2	CMT2Z
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT4A
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT2K
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, 607706 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMTRIA
Charcot-Marie-Tooth disease, dominant intermediate A (2)	CMTDIA	606483	10q24.1-q25.1	CMTDIA
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDIB
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDI1
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMT2M
Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	LCCS5
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	YARS
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	CMTDIC
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	TYRRS
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	YTS
Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)	YARS, CMTDIC, TYRRS, YTS, YRS	603623	1p35.1	YRS
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	INF2
Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	FSGS5
Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	C14orf173
Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	CMTDIE
Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	GNB4, CMTD1F	610863	3q26.33	GNB4
Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3)	GNB4, CMTD1F	610863	3q26.33	CMTD1F
Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOXD10
Charcot-Marie-Tooth disease, foot deformity of, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOX4D
Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	PLEKHG5
Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	KIAA0720
Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	DSMA4
Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	CMTRIC
Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	COX6A1, CMTRID	602072	12q24.31	COX6A1
Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3)	COX6A1, CMTRID	602072	12q24.31	CMTRID
Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT4A
Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT2K
Charcot-Marie-Tooth disease, recessive intermediate, A, 608340 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMTRIA
Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Charcot-Marie-Tooth disease, type 1A, 118220 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Charcot-Marie-Tooth disease, type 1B, 118200 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Charcot-Marie-Tooth disease, type 1C, 601098 (3)	LITAF, CMT1C	603795	16p13.13	LITAF
Charcot-Marie-Tooth disease, type 1C, 601098 (3)	LITAF, CMT1C	603795	16p13.13	CMT1C
Charcot-Marie-Tooth disease, type 1D, 607678 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Charcot-Marie-Tooth disease, type 1D, 607678 (3)	EGR2, KROX20	129010	10q21.3	KROX20
Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Charcot-Marie-Tooth disease, type 1E, 118300 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Charcot-Marie-Tooth disease, type 1F, 607734 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	NEFL
Charcot-Marie-Tooth disease, type 1F, 607734 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	CMT2E
Charcot-Marie-Tooth disease, type 1F, 607734 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	CMT1F
Charcot-Marie-Tooth disease, type 2A2, 609260 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	MFN2
Charcot-Marie-Tooth disease, type 2A2, 609260 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	KIAA0214
Charcot-Marie-Tooth disease, type 2A2, 609260 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	CMT2A2
Charcot-Marie-Tooth disease, type 2A2, 609260 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	HMSN6A
Charcot-Marie-Tooth disease, type 2B, 600882 (3)	RAB7, CMT2B, PSN	602298	3q21.3	RAB7
Charcot-Marie-Tooth disease, type 2B, 600882 (3)	RAB7, CMT2B, PSN	602298	3q21.3	CMT2B
Charcot-Marie-Tooth disease, type 2B, 600882 (3)	RAB7, CMT2B, PSN	602298	3q21.3	PSN
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Charcot-Marie-Tooth disease, type 2B1, 605588 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	GARS
Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	SMAD1
Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	CMT2D
Charcot-Marie-Tooth disease, type 2D, 601472 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	HMN5
Charcot-Marie-Tooth disease, type 2E, 607684 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	NEFL
Charcot-Marie-Tooth disease, type 2E, 607684 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	CMT2E
Charcot-Marie-Tooth disease, type 2E, 607684 (3)	NEFL, CMT2E, CMT1F	162280	8p21.2	CMT1F
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Charcot-Marie-Tooth disease, type 2I, 607677 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Charcot-Marie-Tooth disease, type 2J, 607736 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Charcot-Marie-Tooth disease, type 2R, 615490 (3)	TRIM2, KIAA0517, CMT2R	614141	4q31.3	TRIM2
Charcot-Marie-Tooth disease, type 2R, 615490 (3)	TRIM2, KIAA0517, CMT2R	614141	4q31.3	KIAA0517
Charcot-Marie-Tooth disease, type 2R, 615490 (3)	TRIM2, KIAA0517, CMT2R	614141	4q31.3	CMT2R
Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	IBMPFD1
Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	ALS14
Charcot-Marie-Tooth disease, type 2Y, 616687 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	CMT2Y
Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	GDAP1
Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT4A
Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMT2K
Charcot-Marie-Tooth disease, type 4A, 214400 (3)	GDAP1, CMT4A, CMT2K, CMTRIA	606598	8q21.11	CMTRIA
Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	MTMR2, CMT4B1	603557	11q21	MTMR2
Charcot-Marie-Tooth disease, type 4B1, 601382 (3)	MTMR2, CMT4B1	603557	11q21	CMT4B1
Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	SBF2, MTMR13, CMT4B2	607697	11p15.4	SBF2
Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	SBF2, MTMR13, CMT4B2	607697	11p15.4	MTMR13
Charcot-Marie-Tooth disease, type 4B2, 604563 (3)	SBF2, MTMR13, CMT4B2	607697	11p15.4	CMT4B2
Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	SBF1, MTMR5, CMT4B3	603560	22q13.33	SBF1
Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	SBF1, MTMR5, CMT4B3	603560	22q13.33	MTMR5
Charcot-Marie-Tooth disease, type 4B3, 615284 (3)	SBF1, MTMR5, CMT4B3	603560	22q13.33	CMT4B3
Charcot-Marie-Tooth disease, type 4C, 601596 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	SH3TC2
Charcot-Marie-Tooth disease, type 4C, 601596 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	KIAA1985
Charcot-Marie-Tooth disease, type 4C, 601596 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	MNMN
Charcot-Marie-Tooth disease, type 4D, 601455 (3)	NDRG1, HMSNL, CMT4D	605262	8q24.22	NDRG1
Charcot-Marie-Tooth disease, type 4D, 601455 (3)	NDRG1, HMSNL, CMT4D	605262	8q24.22	HMSNL
Charcot-Marie-Tooth disease, type 4D, 601455 (3)	NDRG1, HMSNL, CMT4D	605262	8q24.22	CMT4D
Charcot-Marie-Tooth disease, type 4F, 614895 (3)	PRX, CMT4F	605725	19q13.2	PRX
Charcot-Marie-Tooth disease, type 4F, 614895 (3)	PRX, CMT4F	605725	19q13.2	CMT4F
Charcot-Marie-Tooth disease, type 4H, 609311 (3)	FGD4, FRABIN, CMT4H	611104	12p11.21	FGD4
Charcot-Marie-Tooth disease, type 4H, 609311 (3)	FGD4, FRABIN, CMT4H	611104	12p11.21	FRABIN
Charcot-Marie-Tooth disease, type 4H, 609311 (3)	FGD4, FRABIN, CMT4H	611104	12p11.21	CMT4H
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	KIAA0274
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	SAC3
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	ALS11
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	YVS
Charcot-Marie-Tooth disease, type 4J, 611228 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	BTOP
Charcot-Marie-Tooth disease, type 4K, 616684 (3)	SURF1, CMT4K	185620	9q34.2	SURF1
Charcot-Marie-Tooth disease, type 4K, 616684 (3)	SURF1, CMT4K	185620	9q34.2	CMT4K
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	GJB1, CX32, CMTX1	304040	Xq13.1	GJB1
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	GJB1, CX32, CMTX1	304040	Xq13.1	CX32
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)	GJB1, CX32, CMTX1	304040	Xq13.1	CMTX1
Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)	CMTX2	302801	Xp22.2	CMTX2
Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)	CMTX3	302802	Xq26	CMTX3
Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	LRSAM1, TAL, RIFLE, CMT2P	610933	9q33.3-q34.1	LRSAM1
Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	LRSAM1, TAL, RIFLE, CMT2P	610933	9q33.3-q34.1	TAL
Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	LRSAM1, TAL, RIFLE, CMT2P	610933	9q33.3-q34.1	RIFLE
Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)	LRSAM1, TAL, RIFLE, CMT2P	610933	9q33.3-q34.1	CMT2P
Chediak-Higashi syndrome, 214500 (3)	LYST, CHS1	606897	1q42.3	LYST
Chediak-Higashi syndrome, 214500 (3)	LYST, CHS1	606897	1q42.3	CHS1
Cherubism, 118400 (3)	SH3BP2, CRPM	602104	4p16.3	SH3BP2
Cherubism, 118400 (3)	SH3BP2, CRPM	602104	4p16.3	CRPM
Chilblain lupus, 610448 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Chilblain lupus, 610448 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	AGS1
Chilblain lupus, 610448 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	CRV
Chilblain lupus, 610448 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	HERNS
Choanal atresia and lymphedema, 613611 (3)	PTPN14, PEZ	603155	1q32-q41	PTPN14
Choanal atresia and lymphedema, 613611 (3)	PTPN14, PEZ	603155	1q32-q41	PEZ
Cholangitis, primary sclerosing (2)	PSC	613806	3p21	PSC
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	ABCB11
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	BSEP
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	SPGP
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	PFIC2
Cholestasis, benign recurrent intrahepatic, 2, 605479 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	BRIC2
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	FIC1
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	BRIC
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	PFIC1
Cholestasis, benign recurrent intrahepatic, 243300 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ICP1
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	FIC1
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	BRIC
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	PFIC1
Cholestasis, intrahepatic, of pregnancy, 1, 147480 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ICP1
Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	PGY3
Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	MDR3
Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ICP3
Cholestasis, progressive canalicular (1)	VIL1	193040	2q35	VIL1
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ATP8B1
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	FIC1
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	BRIC
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	PFIC1
Cholestasis, progressive familial intrahepatic 1, 211600 (3)	ATP8B1, FIC1, BRIC, PFIC1, ICP1	602397	18q21.31	ICP1
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	ABCB11
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	BSEP
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	SPGP
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	PFIC2
Cholestasis, progressive familial intrahepatic 2, 601847 (3)	ABCB11, BSEP, SPGP, PFIC2, BRIC2	603201	2q31.1	BRIC2
Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	PGY3
Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	MDR3
Cholestasis, progressive familial intrahepatic 3, 602347 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ICP3
Cholestasis, progressive familial intrahepatic 4, 615878 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	TJP2
Cholestasis, progressive familial intrahepatic 4, 615878 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	ZO2
Cholestasis, progressive familial intrahepatic 4, 615878 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	PFIC4
Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	NR1H4, FXR, RIP14, PFIC5	603826	12q23.1	NR1H4
Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	NR1H4, FXR, RIP14, PFIC5	603826	12q23.1	FXR
Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	NR1H4, FXR, RIP14, PFIC5	603826	12q23.1	RIP14
Cholestasis, progressive familial intrahepatic, 5, 617049 (3)	NR1H4, FXR, RIP14, PFIC5	603826	12q23.1	PFIC5
Cholestasis-lymphedema syndrome (2)	LCS1, CHLS	214900	15q	LCS1
Cholestasis-lymphedema syndrome (2)	LCS1, CHLS	214900	15q	CHLS
Cholesteryl ester storage disease, 278000 (3)	LIPA, CESD	613497	10q23.31	LIPA
Cholesteryl ester storage disease, 278000 (3)	LIPA, CESD	613497	10q23.31	CESD
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANKH
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	HANK
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANK
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CMDJ
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CCAL2
Chondrocalcinosis 2, 118600 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CPPDD
Chondrocalcinosis with early-onset osteoarthritis (2)	CCAL1	600668	8q	CCAL1
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	EBP
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CDPX2
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CPXD
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CPX
Chondrodysplasia punctata, X-linked dominant, 302960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	MEND
Chondrodysplasia punctata, X-linked recessive, 302950 (3)	ARSE, CDPX1, CDPXR	300180	Xp22.33	ARSE
Chondrodysplasia punctata, X-linked recessive, 302950 (3)	ARSE, CDPX1, CDPXR	300180	Xp22.33	CDPX1
Chondrodysplasia punctata, X-linked recessive, 302950 (3)	ARSE, CDPX1, CDPXR	300180	Xp22.33	CDPXR
Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	IMPAD1, GPAPP, IMPA3	614010	8q12.1	IMPAD1
Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	IMPAD1, GPAPP, IMPA3	614010	8q12.1	GPAPP
Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3)	IMPAD1, GPAPP, IMPA3	614010	8q12.1	IMPA3
Chondrodysplasia, Blomstrand type, 215045 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Chondrodysplasia, Blomstrand type, 215045 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR
Chondrodysplasia, Blomstrand type, 215045 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PFE
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Chondrodysplasia, Grebe type, 200700 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Chondrosarcoma, 215300 (3)	EXT1	608177	8q24.11	EXT1
Chondrosarcoma, extraskeletal myxoid, 612237 (1)	TAF15, TAF2N, RBP56	601574	17q12	TAF15
Chondrosarcoma, extraskeletal myxoid, 612237 (1)	TAF15, TAF2N, RBP56	601574	17q12	TAF2N
Chondrosarcoma, extraskeletal myxoid, 612237 (1)	TAF15, TAF2N, RBP56	601574	17q12	RBP56
Chondrosarcoma, extraskeletal myxoid, 612237 (3)	CSMF	600542	9q31.1	CSMF
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TITF1
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2A
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TTF1
Chorea, hereditary benign, 118700 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NMTC1
Choreoacanthocytosis, 200150 (3)	VPS13A, CHAC	605978	9q21.2	VPS13A
Choreoacanthocytosis, 200150 (3)	VPS13A, CHAC	605978	9q21.2	CHAC
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TITF1
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2A
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TTF1
Choreoathetosis, hypothyroidism, and neonatal respiratory distress, 610978 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NMTC1
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Choriodal dystrophy, central areolar 2, 613105 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Chorioretinal atrophy, progressive bifocal (2)	PBCRA, CRAPB	600790	6q14-q16.2	PBCRA
Chorioretinal atrophy, progressive bifocal (2)	PBCRA, CRAPB	600790	6q14-q16.2	CRAPB
Choroid plexus papilloma, 260500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Choroid plexus papilloma, 260500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Choroid plexus papilloma, 260500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Choroid plexus papilloma, 260500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Choroidal dystrophy, central areolar 1 (2)	CACD1	215500	17p	CACD1
Choroideremia, 303100 (3)	CHM, TCD	300390	Xq21.2	CHM
Choroideremia, 303100 (3)	CHM, TCD	300390	Xq21.2	TCD
Choroideremia, deafness, and mental retardation (4)	DELXq21, CXDELq21	303110	Xq21	DELXq21
Choroideremia, deafness, and mental retardation (4)	DELXq21, CXDELq21	303110	Xq21	CXDELq21
Chromosome 10q22.3-q23.2 deletion syndrome (4)	DEL10q23, C10DELq23	612242	10q23	DEL10q23
Chromosome 10q22.3-q23.2 deletion syndrome (4)	DEL10q23, C10DELq23	612242	10q23	C10DELq23
Chromosome 10q26 deletion syndrome (4)	DEL10q26, C10q26DEL	609625	10q26	DEL10q26
Chromosome 10q26 deletion syndrome (4)	DEL10q26, C10q26DEL	609625	10q26	C10q26DEL
Chromosome 11p13 deletion syndrome, distal, 616902 (4)	DEL11p13, C11DELp13	616902	11p13	DEL11p13
Chromosome 11p13 deletion syndrome, distal, 616902 (4)	DEL11p13, C11DELp13	616902	11p13	C11DELp13
Chromosome 11p15-p14 deletion syndrome (4)	DEL11p15p14, C11DELp15p14	606528	11p15-p14	DEL11p15p14
Chromosome 11p15-p14 deletion syndrome (4)	DEL11p15p14, C11DELp15p14	606528	11p15-p14	C11DELp15p14
Chromosome 13q14 deletion syndrome (4)	DEL13q14, C13DELq14	613884	13q14	DEL13q14
Chromosome 13q14 deletion syndrome (4)	DEL13q14, C13DELq14	613884	13q14	C13DELq14
Chromosome 14q11-q22 deletion syndrome (4)	DEL14q11q22, C14DELq11q22	613457	14q11-q22	DEL14q11q22
Chromosome 14q11-q22 deletion syndrome (4)	DEL14q11q22, C14DELq11q22	613457	14q11-q22	C14DELq11q22
Chromosome 15q11.2 deletion syndrome (4)	DEL15q11.2, C15DELq11.2	615656	15q11.2	DEL15q11.2
Chromosome 15q11.2 deletion syndrome (4)	DEL15q11.2, C15DELq11.2	615656	15q11.2	C15DELq11.2
Chromosome 15q13.3 microdeletion syndrome (4)	DEL15q13.3, MICRODEL15q13.3	612001	15q13.3	DEL15q13.3
Chromosome 15q13.3 microdeletion syndrome (4)	DEL15q13.3, MICRODEL15q13.3	612001	15q13.3	MICRODEL15q13.3
Chromosome 15q14 deletion syndrome (4)	DEL15q14, C15DELq14	616898	15q14	DEL15q14
Chromosome 15q14 deletion syndrome (4)	DEL15q14, C15DELq14	616898	15q14	C15DELq14
Chromosome 15q24 deletion syndrome (4)	DEL15q24, CHR15DELq24	613406	15q24	DEL15q24
Chromosome 15q24 deletion syndrome (4)	DEL15q24, CHR15DELq24	613406	15q24	CHR15DELq24
Chromosome 15q25 deletion syndrome (4)	DEL15q25, C15DELq25	614294	15q25	DEL15q25
Chromosome 15q25 deletion syndrome (4)	DEL15q25, C15DELq25	614294	15q25	C15DELq25
Chromosome 15q26-qter deletion syndrome (4)	DEL15q26qter, C15DELq26qter	612626	15q26-qter	DEL15q26qter
Chromosome 15q26-qter deletion syndrome (4)	DEL15q26qter, C15DELq26qter	612626	15q26-qter	C15DELq26qter
Chromosome 16p11.2 deletion syndrome, 220kb (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	BMIQ16
Chromosome 16p11.2 deletion syndrome, 220kb (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	DEL16p.11.2
Chromosome 16p11.2 deletion syndrome, 220kb (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	C16DELp11.2
Chromosome 16p11.2 deletion syndrome, 593kb (4)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	DEL16p11.2
Chromosome 16p11.2 deletion syndrome, 593kb (4)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	C16DELp11.2
Chromosome 16p11.2 deletion syndrome, 593kb (4)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	AUTS14A
Chromosome 16p11.2 duplication syndrome (4)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	DUP16p11.2
Chromosome 16p11.2 duplication syndrome (4)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	C16DUPp11.2
Chromosome 16p11.2 duplication syndrome (4)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	AUTS14B
Chromosome 16p12.1 deletion syndrome, 520kb (4)	DEL16p12.1, C16DELp12.1	136570	16p12	DEL16p12.1
Chromosome 16p12.1 deletion syndrome, 520kb (4)	DEL16p12.1, C16DELp12.1	136570	16p12	C16DELp12.1
Chromosome 16p12.2-p11.2 deletion syndrome (4)	DEL16p12.1p11.2, C16DELp12.1p11.2	613604	16p12.2-p11.2	DEL16p12.1p11.2
Chromosome 16p12.2-p11.2 deletion syndrome (4)	DEL16p12.1p11.2, C16DELp12.1p11.2	613604	16p12.2-p11.2	C16DELp12.1p11.2
Chromosome 16p13.2 deletion syndrome (4)	DEL16p13.2, C16DELp13.2	616863	16p13.2	DEL16p13.2
Chromosome 16p13.2 deletion syndrome (4)	DEL16p13.2, C16DELp13.2	616863	16p13.2	C16DELp13.2
Chromosome 16p13.3 deletion syndrome (4)	DEL16p13.3, RSTSS	610543	16p13.3	DEL16p13.3
Chromosome 16p13.3 deletion syndrome (4)	DEL16p13.3, RSTSS	610543	16p13.3	RSTSS
Chromosome 16p13.3 duplication syndrome (4)	DUP16p13.3, C16DUPq13.3	613458	16p13.3	DUP16p13.3
Chromosome 16p13.3 duplication syndrome (4)	DUP16p13.3, C16DUPq13.3	613458	16p13.3	C16DUPq13.3
Chromosome 16q22 deletion syndrome (4)	C16DELq22, DEL16q22	614541	16q22	C16DELq22
Chromosome 16q22 deletion syndrome (4)	C16DELq22, DEL16q22	614541	16q22	DEL16q22
Chromosome 17p13.1 deletion syndrome (4)	DEL17p13.1, C17DELp13.1	613776	17p13.1	DEL17p13.1
Chromosome 17p13.1 deletion syndrome (4)	DEL17p13.1, C17DELp13.1	613776	17p13.1	C17DELp13.1
Chromosome 17p13.3 duplication syndrome (4)	DUP17p13.3, C17DUPp13.3	613215	17p13.3	DUP17p13.3
Chromosome 17p13.3 duplication syndrome (4)	DUP17p13.3, C17DUPp13.3	613215	17p13.3	C17DUPp13.3
Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	DEL17q11.2, C17DELq11.2	613675	17q11.2	DEL17q11.2
Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)	DEL17q11.2, C17DELq11.2	613675	17q11.2	C17DELq11.2
Chromosome 17q12 deletion syndrome (4)	DEL17q12, C17DELq12	614527	17q12	DEL17q12
Chromosome 17q12 deletion syndrome (4)	DEL17q12, C17DELq12	614527	17q12	C17DELq12
Chromosome 17q12 duplication syndrome (4)	DUP17q12, C17DUPq12	614526	17q12	DUP17q12
Chromosome 17q12 duplication syndrome (4)	DUP17q12, C17DUPq12	614526	17q12	C17DUPq12
Chromosome 17q21.31 duplication syndrome (4)	DUP17q21.31, C17DUPq21.31	613533	17q21.31	DUP17q21.31
Chromosome 17q21.31 duplication syndrome (4)	DUP17q21.31, C17DUPq21.31	613533	17q21.31	C17DUPq21.31
Chromosome 17q23.1-q23.2 deletion syndrome (4)	DEL17q23.1q23.2, C17DELq23.1q23.2	613355	17q23.1-q23.2	DEL17q23.1q23.2
Chromosome 17q23.1-q23.2 deletion syndrome (4)	DEL17q23.1q23.2, C17DELq23.1q23.2	613355	17q23.1-q23.2	C17DELq23.1q23.2
Chromosome 17q23.1-q23.2 duplication syndrome (4)	DUP17q23.1q23.2, C17DUPq23.1q23.2	613618	17q23.1-q23.2	DUP17q23.1q23.2
Chromosome 17q23.1-q23.2 duplication syndrome (4)	DUP17q23.1q23.2, C17DUPq23.1q23.2	613618	17q23.1-q23.2	C17DUPq23.1q23.2
Chromosome 18 pericentric inversion (4)	DUP18pDEL18q, DUP18qDEL18p	609334	18q22	DUP18pDEL18q
Chromosome 18 pericentric inversion (4)	DUP18pDEL18q, DUP18qDEL18p	609334	18q22	DUP18qDEL18p
Chromosome 18p deletion syndrome (4)	DEL18p, C18DELp	146390	18p	DEL18p
Chromosome 18p deletion syndrome (4)	DEL18p, C18DELp	146390	18p	C18DELp
Chromosome 18q deletion syndrome (4)	DEL18q	601808	18q	DEL18q
Chromosome 19p13.13 deletion syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DEL19p13.13
Chromosome 19p13.13 deletion syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	C19DELp13.13
Chromosome 19p13.13 deletion syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DUP19p13.13
Chromosome 19p13.13 deletion syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	C19DUPp13.13
Chromosome 19p13.13 duplication syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DEL19p13.13
Chromosome 19p13.13 duplication syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	C19DELp13.13
Chromosome 19p13.13 duplication syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	DUP19p13.13
Chromosome 19p13.13 duplication syndrome (4)	DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13	613638	19p13.13	C19DUPp13.13
Chromosome 19q13.11 deletion syndrome (4)	DEL19q13.11, C19DELq13.11	613026	19q13.11	DEL19q13.11
Chromosome 19q13.11 deletion syndrome (4)	DEL19q13.11, C19DELq13.11	613026	19q13.11	C19DELq13.11
Chromosome 1p32-p31 deletion syndrome (4)	DEL1p32p31, C1DELp32p31	613735	1p32-p31	DEL1p32p31
Chromosome 1p32-p31 deletion syndrome (4)	DEL1p32p31, C1DELp32p31	613735	1p32-p31	C1DELp32p31
Chromosome 1p36 deletion syndrome (4)	DEL1p36, C1DELp36	607872	1p36	DEL1p36
Chromosome 1p36 deletion syndrome (4)	DEL1p36, C1DELp36	607872	1p36	C1DELp36
Chromosome 1q21.1 deletion syndrome (4)	DEL1q21, C1DELq21	612474	1q21.1	DEL1q21
Chromosome 1q21.1 deletion syndrome (4)	DEL1q21, C1DELq21	612474	1q21.1	C1DELq21
Chromosome 1q21.1 duplication syndrome (4)	DUP1q21, C1DUPq21	612475	1q21.1	DUP1q21
Chromosome 1q21.1 duplication syndrome (4)	DUP1q21, C1DUPq21	612475	1q21.1	C1DUPq21
Chromosome 1q41-q42 deletion syndrome (4)	DEL1q41q42, C1DELq41q42	612530	1q41-q42	DEL1q41q42
Chromosome 1q41-q42 deletion syndrome (4)	DEL1q41q42, C1DELq41q42	612530	1q41-q42	C1DELq41q42
Chromosome 22q11.2 deletion syndrome, distal (4)	DEL22q11.2, C22DELq11.2	611867	22q11.2	DEL22q11.2
Chromosome 22q11.2 deletion syndrome, distal (4)	DEL22q11.2, C22DELq11.2	611867	22q11.2	C22DELq11.2
Chromosome 22q11.2 microduplication syndrome (4)	DUP22q11.2	608363	22q11.2	DUP22q11.2
Chromosome 22q13 duplication syndrome, 615538 (4)	DUP22q13, C22DUPq13	615538	22q13	DUP22q13
Chromosome 22q13 duplication syndrome, 615538 (4)	DUP22q13, C22DUPq13	615538	22q13	C22DUPq13
Chromosome 2p12-p11.2 deletion syndrome (4)	DEL2p12p11.2, C2DELp12p11.2	613564	2p12-p11.2	DEL2p12p11.2
Chromosome 2p12-p11.2 deletion syndrome (4)	DEL2p12p11.2, C2DELp12p11.2	613564	2p12-p11.2	C2DELp12p11.2
Chromosome 2p16.1-p15 deletion syndrome (4)	DEL2p16.1-p15, C2DELp161-p15	612513	2p16.1-p15	DEL2p16.1-p15
Chromosome 2p16.1-p15 deletion syndrome (4)	DEL2p16.1-p15, C2DELp161-p15	612513	2p16.1-p15	C2DELp161-p15
Chromosome 2q31.1 duplication syndrome (4)	DUP2q31.1, C2DUPq31.1	613681	2q31.1	DUP2q31.1
Chromosome 2q31.1 duplication syndrome (4)	DUP2q31.1, C2DUPq31.1	613681	2q31.1	C2DUPq31.1
Chromosome 2q31.2 deletion syndrome (4)	DEL2q31	612345	2q31.2	DEL2q31
Chromosome 2q37 deletion syndrome (4)	BDMR, C2DELq37, DEL2q37	600430	2q37	BDMR
Chromosome 2q37 deletion syndrome (4)	BDMR, C2DELq37, DEL2q37	600430	2q37	C2DELq37
Chromosome 2q37 deletion syndrome (4)	BDMR, C2DELq37, DEL2q37	600430	2q37	DEL2q37
Chromosome 3q13.31 deletion syndrome (4)	DEL3q13.31, C13DELq13.31	615433	3q13.31	DEL3q13.31
Chromosome 3q13.31 deletion syndrome (4)	DEL3q13.31, C13DELq13.31	615433	3q13.31	C13DELq13.31
Chromosome 3q29 microdeletion syndrome (4)	DEL3q29, MICRODEL3q29	609425	3q29	DEL3q29
Chromosome 3q29 microdeletion syndrome (4)	DEL3q29, MICRODEL3q29	609425	3q29	MICRODEL3q29
Chromosome 3q29 microduplication syndrome (4)	DUP3q29, MICRODUP3q29	611936	3q29	DUP3q29
Chromosome 3q29 microduplication syndrome (4)	DUP3q29, MICRODUP3q29	611936	3q29	MICRODUP3q29
Chromosome 4q21 deletion syndrome (4)	DEL4q21, C4DELq21	613509	4q21	DEL4q21
Chromosome 4q21 deletion syndrome (4)	DEL4q21, C4DELq21	613509	4q21	C4DELq21
Chromosome 4q32.1-q32.2 triplication syndrome (4)	TRIP4q32.1q32.2, C4TRIPq32.1q32.2	613603	4q32.1-q32.2	TRIP4q32.1q32.2
Chromosome 4q32.1-q32.2 triplication syndrome (4)	TRIP4q32.1q32.2, C4TRIPq32.1q32.2	613603	4q32.1-q32.2	C4TRIPq32.1q32.2
Chromosome 5p13 duplication syndrome (4)	DUP5p13, C5DUPp13	613174	5p13	DUP5p13
Chromosome 5p13 duplication syndrome (4)	DUP5p13, C5DUPp13	613174	5p13	C5DUPp13
Chromosome 5q12 deletion syndrome (4)	DEL5q12, C5DELq12	615668	5q12	DEL5q12
Chromosome 5q12 deletion syndrome (4)	DEL5q12, C5DELq12	615668	5q12	C5DELq12
Chromosome 5q14.3 deletion syndrome, 613443 (4)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	MEF2C
Chromosome 5q14.3 deletion syndrome, 613443 (4)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	C5DELq14.3
Chromosome 5q14.3 deletion syndrome, 613443 (4)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	DEL5q14.3
Chromosome 6pter-p24 deletion syndrome (4)	DEL6pter, C6DELpter	612582	6pter-p24	DEL6pter
Chromosome 6pter-p24 deletion syndrome (4)	DEL6pter, C6DELpter	612582	6pter-p24	C6DELpter
Chromosome 6q11-q14 deletion syndrome (4)	DEL6q11q14, C6DELq11q14	613544	6q11-q14	DEL6q11q14
Chromosome 6q11-q14 deletion syndrome (4)	DEL6q11q14, C6DELq11q14	613544	6q11-q14	C6DELq11q14
Chromosome 6q25-q25 deletion syndrome (4)	DEL6q24q25, C6DELq25q25	612863	6q24-q25	DEL6q24q25
Chromosome 6q25-q25 deletion syndrome (4)	DEL6q24q25, C6DELq25q25	612863	6q24-q25	C6DELq25q25
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	DEL7q11.23, C7DELq11.23	613729	7q11.23	DEL7q11.23
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)	DEL7q11.23, C7DELq11.23	613729	7q11.23	C7DELq11.23
Chromosome 7q11.23 duplication syndrome (4)	DUP7q11.23, C7DUPq11.23	609757	7q11.23	DUP7q11.23
Chromosome 7q11.23 duplication syndrome (4)	DUP7q11.23, C7DUPq11.23	609757	7q11.23	C7DUPq11.23
Chromosome 8p11 myeloproliferative syndrome (4)	SCLL	613523	8p11	SCLL
Chromosome 8q21.11 deletion syndrome (4)	DEL8q21.11, C8DELq21.11	614230	8q21.11	DEL8q21.11
Chromosome 8q21.11 deletion syndrome (4)	DEL8q21.11, C8DELq21.11	614230	8q21.11	C8DELq21.11
Chromosome 9p deletion syndrome (4)	DEL9p, C9DELp	158170	9p	DEL9p
Chromosome 9p deletion syndrome (4)	DEL9p, C9DELp	158170	9p	C9DELp
Chromosome Xp11.23-p11.22 duplication syndrome (4)	DUPXp11.23p11.22, CXDUPp11.23p11.22	300801	Xp11.23-p11.22	DUPXp11.23p11.22
Chromosome Xp11.23-p11.22 duplication syndrome (4)	DUPXp11.23p11.22, CXDUPp11.23p11.22	300801	Xp11.23-p11.22	CXDUPp11.23p11.22
Chromosome Xp11.3 deletion syndrome (4)	DELXp11.3, CXDELp11.3	300578	Xp11.3	DELXp11.3
Chromosome Xp11.3 deletion syndrome (4)	DELXp11.3, CXDELp11.3	300578	Xp11.3	CXDELp11.3
Chromosome Xp21 deletion syndrome (4)	DELXp21, CXDELp21	300679	Xp21	DELXp21
Chromosome Xp21 deletion syndrome (4)	DELXp21, CXDELp21	300679	Xp21	CXDELp21
Chromosome Xq26.3 duplication syndrome (4)	CXDUPq26.3, DUPXq26.3, XLAG	300942	Xq26.3	CXDUPq26.3
Chromosome Xq26.3 duplication syndrome (4)	CXDUPq26.3, DUPXq26.3, XLAG	300942	Xq26.3	DUPXq26.3
Chromosome Xq26.3 duplication syndrome (4)	CXDUPq26.3, DUPXq26.3, XLAG	300942	Xq26.3	XLAG
Chromosome Xq27.3-q28 duplication syndrome (4)	DUPXq27.3q28, CXDUPq27.3q28	300869	Xq27.3-q28	DUPXq27.3q28
Chromosome Xq27.3-q28 duplication syndrome (4)	DUPXq27.3q28, CXDUPq27.3q28	300869	Xq27.3-q28	CXDUPq27.3q28
Chromosome Xq28 duplication syndrome (4)	DUPXq28, CXq28	300815	Xq28	DUPXq28
Chromosome Xq28 duplication syndrome (4)	DUPXq28, CXq28	300815	Xq28	CXq28
Chronic atrial and intestinal dysrhythmia, 616201 (3)	SGOL1, SGO, SGO1, CAID	609168	3p24.3	SGOL1
Chronic atrial and intestinal dysrhythmia, 616201 (3)	SGOL1, SGO, SGO1, CAID	609168	3p24.3	SGO
Chronic atrial and intestinal dysrhythmia, 616201 (3)	SGOL1, SGO, SGO1, CAID	609168	3p24.3	SGO1
Chronic atrial and intestinal dysrhythmia, 616201 (3)	SGOL1, SGO, SGO1, CAID	609168	3p24.3	CAID
Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)	NCF1	608512	7q11.23	NCF1
Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)	NCF2	608515	1q25.3	NCF2
Chronic granulomatous disease, X-linked, 306400 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CYBB
Chronic granulomatous disease, X-linked, 306400 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CGD
Chronic granulomatous disease, X-linked, 306400 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	AMCBX2
Chronic granulomatous disease, X-linked, 306400 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	IMD34
Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3)	CYBA	608508	16q24.2	CYBA
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	GPSM2
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	LGN
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	PINS
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	DFNB82
Chudley-McCullough syndrome, 604213 (3)	GPSM2, LGN, PINS, DFNB82, CMCS	609245	1p13.3	CMCS
Chylomicron retention disease, 246700 (3)	SAR1B, CMRD, SARA2, ANDD	607690	5q31.1	SAR1B
Chylomicron retention disease, 246700 (3)	SAR1B, CMRD, SARA2, ANDD	607690	5q31.1	CMRD
Chylomicron retention disease, 246700 (3)	SAR1B, CMRD, SARA2, ANDD	607690	5q31.1	SARA2
Chylomicron retention disease, 246700 (3)	SAR1B, CMRD, SARA2, ANDD	607690	5q31.1	ANDD
Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	DNAI1, CILD1, ICS, PCD	604366	9p13.3	DNAI1
Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	DNAI1, CILD1, ICS, PCD	604366	9p13.3	CILD1
Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	DNAI1, CILD1, ICS, PCD	604366	9p13.3	ICS
Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3)	DNAI1, CILD1, ICS, PCD	604366	9p13.3	PCD
Ciliary dyskinesia, primary, 10, 612518 (3)	KTU, C14orf104, CILD10	612517	14q21.3	KTU
Ciliary dyskinesia, primary, 10, 612518 (3)	KTU, C14orf104, CILD10	612517	14q21.3	C14orf104
Ciliary dyskinesia, primary, 10, 612518 (3)	KTU, C14orf104, CILD10	612517	14q21.3	CILD10
Ciliary dyskinesia, primary, 11, 612649 (3)	RSPH4A, CILD11	612647	6q22.1	RSPH4A
Ciliary dyskinesia, primary, 11, 612649 (3)	RSPH4A, CILD11	612647	6q22.1	CILD11
Ciliary dyskinesia, primary, 12, 612650 (3)	RSPH9, CILD12	612648	6p21.1	RSPH9
Ciliary dyskinesia, primary, 12, 612650 (3)	RSPH9, CILD12	612648	6p21.1	CILD12
Ciliary dyskinesia, primary, 13, 613193 (3)	LRRC50, ODA7, CILD13	613190	16q24.1	LRRC50
Ciliary dyskinesia, primary, 13, 613193 (3)	LRRC50, ODA7, CILD13	613190	16q24.1	ODA7
Ciliary dyskinesia, primary, 13, 613193 (3)	LRRC50, ODA7, CILD13	613190	16q24.1	CILD13
Ciliary dyskinesia, primary, 14, 613807 (3)	CCDC39	613798	3q26.33	CCDC39
Ciliary dyskinesia, primary, 15, 613808 (3)	CCDC40, KIAA1640	613799	17q25.3	CCDC40
Ciliary dyskinesia, primary, 15, 613808 (3)	CCDC40, KIAA1640	613799	17q25.3	KIAA1640
Ciliary dyskinesia, primary, 16, 614017 (3)	DNAL1, C14orf168, CILD16	610062	14q24.3	DNAL1
Ciliary dyskinesia, primary, 16, 614017 (3)	DNAL1, C14orf168, CILD16	610062	14q24.3	C14orf168
Ciliary dyskinesia, primary, 16, 614017 (3)	DNAL1, C14orf168, CILD16	610062	14q24.3	CILD16
Ciliary dyskinesia, primary, 17, 614679 (3)	CCDC103, SMH, PR46B, CILD17	614677	17q21.31	CCDC103
Ciliary dyskinesia, primary, 17, 614679 (3)	CCDC103, SMH, PR46B, CILD17	614677	17q21.31	SMH
Ciliary dyskinesia, primary, 17, 614679 (3)	CCDC103, SMH, PR46B, CILD17	614677	17q21.31	PR46B
Ciliary dyskinesia, primary, 17, 614679 (3)	CCDC103, SMH, PR46B, CILD17	614677	17q21.31	CILD17
Ciliary dyskinesia, primary, 18, 614874 (3)	HEATR2, CILD18	614864	7p22.3	HEATR2
Ciliary dyskinesia, primary, 18, 614874 (3)	HEATR2, CILD18	614864	7p22.3	CILD18
Ciliary dyskinesia, primary, 19, 614935 (3)	LRRC6, LRTP, CILD19	614930	8q24.22	LRRC6
Ciliary dyskinesia, primary, 19, 614935 (3)	LRRC6, LRTP, CILD19	614930	8q24.22	LRTP
Ciliary dyskinesia, primary, 19, 614935 (3)	LRRC6, LRTP, CILD19	614930	8q24.22	CILD19
Ciliary dyskinesia, primary, 2, 606763 (3)	DNAAF3, PF22, DAB1, CILD2	614566	19q13.42	DNAAF3
Ciliary dyskinesia, primary, 2, 606763 (3)	DNAAF3, PF22, DAB1, CILD2	614566	19q13.42	PF22
Ciliary dyskinesia, primary, 2, 606763 (3)	DNAAF3, PF22, DAB1, CILD2	614566	19q13.42	DAB1
Ciliary dyskinesia, primary, 2, 606763 (3)	DNAAF3, PF22, DAB1, CILD2	614566	19q13.42	CILD2
Ciliary dyskinesia, primary, 20, 615067 (3)	CCDC114, CILD20	615038	19q13.33	CCDC114
Ciliary dyskinesia, primary, 20, 615067 (3)	CCDC114, CILD20	615038	19q13.33	CILD20
Ciliary dyskinesia, primary, 21, 615294 (3)	DRC1, CCDC164, C2orf39, CILD21	615288	2p23.3	DRC1
Ciliary dyskinesia, primary, 21, 615294 (3)	DRC1, CCDC164, C2orf39, CILD21	615288	2p23.3	CCDC164
Ciliary dyskinesia, primary, 21, 615294 (3)	DRC1, CCDC164, C2orf39, CILD21	615288	2p23.3	C2orf39
Ciliary dyskinesia, primary, 21, 615294 (3)	DRC1, CCDC164, C2orf39, CILD21	615288	2p23.3	CILD21
Ciliary dyskinesia, primary, 22, 615444 (3)	ZMYND10, BLU	607070	3p21.31	ZMYND10
Ciliary dyskinesia, primary, 22, 615444 (3)	ZMYND10, BLU	607070	3p21.31	BLU
Ciliary dyskinesia, primary, 23, 615451 (3)	ARMC4, CILD23	615408	10p12.1	ARMC4
Ciliary dyskinesia, primary, 23, 615451 (3)	ARMC4, CILD23	615408	10p12.1	CILD23
Ciliary dyskinesia, primary, 24, 615481 (3)	RSPH1, TSGA2, TSA2, CILD24	609314	21q22.3	RSPH1
Ciliary dyskinesia, primary, 24, 615481 (3)	RSPH1, TSGA2, TSA2, CILD24	609314	21q22.3	TSGA2
Ciliary dyskinesia, primary, 24, 615481 (3)	RSPH1, TSGA2, TSA2, CILD24	609314	21q22.3	TSA2
Ciliary dyskinesia, primary, 24, 615481 (3)	RSPH1, TSGA2, TSA2, CILD24	609314	21q22.3	CILD24
Ciliary dyskinesia, primary, 25, 615482 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYX1C1
Ciliary dyskinesia, primary, 25, 615482 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYXC1
Ciliary dyskinesia, primary, 25, 615482 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYX1
Ciliary dyskinesia, primary, 25, 615482 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	CILD25
Ciliary dyskinesia, primary, 26, 615500 (3)	C21ORF59, CILD26	615494	21q22.11	C21ORF59
Ciliary dyskinesia, primary, 26, 615500 (3)	C21ORF59, CILD26	615494	21q22.11	CILD26
Ciliary dyskinesia, primary, 27, 615504 (3)	CCDC65, CILD27	611088	12q13.12	CCDC65
Ciliary dyskinesia, primary, 27, 615504 (3)	CCDC65, CILD27	611088	12q13.12	CILD27
Ciliary dyskinesia, primary, 28, 615505 (3)	SPAG1, CILD28	603395	8q22.2	SPAG1
Ciliary dyskinesia, primary, 28, 615505 (3)	SPAG1, CILD28	603395	8q22.2	CILD28
Ciliary dyskinesia, primary, 29, 615872 (3)	CCNO, UNG2, CILD29	607752	5q11.2	CCNO
Ciliary dyskinesia, primary, 29, 615872 (3)	CCNO, UNG2, CILD29	607752	5q11.2	UNG2
Ciliary dyskinesia, primary, 29, 615872 (3)	CCNO, UNG2, CILD29	607752	5q11.2	CILD29
Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	DNAH5, HL1, PCD, CILD3	603335	5p15.2	DNAH5
Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	DNAH5, HL1, PCD, CILD3	603335	5p15.2	HL1
Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	DNAH5, HL1, PCD, CILD3	603335	5p15.2	PCD
Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)	DNAH5, HL1, PCD, CILD3	603335	5p15.2	CILD3
Ciliary dyskinesia, primary, 30, 616037 (3)	CCDC151, CILD30	615956	19p13.2	CCDC151
Ciliary dyskinesia, primary, 30, 616037 (3)	CCDC151, CILD30	615956	19p13.2	CILD30
Ciliary dyskinesia, primary, 32, 616481 (3)	RSPH3, RSHL2, RSP3, CILD32	615876	6q25.3	RSPH3
Ciliary dyskinesia, primary, 32, 616481 (3)	RSPH3, RSHL2, RSP3, CILD32	615876	6q25.3	RSHL2
Ciliary dyskinesia, primary, 32, 616481 (3)	RSPH3, RSHL2, RSP3, CILD32	615876	6q25.3	RSP3
Ciliary dyskinesia, primary, 32, 616481 (3)	RSPH3, RSHL2, RSP3, CILD32	615876	6q25.3	CILD32
Ciliary dyskinesia, primary, 33, 616726 (3)	GAS8, GAS11, CILD33	605178	16q24.3	GAS8
Ciliary dyskinesia, primary, 33, 616726 (3)	GAS8, GAS11, CILD33	605178	16q24.3	GAS11
Ciliary dyskinesia, primary, 33, 616726 (3)	GAS8, GAS11, CILD33	605178	16q24.3	CILD33
Ciliary dyskinesia, primary, 4 (2)	CILD4	608646	15q13.1-q15.1	CILD4
Ciliary dyskinesia, primary, 5, 608647 (3)	HYDIN, HYDIN1, CILD5	610812	16q22.2	HYDIN
Ciliary dyskinesia, primary, 5, 608647 (3)	HYDIN, HYDIN1, CILD5	610812	16q22.2	HYDIN1
Ciliary dyskinesia, primary, 5, 608647 (3)	HYDIN, HYDIN1, CILD5	610812	16q22.2	CILD5
Ciliary dyskinesia, primary, 6, 610852 (3)	NME8, TXNDC3, SPTRX2, CILD6	607421	7p14.1	NME8
Ciliary dyskinesia, primary, 6, 610852 (3)	NME8, TXNDC3, SPTRX2, CILD6	607421	7p14.1	TXNDC3
Ciliary dyskinesia, primary, 6, 610852 (3)	NME8, TXNDC3, SPTRX2, CILD6	607421	7p14.1	SPTRX2
Ciliary dyskinesia, primary, 6, 610852 (3)	NME8, TXNDC3, SPTRX2, CILD6	607421	7p14.1	CILD6
Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	DNAH11, DNAHC11, CILD7, DNAHBL	603339	7p15.3	DNAH11
Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	DNAH11, DNAHC11, CILD7, DNAHBL	603339	7p15.3	DNAHC11
Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	DNAH11, DNAHC11, CILD7, DNAHBL	603339	7p15.3	CILD7
Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3)	DNAH11, DNAHC11, CILD7, DNAHBL	603339	7p15.3	DNAHBL
Ciliary dyskinesia, primary, 8 (2)	CILD8	612274	15q24-q25	CILD8
Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	DNAI2, CILD9	605483	17q25.1	DNAI2
Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)	DNAI2, CILD9	605483	17q25.1	CILD9
Cirrhosis due to liver phosphorylase kinase deficiency (3)	PHKG2, GSD9C	172471	16p11.2	PHKG2
Cirrhosis due to liver phosphorylase kinase deficiency (3)	PHKG2, GSD9C	172471	16p11.2	GSD9C
Cirrhosis, North American Indian childhood type, 604901 (3)	CIRH1A, NAIC, TEX292, KIAA1988	607456	16q22.1	CIRH1A
Cirrhosis, North American Indian childhood type, 604901 (3)	CIRH1A, NAIC, TEX292, KIAA1988	607456	16q22.1	NAIC
Cirrhosis, North American Indian childhood type, 604901 (3)	CIRH1A, NAIC, TEX292, KIAA1988	607456	16q22.1	TEX292
Cirrhosis, North American Indian childhood type, 604901 (3)	CIRH1A, NAIC, TEX292, KIAA1988	607456	16q22.1	KIAA1988
Cirrhosis, cryptogenic, 215600 (3)	KRT18	148070	12q13.13	KRT18
Cirrhosis, cryptogenic, 215600 (3)	KRT8	148060	12q13.13	KRT8
Citrullinemia, 215700 (3)	ASS1, ASS	603470	9q34.11	ASS1
Citrullinemia, 215700 (3)	ASS1, ASS	603470	9q34.11	ASS
Citrullinemia, adult-onset type II, 603471 (3)	SLC25A13, CTLN2	603859	7q21.3	SLC25A13
Citrullinemia, adult-onset type II, 603471 (3)	SLC25A13, CTLN2	603859	7q21.3	CTLN2
Citrullinemia, type II, neonatal-onset, 605814 (3)	SLC25A13, CTLN2	603859	7q21.3	SLC25A13
Citrullinemia, type II, neonatal-onset, 605814 (3)	SLC25A13, CTLN2	603859	7q21.3	CTLN2
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	NECTIN1
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PVRL1
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	HVEC
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PVRR1
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PRR1
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	ED4
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	OFC7
Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	CLPED1
Cleft palate with ankyloglossia, 303400 (3)	TBX22, CPX, ABERS	300307	Xq21.1	TBX22
Cleft palate with ankyloglossia, 303400 (3)	TBX22, CPX, ABERS	300307	Xq21.1	CPX
Cleft palate with ankyloglossia, 303400 (3)	TBX22, CPX, ABERS	300307	Xq21.1	ABERS
Cleft palate, isolated, 119540 (2)	UBB	191339	17p11.2	UBB
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	KDM1A
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	LSD1
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	AOF2
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	BHC110
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	KIAA0601
Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3)	KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF	609132	1p36.12	CPRF
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CBFA1
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	PEBP2A1
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	AML3
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CCD
Cleidocranial dysplasia, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CLCD
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CBFA1
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	PEBP2A1
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	AML3
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CCD
Cleidocranial dysplasia, forme fruste, dental anomalies only, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CLCD
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CBFA1
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	PEBP2A1
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	AML3
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CCD
Cleidocranial dysplasia, forme fruste, with brachydactyly, 119600 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CLCD
Clopidogrel, impaired responsiveness to, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Clopidogrel, impaired responsiveness to, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C19
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PITX1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PTX1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	BFT
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	POTX
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	CCF
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	LBNBG
Cockayne syndrome, type A, 216400 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	ERCC8
Cockayne syndrome, type A, 216400 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	CKN1
Cockayne syndrome, type A, 216400 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	CSA
Cockayne syndrome, type A, 216400 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	UVSS2
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
Cockayne syndrome, type B, 133540 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	CHUK
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	IKBKA
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	NFKBIKA
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	IKKA
Cocoon syndrome, 613630 (3)	CHUK, IKBKA, NFKBIKA, IKKA, IKK1	600664	10q24.31	IKK1
Coenzyme Q10 deficiency, primary, 1, 607426 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ2
Coenzyme Q10 deficiency, primary, 1, 607426 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ10D1
Coenzyme Q10 deficiency, primary, 1, 607426 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	MSA1
Coenzyme Q10 deficiency, primary, 2, 614651 (3)	PDSS1, TPT, COQ1, COQ10D2	607429	10p12.1	PDSS1
Coenzyme Q10 deficiency, primary, 2, 614651 (3)	PDSS1, TPT, COQ1, COQ10D2	607429	10p12.1	TPT
Coenzyme Q10 deficiency, primary, 2, 614651 (3)	PDSS1, TPT, COQ1, COQ10D2	607429	10p12.1	COQ1
Coenzyme Q10 deficiency, primary, 2, 614651 (3)	PDSS1, TPT, COQ1, COQ10D2	607429	10p12.1	COQ10D2
Coenzyme Q10 deficiency, primary, 3, 614652 (3)	PDSS2, DLP1, C6orf210, COQ10D3	610564	6q21	PDSS2
Coenzyme Q10 deficiency, primary, 3, 614652 (3)	PDSS2, DLP1, C6orf210, COQ10D3	610564	6q21	DLP1
Coenzyme Q10 deficiency, primary, 3, 614652 (3)	PDSS2, DLP1, C6orf210, COQ10D3	610564	6q21	C6orf210
Coenzyme Q10 deficiency, primary, 3, 614652 (3)	PDSS2, DLP1, C6orf210, COQ10D3	610564	6q21	COQ10D3
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	ADCK3
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	COQ8
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	CABC1
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	SCAR9
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	ARCA2
Coenzyme Q10 deficiency, primary, 4, 612016 (3)	ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4	606980	1q42.13	COQ10D4
Coenzyme Q10 deficiency, primary, 5, 614654 (3)	COQ9, C16orf49, COQ10D5	612837	16q21	COQ9
Coenzyme Q10 deficiency, primary, 5, 614654 (3)	COQ9, C16orf49, COQ10D5	612837	16q21	C16orf49
Coenzyme Q10 deficiency, primary, 5, 614654 (3)	COQ9, C16orf49, COQ10D5	612837	16q21	COQ10D5
Coenzyme Q10 deficiency, primary, 6, 614650 (3)	COQ6, CGI10, COQ10D6	614647	14q24.3	COQ6
Coenzyme Q10 deficiency, primary, 6, 614650 (3)	COQ6, CGI10, COQ10D6	614647	14q24.3	CGI10
Coenzyme Q10 deficiency, primary, 6, 614650 (3)	COQ6, CGI10, COQ10D6	614647	14q24.3	COQ10D6
Coenzyme Q10 deficiency, primary, 7, 616276 (3)	COQ4, COQ10D7	612898	9q34.11	COQ4
Coenzyme Q10 deficiency, primary, 7, 616276 (3)	COQ4, COQ10D7	612898	9q34.11	COQ10D7
Coffin-Lowry syndrome, 303600 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RPS6KA3
Coffin-Lowry syndrome, 303600 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RSK2
Coffin-Lowry syndrome, 303600 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	MRX19
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	ARID1B
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	BAF250B
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	KIAA1235
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	MRD12
Coffin-Siris syndrome 1, 135900 (3)	ARID1B, BAF250B, KIAA1235, MRD12, CSS1	614556	6q25.3	CSS1
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	ARID1A
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	C1orf4
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	B120
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	SMARCF1
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	MRD14
Coffin-Siris syndrome 2, 614607 (3)	ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2	603024	1p36.11	CSS2
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SNF5
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	INI1
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RDT
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RTPS1
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	MRD15
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SWNTS1
Coffin-Siris syndrome 3, 614608 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	CSS3
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	SMARCA4
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	BRG1
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	RTPS2
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	MRD16
Coffin-Siris syndrome 4, 614609 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	CSS4
Coffin-Siris syndrome 5, 616938 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	SMARCE1
Coffin-Siris syndrome 5, 616938 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	BAF57
Coffin-Siris syndrome 5, 616938 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	CSS5
Cohen syndrome, 216550 (3)	VPS13B, KIAA0532, COH1	607817	8q22.2	VPS13B
Cohen syndrome, 216550 (3)	VPS13B, KIAA0532, COH1	607817	8q22.2	KIAA0532
Cohen syndrome, 216550 (3)	VPS13B, KIAA0532, COH1	607817	8q22.2	COH1
Cold-induced sweating syndrome 1, 272430 (3)	CRLF1, CISS1	604237	19p13.11	CRLF1
Cold-induced sweating syndrome 1, 272430 (3)	CRLF1, CISS1	604237	19p13.11	CISS1
Cold-induced sweating syndrome 2, 610313 (3)	CLCF1, BSF3, CLC, CISS2	607672	11q13.2	CLCF1
Cold-induced sweating syndrome 2, 610313 (3)	CLCF1, BSF3, CLC, CISS2	607672	11q13.2	BSF3
Cold-induced sweating syndrome 2, 610313 (3)	CLCF1, BSF3, CLC, CISS2	607672	11q13.2	CLC
Cold-induced sweating syndrome 2, 610313 (3)	CLCF1, BSF3, CLC, CISS2	607672	11q13.2	CISS2
Cold-induced sweating syndrome 3, 617055 (3)	KLHL7, RP42, CISS3	611119	7p15.3	KLHL7
Cold-induced sweating syndrome 3, 617055 (3)	KLHL7, RP42, CISS3	611119	7p15.3	RP42
Cold-induced sweating syndrome 3, 617055 (3)	KLHL7, RP42, CISS3	611119	7p15.3	CISS3
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PDNP1
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	NPPS
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	M6S1
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PCA1
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ARHR2
Cole disease, 615522 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	COLED
Cole-Carpenter syndrome 1, 112240 (3)	P4HB, PROHB, CLCRP1	176790	17q25.3	P4HB
Cole-Carpenter syndrome 1, 112240 (3)	P4HB, PROHB, CLCRP1	176790	17q25.3	PROHB
Cole-Carpenter syndrome 1, 112240 (3)	P4HB, PROHB, CLCRP1	176790	17q25.3	CLCRP1
Cole-Carpenter syndrome 2, 616294 (3)	SEC24D, KIAA0755, CLCRP2	607186	4q26	SEC24D
Cole-Carpenter syndrome 2, 616294 (3)	SEC24D, KIAA0755, CLCRP2	607186	4q26	KIAA0755
Cole-Carpenter syndrome 2, 616294 (3)	SEC24D, KIAA0755, CLCRP2	607186	4q26	CLCRP2
Coloboma of optic nerve, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Coloboma of optic nerve, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Coloboma of optic nerve, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Coloboma of optic nerve, 120430 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Coloboma, ocular, 120200 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Coloboma, ocular, 120200 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Coloboma, ocular, 120200 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Coloboma, ocular, 120200 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Coloboma, ocular, 120433 (3)	YAP1, COB1	606608	11q22.1	YAP1
Coloboma, ocular, 120433 (3)	YAP1, COB1	606608	11q22.1	COB1
Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3)	YAP1, COB1	606608	11q22.1	YAP1
Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3)	YAP1, COB1	606608	11q22.1	COB1
Colon cancer, advanced, somatic, 114500 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC
Colon cancer, advanced, somatic, 114500 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	ASV
Colon cancer, advanced, somatic, 114500 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	SRC1
Colon cancer, advanced, somatic, 114500 (3)	SRC, ASV, SRC1, THC6	190090	20q11.23	THC6
Colon cancer, somatic, 114500 (3)	PTPN12, PTPG1	600079	7q11.23	PTPN12
Colon cancer, somatic, 114500 (3)	PTPN12, PTPG1	600079	7q11.23	PTPG1
Colon cancer, somatic, 114500 (3)	PTPRJ, DEP1	600925	11p11.2	PTPRJ
Colon cancer, somatic, 114500 (3)	PTPRJ, DEP1	600925	11p11.2	DEP1
Colon cancer, somatic, 114500 (3)	RAD54B	604289	8q22.1	RAD54B
Colorblindness, deutan, 303800 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	OPN1MW
Colorblindness, deutan, 303800 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	GCP
Colorblindness, deutan, 303800 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	CBD
Colorblindness, deutan, 303800 (3)	OPN1MW, GCP, CBD, CBBM	300821	Xq28	CBBM
Colorblindness, protan, 303900 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	OPN1LW
Colorblindness, protan, 303900 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	RCP
Colorblindness, protan, 303900 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	CBP
Colorblindness, protan, 303900 (3)	OPN1LW, RCP, CBP, CBBM	300822	Xq28	CBBM
Colorblindness, tritan, 190900 (3)	OPN1SW, BCP, CBT	613522	7q32.1	OPN1SW
Colorblindness, tritan, 190900 (3)	OPN1SW, BCP, CBT	613522	7q32.1	BCP
Colorblindness, tritan, 190900 (3)	OPN1SW, BCP, CBT	613522	7q32.1	CBT
Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas, 132600 (3)	MUTYH, MYH	604933	1p34.1	MYH
Colorectal cancer with chromosomal instability, somatic (3)	BUB1	602452	2q13	BUB1
Colorectal cancer, 114500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Colorectal cancer, 114500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Colorectal cancer, 114500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Colorectal cancer, 114500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	COCA1
Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	FCC1
Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	HNPCC1
Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	COCA2
Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	HNPCC2
Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMS2
Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMSL2
Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	HNPCC4
Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	GTBP
Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	HNPCC5
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	HNPCC6
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	AAT3
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	MFS2
Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	LDS2
Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3)	MLH3, HNPCC7	604395	14q24.3	HNPCC7
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	EPCAM
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	ACSTD1
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	TROP1
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	M4S1
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	MIC18
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	DIAR5
Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	HNPCC8
Colorectal cancer, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Colorectal cancer, somatic (3)	BRAF, NS7	164757	7q34	NS7
Colorectal cancer, somatic, 114500 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Colorectal cancer, somatic, 114500 (3)	AKT1, CWS6	164730	14q32.33	CWS6
Colorectal cancer, somatic, 114500 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Colorectal cancer, somatic, 114500 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Colorectal cancer, somatic, 114500 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Colorectal cancer, somatic, 114500 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Colorectal cancer, somatic, 114500 (3)	AXIN2, ODCRCS	604025	17q24.1	AXIN2
Colorectal cancer, somatic, 114500 (3)	AXIN2, ODCRCS	604025	17q24.1	ODCRCS
Colorectal cancer, somatic, 114500 (3)	BAX	600040	19q13.33	BAX
Colorectal cancer, somatic, 114500 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
Colorectal cancer, somatic, 114500 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUBR1
Colorectal cancer, somatic, 114500 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	MVA1
Colorectal cancer, somatic, 114500 (3)	CTNNB1, MRD19	116806	3p22.1	CTNNB1
Colorectal cancer, somatic, 114500 (3)	CTNNB1, MRD19	116806	3p22.1	MRD19
Colorectal cancer, somatic, 114500 (3)	DCC, MRMV1	120470	18q21.2	DCC
Colorectal cancer, somatic, 114500 (3)	DCC, MRMV1	120470	18q21.2	MRMV1
Colorectal cancer, somatic, 114500 (3)	DLC1	604258	8p22	DLC1
Colorectal cancer, somatic, 114500 (3)	EP300, RSTS2	602700	22q13.2	EP300
Colorectal cancer, somatic, 114500 (3)	EP300, RSTS2	602700	22q13.2	RSTS2
Colorectal cancer, somatic, 114500 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Colorectal cancer, somatic, 114500 (3)	FGFR3, ACH	134934	4p16.3	ACH
Colorectal cancer, somatic, 114500 (3)	FLCN, BHD	607273	17p11.2	FLCN
Colorectal cancer, somatic, 114500 (3)	FLCN, BHD	607273	17p11.2	BHD
Colorectal cancer, somatic, 114500 (3)	MCC	159350	5q22.2	MCC
Colorectal cancer, somatic, 114500 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
Colorectal cancer, somatic, 114500 (3)	MLH3, HNPCC7	604395	14q24.3	HNPCC7
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Colorectal cancer, somatic, 114500 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Colorectal cancer, somatic, 114500 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGFRL
Colorectal cancer, somatic, 114500 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGRL
Colorectal cancer, somatic, 114500 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PRLTS
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Colorectal cancer, somatic, 114500 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Combined C6/C7 deficiency (3)	C6	217050	5p13.1	C6
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	SLC25A1, SLC20A3, CTP, D2L2AD	190315	22q11.21	SLC25A1
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	SLC25A1, SLC20A3, CTP, D2L2AD	190315	22q11.21	SLC20A3
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	SLC25A1, SLC20A3, CTP, D2L2AD	190315	22q11.21	CTP
Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3)	SLC25A1, SLC20A3, CTP, D2L2AD	190315	22q11.21	D2L2AD
Combined SAP deficiency, 611721 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Combined SAP deficiency, 611721 (3)	PSAP, SAP1	176801	10q22.1	SAP1
Combined cellular and humoral immune defects with granulomas, 233650 (3)	RAG1	179615	11p12	RAG1
Combined cellular and humoral immune defects with granulomas, 233650 (3)	RAG2	179616	11p12	RAG2
Combined factor V and VIII deficiency, 227300 (3)	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.32	LMAN1
Combined factor V and VIII deficiency, 227300 (3)	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.32	ERGIC53
Combined factor V and VIII deficiency, 227300 (3)	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.32	F5F8D
Combined factor V and VIII deficiency, 227300 (3)	LMAN1, ERGIC53, F5F8D, MCFD1	601567	18q21.32	MCFD1
Combined hyperlipidemia, familial, 144250 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
Combined hyperlipidemia, familial, 144250 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LIPD
Combined hyperlipidemia, familial, 144250 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	HDLCQ11
Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IL2RG
Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	SCIDX1
Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	SCIDX
Combined immunodeficiency, X-linked, moderate, 312863 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IMD4
Combined malonic and methylmalonic aciduria, 614265 (3)	ACSF3	614245	16q24.3	ACSF3
Combined oxidative phosphorylation deficiency 1, 609060 (3)	GFM1, EFG1, GFM, COXPD1	606639	3q25.32	GFM1
Combined oxidative phosphorylation deficiency 1, 609060 (3)	GFM1, EFG1, GFM, COXPD1	606639	3q25.32	EFG1
Combined oxidative phosphorylation deficiency 1, 609060 (3)	GFM1, EFG1, GFM, COXPD1	606639	3q25.32	GFM
Combined oxidative phosphorylation deficiency 1, 609060 (3)	GFM1, EFG1, GFM, COXPD1	606639	3q25.32	COXPD1
Combined oxidative phosphorylation deficiency 10, 614702 (3)	MTO1, COXPD10	614667	6q13	MTO1
Combined oxidative phosphorylation deficiency 10, 614702 (3)	MTO1, COXPD10	614667	6q13	COXPD10
Combined oxidative phosphorylation deficiency 11, 614922 (3)	RMND1, COXPD11	614917	6q25.1	RMND1
Combined oxidative phosphorylation deficiency 11, 614922 (3)	RMND1, COXPD11	614917	6q25.1	COXPD11
Combined oxidative phosphorylation deficiency 12, 614924 (3)	EARS2, KIAA1970, COXPD12	612799	16p12.2	EARS2
Combined oxidative phosphorylation deficiency 12, 614924 (3)	EARS2, KIAA1970, COXPD12	612799	16p12.2	KIAA1970
Combined oxidative phosphorylation deficiency 12, 614924 (3)	EARS2, KIAA1970, COXPD12	612799	16p12.2	COXPD12
Combined oxidative phosphorylation deficiency 13, 614932 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	PNPT1
Combined oxidative phosphorylation deficiency 13, 614932 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	OLD35
Combined oxidative phosphorylation deficiency 13, 614932 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	COXPD13
Combined oxidative phosphorylation deficiency 13, 614932 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	DFNB70
Combined oxidative phosphorylation deficiency 14, 614946 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS2
Combined oxidative phosphorylation deficiency 14, 614946 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	FARS1
Combined oxidative phosphorylation deficiency 14, 614946 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	COXPD14
Combined oxidative phosphorylation deficiency 14, 614946 (3)	FARS2, FARS1, COXPD14, SPG77	611592	6p25.1	SPG77
Combined oxidative phosphorylation deficiency 15, 614947 (3)	MTFMT, COXPD15	611766	15q22.31	MTFMT
Combined oxidative phosphorylation deficiency 15, 614947 (3)	MTFMT, COXPD15	611766	15q22.31	COXPD15
Combined oxidative phosphorylation deficiency 17, 615440 (3)	ELAC2, HPC2, COXPD17	605367	17p12	ELAC2
Combined oxidative phosphorylation deficiency 17, 615440 (3)	ELAC2, HPC2, COXPD17	605367	17p12	HPC2
Combined oxidative phosphorylation deficiency 17, 615440 (3)	ELAC2, HPC2, COXPD17	605367	17p12	COXPD17
Combined oxidative phosphorylation deficiency 18, 615578 (3)	SFXN4, COXPD18	615564	10q26.11	SFXN4
Combined oxidative phosphorylation deficiency 18, 615578 (3)	SFXN4, COXPD18	615564	10q26.11	COXPD18
Combined oxidative phosphorylation deficiency 2, 610498 (3)	MRPS16, COXPD2	609204	10q22.2	MRPS16
Combined oxidative phosphorylation deficiency 2, 610498 (3)	MRPS16, COXPD2	609204	10q22.2	COXPD2
Combined oxidative phosphorylation deficiency 20, 615917 (3)	VARS2, KIAA1885, COXPD20	612802	6p21.33	VARS2
Combined oxidative phosphorylation deficiency 20, 615917 (3)	VARS2, KIAA1885, COXPD20	612802	6p21.33	KIAA1885
Combined oxidative phosphorylation deficiency 20, 615917 (3)	VARS2, KIAA1885, COXPD20	612802	6p21.33	COXPD20
Combined oxidative phosphorylation deficiency 23, 616198 (3)	GTPBP3, MSS1, COXPD23	608536	19p13.11	GTPBP3
Combined oxidative phosphorylation deficiency 23, 616198 (3)	GTPBP3, MSS1, COXPD23	608536	19p13.11	MSS1
Combined oxidative phosphorylation deficiency 23, 616198 (3)	GTPBP3, MSS1, COXPD23	608536	19p13.11	COXPD23
Combined oxidative phosphorylation deficiency 24, 616239 (3)	NARS2, COXPD24	612803	11q14.1	NARS2
Combined oxidative phosphorylation deficiency 24, 616239 (3)	NARS2, COXPD24	612803	11q14.1	COXPD24
Combined oxidative phosphorylation deficiency 26, 616539 (3)	TRMT5, TRM5, KIAA1393, COXPD26	611023	14q23.1	TRMT5
Combined oxidative phosphorylation deficiency 26, 616539 (3)	TRMT5, TRM5, KIAA1393, COXPD26	611023	14q23.1	TRM5
Combined oxidative phosphorylation deficiency 26, 616539 (3)	TRMT5, TRM5, KIAA1393, COXPD26	611023	14q23.1	KIAA1393
Combined oxidative phosphorylation deficiency 26, 616539 (3)	TRMT5, TRM5, KIAA1393, COXPD26	611023	14q23.1	COXPD26
Combined oxidative phosphorylation deficiency 27, 616672 (3)	CARS2, COXPD27	612800	13q34	CARS2
Combined oxidative phosphorylation deficiency 27, 616672 (3)	CARS2, COXPD27	612800	13q34	COXPD27
Combined oxidative phosphorylation deficiency 28, 616794 (3)	SLC25A26, SAMC, COXPD28	611037	3p14.1	SLC25A26
Combined oxidative phosphorylation deficiency 28, 616794 (3)	SLC25A26, SAMC, COXPD28	611037	3p14.1	SAMC
Combined oxidative phosphorylation deficiency 28, 616794 (3)	SLC25A26, SAMC, COXPD28	611037	3p14.1	COXPD28
Combined oxidative phosphorylation deficiency 3, 610505 (3)	TSFM, COXPD3	604723	12q14.1	TSFM
Combined oxidative phosphorylation deficiency 3, 610505 (3)	TSFM, COXPD3	604723	12q14.1	COXPD3
Combined oxidative phosphorylation deficiency 30, 616974 (3)	TRMT10C, RG9MTD1, MRPP1, COXPD30	615423	3q12.3	TRMT10C
Combined oxidative phosphorylation deficiency 30, 616974 (3)	TRMT10C, RG9MTD1, MRPP1, COXPD30	615423	3q12.3	RG9MTD1
Combined oxidative phosphorylation deficiency 30, 616974 (3)	TRMT10C, RG9MTD1, MRPP1, COXPD30	615423	3q12.3	MRPP1
Combined oxidative phosphorylation deficiency 30, 616974 (3)	TRMT10C, RG9MTD1, MRPP1, COXPD30	615423	3q12.3	COXPD30
Combined oxidative phosphorylation deficiency 4, 610678 (3)	TUFM, EFTU, COXPD4	602389	16p11.2	TUFM
Combined oxidative phosphorylation deficiency 4, 610678 (3)	TUFM, EFTU, COXPD4	602389	16p11.2	EFTU
Combined oxidative phosphorylation deficiency 4, 610678 (3)	TUFM, EFTU, COXPD4	602389	16p11.2	COXPD4
Combined oxidative phosphorylation deficiency 5, 611719 (3)	MRPS22, C3orf5, COXPD5	605810	3q23	MRPS22
Combined oxidative phosphorylation deficiency 5, 611719 (3)	MRPS22, C3orf5, COXPD5	605810	3q23	C3orf5
Combined oxidative phosphorylation deficiency 5, 611719 (3)	MRPS22, C3orf5, COXPD5	605810	3q23	COXPD5
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	PDCD8
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIF
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COXPD6
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COWCK
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	CMTX4
Combined oxidative phosphorylation deficiency 6, 300816 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	DFNX5
Combined oxidative phosphorylation deficiency 7, 613559 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	C12orf65
Combined oxidative phosphorylation deficiency 7, 613559 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	COXPD7
Combined oxidative phosphorylation deficiency 7, 613559 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	SPG55
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	AARS2
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	KIAA1270
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	MTALARS
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	COXPD8
Combined oxidative phosphorylation deficiency 8, 614096 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	LKENP
Combined oxidative phosphorylation deficiency 9, 614582 (3)	MRPL3, MRL3, COXPD9	607118	3q22.1	MRPL3
Combined oxidative phosphorylation deficiency 9, 614582 (3)	MRPL3, MRL3, COXPD9	607118	3q22.1	MRL3
Combined oxidative phosphorylation deficiency 9, 614582 (3)	MRPL3, MRL3, COXPD9	607118	3q22.1	COXPD9
Complement component 4, partial deficiency of, 120790 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	C1NH
Complement component 4, partial deficiency of, 120790 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	HAE1
Complement component 4, partial deficiency of, 120790 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	HAE2
Complement component 4, partial deficiency of, 120790 (3)	C1NH, HAE1, HAE2, SERPING1	606860	11q12.1	SERPING1
Complement factor D deficiency, 613912 (3)	CFD, ADN	134350	19p13.3	CFD
Complement factor D deficiency, 613912 (3)	CFD, ADN	134350	19p13.3	ADN
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HF1
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HUS
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	ARMD4
Complement factor H deficiency, 609814 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	AHUS1
Complement factor I deficiency, 610984 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
Complement factor I deficiency, 610984 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	FI
Complement factor I deficiency, 610984 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	AHUS3
Complement factor I deficiency, 610984 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	ARMD13
Cone dystrophy 4, 613093 (3)	PDE6C, PDEA2, COD4	600827	10q23.33	PDE6C
Cone dystrophy 4, 613093 (3)	PDE6C, PDEA2, COD4	600827	10q23.33	PDEA2
Cone dystrophy 4, 613093 (3)	PDE6C, PDEA2, COD4	600827	10q23.33	COD4
Cone dystrophy, progressive X-linked, 2 (2)	COD2	300085	Xq27	COD2
Cone dystrophy-3, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GUCA1A
Cone dystrophy-3, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GCAP
Cone dystrophy-3, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	COD3
Cone dystrophy-3, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	CORD14
Cone-rod dystrophy 10, 610283 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMA4A
Cone-rod dystrophy 10, 610283 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMB
Cone-rod dystrophy 10, 610283 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	RP35
Cone-rod dystrophy 10, 610283 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	CORD10
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAX2
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	RAXL1
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	QRX
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	CORD11
Cone-rod dystrophy 11, 610381 (3)	RAX2, RAXL1, QRX, CORD11, ARMD6	610362	19p13.3	ARMD6
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROML1
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	AC133
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	RP41
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CORD12
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CD133
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	MCDR2
Cone-rod dystrophy 12, 612657 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	STGD4
Cone-rod dystrophy 13, 608194 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	RPGRIP1
Cone-rod dystrophy 13, 608194 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	LCA6
Cone-rod dystrophy 13, 608194 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	CORD13
Cone-rod dystrophy 14, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GUCA1A
Cone-rod dystrophy 14, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	GCAP
Cone-rod dystrophy 14, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	COD3
Cone-rod dystrophy 14, 602093 (3)	GUCA1A, GCAP, COD3, CORD14	600364	6p21.1	CORD14
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CDHR1
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	PCDH21
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	PRCAD
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CORD15
Cone-rod dystrophy 15, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	RP65
Cone-rod dystrophy 16, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	C8orf37
Cone-rod dystrophy 16, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	CORD16
Cone-rod dystrophy 16, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	RP64
Cone-rod dystrophy 17 (2)	CORD17	615163	10q26	CORD17
Cone-rod dystrophy 18, 615374 (3)	RAB28, CORD18	612994	4p15.33	RAB28
Cone-rod dystrophy 18, 615374 (3)	RAB28, CORD18	612994	4p15.33	CORD18
Cone-rod dystrophy 19, 615860 (3)	TTLL5, STAMP, KIAA0998, CORD19	612268	14q24.3	TTLL5
Cone-rod dystrophy 19, 615860 (3)	TTLL5, STAMP, KIAA0998, CORD19	612268	14q24.3	STAMP
Cone-rod dystrophy 19, 615860 (3)	TTLL5, STAMP, KIAA0998, CORD19	612268	14q24.3	KIAA0998
Cone-rod dystrophy 19, 615860 (3)	TTLL5, STAMP, KIAA0998, CORD19	612268	14q24.3	CORD19
Cone-rod dystrophy 20, 615973 (3)	POC1B, PIX1, CORD20	614784	12q21.33	POC1B
Cone-rod dystrophy 20, 615973 (3)	POC1B, PIX1, CORD20	614784	12q21.33	PIX1
Cone-rod dystrophy 20, 615973 (3)	POC1B, PIX1, CORD20	614784	12q21.33	CORD20
Cone-rod dystrophy 21, 616502 (3)	DRAM2, TMEM77, CORD21	613360	1p13.3	DRAM2
Cone-rod dystrophy 21, 616502 (3)	DRAM2, TMEM77, CORD21	613360	1p13.3	TMEM77
Cone-rod dystrophy 21, 616502 (3)	DRAM2, TMEM77, CORD21	613360	1p13.3	CORD21
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
Cone-rod dystrophy 3, 604116 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
Cone-rod dystrophy 5, 600977 (3)	PITPNM3, NIR1, CORD5	608921	17p13.2-p13.1	PITPNM3
Cone-rod dystrophy 5, 600977 (3)	PITPNM3, NIR1, CORD5	608921	17p13.2-p13.1	NIR1
Cone-rod dystrophy 5, 600977 (3)	PITPNM3, NIR1, CORD5	608921	17p13.2-p13.1	CORD5
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	GUCY2D
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	GUC2D
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	LCA1
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	CORD6
Cone-rod dystrophy 6, 601777 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	RCD2
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	RIMS1
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	RIM1
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	RIM
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	KIAA0340
Cone-rod dystrophy 7, 603649 (3)	RIMS1, RIM1, RIM, KIAA0340, CORD7	606629	6q13	CORD7
Cone-rod dystrophy 8 (2)	CORD8	605549	1q12-q24	CORD8
Cone-rod dystrophy 9, 612775 (3)	ADAM9, MDC9, MCMP, CORD9	602713	8p11.22	ADAM9
Cone-rod dystrophy 9, 612775 (3)	ADAM9, MDC9, MCMP, CORD9	602713	8p11.22	MDC9
Cone-rod dystrophy 9, 612775 (3)	ADAM9, MDC9, MCMP, CORD9	602713	8p11.22	MCMP
Cone-rod dystrophy 9, 612775 (3)	ADAM9, MDC9, MCMP, CORD9	602713	8p11.22	CORD9
Cone-rod dystrophy, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Cone-rod dystrophy, 604393 (3)	AIPL1, LCA4	604392	17p13.2	LCA4
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP3
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CRD
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP15
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	COD1
Cone-rod dystrophy, X-linked, 1, 304020 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CORDX1
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CORDX3
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2A
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	AIED
Cone-rod dystrophy, X-linked, 3, 300476 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	OA2
Cone-rod retinal dystrophy-1 (2)	CORD1, CRD1	600624	18q21.1-q21.3	CORD1
Cone-rod retinal dystrophy-1 (2)	CORD1, CRD1	600624	18q21.1-q21.3	CRD1
Cone-rod retinal dystrophy-2, 120970 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRX
Cone-rod retinal dystrophy-2, 120970 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CORD2
Cone-rod retinal dystrophy-2, 120970 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRD
Cone-rod retinal dystrophy-2, 120970 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	LCA7
Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	CABP4, CRSD, CSNB2B	608965	11q13.2	CABP4
Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	CABP4, CRSD, CSNB2B	608965	11q13.2	CRSD
Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3)	CABP4, CRSD, CSNB2B	608965	11q13.2	CSNB2B
Congenital anomalies of kidney and urinary tract 2, 143400 (3)	TBX18, CAKUT2	604613	6q14.3	TBX18
Congenital anomalies of kidney and urinary tract 2, 143400 (3)	TBX18, CAKUT2	604613	6q14.3	CAKUT2
Congenital bilateral absence of vas deferens, 277180 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Congenital bilateral absence of vas deferens, 277180 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
Congenital bilateral absence of vas deferens, 277180 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
Congenital bilateral absence of vas deferens, 277180 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	CTDP1, FCP1, CCFDN	604927	18q23	CTDP1
Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	CTDP1, FCP1, CCFDN	604927	18q23	FCP1
Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)	CTDP1, FCP1, CCFDN	604927	18q23	CCFDN
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SLC33A1
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	ACATN
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	AT1
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SPG42
Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	CCHLND
Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	NALCN
Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	IHPRF1
Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	CLIFAHDD
Congenital disorder of deglycosylation, 615273 (3)	NGLY1, PNG1, CDDG, CDG1V	610661	3p24.2	NGLY1
Congenital disorder of deglycosylation, 615273 (3)	NGLY1, PNG1, CDDG, CDG1V	610661	3p24.2	PNG1
Congenital disorder of deglycosylation, 615273 (3)	NGLY1, PNG1, CDDG, CDG1V	610661	3p24.2	CDDG
Congenital disorder of deglycosylation, 615273 (3)	NGLY1, PNG1, CDDG, CDG1V	610661	3p24.2	CDG1V
Congenital disorder of glycosylation, type IIa, 212066 (3)	MGAT2, CDGS2, CDG2A	602616	14q21.3	MGAT2
Congenital disorder of glycosylation, type IIa, 212066 (3)	MGAT2, CDGS2, CDG2A	602616	14q21.3	CDGS2
Congenital disorder of glycosylation, type IIa, 212066 (3)	MGAT2, CDGS2, CDG2A	602616	14q21.3	CDG2A
Congenital disorder of glycosylation, type IIb, 606056 (3)	MOGS, GCS1, CDG2B	601336	2p13.1	MOGS
Congenital disorder of glycosylation, type IIb, 606056 (3)	MOGS, GCS1, CDG2B	601336	2p13.1	GCS1
Congenital disorder of glycosylation, type IIb, 606056 (3)	MOGS, GCS1, CDG2B	601336	2p13.1	CDG2B
Congenital disorder of glycosylation, type IIc, 266265 (3)	SLC35C1, FUCT1, CDG2C	605881	11p11.2	SLC35C1
Congenital disorder of glycosylation, type IIc, 266265 (3)	SLC35C1, FUCT1, CDG2C	605881	11p11.2	FUCT1
Congenital disorder of glycosylation, type IIc, 266265 (3)	SLC35C1, FUCT1, CDG2C	605881	11p11.2	CDG2C
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	B4GALT1
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	GGTB2
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	GT1
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	GTB
Congenital disorder of glycosylation, type IId, 607091 (3)	B4GALT1, GGTB2, GT1, GTB, CDG2D	137060	9p21.1	CDG2D
Congenital disorder of glycosylation, type IIe, 608779 (3)	COG7, CDG2E	606978	16p12.2	COG7
Congenital disorder of glycosylation, type IIe, 608779 (3)	COG7, CDG2E	606978	16p12.2	CDG2E
Congenital disorder of glycosylation, type IIf, 603585 (3)	SLC35A1, CST, CDG2F	605634	6q15	SLC35A1
Congenital disorder of glycosylation, type IIf, 603585 (3)	SLC35A1, CST, CDG2F	605634	6q15	CST
Congenital disorder of glycosylation, type IIf, 603585 (3)	SLC35A1, CST, CDG2F	605634	6q15	CDG2F
Congenital disorder of glycosylation, type IIg, 611209 (3)	COG1, LDLB, KIAA1381, CDG2G	606973	17q25.1	COG1
Congenital disorder of glycosylation, type IIg, 611209 (3)	COG1, LDLB, KIAA1381, CDG2G	606973	17q25.1	LDLB
Congenital disorder of glycosylation, type IIg, 611209 (3)	COG1, LDLB, KIAA1381, CDG2G	606973	17q25.1	KIAA1381
Congenital disorder of glycosylation, type IIg, 611209 (3)	COG1, LDLB, KIAA1381, CDG2G	606973	17q25.1	CDG2G
Congenital disorder of glycosylation, type IIh, 611182 (3)	COG8, DOR1, CDG2H	606979	16q22.1	COG8
Congenital disorder of glycosylation, type IIh, 611182 (3)	COG8, DOR1, CDG2H	606979	16q22.1	DOR1
Congenital disorder of glycosylation, type IIh, 611182 (3)	COG8, DOR1, CDG2H	606979	16q22.1	CDG2H
Congenital disorder of glycosylation, type IIi, 613612 (3)	COG5, GOLTC1, GTC90, CDG2I	606821	7q22.3	COG5
Congenital disorder of glycosylation, type IIi, 613612 (3)	COG5, GOLTC1, GTC90, CDG2I	606821	7q22.3	GOLTC1
Congenital disorder of glycosylation, type IIi, 613612 (3)	COG5, GOLTC1, GTC90, CDG2I	606821	7q22.3	GTC90
Congenital disorder of glycosylation, type IIi, 613612 (3)	COG5, GOLTC1, GTC90, CDG2I	606821	7q22.3	CDG2I
Congenital disorder of glycosylation, type IIj, 613489 (3)	COG4, COD1, CDG2J	606976	16q22.1	COG4
Congenital disorder of glycosylation, type IIj, 613489 (3)	COG4, COD1, CDG2J	606976	16q22.1	COD1
Congenital disorder of glycosylation, type IIj, 613489 (3)	COG4, COD1, CDG2J	606976	16q22.1	CDG2J
Congenital disorder of glycosylation, type IIk, 614727 (3)	TMEM165, FT27, CDG2K	614726	4q12	TMEM165
Congenital disorder of glycosylation, type IIk, 614727 (3)	TMEM165, FT27, CDG2K	614726	4q12	FT27
Congenital disorder of glycosylation, type IIk, 614727 (3)	TMEM165, FT27, CDG2K	614726	4q12	CDG2K
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COG6
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COD2
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	KIAA1134
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	CDG2L
Congenital disorder of glycosylation, type IIl, 614576 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	SHNS
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	SLC35A2
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	UGALT
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	UGTL
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	UGT2
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	CDGX
Congenital disorder of glycosylation, type IIm, 300896 (3)	SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M	314375	Xp11.23	CDG2M
Congenital disorder of glycosylation, type IIn, 616721 (3)	SLC39A8, BIGM103, CDG2N	608732	4q24	SLC39A8
Congenital disorder of glycosylation, type IIn, 616721 (3)	SLC39A8, BIGM103, CDG2N	608732	4q24	BIGM103
Congenital disorder of glycosylation, type IIn, 616721 (3)	SLC39A8, BIGM103, CDG2N	608732	4q24	CDG2N
Congenital disorder of glycosylation, type IIo, 616828 (3)	CCDC115, CCP1, CDG2O	613734	2q21.1	CCDC115
Congenital disorder of glycosylation, type IIo, 616828 (3)	CCDC115, CCP1, CDG2O	613734	2q21.1	CCP1
Congenital disorder of glycosylation, type IIo, 616828 (3)	CCDC115, CCP1, CDG2O	613734	2q21.1	CDG2O
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	TMEM199
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	VMA12
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	VPH2
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	C17orf32
Congenital disorder of glycosylation, type IIp, 616829 (3)	TMEM199, VMA12, VPH2, C17orf32, CDG2P	616815	17q11.2	CDG2P
Congenital disorder of glycosylation, type Ia, 212065 (3)	PMM2, CDG1A	601785	16p13.2	PMM2
Congenital disorder of glycosylation, type Ia, 212065 (3)	PMM2, CDG1A	601785	16p13.2	CDG1A
Congenital disorder of glycosylation, type Ib, 602579 (3)	MPI, PMI1, CDG1B	154550	15q24.1	MPI
Congenital disorder of glycosylation, type Ib, 602579 (3)	MPI, PMI1, CDG1B	154550	15q24.1	PMI1
Congenital disorder of glycosylation, type Ib, 602579 (3)	MPI, PMI1, CDG1B	154550	15q24.1	CDG1B
Congenital disorder of glycosylation, type Ic, 603147 (3)	ALG6, CDG1C	604566	1p31.3	ALG6
Congenital disorder of glycosylation, type Ic, 603147 (3)	ALG6, CDG1C	604566	1p31.3	CDG1C
Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3, NOT56L, CDGS4, CDG1D	608750	3q27.1	ALG3
Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3, NOT56L, CDGS4, CDG1D	608750	3q27.1	NOT56L
Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3, NOT56L, CDGS4, CDG1D	608750	3q27.1	CDGS4
Congenital disorder of glycosylation, type Id, 601110 (3)	ALG3, NOT56L, CDGS4, CDG1D	608750	3q27.1	CDG1D
Congenital disorder of glycosylation, type Ie, 608799 (3)	DPM1, MPDS, CDGIE	603503	20q13.13	DPM1
Congenital disorder of glycosylation, type Ie, 608799 (3)	DPM1, MPDS, CDGIE	603503	20q13.13	MPDS
Congenital disorder of glycosylation, type Ie, 608799 (3)	DPM1, MPDS, CDGIE	603503	20q13.13	CDGIE
Congenital disorder of glycosylation, type If, 609180 (3)	MPDU1, SL15, CDGIF	604041	17p13.1	MPDU1
Congenital disorder of glycosylation, type If, 609180 (3)	MPDU1, SL15, CDGIF	604041	17p13.1	SL15
Congenital disorder of glycosylation, type If, 609180 (3)	MPDU1, SL15, CDGIF	604041	17p13.1	CDGIF
Congenital disorder of glycosylation, type Ig, 607143 (3)	ALG12, CDG1G	607144	22q13.33	ALG12
Congenital disorder of glycosylation, type Ig, 607143 (3)	ALG12, CDG1G	607144	22q13.33	CDG1G
Congenital disorder of glycosylation, type Ih, 608104 (3)	ALG8, CDG1H	608103	11q14.1	ALG8
Congenital disorder of glycosylation, type Ih, 608104 (3)	ALG8, CDG1H	608103	11q14.1	CDG1H
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT1
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT2
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DGPT
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CDG1J
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CMSTA2
Congenital disorder of glycosylation, type Ij, 608093 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CMS13
Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1, HMAT1, HMT1, CDG1K	605907	16p13.3	ALG1
Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1, HMAT1, HMT1, CDG1K	605907	16p13.3	HMAT1
Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1, HMAT1, HMT1, CDG1K	605907	16p13.3	HMT1
Congenital disorder of glycosylation, type Ik, 608540 (3)	ALG1, HMAT1, HMT1, CDG1K	605907	16p13.3	CDG1K
Congenital disorder of glycosylation, type Il, 608776 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	ALG9
Congenital disorder of glycosylation, type Il, 608776 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	DIBD1
Congenital disorder of glycosylation, type Il, 608776 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	CDG1L
Congenital disorder of glycosylation, type Il, 608776 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	GIKANIS
Congenital disorder of glycosylation, type Im, 610768 (3)	TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	TMEM15
Congenital disorder of glycosylation, type Im, 610768 (3)	TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	DK1
Congenital disorder of glycosylation, type Im, 610768 (3)	TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	SEC59
Congenital disorder of glycosylation, type Im, 610768 (3)	TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	KIAA1094
Congenital disorder of glycosylation, type Im, 610768 (3)	TMEM15, DK1, SEC59, KIAA1094, CDG1M	610746	9q34.11	CDG1M
Congenital disorder of glycosylation, type In, 612015 (3)	RFT1, CDG1N	611908	3p21.1	RFT1
Congenital disorder of glycosylation, type In, 612015 (3)	RFT1, CDG1N	611908	3p21.1	CDG1N
Congenital disorder of glycosylation, type Io, 612937 (3)	DPM3, CDG1O	605951	1q22	DPM3
Congenital disorder of glycosylation, type Io, 612937 (3)	DPM3, CDG1O	605951	1q22	CDG1O
Congenital disorder of glycosylation, type Ip, 613661 (3)	ALG11, KIAA1266, CDG1P	613666	13q14.3	ALG11
Congenital disorder of glycosylation, type Ip, 613661 (3)	ALG11, KIAA1266, CDG1P	613666	13q14.3	KIAA1266
Congenital disorder of glycosylation, type Ip, 613661 (3)	ALG11, KIAA1266, CDG1P	613666	13q14.3	CDG1P
Congenital disorder of glycosylation, type Iq, 612379 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A3
Congenital disorder of glycosylation, type Iq, 612379 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A2L
Congenital disorder of glycosylation, type Iq, 612379 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	CDG1Q
Congenital disorder of glycosylation, type Iq, 612379 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	KRIZI
Congenital disorder of glycosylation, type It, 614921 (3)	PGM1, GSD14, CDG1T	171900	1p31.3	PGM1
Congenital disorder of glycosylation, type It, 614921 (3)	PGM1, GSD14, CDG1T	171900	1p31.3	GSD14
Congenital disorder of glycosylation, type It, 614921 (3)	PGM1, GSD14, CDG1T	171900	1p31.3	CDG1T
Congenital disorder of glycosylation, type Iu, 615042 (3)	DPM2, CDG1U	603564	9q34.11	DPM2
Congenital disorder of glycosylation, type Iu, 615042 (3)	DPM2, CDG1U	603564	9q34.11	CDG1U
Congenital heart defects, multiple types, 3 (2)	CHDT3	614954	9q31.1	CHDT3
Congenital heart defects, multiple types, 4, 615779 (3)	NR2F2, TFCOUP2, ARP1, CHTD4	107773	15q26.2	NR2F2
Congenital heart defects, multiple types, 4, 615779 (3)	NR2F2, TFCOUP2, ARP1, CHTD4	107773	15q26.2	TFCOUP2
Congenital heart defects, multiple types, 4, 615779 (3)	NR2F2, TFCOUP2, ARP1, CHTD4	107773	15q26.2	ARP1
Congenital heart defects, multiple types, 4, 615779 (3)	NR2F2, TFCOUP2, ARP1, CHTD4	107773	15q26.2	CHTD4
Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX1
Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX
Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	VACTERLX
Congenital heart defects, nonsyndromic, 2, 614980 (3)	TAB2, MAP3K7IP2, KIAA0733, CHTD2	605101	6q25.1	TAB2
Congenital heart defects, nonsyndromic, 2, 614980 (3)	TAB2, MAP3K7IP2, KIAA0733, CHTD2	605101	6q25.1	MAP3K7IP2
Congenital heart defects, nonsyndromic, 2, 614980 (3)	TAB2, MAP3K7IP2, KIAA0733, CHTD2	605101	6q25.1	KIAA0733
Congenital heart defects, nonsyndromic, 2, 614980 (3)	TAB2, MAP3K7IP2, KIAA0733, CHTD2	605101	6q25.1	CHTD2
Congenital myopathy with excess of muscle spindles, 218040 (3)	HRAS	190020	11p15.5	HRAS
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Congenital short bowel syndrome, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Congenital short bowel syndrome, 615237 (3)	CLMP, ASAM, ACAM, CSBS	611693	11q24.1	CLMP
Congenital short bowel syndrome, 615237 (3)	CLMP, ASAM, ACAM, CSBS	611693	11q24.1	ASAM
Congenital short bowel syndrome, 615237 (3)	CLMP, ASAM, ACAM, CSBS	611693	11q24.1	ACAM
Congenital short bowel syndrome, 615237 (3)	CLMP, ASAM, ACAM, CSBS	611693	11q24.1	CSBS
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGS
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CTHM
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CAFS
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TGA
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DORV
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	VCFS
Conotruncal anomaly face syndrome, 217095 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGCR
Conotruncal heart malformations, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	NKX2-6
Conotruncal heart malformations, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	CSX2
Conotruncal heart malformations, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	CTHM
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Conotruncal heart malformations, variable, 217095 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Contractural arachnodactyly, congenital, 121050 (3)	FBN2, CCA, EOMD	612570	5q23.3	FBN2
Contractural arachnodactyly, congenital, 121050 (3)	FBN2, CCA, EOMD	612570	5q23.3	CCA
Contractural arachnodactyly, congenital, 121050 (3)	FBN2, CCA, EOMD	612570	5q23.3	EOMD
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PKC
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	DYT10
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	EKD1
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIS2
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIC2
Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	ICCA
Coproporphyria, 121300 (3)	CPOX	612732	3q11.2	CPOX
Cornea plana 1, autosomal dominant (2)	CNA1	121400	12q21.33	CNA1
Cornea plana 2, autosomal recessive, 217300 (3)	KERA, CNA2	603288	12q21.33	KERA
Cornea plana 2, autosomal recessive, 217300 (3)	KERA, CNA2	603288	12q21.33	CNA2
Corneal clouding, autosomal recessive (3)	APOA1	107680	11q23.3	APOA1
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, Avellino type, 607541 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	COL8A2
Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	FECD1
Corneal dystrophy, Fuchs endothelial, 1, 136800 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	PPCD2
Corneal dystrophy, Fuchs endothelial, 2 (2)	FECD2, FCD1	610158	13pter-q12.13	FECD2
Corneal dystrophy, Fuchs endothelial, 2 (2)	FECD2, FCD1	610158	13pter-q12.13	FCD1
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	TCF4
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	SEF2
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	ITF2
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	PTHS
Corneal dystrophy, Fuchs endothelial, 3, 613267 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	FECD3
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	BTR1
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	NABC1
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CHED
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CDPD
Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	FECD4
Corneal dystrophy, Fuchs endothelial, 5 (2)	FECD5, FCD3	613269	5q33.1-q35.2	FECD5
Corneal dystrophy, Fuchs endothelial, 5 (2)	FECD5, FCD3	613269	5q33.1-q35.2	FCD3
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	ZEB1
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	TCF8
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	NIL2A
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	PPCD3
Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	FECD6
Corneal dystrophy, Fuchs endothelial, 7 (2)	FECD7, FCD4	613271	9p24.1-p22.1	FECD7
Corneal dystrophy, Fuchs endothelial, 7 (2)	FECD7, FCD4	613271	9p24.1-p22.1	FCD4
Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	AGBL1, CCP4, FECD8	615496	15q25.3	AGBL1
Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	AGBL1, CCP4, FECD8	615496	15q25.3	CCP4
Corneal dystrophy, Fuchs endothelial, 8, 615523 (3)	AGBL1, CCP4, FECD8	615496	15q25.3	FECD8
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, Groenouw type I, 121900 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, Lisch epithelial (2)	LECD	300778	Xp22.3	LECD
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, Reis-Bucklers type, 608470 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, Schnyder type, 121800 (3)	UBIAD1, TERE1, SCCD	611632	1p36.22	UBIAD1
Corneal dystrophy, Schnyder type, 121800 (3)	UBIAD1, TERE1, SCCD	611632	1p36.22	TERE1
Corneal dystrophy, Schnyder type, 121800 (3)	UBIAD1, TERE1, SCCD	611632	1p36.22	SCCD
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, Thiel-Behnke type, 602082 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, congenital stromal, 610048 (3)	DCN, CSCD	125255	12q21.33	DCN
Corneal dystrophy, congenital stromal, 610048 (3)	DCN, CSCD	125255	12q21.33	CSCD
Corneal dystrophy, endothelial, X-linked (2)	XECD	300779	Xq25	XECD
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, epithelial basement membrane, 121820 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, gelatinous drop-like, 204870 (3)	TACSTD2, TROP2, M1S1	137290	1p32.1	TACSTD2
Corneal dystrophy, gelatinous drop-like, 204870 (3)	TACSTD2, TROP2, M1S1	137290	1p32.1	TROP2
Corneal dystrophy, gelatinous drop-like, 204870 (3)	TACSTD2, TROP2, M1S1	137290	1p32.1	M1S1
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, lattice type I, 122200 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	TGFBI
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD2
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDGG1
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CSD
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	BIGH3
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	CDG2
Corneal dystrophy, lattice type IIIA, 608471 (3)	TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD	601692	5q31.1	EBMD
Corneal dystrophy, posterior polymorphous 2, 609140 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	COL8A2
Corneal dystrophy, posterior polymorphous 2, 609140 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	FECD1
Corneal dystrophy, posterior polymorphous 2, 609140 (3)	COL8A2, FECD1, PPCD2	120252	1p34.3	PPCD2
Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	OVOL2, ZNF339, PPCD1	616441	20p11.23	OVOL2
Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	OVOL2, ZNF339, PPCD1	616441	20p11.23	ZNF339
Corneal dystrophy, posterior polymorphous, 1, 122000 (3)	OVOL2, ZNF339, PPCD1	616441	20p11.23	PPCD1
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	ZEB1
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	TCF8
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	NIL2A
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	PPCD3
Corneal dystrophy, posterior polymorphous, 3, 609141 (3)	ZEB1, TCF8, NIL2A, PPCD3, FECD6	189909	10p11.22	FECD6
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	BTR1
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	NABC1
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CHED
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CDPD
Corneal endothelial dystrophy and perceptive deafness, 217400 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	FECD4
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	SLC4A11
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	BTR1
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	NABC1
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CHED
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	CDPD
Corneal endothelial dystrophy, autosomal recessive, 217700 (3)	SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4	610206	20p13	FECD4
Corneal fleck dystrophy, 121850 (3)	PIKFYVE, PIP5K3	609414	2q34	PIKFYVE
Corneal fleck dystrophy, 121850 (3)	PIKFYVE, PIP5K3	609414	2q34	PIP5K3
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	PXDN
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	D2S448E
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	KIAA0230
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	PRG2
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	PXN
Corneal opacification and other ocular anomalies, 269400 (3)	PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA	605158	2p25.3	COPOA
Cornelia de Lange syndrome 1, 122470 (3)	NIPBL, CDLS1	608667	5p13.2	NIPBL
Cornelia de Lange syndrome 1, 122470 (3)	NIPBL, CDLS1	608667	5p13.2	CDLS1
Cornelia de Lange syndrome 2, 300590 (3)	DXS423E, SMC1, CDLS2	300040	Xp11.22	DXS423E
Cornelia de Lange syndrome 2, 300590 (3)	DXS423E, SMC1, CDLS2	300040	Xp11.22	SMC1
Cornelia de Lange syndrome 2, 300590 (3)	DXS423E, SMC1, CDLS2	300040	Xp11.22	CDLS2
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	SMC3
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	CSPG6
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	HCAP
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	BAM
Cornelia de Lange syndrome 3, 610759 (3)	SMC3, CSPG6, HCAP, BAM, CDLS3	606062	10q25.2	CDLS3
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	RAD21
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	SCC1
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	NXP1
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	KIAA0078
Cornelia de Lange syndrome 4, 614701 (3)	RAD21, SCC1, NXP1, KIAA0078, CDLS4	606462	8q24.11	CDLS4
Cornelia de Lange syndrome 5, 300882 (3)	HDAC8, MRXS6, CDLS5	300269	Xq13.1	HDAC8
Cornelia de Lange syndrome 5, 300882 (3)	HDAC8, MRXS6, CDLS5	300269	Xq13.1	MRXS6
Cornelia de Lange syndrome 5, 300882 (3)	HDAC8, MRXS6, CDLS5	300269	Xq13.1	CDLS5
Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3)	IGBP1	300139	Xq13.1	IGBP1
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
Corpus callosum, partial agenesis of, 304100 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB3
Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB4
Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	CFEOM3A
Cortical dysplasia, complex, with other brain malformations 1, 614039 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	CDCBM1
Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	KIF5C, NKHC2, CDCBM2	604593	2q23.1-q23.2	KIF5C
Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	KIF5C, NKHC2, CDCBM2	604593	2q23.1-q23.2	NKHC2
Cortical dysplasia, complex, with other brain malformations 2, 615282 (3)	KIF5C, NKHC2, CDCBM2	604593	2q23.1-q23.2	CDCBM2
Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	KIF2A, CDCBM3	602591	5q12.1	KIF2A
Cortical dysplasia, complex, with other brain malformations 3, 615411 (3)	KIF2A, CDCBM3	602591	5q12.1	CDCBM3
Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	TUBG1, CDCBM4	191135	17q21.2	TUBG1
Cortical dysplasia, complex, with other brain malformations 4, 615412 (3)	TUBG1, CDCBM4	191135	17q21.2	CDCBM4
Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	TUBB2A, CDCBM5	615101	6p25.2	TUBB2A
Cortical dysplasia, complex, with other brain malformations 5, 615763 (3)	TUBB2A, CDCBM5	615101	6p25.2	CDCBM5
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB5
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	M40
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	CDCBM6
Cortical dysplasia, complex, with other brain malformations 6, 615771 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	CSCSC1
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CASPR2
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	NRXN4
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CDFE
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	AUTS15
Cortical dysplasia-focal epilepsy syndrome, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	PTHSL1
Cortical malformations, occipital, 614115 (3)	LAMC3, OCCM	604349	9q34.12	LAMC3
Cortical malformations, occipital, 614115 (3)	LAMC3, OCCM	604349	9q34.12	OCCM
Corticosteroid-binding globulin deficiency, 611489 (3)	CBG, SERPINA6	122500	14q32.13	CBG
Corticosteroid-binding globulin deficiency, 611489 (3)	CBG, SERPINA6	122500	14q32.13	SERPINA6
Cortisone reductase deficiency 1, 604931 (3)	H6PD, GDH, G6PDH, CORTRD1	138090	1p36.22	H6PD
Cortisone reductase deficiency 1, 604931 (3)	H6PD, GDH, G6PDH, CORTRD1	138090	1p36.22	GDH
Cortisone reductase deficiency 1, 604931 (3)	H6PD, GDH, G6PDH, CORTRD1	138090	1p36.22	G6PDH
Cortisone reductase deficiency 1, 604931 (3)	H6PD, GDH, G6PDH, CORTRD1	138090	1p36.22	CORTRD1
Cortisone reductase deficiency 2, 614662 (3)	HSD11B1, HSD11, HSD11L, CORTRD2	600713	1q32.2	HSD11B1
Cortisone reductase deficiency 2, 614662 (3)	HSD11B1, HSD11, HSD11L, CORTRD2	600713	1q32.2	HSD11
Cortisone reductase deficiency 2, 614662 (3)	HSD11B1, HSD11, HSD11L, CORTRD2	600713	1q32.2	HSD11L
Cortisone reductase deficiency 2, 614662 (3)	HSD11B1, HSD11, HSD11L, CORTRD2	600713	1q32.2	CORTRD2
Costello syndrome, 218040 (3)	HRAS	190020	11p15.5	HRAS
Coumarin resistance, 122700 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
Coumarin resistance, 122700 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A3
Coumarin resistance, 122700 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A
Coumarin resistance, 122700 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	P450C2A
Cousin syndrome, 260660 (3)	TBX15	604127	1p12	TBX15
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	PDCD8
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIF
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COXPD6
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COWCK
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	CMTX4
Cowchock syndrome, 310490 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	DFNX5
Cowden syndrome 1, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Cowden syndrome 1, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Cowden syndrome 1, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Cowden syndrome 1, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDH2
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHIP
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	PGL4
Cowden syndrome 2, 612359 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	CWS2
Cowden syndrome 3, 615106 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Cowden syndrome 3, 615106 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Cowden syndrome 3, 615106 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Cowden syndrome 4, 615107 (3)	KLLN, CWS4	612105	10q23.31	KLLN
Cowden syndrome 4, 615107 (3)	KLLN, CWS4	612105	10q23.31	CWS4
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Cowden syndrome 5, 615108 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Cowden syndrome 6, 615109 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Cowden syndrome 6, 615109 (3)	AKT1, CWS6	164730	14q32.33	CWS6
Cowden syndrome 7, 616858 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	SEC23B
Cowden syndrome 7, 616858 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	CDAN2
Cowden syndrome 7, 616858 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	HEMPAS
Cowden syndrome 7, 616858 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	CWS7
Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	VBCH
Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	CDD
Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST1
Cranioectodermal dysplasia 1, 218330 (3)	IFT122, WDR10, CED1	606045	3q21.3-q22.1	IFT122
Cranioectodermal dysplasia 1, 218330 (3)	IFT122, WDR10, CED1	606045	3q21.3-q22.1	WDR10
Cranioectodermal dysplasia 1, 218330 (3)	IFT122, WDR10, CED1	606045	3q21.3-q22.1	CED1
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	WDR35
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	NAOFEN
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	KIAA1336
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	CED2
Cranioectodermal dysplasia 2, 613610 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	SRTD7
Cranioectodermal dysplasia 3, 614099 (3)	IFT43, C14orf179, CED3	614068	14q24.3	IFT43
Cranioectodermal dysplasia 3, 614099 (3)	IFT43, C14orf179, CED3	614068	14q24.3	C14orf179
Cranioectodermal dysplasia 3, 614099 (3)	IFT43, C14orf179, CED3	614068	14q24.3	CED3
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	TMCO1, CFSMR	614123	1q24.1	TMCO1
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3)	TMCO1, CFSMR	614123	1q24.1	CFSMR
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS1
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	HUP2
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	CDHS
Craniofacial-deafness-hand syndrome, 122880 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS3
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Craniofacial-skeletal-dermatologic dysplasia, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Craniofrontonasal dysplasia, 304110 (3)	EFNB1, EPLG2, CFNS, CFND	300035	Xq13.1	EFNB1
Craniofrontonasal dysplasia, 304110 (3)	EFNB1, EPLG2, CFNS, CFND	300035	Xq13.1	EPLG2
Craniofrontonasal dysplasia, 304110 (3)	EFNB1, EPLG2, CFNS, CFND	300035	Xq13.1	CFNS
Craniofrontonasal dysplasia, 304110 (3)	EFNB1, EPLG2, CFNS, CFND	300035	Xq13.1	CFND
Craniolenticulosutural dysplasia, 607812 (3)	SEC23A, CLSD	610511	14q21.1	SEC23A
Craniolenticulosutural dysplasia, 607812 (3)	SEC23A, CLSD	610511	14q21.1	CLSD
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANKH
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	HANK
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	ANK
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CMDJ
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CCAL2
Craniometaphyseal dysplasia, 123000 (3)	ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD	605145	5p15.2	CPPDD
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Craniometaphyseal dysplasia, autosomal recessive, 218400 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Cranioosteoarthropathy, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Cranioosteoarthropathy, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PGDH1
Cranioosteoarthropathy, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PHOAR1
Craniosynostosis 3, 615314 (3)	TCF12, HTF4, CRS3	600480	15q21.3	TCF12
Craniosynostosis 3, 615314 (3)	TCF12, HTF4, CRS3	600480	15q21.3	HTF4
Craniosynostosis 3, 615314 (3)	TCF12, HTF4, CRS3	600480	15q21.3	CRS3
Craniosynostosis 4, 600775 (3)	ERF, PE2, CRS4	611888	19q13.2	ERF
Craniosynostosis 4, 600775 (3)	ERF, PE2, CRS4	611888	19q13.2	PE2
Craniosynostosis 4, 600775 (3)	ERF, PE2, CRS4	611888	19q13.2	CRS4
Craniosynostosis 6, 616602 (3)	ZIC1, CRS6	600470	3q24	ZIC1
Craniosynostosis 6, 616602 (3)	ZIC1, CRS6	600470	3q24	CRS6
Craniosynostosis and dental anomalies, 614188 (3)	IL11RA, CRSDA	600939	9p13.3	IL11RA
Craniosynostosis and dental anomalies, 614188 (3)	IL11RA, CRSDA	600939	9p13.3	CRSDA
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	CYP26B1, CYP26A2, P450RAI2, RHFCA	605207	2p13.2	CYP26B1
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	CYP26B1, CYP26A2, P450RAI2, RHFCA	605207	2p13.2	CYP26A2
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	CYP26B1, CYP26A2, P450RAI2, RHFCA	605207	2p13.2	P450RAI2
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)	CYP26B1, CYP26A2, P450RAI2, RHFCA	605207	2p13.2	RHFCA
Craniosynostosis, Adelaide type (2)	CRSA, CRS3	600593	4p16	CRSA
Craniosynostosis, Adelaide type (2)	CRSA, CRS3	600593	4p16	CRS3
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Craniosynostosis, nonspecific (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Craniosynostosis, type 1, 123100 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	TWIST1
Craniosynostosis, type 1, 123100 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	ACS3
Craniosynostosis, type 1, 123100 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	SCS
Craniosynostosis, type 1, 123100 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	CRS1
Craniosynostosis, type 2, 604757 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Craniosynostosis, type 2, 604757 (3)	MSX2, CRS2, HOX8	123101	5q35.2	CRS2
Craniosynostosis, type 2, 604757 (3)	MSX2, CRS2, HOX8	123101	5q35.2	HOX8
Creatine phosphokinase, elevated serum, 123320 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Creatine phosphokinase, elevated serum, 123320 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Creatine phosphokinase, elevated serum, 123320 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Creatinine clearance QTL (2)	CRCL	607135	3p	CRCL
Creutzfeldt-Jakob disease, 123400 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Creutzfeldt-Jakob disease, 123400 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Creutzfeldt-Jakob disease, 123400 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Creutzfeldt-Jakob disease, 123400 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1
Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	GNT1
Crigler-Najjar syndrome, type I, 218800 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	BILIQTL1
Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1
Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	GNT1
Crigler-Najjar syndrome, type II, 606785 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	BILIQTL1
Crouzon syndrome with acanthosis nigricans, 612247 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Crouzon syndrome with acanthosis nigricans, 612247 (3)	FGFR3, ACH	134934	4p16.3	ACH
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Crouzon syndrome, 123500 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
Cryohydrocytosis, 185020 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
Cryptorchidism, 219050 (3)	INSL3	146738	19p13.11	INSL3
Cubitus valgus with mental retardation and unusual facies (2)	CVMRF	300471	Chr.X	CVMRF
Culler-Jones syndrome, 615849 (3)	GLI2, HPE9, CJS	165230	2q14.2	GLI2
Culler-Jones syndrome, 615849 (3)	GLI2, HPE9, CJS	165230	2q14.2	HPE9
Culler-Jones syndrome, 615849 (3)	GLI2, HPE9, CJS	165230	2q14.2	CJS
Currarino syndrome, 176450 (3)	MNX1, HLXB9, HOXHB9, SCRA1	142994	7q36.3	MNX1
Currarino syndrome, 176450 (3)	MNX1, HLXB9, HOXHB9, SCRA1	142994	7q36.3	HLXB9
Currarino syndrome, 176450 (3)	MNX1, HLXB9, HOXHB9, SCRA1	142994	7q36.3	HOXHB9
Currarino syndrome, 176450 (3)	MNX1, HLXB9, HOXHB9, SCRA1	142994	7q36.3	SCRA1
Curry-Jones syndrome, somatic mosaic, 601707 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMOH
Curry-Jones syndrome, somatic mosaic, 601707 (3)	SMOH, SMO, CRJS	601500	7q32.1	SMO
Curry-Jones syndrome, somatic mosaic, 601707 (3)	SMOH, SMO, CRJS	601500	7q32.1	CRJS
Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)	PRKACA	601639	19p13.12	PRKACA
Cutis laxa, AD, 123700 (3)	ELN	130160	7q11.23	ELN
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARMD3
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ADCL2
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARCL1A
Cutis laxa, autosomal dominant 2, 614434 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	HNARMD
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	PYCS
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	GSAS
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ARCL3A
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9A
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9B
Cutis laxa, autosomal dominant 3, 616603 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ADCL3
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARMD3
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ADCL2
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARCL1A
Cutis laxa, autosomal recessive, type IA, 219100 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	HNARMD
Cutis laxa, autosomal recessive, type IB, 614437 (3)	EFEMP2, FBLN4, UPH1, ARCL1B	604633	11q13.1	EFEMP2
Cutis laxa, autosomal recessive, type IB, 614437 (3)	EFEMP2, FBLN4, UPH1, ARCL1B	604633	11q13.1	FBLN4
Cutis laxa, autosomal recessive, type IB, 614437 (3)	EFEMP2, FBLN4, UPH1, ARCL1B	604633	11q13.1	UPH1
Cutis laxa, autosomal recessive, type IB, 614437 (3)	EFEMP2, FBLN4, UPH1, ARCL1B	604633	11q13.1	ARCL1B
Cutis laxa, autosomal recessive, type IC, 613177 (3)	LTBP4, LTBP4S, LTBP4L, ARCL1C	604710	19q13.2	LTBP4
Cutis laxa, autosomal recessive, type IC, 613177 (3)	LTBP4, LTBP4S, LTBP4L, ARCL1C	604710	19q13.2	LTBP4S
Cutis laxa, autosomal recessive, type IC, 613177 (3)	LTBP4, LTBP4S, LTBP4L, ARCL1C	604710	19q13.2	LTBP4L
Cutis laxa, autosomal recessive, type IC, 613177 (3)	LTBP4, LTBP4S, LTBP4L, ARCL1C	604710	19q13.2	ARCL1C
Cutis laxa, autosomal recessive, type IIA, 219200 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ATP6V0A2
Cutis laxa, autosomal recessive, type IIA, 219200 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	WSS
Cutis laxa, autosomal recessive, type IIA, 219200 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ARCL2A
Cutis laxa, autosomal recessive, type IIB, 612940 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PYCR1
Cutis laxa, autosomal recessive, type IIB, 612940 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PRO3
Cutis laxa, autosomal recessive, type IIB, 612940 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	ARCL2B
Cutis laxa, autosomal recessive, type IIB, 612940 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	ARCL3B
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	PYCS
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	GSAS
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ARCL3A
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9A
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9B
Cutis laxa, autosomal recessive, type IIIA, 219150 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ADCL3
Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PYCR1
Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	PRO3
Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	ARCL2B
Cutis laxa, autosomal recessive, type IIIB, 614438 (3)	PYCR1, PRO3, ARCL2B, ARCL3B	179035	17q25.3	ARCL3B
Cyanosis, transient neonatal, 613977 (3)	HBG2, TNCY	142250	11p15.4	HBG2
Cyanosis, transient neonatal, 613977 (3)	HBG2, TNCY	142250	11p15.4	TNCY
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CDMT
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	EAC
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	MFT1
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	KIAA0849
Cylindromatosis, familial, 132700 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	BRSS
Cystathioninuria, 219500 (3)	CTH	607657	1p31.1	CTH
Cystic fibrosis, 219700 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Cystic fibrosis, 219700 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
Cystic fibrosis, 219700 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
Cystic fibrosis, 219700 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
Cystinosis, atypical nephropathic, 219800 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, late-onset juvenile or adolescent nephropathic, 219900 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, nephropathic, 219800 (3)	CTNS	606272	17p13.2	CTNS
Cystinosis, ocular nonnephropathic, 219750 (3)	CTNS	606272	17p13.2	CTNS
Cystinuria, 220100 (3)	SLC3A1, ATR1, D2H, NBAT	104614	2p21	SLC3A1
Cystinuria, 220100 (3)	SLC3A1, ATR1, D2H, NBAT	104614	2p21	ATR1
Cystinuria, 220100 (3)	SLC3A1, ATR1, D2H, NBAT	104614	2p21	D2H
Cystinuria, 220100 (3)	SLC3A1, ATR1, D2H, NBAT	104614	2p21	NBAT
Cystinuria, 220100 (3)	SLC7A9, CSNU3	604144	19q13.11	SLC7A9
Cystinuria, 220100 (3)	SLC7A9, CSNU3	604144	19q13.11	CSNU3
Czech dysplasia, 609162 (3)	COL2A1	120140	12q13.11	COL2A1
D-2-hydroxyglutaric aciduria 2, 613657 (3)	IDH2, IDPM, D2HGA2	147650	15q26.1	IDH2
D-2-hydroxyglutaric aciduria 2, 613657 (3)	IDH2, IDPM, D2HGA2	147650	15q26.1	IDPM
D-2-hydroxyglutaric aciduria 2, 613657 (3)	IDH2, IDPM, D2HGA2	147650	15q26.1	D2HGA2
D-2-hydroxyglutaric aciduria, 600721 (3)	D2HGDH, D2HGD	609186	2q37.3	D2HGDH
D-2-hydroxyglutaric aciduria, 600721 (3)	D2HGDH, D2HGD	609186	2q37.3	D2HGD
D-bifunctional protein deficiency, 261515 (3)	HSD17B4, PRLTS1	601860	5q23.1	HSD17B4
D-bifunctional protein deficiency, 261515 (3)	HSD17B4, PRLTS1	601860	5q23.1	PRLTS1
D-glyceric aciduria, 220120 (3)	GLYCTK, GLYCTK1	610516	3p21.2	GLYCTK
D-glyceric aciduria, 220120 (3)	GLYCTK, GLYCTK1	610516	3p21.2	GLYCTK1
DNA ligase I deficiency (3)	LIG1	126391	19q13.33	LIG1
DNA topoisomerase I, camptothecin-resistant (3)	TOP1	126420	20q12	TOP1
DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	TOP2A, TOP2	126430	17q21.2	TOP2A
DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)	TOP2A, TOP2	126430	17q21.2	TOP2
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	KIAA1171
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	FIME
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	EIEE16
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DOORS
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNB86
DOOR syndrome, 220500 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNA65
Dandy-Walker syndrome (4)	DWS, C3DELq22q24, DEL3q22q24	220200	3q22-q24	DWS
Dandy-Walker syndrome (4)	DWS, C3DELq22q24, DEL3q22q24	220200	3q22-q24	C3DELq22q24
Dandy-Walker syndrome (4)	DWS, C3DELq22q24, DEL3q22q24	220200	3q22-q24	DEL3q22q24
Danon disease, 300257 (3)	LAMP2, LAMPB, LGP110	309060	Xq24	LAMP2
Danon disease, 300257 (3)	LAMP2, LAMPB, LGP110	309060	Xq24	LAMPB
Danon disease, 300257 (3)	LAMP2, LAMPB, LGP110	309060	Xq24	LGP110
Darier disease, 124200 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2A2
Darier disease, 124200 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	ATP2B
Darier disease, 124200 (3)	ATP2A2, ATP2B, DAR	108740	12q24.11	DAR
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
De Sanctis-Cacchione syndrome, 278800 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
De la Chapelle dysplasia, 256050 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	KIAA1171
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	FIME
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	EIEE16
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DOORS
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNB86
Deafness , autosomal recessive 86, 614617 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNA65
Deafness and male infertility (4)	DEL15q15.3, C15DELq15.3	611102	15q15.3	DEL15q15.3
Deafness and male infertility (4)	DEL15q15.3, C15DELq15.3	611102	15q15.3	C15DELq15.3
Deafness and myopia, 221200 (3)	SLITRK6, DFNMYP	609681	13q31.1	SLITRK6
Deafness and myopia, 221200 (3)	SLITRK6, DFNMYP	609681	13q31.1	DFNMYP
Deafness, X-linked 1, 304500 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Deafness, X-linked 1, 304500 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	CMTX5
Deafness, X-linked 1, 304500 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFNX1
Deafness, X-linked 1, 304500 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFN2
Deafness, X-linked 2, 304400 (3)	POU3F4, DFN3, DFNX2	300039	Xq21.1	POU3F4
Deafness, X-linked 2, 304400 (3)	POU3F4, DFN3, DFNX2	300039	Xq21.1	DFN3
Deafness, X-linked 2, 304400 (3)	POU3F4, DFN3, DFNX2	300039	Xq21.1	DFNX2
Deafness, X-linked 3 (2)	DFNX3, DFN4	300030	Xp21.2	DFNX3
Deafness, X-linked 3 (2)	DFNX3, DFN4	300030	Xp21.2	DFN4
Deafness, X-linked 4, 300066 (3)	SMPX, DFNX4	300226	Xp22.12	SMPX
Deafness, X-linked 4, 300066 (3)	SMPX, DFNX4	300226	Xp22.12	DFNX4
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIFM1
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	PDCD8
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	AIF
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COXPD6
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	COWCK
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	CMTX4
Deafness, X-linked 5, 300614 (3)	AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5	300169	Xq26.1	DFNX5
Deafness, Y-linked 1 (1)	DFNY1	400043	Chr.Y	DFNY1
Deafness, autosomal dominant 1, 124900 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DIAPH1
Deafness, autosomal dominant 1, 124900 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DFNA1
Deafness, autosomal dominant 1, 124900 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	LFHL1
Deafness, autosomal dominant 1, 124900 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	SCBMS
Deafness, autosomal dominant 10, 601316 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	EYA4
Deafness, autosomal dominant 10, 601316 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	DFNA10
Deafness, autosomal dominant 10, 601316 (3)	EYA4, DFNA10, CMD1J	603550	6q23.2	CMD1J
Deafness, autosomal dominant 11, 601317 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Deafness, autosomal dominant 11, 601317 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	USH1B
Deafness, autosomal dominant 11, 601317 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNB2
Deafness, autosomal dominant 11, 601317 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNA11
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Deafness, autosomal dominant 13, 601868 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Deafness, autosomal dominant 15, 602459 (3)	POU4F3, BRN3C	602460	5q32	POU4F3
Deafness, autosomal dominant 15, 602459 (3)	POU4F3, BRN3C	602460	5q32	BRN3C
Deafness, autosomal dominant 16 (2)	DFNA16	603964	2q23-q24.3	DFNA16
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
Deafness, autosomal dominant 17, 603622 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
Deafness, autosomal dominant 18 (2)	DFNA18	606012	3q22	DFNA18
Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	ACTG1
Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	DFNA20
Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	DFNA26
Deafness, autosomal dominant 20/26, 604717 (3)	ACTG1, DFNA20, DFNA26, BRWS2	102560	17q25.3	BRWS2
Deafness, autosomal dominant 21 (2)	DFNA21	607017	6p24.1-p22.3	DFNA21
Deafness, autosomal dominant 22, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal dominant 22, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNA22
Deafness, autosomal dominant 22, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNB37
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNA22
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy, 606346 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNB37
Deafness, autosomal dominant 23, 605192 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	SIX1
Deafness, autosomal dominant 23, 605192 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	BOS3
Deafness, autosomal dominant 23, 605192 (3)	SIX1, BOS3, DFNA23	601205	14q23.1	DFNA23
Deafness, autosomal dominant 24 (2)	DFNA24	606282	4q35-qter	DFNA24
Deafness, autosomal dominant 25, 605583 (3)	SLC17A8, VGLUT3, DFNA25	607557	12q23.1	SLC17A8
Deafness, autosomal dominant 25, 605583 (3)	SLC17A8, VGLUT3, DFNA25	607557	12q23.1	VGLUT3
Deafness, autosomal dominant 25, 605583 (3)	SLC17A8, VGLUT3, DFNA25	607557	12q23.1	DFNA25
Deafness, autosomal dominant 27 (2)	DFNA27	612431	4q12-q13.1	DFNA27
Deafness, autosomal dominant 28, 608641 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	GRHL2
Deafness, autosomal dominant 28, 608641 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	TFCP2L3
Deafness, autosomal dominant 28, 608641 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	DFNA28
Deafness, autosomal dominant 28, 608641 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	ECTDS
Deafness, autosomal dominant 2A, 600101 (3)	KCNQ4, DFNA2A	603537	1p34.2	KCNQ4
Deafness, autosomal dominant 2A, 600101 (3)	KCNQ4, DFNA2A	603537	1p34.2	DFNA2A
Deafness, autosomal dominant 2B, 612644 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	GJB3
Deafness, autosomal dominant 2B, 612644 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	CX31
Deafness, autosomal dominant 2B, 612644 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	DFNA2B
Deafness, autosomal dominant 30 (2)	DFNA30	606451	15q25-q26	DFNA30
Deafness, autosomal dominant 31 (2)	DFNA31	608645	6p21.3	DFNA31
Deafness, autosomal dominant 33 (2)	DFNA33	614211	13q34	DFNA33
Deafness, autosomal dominant 36, 606705 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	TMC1
Deafness, autosomal dominant 36, 606705 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNB7
Deafness, autosomal dominant 36, 606705 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNB11
Deafness, autosomal dominant 36, 606705 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNA36
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DPP
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DGI1
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DFNA39
Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DTDP2
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Deafness, autosomal dominant 3A, 601544 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	CX30
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNA3B
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNB1B
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	ECTD2
Deafness, autosomal dominant 3B, 612643 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	HED2
Deafness, autosomal dominant 40, 616357 (3)	CRYM, DFNA40	123740	16p12.2	CRYM
Deafness, autosomal dominant 40, 616357 (3)	CRYM, DFNA40	123740	16p12.2	DFNA40
Deafness, autosomal dominant 41, 608224 (3)	P2RX2, P2X2, DFNA41	600844	12q24.33	P2RX2
Deafness, autosomal dominant 41, 608224 (3)	P2RX2, P2X2, DFNA41	600844	12q24.33	P2X2
Deafness, autosomal dominant 41, 608224 (3)	P2RX2, P2X2, DFNA41	600844	12q24.33	DFNA41
Deafness, autosomal dominant 43 (2)	DFNA43	608394	2p12	DFNA43
Deafness, autosomal dominant 47 (2)	DFNA47, DFNB83	608652	9p22-p21	DFNA47
Deafness, autosomal dominant 47 (2)	DFNA47, DFNB83	608652	9p22-p21	DFNB83
Deafness, autosomal dominant 48 (2)	DFNA48	607841	12q13-q14	DFNA48
Deafness, autosomal dominant 49 (2)	DFNA49	608372	1q21-q23	DFNA49
Deafness, autosomal dominant 4A, 600652 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	MYH14
Deafness, autosomal dominant 4A, 600652 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	KIAA2034
Deafness, autosomal dominant 4A, 600652 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	DFNA4A
Deafness, autosomal dominant 4A, 600652 (3)	MYH14, KIAA2034, DFNA4A, PNMHH	608568	19q13.33	PNMHH
Deafness, autosomal dominant 4B, 614614 (3)	CEACAM16, CEAL2, DFNA4B	614591	19q13.31-q13.32	CEACAM16
Deafness, autosomal dominant 4B, 614614 (3)	CEACAM16, CEAL2, DFNA4B	614591	19q13.31-q13.32	CEAL2
Deafness, autosomal dominant 4B, 614614 (3)	CEACAM16, CEAL2, DFNA4B	614591	19q13.31-q13.32	DFNA4B
Deafness, autosomal dominant 5, 600994 (3)	DFNA5	608798	7p15.3	DFNA5
Deafness, autosomal dominant 50, 613074 (3)	MIR96, MIRN96, DFNA50	611606	7q32.2	MIR96
Deafness, autosomal dominant 50, 613074 (3)	MIR96, MIRN96, DFNA50	611606	7q32.2	MIRN96
Deafness, autosomal dominant 50, 613074 (3)	MIR96, MIRN96, DFNA50	611606	7q32.2	DFNA50
Deafness, autosomal dominant 51 (4)	DFNA51, C9DUPq21.11, DUP9q21.11	613558	9q21.11	DFNA51
Deafness, autosomal dominant 51 (4)	DFNA51, C9DUPq21.11, DUP9q21.11	613558	9q21.11	C9DUPq21.11
Deafness, autosomal dominant 51 (4)	DFNA51, C9DUPq21.11, DUP9q21.11	613558	9q21.11	DUP9q21.11
Deafness, autosomal dominant 52 (2)	DFNA52, DFNA42	607683	5q31.1-q32	DFNA52
Deafness, autosomal dominant 52 (2)	DFNA52, DFNA42	607683	5q31.1-q32	DFNA42
Deafness, autosomal dominant 53 (2)	DFNA53	609965	14q11.2-q12	DFNA53
Deafness, autosomal dominant 54 (2)	DFNA54	615649	5q31	DFNA54
Deafness, autosomal dominant 56, 615629 (3)	TNC, HXB, DFNA56	187380	9q33.1	TNC
Deafness, autosomal dominant 56, 615629 (3)	TNC, HXB, DFNA56	187380	9q33.1	HXB
Deafness, autosomal dominant 56, 615629 (3)	TNC, HXB, DFNA56	187380	9q33.1	DFNA56
Deafness, autosomal dominant 58 (2)	DFNA58	615654	2p21-p12	DFNA58
Deafness, autosomal dominant 59 (2)	DFNA59	612642	11p14.2-q12.3	DFNA59
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFRS
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA6
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA14
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA38
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFSL
Deafness, autosomal dominant 6/14/38, 600965 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	CTRCT41
Deafness, autosomal dominant 64, 614152 (3)	SMAC, DIABLO, DFNA64	605219	12q24.31	SMAC
Deafness, autosomal dominant 64, 614152 (3)	SMAC, DIABLO, DFNA64	605219	12q24.31	DIABLO
Deafness, autosomal dominant 64, 614152 (3)	SMAC, DIABLO, DFNA64	605219	12q24.31	DFNA64
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	KIAA1171
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	FIME
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	EIEE16
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DOORS
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNB86
Deafness, autosomal dominant 65, 616044 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNA65
Deafness, autosomal dominant 67, 616340 (3)	OSBPL2, ORP2, KIAA0772, DNFA67	606731	20q13.33	OSBPL2
Deafness, autosomal dominant 67, 616340 (3)	OSBPL2, ORP2, KIAA0772, DNFA67	606731	20q13.33	ORP2
Deafness, autosomal dominant 67, 616340 (3)	OSBPL2, ORP2, KIAA0772, DNFA67	606731	20q13.33	KIAA0772
Deafness, autosomal dominant 67, 616340 (3)	OSBPL2, ORP2, KIAA0772, DNFA67	606731	20q13.33	DNFA67
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	MGF
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SF
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SCF
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SHEP7
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	FPHH
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DCUA
Deafness, autosomal dominant 69, unilateral or asymmetric, 616697 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DFNA69
Deafness, autosomal dominant 7 (2)	DFNA7	601412	1q21-q23	DFNA7
Deafness, autosomal dominant 8/12, 601543 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	TECTA
Deafness, autosomal dominant 8/12, 601543 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNA8
Deafness, autosomal dominant 8/12, 601543 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNA12
Deafness, autosomal dominant 8/12, 601543 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNB21
Deafness, autosomal dominant 9, 601369 (3)	COCH, DFNA9	603196	14q12	COCH
Deafness, autosomal dominant 9, 601369 (3)	COCH, DFNA9	603196	14q12	DFNA9
Deafness, autosomal dominant, with peripheral neuropathy (3)	GJB3, CX31, DFNA2B	603324	1p34.3	GJB3
Deafness, autosomal dominant, with peripheral neuropathy (3)	GJB3, CX31, DFNA2B	603324	1p34.3	CX31
Deafness, autosomal dominant, with peripheral neuropathy (3)	GJB3, CX31, DFNA2B	603324	1p34.3	DFNA2B
Deafness, autosomal recessive (3)	GJB3, CX31, DFNA2B	603324	1p34.3	GJB3
Deafness, autosomal recessive (3)	GJB3, CX31, DFNA2B	603324	1p34.3	CX31
Deafness, autosomal recessive (3)	GJB3, CX31, DFNA2B	603324	1p34.3	DFNA2B
Deafness, autosomal recessive 105, 616958 (3)	CDC14A, DFNB105	603504	1p21.2	CDC14A
Deafness, autosomal recessive 105, 616958 (3)	CDC14A, DFNB105	603504	1p21.2	DFNB105
Deafness, autosomal recessive 12, 601386 (3)	CDH23, USH1D	605516	10q22.1	CDH23
Deafness, autosomal recessive 12, 601386 (3)	CDH23, USH1D	605516	10q22.1	USH1D
Deafness, autosomal recessive 13 (2)	DFNB13	603098	7q34-q36	DFNB13
Deafness, autosomal recessive 14 (2)	DFNB14	603678	7q31	DFNB14
Deafness, autosomal recessive 15, 601869 (3)	GIPC3, DFNB15, DFNB72, DFNB95	608792	19p13.3	GIPC3
Deafness, autosomal recessive 15, 601869 (3)	GIPC3, DFNB15, DFNB72, DFNB95	608792	19p13.3	DFNB15
Deafness, autosomal recessive 15, 601869 (3)	GIPC3, DFNB15, DFNB72, DFNB95	608792	19p13.3	DFNB72
Deafness, autosomal recessive 15, 601869 (3)	GIPC3, DFNB15, DFNB72, DFNB95	608792	19p13.3	DFNB95
Deafness, autosomal recessive 16, 603720 (3)	STRC, DFNB16	606440	15q15.3	STRC
Deafness, autosomal recessive 16, 603720 (3)	STRC, DFNB16	606440	15q15.3	DFNB16
Deafness, autosomal recessive 17 (2)	DFNB17	603010	7q31	DFNB17
Deafness, autosomal recessive 18A, 602092 (3)	USH1C, DFNB18A	605242	11p15.1	USH1C
Deafness, autosomal recessive 18A, 602092 (3)	USH1C, DFNB18A	605242	11p15.1	DFNB18A
Deafness, autosomal recessive 18B, 614945 (3)	OTOG, OTGN, DFNB18B	604487	11p15.1	OTOG
Deafness, autosomal recessive 18B, 614945 (3)	OTOG, OTGN, DFNB18B	604487	11p15.1	OTGN
Deafness, autosomal recessive 18B, 614945 (3)	OTOG, OTGN, DFNB18B	604487	11p15.1	DFNB18B
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Deafness, autosomal recessive 1A, 220290 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	CX30
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNA3B
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNB1B
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	ECTD2
Deafness, autosomal recessive 1B, 612645 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	HED2
Deafness, autosomal recessive 2, 600060 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Deafness, autosomal recessive 2, 600060 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	USH1B
Deafness, autosomal recessive 2, 600060 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNB2
Deafness, autosomal recessive 2, 600060 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNA11
Deafness, autosomal recessive 20 (2)	DFNB20	604060	11q25-qter	DFNB20
Deafness, autosomal recessive 21, 603629 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	TECTA
Deafness, autosomal recessive 21, 603629 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNA8
Deafness, autosomal recessive 21, 603629 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNA12
Deafness, autosomal recessive 21, 603629 (3)	TECTA, DFNA8, DFNA12, DFNB21	602574	11q23.3	DFNB21
Deafness, autosomal recessive 22, 607039 (3)	OTOA, DFNB22	607038	16p12.2	OTOA
Deafness, autosomal recessive 22, 607039 (3)	OTOA, DFNB22	607038	16p12.2	DFNB22
Deafness, autosomal recessive 23, 609533 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Deafness, autosomal recessive 23, 609533 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	DFNB23
Deafness, autosomal recessive 23, 609533 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	USH1F
Deafness, autosomal recessive 24, 611022 (3)	RDX, DFNB24	179410	11q22.3	RDX
Deafness, autosomal recessive 24, 611022 (3)	RDX, DFNB24	179410	11q22.3	DFNB24
Deafness, autosomal recessive 25, 613285 (3)	GRXCR1	613283	4p13	GRXCR1
Deafness, autosomal recessive 26 (2)	DFNB26	605428	4q31	DFNB26
Deafness, autosomal recessive 27 (2)	DFNB27	605818	2q23-q31	DFNB27
Deafness, autosomal recessive 28, 609823 (3)	TRIOBP, KIAA1662	609761	22q13.1	TRIOBP
Deafness, autosomal recessive 28, 609823 (3)	TRIOBP, KIAA1662	609761	22q13.1	KIAA1662
Deafness, autosomal recessive 29, 614035 (3)	CLDN14, DFNB29	605608	21q22.13	CLDN14
Deafness, autosomal recessive 29, 614035 (3)	CLDN14, DFNB29	605608	21q22.13	DFNB29
Deafness, autosomal recessive 3, 600316 (3)	MYO15A, DFNB3	602666	17p11.2	MYO15A
Deafness, autosomal recessive 3, 600316 (3)	MYO15A, DFNB3	602666	17p11.2	DFNB3
Deafness, autosomal recessive 30, 607101 (3)	MYO3A, DFNB30	606808	10p12.1	MYO3A
Deafness, autosomal recessive 30, 607101 (3)	MYO3A, DFNB30	606808	10p12.1	DFNB30
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	WHRN
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	CIP98
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	KIAA1526
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	DFNB31
Deafness, autosomal recessive 31, 607084 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	USH2D
Deafness, autosomal recessive 32 (2)	DFNB32	608653	1p22.1-p13.3	DFNB32
Deafness, autosomal recessive 33 (2)	DFNB33	607239	10p11.23-q21.1	DFNB33
Deafness, autosomal recessive 35, 608565 (3)	ESRRB, ESRL2, DFNB35	602167	14q24.3	ESRRB
Deafness, autosomal recessive 35, 608565 (3)	ESRRB, ESRL2, DFNB35	602167	14q24.3	ESRL2
Deafness, autosomal recessive 35, 608565 (3)	ESRRB, ESRL2, DFNB35	602167	14q24.3	DFNB35
Deafness, autosomal recessive 36, 609006 (3)	ESPN	606351	1p36.31	ESPN
Deafness, autosomal recessive 37, 607821 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	MYO6
Deafness, autosomal recessive 37, 607821 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNA22
Deafness, autosomal recessive 37, 607821 (3)	MYO6, DFNA22, DFNB37	600970	6q14.1	DFNB37
Deafness, autosomal recessive 38 (2)	DFNB38	608219	6q26-q27	DFNB38
Deafness, autosomal recessive 39, 608265 (3)	HGF, DFNB39	142409	7q21.11	HGF
Deafness, autosomal recessive 39, 608265 (3)	HGF, DFNB39	142409	7q21.11	DFNB39
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	SLC26A4
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	PDS
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	DFNB4
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	EVA
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	TDH2B
Deafness, autosomal recessive 40 (2)	DFNB40	608264	22q11.21-q12.1	DFNB40
Deafness, autosomal recessive 42, 609646 (3)	ILDR1, DFNB42	609739	3q13.33	ILDR1
Deafness, autosomal recessive 42, 609646 (3)	ILDR1, DFNB42	609739	3q13.33	DFNB42
Deafness, autosomal recessive 45 (2)	DFNB45	612433	1q43-q44	DFNB45
Deafness, autosomal recessive 46 (2)	DFNB46	609647	18p11.32-p11.31	DFNB46
Deafness, autosomal recessive 48, 609439 (3)	CIB2, KIP2	605564	15q25.1	CIB2
Deafness, autosomal recessive 48, 609439 (3)	CIB2, KIP2	605564	15q25.1	KIP2
Deafness, autosomal recessive 49, 610153 (3)	MARVELD2, MARVD2, TRIC, DFNB49	610572	5q13.2	MARVELD2
Deafness, autosomal recessive 49, 610153 (3)	MARVELD2, MARVD2, TRIC, DFNB49	610572	5q13.2	MARVD2
Deafness, autosomal recessive 49, 610153 (3)	MARVELD2, MARVD2, TRIC, DFNB49	610572	5q13.2	TRIC
Deafness, autosomal recessive 49, 610153 (3)	MARVELD2, MARVD2, TRIC, DFNB49	610572	5q13.2	DFNB49
Deafness, autosomal recessive 5 (2)	DFNB5	600792	14q12	DFNB5
Deafness, autosomal recessive 51 (2)	DFNB51	609941	11p13-p12	DFNB51
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Deafness, autosomal recessive 53, 609706 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Deafness, autosomal recessive 55 (2)	DFNB55	609952	4q12-q13.2	DFNB55
Deafness, autosomal recessive 59, 610220 (3)	PJVK, DFNB59	610219	2q31.2	PJVK
Deafness, autosomal recessive 59, 610220 (3)	PJVK, DFNB59	610219	2q31.2	DFNB59
Deafness, autosomal recessive 6, 600971 (3)	TMIE, DFNB6	607237	3p21.31	TMIE
Deafness, autosomal recessive 6, 600971 (3)	TMIE, DFNB6	607237	3p21.31	DFNB6
Deafness, autosomal recessive 62 (2)	DFNB62	610143	12p13.2-p11.23	DFNB62
Deafness, autosomal recessive 63, 611451 (3)	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	612414	11q13.4	LRTOMT
Deafness, autosomal recessive 63, 611451 (3)	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	612414	11q13.4	LRTOMT1
Deafness, autosomal recessive 63, 611451 (3)	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	612414	11q13.4	LRTOMT2
Deafness, autosomal recessive 63, 611451 (3)	LRTOMT, LRTOMT1, LRTOMT2, DFNB63	612414	11q13.4	DFNB63
Deafness, autosomal recessive 65 (2)	DFNB65	610248	20q13.2-q13.3	DFNB65
Deafness, autosomal recessive 67, 610265 (3)	LHFPL5, TMHS, DFNB67	609427	6p21.31	LHFPL5
Deafness, autosomal recessive 67, 610265 (3)	LHFPL5, TMHS, DFNB67	609427	6p21.31	TMHS
Deafness, autosomal recessive 67, 610265 (3)	LHFPL5, TMHS, DFNB67	609427	6p21.31	DFNB67
Deafness, autosomal recessive 68, 610419 (3)	S1PR2, EDG5, DFNB68	605111	19p13.2	S1PR2
Deafness, autosomal recessive 68, 610419 (3)	S1PR2, EDG5, DFNB68	605111	19p13.2	EDG5
Deafness, autosomal recessive 68, 610419 (3)	S1PR2, EDG5, DFNB68	605111	19p13.2	DFNB68
Deafness, autosomal recessive 7, 600974 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	TMC1
Deafness, autosomal recessive 7, 600974 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNB7
Deafness, autosomal recessive 7, 600974 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNB11
Deafness, autosomal recessive 7, 600974 (3)	TMC1, DFNB7, DFNB11, DFNA36	606706	9q21.13	DFNA36
Deafness, autosomal recessive 70, 614934 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	PNPT1
Deafness, autosomal recessive 70, 614934 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	OLD35
Deafness, autosomal recessive 70, 614934 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	COXPD13
Deafness, autosomal recessive 70, 614934 (3)	PNPT1, OLD35, COXPD13, DFNB70	610316	2p16.1	DFNB70
Deafness, autosomal recessive 71 (2)	DFNB71	612789	8p22-p21.3	DFNB71
Deafness, autosomal recessive 74, 613718 (3)	MSRB3, DFNB74	613719	12q14.3	MSRB3
Deafness, autosomal recessive 74, 613718 (3)	MSRB3, DFNB74	613719	12q14.3	DFNB74
Deafness, autosomal recessive 76, 615540 (3)	SYNE4, NESP4, C19orf46, DFNB76	615535	19q13.12	SYNE4
Deafness, autosomal recessive 76, 615540 (3)	SYNE4, NESP4, C19orf46, DFNB76	615535	19q13.12	NESP4
Deafness, autosomal recessive 76, 615540 (3)	SYNE4, NESP4, C19orf46, DFNB76	615535	19q13.12	C19orf46
Deafness, autosomal recessive 76, 615540 (3)	SYNE4, NESP4, C19orf46, DFNB76	615535	19q13.12	DFNB76
Deafness, autosomal recessive 77, 613079 (3)	LOXHD1, DFNB77	613072	18q21.1	LOXHD1
Deafness, autosomal recessive 77, 613079 (3)	LOXHD1, DFNB77	613072	18q21.1	DFNB77
Deafness, autosomal recessive 79, 613307 (3)	TPRN, C9orf75, DFNB79	613354	9q34.3	TPRN
Deafness, autosomal recessive 79, 613307 (3)	TPRN, C9orf75, DFNB79	613354	9q34.3	C9orf75
Deafness, autosomal recessive 79, 613307 (3)	TPRN, C9orf75, DFNB79	613354	9q34.3	DFNB79
Deafness, autosomal recessive 8/10, 601072 (3)	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	TMPRSS3
Deafness, autosomal recessive 8/10, 601072 (3)	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	ECHOS1
Deafness, autosomal recessive 8/10, 601072 (3)	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	DFNB8
Deafness, autosomal recessive 8/10, 601072 (3)	TMPRSS3, ECHOS1, DFNB8, DFNB10	605511	21q22.3	DFNB10
Deafness, autosomal recessive 83 (2)	DFNB83	613685	9p23-p21.2	DFNB83
Deafness, autosomal recessive 84A, 613391 (3)	PTPRQ, PTPGMC1, DFNB84A	603317	12q21.31	PTPRQ
Deafness, autosomal recessive 84A, 613391 (3)	PTPRQ, PTPGMC1, DFNB84A	603317	12q21.31	PTPGMC1
Deafness, autosomal recessive 84A, 613391 (3)	PTPRQ, PTPGMC1, DFNB84A	603317	12q21.31	DFNB84A
Deafness, autosomal recessive 84B, 614944 (3)	OTOGL, C12orf64, DFNB84B	614925	12q21.31	OTOGL
Deafness, autosomal recessive 84B, 614944 (3)	OTOGL, C12orf64, DFNB84B	614925	12q21.31	C12orf64
Deafness, autosomal recessive 84B, 614944 (3)	OTOGL, C12orf64, DFNB84B	614925	12q21.31	DFNB84B
Deafness, autosomal recessive 85 (2)	DFNB85	613392	17p12-q11.2	DFNB85
Deafness, autosomal recessive 89, 613916 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	KARS
Deafness, autosomal recessive 89, 613916 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	CMTRIB
Deafness, autosomal recessive 89, 613916 (3)	KARS, CMTRIB, DFNB89	601421	16q23.1	DFNB89
Deafness, autosomal recessive 9, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	OTOF
Deafness, autosomal recessive 9, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	DFNB9
Deafness, autosomal recessive 9, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	NSRD9
Deafness, autosomal recessive 9, 601071 (3)	OTOF, DFNB9, NSRD9, AUNB1	603681	2p23.3	AUNB1
Deafness, autosomal recessive 93, 614899 (3)	CABP2, DFNB93	607314	11q13.2	CABP2
Deafness, autosomal recessive 93, 614899 (3)	CABP2, DFNB93	607314	11q13.2	DFNB93
Deafness, autosomal recessive 96 (2)	DFNB96	614414	1p36.31-p36.13	DFNB96
Deafness, autosomal recessive 98, 614861 (3)	TSPEAR, C21orf29, DFNB98	612920	21q22.3	TSPEAR
Deafness, autosomal recessive 98, 614861 (3)	TSPEAR, C21orf29, DFNB98	612920	21q22.3	C21orf29
Deafness, autosomal recessive 98, 614861 (3)	TSPEAR, C21orf29, DFNB98	612920	21q22.3	DFNB98
Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)	DFCTRPS	300719	Chr.X	DFCTRPS
Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	FGF3, INT2	164950	11q13.3	FGF3
Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3)	FGF3, INT2	164950	11q13.3	INT2
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6B1B2
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6B2
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	VPP3
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	DOOD
Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ZLS2
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	CX30
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNA3B
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNB1B
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	ECTD2
Deafness, digenic GJB2/GJB6, 220290 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	HED2
Deafness, digenic, GJB2/GJB3, 220290 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	GJB3
Deafness, digenic, GJB2/GJB3, 220290 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	CX31
Deafness, digenic, GJB2/GJB3, 220290 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	DFNA2B
Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	BCAP31, BAP31, DXS1357E, DDCH	300398	Xq28	BCAP31
Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	BCAP31, BAP31, DXS1357E, DDCH	300398	Xq28	BAP31
Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	BCAP31, BAP31, DXS1357E, DDCH	300398	Xq28	DXS1357E
Deafness, dystonia, and cerebral hypomyelination, 300475 (3)	BCAP31, BAP31, DXS1357E, DDCH	300398	Xq28	DDCH
Deafness, neurosensory, autosomal recessive 47 (2)	DFNB47	609946	2p25.1-p24.3	DFNB47
Deafness, neurosensory, without vestibular involvement, autosomal dominant (3)	ESPN	606351	1p36.31	ESPN
Dehydrated hereditary stomatocytosis 2, 616689 (3)	KCNN4, KCA4, SK4, DHS2	602754	19q13.31	KCNN4
Dehydrated hereditary stomatocytosis 2, 616689 (3)	KCNN4, KCA4, SK4, DHS2	602754	19q13.31	KCA4
Dehydrated hereditary stomatocytosis 2, 616689 (3)	KCNN4, KCA4, SK4, DHS2	602754	19q13.31	SK4
Dehydrated hereditary stomatocytosis 2, 616689 (3)	KCNN4, KCA4, SK4, DHS2	602754	19q13.31	DHS2
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	PIEZO1
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	FAM38A
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	MIB
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	DHS
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	LMPH3
Dejerine-Sottas disease, 145900 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Dejerine-Sottas disease, 145900 (3)	EGR2, KROX20	129010	10q21.3	KROX20
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Dejerine-Sottas disease, 145900 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Dejerine-Sottas disease, 145900 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Dejerine-Sottas disease, 145900 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Dejerine-Sottas disease, 145900 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Dejerine-Sottas disease, 145900 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Dejerine-Sottas disease, 145900 (3)	PRX, CMT4F	605725	19q13.2	PRX
Dejerine-Sottas disease, 145900 (3)	PRX, CMT4F	605725	19q13.2	CMT4F
Delta-beta thalassemia, 141749 (3)	HBB	141900	11p15.4	HBB
Dementia, Lewy body, 127750 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Dementia, Lewy body, 127750 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	NACP
Dementia, Lewy body, 127750 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK1
Dementia, Lewy body, 127750 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK4
Dementia, Lewy body, 127750 (3)	SNCB	602569	5q35.2	SNCB
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	BRI
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ABRI
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	FBD
Dementia, familial British, 176500 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	RDGCA
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ITM2B
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	BRI
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	ABRI
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	FBD
Dementia, familial Danish, 117300 (3)	ITM2B, BRI, ABRI, FBD, RDGCA	603904	13q14.2	RDGCA
Dementia, familial, nonspecific, 600795 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	CHMP2B
Dementia, familial, nonspecific, 600795 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	DMT1
Dementia, familial, nonspecific, 600795 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	VPS2B
Dementia, familial, nonspecific, 600795 (3)	CHMP2B, DMT1, VPS2B, ALS17	609512	3p11.2	ALS17
Dementia, frontotemporal, 600274 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Dementia, frontotemporal, 600274 (3)	PSEN1, AD3	104311	14q24.2	AD3
Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MTBT1
Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	DDPAC
Dementia, frontotemporal, with or without parkinsonism, 600274 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MSTD
Dent disease 2, 300555 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL
Dent disease 2, 300555 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	LOCR
Dent disease 2, 300555 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL1
Dent disease 2, 300555 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	NPHL2
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCK2
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL2
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	DENTS
Dent disease, 300009 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL1
Dental anomalies and short stature, 601216 (3)	LTBP3, LTBP2, DASS	602090	11q13.1	LTBP3
Dental anomalies and short stature, 601216 (3)	LTBP3, LTBP2, DASS	602090	11q13.1	LTBP2
Dental anomalies and short stature, 601216 (3)	LTBP3, LTBP2, DASS	602090	11q13.1	DASS
Dentatorubro-pallidoluysian atrophy, 125370 (3)	ATN1, DRPLA, HRS, NOD	607462	12p13.31	ATN1
Dentatorubro-pallidoluysian atrophy, 125370 (3)	ATN1, DRPLA, HRS, NOD	607462	12p13.31	DRPLA
Dentatorubro-pallidoluysian atrophy, 125370 (3)	ATN1, DRPLA, HRS, NOD	607462	12p13.31	HRS
Dentatorubro-pallidoluysian atrophy, 125370 (3)	ATN1, DRPLA, HRS, NOD	607462	12p13.31	NOD
Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	SMOC2, SMAP2, DTDP1	607223	6q27	SMOC2
Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	SMOC2, SMAP2, DTDP1	607223	6q27	SMAP2
Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3)	SMOC2, SMAP2, DTDP1	607223	6q27	DTDP1
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DPP
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DGI1
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DFNA39
Dentin dysplasia, type II, 125420 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DTDP2
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DPP
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DGI1
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DFNA39
Dentinogenesis imperfecta, Shields type II, 125490 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DTDP2
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DSPP
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DPP
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DGI1
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DFNA39
Dentinogenesis imperfecta, Shields type III, 125500 (3)	DSPP, DPP, DGI1, DFNA39, DTDP2	125485	4q22.1	DTDP2
Denys-Drash syndrome, 194080 (3)	WT1, NPHS4	607102	11p13	WT1
Denys-Drash syndrome, 194080 (3)	WT1, NPHS4	607102	11p13	NPHS4
Dermatofibrosarcoma protuberans, 607907 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Dermatofibrosarcoma protuberans, 607907 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	SIS
Dermatofibrosarcoma protuberans, 607907 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	IBGC5
Dermatopathia pigmentosa reticularis, 125595 (3)	KRT14	148066	17q21.2	KRT14
Dermoids of cornea (2)	CND	304730	Xq24-qter	CND
Desanto-Shinawi syndrome, 616708 (3)	WAC, KIAA1844, DESSH	615049	10p12.1	WAC
Desanto-Shinawi syndrome, 616708 (3)	WAC, KIAA1844, DESSH	615049	10p12.1	KIAA1844
Desanto-Shinawi syndrome, 616708 (3)	WAC, KIAA1844, DESSH	615049	10p12.1	DESSH
Desbuquois dysplasia 1, 251450 (3)	CANT1, SCAN1, DBQD1	613165	17q25.3	CANT1
Desbuquois dysplasia 1, 251450 (3)	CANT1, SCAN1, DBQD1	613165	17q25.3	SCAN1
Desbuquois dysplasia 1, 251450 (3)	CANT1, SCAN1, DBQD1	613165	17q25.3	DBQD1
Desbuquois dysplasia 2, 615777 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XYLT1
Desbuquois dysplasia 2, 615777 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XT1
Desbuquois dysplasia 2, 615777 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	DBQD2
Desmoid disease, hereditary, 135290 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Desmoid disease, hereditary, 135290 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Desmoid disease, hereditary, 135290 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Desmoid disease, hereditary, 135290 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Desmosterolosis, 602398 (3)	DHCR24, KIAA0018	606418	1p32.3	DHCR24
Desmosterolosis, 602398 (3)	DHCR24, KIAA0018	606418	1p32.3	KIAA0018
Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	DPH1, DPH2L1, OVCA1, DEDSSH	603527	17p13.3	DPH1
Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	DPH1, DPH2L1, OVCA1, DEDSSH	603527	17p13.3	DPH2L1
Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	DPH1, DPH2L1, OVCA1, DEDSSH	603527	17p13.3	OVCA1
Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3)	DPH1, DPH2L1, OVCA1, DEDSSH	603527	17p13.3	DEDSSH
Developmental dysplasia of the hip 1 (2)	DDH1	142700	13q22	DDH1
Developmental dysplasia of the hip 2 (2)	DDH2	615612	3p22.2	DDH2
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGS
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CTHM
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CAFS
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TGA
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DORV
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	VCFS
DiGeorge syndrome, 188400 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGCR
DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	DGCR2, DGS2	601362	10p14-p13	DGCR2
DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)	DGCR2, DGS2	601362	10p14-p13	DGS2
Diabetes insipidus, nephrogenic, 125800 (3)	AQP2	107777	12q13.12	AQP2
Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	AVPR2
Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	DIR
Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	DI1
Diabetes insipidus, nephrogenic, 304800 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	ADHR
Diabetes insipidus, neurohypophyseal, 125700 (3)	AVP, AVRP, VP	192340	20p13	AVP
Diabetes insipidus, neurohypophyseal, 125700 (3)	AVP, AVRP, VP	192340	20p13	AVRP
Diabetes insipidus, neurohypophyseal, 125700 (3)	AVP, AVRP, VP	192340	20p13	VP
Diabetes mellitus, insulin-dependent, 2, 125852 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Diabetes mellitus, insulin-dependent, 2, 125852 (3)	INS, MODY10, IDDM2	176730	11p15.5	MODY10
Diabetes mellitus, insulin-dependent, 2, 125852 (3)	INS, MODY10, IDDM2	176730	11p15.5	IDDM2
Diabetes mellitus, insulin-dependent, 20, 612520 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Diabetes mellitus, insulin-dependent, 20, 612520 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
Diabetes mellitus, insulin-dependent, 20, 612520 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
Diabetes mellitus, insulin-dependent, 20, 612520 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)	INSR, HHF5	147670	19p13.2	INSR
Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)	INSR, HHF5	147670	19p13.2	HHF5
Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	GLIS3, ZNF515, NDH	610192	9p24.2	GLIS3
Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	GLIS3, ZNF515, NDH	610192	9p24.2	ZNF515
Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3)	GLIS3, ZNF515, NDH	610192	9p24.2	NDH
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	PHHI
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR1
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	HHF1
Diabetes mellitus, noninsulin-dependent, 125853 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	TNDM2
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	TCF2
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF2
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	MODY5
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	FJHN
Diabetes mellitus, noninsulin-dependent, 125853 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HPC11
Diabetes mellitus, noninsulin-dependent, 2 (2)	NIDDM2	601407	12q24.2	NIDDM2
Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)	GCK, HHF3	138079	7p13	GCK
Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3)	GCK, HHF3	138079	7p13	HHF3
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	PHHI
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR1
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	HHF1
Diabetes mellitus, permanent neonatal, 606176 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	TNDM2
Diabetes mellitus, permanent neonatal, 606176 (3)	GCK, HHF3	138079	7p13	GCK
Diabetes mellitus, permanent neonatal, 606176 (3)	GCK, HHF3	138079	7p13	HHF3
Diabetes mellitus, permanent neonatal, 606176 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Diabetes mellitus, permanent neonatal, 606176 (3)	INS, MODY10, IDDM2	176730	11p15.5	MODY10
Diabetes mellitus, permanent neonatal, 606176 (3)	INS, MODY10, IDDM2	176730	11p15.5	IDDM2
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
Diabetes mellitus, permanent neonatal, with neurologic features, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	PHHI
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR1
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	HHF1
Diabetes mellitus, transient neonatal 2, 610374 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	TNDM2
Diabetes mellitus, transient neonatal, 1, 601410 (3)	ZFP57, TNDM1	612192	6p22.1	ZFP57
Diabetes mellitus, transient neonatal, 1, 601410 (3)	ZFP57, TNDM1	612192	6p22.1	TNDM1
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
Diabetes mellitus, transient neonatal, 3, 610582 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
Diabetes mellitus, type 2, 125853 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
Diabetes mellitus, type 2, 125853 (3)	PAX4, MODY9, KPD	167413	7q32.1	MODY9
Diabetes mellitus, type 2, 125853 (3)	PAX4, MODY9, KPD	167413	7q32.1	KPD
Diabetes mellitus, type II, 125853 (3)	AKT2, HIHGHH	164731	19q13.2	AKT2
Diabetes mellitus, type II, 125853 (3)	AKT2, HIHGHH	164731	19q13.2	HIHGHH
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
Diabetes, permanent neonatal, 606176 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	RPS28, DBA15	603685	19p13.2	RPS28
Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3)	RPS28, DBA15	603685	19p13.2	DBA15
Diamond-Blackfan anemia 1, 105650 (3)	RPS19, DBA, DBA1	603474	19q13.2	RPS19
Diamond-Blackfan anemia 1, 105650 (3)	RPS19, DBA, DBA1	603474	19q13.2	DBA
Diamond-Blackfan anemia 1, 105650 (3)	RPS19, DBA, DBA1	603474	19q13.2	DBA1
Diamond-Blackfan anemia 10, 613309 (3)	RPS26, DBA10	603701	12q13.2	RPS26
Diamond-Blackfan anemia 10, 613309 (3)	RPS26, DBA10	603701	12q13.2	DBA10
Diamond-Blackfan anemia 13, 615909 (3)	RPS29, DBA13	603633	14q21.3	RPS29
Diamond-Blackfan anemia 13, 615909 (3)	RPS29, DBA13	603633	14q21.3	DBA13
Diamond-Blackfan anemia 2 (2)	DBA2	606129	8p23.3-p22	DBA2
Diamond-Blackfan anemia 4, 612527 (3)	RPS17, RPS17L1, RPS17L2, DBA4	180472	15q25.2	RPS17
Diamond-Blackfan anemia 4, 612527 (3)	RPS17, RPS17L1, RPS17L2, DBA4	180472	15q25.2	RPS17L1
Diamond-Blackfan anemia 4, 612527 (3)	RPS17, RPS17L1, RPS17L2, DBA4	180472	15q25.2	RPS17L2
Diamond-Blackfan anemia 4, 612527 (3)	RPS17, RPS17L1, RPS17L2, DBA4	180472	15q25.2	DBA4
Diamond-Blackfan anemia 5, 612528 (3)	RPL35A, DBA5	180468	3q29	RPL35A
Diamond-Blackfan anemia 5, 612528 (3)	RPL35A, DBA5	180468	3q29	DBA5
Diamond-Blackfan anemia 6, 612561 (3)	RPL5, DBA6	603634	1p22.1	RPL5
Diamond-Blackfan anemia 6, 612561 (3)	RPL5, DBA6	603634	1p22.1	DBA6
Diamond-Blackfan anemia 7, 612562 (3)	RPL11, DBA7	604175	1p36.11	RPL11
Diamond-Blackfan anemia 7, 612562 (3)	RPL11, DBA7	604175	1p36.11	DBA7
Diamond-Blackfan anemia 8, 612563 (3)	RPS7, DBA8	603658	2p25.3	RPS7
Diamond-Blackfan anemia 8, 612563 (3)	RPS7, DBA8	603658	2p25.3	DBA8
Diamond-Blackfan anemia 9, 613308 (3)	RPS10, DBA9	603632	6p21.31	RPS10
Diamond-Blackfan anemia 9, 613308 (3)	RPS10, DBA9	603632	6p21.31	DBA9
Diamond-blackfan anemia 3, 610629 (3)	RPS24, DBA3	602412	10q22.3	RPS24
Diamond-blackfan anemia 3, 610629 (3)	RPS24, DBA3	602412	10q22.3	DBA3
Diaphanospondylodysostosis, 608022 (3)	BMPER, CV2	608699	7p14.3	BMPER
Diaphanospondylodysostosis, 608022 (3)	BMPER, CV2	608699	7p14.3	CV2
Diaphragmatic hernia 3, 610187 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
Diaphragmatic hernia 3, 610187 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	FOG2
Diaphragmatic hernia 3, 610187 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	DIH3
Diaphragmatic hernia 3, 610187 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	SRXY9
Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	MTAP, DMSMFH	156540	9p21.3	MTAP
Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3)	MTAP, DMSMFH	156540	9p21.3	DMSMFH
Diarrhea 1, secretory chloride, congenital, 214700 (3)	SLC26A3, DRA, CLD	126650	7q22.3-q31.1	SLC26A3
Diarrhea 1, secretory chloride, congenital, 214700 (3)	SLC26A3, DRA, CLD	126650	7q22.3-q31.1	DRA
Diarrhea 1, secretory chloride, congenital, 214700 (3)	SLC26A3, DRA, CLD	126650	7q22.3-q31.1	CLD
Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	SPINT2, HAI2, DIAR3	605124	19q13.2	SPINT2
Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	SPINT2, HAI2, DIAR3	605124	19q13.2	HAI2
Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)	SPINT2, HAI2, DIAR3	605124	19q13.2	DIAR3
Diarrhea 4, malabsorptive, congenital, 610370 (3)	NEUROG3, NGN3, ATOH5	604882	10q22.1	NEUROG3
Diarrhea 4, malabsorptive, congenital, 610370 (3)	NEUROG3, NGN3, ATOH5	604882	10q22.1	NGN3
Diarrhea 4, malabsorptive, congenital, 610370 (3)	NEUROG3, NGN3, ATOH5	604882	10q22.1	ATOH5
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	EPCAM
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	ACSTD1
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	TROP1
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	M4S1
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	MIC18
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	DIAR5
Diarrhea 5, with tufting enteropathy, congenital, 613217 (3)	EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8	185535	2p21	HNPCC8
Diarrhea 6, 614616 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUCY2C
Diarrhea 6, 614616 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUC2C
Diarrhea 6, 614616 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	DIAR6
Diarrhea 6, 614616 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	MECIL
Diarrhea 8, secretory sodium, congenital, 616868 (3)	SLC9A3, NHE3, DIAR8	182307	5p15.33	SLC9A3
Diarrhea 8, secretory sodium, congenital, 616868 (3)	SLC9A3, NHE3, DIAR8	182307	5p15.33	NHE3
Diarrhea 8, secretory sodium, congenital, 616868 (3)	SLC9A3, NHE3, DIAR8	182307	5p15.33	DIAR8
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
Diastrophic dysplasia, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
Diastrophic dysplasia, broad bone-platyspondylic variant, 222600 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Dicarboxylic aminoaciduria, 222730 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SLC1A1
Dicarboxylic aminoaciduria, 222730 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	EAAC1
Dicarboxylic aminoaciduria, 222730 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SCZD18
Dicarboxylic aminoaciduria, 222730 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	DCBXA
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Digital arthropathy-brachydactyly, familial, 606835 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Digital clubbing, isolated congenital, 119900 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Digital clubbing, isolated congenital, 119900 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PGDH1
Digital clubbing, isolated congenital, 119900 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PHOAR1
Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	DLD, LAD, PHE3, DLDD	238331	7q31.1	DLD
Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	DLD, LAD, PHE3, DLDD	238331	7q31.1	LAD
Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	DLD, LAD, PHE3, DLDD	238331	7q31.1	PHE3
Dihydrolipoamide dehydrogenase deficiency, 246900 (3)	DLD, LAD, PHE3, DLDD	238331	7q31.1	DLDD
Dihydropyrimidine dehydrogenase deficiency, 274270 (3)	DPYD, DPD	612779	1p21.3	DPYD
Dihydropyrimidine dehydrogenase deficiency, 274270 (3)	DPYD, DPD	612779	1p21.3	DPD
Dihydropyrimidinuria, 222748 (3)	DPYS, DHP	613326	8q22.3	DPYS
Dihydropyrimidinuria, 222748 (3)	DPYS, DHP	613326	8q22.3	DHP
Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Dilated cardiomyopathy with woolly hair, keratoderma, and tooth agenesis, 615821 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Dimethylglycine dehydrogenase deficiency, 605850 (3)	DMGDH, DMGDHD	605849	5q14.1	DMGDH
Dimethylglycine dehydrogenase deficiency, 605850 (3)	DMGDH, DMGDHD	605849	5q14.1	DMGDHD
Diphenylhydantoin toxicity (1)	EPHX1	132810	1q42.12	EPHX1
Disordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3)	POR	124015	7q11.23	POR
Donnai-Barrow syndrome, 222448 (3)	LRP2, DBS	600073	2q31.1	LRP2
Donnai-Barrow syndrome, 222448 (3)	LRP2, DBS	600073	2q31.1	DBS
Dopamine beta-hydroxylase deficiency, 223360 (3)	DBH	609312	9q34.2	DBH
Dopamine receptor D2, reduced brain density of (3)	ANKK1	608774	11q23.2	ANKK1
Double-outlet right ventricle, 217095 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Double-outlet right ventricle, 217095 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DTGA3
Double-outlet right ventricle, 217095 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DORV
Double-outlet right ventricle, 217095 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	RAI
Dowling-Degos disease 1, 179850 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Dowling-Degos disease 1, 179850 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Dowling-Degos disease 2, 615327 (3)	POFUT1, OFUCT1, KIAA0180, DDD2	607491	20q11.21	POFUT1
Dowling-Degos disease 2, 615327 (3)	POFUT1, OFUCT1, KIAA0180, DDD2	607491	20q11.21	OFUCT1
Dowling-Degos disease 2, 615327 (3)	POFUT1, OFUCT1, KIAA0180, DDD2	607491	20q11.21	KIAA0180
Dowling-Degos disease 2, 615327 (3)	POFUT1, OFUCT1, KIAA0180, DDD2	607491	20q11.21	DDD2
Dowling-Degos disease 3 (2)	DDD3	615674	17q21.3-q22	DDD3
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	POGLUT1
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	CLP46
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	KTELC1
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	RUMI
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	C3orf9
Dowling-Degos disease 4, 615696 (3)	POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4	615618	3q13.33	DDD4
Down syndrome (4)	DCR, DSCR	190685	21q22.3	DCR
Down syndrome (4)	DCR, DSCR	190685	21q22.3	DSCR
Doyne honeycomb degeneration of retina, 126600 (3)	EFEMP1, FBNL, DHRD	601548	2p16.1	EFEMP1
Doyne honeycomb degeneration of retina, 126600 (3)	EFEMP1, FBNL, DHRD	601548	2p16.1	FBNL
Doyne honeycomb degeneration of retina, 126600 (3)	EFEMP1, FBNL, DHRD	601548	2p16.1	DHRD
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	GEFSP2
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SMEI
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FEB3A
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	EIEE6
Dravet syndrome, 607208 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FHM3
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Du Pan syndrome, 228900 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Duane retraction syndrome 1 (2)	DURS1, DUS	126800	8q13	DURS1
Duane retraction syndrome 1 (2)	DURS1, DUS	126800	8q13	DUS
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	CHN1
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	CHN
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	ARHGAP2
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	RHOGAP2
Duane retraction syndrome 2, 604356 (3)	CHN1, CHN, ARHGAP2, RHOGAP2, DURS2	118423	2q31.1	DURS2
Duane retraction syndrome 3, 617041 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MAFB
Duane retraction syndrome 3, 617041 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	KRML
Duane retraction syndrome 3, 617041 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MCTO
Duane retraction syndrome 3, 617041 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	DURS3
Duane-radial ray syndrome, 607323 (3)	SALL4, HSAL4	607343	20q13.2	SALL4
Duane-radial ray syndrome, 607323 (3)	SALL4, HSAL4	607343	20q13.2	HSAL4
Dubin-Johnson syndrome, 237500 (3)	ABCC2, CMOAT	601107	10q24.2	ABCC2
Dubin-Johnson syndrome, 237500 (3)	ABCC2, CMOAT	601107	10q24.2	CMOAT
Duchenne muscular dystrophy, 310200 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	DMD
Duchenne muscular dystrophy, 310200 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	BMD
Duchenne muscular dystrophy, 310200 (3)	DMD, BMD, CMD3B	300377	Xp21.2-p21.1	CMD3B
Dupuytren contracture 1 (2)	DUPC1	126900	16q11.1-q22	DUPC1
Dursun syndrome, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	G6PC3
Dursun syndrome, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	UGRP
Dursun syndrome, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	SCN4
Dyggve-Melchior-Clausen disease, 223800 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DYM
Dyggve-Melchior-Clausen disease, 223800 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	FLJ90130
Dyggve-Melchior-Clausen disease, 223800 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DMC
Dyggve-Melchior-Clausen disease, 223800 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	SMC
Dysautonomia, familial, 223900 (3)	IKBKAP, IKAP	603722	9q31.3	IKBKAP
Dysautonomia, familial, 223900 (3)	IKBKAP, IKAP	603722	9q31.3	IKAP
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	ADAR
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DRADA
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DSH
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	DSRAD
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	IFI4
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	G1P1
Dyschromatosis symmetrica hereditaria, 127400 (3)	ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6	146920	1q21.3	AGS6
Dyschromatosis universalis hereditaria 1 (2)	DUH1, DUH	127500	6q24.2-q25.2	DUH1
Dyschromatosis universalis hereditaria 1 (2)	DUH1, DUH	127500	6q24.2-q25.2	DUH
Dyschromatosis universalis hereditaria 2 (2)	DUH2	612715	12q21-q23	DUH2
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MTABC3
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MCOPCB7
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	LAN
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	DUH3
Dyschromatosis universalis hereditaria 3, 615402 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	PSHK2
Dyserythropoietic anemia, congenital, type II, 224100 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	SEC23B
Dyserythropoietic anemia, congenital, type II, 224100 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	CDAN2
Dyserythropoietic anemia, congenital, type II, 224100 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	HEMPAS
Dyserythropoietic anemia, congenital, type II, 224100 (3)	SEC23B, CDAN2, HEMPAS, CWS7	610512	20p11.23	CWS7
Dyserythropoietic anemia, congenital, type III (2)	CDAN3, CDA3	105600	15q21	CDAN3
Dyserythropoietic anemia, congenital, type III (2)	CDAN3, CDA3	105600	15q21	CDA3
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	EKLF
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	INLU
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	HBFQTL6
Dyserythropoietic anemia, congenital, type IV, 613673 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	CDAN4
Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	CDAN1, CDA1, CDAN1A	607465	15q15.2	CDAN1
Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	CDAN1, CDA1, CDAN1A	607465	15q15.2	CDA1
Dyserythropoietic anemia, congenital, type Ia, 224120 (3)	CDAN1, CDA1, CDAN1A	607465	15q15.2	CDAN1A
Dyserythropoietic anemia, congenital, type Ib, 615631 (3)	C15orf41	615626	15q14	C15orf41
Dysfibrinogenemia, congenital, 616004 (3)	FGA	134820	4q31.3	FGA
Dysfibrinogenemia, congenital, 616004 (3)	FGB	134830	4q31.3	FGB
Dysfibrinogenemia, congenital, 616004 (3)	FGG	134850	4q32.1	FGG
Dyskeratosis congenita, X-linked, 305000 (3)	DKC1, DKCX	300126	Xq28	DKC1
Dyskeratosis congenita, X-linked, 305000 (3)	DKC1, DKCX	300126	Xq28	DKCX
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TRC3
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TR
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	DKCA1
Dyskeratosis congenita, autosomal dominant 1, 127550 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	PFBMFT2
Dyskeratosis congenita, autosomal dominant 3, 613990 (3)	TINF2, TIN2, DKCA3	604319	14q12	TINF2
Dyskeratosis congenita, autosomal dominant 3, 613990 (3)	TINF2, TIN2, DKCA3	604319	14q12	TIN2
Dyskeratosis congenita, autosomal dominant 3, 613990 (3)	TINF2, TIN2, DKCA3	604319	14q12	DKCA3
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	C20orf41
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	NHL
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	KIAA1088
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCB5
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCA4
Dyskeratosis congenita, autosomal dominant 4, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	PFBMFT3
Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	NOLA3, NOP10, DKCB1	606471	15q14	NOLA3
Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	NOLA3, NOP10, DKCB1	606471	15q14	NOP10
Dyskeratosis congenita, autosomal recessive 1, 224230 (3)	NOLA3, NOP10, DKCB1	606471	15q14	DKCB1
Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	NOLA2, NHP2, DKCB2	606470	5q35.3	NOLA2
Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	NOLA2, NHP2, DKCB2	606470	5q35.3	NHP2
Dyskeratosis congenita, autosomal recessive 2, 613987 (3)	NOLA2, NHP2, DKCB2	606470	5q35.3	DKCB2
Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	WRAP53, TCAB1, WDR79, DKCB3	612661	17p13.1	WRAP53
Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	WRAP53, TCAB1, WDR79, DKCB3	612661	17p13.1	TCAB1
Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	WRAP53, TCAB1, WDR79, DKCB3	612661	17p13.1	WDR79
Dyskeratosis congenita, autosomal recessive 3, 613988 (3)	WRAP53, TCAB1, WDR79, DKCB3	612661	17p13.1	DKCB3
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	C20orf41
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	NHL
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	KIAA1088
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCB5
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCA4
Dyskeratosis congenita, autosomal recessive 5, 615190 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	PFBMFT3
Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PARN
Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	DAN
Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	DKCB6
Dyskeratosis congenita, autosomal recessive 6, 616353 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PFBMFT4
Dyskeratosis, hereditary benign intraepithelial (2)	DKBI	127600	4q35	DKBI
Dyskinesia, familial, with facial myokymia, 606703 (3)	ADCY5, FDFM	600293	3q21.1	ADCY5
Dyskinesia, familial, with facial myokymia, 606703 (3)	ADCY5, FDFM	600293	3q21.1	FDFM
Dyskinesia, limb and orofacial, infantile-onset, 616921 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	PDE10A
Dyskinesia, limb and orofacial, infantile-onset, 616921 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	IOLOD
Dyskinesia, limb and orofacial, infantile-onset, 616921 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	ADSD2
Dysplasminogenemia, 217090 (3)	PLG	173350	6q26	PLG
Dysprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Dysprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	THPH1
Dysprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	RPRGL2
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	HSPG2
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	PLC
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJS
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJA
Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJS1
Dystonia 13, torsion (2)	DYT13	607671	1p36.32-p36.13	DYT13
Dystonia 16, 612067 (3)	PRKRA, PACT, RAX, DYT16	603424	2q31.2	PRKRA
Dystonia 16, 612067 (3)	PRKRA, PACT, RAX, DYT16	603424	2q31.2	PACT
Dystonia 16, 612067 (3)	PRKRA, PACT, RAX, DYT16	603424	2q31.2	RAX
Dystonia 16, 612067 (3)	PRKRA, PACT, RAX, DYT16	603424	2q31.2	DYT16
Dystonia 2, torsion, autosomal recessive, 224500 (3)	HPCA, DYT2	142622	1p35.1	HPCA
Dystonia 2, torsion, autosomal recessive, 224500 (3)	HPCA, DYT2	142622	1p35.1	DYT2
Dystonia 21 (2)	DYT21	614588	2q14.3-q21.3	DYT21
Dystonia 24, 615034 (3)	ANO3, TMEM16C, C11orf25, DYT24	610110	11p14.3-p14.2	ANO3
Dystonia 24, 615034 (3)	ANO3, TMEM16C, C11orf25, DYT24	610110	11p14.3-p14.2	TMEM16C
Dystonia 24, 615034 (3)	ANO3, TMEM16C, C11orf25, DYT24	610110	11p14.3-p14.2	C11orf25
Dystonia 24, 615034 (3)	ANO3, TMEM16C, C11orf25, DYT24	610110	11p14.3-p14.2	DYT24
Dystonia 25, 615073 (3)	GNAL, DYT25	139312	18p11.21	GNAL
Dystonia 25, 615073 (3)	GNAL, DYT25	139312	18p11.21	DYT25
Dystonia 26, myoclonic, 616398 (3)	KCTD17	616386	22q12.3	KCTD17
Dystonia 27, 616411 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Dystonia 27, 616411 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	DYT27
Dystonia 27, 616411 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	BTHLM1
Dystonia 27, 616411 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	UCMD1
Dystonia 4, torsion, autosomal dominant, 128101 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	TUBB4A
Dystonia 4, torsion, autosomal dominant, 128101 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	DYT4
Dystonia 4, torsion, autosomal dominant, 128101 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	HLD6
Dystonia 6, torsion, 602629 (3)	THAP1, DYT6	609520	8p11.21	THAP1
Dystonia 6, torsion, 602629 (3)	THAP1, DYT6	609520	8p11.21	DYT6
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT18
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	PED
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1DS
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	EIG12
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT9
Dystonia 9, 601042 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SDCHCN
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	GCH1
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	DYT5
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	HPABH4B
Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3)	SPR	182125	2p13.2	SPR
Dystonia, primary cervical (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
Dystonia, primary cervical (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1B
Dystonia, primary cervical (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1L2
Dystonia-1, torsion, 128100 (3)	DYT1, TOR1A	605204	9q34.11	DYT1
Dystonia-1, torsion, 128100 (3)	DYT1, TOR1A	605204	9q34.11	TOR1A
Dystonia-11, myoclonic, 159900 (3)	SGCE, DYT11	604149	7q21.3	SGCE
Dystonia-11, myoclonic, 159900 (3)	SGCE, DYT11	604149	7q21.3	DYT11
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	ATP1A3
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	DYT12
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	RDP
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	AHC2
Dystonia-12, 128235 (3)	ATP1A3, DYT12, RDP, AHC2, CAPOS	182350	19q13.2	CAPOS
Dystonia-15, myoclonic (2)	DYT15	607488	18p11	DYT15
Dystonia-17, primary torsion (2)	DYT17	612406	20p11.2-q13.12	DYT17
Dystonia-7, torsion (2)	DYT7	602124	18p	DYT7
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF1
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF2A
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	CCG1
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	BA2R
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	DYT3
Dystonia-Parkinsonism, X-linked, 314250 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	MRXS33
EBD inversa, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EBD inversa, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
EBD, Bart type, 132000 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EBD, Bart type, 132000 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
EBD, localisata variant (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
EBD, localisata variant (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
EDICT syndrome, 614303 (3)	MIR184, MIRN184, KTCNCT, EDICT	613146	15q25.1	MIR184
EDICT syndrome, 614303 (3)	MIR184, MIRN184, KTCNCT, EDICT	613146	15q25.1	MIRN184
EDICT syndrome, 614303 (3)	MIR184, MIRN184, KTCNCT, EDICT	613146	15q25.1	KTCNCT
EDICT syndrome, 614303 (3)	MIR184, MIRN184, KTCNCT, EDICT	613146	15q25.1	EDICT
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	EDA
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	ED1
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	ECTD1
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	EDA
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	HED1
Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	STHAGX1
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	DL
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ED3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDA3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	HRM1
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10A
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10B
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	DL
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ED3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDA3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	HRM1
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10A
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive, 224900 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10B
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDARADD
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ED3
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDA3
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ECTD11B
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ECTD11A
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDARADD
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ED3
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	EDA3
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ECTD11B
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3)	EDARADD, ED3, EDA3, ECTD11B, ECTD11A	606603	1q42-q43	ECTD11A
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	GJB6
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	CX30
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNA3B
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	DFNB1B
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	ECTD2
Ectodermal dysplasia 2, Clouston type, 129500 (3)	GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2	604418	13q12.11	HED2
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HOX7
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HYD1
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	OFC5
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	STHAG1
Ectodermal dysplasia 3, Witkop type, 189500 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	ECTD3
Ectodermal dysplasia 4, hair/nail type, 602032 (3)	KRT85, KRTHB5, HB5, ECTD4	602767	12q13.13	KRT85
Ectodermal dysplasia 4, hair/nail type, 602032 (3)	KRT85, KRTHB5, HB5, ECTD4	602767	12q13.13	KRTHB5
Ectodermal dysplasia 4, hair/nail type, 602032 (3)	KRT85, KRTHB5, HB5, ECTD4	602767	12q13.13	HB5
Ectodermal dysplasia 4, hair/nail type, 602032 (3)	KRT85, KRTHB5, HB5, ECTD4	602767	12q13.13	ECTD4
Ectodermal dysplasia 5, hair/nail type (2)	ECTD5	614927	10q24.32-q25.1	ECTD5
Ectodermal dysplasia 6, hair/nail type (2)	ECTD6	614928	17p12-q21.2	ECTD6
Ectodermal dysplasia 8, hair/tooth/nail type (2)	ECTD8	602401	18q22.1-q22.3	ECTD8
Ectodermal dysplasia 9, hair/nail type, 614931 (3)	HOXC13, HOX3G, ECTD9	142976	12q13.13	HOXC13
Ectodermal dysplasia 9, hair/nail type, 614931 (3)	HOXC13, HOX3G, ECTD9	142976	12q13.13	HOX3G
Ectodermal dysplasia 9, hair/nail type, 614931 (3)	HOXC13, HOX3G, ECTD9	142976	12q13.13	ECTD9
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	NFKBIA, IKBA	164008	14q13.2	NFKBIA
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency, 612132 (3)	NFKBIA, IKBA	164008	14q13.2	IKBA
Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDH3
Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDHP
Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	PCAD
Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	HJMD
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Ectodermal dysplasia, hypohidrotic, with immune deficiency, 300291 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	PVRL4, PRR4, EDSS1	609607	1q23.3	PVRL4
Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	PVRL4, PRR4, EDSS1	609607	1q23.3	PRR4
Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)	PVRL4, PRR4, EDSS1	609607	1q23.3	EDSS1
Ectodermal dysplasia-syndactyly syndrome 2 (2)	EDSS2	613576	7p21.2-p14.3	EDSS2
Ectodermal dysplasia/short stature syndrome, 616029 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	GRHL2
Ectodermal dysplasia/short stature syndrome, 616029 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	TFCP2L3
Ectodermal dysplasia/short stature syndrome, 616029 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	DFNA28
Ectodermal dysplasia/short stature syndrome, 616029 (3)	GRHL2, TFCP2L3, DFNA28, ECTDS	608576	8q22.3	ECTDS
Ectodermal dysplasia/skin fragility syndrome, 604536 (3)	PKP1	601975	1q32.1	PKP1
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency, 300301 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Ectopia lentis et pupillae, 225200 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ADAMTSL4
Ectopia lentis et pupillae, 225200 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	TSRC1
Ectopia lentis et pupillae, 225200 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ECTOL2
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Ectopia lentis, familial, 129600 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Ectopia lentis, isolated, autosomal recessive, 225100 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ADAMTSL4
Ectopia lentis, isolated, autosomal recessive, 225100 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	TSRC1
Ectopia lentis, isolated, autosomal recessive, 225100 (3)	ADAMTSL4, TSRC1, ECTOL2	610113	1q21.2	ECTOL2
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3, 604292 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Efavirenz, poor metabolism of, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B6
Efavirenz, poor metabolism of, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B
Efavirenz, poor metabolism of, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	EFVM
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNX
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB1
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXBS
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB2
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	EDS3
Ehlers-Danlos syndrome due to tenascin X deficiency, 606408 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	VUR8
Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss, 614557 (3)	FKBP14, EDSKMH	614505	7p14.3	FKBP14
Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss, 614557 (3)	FKBP14, EDSKMH	614505	7p14.3	EDSKMH
Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 (3)	B4GALT7, XGALT1, XGPT1, EDSSLA	604327	5q35.3	B4GALT7
Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 (3)	B4GALT7, XGALT1, XGPT1, EDSSLA	604327	5q35.3	XGALT1
Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 (3)	B4GALT7, XGALT1, XGPT1, EDSSLA	604327	5q35.3	XGPT1
Ehlers-Danlos syndrome with short stature and limb anomalies, 130070 (3)	B4GALT7, XGALT1, XGPT1, EDSSLA	604327	5q35.3	EDSSLA
Ehlers-Danlos syndrome, cardiac valvular form, 225320 (3)	COL1A2	120160	7q21.3	COL1A2
Ehlers-Danlos syndrome, classic type, 130000 (3)	COL5A1, EDSC	120215	9q34.3	COL5A1
Ehlers-Danlos syndrome, classic type, 130000 (3)	COL5A1, EDSC	120215	9q34.3	EDSC
Ehlers-Danlos syndrome, classic type, 130000 (3)	COL5A2, EDSC	120190	2q32.2	COL5A2
Ehlers-Danlos syndrome, classic type, 130000 (3)	COL5A2, EDSC	120190	2q32.2	EDSC
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Ehlers-Danlos syndrome, classic, 130000 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	CHST14, D4ST1, ATCS, EDSMC1	608429	15q15.1	CHST14
Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	CHST14, D4ST1, ATCS, EDSMC1	608429	15q15.1	D4ST1
Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	CHST14, D4ST1, ATCS, EDSMC1	608429	15q15.1	ATCS
Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3)	CHST14, D4ST1, ATCS, EDSMC1	608429	15q15.1	EDSMC1
Ehlers-Danlos syndrome, progeroid type, 2, 615349 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	B3GALT6
Ehlers-Danlos syndrome, progeroid type, 2, 615349 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	SEMDJL1
Ehlers-Danlos syndrome, progeroid type, 2, 615349 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	EDSP2
Ehlers-Danlos syndrome, type IV, 130050 (3)	COL3A1	120180	2q32.2	COL3A1
Ehlers-Danlos syndrome, type VI, 225400 (3)	PLOD1, LH1, LLH, EDS6	153454	1p36.22	PLOD1
Ehlers-Danlos syndrome, type VI, 225400 (3)	PLOD1, LH1, LLH, EDS6	153454	1p36.22	LH1
Ehlers-Danlos syndrome, type VI, 225400 (3)	PLOD1, LH1, LLH, EDS6	153454	1p36.22	LLH
Ehlers-Danlos syndrome, type VI, 225400 (3)	PLOD1, LH1, LLH, EDS6	153454	1p36.22	EDS6
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Ehlers-Danlos syndrome, type VIIA, 130060 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Ehlers-Danlos syndrome, type VIIB, 130060 (3)	COL1A2	120160	7q21.3	COL1A2
Ehlers-Danlos syndrome, type VIIC, 225410 (3)	ADAMTS2, NPI	604539	5q35.3	ADAMTS2
Ehlers-Danlos syndrome, type VIIC, 225410 (3)	ADAMTS2, NPI	604539	5q35.3	NPI
Ehlers-Danlos syndrome, type VIII (2)	EDS8	130080	12p13	EDS8
Eiken syndrome, 600002 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Eiken syndrome, 600002 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR
Eiken syndrome, 600002 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PFE
Elliptocytosis-1, 611804 (3)	EPB41, EL1	130500	1p35.3	EPB41
Elliptocytosis-1, 611804 (3)	EPB41, EL1	130500	1p35.3	EL1
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	EL2
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPH3
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HS3
Elliptocytosis-2, 130600 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HPP
Elliptocytosis-3 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Elliptocytosis-3 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPH2
Elliptocytosis-3 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	EL3
Elliptocytosis-3 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	HS2
Ellis-van Creveld syndrome, 225500 (3)	EVC	604831	4p16.2	EVC
Ellis-van Creveld syndrome, 225500 (3)	LBN, EVC2, WAD	607261	4p16.2	LBN
Ellis-van Creveld syndrome, 225500 (3)	LBN, EVC2, WAD	607261	4p16.2	EVC2
Ellis-van Creveld syndrome, 225500 (3)	LBN, EVC2, WAD	607261	4p16.2	WAD
Emanuel syndrome (4)	DER22t11-22	609029	22q11.2	DER22t11-22
Emberger syndrome, 614038 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
Emberger syndrome, 614038 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	DCML
Emberger syndrome, 614038 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	MONOMAC
Emberger syndrome, 614038 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	IMD21
Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	EMD, EDMD, STA	300384	Xq28	EMD
Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	EMD, EDMD, STA	300384	Xq28	EDMD
Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)	EMD, EDMD, STA	300384	Xq28	STA
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Emery-Dreifuss muscular dystrophy 3, AR, 616516 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SYNE1
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA0796
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA1756
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA1262
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SCAR8
Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	EDMD4
Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	SYNE2, NUANCE, KIAA1011, EDMD5	608442	14q23.2	SYNE2
Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	SYNE2, NUANCE, KIAA1011, EDMD5	608442	14q23.2	NUANCE
Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	SYNE2, NUANCE, KIAA1011, EDMD5	608442	14q23.2	KIAA1011
Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)	SYNE2, NUANCE, KIAA1011, EDMD5	608442	14q23.2	EDMD5
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	SLIM1
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	XMPMA
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	KYOT
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1A
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1B
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1A
Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1B
Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	TMEM43
Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	ARVD5
Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	ARVC5
Emery-Dreifuss muscular dystrophy 7, AD, 614302 (3)	TMEM43, ARVD5, ARVC5, EDMD7	612048	3p25.1	EDMD7
Emphysema due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Emphysema due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	PI
Emphysema due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	AAT
Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	PI
Emphysema-cirrhosis, due to AAT deficiency, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	AAT
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Encephalocraniocutaneous lipomatosis, 613001 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF	603850	12p11.21	DNM1L
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF	603850	12p11.21	DRP1
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF	603850	12p11.21	DVLP
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF	603850	12p11.21	DYMPLE
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission, 614388 (3)	DNM1L, DRP1, DVLP, DYMPLE, EMPF	603850	12p11.21	EMPF
Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	SERPINI1, PI12	602445	3q26.1	SERPINI1
Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3)	SERPINI1, PI12	602445	3q26.1	PI12
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Encephalopathy, neonatal severe, 300673 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	SPG17
Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	HMN5
Encephalopathy, progressive, with or without lipodystrophy, 615924 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	PELD
Endocrine-cerebroosteodysplasia, 612651 (3)	ICK, MRK, KIAA0936, ECO	612325	6p12.1	ICK
Endocrine-cerebroosteodysplasia, 612651 (3)	ICK, MRK, KIAA0936, ECO	612325	6p12.1	MRK
Endocrine-cerebroosteodysplasia, 612651 (3)	ICK, MRK, KIAA0936, ECO	612325	6p12.1	KIAA0936
Endocrine-cerebroosteodysplasia, 612651 (3)	ICK, MRK, KIAA0936, ECO	612325	6p12.1	ECO
Endometrial cancer, familial, 608089 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Endometrial cancer, familial, 608089 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	GTBP
Endometrial cancer, familial, 608089 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	HNPCC5
Endometrial carcinoma, somatic, 608089 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	CDH1
Endometrial carcinoma, somatic, 608089 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	UVO
Endometrial carcinoma, somatic, 608089 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	LCAM
Endometrial carcinoma, somatic, 608089 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	ECAD
Endometrial carcinoma, somatic, 608089 (3)	MSH3	600887	5q14.1	MSH3
Endometrial carcinoma, somatic, 608089 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Endometrial carcinoma, somatic, 608089 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Endometrial carcinoma, somatic, 608089 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Endometrial carcinoma, somatic, 608089 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Enhanced S-cone syndrome, 268100 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	NR2E3
Enhanced S-cone syndrome, 268100 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	PNR
Enhanced S-cone syndrome, 268100 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	ESCS
Enhanced S-cone syndrome, 268100 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	RP37
Enlarged vestibular aqueduct, 600791 (3)	FOXI1, FKHL10, FREAC6	601093	5q35.1	FOXI1
Enlarged vestibular aqueduct, 600791 (3)	FOXI1, FKHL10, FREAC6	601093	5q35.1	FKHL10
Enlarged vestibular aqueduct, 600791 (3)	FOXI1, FKHL10, FREAC6	601093	5q35.1	FREAC6
Enlarged vestibular aqueduct, digenic, 600791 (3)	KCNJ10, SESAME	602208	1q23.2	KCNJ10
Enlarged vestibular aqueduct, digenic, 600791 (3)	KCNJ10, SESAME	602208	1q23.2	SESAME
Enolase deficiency (1)	ENO1, PPH, MPB1	172430	1p36.23	ENO1
Enolase deficiency (1)	ENO1, PPH, MPB1	172430	1p36.23	PPH
Enolase deficiency (1)	ENO1, PPH, MPB1	172430	1p36.23	MPB1
Enterokinase deficiency, 226200 (3)	PRSS7, ENTK	606635	21q21.1	PRSS7
Enterokinase deficiency, 226200 (3)	PRSS7, ENTK	606635	21q21.1	ENTK
Enuresis, nocturnal, 1 (2)	ENUR1	600631	13q13-q14.3	ENUR1
Enuresis, nocturnal, 2 (2)	ENUR2	600808	12q13-q21	ENUR2
Eosinophilia, familial (2)	EOS	131400	5q31-q33	EOS
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Epidermal nevus, somatic, 162900 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Epidermodysplasia verruciformis, 226400 (3)	TMC6, EVER1, EV1	605828	17q25.3	TMC6
Epidermodysplasia verruciformis, 226400 (3)	TMC6, EVER1, EV1	605828	17q25.3	EVER1
Epidermodysplasia verruciformis, 226400 (3)	TMC6, EVER1, EV1	605828	17q25.3	EV1
Epidermodysplasia verruciformis, 226400 (3)	TMC8, EVER2, EV2	605829	17q25.3	TMC8
Epidermodysplasia verruciformis, 226400 (3)	TMC8, EVER2, EV2	605829	17q25.3	EVER2
Epidermodysplasia verruciformis, 226400 (3)	TMC8, EVER2, EV2	605829	17q25.3	EV2
Epidermolysis bullosa dystrophica, AD, 131750 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa dystrophica, AD, 131750 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Epidermolysis bullosa dystrophica, AR, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa dystrophica, AR, 226600 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Epidermolysis bullosa of hands and feet, 131800 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa pruriginosa, 604129 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa pruriginosa, 604129 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLTN
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBS1
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	LGMD2Q
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSOG
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSPA
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSMD
Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSND
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLTN
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBS1
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	LGMD2Q
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSOG
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSPA
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSMD
Epidermolysis bullosa simplex with pyloric atresia, 612138 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSND
Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epidermolysis bullosa simplex, Koebner type, 131900 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Koebner type, 131900 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, Koebner type, 131900 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLTN
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBS1
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	LGMD2Q
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSOG
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSPA
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSMD
Epidermolysis bullosa simplex, Ogna type, 131950 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSND
Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, Weber-Cockayne type, 131800 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DST
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	BPAG1
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	DMH
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	D6S1101
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	HSAN6
Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3)	DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2	113810	6p12.1	EBSB2
Epidermolysis bullosa simplex, recessive 1, 601001 (3)	KRT14	148066	17q21.2	KRT14
Epidermolysis bullosa simplex, recessive 1, 601001 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex, recessive 1, 601001 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epidermolysis bullosa simplex-MP, 131960 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermolysis bullosa simplex-MP, 131960 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Epidermolysis bullosa, generalized atrophic benign, 226650 (3)	LAMA3, LOCS	600805	18q11.2	LOCS
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMA3, LOCS	600805	18q11.2	LOCS
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMB3, AI1A	150310	1q32.2	AI1A
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMC2
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMNB2
Epidermolysis bullosa, junctional, Herlitz type, 226700 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMB2T
Epidermolysis bullosa, junctional, localisata variant, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epidermolysis bullosa, junctional, localisata variant, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	BPAG2
Epidermolysis bullosa, junctional, localisata variant, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	ERED
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	BPAG2
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	ERED
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMB3, AI1A	150310	1q32.2	LAMB3
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMB3, AI1A	150310	1q32.2	AI1A
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMC2
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMNB2
Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)	LAMC2, LAMNB2, LAMB2T	150292	1q25.3	LAMB2T
Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3)	ITGB4	147557	17q25.1	ITGB4
Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3)	ITGA6	147556	2q31.1	ITGA6
Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Epidermolysis bullosa, lethal acantholytic, 609638 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	EXPH5, SLAC2B, KIAA0624	612878	11q22.3	EXPH5
Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	EXPH5, SLAC2B, KIAA0624	612878	11q22.3	SLAC2B
Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3)	EXPH5, SLAC2B, KIAA0624	612878	11q22.3	KIAA0624
Epidermolysis bullosa, pretibial, 131850 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Epidermolysis bullosa, pretibial, 131850 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Epidermolytic hyperkeratosis, 113800 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Epidermolytic hyperkeratosis, 113800 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Epidermolytic hyperkeratosis, 113800 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Epidermolytic hyperkeratosis, 113800 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Epidermolytic hyperkeratosis, 113800 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Epidermolytic hyperkeratosis, 113800 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	EHK
Epidermolytic hyperkeratosis, 113800 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BCIE
Epidermolytic hyperkeratosis, 113800 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BIE
Epidermylysis bullosa simplex-MCR, 609352 (3)	KRT5, DDD1	148040	12q13.13	KRT5
Epidermylysis bullosa simplex-MCR, 609352 (3)	KRT5, DDD1	148040	12q13.13	DDD1
Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3)	SYN1	313440	Xp11.3-p11.2	SYN1
Epilepsy, childhood absence, 1 (2)	ECA1	600131	8q24	ECA1
Epilepsy, familial focal, with variable foci, 604364 (3)	DEPDC5, KIAA0645, FFEVF	614191	22q12.2-q12.3	DEPDC5
Epilepsy, familial focal, with variable foci, 604364 (3)	DEPDC5, KIAA0645, FFEVF	614191	22q12.2-q12.3	KIAA0645
Epilepsy, familial focal, with variable foci, 604364 (3)	DEPDC5, KIAA0645, FFEVF	614191	22q12.2-q12.3	FFEVF
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	LGI1
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	EPT
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	ETL1
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	ADLTE
Epilepsy, familial temporal lobe, 1, 600512 (3)	LGI1, EPT, ETL1, ADLTE, ADPEAF	604619	10q23.33	ADPEAF
Epilepsy, familial temporal lobe, 2 (2)	ETL2, FTLE	608096	12q22-q23.3	ETL2
Epilepsy, familial temporal lobe, 2 (2)	ETL2, FTLE	608096	12q22-q23.3	FTLE
Epilepsy, familial temporal lobe, 3 (2)	ETL3, FMTLE	611630	4q13.2-q21.3	ETL3
Epilepsy, familial temporal lobe, 3 (2)	ETL3, FMTLE	611630	4q13.2-q21.3	FMTLE
Epilepsy, familial temporal lobe, 4 (2)	ETL4, ETOLM	611631	9q21-q22	ETL4
Epilepsy, familial temporal lobe, 4 (2)	ETL4, ETOLM	611631	9q21-q22	ETOLM
Epilepsy, familial temporal lobe, 5, 614417 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPA6
Epilepsy, familial temporal lobe, 5, 614417 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPAH
Epilepsy, familial temporal lobe, 5, 614417 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	ETL5
Epilepsy, familial temporal lobe, 5, 614417 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	FEB11
Epilepsy, familial temporal lobe, 6 (2)	ETL6	615697	3q25-q26	ETL6
Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	GRIN2A, NMDAR2A, FESD, LKS	138253	16p13.2	GRIN2A
Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	GRIN2A, NMDAR2A, FESD, LKS	138253	16p13.2	NMDAR2A
Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	GRIN2A, NMDAR2A, FESD, LKS	138253	16p13.2	FESD
Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3)	GRIN2A, NMDAR2A, FESD, LKS	138253	16p13.2	LKS
Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	SCN1B
Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	GEFSP1
Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	BRGDA5
Epilepsy, generalized, with febrile seizures plus, type 1, 604233 (3)	SCN1B, GEFSP1, BRGDA5, ATFB13	600235	19q13.11	ATFB13
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	GEFSP2
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SMEI
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FEB3A
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	EIEE6
Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FHM3
Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GEFSP3
Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	CAE2
Epilepsy, generalized, with febrile seizures plus, type 3, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	ECA2
Epilepsy, generalized, with febrile seizures plus, type 4 (2)	GEFSP4	609800	2p24	GEFSP4
Epilepsy, generalized, with febrile seizures plus, type 6 (2)	GEFSP6	612279	8p23-p21	GEFSP6
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Epilepsy, generalized, with febrile seizures plus, type 7, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	SPATA5, SPAF, EHLMRS	613940	4q28.1	SPATA5
Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	SPATA5, SPAF, EHLMRS	613940	4q28.1	SPAF
Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3)	SPATA5, SPAF, EHLMRS	613940	4q28.1	EHLMRS
Epilepsy, hot water, 1 (2)	HWE1	613339	10q21.3-q22.3	HWE1
Epilepsy, hot water, 2 (2)	HWE2	613340	4q24-q28	HWE2
Epilepsy, juvenile myoclonic (2)	EIG7, EJM2	604827	15q14	EIG7
Epilepsy, juvenile myoclonic (2)	EIG7, EJM2	604827	15q14	EJM2
Epilepsy, juvenile myoclonic 3 (2)	EJM3	608816	6p21	EJM3
Epilepsy, myoclonic, familial adult, 1 (2)	FAME1, BAFME1, MEBA	601068	8q24	FAME1
Epilepsy, myoclonic, familial adult, 1 (2)	FAME1, BAFME1, MEBA	601068	8q24	BAFME1
Epilepsy, myoclonic, familial adult, 1 (2)	FAME1, BAFME1, MEBA	601068	8q24	MEBA
Epilepsy, myoclonic, familial adult, 2, 607876 (3)	ADRA2B, ADRA2L1, FAME2	104260	2q11.2	ADRA2B
Epilepsy, myoclonic, familial adult, 2, 607876 (3)	ADRA2B, ADRA2L1, FAME2	104260	2q11.2	ADRA2L1
Epilepsy, myoclonic, familial adult, 2, 607876 (3)	ADRA2B, ADRA2L1, FAME2	104260	2q11.2	FAME2
Epilepsy, myoclonic, familial adult, 3 (2)	FAME3, FCMTE3	613608	5p15.31-p15.1	FAME3
Epilepsy, myoclonic, familial adult, 3 (2)	FAME3, FCMTE3	613608	5p15.31-p15.1	FCMTE3
Epilepsy, myoclonic, familial adult, 4 (2)	FAME4, FCMTE4	615127	3q26.32-q28	FAME4
Epilepsy, myoclonic, familial adult, 4 (2)	FAME4, FCMTE4	615127	3q26.32-q28	FCMTE4
Epilepsy, nocturnal frontal lobe, 1, 600513 (3)	CHRNA4, ENFL1	118504	20q13.33	CHRNA4
Epilepsy, nocturnal frontal lobe, 1, 600513 (3)	CHRNA4, ENFL1	118504	20q13.33	ENFL1
Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	CHRNB2, EFNL3	118507	1q21.3	CHRNB2
Epilepsy, nocturnal frontal lobe, 3, 605375 (3)	CHRNB2, EFNL3	118507	1q21.3	EFNL3
Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KCNT1
Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KIAA1422
Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	EIEE14
Epilepsy, nocturnal frontal lobe, 5, 615005 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	ENFL5
Epilepsy, nocturnal frontal lobe, type 2 (2)	ENFL2	603204	15q24	ENFL2
Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)	CHRNA2	118502	8p21.2	CHRNA2
Epilepsy, partial, with pericentral spikes (2)	EPPS	607221	4p15	EPPS
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	CSTB
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	STFB
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	EPM1
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	PME
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	EPM1A
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3)	CSTB, STFB, EPM1, PME, EPM1A, ULD	601145	21q22.3	ULD
Epilepsy, progressive myoclonic 1B, 612437 (3)	PRICKLE1, RILP, EPM1B	608500	12q12	PRICKLE1
Epilepsy, progressive myoclonic 1B, 612437 (3)	PRICKLE1, RILP, EPM1B	608500	12q12	RILP
Epilepsy, progressive myoclonic 1B, 612437 (3)	PRICKLE1, RILP, EPM1B	608500	12q12	EPM1B
Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	EPM2A, MELF, EPM2	607566	6q24.3	EPM2A
Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	EPM2A, MELF, EPM2	607566	6q24.3	MELF
Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)	EPM2A, MELF, EPM2	607566	6q24.3	EPM2
Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	NHLRC1, EPM2A, EPM2B	608072	6p22.3	NHLRC1
Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	NHLRC1, EPM2A, EPM2B	608072	6p22.3	EPM2A
Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)	NHLRC1, EPM2A, EPM2B	608072	6p22.3	EPM2B
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	KCTD7, EPM3, CLN14	611725	7q11.21	KCTD7
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	KCTD7, EPM3, CLN14	611725	7q11.21	EPM3
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3)	KCTD7, EPM3, CLN14	611725	7q11.21	CLN14
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	SCARB2
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	CD36L2
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	LIMPII
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	AMRF
Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3)	SCARB2, CD36L2, LIMPII, AMRF, EPM4	602257	4q21.1	EPM4
Epilepsy, progressive myoclonic 6, 614018 (3)	GOSR2, GS27, EPM6	604027	17q21.32	GOSR2
Epilepsy, progressive myoclonic 6, 614018 (3)	GOSR2, GS27, EPM6	604027	17q21.32	GS27
Epilepsy, progressive myoclonic 6, 614018 (3)	GOSR2, GS27, EPM6	604027	17q21.32	EPM6
Epilepsy, progressive myoclonic 7, 616187 (3)	KCNC1, EPM7	176258	11p15.1	KCNC1
Epilepsy, progressive myoclonic 7, 616187 (3)	KCNC1, EPM7	176258	11p15.1	EPM7
Epilepsy, pyridoxine-dependent, 266100 (3)	ALDH7A1, ATQ1, EPD, PDE	107323	5q23.2	ALDH7A1
Epilepsy, pyridoxine-dependent, 266100 (3)	ALDH7A1, ATQ1, EPD, PDE	107323	5q23.2	ATQ1
Epilepsy, pyridoxine-dependent, 266100 (3)	ALDH7A1, ATQ1, EPD, PDE	107323	5q23.2	EPD
Epilepsy, pyridoxine-dependent, 266100 (3)	ALDH7A1, ATQ1, EPD, PDE	107323	5q23.2	PDE
Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp (2)	EPRPDC	608105	16p12-p11.2	EPRPDC
Epileptic encephalopathy, childhood-onset, 615369 (3)	CHD2, EEOC	602119	15q26.1	CHD2
Epileptic encephalopathy, childhood-onset, 615369 (3)	CHD2, EEOC	602119	15q26.1	EEOC
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Epileptic encephalopathy, early infantile, 1, 308350 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A1
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFIC3
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	EIEE11
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFIS3
Epileptic encephalopathy, early infantile, 11, 613721 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFNIS
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	PLCB1
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	KIAA0581
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	PLCB1A
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	PLCB1B
Epileptic encephalopathy, early infantile, 12, 613722 (3)	PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12	607120	20p12.3	EIEE12
Epileptic encephalopathy, early infantile, 13, 614558 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	SCN8A
Epileptic encephalopathy, early infantile, 13, 614558 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	CIAT
Epileptic encephalopathy, early infantile, 13, 614558 (3)	SCN8A, CIAT, EIEE13	600702	12q13.13	EIEE13
Epileptic encephalopathy, early infantile, 14, 614959 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KCNT1
Epileptic encephalopathy, early infantile, 14, 614959 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	KIAA1422
Epileptic encephalopathy, early infantile, 14, 614959 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	EIEE14
Epileptic encephalopathy, early infantile, 14, 614959 (3)	KCNT1, KIAA1422, EIEE14, ENFL5	608167	9q34.3	ENFL5
Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GAL3
Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	SIAT6
Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GALII
Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	MRT12
Epileptic encephalopathy, early infantile, 15, 615006 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	EIEE15
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	KIAA1171
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	FIME
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	EIEE16
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DOORS
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNB86
Epileptic encephalopathy, early infantile, 16, 615338 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNA65
Epileptic encephalopathy, early infantile, 17, 615473 (3)	GNAO1, EIEE17	139311	16q13	GNAO1
Epileptic encephalopathy, early infantile, 17, 615473 (3)	GNAO1, EIEE17	139311	16q13	EIEE17
Epileptic encephalopathy, early infantile, 18, 615476 (3)	SZT2, KIAA0467, EIEE18	615463	1p34.2	SZT2
Epileptic encephalopathy, early infantile, 18, 615476 (3)	SZT2, KIAA0467, EIEE18	615463	1p34.2	KIAA0467
Epileptic encephalopathy, early infantile, 18, 615476 (3)	SZT2, KIAA0467, EIEE18	615463	1p34.2	EIEE18
Epileptic encephalopathy, early infantile, 19, 615744 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
Epileptic encephalopathy, early infantile, 19, 615744 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EJM5
Epileptic encephalopathy, early infantile, 19, 615744 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	ECA4
Epileptic encephalopathy, early infantile, 19, 615744 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EIEE19
Epileptic encephalopathy, early infantile, 2, 300672 (3)	CDKL5, STK9, ISSX, EIEE2	300203	Xp22.13	CDKL5
Epileptic encephalopathy, early infantile, 2, 300672 (3)	CDKL5, STK9, ISSX, EIEE2	300203	Xp22.13	STK9
Epileptic encephalopathy, early infantile, 2, 300672 (3)	CDKL5, STK9, ISSX, EIEE2	300203	Xp22.13	ISSX
Epileptic encephalopathy, early infantile, 2, 300672 (3)	CDKL5, STK9, ISSX, EIEE2	300203	Xp22.13	EIEE2
Epileptic encephalopathy, early infantile, 23, 615859 (3)	DOCK7, KIAA1771, EIEE23	615730	1p31.3	DOCK7
Epileptic encephalopathy, early infantile, 23, 615859 (3)	DOCK7, KIAA1771, EIEE23	615730	1p31.3	KIAA1771
Epileptic encephalopathy, early infantile, 23, 615859 (3)	DOCK7, KIAA1771, EIEE23	615730	1p31.3	EIEE23
Epileptic encephalopathy, early infantile, 24, 615871 (3)	HCN1, BCNG1, EIEE24	602780	5p12	HCN1
Epileptic encephalopathy, early infantile, 24, 615871 (3)	HCN1, BCNG1, EIEE24	602780	5p12	BCNG1
Epileptic encephalopathy, early infantile, 24, 615871 (3)	HCN1, BCNG1, EIEE24	602780	5p12	EIEE24
Epileptic encephalopathy, early infantile, 25, 615905 (3)	SLC13A5, NACT, EIEE25	608305	17p13.1	SLC13A5
Epileptic encephalopathy, early infantile, 25, 615905 (3)	SLC13A5, NACT, EIEE25	608305	17p13.1	NACT
Epileptic encephalopathy, early infantile, 25, 615905 (3)	SLC13A5, NACT, EIEE25	608305	17p13.1	EIEE25
Epileptic encephalopathy, early infantile, 26, 616056 (3)	KCNB1, EIEE26	600397	20q13.13	KCNB1
Epileptic encephalopathy, early infantile, 26, 616056 (3)	KCNB1, EIEE26	600397	20q13.13	EIEE26
Epileptic encephalopathy, early infantile, 27, 616139 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	GRIN2B
Epileptic encephalopathy, early infantile, 27, 616139 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	NMDAR2B
Epileptic encephalopathy, early infantile, 27, 616139 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	MRD6
Epileptic encephalopathy, early infantile, 27, 616139 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	EIEE27
Epileptic encephalopathy, early infantile, 28, 616211 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Epileptic encephalopathy, early infantile, 28, 616211 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	FOR
Epileptic encephalopathy, early infantile, 28, 616211 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	SCAR12
Epileptic encephalopathy, early infantile, 28, 616211 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	EIEE28
Epileptic encephalopathy, early infantile, 29, 616339 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	AARS
Epileptic encephalopathy, early infantile, 29, 616339 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	CMT2N
Epileptic encephalopathy, early infantile, 29, 616339 (3)	AARS, CMT2N, EIEE29	601065	16q22.1	EIEE29
Epileptic encephalopathy, early infantile, 3, 609304 (3)	SLC25A22, GC1, EIEE3	609302	11p15.5	SLC25A22
Epileptic encephalopathy, early infantile, 3, 609304 (3)	SLC25A22, GC1, EIEE3	609302	11p15.5	GC1
Epileptic encephalopathy, early infantile, 3, 609304 (3)	SLC25A22, GC1, EIEE3	609302	11p15.5	EIEE3
Epileptic encephalopathy, early infantile, 30, 616341 (3)	SIK1, SNF1LK, MSK, EIEE30	605705	21q22.3	SIK1
Epileptic encephalopathy, early infantile, 30, 616341 (3)	SIK1, SNF1LK, MSK, EIEE30	605705	21q22.3	SNF1LK
Epileptic encephalopathy, early infantile, 30, 616341 (3)	SIK1, SNF1LK, MSK, EIEE30	605705	21q22.3	MSK
Epileptic encephalopathy, early infantile, 30, 616341 (3)	SIK1, SNF1LK, MSK, EIEE30	605705	21q22.3	EIEE30
Epileptic encephalopathy, early infantile, 31, 616346 (3)	DNM1, EIEE31	602377	9q34.11	DNM1
Epileptic encephalopathy, early infantile, 31, 616346 (3)	DNM1, EIEE31	602377	9q34.11	EIEE31
Epileptic encephalopathy, early infantile, 32, 616366 (3)	KCNA2, EIEE32	176262	1p13.3	KCNA2
Epileptic encephalopathy, early infantile, 32, 616366 (3)	KCNA2, EIEE32	176262	1p13.3	EIEE32
Epileptic encephalopathy, early infantile, 33, 616409 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EEF1A2
Epileptic encephalopathy, early infantile, 33, 616409 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EIEE33
Epileptic encephalopathy, early infantile, 33, 616409 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	MRD38
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	SLC12A5
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	KCC2
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	KIAA1176
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	EIEE34
Epileptic encephalopathy, early infantile, 34, 616645 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	EIG14
Epileptic encephalopathy, early infantile, 35, 616647 (3)	ITPA, EIEE35	147520	20p13	ITPA
Epileptic encephalopathy, early infantile, 35, 616647 (3)	ITPA, EIEE35	147520	20p13	EIEE35
Epileptic encephalopathy, early infantile, 36, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	ALG13
Epileptic encephalopathy, early infantile, 36, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	GLT28D1
Epileptic encephalopathy, early infantile, 36, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	CDG1S
Epileptic encephalopathy, early infantile, 36, 300884 (3)	ALG13, GLT28D1, CDG1S, EIEE36	300776	Xq23	EIEE36
Epileptic encephalopathy, early infantile, 37, 616981 (3)	FRRS1L, C9orf4, CG6, EIEE37	604574	9q31.3	FRRS1L
Epileptic encephalopathy, early infantile, 37, 616981 (3)	FRRS1L, C9orf4, CG6, EIEE37	604574	9q31.3	C9orf4
Epileptic encephalopathy, early infantile, 37, 616981 (3)	FRRS1L, C9orf4, CG6, EIEE37	604574	9q31.3	CG6
Epileptic encephalopathy, early infantile, 37, 616981 (3)	FRRS1L, C9orf4, CG6, EIEE37	604574	9q31.3	EIEE37
Epileptic encephalopathy, early infantile, 38, 617020 (3)	ARV1, EIEE38	611647	1q42.2	ARV1
Epileptic encephalopathy, early infantile, 38, 617020 (3)	ARV1, EIEE38	611647	1q42.2	EIEE38
Epileptic encephalopathy, early infantile, 39, 612949 (3)	SLC25A12, ARALAR, EIEE39	603667	2q31.1	SLC25A12
Epileptic encephalopathy, early infantile, 39, 612949 (3)	SLC25A12, ARALAR, EIEE39	603667	2q31.1	ARALAR
Epileptic encephalopathy, early infantile, 39, 612949 (3)	SLC25A12, ARALAR, EIEE39	603667	2q31.1	EIEE39
Epileptic encephalopathy, early infantile, 4, 612164 (3)	STXBP1, UNC18, EIEE4	602926	9q34.11	STXBP1
Epileptic encephalopathy, early infantile, 4, 612164 (3)	STXBP1, UNC18, EIEE4	602926	9q34.11	UNC18
Epileptic encephalopathy, early infantile, 4, 612164 (3)	STXBP1, UNC18, EIEE4	602926	9q34.11	EIEE4
Epileptic encephalopathy, early infantile, 5, 613477 (3)	SPTAN1, NEAS, EIEE5	182810	9q34.11	SPTAN1
Epileptic encephalopathy, early infantile, 5, 613477 (3)	SPTAN1, NEAS, EIEE5	182810	9q34.11	NEAS
Epileptic encephalopathy, early infantile, 5, 613477 (3)	SPTAN1, NEAS, EIEE5	182810	9q34.11	EIEE5
Epileptic encephalopathy, early infantile, 7, 613720 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Epileptic encephalopathy, early infantile, 7, 613720 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EBN1
Epileptic encephalopathy, early infantile, 7, 613720 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EIEE7
Epileptic encephalopathy, early infantile, 7, 613720 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	BFNS1
Epileptic encephalopathy, early infantile, 8, 300607 (3)	ARHGEF9, PEM2, KIAA0424, EIEE8	300429	Xq11.1	ARHGEF9
Epileptic encephalopathy, early infantile, 8, 300607 (3)	ARHGEF9, PEM2, KIAA0424, EIEE8	300429	Xq11.1	PEM2
Epileptic encephalopathy, early infantile, 8, 300607 (3)	ARHGEF9, PEM2, KIAA0424, EIEE8	300429	Xq11.1	KIAA0424
Epileptic encephalopathy, early infantile, 8, 300607 (3)	ARHGEF9, PEM2, KIAA0424, EIEE8	300429	Xq11.1	EIEE8
Epileptic encephalopathy, early infantile, 9, 300088 (3)	PCDH19, KIAA1313, EFMR, EIEE9	300460	Xq22.1	PCDH19
Epileptic encephalopathy, early infantile, 9, 300088 (3)	PCDH19, KIAA1313, EFMR, EIEE9	300460	Xq22.1	KIAA1313
Epileptic encephalopathy, early infantile, 9, 300088 (3)	PCDH19, KIAA1313, EFMR, EIEE9	300460	Xq22.1	EFMR
Epileptic encephalopathy, early infantile, 9, 300088 (3)	PCDH19, KIAA1313, EFMR, EIEE9	300460	Xq22.1	EIEE9
Epilespy, generalized, with febrile seizures plus, type 8 (2)	GEFSP8	613828	6q16.3-q22.31	GEFSP8
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ANPRB
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	AMDM
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ECDM
Epiphyseal chondrodysplasia, Miura type, 615923 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	SNSK
Epiphyseal dysplasia, multiple, 1, 132400 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	COMP
Epiphyseal dysplasia, multiple, 1, 132400 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	EDM1
Epiphyseal dysplasia, multiple, 1, 132400 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	MED
Epiphyseal dysplasia, multiple, 1, 132400 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	PSACH
Epiphyseal dysplasia, multiple, 2, 600204 (3)	COL9A2, EDM2, STL5	120260	1p34.2	COL9A2
Epiphyseal dysplasia, multiple, 2, 600204 (3)	COL9A2, EDM2, STL5	120260	1p34.2	EDM2
Epiphyseal dysplasia, multiple, 2, 600204 (3)	COL9A2, EDM2, STL5	120260	1p34.2	STL5
Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3)	COL9A3, EDM3, IDD	120270	20q13.33	COL9A3
Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3)	COL9A3, EDM3, IDD	120270	20q13.33	EDM3
Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3)	COL9A3, EDM3, IDD	120270	20q13.33	IDD
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	SLC26A2
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTD
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	DTDST
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	D5S1708
Epiphyseal dysplasia, multiple, 4, 226900 (3)	SLC26A2, DTD, DTDST, D5S1708, EDM4	606718	5q32	EDM4
Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	EDM5
Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	HOA
Epiphyseal dysplasia, multiple, 5, 607078 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	OS2
Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3)	COL2A1	120140	12q13.11	COL2A1
Episodic ataxia, type 2, 108500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNA1A
Episodic ataxia, type 2, 108500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNL1A4
Episodic ataxia, type 2, 108500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	SCA6
Episodic ataxia, type 3 (2)	EA3	606554	1q42	EA3
Episodic ataxia, type 5, 613855 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
Episodic ataxia, type 5, 613855 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EJM6
Episodic ataxia, type 5, 613855 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EA5
Episodic ataxia, type 5, 613855 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EIG9
Episodic ataxia, type 6, 612656 (3)	SLC1A3, EAAT1, EA6	600111	5p13.2	SLC1A3
Episodic ataxia, type 6, 612656 (3)	SLC1A3, EAAT1, EA6	600111	5p13.2	EAAT1
Episodic ataxia, type 6, 612656 (3)	SLC1A3, EAAT1, EA6	600111	5p13.2	EA6
Episodic ataxia, type 7 (2)	EA7	611907	19q13	EA7
Episodic ataxia, type 8 (2)	EA8	616055	1p36.13-p34.3	EA8
Episodic ataxia/myokymia syndrome, 160120 (3)	KCNA1, AEMK, EA1	176260	12p13.32	KCNA1
Episodic ataxia/myokymia syndrome, 160120 (3)	KCNA1, AEMK, EA1	176260	12p13.32	AEMK
Episodic ataxia/myokymia syndrome, 160120 (3)	KCNA1, AEMK, EA1	176260	12p13.32	EA1
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PKC
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	DYT10
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	EKD1
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIS2
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIC2
Episodic kinesigenic dyskinesia 1, 128200 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	ICCA
Episodic kinesigenic dyskinesia 2 (2)	EKD2	611031	16q13-q22.1	EKD2
Episodic muscle weakness, X-linked (2)	EMWX	300211	Xp22.3	EMWX
Episodic pain syndrome, familial, 2, 615551 (3)	SCN10A, FEPS2	604427	3p22.2	SCN10A
Episodic pain syndrome, familial, 2, 615551 (3)	SCN10A, FEPS2	604427	3p22.2	FEPS2
Episodic pain syndrome, familial, 3, 615552 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	SCN11A
Episodic pain syndrome, familial, 3, 615552 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	HSAN7
Episodic pain syndrome, familial, 3, 615552 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	FEPS3
Episodic pain syndrome, familial, 615040 (3)	TRPA1, ANKTM1, FEPS	604775	8q21.11	TRPA1
Episodic pain syndrome, familial, 615040 (3)	TRPA1, ANKTM1, FEPS	604775	8q21.11	ANKTM1
Episodic pain syndrome, familial, 615040 (3)	TRPA1, ANKTM1, FEPS	604775	8q21.11	FEPS
Epithelial recurrent erosion dystrophy, 122400 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	COL17A1
Epithelial recurrent erosion dystrophy, 122400 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	BPAG2
Epithelial recurrent erosion dystrophy, 122400 (3)	COL17A1, BPAG2, ERED	113811	10q25.1	ERED
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
Epstein syndrome, 153650 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Erythermalgia, primary, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Erythremias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBA1
Erythremias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBH
Erythremias, beta- (3)	HBB	141900	11p15.4	HBB
Erythrocyte lactate transporter defect, 245340 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Erythrocyte lactate transporter defect, 245340 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1
Erythrocyte lactate transporter defect, 245340 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	HHF7
Erythrocyte lactate transporter defect, 245340 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1D
Erythrocytosis (3)	HBA2, HBH	141850	16p13.3	HBA2
Erythrocytosis (3)	HBA2, HBH	141850	16p13.3	HBH
Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3)	BPGM	613896	7q33	BPGM
Erythrocytosis, familial, 2, 263400 (3)	VHL	608537	3p25.3	VHL
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	EGLN1
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	PHD2
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	HIFPH2
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	C1orf12
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	ZMYND6
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	SM20
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	ECYT3
Erythrocytosis, familial, 3, 609820 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	HALAH
Erythrocytosis, familial, 4, 611783 (3)	EPAS1, MOP2, HIF2A, ECYT4	603349	2p21	EPAS1
Erythrocytosis, familial, 4, 611783 (3)	EPAS1, MOP2, HIF2A, ECYT4	603349	2p21	MOP2
Erythrocytosis, familial, 4, 611783 (3)	EPAS1, MOP2, HIF2A, ECYT4	603349	2p21	HIF2A
Erythrocytosis, familial, 4, 611783 (3)	EPAS1, MOP2, HIF2A, ECYT4	603349	2p21	ECYT4
Erythrocytosis, somatic, 133100 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Erythrocytosis, somatic, 133100 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
Erythrocytosis, somatic, 133100 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Erythrocytosis, somatic, 133100 (3)	SH2B3, LNK	605093	12q24.12	LNK
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	DSG1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	PPKS1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	SPPK1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	EPKHE
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	GJB3
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	CX31
Erythrokeratodermia variabilis et progressiva, 133200 (3)	GJB3, CX31, DFNA2B	603324	1p34.3	DFNA2B
Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)	GJB4, CX30.3	605425	1p34.3	GJB4
Erythrokeratodermia variabilis with erythema gyratum repens, 133200 (3)	GJB4, CX30.3	605425	1p34.3	CX30.3
Escobar syndrome, 265000 (3)	CHRNG, ACHRG	100730	2q37.1	CHRNG
Escobar syndrome, 265000 (3)	CHRNG, ACHRG	100730	2q37.1	ACHRG
Esophageal cancer, 133239 (1)	DLEC1, DLC1	604050	3p22.2	DLEC1
Esophageal cancer, 133239 (1)	DLEC1, DLC1	604050	3p22.2	DLC1
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	HNPCC6
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	AAT3
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	MFS2
Esophageal cancer, somatic, 133239 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	LDS2
Esophageal carcinoma, somatic 133239 (3)	DCC, MRMV1	120470	18q21.2	DCC
Esophageal carcinoma, somatic 133239 (3)	DCC, MRMV1	120470	18q21.2	MRMV1
Esophageal carcinoma, somatic, 133239 (3)	RNF6	604242	13q12.13	RNF6
Esophageal squamous cell carcinoma, 133239 (1)	DEC1	604767	9q33.1	DEC1
Esophageal squamous cell carcinoma, 133239 (3)	LZTS1, F37, FEZ1	606551	8p21.3	LZTS1
Esophageal squamous cell carcinoma, 133239 (3)	LZTS1, F37, FEZ1	606551	8p21.3	F37
Esophageal squamous cell carcinoma, 133239 (3)	LZTS1, F37, FEZ1	606551	8p21.3	FEZ1
Esophageal squamous cell carcinoma, somatic, 133239 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Esophageal squamous cell carcinoma, somatic, 133239 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	FOR
Esophageal squamous cell carcinoma, somatic, 133239 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	SCAR12
Esophageal squamous cell carcinoma, somatic, 133239 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	EIEE28
Estrogen resistance, 615363 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
Estrogen resistance, 615363 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
Estrogen resistance, 615363 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
Ethylmalonic encephalopathy, 602473 (3)	ETHE1, HSCO, D83198	608451	19q13.31	ETHE1
Ethylmalonic encephalopathy, 602473 (3)	ETHE1, HSCO, D83198	608451	19q13.31	HSCO
Ethylmalonic encephalopathy, 602473 (3)	ETHE1, HSCO, D83198	608451	19q13.31	D83198
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	HSPA9B
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	MOT2
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	GRP75
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	EVPLS
Even-plus syndrome, 616854 (3)	HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4	600548	5q31.2	SIDBA4
Ewing sarcoma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWSR1
Ewing sarcoma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWS
Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3)	COX4I2	607976	20q11.21	COX4I2
Exostoses, multiple, type 1, 133700 (3)	EXT1	608177	8q24.11	EXT1
Exostoses, multiple, type 2, 133701 (3)	EXT2, SSMS	608210	11p11.2	EXT2
Exostoses, multiple, type 2, 133701 (3)	EXT2, SSMS	608210	11p11.2	SSMS
Exostoses, multiple, type 3 (2)	EXT3	600209	19p	EXT3
Exudative vitreoretinopathy 1, 133780 (3)	FZD4, EVR1	604579	11q14.2	FZD4
Exudative vitreoretinopathy 1, 133780 (3)	FZD4, EVR1	604579	11q14.2	EVR1
Exudative vitreoretinopathy 2, X-linked, 305390 (3)	NDP, ND, EVR2	300658	Xp11.3	NDP
Exudative vitreoretinopathy 2, X-linked, 305390 (3)	NDP, ND, EVR2	300658	Xp11.3	ND
Exudative vitreoretinopathy 2, X-linked, 305390 (3)	NDP, ND, EVR2	300658	Xp11.3	EVR2
Exudative vitreoretinopathy 3 (2)	EVR3	605750	11p13-p12	EVR3
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
Exudative vitreoretinopathy 4, 601813 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
Exudative vitreoretinopathy 5, 613310 (3)	TSPAN12, NET2, EVR5	613138	7q31.31	TSPAN12
Exudative vitreoretinopathy 5, 613310 (3)	TSPAN12, NET2, EVR5	613138	7q31.31	NET2
Exudative vitreoretinopathy 5, 613310 (3)	TSPAN12, NET2, EVR5	613138	7q31.31	EVR5
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
FG syndrome 2, 300321 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
FG syndrome 3 (2)	FGS3	300406	Xp22.3	FGS3
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MICPCH
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	FGS4
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CMG
FG syndrome 4, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MRXSNA
FG syndrome 5 (2)	FGS5	300581	Xq22.3	FGS5
FILS syndrome, 615139 (3)	POLE1, CRCS12, FILS	174762	12q24.33	POLE1
FILS syndrome, 615139 (3)	POLE1, CRCS12, FILS	174762	12q24.33	CRCS12
FILS syndrome, 615139 (3)	POLE1, CRCS12, FILS	174762	12q24.33	FILS
Fabry disease, 301500 (3)	GLA	300644	Xq22.1	GLA
Fabry disease, cardiac variant, 301500 (3)	GLA	300644	Xq22.1	GLA
Facial paresis, hereditary congenital, 1 (2)	HCFP1, MBS2	601471	3q21-q22	HCFP1
Facial paresis, hereditary congenital, 1 (2)	HCFP1, MBS2	601471	3q21-q22	MBS2
Facial paresis, hereditary congenital, 2 (2)	HCFP2	604185	10q21.3-q22.1	HCFP2
Facial paresis, hereditary congenital, 3, 614744 (3)	HOXB1, HOX2I, HCFP3	142968	17q21.32	HOXB1
Facial paresis, hereditary congenital, 3, 614744 (3)	HOXB1, HOX2I, HCFP3	142968	17q21.32	HOX2I
Facial paresis, hereditary congenital, 3, 614744 (3)	HOXB1, HOX2I, HCFP3	142968	17q21.32	HCFP3
Facioscapulohumeral muscular dystrophy 1 (4)	FSHD1, FSHD1A	158900	4q35	FSHD1
Facioscapulohumeral muscular dystrophy 1 (4)	FSHD1, FSHD1A	158900	4q35	FSHD1A
Factor V and factor VIII, combined deficiency of, 613625 (3)	MCFD2, F5F8D2	607788	2p21	MCFD2
Factor V and factor VIII, combined deficiency of, 613625 (3)	MCFD2, F5F8D2	607788	2p21	F5F8D2
Factor V deficiency, 227400 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
Factor V deficiency, 227400 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
Factor V deficiency, 227400 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
Factor VII deficiency, 227500 (3)	F7	613878	13q34	F7
Factor X deficiency, 227600 (3)	F10	613872	13q34	F10
Factor XI deficiency, autosomal dominant, 612416 (3)	F11	264900	4q35.2	F11
Factor XI deficiency, autosomal recessive, 612416 (3)	F11	264900	4q35.2	F11
Factor XII deficiency, 234000 (3)	F12, HAF, HAE3	610619	5q35.3	F12
Factor XII deficiency, 234000 (3)	F12, HAF, HAE3	610619	5q35.3	HAF
Factor XII deficiency, 234000 (3)	F12, HAF, HAE3	610619	5q35.3	HAE3
Factor XIIIA deficiency, 613225 (3)	F13A1, F13A	134570	6p25.1	F13A1
Factor XIIIA deficiency, 613225 (3)	F13A1, F13A	134570	6p25.1	F13A
Factor XIIIB deficiency, 613235 (3)	F13B	134580	1q31.3	F13B
Failure of tooth eruption, primary, 125350 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Failure of tooth eruption, primary, 125350 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR
Failure of tooth eruption, primary, 125350 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PFE
Familial Mediterranean fever, AD, 134610 (3)	MEFV, MEF, FMF	608107	16p13.3	MEFV
Familial Mediterranean fever, AD, 134610 (3)	MEFV, MEF, FMF	608107	16p13.3	MEF
Familial Mediterranean fever, AD, 134610 (3)	MEFV, MEF, FMF	608107	16p13.3	FMF
Familial Mediterranean fever, AR, 249100 (3)	MEFV, MEF, FMF	608107	16p13.3	MEFV
Familial Mediterranean fever, AR, 249100 (3)	MEFV, MEF, FMF	608107	16p13.3	MEF
Familial Mediterranean fever, AR, 249100 (3)	MEFV, MEF, FMF	608107	16p13.3	FMF
Familial adenomatous polyposis 3, 616415 (3)	NTHL1, OCTS3, FAP3	602656	16p13.3	NTHL1
Familial adenomatous polyposis 3, 616415 (3)	NTHL1, OCTS3, FAP3	602656	16p13.3	OCTS3
Familial adenomatous polyposis 3, 616415 (3)	NTHL1, OCTS3, FAP3	602656	16p13.3	FAP3
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	NLRP12
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	NALP12
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	PYPAF7
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	RNO
Familial cold autoinflammatory syndrome 2, 611762 (3)	NLRP12, NALP12, PYPAF7, RNO, FCAS2	609648	19q13.42	FCAS2
Familial cold autoinflammatory syndrome 3, 614468 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	PLCG2
Familial cold autoinflammatory syndrome 3, 614468 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	FCAS3
Familial cold autoinflammatory syndrome 3, 614468 (3)	PLCG2, FCAS3, APLAID	600220	16q23.3	APLAID
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NLRP3
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	CIAS1
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCU
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCAS1
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NALP3
Familial cold-induced inflammatory syndrome 1, 120100 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	PYPAF1
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FANCA
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FACA
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FA1
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FA
Fanconi anemia, complementation group A, 227650 (3)	FANCA, FACA, FA1, FA, FAA	607139	16q24.3	FAA
Fanconi anemia, complementation group B, 300514 (3)	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.2	FAAP95
Fanconi anemia, complementation group B, 300514 (3)	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.2	FAAP90
Fanconi anemia, complementation group B, 300514 (3)	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.2	FLJ34064
Fanconi anemia, complementation group B, 300514 (3)	FAAP95, FAAP90, FLJ34064, FANCB	300515	Xp22.2	FANCB
Fanconi anemia, complementation group C, 227645 (3)	FANCC, FACC	613899	9q22.32	FANCC
Fanconi anemia, complementation group C, 227645 (3)	FANCC, FACC	613899	9q22.32	FACC
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
Fanconi anemia, complementation group D1, 605724 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
Fanconi anemia, complementation group D2, 227646 (3)	FANCD2, FANCD, FACD, FAD	613984	3p25.3	FANCD2
Fanconi anemia, complementation group D2, 227646 (3)	FANCD2, FANCD, FACD, FAD	613984	3p25.3	FANCD
Fanconi anemia, complementation group D2, 227646 (3)	FANCD2, FANCD, FACD, FAD	613984	3p25.3	FACD
Fanconi anemia, complementation group D2, 227646 (3)	FANCD2, FANCD, FACD, FAD	613984	3p25.3	FAD
Fanconi anemia, complementation group E, 600901 (3)	FANCE, FACE	613976	6p21.31	FANCE
Fanconi anemia, complementation group E, 600901 (3)	FANCE, FACE	613976	6p21.31	FACE
Fanconi anemia, complementation group F, 603467 (3)	FANCF	613897	11p14.3	FANCF
Fanconi anemia, complementation group G, 614082 (3)	XRCC9, FANCG	602956	9p13.3	XRCC9
Fanconi anemia, complementation group G, 614082 (3)	XRCC9, FANCG	602956	9p13.3	FANCG
Fanconi anemia, complementation group I, 609053 (3)	FANCI, KIAA1794	611360	15q26.1	FANCI
Fanconi anemia, complementation group I, 609053 (3)	FANCI, KIAA1794	611360	15q26.1	KIAA1794
Fanconi anemia, complementation group J, 609054 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BRIP1
Fanconi anemia, complementation group J, 609054 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	BACH1
Fanconi anemia, complementation group J, 609054 (3)	BRIP1, BACH1, FANCJ	605882	17q23.2	FANCJ
Fanconi anemia, complementation group L, 614083 (3)	PHF9, FANCL	608111	2p16.1	PHF9
Fanconi anemia, complementation group L, 614083 (3)	PHF9, FANCL	608111	2p16.1	FANCL
Fanconi anemia, complementation group N, 610832 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
Fanconi anemia, complementation group N, 610832 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	FANCN
Fanconi anemia, complementation group N, 610832 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PNCA3
Fanconi anemia, complementation group O, 613390 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	RAD51C
Fanconi anemia, complementation group O, 613390 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	FANCO
Fanconi anemia, complementation group O, 613390 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	BROVCA3
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	SLX4
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	BTBD12
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	MUS312
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	KIAA1784
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	KIAA1987
Fanconi anemia, complementation group P, 613951 (3)	SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP	613278	16p13.3	FANCP
Fanconi anemia, complementation group Q, 615272 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Fanconi anemia, complementation group Q, 615272 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XPF
Fanconi anemia, complementation group Q, 615272 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	FANCQ
Fanconi anemia, complementation group Q, 615272 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XFEPS
Fanconi anemia, complementation group T, 616435 (3)	UBE2T, HSPC150, FANCT	610538	1q32.1	UBE2T
Fanconi anemia, complementation group T, 616435 (3)	UBE2T, HSPC150, FANCT	610538	1q32.1	HSPC150
Fanconi anemia, complementation group T, 616435 (3)	UBE2T, HSPC150, FANCT	610538	1q32.1	FANCT
Fanconi renotubular syndrome 1 (2)	FRTS1, FRTS, RFS	134600	15q15.3	FRTS1
Fanconi renotubular syndrome 1 (2)	FRTS1, FRTS, RFS	134600	15q15.3	FRTS
Fanconi renotubular syndrome 1 (2)	FRTS1, FRTS, RFS	134600	15q15.3	RFS
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC17A2
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPT2
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPHLOP1
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	FRTS2
Fanconi renotubular syndrome 2, 613388 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	HCINF2
Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	TCF14
Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	MODY1
Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young, 616026 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	FRTS4
Fanconi-Bickel syndrome, 227810 (3)	SLC2A2, GLUT2	138160	3q26.2	SLC2A2
Fanconi-Bickel syndrome, 227810 (3)	SLC2A2, GLUT2	138160	3q26.2	GLUT2
Farber lipogranulomatosis, 228000 (3)	ASAH1, AC, SMAPME	613468	8p22	ASAH1
Farber lipogranulomatosis, 228000 (3)	ASAH1, AC, SMAPME	613468	8p22	AC
Farber lipogranulomatosis, 228000 (3)	ASAH1, AC, SMAPME	613468	8p22	SMAPME
Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3)	SMCHD1, KIAA0650	614982	18p11.32	SMCHD1
Fascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3)	SMCHD1, KIAA0650	614982	18p11.32	KIAA0650
Fatty liver, acute, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
Fatty liver, acute, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	MTPA
Favism, 134700 (3)	G6PD, G6PD1	305900	Xq28	G6PD
Favism, 134700 (3)	G6PD, G6PD1	305900	Xq28	G6PD1
Fazio-Londe disease, 211500 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	SLC52A3
Fazio-Londe disease, 211500 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	C20orf54
Fazio-Londe disease, 211500 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	RFT2
Fazio-Londe disease, 211500 (3)	SLC52A3, C20orf54, RFT2, BVVLS1	613350	20p13	BVVLS1
Febrile seizures, familial, 1 (2)	FEB1	121210	8q13-q21	FEB1
Febrile seizures, familial, 10 (2)	FEB10	612637	3q26.2-q26.33	FEB10
Febrile seizures, familial, 11, 614418 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPA6
Febrile seizures, familial, 11, 614418 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	CPAH
Febrile seizures, familial, 11, 614418 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	ETL5
Febrile seizures, familial, 11, 614418 (3)	CPA6, CPAH, ETL5, FEB11	609562	8q13.2	FEB11
Febrile seizures, familial, 2 (2)	FEB2	602477	19p13.3	FEB2
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	GEFSP2
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SMEI
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FEB3A
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	EIEE6
Febrile seizures, familial, 3A, 604403 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FHM3
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Febrile seizures, familial, 3B, 613863 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Febrile seizures, familial, 5 (2)	FEB5	609255	6q22-q24	FEB5
Febrile seizures, familial, 6 (2)	FEB6	609253	18p11.2	FEB6
Febrile seizures, familial, 7 (2)	FEB7	611515	21q22	FEB7
Febrile seizures, familial, 8, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
Febrile seizures, familial, 8, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GEFSP3
Febrile seizures, familial, 8, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	CAE2
Febrile seizures, familial, 8, 611277 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	ECA2
Febrile seizures, familial, 9 (2)	FEB9	611634	3p24.2-p23	FEB9
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
Fechtner syndrome, 153640 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	MIR17HG
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	MIRH1
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	MIHG1
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	MIRHG1
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	C13orf25
Feingold syndrome 2, 614326 (3)	MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2	609415	13q31.3	FGLDS2
Feingold syndrome, 164280 (3)	MYCN, NMYC, ODED, MODED	164840	2p24.3	MYCN
Feingold syndrome, 164280 (3)	MYCN, NMYC, ODED, MODED	164840	2p24.3	NMYC
Feingold syndrome, 164280 (3)	MYCN, NMYC, ODED, MODED	164840	2p24.3	ODED
Feingold syndrome, 164280 (3)	MYCN, NMYC, ODED, MODED	164840	2p24.3	MODED
Fetal akinesia deformation sequence, 208150 (3)	MUSK, CMS9, FADS	601296	9q31.3	MUSK
Fetal akinesia deformation sequence, 208150 (3)	MUSK, CMS9, FADS	601296	9q31.3	CMS9
Fetal akinesia deformation sequence, 208150 (3)	MUSK, CMS9, FADS	601296	9q31.3	FADS
Fetal akinesia deformation sequence, 208150 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	RAPSN
Fetal akinesia deformation sequence, 208150 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	CMS1D
Fetal akinesia deformation sequence, 208150 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	CMS11
Fetal akinesia deformation sequence, 208150 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	FADS
Fetal hemoglobin quantitative trait locus 1, 141749 (3)	HBG1	142200	11p15.4	HBG1
Fetal hemoglobin quantitative trait locus 1, 141749 (3)	HBG2, TNCY	142250	11p15.4	HBG2
Fetal hemoglobin quantitative trait locus 1, 141749 (3)	HBG2, TNCY	142250	11p15.4	TNCY
Fetal hemoglobin quantitative trait locus 2 (2)	HBFQTL2, FCP	142470	6q22.3-q23.1	HBFQTL2
Fetal hemoglobin quantitative trait locus 2 (2)	HBFQTL2, FCP	142470	6q22.3-q23.1	FCP
Fetal hemoglobin quantitative trait locus 3 (2)	HBFQTL3, FCP1, FCPX, FCP	305435	Xp22.2	HBFQTL3
Fetal hemoglobin quantitative trait locus 3 (2)	HBFQTL3, FCP1, FCPX, FCP	305435	Xp22.2	FCP1
Fetal hemoglobin quantitative trait locus 3 (2)	HBFQTL3, FCP1, FCPX, FCP	305435	Xp22.2	FCPX
Fetal hemoglobin quantitative trait locus 3 (2)	HBFQTL3, FCP1, FCPX, FCP	305435	Xp22.2	FCP
Fetal hemoglobin quantitative trait locus 4 (2)	HBFQTL4	606789	8q	HBFQTL4
Fibrochondrogenesis 1, 228520 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Fibrochondrogenesis 1, 228520 (3)	COL11A1, STL2	120280	1p21.1	STL2
Fibrochondrogenesis 2, 614524 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Fibrochondrogenesis 2, 614524 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Fibrochondrogenesis 2, 614524 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Fibrochondrogenesis 2, 614524 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Fibrochondrogenesis 2, 614524 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Fibrodysplasia ossificans progressiva, 135100 (3)	ACVR1, ACVRLK2, ALK2, FOP	102576	2q24.1	ACVR1
Fibrodysplasia ossificans progressiva, 135100 (3)	ACVR1, ACVRLK2, ALK2, FOP	102576	2q24.1	ACVRLK2
Fibrodysplasia ossificans progressiva, 135100 (3)	ACVR1, ACVRLK2, ALK2, FOP	102576	2q24.1	ALK2
Fibrodysplasia ossificans progressiva, 135100 (3)	ACVR1, ACVRLK2, ALK2, FOP	102576	2q24.1	FOP
Fibromatosis, gingival, 2 (2)	GINGF2, GGF2, HGF2	605544	5q13-q22	GINGF2
Fibromatosis, gingival, 2 (2)	GINGF2, GGF2, HGF2	605544	5q13-q22	GGF2
Fibromatosis, gingival, 2 (2)	GINGF2, GGF2, HGF2	605544	5q13-q22	HGF2
Fibromatosis, gingival, 3 (2)	GINGF3, HGF3, GGF3	609955	2p23.3-p22.3	GINGF3
Fibromatosis, gingival, 3 (2)	GINGF3, HGF3, GGF3	609955	2p23.3-p22.3	HGF3
Fibromatosis, gingival, 3 (2)	GINGF3, HGF3, GGF3	609955	2p23.3-p22.3	GGF3
Fibromatosis, gingival, 4 (2)	GINGF4, HGF4, GGF4	611010	11p15	GINGF4
Fibromatosis, gingival, 4 (2)	GINGF4, HGF4, GGF4	611010	11p15	HGF4
Fibromatosis, gingival, 4 (2)	GINGF4, HGF4, GGF4	611010	11p15	GGF4
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIF21A
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIAA1708
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	FEOM1
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	CFEOM1
Fibrosis of extraocular muscles, congenital, 1, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	CFEOM3B
Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	PHOX2A, ARIX, CFEOM2	602753	11q13.4	PHOX2A
Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	PHOX2A, ARIX, CFEOM2	602753	11q13.4	ARIX
Fibrosis of extraocular muscles, congenital, 2, 602078 (3)	PHOX2A, ARIX, CFEOM2	602753	11q13.4	CFEOM2
Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB3
Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	TUBB4
Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	CFEOM3A
Fibrosis of extraocular muscles, congenital, 3A, 600638 (3)	TUBB3, TUBB4, CFEOM3A, CDCBM1	602661	16q24.3	CDCBM1
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIF21A
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	KIAA1708
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	FEOM1
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	CFEOM1
Fibrosis of extraocular muscles, congenital, 3B, 135700 (3)	KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B	608283	12q12	CFEOM3B
Fibrosis of extraocular muscles, congenital, 3C (2)	CFEOM3C, FEOM4	609384	13q12.11	CFEOM3C
Fibrosis of extraocular muscles, congenital, 3C (2)	CFEOM3C, FEOM4	609384	13q12.11	FEOM4
Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	COL25A1, CLAC, CFEOM5	610004	4q25	COL25A1
Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	COL25A1, CLAC, CFEOM5	610004	4q25	CLAC
Fibrosis of extraocular muscles, congenital, 5, 616219 (3)	COL25A1, CLAC, CFEOM5	610004	4q25	CFEOM5
Filippi syndrome, 272440 (3)	CKAP2L, RADMIS	616174	2q14.1	CKAP2L
Filippi syndrome, 272440 (3)	CKAP2L, RADMIS	616174	2q14.1	RADMIS
Fish-eye disease, 136120 (3)	LCAT	606967	16q22.1	LCAT
Fletcher factor (prekallikrein) deficiency, 612423 (3)	KLKB1, KLK3, PKKD	229000	4q35.2	KLKB1
Fletcher factor (prekallikrein) deficiency, 612423 (3)	KLKB1, KLK3, PKKD	229000	4q35.2	KLK3
Fletcher factor (prekallikrein) deficiency, 612423 (3)	KLKB1, KLK3, PKKD	229000	4q35.2	PKKD
Floating-Harbor syndrome, 136140 (3)	SRCAP, SWR1, KIAA0309, FLHS	611421	16p11.2	SRCAP
Floating-Harbor syndrome, 136140 (3)	SRCAP, SWR1, KIAA0309, FLHS	611421	16p11.2	SWR1
Floating-Harbor syndrome, 136140 (3)	SRCAP, SWR1, KIAA0309, FLHS	611421	16p11.2	KIAA0309
Floating-Harbor syndrome, 136140 (3)	SRCAP, SWR1, KIAA0309, FLHS	611421	16p11.2	FLHS
Focal dermal hypoplasia, 305600 (3)	PORCN, PORC, DHOF, FODH	300651	Xp11.23	PORCN
Focal dermal hypoplasia, 305600 (3)	PORCN, PORC, DHOF, FODH	300651	Xp11.23	PORC
Focal dermal hypoplasia, 305600 (3)	PORCN, PORC, DHOF, FODH	300651	Xp11.23	DHOF
Focal dermal hypoplasia, 305600 (3)	PORCN, PORC, DHOF, FODH	300651	Xp11.23	FODH
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	TWIST2
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	DERMO1
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	SETLSS
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	FFDD3
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	BBRSAY
Focal facial dermal dysplasia 3, Setleis type, 227260 (3)	TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS	607556	2q37.3	AMS
Focal facial dermal dysplasia 4, 614974 (3)	CYP26C1, FFDD4	608428	10q23.33	CYP26C1
Focal facial dermal dysplasia 4, 614974 (3)	CYP26C1, FFDD4	608428	10q23.33	FFDD4
Focal segmental glomerulosclerosis 8, 616032 (3)	ANLN, FSFS8	616027	7p14.2	ANLN
Focal segmental glomerulosclerosis 8, 616032 (3)	ANLN, FSFS8	616027	7p14.2	FSFS8
Focal segmental glomerulosclerosis 9, 616220 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	CRB2
Focal segmental glomerulosclerosis 9, 616220 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	FSGS9
Focal segmental glomerulosclerosis 9, 616220 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	VMCKD
Folate malabsorption, hereditary, 229050 (3)	SLC46A1, HCP1, PCFT	611672	17q11.2	SLC46A1
Folate malabsorption, hereditary, 229050 (3)	SLC46A1, HCP1, PCFT	611672	17q11.2	HCP1
Folate malabsorption, hereditary, 229050 (3)	SLC46A1, HCP1, PCFT	611672	17q11.2	PCFT
Forebrain defects (3)	TDGF1	187395	3p21.31	TDGF1
Forsythe-Wakeling syndrome (2)	FWS	613606	1p33-p31.1	FWS
Foveal hypoplasia 1, 136520 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Foveal hypoplasia 1, 136520 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Foveal hypoplasia 1, 136520 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Foveal hypoplasia 1, 136520 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	SLC38A8, FVH2	615585	16q23.3	SLC38A8
Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3)	SLC38A8, FVH2	615585	16q23.3	FVH2
Fragile X syndrome, 300624 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Fragile X syndrome, 300624 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FRAXA
Fragile X syndrome, 300624 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	POF1
Fragile X tremor/ataxia syndrome, 300623 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Fragile X tremor/ataxia syndrome, 300623 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FRAXA
Fragile X tremor/ataxia syndrome, 300623 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	POF1
Frank-ter Haar syndrome, 249420 (3)	SH3PXD2B, TKS4, KIAA1295, FTHS	613293	5q35.1	SH3PXD2B
Frank-ter Haar syndrome, 249420 (3)	SH3PXD2B, TKS4, KIAA1295, FTHS	613293	5q35.1	TKS4
Frank-ter Haar syndrome, 249420 (3)	SH3PXD2B, TKS4, KIAA1295, FTHS	613293	5q35.1	KIAA1295
Frank-ter Haar syndrome, 249420 (3)	SH3PXD2B, TKS4, KIAA1295, FTHS	613293	5q35.1	FTHS
Fraser syndrome, 219000 (3)	FRAS1	607830	4q21.21	FRAS1
Fraser syndrome, 219000 (3)	FREM2	608945	13q13.3	FREM2
Fraser syndrome, 219000 (3)	GRIP1	604597	12q14.3	GRIP1
Frasier syndrome, 136680 (3)	WT1, NPHS4	607102	11p13	WT1
Frasier syndrome, 136680 (3)	WT1, NPHS4	607102	11p13	NPHS4
Frias syndrome (4)	FRIASS, DEL14q22, C14DELq22	609640	14q22.1-q22.3	FRIASS
Frias syndrome (4)	FRIASS, DEL14q22, C14DELq22	609640	14q22.1-q22.3	DEL14q22
Frias syndrome (4)	FRIASS, DEL14q22, C14DELq22	609640	14q22.1-q22.3	C14DELq22
Friedreich ataxia 2 (2)	FRDA2	601992	9p23-p11	FRDA2
Friedreich ataxia with retained reflexes, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FXN
Friedreich ataxia with retained reflexes, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FRDA
Friedreich ataxia with retained reflexes, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FARR
Friedreich ataxia with retained reflexes, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	X25
Friedreich ataxia, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FXN
Friedreich ataxia, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FRDA
Friedreich ataxia, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	FARR
Friedreich ataxia, 229300 (3)	FXN, FRDA, FARR, X25	606829	9q21.11	X25
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Frontometaphyseal dysplasia, 305620 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Frontonasal dysplasia 1, 136760 (3)	ALX3, FND1	606014	1p13.3	ALX3
Frontonasal dysplasia 1, 136760 (3)	ALX3, FND1	606014	1p13.3	FND1
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	PFM2
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FPP
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FND2
Frontonasal dysplasia 2, 613451 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	CRS5
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	C9orf72, FTDALS1, FTDALS, ALSFTD	614260	9p21.2	C9orf72
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	C9orf72, FTDALS1, FTDALS, ALSFTD	614260	9p21.2	FTDALS1
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	C9orf72, FTDALS1, FTDALS, ALSFTD	614260	9p21.2	FTDALS
Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3)	C9orf72, FTDALS1, FTDALS, ALSFTD	614260	9p21.2	ALSFTD
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	FTDALS2
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	SMAJ
Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	IMMD
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	SQSTM1
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	P62
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	PDB3
Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	FTDALS3
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	TBK1, NAK, FTDALS4	604834	12q14.2	TBK1
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	TBK1, NAK, FTDALS4	604834	12q14.2	NAK
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, 616439 (3)	TBK1, NAK, FTDALS4	604834	12q14.2	FTDALS4
Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)	GRN, CLN11	138945	17q21.31	GRN
Frontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3)	GRN, CLN11	138945	17q21.31	CLN11
Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TARDBP
Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	TDP43
Frontotemporal lobar degeneration, TARDBP-related, 612069 (3)	TARDBP, TDP43, ALS10	605078	1p36.22	ALS10
Fructose intolerance, 229600 (3)	ALDOB	612724	9q31.1	ALDOB
Fructose-1,6-bisphosphatase deficiency, 229700 (3)	FBP1	611570	9q22.32	FBP1
Fucosidosis, 230000 (3)	FUCA1	612280	1p36.11	FUCA1
Fucosyltransferase 6 deficiency, 613852 (3)	FUT6	136836	19p13.3	FUT6
Fuhrmann syndrome, 228930 (3)	WNT7A	601570	3p25.1	WNT7A
Fumarase deficiency, 606812 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FH
Fumarase deficiency, 606812 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	HLRCC
Fumarase deficiency, 606812 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	MCUL1
Fumarase deficiency, 606812 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FMRD
Fundus albipunctatus, 136880 (3)	RDH5	601617	12q13.2	RDH5
Fundus albipunctatus, 136880 (3)	RLBP1	180090	15q26.1	RLBP1
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
Fundus flavimaculatus, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
GABA-transaminase deficiency, 613163 (3)	ABAT, GABAT	137150	16p13.2	ABAT
GABA-transaminase deficiency, 613163 (3)	ABAT, GABAT	137150	16p13.2	GABAT
GAPO syndrome, 230740 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ANTXR1
GAPO syndrome, 230740 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	TEM8
GAPO syndrome, 230740 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ATR
GAPO syndrome, 230740 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	GAPO
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT18
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	PED
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1DS
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	EIG12
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT9
GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SDCHCN
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT18
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	PED
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1DS
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	EIG12
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT9
GLUT1 deficiency syndrome 2, childhood onset, 612126 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SDCHCN
GM1-gangliosidosis, type I, 230500 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM1-gangliosidosis, type I, 230500 (3)	GLB1, MPS4B	611458	3p22.3	MPS4B
GM1-gangliosidosis, type II, 230600 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM1-gangliosidosis, type II, 230600 (3)	GLB1, MPS4B	611458	3p22.3	MPS4B
GM1-gangliosidosis, type III, 230650 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
GM1-gangliosidosis, type III, 230650 (3)	GLB1, MPS4B	611458	3p22.3	MPS4B
GM2-gangliosidosis, AB variant, 272750 (3)	GM2A	613109	5q33.1	GM2A
GM2-gangliosidosis, several forms, 272800 (3)	HEXA, TSD	606869	15q23	HEXA
GM2-gangliosidosis, several forms, 272800 (3)	HEXA, TSD	606869	15q23	TSD
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	FLNMS
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	GRACILE
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BJS
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	PTD
GRACILE syndrome, 603358 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	MC3DN1
Galactokinase deficiency with cataracts, 230200 (3)	GALK1	604313	17q25.1	GALK1
Galactose epimerase deficiency, 230350 (3)	GALE	606953	1p36.11	GALE
Galactosemia, 230400 (3)	GALT	606999	9p13.3	GALT
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	CTSA
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	PPGB
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	GSL
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	NGBE
Galactosialidosis, 256540 (3)	CTSA, PPGB, GSL, NGBE, GLB2	613111	20q13.12	GLB2
Gallbladder disease 1, 600803 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ABCB4
Gallbladder disease 1, 600803 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	PGY3
Gallbladder disease 1, 600803 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	MDR3
Gallbladder disease 1, 600803 (3)	ABCB4, PGY3, MDR3, ICP3	171060	7q21.12	ICP3
Gallbladder disease 2 (2)	GBD2	609918	1p36.21	GBD2
Gallbladder disease 3 (2)	GBD3	609919	1p34.3	GBD3
Galloway-Mowat syndrome, 251300 (3)	WDR73, HSPC264, GAMOS	616144	15q25.2	WDR73
Galloway-Mowat syndrome, 251300 (3)	WDR73, HSPC264, GAMOS	616144	15q25.2	HSPC264
Galloway-Mowat syndrome, 251300 (3)	WDR73, HSPC264, GAMOS	616144	15q25.2	GAMOS
Gardner syndrome, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Gardner syndrome, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Gardner syndrome, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Gardner syndrome, 175100 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	CDH1
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	UVO
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	LCAM
Gastric cancer, familial diffuse, with or without cleft lip and/or palate, 137215 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	ECAD
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Gastric cancer, somatic, 137215 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Gastric cancer, somatic, 613659 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Gastric cancer, somatic, 613659 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Gastric cancer, somatic, 613659 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Gastric cancer, somatic, 613659 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Gastric cancer, somatic, 613659 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Gastric cancer, somatic, 613659 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	MCH4
Gastric cancer, somatic, 613659 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	ALPS2
Gastric cancer, somatic, 613659 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Gastric cancer, somatic, 613659 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NGL
Gastric cancer, somatic, 613659 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NEU
Gastric cancer, somatic, 613659 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	HER2
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Gastric cancer, somatic, 613659 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Gastric cancer, somatic, 613659 (3)	IRF1, MAR	147575	5q31.1	IRF1
Gastric cancer, somatic, 613659 (3)	IRF1, MAR	147575	5q31.1	MAR
Gastric cancer, somatic, 613659 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	KLF6
Gastric cancer, somatic, 613659 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	COPEB
Gastric cancer, somatic, 613659 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	BCD1
Gastric cancer, somatic, 613659 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	ZF9
Gastric cancer, somatic, 613659 (3)	MUTYH, MYH	604933	1p34.1	MUTYH
Gastric cancer, somatic, 613659 (3)	MUTYH, MYH	604933	1p34.1	MYH
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Gastric cancer, somatic, 613659 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Gastroesophageal reflux (2)	GER	109350	13q14	GER
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	TTC7A
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	TTC7
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	KIAA1140
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	MINAT
Gastrointestinal defects and immunodeficiency syndrome, 243150 (3)	TTC7A, TTC7, KIAA1140, MINAT, GIDID	609332	2p21	GIDID
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDH2
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHIP
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	PGL4
Gastrointestinal stromal tumor, 606764 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	CWS2
Gastrointestinal stromal tumor, 606764 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Gastrointestinal stromal tumor, 606764 (3)	SDHC, PGL3	602413	1q23.3	PGL3
Gastrointestinal stromal tumor, familial, 606764 (3)	KIT, PBT	164920	4q12	KIT
Gastrointestinal stromal tumor, familial, 606764 (3)	KIT, PBT	164920	4q12	PBT
Gastrointestinal stromal tumor, somatic, 606764 (3)	PDGFRA	173490	4q12	PDGFRA
Gaucher disease, atypical, 610539 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Gaucher disease, atypical, 610539 (3)	PSAP, SAP1	176801	10q22.1	SAP1
Gaucher disease, perinatal lethal, 608013 (3)	GBA	606463	1q22	GBA
Gaucher disease, type I, 230800 (3)	GBA	606463	1q22	GBA
Gaucher disease, type II, 230900 (3)	GBA	606463	1q22	GBA
Gaucher disease, type III, 231000 (3)	GBA	606463	1q22	GBA
Gaucher disease, type IIIC, 231005 (3)	GBA	606463	1q22	GBA
Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	ROBO3, RBIG1, RIG1, HGPPS	608630	11q24.2	ROBO3
Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	ROBO3, RBIG1, RIG1, HGPPS	608630	11q24.2	RBIG1
Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	ROBO3, RBIG1, RIG1, HGPPS	608630	11q24.2	RIG1
Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)	ROBO3, RBIG1, RIG1, HGPPS	608630	11q24.2	HGPPS
Geleophysic dysplasia 1, 231050 (3)	ADAMTSL2, KIAA0605, GPHYSD1	612277	9q34.2	ADAMTSL2
Geleophysic dysplasia 1, 231050 (3)	ADAMTSL2, KIAA0605, GPHYSD1	612277	9q34.2	KIAA0605
Geleophysic dysplasia 1, 231050 (3)	ADAMTSL2, KIAA0605, GPHYSD1	612277	9q34.2	GPHYSD1
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Geleophysic dysplasia 2, 614185 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)	KCNMA1, SLO	600150	10q22.3	KCNMA1
Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)	KCNMA1, SLO	600150	10q22.3	SLO
Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	STX1B, GEFSP9	601485	16p11.2	STX1B
Generalized epilepsy with febrile seizures plus, type 9, 616172 (3)	STX1B, GEFSP9	601485	16p11.2	GEFSP9
Geniospasm (2)	GSM1, GSP	190100	9q13-q21	GSM1
Geniospasm (2)	GSM1, GSP	190100	9q13-q21	GSP
Genitopatellar syndrome, 606170 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	KAT6B
Genitopatellar syndrome, 606170 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	MYST4
Genitopatellar syndrome, 606170 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	MORF
Genitopatellar syndrome, 606170 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	GTPTS
Germ cell tumors, 273300 (3)	KIT, PBT	164920	4q12	KIT
Germ cell tumors, 273300 (3)	KIT, PBT	164920	4q12	PBT
Geroderma osteodysplasticum, 231070 (3)	GORAB, SCYL1BP1, NTKLBP1, GO	607983	1q24.2	GORAB
Geroderma osteodysplasticum, 231070 (3)	GORAB, SCYL1BP1, NTKLBP1, GO	607983	1q24.2	SCYL1BP1
Geroderma osteodysplasticum, 231070 (3)	GORAB, SCYL1BP1, NTKLBP1, GO	607983	1q24.2	NTKLBP1
Geroderma osteodysplasticum, 231070 (3)	GORAB, SCYL1BP1, NTKLBP1, GO	607983	1q24.2	GO
Gerstmann-Straussler disease, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Gerstmann-Straussler disease, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Gerstmann-Straussler disease, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Gerstmann-Straussler disease, 137440 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Ghosal hematodiaphyseal syndrome, 231095 (3)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	TBXAS1
Ghosal hematodiaphyseal syndrome, 231095 (3)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	GHOSAL
Ghosal hematodiaphyseal syndrome, 231095 (3)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	CYP5
Ghosal hematodiaphyseal syndrome, 231095 (3)	TBXAS1, GHOSAL, CYP5, BDPLT14	274180	7q34	BDPLT14
Giant axonal neuropathy-1, 256850 (3)	GAN, GAN1	605379	16q23.2	GAN
Giant axonal neuropathy-1, 256850 (3)	GAN, GAN1	605379	16q23.2	GAN1
Giant platelet disorder, isolated, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	GP1BB
Giant platelet disorder, isolated, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	BS
Giant platelet disorder, isolated, 231200 (3)	GP1BB, BS, BDPLT1	138720	22q11.21	BDPLT1
Gigantism due to GHRF hypersecretion (1)	GHRH, GHRF	139190	20q11.23	GHRH
Gigantism due to GHRF hypersecretion (1)	GHRH, GHRF	139190	20q11.23	GHRF
Gillespie syndrome, 206700 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Gillespie syndrome, 206700 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA15
Gillespie syndrome, 206700 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA16
Gillespie syndrome, 206700 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA29
Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	ALG9
Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	DIBD1
Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	CDG1L
Gillessen-Kaesbach-Nishimura syndrome, 263210 (3)	ALG9, DIBD1, CDG1L, GIKANIS	606941	11q23.1	GIKANIS
Gitelman syndrome, 263800 (3)	SLC12A3, NCCT, TSC	600968	16q13	SLC12A3
Gitelman syndrome, 263800 (3)	SLC12A3, NCCT, TSC	600968	16q13	NCCT
Gitelman syndrome, 263800 (3)	SLC12A3, NCCT, TSC	600968	16q13	TSC
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GP2B
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	CD41B
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GT
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT2
Glanzmann thrombasthenia, 273800 (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT16
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GP3A
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GT
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT2
Glanzmann thrombasthenia, 273800 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT16
Glass syndrome, 612313 (3)	SATB2, KIAA1034, GLSS	608148	2q33.1	SATB2
Glass syndrome, 612313 (3)	SATB2, KIAA1034, GLSS	608148	2q33.1	KIAA1034
Glass syndrome, 612313 (3)	SATB2, KIAA1034, GLSS	608148	2q33.1	GLSS
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	NTF4
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	NTF5
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	NT5
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	NT4
Glaucoma 1, open angle, 1O, 613100 (3)	NTF4 , NTF5, NT5, NT4, GLC1O	162662	19q13.33	GLC1O
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	GLC1E
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	FIP2
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	HYPL
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	NRP
Glaucoma 1, open angle, E, 137760 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	ALS12
Glaucoma 1, open angle, F, 603383 (3)	ASB10, GLC1F	615054	7q36.1	ASB10
Glaucoma 1, open angle, F, 603383 (3)	ASB10, GLC1F	615054	7q36.1	GLC1F
Glaucoma 1, open angle, G, 609887 (3)	WDR36, TAWDRP, GLC1G	609669	5q22.1	WDR36
Glaucoma 1, open angle, G, 609887 (3)	WDR36, TAWDRP, GLC1G	609669	5q22.1	TAWDRP
Glaucoma 1, open angle, G, 609887 (3)	WDR36, TAWDRP, GLC1G	609669	5q22.1	GLC1G
Glaucoma 1, open angle, H (2)	GLC1H	611276	2p16-p15	GLC1H
Glaucoma 1, open angle, I (2)	GLC1I	609745	15q11-q13	GLC1I
Glaucoma 1, open angle, M (2)	GLC1M	610535	5q22.1-q32	GLC1M
Glaucoma 1, open angle, N (2)	GLC1N	611274	15q22-q24	GLC1N
Glaucoma 1, open angle, P (4)	GLC1P	177700	12q14	GLC1P
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	MYOC
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	TIGR
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	GLC1A
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	JOAG
Glaucoma 1A, primary open angle, 137750 (3)	MYOC, TIGR, GLC1A, JOAG, GPOA	601652	1q24.3	GPOA
Glaucoma 1B, primary open angle, adult onset, (2)	GLC1B	606689	2cen-q13	GLC1B
Glaucoma 1C, primary open angle (2)	GLC1C	601682	3q21-q24	GLC1C
Glaucoma 1D, primary open angle (2)	GLC1D	602429	8q23	GLC1D
Glaucoma 1K, primary open angle, juvenile-onset (2)	GLC1K, JOAG3	608696	20p12	GLC1K
Glaucoma 1K, primary open angle, juvenile-onset (2)	GLC1K, JOAG3	608696	20p12	JOAG3
Glaucoma 3, primary congenital, C (2)	GLC3C	613085	14q24.3	GLC3C
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP3
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	GLC3D
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	MSPKA
Glaucoma 3, primary congenital, D, 613086 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	WMS3
Glaucoma 3, primary infantile, B (2)	GLC3B	600975	1p36.2-p36.1	GLC3B
Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3)	CYP1B1, GLC3A	601771	2p22.2	CYP1B1
Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3)	CYP1B1, GLC3A	601771	2p22.2	GLC3A
Glaucoma, primary open angle, juvenile-onset, 2 (2)	JOAG2	608695	9q22	JOAG2
Glioblastoma, somatic, 137800 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Glioblastoma, somatic, 137800 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NGL
Glioblastoma, somatic, 137800 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NEU
Glioblastoma, somatic, 137800 (3)	ERBB2, NGL, NEU, HER2	164870	17q12	HER2
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	HNFJ1
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	FJHN
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	MCKD2
Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	ADMCKD2
Glomerulopathy with fibronectin deposits 1 (2)	GFND1	137950	1q32	GFND1
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FN1
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FN
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	LETS
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FNZ
Glomerulopathy with fibronectin deposits 2, 601894 (3)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	GFND2
Glomerulosclerosis, focal segmental, 1, 603278 (3)	ACTN4, FSGS1, FSGS	604638	19q13.2	ACTN4
Glomerulosclerosis, focal segmental, 1, 603278 (3)	ACTN4, FSGS1, FSGS	604638	19q13.2	FSGS1
Glomerulosclerosis, focal segmental, 1, 603278 (3)	ACTN4, FSGS1, FSGS	604638	19q13.2	FSGS
Glomerulosclerosis, focal segmental, 2, 603965 (3)	TRPC6, TRP6, FSGS2	603652	11q22.1	TRPC6
Glomerulosclerosis, focal segmental, 2, 603965 (3)	TRPC6, TRP6, FSGS2	603652	11q22.1	TRP6
Glomerulosclerosis, focal segmental, 2, 603965 (3)	TRPC6, TRP6, FSGS2	603652	11q22.1	FSGS2
Glomerulosclerosis, focal segmental, 3, 607832 (3)	CD2AP, CMS	604241	6p12.3	CD2AP
Glomerulosclerosis, focal segmental, 3, 607832 (3)	CD2AP, CMS	604241	6p12.3	CMS
Glomerulosclerosis, focal segmental, 5, 613237 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	INF2
Glomerulosclerosis, focal segmental, 5, 613237 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	FSGS5
Glomerulosclerosis, focal segmental, 5, 613237 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	C14orf173
Glomerulosclerosis, focal segmental, 5, 613237 (3)	INF2, FSGS5, C14orf173, CMTDIE	610982	14q32.33	CMTDIE
Glomerulosclerosis, focal segmental, 6, 614131 (3)	MYO1E, MYO1C, FSGS6	601479	15q22.2	MYO1E
Glomerulosclerosis, focal segmental, 6, 614131 (3)	MYO1E, MYO1C, FSGS6	601479	15q22.2	MYO1C
Glomerulosclerosis, focal segmental, 6, 614131 (3)	MYO1E, MYO1C, FSGS6	601479	15q22.2	FSGS6
Glomerulosclerosis, focal segmental, 7, 616002 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAX2
Glomerulosclerosis, focal segmental, 7, 616002 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAPRS
Glomerulosclerosis, focal segmental, 7, 616002 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	FSGS7
Glomuvenous malformations, 138000 (3)	GLML, GVM, VMGLOM	601749	1p22.1	GLML
Glomuvenous malformations, 138000 (3)	GLML, GVM, VMGLOM	601749	1p22.1	GVM
Glomuvenous malformations, 138000 (3)	GLML, GVM, VMGLOM	601749	1p22.1	VMGLOM
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	MRAP
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	FALP
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	C21orf61
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	GCCD2
Glucocorticoid deficiency 2, 607398 (3)	MRAP, FALP, C21orf61, GCCD2, FGD2	609196	21q22.11	FGD2
Glucocorticoid deficiency 3 (2)	GCCD3, FGD3, GCCD2	609197	8q11.2-q13.2	GCCD3
Glucocorticoid deficiency 3 (2)	GCCD3, FGD3, GCCD2	609197	8q11.2-q13.2	FGD3
Glucocorticoid deficiency 3 (2)	GCCD3, FGD3, GCCD2	609197	8q11.2-q13.2	GCCD2
Glucocorticoid deficiency 4, 614736 (3)	NNT, GCCD4	607878	5p12	NNT
Glucocorticoid deficiency 4, 614736 (3)	NNT, GCCD4	607878	5p12	GCCD4
Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)	MC2R	607397	18p11.21	MC2R
Glucocorticoid resistance, 615962 (3)	NR3C1, GCR, GRL, GCRST	138040	5q31.3	NR3C1
Glucocorticoid resistance, 615962 (3)	NR3C1, GCR, GRL, GCRST	138040	5q31.3	GCR
Glucocorticoid resistance, 615962 (3)	NR3C1, GCR, GRL, GCRST	138040	5q31.3	GRL
Glucocorticoid resistance, 615962 (3)	NR3C1, GCR, GRL, GCRST	138040	5q31.3	GCRST
Glucose/galactose malabsorption, 606824 (3)	SLC5A1, SGLT1	182380	22q12.3	SLC5A1
Glucose/galactose malabsorption, 606824 (3)	SLC5A1, SGLT1	182380	22q12.3	SGLT1
Glutamate formiminotransferase deficiency, 229100 (3)	FTCD	606806	21q22.3	FTCD
Glutamine deficiency, congenital, 610015 (3)	GLUL, GLNS	138290	1q25.3	GLUL
Glutamine deficiency, congenital, 610015 (3)	GLUL, GLNS	138290	1q25.3	GLNS
Glutaric acidemia IIA, 231680 (3)	ETFA, GA2, MADD	608053	15q24.2-q24.3	ETFA
Glutaric acidemia IIA, 231680 (3)	ETFA, GA2, MADD	608053	15q24.2-q24.3	GA2
Glutaric acidemia IIA, 231680 (3)	ETFA, GA2, MADD	608053	15q24.2-q24.3	MADD
Glutaric acidemia IIB, 231680 (3)	ETFB, MADD	130410	19q13.41	ETFB
Glutaric acidemia IIB, 231680 (3)	ETFB, MADD	130410	19q13.41	MADD
Glutaric acidemia IIC, 231680 (3)	ETFDH, MADD	231675	4q32.1	ETFDH
Glutaric acidemia IIC, 231680 (3)	ETFDH, MADD	231675	4q32.1	MADD
Glutaric aciduria III, 231690 (3)	C7orf10, GA3	609187	7p14.1	C7orf10
Glutaric aciduria III, 231690 (3)	C7orf10, GA3	609187	7p14.1	GA3
Glutaricaciduria, type I, 231670 (3)	GCDH	608801	19p13.13	GCDH
Glutathione synthetase deficiency, 266130 (3)	GSS, GSHS	601002	20q11.22	GSS
Glutathione synthetase deficiency, 266130 (3)	GSS, GSHS	601002	20q11.22	GSHS
Glutathioninuria (1)	GGT1, GTG	231950	22q11.1-q11.2	GGT1
Glutathioninuria (1)	GGT1, GTG	231950	22q11.1-q11.2	GTG
Glycerol kinase deficiency, 307030 (3)	GK	300474	Xp21.2	GK
Glycine N-methyltransferase deficiency, 606664 (3)	GNMT	606628	6p21.1	GNMT
Glycine encephalopathy, 605899 (3)	AMT, NKH, GCE	238310	3p21.31	AMT
Glycine encephalopathy, 605899 (3)	AMT, NKH, GCE	238310	3p21.31	NKH
Glycine encephalopathy, 605899 (3)	AMT, NKH, GCE	238310	3p21.31	GCE
Glycine encephalopathy, 605899 (3)	GCSH, NKH	238330	16q23.2	GCSH
Glycine encephalopathy, 605899 (3)	GCSH, NKH	238330	16q23.2	NKH
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	GLDC
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	HYGN1
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	GCSP
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	GCE
Glycine encephalopathy, 605899 (3)	GLDC, HYGN1, GCSP, GCE, NKH	238300	9p24.1	NKH
Glycogen storage disease 0, liver, 240600 (3)	GYS2	138571	12p12.1	GYS2
Glycogen storage disease 0, muscle, 611556 (3)	GYS1, GYS	138570	19q13.33	GYS1
Glycogen storage disease 0, muscle, 611556 (3)	GYS1, GYS	138570	19q13.33	GYS
Glycogen storage disease II, 232300 (3)	GAA	606800	17q25.3	GAA
Glycogen storage disease IIIa, 232400 (3)	AGL, GDE	610860	1p21.2	AGL
Glycogen storage disease IIIa, 232400 (3)	AGL, GDE	610860	1p21.2	GDE
Glycogen storage disease IIIb, 232400 (3)	AGL, GDE	610860	1p21.2	AGL
Glycogen storage disease IIIb, 232400 (3)	AGL, GDE	610860	1p21.2	GDE
Glycogen storage disease IV, 232500 (3)	GBE1, GSD4, APBD	607839	3p12.2	GBE1
Glycogen storage disease IV, 232500 (3)	GBE1, GSD4, APBD	607839	3p12.2	GSD4
Glycogen storage disease IV, 232500 (3)	GBE1, GSD4, APBD	607839	3p12.2	APBD
Glycogen storage disease IXc, 613027 (3)	PHKG2, GSD9C	172471	16p11.2	PHKG2
Glycogen storage disease IXc, 613027 (3)	PHKG2, GSD9C	172471	16p11.2	GSD9C
Glycogen storage disease Ia, 232200 (3)	G6PC, G6PT	613742	17q21.31	G6PC
Glycogen storage disease Ia, 232200 (3)	G6PC, G6PT	613742	17q21.31	G6PT
Glycogen storage disease Ib, 232220 (3)	SLC37A4, G6PT1	602671	11q23.3	SLC37A4
Glycogen storage disease Ib, 232220 (3)	SLC37A4, G6PT1	602671	11q23.3	G6PT1
Glycogen storage disease Ic, 232240 (3)	SLC37A4, G6PT1	602671	11q23.3	SLC37A4
Glycogen storage disease Ic, 232240 (3)	SLC37A4, G6PT1	602671	11q23.3	G6PT1
Glycogen storage disease VI, 232700 (3)	PYGL	613741	14q22.1	PYGL
Glycogen storage disease VII, 232800 (3)	PFKM, GSD7	610681	12q13.11	PFKM
Glycogen storage disease VII, 232800 (3)	PFKM, GSD7	610681	12q13.11	GSD7
Glycogen storage disease X, 261670 (3)	PGAM2, PGAMM, GSD10	612931	7p13	PGAM2
Glycogen storage disease X, 261670 (3)	PGAM2, PGAMM, GSD10	612931	7p13	PGAMM
Glycogen storage disease X, 261670 (3)	PGAM2, PGAMM, GSD10	612931	7p13	GSD10
Glycogen storage disease XI, 612933 (3)	LDHA, LDH1, GSD11	150000	11p15.1	LDHA
Glycogen storage disease XI, 612933 (3)	LDHA, LDH1, GSD11	150000	11p15.1	LDH1
Glycogen storage disease XI, 612933 (3)	LDHA, LDH1, GSD11	150000	11p15.1	GSD11
Glycogen storage disease XII, 611881 (3)	ALDOA, GSD12	103850	16p11.2	ALDOA
Glycogen storage disease XII, 611881 (3)	ALDOA, GSD12	103850	16p11.2	GSD12
Glycogen storage disease of heart, lethal congenital, 261740 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Glycogen storage disease of heart, lethal congenital, 261740 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	WPWS
Glycogen storage disease of heart, lethal congenital, 261740 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	CMH6
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHKA2
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHK
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	XLG
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHK
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PYKL
Glycogen storage disease, type IXa1, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	GSD9A
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHKA2
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHK
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	XLG
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PHK
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	PYKL
Glycogen storage disease, type IXa2, 306000 (3)	PHKA2, PHK, XLG, PHK, PYKL, GSD9A	300798	Xp22.13	GSD9A
Glycosylphosphatidylinositol deficiency, 610293 (3)	PIGM	610273	1q23.2	PIGM
Gnathodiaphyseal dysplasia, 166260 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Gnathodiaphyseal dysplasia, 166260 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	TMEM16E
Gnathodiaphyseal dysplasia, 166260 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	GDD1
Gnathodiaphyseal dysplasia, 166260 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	LGMD2L
Goeminne TKCR syndrome (2)	TKCR, TKC	314300	Xq28	TKCR
Goeminne TKCR syndrome (2)	TKCR, TKC	314300	Xq28	TKC
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	HERNA
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	KIAA0928
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	MNG1
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors, 138800 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	RMSE2
Goiter, multinodular, 2 (2)	MNG2	300273	Xp22	MNG2
Goiter, multinodular, 3 (2)	MNG3	606082	3q26.1-q26.3	MNG3
Goldberg-Shprintzen megacolon syndrome, 609460 (3)	KIAA1279	609367	10q22.1	KIAA1279
Gout, PRPS-related, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Gout, PRPS-related, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	CMTX5
Gout, PRPS-related, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFNX1
Gout, PRPS-related, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFN2
Gracile bone dysplasia, 602361 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	FAM111A
Gracile bone dysplasia, 602361 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	KIAA1895
Gracile bone dysplasia, 602361 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	KCS2
Gracile bone dysplasia, 602361 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	GCLEB
Gray platelet syndrome, 139090 (3)	NBEAL2, KIAA0540, GPS, BDPLT4	614169	3p21.31	NBEAL2
Gray platelet syndrome, 139090 (3)	NBEAL2, KIAA0540, GPS, BDPLT4	614169	3p21.31	KIAA0540
Gray platelet syndrome, 139090 (3)	NBEAL2, KIAA0540, GPS, BDPLT4	614169	3p21.31	GPS
Gray platelet syndrome, 139090 (3)	NBEAL2, KIAA0540, GPS, BDPLT4	614169	3p21.31	BDPLT4
Greenberg skeletal dysplasia, 215140 (3)	LBR, PHA	600024	1q42.12	LBR
Greenberg skeletal dysplasia, 215140 (3)	LBR, PHA	600024	1q42.12	PHA
Greig cephalopolysyndactyly syndrome, 175700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Greig cephalopolysyndactyly syndrome, 175700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPA
Greig cephalopolysyndactyly syndrome, 175700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPB
Griscelli syndrome, type 1, 214450 (3)	MYO5A, MYH12, GS1	160777	15q21.2	MYO5A
Griscelli syndrome, type 1, 214450 (3)	MYO5A, MYH12, GS1	160777	15q21.2	MYH12
Griscelli syndrome, type 1, 214450 (3)	MYO5A, MYH12, GS1	160777	15q21.2	GS1
Griscelli syndrome, type 2, 607624 (3)	RAB27A, RAM, GS2	603868	15q21.3	RAB27A
Griscelli syndrome, type 2, 607624 (3)	RAB27A, RAM, GS2	603868	15q21.3	RAM
Griscelli syndrome, type 2, 607624 (3)	RAB27A, RAM, GS2	603868	15q21.3	GS2
Griscelli syndrome, type 3, 609227 (3)	MLPH	606526	2q37.3	MLPH
Growth hormone deficiency with pituitary anomalies, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Growth hormone deficiency with pituitary anomalies, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	RPX
Growth hormone deficiency with pituitary anomalies, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	CPHD5
Growth hormone deficiency, isolated partial, 615925 (3)	GHSR, GHDP	601898	3q26.31	GHSR
Growth hormone deficiency, isolated partial, 615925 (3)	GHSR, GHDP	601898	3q26.31	GHDP
Growth hormone deficiency, isolated, type IA, 262400 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone deficiency, isolated, type IA, 262400 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GHN
Growth hormone deficiency, isolated, type IA, 262400 (3)	GH1, GHN, IGHD1B	139250	17q23.3	IGHD1B
Growth hormone deficiency, isolated, type IB, 612781 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone deficiency, isolated, type IB, 612781 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GHN
Growth hormone deficiency, isolated, type IB, 612781 (3)	GH1, GHN, IGHD1B	139250	17q23.3	IGHD1B
Growth hormone deficiency, isolated, type IB, 612781 (3)	GHRHR, GHRFR, IGHD1B	139191	7p14.3	GHRHR
Growth hormone deficiency, isolated, type IB, 612781 (3)	GHRHR, GHRFR, IGHD1B	139191	7p14.3	GHRFR
Growth hormone deficiency, isolated, type IB, 612781 (3)	GHRHR, GHRFR, IGHD1B	139191	7p14.3	IGHD1B
Growth hormone deficiency, isolated, type II, 173100 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Growth hormone deficiency, isolated, type II, 173100 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GHN
Growth hormone deficiency, isolated, type II, 173100 (3)	GH1, GHN, IGHD1B	139250	17q23.3	IGHD1B
Growth hormone insensitivity with immunodeficiency, 245590 (3)	STAT5B	604260	17q21.2	STAT5B
Growth hormone insensitivity, partial, 604271 (3)	GHR, GHIP	600946	5p13-p12	GHR
Growth hormone insensitivity, partial, 604271 (3)	GHR, GHIP	600946	5p13-p12	GHIP
Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3)	IGF1	147440	12q23.2	IGF1
Growth retardation, developmental delay, facial dysmorphism, 612938 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	FTO
Growth retardation, developmental delay, facial dysmorphism, 612938 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	GDFD
Growth retardation, developmental delay, facial dysmorphism, 612938 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	BMIQ14
Gustavson syndrome (2)	GUST	309555	Xq26	GUST
Guttmacher syndrome, 176305 (3)	HOXA13, HOX1J	142959	7p15.2	HOXA13
Guttmacher syndrome, 176305 (3)	HOXA13, HOX1J	142959	7p15.2	HOX1J
Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	OAT, GACR	613349	10q26.13	OAT
Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3)	OAT, GACR	613349	10q26.13	GACR
HARP syndrome, 607236 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PANK2
HARP syndrome, 607236 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	NBIA1
HARP syndrome, 607236 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PKAN
HARP syndrome, 607236 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	HARP
HDL deficiency, type 2, 604091 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
HDL deficiency, type 2, 604091 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABC1
HDL deficiency, type 2, 604091 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	HDLDT1
HDL deficiency, type 2, 604091 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	TGD
HELLP syndrome, maternal, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
HELLP syndrome, maternal, of pregnancy, 609016 (3)	HADHA, MTPA	600890	2p23.3	MTPA
HMG-CoA lyase deficiency, 246450 (3)	HMGCL	613898	1p36.11	HMGCL
HMG-CoA synthase-2 deficiency, 605911 (3)	HMGCS2	600234	1p12	HMGCS2
HPRT-related gout, 300323 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT1
HPRT-related gout, 300323 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
HSAN2D, autosomal recessive, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Haddad syndrome, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASCL1
Haddad syndrome, 209880 (3)	ASCL1, ASH1	100790	12q23.2	ASH1
Hailey-Hailey disease, 169600 (3)	ATP2C1, BCPM, HHD	604384	3q22.1	ATP2C1
Hailey-Hailey disease, 169600 (3)	ATP2C1, BCPM, HHD	604384	3q22.1	BCPM
Hailey-Hailey disease, 169600 (3)	ATP2C1, BCPM, HHD	604384	3q22.1	HHD
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CPPI
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PALS
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PLS
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	HMS
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PDON1
Haim-Munk syndrome, 245010 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	JPD
Hair, curly (2)	HRM2	139450	1q21.3	HRM2
Hajdu-Cheney syndrome, 102500 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	NOTCH2
Hajdu-Cheney syndrome, 102500 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	AGS2
Hajdu-Cheney syndrome, 102500 (3)	NOTCH2, AGS2, HJCYS	600275	1p12	HJCYS
Hamamy syndrome, 611174 (3)	IRX5, HMMS	606195	16q12.2	IRX5
Hamamy syndrome, 611174 (3)	IRX5, HMMS	606195	16q12.2	HMMS
Hand-foot-uterus syndrome, 140000 (3)	HOXA13, HOX1J	142959	7p15.2	HOXA13
Hand-foot-uterus syndrome, 140000 (3)	HOXA13, HOX1J	142959	7p15.2	HOX1J
Harderoporphyria, 121300 (3)	CPOX	612732	3q11.2	CPOX
Hartnup disorder, 234500 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Hartnup disorder, 234500 (3)	SLC6A19, HND	608893	5p15.33	HND
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Hartsfield syndrome, 615465 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Hashimoto thyroiditis (2)	HT	140300	8q23-q24	HT
Hawkinsinuria, 140350 (3)	HPD	609695	12q24.31	HPD
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Hay-Wells syndrome, 106260 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Heart and brain malformation syndrome, 616920 (3)	C19orf61, SMG9, HBMS	613176	19q13.31	C19orf61
Heart and brain malformation syndrome, 616920 (3)	C19orf61, SMG9, HBMS	613176	19q13.31	SMG9
Heart and brain malformation syndrome, 616920 (3)	C19orf61, SMG9, HBMS	613176	19q13.31	HBMS
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Heart block, nonprogressive, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Heart block, progressive, type IA, 113900 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Heart-hand syndrome, Slovenian type, 610140 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	ZWS1
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1A
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1B
Heimler syndrome 1, 234580 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	HMLR1
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PXAAA1
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PAF2
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PBD4A
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PDB4B
Heimler syndrome 2, 616617 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	HMLR2
Heinz body anemia, 140700 (3)	HBA2, HBH	141850	16p13.3	HBA2
Heinz body anemia, 140700 (3)	HBA2, HBH	141850	16p13.3	HBH
Heinz body anemias, alpha-, 140700 (3)	HBA1, HBH	141800	16p13.3	HBA1
Heinz body anemias, alpha-, 140700 (3)	HBA1, HBH	141800	16p13.3	HBH
Heinz body anemias, beta-, 140700 (3)	HBB	141900	11p15.4	HBB
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	ADNP
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	ADNP1
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	KIAA0784
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	HVDAS
Helsmoortel-van der Aa syndrome, 615873 (3)	ADNP, ADNP1, KIAA0784, HVDAS, MRD28	611386	20q13.13	MRD28
Hemangioblastoma, cerebellar, somatic (3)	VHL	608537	3p25.3	VHL
Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	FLT4
Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	VEGFR3
Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	PCL
Hemangioma, capillary infantile, somatic, 602089 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	LMPH1A
Hemangioma, capillary infantile, somatic, 602089 (3)	KDR	191306	4q12	KDR
Hematuria, benign familial, 141200 (3)	COL4A3	120070	2q36.3	COL4A3
Hematuria, familial benign (3)	COL4A4	120131	2q36.3	COL4A4
Heme oxygenase-1 deficiency, 614034 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1
Heme oxygenase-1 deficiency, 614034 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1D
Hemifacial microsomia (2)	HFM	164210	14q32	HFM
Hemihypertrophy (2)	IH, HHP	235000	11p15	IH
Hemihypertrophy (2)	IH, HHP	235000	11p15	HHP
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
Hemochromatosis, 235200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
Hemochromatosis, type 2A, 602390 (3)	HJV, HFE2A	608374	1q21.1	HJV
Hemochromatosis, type 2A, 602390 (3)	HJV, HFE2A	608374	1q21.1	HFE2A
Hemochromatosis, type 2B, 613313 (3)	HAMP, LEAP1, HEPC, HFE2B	606464	19q13.12	HAMP
Hemochromatosis, type 2B, 613313 (3)	HAMP, LEAP1, HEPC, HFE2B	606464	19q13.12	LEAP1
Hemochromatosis, type 2B, 613313 (3)	HAMP, LEAP1, HEPC, HFE2B	606464	19q13.12	HEPC
Hemochromatosis, type 2B, 613313 (3)	HAMP, LEAP1, HEPC, HFE2B	606464	19q13.12	HFE2B
Hemochromatosis, type 3, 604250 (3)	TFR2, HFE3	604720	7q22.1	TFR2
Hemochromatosis, type 3, 604250 (3)	TFR2, HFE3	604720	7q22.1	HFE3
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	SLC40A1
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	SLC11A3
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	FPN1
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	IREG1
Hemochromatosis, type 4, 606069 (3)	SLC40A1, SLC11A3, FPN1, IREG1, HFE4	604653	2q32.2	HFE4
Hemoglobin H disease, nondeletional, 613978 (3)	HBA1, HBH	141800	16p13.3	HBA1
Hemoglobin H disease, nondeletional, 613978 (3)	HBA1, HBH	141800	16p13.3	HBH
Hemoglobin H disease, nondeletional, 613978 (3)	HBA2, HBH	141850	16p13.3	HBA2
Hemoglobin H disease, nondeletional, 613978 (3)	HBA2, HBH	141850	16p13.3	HBH
Hemolytic anemia due to G6PD deficiency, 300908 (3)	G6PD, G6PD1	305900	Xq28	G6PD
Hemolytic anemia due to G6PD deficiency, 300908 (3)	G6PD, G6PD1	305900	Xq28	G6PD1
Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)	AK1	103000	9q34.11	AK1
Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)	GCLC, GLCLC	606857	6p12.1	GCLC
Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3)	GCLC, GLCLC	606857	6p12.1	GLCLC
Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	GPX1, GPXD	138320	3p21.31	GPX1
Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)	GPX1, GPXD	138320	3p21.31	GPXD
Hemolytic anemia due to glutathione reductase deficiency (1)	GSR	138300	8p12	GSR
Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)	GSS, GSHS	601002	20q11.22	GSS
Hemolytic anemia due to glutathione synthetase deficiency, 231900 (3)	GSS, GSHS	601002	20q11.22	GSHS
Hemolytic anemia due to hexokinase deficiency, 235700 (3)	HK1, HKD, HMSNR	142600	10q22.1	HK1
Hemolytic anemia due to hexokinase deficiency, 235700 (3)	HK1, HKD, HMSNR	142600	10q22.1	HKD
Hemolytic anemia due to hexokinase deficiency, 235700 (3)	HK1, HKD, HMSNR	142600	10q22.1	HMSNR
Hemolytic anemia due to phosphofructokinase deficiency (1)	PFKL	171860	21q22.3	PFKL
Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	TPI1, TPID	190450	12p13.31	TPI1
Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3)	TPI1, TPID	190450	12p13.31	TPID
Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	CD59, MIC11	107271	11p13	CD59
Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3)	CD59, MIC11	107271	11p13	MIC11
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3)	GPI	172400	19q13.11	GPI
Hemophagocytic lymphohistiocytosis, familial, 1 (2)	FHL1, HPLH1, HLH1	267700	9q21.3-q22	FHL1
Hemophagocytic lymphohistiocytosis, familial, 1 (2)	FHL1, HPLH1, HLH1	267700	9q21.3-q22	HPLH1
Hemophagocytic lymphohistiocytosis, familial, 1 (2)	FHL1, HPLH1, HLH1	267700	9q21.3-q22	HLH1
Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	HPLH2
Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	FLH2
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	UNC13D
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	MUNC13-4
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	HPLH3
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	HLH3
Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)	UNC13D, MUNC13-4, HPLH3, HLH3, FHL3	608897	17q25.1	FHL3
Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	STX11, FHL4, HPLH4, HLH4	605014	6q24.2	STX11
Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	STX11, FHL4, HPLH4, HLH4	605014	6q24.2	FHL4
Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	STX11, FHL4, HPLH4, HLH4	605014	6q24.2	HPLH4
Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)	STX11, FHL4, HPLH4, HLH4	605014	6q24.2	HLH4
Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	STXBP2, UNC18B, FHL5	601717	19p13.2	STXBP2
Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	STXBP2, UNC18B, FHL5	601717	19p13.2	UNC18B
Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)	STXBP2, UNC18B, FHL5	601717	19p13.2	FHL5
Hemophilia A, 306700 (3)	F8, F8C, HEMA	300841	Xq28	F8
Hemophilia A, 306700 (3)	F8, F8C, HEMA	300841	Xq28	F8C
Hemophilia A, 306700 (3)	F8, F8C, HEMA	300841	Xq28	HEMA
Hemophilia B, 306900 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
Hemophilia B, 306900 (3)	F9, HEMB, THPH8	300746	Xq27.1	HEMB
Hemophilia B, 306900 (3)	F9, HEMB, THPH8	300746	Xq27.1	THPH8
Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3)	JAM3	606871	11q25	JAM3
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	PI
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh, 613490 (3)	SERPINA1, PI, AAT	107400	14q32.13	AAT
Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3)	CP	117700	3q24-q25	CP
Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	CCBE1, KIAA1983, HKLLS1	612753	18q21.32	CCBE1
Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	CCBE1, KIAA1983, HKLLS1	612753	18q21.32	KIAA1983
Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3)	CCBE1, KIAA1983, HKLLS1	612753	18q21.32	HKLLS1
Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	FAT4
Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	VMLDS2
Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	HKLLS2
Hepatic adenoma, somatic, 142330 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Hepatic adenoma, somatic, 142330 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
Hepatic adenoma, somatic, 142330 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
Hepatic adenoma, somatic, 142330 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
Hepatic lipase deficiency, 614025 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
Hepatic lipase deficiency, 614025 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HL
Hepatic lipase deficiency, 614025 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPH
Hepatic lipase deficiency, 614025 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HDLCQ12
Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	SP110
Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	IFI41
Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	IFI75
Hepatic venoocclusive disease with immunodeficiency, 235550 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	VODI
Hepatoblastoma, somatic, 114550 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	APC
Hepatoblastoma, somatic, 114550 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	GS
Hepatoblastoma, somatic, 114550 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	FPC
Hepatoblastoma, somatic, 114550 (3)	APC, GS, FPC, BTPS2	611731	5q22.2	BTPS2
Hepatocellular cancer, somatic, 114550 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGFRL
Hepatocellular cancer, somatic, 114550 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PDGRL
Hepatocellular cancer, somatic, 114550 (3)	PDGFRL, PDGRL, PRLTS	604584	8p22	PRLTS
Hepatocellular carcinoma, 114550 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Hepatocellular carcinoma, 114550 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Hepatocellular carcinoma, 114550 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Hepatocellular carcinoma, 114550 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Hepatocellular carcinoma, childhood type, somatic, 114550 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
Hepatocellular carcinoma, childhood type, somatic, 114550 (3)	MET, DFNB97, OSFD	164860	7q31.2	DFNB97
Hepatocellular carcinoma, childhood type, somatic, 114550 (3)	MET, DFNB97, OSFD	164860	7q31.2	OSFD
Hepatocellular carcinoma, somatic, 114550 (3)	AXIN1, AXIN	603816	16p13.3	AXIN1
Hepatocellular carcinoma, somatic, 114550 (3)	AXIN1, AXIN	603816	16p13.3	AXIN
Hepatocellular carcinoma, somatic, 114550 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
Hepatocellular carcinoma, somatic, 114550 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	MCH5
Hepatocellular carcinoma, somatic, 114550 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	ALPS2B
Hepatocellular carcinoma, somatic, 114550 (3)	CTNNB1, MRD19	116806	3p22.1	CTNNB1
Hepatocellular carcinoma, somatic, 114550 (3)	CTNNB1, MRD19	116806	3p22.1	MRD19
Hepatocellular carcinoma, somatic, 114550 (3)	IGF2R, MPRI	147280	6q25.3	IGF2R
Hepatocellular carcinoma, somatic, 114550 (3)	IGF2R, MPRI	147280	6q25.3	MPRI
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Hepatocellular carcinoma, somatic, 114550 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Hereditary motor and sensory neuropathy V (2)	HMSN5	600361	4q34.3-q35.2	HMSN5
Hereditary motor and sensory neuropathy VIA, 601152 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	MFN2
Hereditary motor and sensory neuropathy VIA, 601152 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	KIAA0214
Hereditary motor and sensory neuropathy VIA, 601152 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	CMT2A2
Hereditary motor and sensory neuropathy VIA, 601152 (3)	MFN2, KIAA0214, CMT2A2, HMSN6A	608507	1p36.22	HMSN6A
Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3)	TFG, HMSNP, SPG57	602498	3q12.2	TFG
Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3)	TFG, HMSNP, SPG57	602498	3q12.2	HMSNP
Hereditary motor and sensory neuropathy, Okinawa type, 604484 (3)	TFG, HMSNP, SPG57	602498	3q12.2	SPG57
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Hereditary motor and sensory neuropathy, type IIc, 606071 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Hereditary persistence of fetal hemoglobin, 141749 (3)	HBB	141900	11p15.4	HBB
Hermansky-Pudlak syndrome 1, 203300 (3)	HPS1	604982	10q24.2	HPS1
Hermansky-Pudlak syndrome 2, 608233 (3)	AP3B1, ADTB3A, HPS2	603401	5q14.1	AP3B1
Hermansky-Pudlak syndrome 2, 608233 (3)	AP3B1, ADTB3A, HPS2	603401	5q14.1	ADTB3A
Hermansky-Pudlak syndrome 2, 608233 (3)	AP3B1, ADTB3A, HPS2	603401	5q14.1	HPS2
Hermansky-Pudlak syndrome 3, 614072 (3)	HPS3	606118	3q24	HPS3
Hermansky-Pudlak syndrome 4, 614073 (3)	HPS4	606682	22q12.1	HPS4
Hermansky-Pudlak syndrome 5, 614074 (3)	HPS5, RU2, KIAA1017	607521	11p15.1	HPS5
Hermansky-Pudlak syndrome 5, 614074 (3)	HPS5, RU2, KIAA1017	607521	11p15.1	RU2
Hermansky-Pudlak syndrome 5, 614074 (3)	HPS5, RU2, KIAA1017	607521	11p15.1	KIAA1017
Hermansky-Pudlak syndrome 6, 614075 (3)	HPS6, RU	607522	10q24.32	HPS6
Hermansky-Pudlak syndrome 6, 614075 (3)	HPS6, RU	607522	10q24.32	RU
Hermansky-Pudlak syndrome 7, 614076 (3)	DTNBP1, HPS7	607145	6p22.3	DTNBP1
Hermansky-Pudlak syndrome 7, 614076 (3)	DTNBP1, HPS7	607145	6p22.3	HPS7
Hermansky-Pudlak syndrome 8, 614077 (3)	BLOC1S3, BLOS3, HPS8	609762	19q13.32	BLOC1S3
Hermansky-Pudlak syndrome 8, 614077 (3)	BLOC1S3, BLOS3, HPS8	609762	19q13.32	BLOS3
Hermansky-Pudlak syndrome 8, 614077 (3)	BLOC1S3, BLOS3, HPS8	609762	19q13.32	HPS8
Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	BLOC1S6
Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	BLOS6
Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	PLDN
Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	PA
Hermansky-pudlak syndrome 9, 614171 (3)	BLOC1S6, BLOS6, PLDN, PA, HPS9	604310	15q21.1	HPS9
Hernia, congenital diaphragmatic 1 (2)	DIH1, HCD	142340	15q26.1	DIH1
Hernia, congenital diaphragmatic 1 (2)	DIH1, HCD	142340	15q26.1	HCD
Hernia, congenital diaphragmatic 2 (2)	DIH2	222400	8p23.1	DIH2
Heterotaxy, visceral, 1, X-linked 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
Heterotaxy, visceral, 1, X-linked 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX1
Heterotaxy, visceral, 1, X-linked 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX
Heterotaxy, visceral, 1, X-linked 306955 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	VACTERLX
Heterotaxy, visceral, 2, autosomal, 605376 (3)	CFC1, CRYPTIC, HTX2	605194	2q21.1	CFC1
Heterotaxy, visceral, 2, autosomal, 605376 (3)	CFC1, CRYPTIC, HTX2	605194	2q21.1	CRYPTIC
Heterotaxy, visceral, 2, autosomal, 605376 (3)	CFC1, CRYPTIC, HTX2	605194	2q21.1	HTX2
Heterotaxy, visceral, 4, autosomal, 613751 (3)	ACVR2B, ACTRIIB, HTX4	602730	3p22.2	ACVR2B
Heterotaxy, visceral, 4, autosomal, 613751 (3)	ACVR2B, ACTRIIB, HTX4	602730	3p22.2	ACTRIIB
Heterotaxy, visceral, 4, autosomal, 613751 (3)	ACVR2B, ACTRIIB, HTX4	602730	3p22.2	HTX4
Heterotaxy, visceral, 5, 270100 (3)	NODAL, HTX5	601265	10q22.1	NODAL
Heterotaxy, visceral, 5, 270100 (3)	NODAL, HTX5	601265	10q22.1	HTX5
Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	CCDC11, HTX6	614759	18q21.1	CCDC11
Heterotaxy, visceral, 6, autosomal recessive, 614779 (3)	CCDC11, HTX6	614759	18q21.1	HTX6
Heterotaxy, visceral, 7, autosomal, 616749 (3)	MMP21, HTX7	608416	10q26.2	MMP21
Heterotaxy, visceral, 7, autosomal, 616749 (3)	MMP21, HTX7	608416	10q26.2	HTX7
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Heterotopia, periventricular, 300049 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Heterotopia, periventricular, ED variant, 300537 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
High density lipoprotein cholesterol level QTL14 (2)	HDLCQ14, HYLAP	605201	11q23.3	HDLCQ14
High density lipoprotein cholesterol level QTL14 (2)	HDLCQ14, HYLAP	605201	11q23.3	HYLAP
Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3)	ECE1	600423	1p36.12	ECE1
Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)	CREB1	123810	2q33.3	CREB1
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	HJCD, HCLAP	602782	11q25	HJCD
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	HJCD, HCLAP	602782	11q25	HCLAP
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	SLC29A3, ENT3, PHID, HCLAP	612373	10q22.1	SLC29A3
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	SLC29A3, ENT3, PHID, HCLAP	612373	10q22.1	ENT3
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	SLC29A3, ENT3, PHID, HCLAP	612373	10q22.1	PHID
Histiocytosis-lymphadenopathy plus syndrome, 602782 (3)	SLC29A3, ENT3, PHID, HCLAP	612373	10q22.1	HCLAP
Holocarboxylase synthetase deficiency, 253270 (3)	HLCS, HCS	609018	21q22.13	HLCS
Holocarboxylase synthetase deficiency, 253270 (3)	HLCS, HCS	609018	21q22.13	HCS
Holoprosencephaly 1 (2)	HPE1	236100	21q22.3	HPE1
Holoprosencephaly 11, 614226 (3)	CDON, CDO, HPE11	608707	11q24.2	CDON
Holoprosencephaly 11, 614226 (3)	CDON, CDO, HPE11	608707	11q24.2	CDO
Holoprosencephaly 11, 614226 (3)	CDON, CDO, HPE11	608707	11q24.2	HPE11
Holoprosencephaly 2, 157170 (3)	SIX3, HPE2	603714	2p21	SIX3
Holoprosencephaly 2, 157170 (3)	SIX3, HPE2	603714	2p21	HPE2
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HPE3
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HLP3
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SMMCI
Holoprosencephaly 3, 142945 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	MCOPCB5
Holoprosencephaly 4, 142946 (3)	TGIF, HPE4	602630	18p11.31	TGIF
Holoprosencephaly 4, 142946 (3)	TGIF, HPE4	602630	18p11.31	HPE4
Holoprosencephaly 5, 609637 (3)	ZIC2, HPE5	603073	13q32.3	ZIC2
Holoprosencephaly 5, 609637 (3)	ZIC2, HPE5	603073	13q32.3	HPE5
Holoprosencephaly 6 (2)	HPE6	605934	2q37.1-q37.3	HPE6
Holoprosencephaly 7, 610828 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	PTCH1
Holoprosencephaly 7, 610828 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	NBCCS
Holoprosencephaly 7, 610828 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	BCNS
Holoprosencephaly 7, 610828 (3)	PTCH1, NBCCS, BCNS, HPE7	601309	9q22.32	HPE7
Holoprosencephaly 8 (2)	HPE8	609408	14q13	HPE8
Holoprosencephaly 9, 610829 (3)	GLI2, HPE9, CJS	165230	2q14.2	GLI2
Holoprosencephaly 9, 610829 (3)	GLI2, HPE9, CJS	165230	2q14.2	HPE9
Holoprosencephaly 9, 610829 (3)	GLI2, HPE9, CJS	165230	2q14.2	CJS
Holt-Oram syndrome, 142900 (3)	TBX5	601620	12q24.21	TBX5
Homocysteine plasma level (2)	NNMT	600008	11q23.2	NNMT
Homocysteine, total plasma, elevated (3)	CTH	607657	1p31.1	CTH
Homocystinuria due to MTHFR deficiency, 236250 (3)	MTHFR	607093	1p36.22	MTHFR
Homocystinuria, B6-responsive and nonresponsive types, 236200 (3)	CBS	613381	21q22.3	CBS
Homocystinuria, cblD type, variant 1, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Homocystinuria, cblD type, variant 1, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	MMADHC
Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3)	MTRR	602568	5p15.31	MTRR
Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3)	MTR, HMAG	156570	1q43	MTR
Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3)	MTR, HMAG	156570	1q43	HMAG
Humoral hypercalcemia of malignancy (1)	PTHLH, BDE2	168470	12p11.22	PTHLH
Humoral hypercalcemia of malignancy (1)	PTHLH, BDE2	168470	12p11.22	BDE2
Huntington disease, 143100 (3)	HTT, HD, IT15	613004	4p16.3	HTT
Huntington disease, 143100 (3)	HTT, HD, IT15	613004	4p16.3	HD
Huntington disease, 143100 (3)	HTT, HD, IT15	613004	4p16.3	IT15
Huntington disease-like 1, 603218 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Huntington disease-like 1, 603218 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Huntington disease-like 1, 603218 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Huntington disease-like 1, 603218 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Huntington disease-like 2, 606438 (3)	JPH3, JP3, HDL2	605268	16q24.2	JPH3
Huntington disease-like 2, 606438 (3)	JPH3, JP3, HDL2	605268	16q24.2	JP3
Huntington disease-like 2, 606438 (3)	JPH3, JP3, HDL2	605268	16q24.2	HDL2
Huntington disease-like 3 (2)	HDL3, HLN2	604802	4p15.3	HDL3
Huntington disease-like 3 (2)	HDL3, HLN2	604802	4p15.3	HLN2
Huriez syndrome (2)	TYS, HRZ	181600	4q23	TYS
Huriez syndrome (2)	TYS, HRZ	181600	4q23	HRZ
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Hutchinson-Gilford progeria, 176670 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Hyaline fibromatosis syndrome, 228600 (3)	ANTXR2, CMG2, HFS	608041	4q21.21	ANTXR2
Hyaline fibromatosis syndrome, 228600 (3)	ANTXR2, CMG2, HFS	608041	4q21.21	CMG2
Hyaline fibromatosis syndrome, 228600 (3)	ANTXR2, CMG2, HFS	608041	4q21.21	HFS
Hydatidiform mole, recurrent, 1, 231090 (3)	NALP7, NOD12, PYPAF3, HYDM	609661	19q13.42	NALP7
Hydatidiform mole, recurrent, 1, 231090 (3)	NALP7, NOD12, PYPAF3, HYDM	609661	19q13.42	NOD12
Hydatidiform mole, recurrent, 1, 231090 (3)	NALP7, NOD12, PYPAF3, HYDM	609661	19q13.42	PYPAF3
Hydatidiform mole, recurrent, 1, 231090 (3)	NALP7, NOD12, PYPAF3, HYDM	609661	19q13.42	HYDM
Hydatidiform mole, recurrent, 2, 614293 (3)	KHDC3L, C6orf221, ECAT1, HYDM2	611687	6q13	KHDC3L
Hydatidiform mole, recurrent, 2, 614293 (3)	KHDC3L, C6orf221, ECAT1, HYDM2	611687	6q13	C6orf221
Hydatidiform mole, recurrent, 2, 614293 (3)	KHDC3L, C6orf221, ECAT1, HYDM2	611687	6q13	ECAT1
Hydatidiform mole, recurrent, 2, 614293 (3)	KHDC3L, C6orf221, ECAT1, HYDM2	611687	6q13	HYDM2
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Hydranencephaly with abnormal genitalia, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
Hydrocephalus due to aqueductal stenosis, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
Hydrocephalus with Hirschsprung disease, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction, 307000 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 (3)	MPDZ, MUPP1, HYC2	603785	9p23	MPDZ
Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 (3)	MPDZ, MUPP1, HYC2	603785	9p23	MUPP1
Hydrocephalus, nonsyndromic, autosomal recessive 2, 615219 (3)	MPDZ, MUPP1, HYC2	603785	9p23	HYC2
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	CCDC88C
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	HKRP2
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	DAPLE
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	KIAA1509
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	HYC
Hydrocephalus, nonsyndromic, autosomal recessive, 236600 (3)	CCDC88C, HKRP2, DAPLE, KIAA1509, HYC, SCA40	611204	14q32.11-q32.12	SCA40
Hydrolethalus syndrome, 236680 (3)	HYLS1, FLJ32915	610693	11q24.2	HYLS1
Hydrolethalus syndrome, 236680 (3)	HYLS1, FLJ32915	610693	11q24.2	FLJ32915
Hyper-IgD syndrome, 260920 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Hyper-IgD syndrome, 260920 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVLK
Hyper-IgD syndrome, 260920 (3)	MVK, MVLK, POROK3	251170	12q24.11	POROK3
Hyper-IgE recurrent infection syndrome, 147060 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	STAT3
Hyper-IgE recurrent infection syndrome, 147060 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	APRF
Hyper-IgE recurrent infection syndrome, 147060 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	HIES
Hyper-IgE recurrent infection syndrome, 147060 (3)	STAT3, APRF, HIES, ADMIO1	102582	17q21.2	ADMIO1
Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3)	DOCK8	611432	9p24.3	DOCK8
Hyperaldosteronism, familial, type II (2)	FHII	605635	7p22	FHII
Hyperaldosteronism, familial, type III, 613677 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KCNJ5
Hyperaldosteronism, familial, type III, 613677 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	GIRK4
Hyperaldosteronism, familial, type III, 613677 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KATP1
Hyperaldosteronism, familial, type III, 613677 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	LQT13
Hyperaldosteronism, familial, type IV, 617027 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
Hyperaldosteronism, familial, type IV, 617027 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	EIG6
Hyperaldosteronism, familial, type IV, 617027 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	ECA6
Hyperaldosteronism, familial, type IV, 617027 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	HALD4
Hyperalphalipoproteinemia, 143470 (3)	CETP, HDLCQ10	118470	16q13	CETP
Hyperalphalipoproteinemia, 143470 (3)	CETP, HDLCQ10	118470	16q13	HDLCQ10
Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	CA5A, CA5AD	114761	16q24.2	CA5A
Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3)	CA5A, CA5AD	114761	16q24.2	CA5AD
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21A2
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CYP21
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3)	CYP21A2, CYP21, CA21H	613815	6p21.33	CA21H
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	SLCO1B1
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	LST1
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	OATP2
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	OATPC
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	OATP1B1
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR	604843	12p12.1	HBLRR
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	SLCO1B3
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	OATP8
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	OATP1B3
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	SLC21A8
Hyperbilirubinemia, Rotor type, digenic, 237450 (3)	SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR	605495	12p12.2	HBLRR
Hyperbilirubinemia, familial transient neonatal, 237900 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
Hyperbilirubinemia, familial transient neonatal, 237900 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1
Hyperbilirubinemia, familial transient neonatal, 237900 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	GNT1
Hyperbilirubinemia, familial transient neonatal, 237900 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	BILIQTL1
Hyperbiliverdinemia, 614156 (3)	BLVRA	109750	7p13	BLVRA
Hypercalcemia, infantile, 1, 143880 (3)	CYP24A1, CYP24, HCINF1	126065	20q13.2	CYP24A1
Hypercalcemia, infantile, 1, 143880 (3)	CYP24A1, CYP24, HCINF1	126065	20q13.2	CYP24
Hypercalcemia, infantile, 1, 143880 (3)	CYP24A1, CYP24, HCINF1	126065	20q13.2	HCINF1
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC17A2
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPT2
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPHLOP1
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	FRTS2
Hypercalcemia, infantile, 2, 616963 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	HCINF2
Hypercalciuria, absorptive (2)	HCA1	607258	4q33-qter	HCA1
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
Hypercalciuric hypercalcemia (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	BCMO1, BCDO, BCO1	605748	16q23.2	BCMO1
Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	BCMO1, BCDO, BCO1	605748	16q23.2	BCDO
Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3)	BCMO1, BCDO, BCO1	605748	16q23.2	BCO1
Hyperchlorhidrosis, isolated, 143860 (3)	CA12	603263	15q22.2	CA12
Hypercholanemia, familial, 607748 (3)	BAAT	602938	9q31.1	BAAT
Hypercholanemia, familial, 607748 (3)	EPHX1	132810	1q42.12	EPHX1
Hypercholanemia, familial, 607748 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	TJP2
Hypercholanemia, familial, 607748 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	ZO2
Hypercholanemia, familial, 607748 (3)	TJP2, ZO2, PFIC4	607709	9q21.11	PFIC4
Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	APOB
Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	FLDB
Hypercholesterolemia, due to ligand-defective apo B, 144010 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	LDLCQ4
Hypercholesterolemia, familial, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLR
Hypercholesterolemia, familial, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	FHC
Hypercholesterolemia, familial, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	FH
Hypercholesterolemia, familial, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLCQ2
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	PCSK9
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	NARC1
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	HCHOLA3
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	FH3
Hypercholesterolemia, familial, 3, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	LDLCQ1
Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	LDLRAP1, ARH, FHCB2, FHCB1	605747	1p36.11	LDLRAP1
Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	LDLRAP1, ARH, FHCB2, FHCB1	605747	1p36.11	ARH
Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	LDLRAP1, ARH, FHCB2, FHCB1	605747	1p36.11	FHCB2
Hypercholesterolemia, familial, autosomal recessive, 603813 (3)	LDLRAP1, ARH, FHCB2, FHCB1	605747	1p36.11	FHCB1
Hyperchylomicronemia, late-onset, 144650 (3)	APOA5	606368	11q23.3	APOA5
Hyperekplexia 2, autosomal recessive, 614619 (3)	GLRB, HKPX2	138492	4q32.1	GLRB
Hyperekplexia 2, autosomal recessive, 614619 (3)	GLRB, HKPX2	138492	4q32.1	HKPX2
Hyperekplexia 3, 614618 (3)	SLC6A5, GLYT2, HKPX3	604159	11p15.1	SLC6A5
Hyperekplexia 3, 614618 (3)	SLC6A5, GLYT2, HKPX3	604159	11p15.1	GLYT2
Hyperekplexia 3, 614618 (3)	SLC6A5, GLYT2, HKPX3	604159	11p15.1	HKPX3
Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	GLRA1, STHE, HKPX1	138491	5q33.1	GLRA1
Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	GLRA1, STHE, HKPX1	138491	5q33.1	STHE
Hyperekplexia, hereditary 1, autosomal dominant or recessive, 149400 (3)	GLRA1, STHE, HKPX1	138491	5q33.1	HKPX1
Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3)	PDGFRA	173490	4q12	PDGFRA
Hyperferritinemia-cataract syndrome, 600886 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
Hyperferritinemia-cataract syndrome, 600886 (3)	FTL, NBIA3, LFTD	134790	19q13.33	NBIA3
Hyperferritinemia-cataract syndrome, 600886 (3)	FTL, NBIA3, LFTD	134790	19q13.33	LFTD
Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	PLAT
Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	TPA
Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	LIAS, PDHLD, HGCLAS	607031	4p14	LIAS
Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	LIAS, PDHLD, HGCLAS	607031	4p14	PDHLD
Hyperglycinemia, lactic acidosis, and seizures, 614462 (3)	LIAS, PDHLD, HGCLAS	607031	4p14	HGCLAS
Hyperglycinuria, 138500 (3)	SLC36A2, PAT2	608331	5q33.1	SLC36A2
Hyperglycinuria, 138500 (3)	SLC36A2, PAT2	608331	5q33.1	PAT2
Hyperglycinuria, 138500 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Hyperglycinuria, 138500 (3)	SLC6A19, HND	608893	5p15.33	HND
Hyperglycinuria, 138500 (3)	SLC6A20, XT3	605616	3p21.31	SLC6A20
Hyperglycinuria, 138500 (3)	SLC6A20, XT3	605616	3p21.31	XT3
Hyperhidrosis palmaris et plantaris (2)	HHPP	144110	14q11.2-q13	HHPP
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	PHHI
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR1
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	HHF1
Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	TNDM2
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)	GCK, HHF3	138079	7p13	GCK
Hyperinsulinemic hypoglycemia, familial, 3, 602485 (3)	GCK, HHF3	138079	7p13	HHF3
Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HADHSC
Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	HADHSC, SCHAD, HHF4	601609	4q25	SCHAD
Hyperinsulinemic hypoglycemia, familial, 4, 609975 (3)	HADHSC, SCHAD, HHF4	601609	4q25	HHF4
Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	INSR, HHF5	147670	19p13.2	INSR
Hyperinsulinemic hypoglycemia, familial, 5, 609968 (3)	INSR, HHF5	147670	19p13.2	HHF5
Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1
Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	HHF7
Hyperinsulinemic hypoglycemia, familial, 7, 610021 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1D
Hyperinsulinism-hyperammonemia syndrome, 606762 (3)	GLUD1	138130	10q23.2	GLUD1
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HYPP
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	NAC1A
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HOKPP2
Hyperkalemic periodic paralysis, type 2, 170500 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	CMS16
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CCM1
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	CAM
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3)	CCM1, CAM, KRIT1	604214	7q21.2	KRIT1
Hyperlipidemia, combined, 2 (2)	HYPLIP2	604499	11p	HYPLIP2
Hyperlipoproteinemia, type 1D, 615947 (3)	GPIHBP1, HYPL1D	612757	8q24.3	GPIHBP1
Hyperlipoproteinemia, type 1D, 615947 (3)	GPIHBP1, HYPL1D	612757	8q24.3	HYPL1D
Hyperlipoproteinemia, type III (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Hyperlipoproteinemia, type III (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
Hyperlipoproteinemia, type III (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
Hyperlipoproteinemia, type III (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
Hyperlipoproteinemia, type Ib, 207750 (3)	APOC2	608083	19q13.32	APOC2
Hyperlysinemia, 238700 (3)	AASS	605113	7q31.32	AASS
Hypermanganesemia with dystonia 1, 613280 (3)	SLC30A10, ZNT10, HMNDYT1	611146	1q41	SLC30A10
Hypermanganesemia with dystonia 1, 613280 (3)	SLC30A10, ZNT10, HMNDYT1	611146	1q41	ZNT10
Hypermanganesemia with dystonia 1, 613280 (3)	SLC30A10, ZNT10, HMNDYT1	611146	1q41	HMNDYT1
Hypermanganesemia with dystonia 2, 617013 (3)	SLC39A14, ZIP14, KIAA0062, HMNDYT2	608736	8p21.3	SLC39A14
Hypermanganesemia with dystonia 2, 617013 (3)	SLC39A14, ZIP14, KIAA0062, HMNDYT2	608736	8p21.3	ZIP14
Hypermanganesemia with dystonia 2, 617013 (3)	SLC39A14, ZIP14, KIAA0062, HMNDYT2	608736	8p21.3	KIAA0062
Hypermanganesemia with dystonia 2, 617013 (3)	SLC39A14, ZIP14, KIAA0062, HMNDYT2	608736	8p21.3	HMNDYT2
Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)	ADK	102750	10q22.2	ADK
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	AHCY, SAHH	180960	20q11.22	AHCY
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3)	AHCY, SAHH	180960	20q11.22	SAHH
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MAT1A
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MATA1
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	SAMS1
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	SLC25A15, ORNT1, HHH	603861	13q14.11	SLC25A15
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	SLC25A15, ORNT1, HHH	603861	13q14.11	ORNT1
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3)	SLC25A15, ORNT1, HHH	603861	13q14.11	HHH
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
Hyperostosis, endosteal, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
Hyperoxaluria, primary, type 1, 259900 (3)	AGXT, SPAT	604285	2q37.3	AGXT
Hyperoxaluria, primary, type 1, 259900 (3)	AGXT, SPAT	604285	2q37.3	SPAT
Hyperoxaluria, primary, type II, 260000 (3)	GRHPR, GLXR	604296	9p13.2	GRHPR
Hyperoxaluria, primary, type II, 260000 (3)	GRHPR, GLXR	604296	9p13.2	GLXR
Hyperoxaluria, primary, type III, 613616 (3)	HOGA1, DHDPSL, HP3	613597	10q24.2	HOGA1
Hyperoxaluria, primary, type III, 613616 (3)	HOGA1, DHDPSL, HP3	613597	10q24.2	DHDPSL
Hyperoxaluria, primary, type III, 613616 (3)	HOGA1, DHDPSL, HP3	613597	10q24.2	HP3
Hyperparathyroidism 3 (2)	HRPT3	610071	2p14-p13.3	HRPT3
Hyperparathyroidism, familial primary, 145000 (3)	HRPT2, C1orf28	607393	1q31.2	HRPT2
Hyperparathyroidism, familial primary, 145000 (3)	HRPT2, C1orf28	607393	1q31.2	C1orf28
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
Hyperparathyroidism, neonatal, 239200 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
Hyperparathyroidism-jaw tumor syndrome, 145001 (3)	HRPT2, C1orf28	607393	1q31.2	HRPT2
Hyperparathyroidism-jaw tumor syndrome, 145001 (3)	HRPT2, C1orf28	607393	1q31.2	C1orf28
Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)	PTS	612719	11q23.1	PTS
Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	GCH1
Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	DYT5
Hyperphenylalaninemia, BH4-deficient, B, 233910 (3)	GCH1, DYT5, HPABH4B	600225	14q22.2	HPABH4B
Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	QDPR, DHPR	612676	4p15.32	QDPR
Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)	QDPR, DHPR	612676	4p15.32	DHPR
Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	PCBD1, DCOH	126090	10q22.1	PCBD1
Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)	PCBD1, DCOH	126090	10q22.1	DCOH
Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	PIGV, HPMRS1	610274	1p36.11	PIGV
Hyperphosphatasia with mental retardation syndrome 1, 239300 (3)	PIGV, HPMRS1	610274	1p36.11	HPMRS1
Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	PIGO, HPMRS2	614730	9p13.3	PIGO
Hyperphosphatasia with mental retardation syndrome 2, 614749 (3)	PIGO, HPMRS2	614730	9p13.3	HPMRS2
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	PGAP2
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	FRAG1
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	HPMRS3
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	MRT17
Hyperphosphatasia with mental retardation syndrome 3, 614207 (3)	PGAP2, FRAG1, HPMRS3, MRT17, MRT21	615187	11p15.4	MRT21
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	PGAP3
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	PERLD1
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	CAB2
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	MGC9753
Hyperphosphatasia with mental retardation syndrome 4, 615716 (3)	PGAP3, PERLD1, CAB2, MGC9753, HPMRS4	611801	17q12	HPMRS4
Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	PIGY, HPMRS6	610662	4q22.1	PIGY
Hyperphosphatasia with mental retardation syndrome 6, 616809 (3)	PIGY, HPMRS6	610662	4q22.1	HPMRS6
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	MGF
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SF
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SCF
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SHEP7
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	FPHH
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DCUA
Hyperpigmentation with or without hypopigmentation, 145250 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DFNA69
Hyperpigmentation, familial progressive, 1 (2)	FPH1, MUH, HPP	614233	19pter-p13.1	FPH1
Hyperpigmentation, familial progressive, 1 (2)	FPH1, MUH, HPP	614233	19pter-p13.1	MUH
Hyperpigmentation, familial progressive, 1 (2)	FPH1, MUH, HPP	614233	19pter-p13.1	HPP
Hyperproinsulinemia, 616214 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Hyperproinsulinemia, 616214 (3)	INS, MODY10, IDDM2	176730	11p15.5	MODY10
Hyperproinsulinemia, 616214 (3)	INS, MODY10, IDDM2	176730	11p15.5	IDDM2
Hyperprolinemia, type I, 239500 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH
Hyperprolinemia, type I, 239500 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH2
Hyperprolinemia, type I, 239500 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	SCZD4
Hyperprolinemia, type II, 239510 (3)	ALDH4A1, ALDH4, P5CDH	606811	1p36.13	ALDH4A1
Hyperprolinemia, type II, 239510 (3)	ALDH4A1, ALDH4, P5CDH	606811	1p36.13	ALDH4
Hyperprolinemia, type II, 239510 (3)	ALDH4A1, ALDH4, P5CDH	606811	1p36.13	P5CDH
Hypertelorism, preauricular sinus, punctal pits, and deafness (2)	HPPD	614187	14q31	HPPD
Hypertension and brachydactyly syndrome, 112410 (3)	PDE3A, HTNB	123805	12p12.2	PDE3A
Hypertension and brachydactyly syndrome, 112410 (3)	PDE3A, HTNB	123805	12p12.2	HTNB
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	NR3C2, MLR, MCR	600983	4q31.23	NR3C2
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	NR3C2, MLR, MCR	600983	4q31.23	MLR
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy, 605115 (3)	NR3C2, MLR, MCR	600983	4q31.23	MCR
Hypertension, essential, 145500 (3)	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.13	PTGIS
Hypertension, essential, 145500 (3)	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.13	CYP8A1
Hypertension, essential, 145500 (3)	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.13	PGIS
Hypertension, essential, 145500 (3)	PTGIS, CYP8A1, PGIS, CYP8	601699	20q13.13	CYP8
Hypertensive nephropathy (2)	HNP1	608026	9q31-q32	HNP1
Hyperthyroidism, familial gestational, 603373 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hyperthyroidism, familial gestational, 603373 (3)	TSHR, CHNG1	603372	14q31.1	CHNG1
Hyperthyroidism, nonautoimmune, 609152 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hyperthyroidism, nonautoimmune, 609152 (3)	TSHR, CHNG1	603372	14q31.1	CHNG1
Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	HTGH, DEL17q24	135400	17q24.2-q24.3	HTGH
Hypertrichosis terminalis, generalized, with or without gingival hyperplasia (4)	HTGH, DEL17q24	135400	17q24.2-q24.3	DEL17q24
Hypertrichosis, congenital generalized (4)	HTC2, HCG, CGH, CXINSq27.1,	307150	Xq27.1	HTC2
Hypertrichosis, congenital generalized (4)	HTC2, HCG, CGH, CXINSq27.1,	307150	Xq27.1	HCG
Hypertrichosis, congenital generalized (4)	HTC2, HCG, CGH, CXINSq27.1,	307150	Xq27.1	CGH
Hypertrichosis, congenital generalized (4)	HTC2, HCG, CGH, CXINSq27.1,	307150	Xq27.1	CXINSq27.1
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ABCC9
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	SUR2
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CMD1O
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	ATFB12
Hypertrichotic osteochondrodysplasia, 239850 (3)	ABCC9, SUR2, CMD1O, ATFB12, CANTU	601439	12p12.1	CANTU
Hypertriglyceridemia, transient infantile, 614480 (3)	GPD1, HTGTI	138420	12q13.12	GPD1
Hypertriglyceridemia, transient infantile, 614480 (3)	GPD1, HTGTI	138420	12q13.12	HTGTI
Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	HPGD
Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PGDH1
Hypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3)	HPGD, PGDH1, PHOAR1	601688	4q34.1	PHOAR1
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	SLCO2A1
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	OATP2A1
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	PGT
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	SLC21A2
Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3)	SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2	601460	3q22.1-q22.2	PHOAR2
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3)	SARS2	612804	19q13.2	SARS2
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	HNFJ1
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	FJHN
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	MCKD2
Hyperuricemic nephropathy, familial juvenile 1, 162000 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	ADMCKD2
Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	REN, HNFJ2	179820	1q32.1	REN
Hyperuricemic nephropathy, familial juvenile 2, 613092 (3)	REN, HNFJ2	179820	1q32.1	HNFJ2
Hyperuricemic nephropathy, familial juvenile, 3 (2)	HNFJ3	614227	2p22.1-p21	HNFJ3
Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	SEC61A1, SEC61, HNFJ4	609213	3q21.3	SEC61A1
Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	SEC61A1, SEC61, HNFJ4	609213	3q21.3	SEC61
Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3)	SEC61A1, SEC61, HNFJ4	609213	3q21.3	HNFJ4
Hypoaldosteronism, congenital, due to CMO I deficiency, 203400 (3)	CYP11B2	124080	8q24.3	CYP11B2
Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3)	CYP11B2	124080	8q24.3	CYP11B2
Hypoalphalipoproteinemia, 604091 (3)	APOA1	107680	11q23.3	APOA1
Hypobetalipoproteinemia, 615558 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	APOB
Hypobetalipoproteinemia, 615558 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	FLDB
Hypobetalipoproteinemia, 615558 (3)	APOB, FLDB, LDLCQ4	107730	2p24.1	LDLCQ4
Hypobetalipoproteinemia, familial, 2, 605019 (3)	ANGPTL3, ANGPT5, FHBL2	604774	1p31.3	ANGPTL3
Hypobetalipoproteinemia, familial, 2, 605019 (3)	ANGPTL3, ANGPT5, FHBL2	604774	1p31.3	ANGPT5
Hypobetalipoproteinemia, familial, 2, 605019 (3)	ANGPTL3, ANGPT5, FHBL2	604774	1p31.3	FHBL2
Hypocalcemia, autosomal dominant 2, 615361 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	GNA11
Hypocalcemia, autosomal dominant 2, 615361 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	HHC2
Hypocalcemia, autosomal dominant 2, 615361 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	HYPOC2
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
Hypocalcemia, autosomal dominant, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
Hypocalcemia, autosomal dominant, with Bartter syndrome, 601198 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
Hypocalciuric hypercalcemia, familial, type III, 600740 (3)	AP2S1, CLAPS2, AP17, HHC3	602242	19q13.32	AP2S1
Hypocalciuric hypercalcemia, familial, type III, 600740 (3)	AP2S1, CLAPS2, AP17, HHC3	602242	19q13.32	CLAPS2
Hypocalciuric hypercalcemia, familial, type III, 600740 (3)	AP2S1, CLAPS2, AP17, HHC3	602242	19q13.32	AP17
Hypocalciuric hypercalcemia, familial, type III, 600740 (3)	AP2S1, CLAPS2, AP17, HHC3	602242	19q13.32	HHC3
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
Hypocalciuric hypercalcemia, type I, 145980 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
Hypocalciuric hypercalcemia, type II, 145981 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	GNA11
Hypocalciuric hypercalcemia, type II, 145981 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	HHC2
Hypocalciuric hypercalcemia, type II, 145981 (3)	GNA11, HHC2, HYPOC2	139313	19p13.3	HYPOC2
Hypochondroplasia, 146000 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Hypochondroplasia, 146000 (3)	FGFR3, ACH	134934	4p16.3	ACH
Hypochromic microcytic anemia (3)	HBA2, HBH	141850	16p13.3	HBA2
Hypochromic microcytic anemia (3)	HBA2, HBH	141850	16p13.3	HBH
Hypodysfibrinogenemia, 616004 (3)	FGG	134850	4q32.1	FGG
Hypodysfibrinogenemia, congenital, 616004 (3)	FGA	134820	4q31.3	FGA
Hypofibrinogenemia, congenital, 202400 (3)	FGB	134830	4q31.3	FGB
Hypofibrinogenemia, congenital, 202400 (3)	FGG	134850	4q32.1	FGG
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	ABCC8
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	PHHI
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	SUR1
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	HHF1
Hypoglycemia of infancy, leucine-sensitive, 240800 (3)	ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2	600509	11p15.1	TNDM2
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	KAL1, KMS, ADMLX, HH1	300836	Xp22.31	KAL1
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	KAL1, KMS, ADMLX, HH1	300836	Xp22.31	KMS
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	KAL1, KMS, ADMLX, HH1	300836	Xp22.31	ADMLX
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3)	KAL1, KMS, ADMLX, HH1	300836	Xp22.31	HH1
Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	TAC3, NKNB, HH10	162330	12q13.3	TAC3
Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	TAC3, NKNB, HH10	162330	12q13.3	NKNB
Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3)	TAC3, NKNB, HH10	162330	12q13.3	HH10
Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	TACR3, NK3R, HH11	162332	4q24	TACR3
Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	TACR3, NK3R, HH11	162332	4q24	NK3R
Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3)	TACR3, NK3R, HH11	162332	4q24	HH11
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	WDR11
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	DR11
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	KIAA1351
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	BRWD2
Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3)	WDR11, DR11, KIAA1351, BRWD2, HH14	606417	10q26.12	HH14
Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	SPRY4, HH17	607984	5q31.3	SPRY4
Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3)	SPRY4, HH17	607984	5q31.3	HH17
Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	IL17RD, SEF, HH18	606807	3p14.3	IL17RD
Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	IL17RD, SEF, HH18	606807	3p14.3	SEF
Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3)	IL17RD, SEF, HH18	606807	3p14.3	HH18
Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	DUSP6, MKP3, PYST1, HH19	602748	12q21.33	DUSP6
Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	DUSP6, MKP3, PYST1, HH19	602748	12q21.33	MKP3
Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	DUSP6, MKP3, PYST1, HH19	602748	12q21.33	PYST1
Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3)	DUSP6, MKP3, PYST1, HH19	602748	12q21.33	HH19
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Hypogonadotropic hypogonadism 2 with or without anosmia, 147950 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	FGF17, HH20	603725	8p21.3	FGF17
Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3)	FGF17, HH20	603725	8p21.3	HH20
Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	FLRT3, HH21	604808	20p12.1	FLRT3
Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3)	FLRT3, HH21	604808	20p12.1	HH21
Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	FEZF1, FEZ, ZNF312B, HH22	613301	7q31.32	FEZF1
Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	FEZF1, FEZ, ZNF312B, HH22	613301	7q31.32	FEZ
Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	FEZF1, FEZ, ZNF312B, HH22	613301	7q31.32	ZNF312B
Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3)	FEZF1, FEZ, ZNF312B, HH22	613301	7q31.32	HH22
Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	LHB, HH23	152780	19q13.33	LHB
Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3)	LHB, HH23	152780	19q13.33	HH23
Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	FSHB, HH24	136530	11p14.1	FSHB
Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3)	FSHB, HH24	136530	11p14.1	HH24
Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	PROKR2, PKR2, GPR73L1, HH3	607123	20p12.3	PROKR2
Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	PROKR2, PKR2, GPR73L1, HH3	607123	20p12.3	PKR2
Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	PROKR2, PKR2, GPR73L1, HH3	607123	20p12.3	GPR73L1
Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3)	PROKR2, PKR2, GPR73L1, HH3	607123	20p12.3	HH3
Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	PROK2, PK2, BV8, HH4	607002	3p13	PROK2
Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	PROK2, PK2, BV8, HH4	607002	3p13	PK2
Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	PROK2, PK2, BV8, HH4	607002	3p13	BV8
Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3)	PROK2, PK2, BV8, HH4	607002	3p13	HH4
Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	CHD7, HH5	608892	8q12.2	CHD7
Hypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3)	CHD7, HH5	608892	8q12.2	HH5
Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	FGF8, HH6	600483	10q24.32	FGF8
Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3)	FGF8, HH6	600483	10q24.32	HH6
Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	GNRHR, LHRHR, HH7	138850	4q13.2	GNRHR
Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	GNRHR, LHRHR, HH7	138850	4q13.2	LHRHR
Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3)	GNRHR, LHRHR, HH7	138850	4q13.2	HH7
Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	KISS1R
Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	GPR54
Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	HH8
Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3)	KISS1R, GPR54, HH8, CPPB1	604161	19p13.3	CPPB1
Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	NSMF, NELF, HH9	608137	9q34.3	NSMF
Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	NSMF, NELF, HH9	608137	9q34.3	NELF
Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3)	NSMF, NELF, HH9	608137	9q34.3	HH9
Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	AKT2, HIHGHH	164731	19q13.2	AKT2
Hypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3)	AKT2, HIHGHH	164731	19q13.2	HIHGHH
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNL1A3
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CCHL1A3
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	TTPP1
Hypokalemic periodic paralysis, type 1, 170400 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	HOKPP1
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HYPP
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	NAC1A
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HOKPP2
Hypokalemic periodic paralysis, type 2, 613345 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	CMS16
Hypomagnesemia 1, intestinal, 602014 (3)	TRPM6, CHAK2, HOMG1	607009	9q21.13	TRPM6
Hypomagnesemia 1, intestinal, 602014 (3)	TRPM6, CHAK2, HOMG1	607009	9q21.13	CHAK2
Hypomagnesemia 1, intestinal, 602014 (3)	TRPM6, CHAK2, HOMG1	607009	9q21.13	HOMG1
Hypomagnesemia 2, renal, 154020 (3)	FXYD2, ATP1G1, HOMG2	601814	11q23.3	FXYD2
Hypomagnesemia 2, renal, 154020 (3)	FXYD2, ATP1G1, HOMG2	601814	11q23.3	ATP1G1
Hypomagnesemia 2, renal, 154020 (3)	FXYD2, ATP1G1, HOMG2	601814	11q23.3	HOMG2
Hypomagnesemia 3, renal, 248250 (3)	CLDN16, PCLN1, HOMG3	603959	3q28	CLDN16
Hypomagnesemia 3, renal, 248250 (3)	CLDN16, PCLN1, HOMG3	603959	3q28	PCLN1
Hypomagnesemia 3, renal, 248250 (3)	CLDN16, PCLN1, HOMG3	603959	3q28	HOMG3
Hypomagnesemia 4, renal, 611718 (3)	EGF, URG, HOMG4	131530	4q25	EGF
Hypomagnesemia 4, renal, 611718 (3)	EGF, URG, HOMG4	131530	4q25	URG
Hypomagnesemia 4, renal, 611718 (3)	EGF, URG, HOMG4	131530	4q25	HOMG4
Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	CLDN19, HOMG5	610036	1p34.2	CLDN19
Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)	CLDN19, HOMG5	610036	1p34.2	HOMG5
Hypomagnesemia 6, renal, 613882 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	CNNM2
Hypomagnesemia 6, renal, 613882 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	ACDP2
Hypomagnesemia 6, renal, 613882 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	HOMG6
Hypomagnesemia 6, renal, 613882 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	HOMGSMR
Hypomagnesemia, seizures, and mental retardation, 616418 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	CNNM2
Hypomagnesemia, seizures, and mental retardation, 616418 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	ACDP2
Hypomagnesemia, seizures, and mental retardation, 616418 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	HOMG6
Hypomagnesemia, seizures, and mental retardation, 616418 (3)	CNNM2, ACDP2, HOMG6, HOMGSMR	607803	10q24.32	HOMGSMR
Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	DARS, HBSL	603084	2q21.3	DARS
Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3)	DARS, HBSL	603084	2q21.3	HBSL
Hypoparathyroidism, X-linked (2)	HPT, HPTX, HYPX	307700	Xq26-q27	HPT
Hypoparathyroidism, X-linked (2)	HPT, HPTX, HYPX	307700	Xq26-q27	HPTX
Hypoparathyroidism, X-linked (2)	HPT, HPTX, HYPX	307700	Xq26-q27	HYPX
Hypoparathyroidism, autosomal dominant, 146200 (3)	PTH	168450	11p15.3	PTH
Hypoparathyroidism, autosomal recessive, 146200 (3)	PTH	168450	11p15.3	PTH
Hypoparathyroidism, familial isolated, 146200 (3)	GCM2, GCMB	603716	6p24.2	GCM2
Hypoparathyroidism, familial isolated, 146200 (3)	GCM2, GCMB	603716	6p24.2	GCMB
Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	GATA3, HDR, HDRS	131320	10p14	GATA3
Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	GATA3, HDR, HDRS	131320	10p14	HDR
Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3)	GATA3, HDR, HDRS	131320	10p14	HDRS
Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	TBCE
Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	KCS
Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	KCS1
Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	HRD
Hypophosphatasia, adult, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatasia, adult, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	HOPS
Hypophosphatasia, adult, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	TNSALP
Hypophosphatasia, childhood, 241510 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatasia, childhood, 241510 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	HOPS
Hypophosphatasia, childhood, 241510 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	TNSALP
Hypophosphatasia, infantile, 241500 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Hypophosphatasia, infantile, 241500 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	HOPS
Hypophosphatasia, infantile, 241500 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	TNSALP
Hypophosphatemic rickets and hyperparathyroidism (2)	HPRHP	612089	13q13.1	HPRHP
Hypophosphatemic rickets with hypercalciuria, 241530 (3)	SLC34A3, NPTIIC, HHRH	609826	9q34.3	SLC34A3
Hypophosphatemic rickets with hypercalciuria, 241530 (3)	SLC34A3, NPTIIC, HHRH	609826	9q34.3	NPTIIC
Hypophosphatemic rickets with hypercalciuria, 241530 (3)	SLC34A3, NPTIIC, HHRH	609826	9q34.3	HHRH
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCK2
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL2
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	DENTS
Hypophosphatemic rickets, 300554 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL1
Hypophosphatemic rickets, AR, 241520 (3)	DMP1, ARHR, ARHP	600980	4q22.1	DMP1
Hypophosphatemic rickets, AR, 241520 (3)	DMP1, ARHR, ARHP	600980	4q22.1	ARHR
Hypophosphatemic rickets, AR, 241520 (3)	DMP1, ARHR, ARHP	600980	4q22.1	ARHP
Hypophosphatemic rickets, X-linked dominant, 307800 (3)	PHEX, HYP, HPDR1, LXHR	300550	Xp22.11	PHEX
Hypophosphatemic rickets, X-linked dominant, 307800 (3)	PHEX, HYP, HPDR1, LXHR	300550	Xp22.11	HYP
Hypophosphatemic rickets, X-linked dominant, 307800 (3)	PHEX, HYP, HPDR1, LXHR	300550	Xp22.11	HPDR1
Hypophosphatemic rickets, X-linked dominant, 307800 (3)	PHEX, HYP, HPDR1, LXHR	300550	Xp22.11	LXHR
Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	ADHR
Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	HPDR2
Hypophosphatemic rickets, autosomal dominant, 193100 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	PHPTC
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PDNP1
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	NPPS
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	M6S1
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PCA1
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ARHR2
Hypophosphatemic rickets, autosomal recessive, 2, 613312 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	COLED
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Hypoplastic left heart syndrome 1, 241550 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Hypoplastic left heart syndrome 2, 614435 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Hypoplastic or aplastic tibia with polydactyly, 188740 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Hypoprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Hypoprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	THPH1
Hypoprothrombinemia, 613679 (3)	F2, THPH1, RPRGL2	176930	11p11.2	RPRGL2
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	DHTR
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	TFM
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SBMA
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	KD
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SMAX1
Hypospadias 1, X-linked, 300633 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	HYSP1
Hypospadias 2, X-linked, 300758 (3)	MAMLD1, CXorf6, F18, HYSP2	300120	Xq28	MAMLD1
Hypospadias 2, X-linked, 300758 (3)	MAMLD1, CXorf6, F18, HYSP2	300120	Xq28	CXorf6
Hypospadias 2, X-linked, 300758 (3)	MAMLD1, CXorf6, F18, HYSP2	300120	Xq28	F18
Hypospadias 2, X-linked, 300758 (3)	MAMLD1, CXorf6, F18, HYSP2	300120	Xq28	HYSP2
Hypospadias 3, autosomal (2)	HYSP3	146450	7q32.2-q36.1	HYSP3
Hypothryoidism, congenital, nongoitrous 4, 275100 (3)	TSHB, CHNG4	188540	1p13.2	TSHB
Hypothryoidism, congenital, nongoitrous 4, 275100 (3)	TSHB, CHNG4	188540	1p13.2	CHNG4
Hypothyroidism, central, and testicular enlargement, 300888 (3)	IGSF1, IGDC1, CHTE	300137	Xq26.1	IGSF1
Hypothyroidism, central, and testicular enlargement, 300888 (3)	IGSF1, IGDC1, CHTE	300137	Xq26.1	IGDC1
Hypothyroidism, central, and testicular enlargement, 300888 (3)	IGSF1, IGDC1, CHTE	300137	Xq26.1	CHTE
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Hypothyroidism, congenital nongoitrous, 5, 225250 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3)	PAX8	167415	2q14.1	PAX8
Hypothyroidism, congenital, nongoitrous, 1 275200 (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Hypothyroidism, congenital, nongoitrous, 1 275200 (3)	TSHR, CHNG1	603372	14q31.1	CHNG1
Hypothyroidism, congenital, nongoitrous, 3 (2)	CHNG3, RTSH	609893	15q25.3-q26.1	CHNG3
Hypothyroidism, congenital, nongoitrous, 3 (2)	CHNG3, RTSH	609893	15q25.3-q26.1	RTSH
Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	THRA, ERBA1, THRA1, CHNG6	190120	17q21.1	THRA
Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	THRA, ERBA1, THRA1, CHNG6	190120	17q21.1	ERBA1
Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	THRA, ERBA1, THRA1, CHNG6	190120	17q21.1	THRA1
Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)	THRA, ERBA1, THRA1, CHNG6	190120	17q21.1	CHNG6
Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	NALCN
Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	IHPRF1
Hypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3)	NALCN, IHPRF1, CLIFAHDD	611549	13q32.3-q33.1	CLIFAHDD
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	UNC80, C2orf21, KIAA1843	612636	2q34	UNC80
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	UNC80, C2orf21, KIAA1843	612636	2q34	C2orf21
Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3)	UNC80, C2orf21, KIAA1843	612636	2q34	KIAA1843
Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	TBCK, IHPRF3	616899	4q24	TBCK
Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3)	TBCK, IHPRF3	616899	4q24	IHPRF3
Hypotonia, infantile, with psychomotor retardation, 616816 (3)	CCDC174, HSPC212, IHPM	616735	3p25.1	CCDC174
Hypotonia, infantile, with psychomotor retardation, 616816 (3)	CCDC174, HSPC212, IHPM	616735	3p25.1	HSPC212
Hypotonia, infantile, with psychomotor retardation, 616816 (3)	CCDC174, HSPC212, IHPM	616735	3p25.1	IHPM
Hypotonia-cystinuria syndrome (4)	DEL2p21, C2DELp21	606407	2p21	DEL2p21
Hypotonia-cystinuria syndrome (4)	DEL2p21, C2DELp21	606407	2p21	C2DELp21
Hypotrichosis 1, 605389 (3)	APCDD1, HHS, HYPT1, HTS	607479	18p11.22	APCDD1
Hypotrichosis 1, 605389 (3)	APCDD1, HHS, HYPT1, HTS	607479	18p11.22	HHS
Hypotrichosis 1, 605389 (3)	APCDD1, HHS, HYPT1, HTS	607479	18p11.22	HYPT1
Hypotrichosis 1, 605389 (3)	APCDD1, HHS, HYPT1, HTS	607479	18p11.22	HTS
Hypotrichosis 10 (2)	HYPT10	614238	7p22.3-p21.3	HYPT10
Hypotrichosis 11, 615059 (3)	SNRPE, HYPT11	128260	1q32.1	SNRPE
Hypotrichosis 11, 615059 (3)	SNRPE, HYPT11	128260	1q32.1	HYPT11
Hypotrichosis 12, 615885 (3)	RPL21, HYPT12	603636	13q12.2	RPL21
Hypotrichosis 12, 615885 (3)	RPL21, HYPT12	603636	13q12.2	HYPT12
Hypotrichosis 2, 146520 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	CDSN
Hypotrichosis 2, 146520 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	HTSS1
Hypotrichosis 2, 146520 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	HYPT2
Hypotrichosis 2, 146520 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	PSS1
Hypotrichosis 4, 146550 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HR
Hypotrichosis 4, 146550 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	AU
Hypotrichosis 4, 146550 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	MUHH1
Hypotrichosis 4, 146550 (3)	HR, AU, MUHH1, HYPT4	602302	8p21.3	HYPT4
Hypotrichosis 5 (2)	HYPT5, MUHH2	612841	1p21.1-q21.3	HYPT5
Hypotrichosis 5 (2)	HYPT5, MUHH2	612841	1p21.1-q21.3	MUHH2
Hypotrichosis 6, 607903 (3)	DSG4, LAH, HYPT6	607892	18q12.1	DSG4
Hypotrichosis 6, 607903 (3)	DSG4, LAH, HYPT6	607892	18q12.1	LAH
Hypotrichosis 6, 607903 (3)	DSG4, LAH, HYPT6	607892	18q12.1	HYPT6
Hypotrichosis 7, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LIPH
Hypotrichosis 7, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LAH2
Hypotrichosis 7, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	ARWH2
Hypotrichosis 7, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	HYPT7
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LPAR6
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	P2RY5
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	P2Y5
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LAH3
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	ARWH1
Hypotrichosis 8, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	HYPT8
Hypotrichosis 9 (2)	HYPT9	614237	10q11.23-q22.3	HYPT9
Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDH3
Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	CDHP
Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	PCAD
Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3)	CDH3, CDHP, PCAD, HJMD	114021	16q22.1	HJMD
Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	SOX18
Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	HLTS
Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	HLTRS
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	SOX18
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	HLTS
Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3)	SOX18, HLTS, HLTRS	601618	20q13.33	HLTRS
Hypouricemia, renal, 2, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	SLC2A9
Hypouricemia, renal, 2, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	GLUT9
Hypouricemia, renal, 2, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	UAQTL2
Hypouricemia, renal, 220150 (3)	SLC22A12, OAT4L, URAT1	607096	11q13.1	SLC22A12
Hypouricemia, renal, 220150 (3)	SLC22A12, OAT4L, URAT1	607096	11q13.1	OAT4L
Hypouricemia, renal, 220150 (3)	SLC22A12, OAT4L, URAT1	607096	11q13.1	URAT1
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Hystrix-like ichthyosis with deafness, 602540 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	S2P
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	IFAP
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	KFSDX
IFAP syndrome with or without BRESHECK syndrome, 308205 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	OLMSX
IMAGE syndrome, 614732 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	CDKN1C
IMAGE syndrome, 614732 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	KIP2
IMAGE syndrome, 614732 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	BWS
IMAGE syndrome, 614732 (3)	CDKN1C, KIP2, BWS, IMAGE	600856	11p15.4	IMAGE
IRAK4 deficiency, 607676 (3)	IRAK4, REN64, IPD1	606883	12q12	IRAK4
IRAK4 deficiency, 607676 (3)	IRAK4, REN64, IPD1	606883	12q12	REN64
IRAK4 deficiency, 607676 (3)	IRAK4, REN64, IPD1	606883	12q12	IPD1
IVIC syndrome, 147750 (3)	SALL4, HSAL4	607343	20q13.2	SALL4
IVIC syndrome, 147750 (3)	SALL4, HSAL4	607343	20q13.2	HSAL4
Ichthyosis bullosa of Siemens, 146800 (3)	KRT2, KRT2A, KRT2E	600194	12q13.13	KRT2
Ichthyosis bullosa of Siemens, 146800 (3)	KRT2, KRT2A, KRT2E	600194	12q13.13	KRT2A
Ichthyosis bullosa of Siemens, 146800 (3)	KRT2, KRT2A, KRT2E	600194	12q13.13	KRT2E
Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Ichthyosis histrix, Curth-Macklin type, 146590 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Ichthyosis prematurity syndrome, 608649 (3)	SLC27A4, FATP4, IPS	604194	9q34.11	SLC27A4
Ichthyosis prematurity syndrome, 608649 (3)	SLC27A4, FATP4, IPS	604194	9q34.11	FATP4
Ichthyosis prematurity syndrome, 608649 (3)	SLC27A4, FATP4, IPS	604194	9q34.11	IPS
Ichthyosis vulgaris, 146700 (3)	FLG, ATOD2	135940	1q21.3	FLG
Ichthyosis vulgaris, 146700 (3)	FLG, ATOD2	135940	1q21.3	ATOD2
Ichthyosis with confetti, 609165 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Ichthyosis with confetti, 609165 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	EHK
Ichthyosis with confetti, 609165 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BCIE
Ichthyosis with confetti, 609165 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BIE
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	STS
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	ARSC1
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	ARSC
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	SSDD
Ichthyosis, X-linked, 308100 (3)	STS, ARSC1, ARSC, SSDD, XLI	300747	Xp22.31	XLI
Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ABCA12
Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ARCI4A
Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ARCI4B
Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ICR2B
Ichthyosis, autosomal recessive 4B (harlequin), 242500 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	LI2
Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	TGM1, ICR2, ARCI1	190195	14q12	TGM1
Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	TGM1, ICR2, ARCI1	190195	14q12	ICR2
Ichthyosis, congenital, autosomal recessive 1, 242300 (3)	TGM1, ICR2, ARCI1	190195	14q12	ARCI1
Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	PNPLA1, ARCI10	612121	6p21.31	PNPLA1
Ichthyosis, congenital, autosomal recessive 10, 615024 (3)	PNPLA1, ARCI10	612121	6p21.31	ARCI10
Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	ST14, MTSP1, ARCI11	606797	11q24.3	ST14
Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	ST14, MTSP1, ARCI11	606797	11q24.3	MTSP1
Ichthyosis, congenital, autosomal recessive 11, 602400 (3)	ST14, MTSP1, ARCI11	606797	11q24.3	ARCI11
Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	ALOX12B, ARCI2	603741	17p13.1	ALOX12B
Ichthyosis, congenital, autosomal recessive 2, 242100 (3)	ALOX12B, ARCI2	603741	17p13.1	ARCI2
Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	ALOXE3, ARCI3	607206	17p13.1	ALOXE3
Ichthyosis, congenital, autosomal recessive 3, 606545 (3)	ALOXE3, ARCI3	607206	17p13.1	ARCI3
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ABCA12
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ARCI4A
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ARCI4B
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	ICR2B
Ichthyosis, congenital, autosomal recessive 4A, 601277 (3)	ABCA12, ARCI4A, ARCI4B, ICR2B, LI2	607800	2q35	LI2
Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	CYP4F22, ARCI5, LI3	611495	19p13.12	CYP4F22
Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	CYP4F22, ARCI5, LI3	611495	19p13.12	ARCI5
Ichthyosis, congenital, autosomal recessive 5, 604777 (3)	CYP4F22, ARCI5, LI3	611495	19p13.12	LI3
Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	NIPAL4, ICHYN, ARCI6	609383	5q33.3	NIPAL4
Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	NIPAL4, ICHYN, ARCI6	609383	5q33.3	ICHYN
Ichthyosis, congenital, autosomal recessive 6, 612281 (3)	NIPAL4, ICHYN, ARCI6	609383	5q33.3	ARCI6
Ichthyosis, congenital, autosomal recessive 7 (2)	ARCI7	615022	12p11.2-q13.1	ARCI7
Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	LIPN, LIPL4, ARCI8, LI4	613924	10q23.31	LIPN
Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	LIPN, LIPL4, ARCI8, LI4	613924	10q23.31	LIPL4
Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	LIPN, LIPL4, ARCI8, LI4	613924	10q23.31	ARCI8
Ichthyosis, congenital, autosomal recessive 8, 613943 (3)	LIPN, LIPL4, ARCI8, LI4	613924	10q23.31	LI4
Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	CERS3, LASS3, ARCI9	615276	15q26.3	CERS3
Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	CERS3, LASS3, ARCI9	615276	15q26.3	LASS3
Ichthyosis, congenital, autosomal recessive 9, 615023 (3)	CERS3, LASS3, ARCI9	615276	15q26.3	ARCI9
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	KRT10
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	EHK
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BCIE
Ichthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3)	KRT10, EHK, BCIE, BIE	148080	17q21.2	BIE
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	CLDN1, SEMP1, ILVASC	603718	3q28	CLDN1
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	CLDN1, SEMP1, ILVASC	603718	3q28	SEMP1
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3)	CLDN1, SEMP1, ILVASC	603718	3q28	ILVASC
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ADMD
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD2
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD3
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ISQMR
Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	SCA34
IgG2 deficiency, selective (3)	IGHG2	147110	14q32.33	IGHG2
Iminoglycinuria, digenic, 242600 (3)	SLC36A2, PAT2	608331	5q33.1	SLC36A2
Iminoglycinuria, digenic, 242600 (3)	SLC36A2, PAT2	608331	5q33.1	PAT2
Iminoglycinuria, digenic, 242600 (3)	SLC6A19, HND	608893	5p15.33	SLC6A19
Iminoglycinuria, digenic, 242600 (3)	SLC6A19, HND	608893	5p15.33	HND
Iminoglycinuria, digenic, 242600 (3)	SLC6A20, XT3	605616	3p21.31	SLC6A20
Iminoglycinuria, digenic, 242600 (3)	SLC6A20, XT3	605616	3p21.31	XT3
Immunodeficiency 10, 612783 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Immunodeficiency 10, 612783 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	TAM1
Immunodeficiency 10, 612783 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	IMD10
Immunodeficiency 10, 612783 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STRMK
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	CARD11
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	CARMA1
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	BIMP3
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	PPBL
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	BENTA
Immunodeficiency 11, 615206 (3)	CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11	607210	7p22.2	IMD11
Immunodeficiency 12, 615468 (3)	MALT1, MLT, IMD12	604860	18q21.32	MALT1
Immunodeficiency 12, 615468 (3)	MALT1, MLT, IMD12	604860	18q21.32	MLT
Immunodeficiency 12, 615468 (3)	MALT1, MLT, IMD12	604860	18q21.32	IMD12
Immunodeficiency 14, 615513 (3)	PIK3CD, APDS, IMD14	602839	1p36.22	PIK3CD
Immunodeficiency 14, 615513 (3)	PIK3CD, APDS, IMD14	602839	1p36.22	APDS
Immunodeficiency 14, 615513 (3)	PIK3CD, APDS, IMD14	602839	1p36.22	IMD14
Immunodeficiency 15, 615592 (3)	IKBKB, NFKBIKB, IMD15	603258	8p11.21	IKBKB
Immunodeficiency 15, 615592 (3)	IKBKB, NFKBIKB, IMD15	603258	8p11.21	NFKBIKB
Immunodeficiency 15, 615592 (3)	IKBKB, NFKBIKB, IMD15	603258	8p11.21	IMD15
Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	CD3G, IMD17	186740	11q23.3	CD3G
Immunodeficiency 17, CD3 gamma deficient, 615607 (3)	CD3G, IMD17	186740	11q23.3	IMD17
Immunodeficiency 18, 615615 (3)	CD3E, IMD18	186830	11q23.3	CD3E
Immunodeficiency 18, 615615 (3)	CD3E, IMD18	186830	11q23.3	IMD18
Immunodeficiency 18, SCID variant, 615615 (3)	CD3E, IMD18	186830	11q23.3	CD3E
Immunodeficiency 18, SCID variant, 615615 (3)	CD3E, IMD18	186830	11q23.3	IMD18
Immunodeficiency 19, 615617 (3)	CD3D, T3D, IMD19	186790	11q23.3	CD3D
Immunodeficiency 19, 615617 (3)	CD3D, T3D, IMD19	186790	11q23.3	T3D
Immunodeficiency 19, 615617 (3)	CD3D, T3D, IMD19	186790	11q23.3	IMD19
Immunodeficiency 20, 615707 (3)	FCGR3A, CD16, IGFR3, IMD20	146740	1q23.3	FCGR3A
Immunodeficiency 20, 615707 (3)	FCGR3A, CD16, IGFR3, IMD20	146740	1q23.3	CD16
Immunodeficiency 20, 615707 (3)	FCGR3A, CD16, IGFR3, IMD20	146740	1q23.3	IGFR3
Immunodeficiency 20, 615707 (3)	FCGR3A, CD16, IGFR3, IMD20	146740	1q23.3	IMD20
Immunodeficiency 21, 614172 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
Immunodeficiency 21, 614172 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	DCML
Immunodeficiency 21, 614172 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	MONOMAC
Immunodeficiency 21, 614172 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	IMD21
Immunodeficiency 23, 615816 (3)	PGM3, AGM1, IMD23	172100	6q14.1	PGM3
Immunodeficiency 23, 615816 (3)	PGM3, AGM1, IMD23	172100	6q14.1	AGM1
Immunodeficiency 23, 615816 (3)	PGM3, AGM1, IMD23	172100	6q14.1	IMD23
Immunodeficiency 24, 615897 (3)	CTPS1, CTPS, IMD24	123860	1p34.2	CTPS1
Immunodeficiency 24, 615897 (3)	CTPS1, CTPS, IMD24	123860	1p34.2	CTPS
Immunodeficiency 24, 615897 (3)	CTPS1, CTPS, IMD24	123860	1p34.2	IMD24
Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	PRKDC, HYRC1, DNPK1, IMD26	600899	8q11.21	PRKDC
Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	PRKDC, HYRC1, DNPK1, IMD26	600899	8q11.21	HYRC1
Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	PRKDC, HYRC1, DNPK1, IMD26	600899	8q11.21	DNPK1
Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3)	PRKDC, HYRC1, DNPK1, IMD26	600899	8q11.21	IMD26
Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
Immunodeficiency 27A, mycobacteriosis, AR, 209950 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
Immunodeficiency 27B, mycobacteriosis, AD, 615978 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
Immunodeficiency 28, mycobacteriosis, 614889 (3)	IFNGR2, IFNGT1, IFGR2, IMD28	147569	21q22.11	IFNGR2
Immunodeficiency 28, mycobacteriosis, 614889 (3)	IFNGR2, IFNGT1, IFGR2, IMD28	147569	21q22.11	IFNGT1
Immunodeficiency 28, mycobacteriosis, 614889 (3)	IFNGR2, IFNGT1, IFGR2, IMD28	147569	21q22.11	IFGR2
Immunodeficiency 28, mycobacteriosis, 614889 (3)	IFNGR2, IFNGT1, IFGR2, IMD28	147569	21q22.11	IMD28
Immunodeficiency 29, mycobacteriosis, 614890 (3)	IL12B, NKSF2, IMD29	161561	5q33.3	IL12B
Immunodeficiency 29, mycobacteriosis, 614890 (3)	IL12B, NKSF2, IMD29	161561	5q33.3	NKSF2
Immunodeficiency 29, mycobacteriosis, 614890 (3)	IL12B, NKSF2, IMD29	161561	5q33.3	IMD29
Immunodeficiency 30, 614891 (3)	IL12RB1, IMD30	601604	19p13.11	IL12RB1
Immunodeficiency 30, 614891 (3)	IL12RB1, IMD30	601604	19p13.11	IMD30
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	CANDF7
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31A
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31B
Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31C
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	CANDF7
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31A
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31B
Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31C
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	STAT1
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	CANDF7
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31A
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31B
Immunodeficiency 31C, autosomal dominant, 614162 (3)	STAT1, CANDF7, IMD31A, IMD31B, IMD31C	600555	2q32.2	IMD31C
Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IRF8
Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	ICSBP1
Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IMD32A
Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IMD32B
Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IRF8
Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	ICSBP1
Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IMD32A
Immunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 614894 (3)	IRF8, ICSBP1, IMD32A, IMD32B	601565	16q24.1	IMD32B
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Immunodeficiency 33, 300636 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CYBB
Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	CGD
Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	AMCBX2
Immunodeficiency 34, mycobacteriosis, X-linked, 300645 (3)	CYBB, CGD, AMCBX2, IMD34	300481	Xp21.1-p11.4	IMD34
Immunodeficiency 35, 611521 (3)	TYK2, IMD35	176941	19p13.2	TYK2
Immunodeficiency 35, 611521 (3)	TYK2, IMD35	176941	19p13.2	IMD35
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	GRB1
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	AGM7
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	SHORT
Immunodeficiency 36, 616005 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	IMD36
Immunodeficiency 38, 616126 (3)	ISG15, G1P2, IFI15, IMD38	147571	1p36.33	ISG15
Immunodeficiency 38, 616126 (3)	ISG15, G1P2, IFI15, IMD38	147571	1p36.33	G1P2
Immunodeficiency 38, 616126 (3)	ISG15, G1P2, IFI15, IMD38	147571	1p36.33	IFI15
Immunodeficiency 38, 616126 (3)	ISG15, G1P2, IFI15, IMD38	147571	1p36.33	IMD38
Immunodeficiency 40, 616433 (3)	DOCK2, IMD40	603122	5q35.1	DOCK2
Immunodeficiency 40, 616433 (3)	DOCK2, IMD40	603122	5q35.1	IMD40
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2RA
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	CD25
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2R
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IDDM10
Immunodeficiency 41 with lymphoproliferation and autoimmunity, 606367 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IMD41
Immunodeficiency 42, 616622 (3)	RORC, RORG, RZRG, IMD42	602943	1q21.3	RORC
Immunodeficiency 42, 616622 (3)	RORC, RORG, RZRG, IMD42	602943	1q21.3	RORG
Immunodeficiency 42, 616622 (3)	RORC, RORG, RZRG, IMD42	602943	1q21.3	RZRG
Immunodeficiency 42, 616622 (3)	RORC, RORG, RZRG, IMD42	602943	1q21.3	IMD42
Immunodeficiency 43, 241600 (3)	B2M, IMD43	109700	15q21.1	B2M
Immunodeficiency 43, 241600 (3)	B2M, IMD43	109700	15q21.1	IMD43
Immunodeficiency 44, 616636 (3)	STAT2, IMD44	600556	12q13.3	STAT2
Immunodeficiency 44, 616636 (3)	STAT2, IMD44	600556	12q13.3	IMD44
Immunodeficiency 46, 616740 (3)	TFRC, TFR, CD71, IMD46	190010	3q29	TFRC
Immunodeficiency 46, 616740 (3)	TFRC, TFR, CD71, IMD46	190010	3q29	TFR
Immunodeficiency 46, 616740 (3)	TFRC, TFR, CD71, IMD46	190010	3q29	CD71
Immunodeficiency 46, 616740 (3)	TFRC, TFR, CD71, IMD46	190010	3q29	IMD46
Immunodeficiency 47, 300972 (3)	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	300197	Xq28	ATP6AP1
Immunodeficiency 47, 300972 (3)	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	300197	Xq28	ATP6IP1
Immunodeficiency 47, 300972 (3)	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	300197	Xq28	ATP6S1
Immunodeficiency 47, 300972 (3)	ATP6AP1, ATP6IP1, ATP6S1, VATPS1	300197	Xq28	VATPS1
Immunodeficiency 48, 269840 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ZAP70
Immunodeficiency 48, 269840 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	SRK
Immunodeficiency 48, 269840 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	ADMIO2
Immunodeficiency 48, 269840 (3)	ZAP70, SRK, ADMIO2, IMD48	176947	2q11.2	IMD48
Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	TRAC, TRCA, TRA, IMD7	186880	14q11.2	TRAC
Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	TRAC, TRCA, TRA, IMD7	186880	14q11.2	TRCA
Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	TRAC, TRCA, TRA, IMD7	186880	14q11.2	TRA
Immunodeficiency 7, TCR-alpha/beta deficient, 615387 (3)	TRAC, TRCA, TRA, IMD7	186880	14q11.2	IMD7
Immunodeficiency 8, 615401 (3)	CORO1A, TACO, CLIPINA, IMD8	605000	16p11.2	CORO1A
Immunodeficiency 8, 615401 (3)	CORO1A, TACO, CLIPINA, IMD8	605000	16p11.2	TACO
Immunodeficiency 8, 615401 (3)	CORO1A, TACO, CLIPINA, IMD8	605000	16p11.2	CLIPINA
Immunodeficiency 8, 615401 (3)	CORO1A, TACO, CLIPINA, IMD8	605000	16p11.2	IMD8
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	ORAI1
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	TMEM142A
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	CRACM1
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	IMD9
Immunodeficiency 9, 612782 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	TAM2
Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	LAMTOR2, MAPBPIP, p14	610389	1q22	LAMTOR2
Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	LAMTOR2, MAPBPIP, p14	610389	1q22	MAPBPIP
Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3)	LAMTOR2, MAPBPIP, p14	610389	1q22	p14
Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	FCN3, HAKA1	604973	1p36.11	FCN3
Immunodeficiency due to ficolin 3 deficiency, 613860 (3)	FCN3, HAKA1	604973	1p36.11	HAKA1
Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	PNP, NP	164050	14q11.2	PNP
Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3)	PNP, NP	164050	14q11.2	NP
Immunodeficiency with hyper IgM, type 5, 608106 (3)	UNG, DGU, HIGM5	191525	12q24.11	UNG
Immunodeficiency with hyper IgM, type 5, 608106 (3)	UNG, DGU, HIGM5	191525	12q24.11	DGU
Immunodeficiency with hyper IgM, type 5, 608106 (3)	UNG, DGU, HIGM5	191525	12q24.11	HIGM5
Immunodeficiency with hyper-IgM, type 2, 605258 (3)	AICDA, AID, HIGM2	605257	12p13.31	AICDA
Immunodeficiency with hyper-IgM, type 2, 605258 (3)	AICDA, AID, HIGM2	605257	12p13.31	AID
Immunodeficiency with hyper-IgM, type 2, 605258 (3)	AICDA, AID, HIGM2	605257	12p13.31	HIGM2
Immunodeficiency with hyper-IgM, type 3, 606843 (3)	CD40, TNFRSF5	109535	20q13.12	CD40
Immunodeficiency with hyper-IgM, type 3, 606843 (3)	CD40, TNFRSF5	109535	20q13.12	TNFRSF5
Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26.3	TNFSF5
Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26.3	CD40LG
Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26.3	HIGM1
Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)	TNFSF5, CD40LG, HIGM1, IGM	300386	Xq26.3	IGM
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	MAGT1, IAP, XMEN	300715	Xq21.1	MAGT1
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	MAGT1, IAP, XMEN	300715	Xq21.1	IAP
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)	MAGT1, IAP, XMEN	300715	Xq21.1	XMEN
Immunodeficiency, common variable, 1, 607594 (3)	ICOS, AILIM, CVID1	604558	2q33.2	ICOS
Immunodeficiency, common variable, 1, 607594 (3)	ICOS, AILIM, CVID1	604558	2q33.2	AILIM
Immunodeficiency, common variable, 1, 607594 (3)	ICOS, AILIM, CVID1	604558	2q33.2	CVID1
Immunodeficiency, common variable, 10, 615577 (3)	NFKB2, LYT10, CVID10	164012	10q24.32	NFKB2
Immunodeficiency, common variable, 10, 615577 (3)	NFKB2, LYT10, CVID10	164012	10q24.32	LYT10
Immunodeficiency, common variable, 10, 615577 (3)	NFKB2, LYT10, CVID10	164012	10q24.32	CVID10
Immunodeficiency, common variable, 12, 616576 (3)	NFKB1, CVID12	164011	4q24	NFKB1
Immunodeficiency, common variable, 12, 616576 (3)	NFKB1, CVID12	164011	4q24	CVID12
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	IKZF1
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	ZNFN1A1
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	IK1
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	LYF1
Immunodeficiency, common variable, 13, 616873 (3)	IKZF1, ZNFN1A1, IK1, LYF1, CVID13	603023	7p12.2	CVID13
Immunodeficiency, common variable, 2, 240500 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TNFRSF13B
Immunodeficiency, common variable, 2, 240500 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TACI
Immunodeficiency, common variable, 2, 240500 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	CVID2
Immunodeficiency, common variable, 3, 613493 (3)	CD19, CVID3	107265	16p11.2	CD19
Immunodeficiency, common variable, 3, 613493 (3)	CD19, CVID3	107265	16p11.2	CVID3
Immunodeficiency, common variable, 4, 613494 (3)	TNFRSF13C, BAFFR, CVID4	606269	22q13.2	TNFRSF13C
Immunodeficiency, common variable, 4, 613494 (3)	TNFRSF13C, BAFFR, CVID4	606269	22q13.2	BAFFR
Immunodeficiency, common variable, 4, 613494 (3)	TNFRSF13C, BAFFR, CVID4	606269	22q13.2	CVID4
Immunodeficiency, common variable, 5, 613495 (3)	MS4A1, CD20, CVID5	112210	11q12.2	MS4A1
Immunodeficiency, common variable, 5, 613495 (3)	MS4A1, CD20, CVID5	112210	11q12.2	CD20
Immunodeficiency, common variable, 5, 613495 (3)	MS4A1, CD20, CVID5	112210	11q12.2	CVID5
Immunodeficiency, common variable, 6, 613496 (3)	CD81, TAPA1, CVID6	186845	11p15.5	CD81
Immunodeficiency, common variable, 6, 613496 (3)	CD81, TAPA1, CVID6	186845	11p15.5	TAPA1
Immunodeficiency, common variable, 6, 613496 (3)	CD81, TAPA1, CVID6	186845	11p15.5	CVID6
Immunodeficiency, common variable, 7, 614699 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CR2
Immunodeficiency, common variable, 7, 614699 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	C3DR
Immunodeficiency, common variable, 7, 614699 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	SLEB9
Immunodeficiency, common variable, 7, 614699 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CVID7
Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	LRBA, LBA, CDC4L, CVID8	606453	4q31.3	LRBA
Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	LRBA, LBA, CDC4L, CVID8	606453	4q31.3	LBA
Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	LRBA, LBA, CDC4L, CVID8	606453	4q31.3	CDC4L
Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3)	LRBA, LBA, CDC4L, CVID8	606453	4q31.3	CVID8
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Immunodeficiency, isolated, 300584 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Immunodeficiency, primary, autosomal recessive, IL21R-related, 615207 (3)	IL21R	605383	16p12.1	IL21R
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	DNMT3B, ICF1	602900	20q11.21	DNMT3B
Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3)	DNMT3B, ICF1	602900	20q11.21	ICF1
Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	CDCA7, JPO1, ICF3	609937	2q31.1	CDCA7
Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	CDCA7, JPO1, ICF3	609937	2q31.1	JPO1
Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3)	CDCA7, JPO1, ICF3	609937	2q31.1	ICF3
Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	HELLS, LSH, ICF4	603946	10q23.33	HELLS
Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	HELLS, LSH, ICF4	603946	10q23.33	LSH
Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3)	HELLS, LSH, ICF4	603946	10q23.33	ICF4
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	ZBTB24
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	PATZ2
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	ZNF450
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	KIAA0441
Immunodeficiency-centromeric instability-facial anomalies syndrome-2, 614069 (3)	ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2	614064	6q21	ICF2
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	FOXP3
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	IPEX
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	AIID
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	XPID
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked, 304790 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	PIDX
Immunoglobulin A deficiency (2)	IGAD1	137100	6p21.3	IGAD1
Immunoglobulin A deficiency 2, 609529 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TNFRSF13B
Immunoglobulin A deficiency 2, 609529 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	TACI
Immunoglobulin A deficiency 2, 609529 (3)	TNFRSF13B, TACI, CVID2	604907	17p11.2	CVID2
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	VCP
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	IBMPFD1
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	ALS14
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3)	VCP, IBMPFD1, ALS14, CMT2Y	601023	9p13.3	CMT2Y
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Incontinentia pigmenti, 308300 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Increased responsiveness to growth hormone (3)	GHR, GHIP	600946	5p13-p12	GHR
Increased responsiveness to growth hormone (3)	GHR, GHIP	600946	5p13-p12	GHIP
Infantile cerebellar-retinal degeneration, 614559 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ACO2
Infantile cerebellar-retinal degeneration, 614559 (3)	ACO2, ICRD, OPA9	100850	22q13.2	ICRD
Infantile cerebellar-retinal degeneration, 614559 (3)	ACO2, ICRD, OPA9	100850	22q13.2	OPA9
Infantile liver failure syndrome 2, 616483 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NBAS
Infantile liver failure syndrome 2, 616483 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NAG
Infantile liver failure syndrome 2, 616483 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	SOPH
Infantile liver failure syndrome 2, 616483 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	ILFS2
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	IPLA2
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	INAD1
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2B
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2A
Infantile neuroaxonal dystrophy 1, 256600 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PARK14
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	PTRH2, BIT1, IMNEPD	608625	17q23.1	PTRH2
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	PTRH2, BIT1, IMNEPD	608625	17q23.1	BIT1
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3)	PTRH2, BIT1, IMNEPD	608625	17q23.1	IMNEPD
Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations, 613759 (3)	FADD	602457	11q13.3	FADD
Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	CRFB4, IBD25	123889	21q22.11	CRFB4
Inflammatory bowel disease 25, early onset, autosomal recessive, 612567 (3)	CRFB4, IBD25	123889	21q22.11	IBD25
Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	IL10RA, IL10R, IBD28	146933	11q23.3	IL10RA
Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	IL10RA, IL10R, IBD28	146933	11q23.3	IL10R
Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3)	IL10RA, IL10R, IBD28	146933	11q23.3	IBD28
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Insensitivity to pain, congenital, 243000 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	NTRK1, TRKA, MTC	191315	1q23.1	NTRK1
Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	NTRK1, TRKA, MTC	191315	1q23.1	TRKA
Insensitivity to pain, congenital, with anhidrosis, 256800 (3)	NTRK1, TRKA, MTC	191315	1q23.1	MTC
Insomnia, fatal familial, 600072 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Insomnia, fatal familial, 600072 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Insomnia, fatal familial, 600072 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Insomnia, fatal familial, 600072 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Insulin resistance, severe, digenic, 125853 (3)	PPP1R3A, PPP1R3	600917	7q31.1	PPP1R3A
Insulin resistance, severe, digenic, 125853 (3)	PPP1R3A, PPP1R3	600917	7q31.1	PPP1R3
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
Insulin resistance, severe, digenic, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
Insulin-like growth factor I, resistance to, 270450 (3)	IGF1R	147370	15q26.3	IGF1R
Insulinoma (1)	ITS	606960	22q12.1-q12.2	ITS
Interferon, alpha, deficiency (1)	IFNA1, IFNA@	147660	9p21.3	IFNA1
Interferon, alpha, deficiency (1)	IFNA1, IFNA@	147660	9p21.3	IFNA@
Interleukin 1 receptor antagonist deficiency, 612852 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
Interleukin 1 receptor antagonist deficiency, 612852 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	MVCD4
Interleukin 1 receptor antagonist deficiency, 612852 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	DIRA
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MARS
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	MTRNS
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	METRS
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	ILLD
Interstitial lung and liver disease, 615486 (3)	MARS, MTRNS, METRS, ILLD, CMT2U	156560	12q13.3	CMT2U
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	ITGA3, CD49C, GAPB3, ILNEB	605025	17q21.33	ITGA3
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	ITGA3, CD49C, GAPB3, ILNEB	605025	17q21.33	CD49C
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	ITGA3, CD49C, GAPB3, ILNEB	605025	17q21.33	GAPB3
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3)	ITGA3, CD49C, GAPB3, ILNEB	605025	17q21.33	ILNEB
Interstitial nephritis, karyomegalic, 614817 (3)	FAN1, MTMR15, KIAA1018, KMIN	613534	15q13.3	FAN1
Interstitial nephritis, karyomegalic, 614817 (3)	FAN1, MTMR15, KIAA1018, KMIN	613534	15q13.3	MTMR15
Interstitial nephritis, karyomegalic, 614817 (3)	FAN1, MTMR15, KIAA1018, KMIN	613534	15q13.3	KIAA1018
Interstitial nephritis, karyomegalic, 614817 (3)	FAN1, MTMR15, KIAA1018, KMIN	613534	15q13.3	KMIN
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Intestinal pseudoobstruction, neuronal, 300048 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Intrinsic factor deficiency, 261000 (3)	GIF, IF	609342	11q12.1	GIF
Intrinsic factor deficiency, 261000 (3)	GIF, IF	609342	11q12.1	IF
Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	IRAK4, REN64, IPD1	606883	12q12	IRAK4
Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	IRAK4, REN64, IPD1	606883	12q12	REN64
Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3)	IRAK4, REN64, IPD1	606883	12q12	IPD1
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IKBKG
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	NEMO
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	FIP3
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IP
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IPD2
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	AMCBX1
Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3)	IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33	300248	Xq28	IMD33
Iridogoniodysgenesis, type 1, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FOXC1
Iridogoniodysgenesis, type 1, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FKHL7
Iridogoniodysgenesis, type 1, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FREAC3
Iridogoniodysgenesis, type 1, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	IRID1
Iridogoniodysgenesis, type 1, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	RIEG3
Iridogoniodysgenesis, type 2, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	PITX2
Iridogoniodysgenesis, type 2, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IDG2
Iridogoniodysgenesis, type 2, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RIEG1
Iridogoniodysgenesis, type 2, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RGS
Iridogoniodysgenesis, type 2, 137600 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IGDS2
Iris hypoplasia and glaucoma, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FOXC1
Iris hypoplasia and glaucoma, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FKHL7
Iris hypoplasia and glaucoma, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FREAC3
Iris hypoplasia and glaucoma, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	IRID1
Iris hypoplasia and glaucoma, 601631 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	RIEG3
Iron-refractory iron deficiency anemia, 206200 (3)	TMPRSS6, IRIDA	609862	22q12.3	TMPRSS6
Iron-refractory iron deficiency anemia, 206200 (3)	TMPRSS6, IRIDA	609862	22q12.3	IRIDA
Ischiocoxopodopatellar syndrome, 147891 (3)	TBX4, ICPPS	601719	17q23.2	TBX4
Ischiocoxopodopatellar syndrome, 147891 (3)	TBX4, ICPPS	601719	17q23.2	ICPPS
Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)	ACAD8	604773	11q25	ACAD8
Isovaleric acidemia, 243500 (3)	IVD	607036	15q15.1	IVD
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Jackson-Weiss syndrome, 123150 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Jackson-Weiss syndrome, 123150 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Jacobsen syndrome (4)	JBS	147791	11q23	JBS
Jalili syndrome, 217080 (3)	CNNM4, ACDP4	607805	2q11.2	CNNM4
Jalili syndrome, 217080 (3)	CNNM4, ACDP4	607805	2q11.2	ACDP4
Jawad syndrome, 251255 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Jawad syndrome, 251255 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RIM
Jawad syndrome, 251255 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	SCKL2
Jawad syndrome, 251255 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	JWDS
Jervell and Lange-Nielsen syndrome 2, 612347 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	KCNE1
Jervell and Lange-Nielsen syndrome 2, 612347 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	JLNS
Jervell and Lange-Nielsen syndrome 2, 612347 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	LQT5
Jervell and Lange-Nielsen syndrome 2, 612347 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	JLNS2
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNA9
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	LQT1
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KVLQT1
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	ATFB3
Jervell and Lange-Nielsen syndrome, 220400 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	SQT2
Johanson-Blizzard syndrome, 243800 (3)	UBR1, JBS	605981	15q15.2	UBR1
Johanson-Blizzard syndrome, 243800 (3)	UBR1, JBS	605981	15q15.2	JBS
Joubert syndrome 1, 213300 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	INPP5E
Joubert syndrome 1, 213300 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	MORMS
Joubert syndrome 1, 213300 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	JBTS1
Joubert syndrome 1, 213300 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	CORS1
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	CXorf5
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	SGBS2
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	JBTS10
Joubert syndrome 10, 300804 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	RP23
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	KIF7
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	HLS2
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	ACLS
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	JBTS12
Joubert syndrome 12, 200990 (3)	KIF7, HLS2, ACLS, JBTS12, AGBK	611254	15q26.1	AGBK
Joubert syndrome 13, 614173 (3)	TECT1, JBTS13	609863	12q24.11	TECT1
Joubert syndrome 13, 614173 (3)	TECT1, JBTS13	609863	12q24.11	JBTS13
Joubert syndrome 14, 614424 (3)	TMEM237, ALS2CR4, JBTS14	614423	2q33.1	TMEM237
Joubert syndrome 14, 614424 (3)	TMEM237, ALS2CR4, JBTS14	614423	2q33.1	ALS2CR4
Joubert syndrome 14, 614424 (3)	TMEM237, ALS2CR4, JBTS14	614423	2q33.1	JBTS14
Joubert syndrome 15, 614464 (3)	CEP41, TSGA14, JBTS15	610523	7q32.2	CEP41
Joubert syndrome 15, 614464 (3)	CEP41, TSGA14, JBTS15	610523	7q32.2	TSGA14
Joubert syndrome 15, 614464 (3)	CEP41, TSGA14, JBTS15	610523	7q32.2	JBTS15
Joubert syndrome 16, 614465 (3)	TMEM138, JBTS16	614459	11q12.2	TMEM138
Joubert syndrome 16, 614465 (3)	TMEM138, JBTS16	614459	11q12.2	JBTS16
Joubert syndrome 17, 614615 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	C5orf42
Joubert syndrome 17, 614615 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	JBTS17
Joubert syndrome 17, 614615 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	OFD6
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TCTN3
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TECT3
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	C10orf61
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	OFD4
Joubert syndrome 18, 614815 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	JBTS18
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZNF423
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZFP423
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	OAZ
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	KIAA0760
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	NPHP14
Joubert syndrome 19, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	JBTS19
Joubert syndrome 2, 608091 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	TMEM216
Joubert syndrome 2, 608091 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	JBTS2
Joubert syndrome 2, 608091 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	CORS2
Joubert syndrome 2, 608091 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	MKS2
Joubert syndrome 20, 614970 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	TMEM231
Joubert syndrome 20, 614970 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	JBTS20
Joubert syndrome 20, 614970 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	MKS11
Joubert syndrome 21, 615636 (3)	CSPP1, CSPP, JBTS21	611654	8q13.1-q13.2	CSPP1
Joubert syndrome 21, 615636 (3)	CSPP1, CSPP, JBTS21	611654	8q13.1-q13.2	CSPP
Joubert syndrome 21, 615636 (3)	CSPP1, CSPP, JBTS21	611654	8q13.1-q13.2	JBTS21
Joubert syndrome 23, 616490 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	KIAA0586
Joubert syndrome 23, 616490 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	TALPID3
Joubert syndrome 23, 616490 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	JBTS23
Joubert syndrome 23, 616490 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	SRTD14
Joubert syndrome 24, 616654 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TCTN2
Joubert syndrome 24, 616654 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	TECT2
Joubert syndrome 24, 616654 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	MKS8
Joubert syndrome 24, 616654 (3)	TCTN2, TECT2, MKS8, JBTS24	613846	12q24.31	JBTS24
Joubert syndrome 25, 616781 (3)	CEP104, GLYBP, KIAA0562, JBTS25	616690	1p36.32	CEP104
Joubert syndrome 25, 616781 (3)	CEP104, GLYBP, KIAA0562, JBTS25	616690	1p36.32	GLYBP
Joubert syndrome 25, 616781 (3)	CEP104, GLYBP, KIAA0562, JBTS25	616690	1p36.32	KIAA0562
Joubert syndrome 25, 616781 (3)	CEP104, GLYBP, KIAA0562, JBTS25	616690	1p36.32	JBTS25
Joubert syndrome 4, 609583 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Joubert syndrome 4, 609583 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPH1
Joubert syndrome 4, 609583 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	SLSN1
Joubert syndrome 4, 609583 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	JBTS4
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	KIAA0373
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	3H11AG
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	JBTS5
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	SLSN6
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	LCA10
Joubert syndrome 5, 610188 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	BBS14
Joubert syndrome 6, 610688 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Joubert syndrome 6, 610688 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	MKS3
Joubert syndrome 6, 610688 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	JBTS6
Joubert syndrome 6, 610688 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	NPHP11
Joubert syndrome 7, 611560 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
Joubert syndrome 7, 611560 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	KIAA1005
Joubert syndrome 7, 611560 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	JBTS7
Joubert syndrome 7, 611560 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	MKS5
Joubert syndrome 8, 612291 (3)	ARL13B, ARL2L1, JBTS8	608922	3q11.1-q11.2	ARL13B
Joubert syndrome 8, 612291 (3)	ARL13B, ARL2L1, JBTS8	608922	3q11.1-q11.2	ARL2L1
Joubert syndrome 8, 612291 (3)	ARL13B, ARL2L1, JBTS8	608922	3q11.1-q11.2	JBTS8
Joubert syndrome 9, 612285 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
Joubert syndrome 9, 612285 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	KIAA1345
Joubert syndrome 9, 612285 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	MKS6
Joubert syndrome-3, 608629 (3)	AHI1	608894	6q23.3	AHI1
Juvenile polyposis syndrome, infantile form, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Juvenile polyposis syndrome, infantile form, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ACVRLK3
Juvenile polyposis syndrome, infantile form, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ALK3
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MADH4
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	DPC4
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	JIP
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MYHRS
KBG syndrome, 148050 (3)	ANKRD11, ANCO1, KBGS	611192	16q24.3	ANKRD11
KBG syndrome, 148050 (3)	ANKRD11, ANCO1, KBGS	611192	16q24.3	ANCO1
KBG syndrome, 148050 (3)	ANKRD11, ANCO1, KBGS	611192	16q24.3	KBGS
Kabuki syndrome 1, 147920 (3)	KMT2D, MLL2, ALR, KABUK1	602113	12q13.12	KMT2D
Kabuki syndrome 1, 147920 (3)	KMT2D, MLL2, ALR, KABUK1	602113	12q13.12	MLL2
Kabuki syndrome 1, 147920 (3)	KMT2D, MLL2, ALR, KABUK1	602113	12q13.12	ALR
Kabuki syndrome 1, 147920 (3)	KMT2D, MLL2, ALR, KABUK1	602113	12q13.12	KABUK1
Kabuki syndrome 2, 300867 (3)	KDM6A, UTX, KABUK2	300128	Xp11.3	KDM6A
Kabuki syndrome 2, 300867 (3)	KDM6A, UTX, KABUK2	300128	Xp11.3	UTX
Kabuki syndrome 2, 300867 (3)	KDM6A, UTX, KABUK2	300128	Xp11.3	KABUK2
Kagami-Ogata syndrome (4)	KAOGS	608149	14q32	KAOGS
Kahrizi syndrome, 612713 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A3
Kahrizi syndrome, 612713 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	SRD5A2L
Kahrizi syndrome, 612713 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	CDG1Q
Kahrizi syndrome, 612713 (3)	SRD5A3, SRD5A2L, CDG1Q, KRIZI	611715	4q12	KRIZI
Kanzaki disease, 609242 (3)	NAGA	104170	22q13.2	NAGA
Kappa light chain deficiency, 614102 (3)	IGKC, IGKCD	147200	2p11.2	IGKC
Kappa light chain deficiency, 614102 (3)	IGKC, IGKCD	147200	2p11.2	IGKCD
Kaufman oculocerebrofacial syndrome, 244450 (3)	UBE3B, BPIDS, KOS	608047	12q24.11	UBE3B
Kaufman oculocerebrofacial syndrome, 244450 (3)	UBE3B, BPIDS, KOS	608047	12q24.11	BPIDS
Kaufman oculocerebrofacial syndrome, 244450 (3)	UBE3B, BPIDS, KOS	608047	12q24.11	KOS
Kenny-Caffey syndrome, type 1, 244460 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	TBCE
Kenny-Caffey syndrome, type 1, 244460 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	KCS
Kenny-Caffey syndrome, type 1, 244460 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	KCS1
Kenny-Caffey syndrome, type 1, 244460 (3)	TBCE, KCS, KCS1, HRD	604934	1q42.3	HRD
Kenny-Caffey syndrome, type 2, 127000 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	FAM111A
Kenny-Caffey syndrome, type 2, 127000 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	KIAA1895
Kenny-Caffey syndrome, type 2, 127000 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	KCS2
Kenny-Caffey syndrome, type 2, 127000 (3)	FAM111A, KIAA1895, KCS2, GCLEB	615292	11q12.1	GCLEB
Keppen-Lubinsky syndrome, 614098 (3)	KCNJ6, GIRK2, KCNJ7, KPLBS	600877	21q22.13	KCNJ6
Keppen-Lubinsky syndrome, 614098 (3)	KCNJ6, GIRK2, KCNJ7, KPLBS	600877	21q22.13	GIRK2
Keppen-Lubinsky syndrome, 614098 (3)	KCNJ6, GIRK2, KCNJ7, KPLBS	600877	21q22.13	KCNJ7
Keppen-Lubinsky syndrome, 614098 (3)	KCNJ6, GIRK2, KCNJ7, KPLBS	600877	21q22.13	KPLBS
Keratitis, 148190 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Keratitis, 148190 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Keratitis, 148190 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Keratitis, 148190 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Keratitis-ichthyosis-deafness syndrome, 148210 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
Keratoconus 1, 148300 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	VSX1
Keratoconus 1, 148300 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	RINX
Keratoconus 1, 148300 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	KTCN1
Keratoconus 1, 148300 (3)	VSX1, RINX, KTCN1, CAASDS	605020	20p11.21	CAASDS
Keratoconus 2 (2)	KTCN2	608932	16q22.3-q23.1	KTCN2
Keratoconus 3 (2)	KTCN3	608586	3p14-q13	KTCN3
Keratoconus 4 (2)	KTCN4	609271	2p24	KTCN4
Keratoconus 5 (2)	KTCN5	614622	5q14.1-q21.3	KTCN5
Keratoconus 6 (2)	KTCN6	614623	9q34	KTCN6
Keratoconus 7 (2)	KTCN7	614629	13q32	KTCN7
Keratoconus 8 (2)	KTCN8	614628	14q24.3	KTCN8
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	AAGAB
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	p34
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	PPKP1A
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	PPKP1
Keratoderma, palmoplantar, punctate type IA, 148600 (3)	AAGAB, p34, PPKP1A, PPKP1, KPPP1	614888	15q23	KPPP1
Keratoderma, palmoplantar, punctate type IB (2)	PPKP1B	614936	8q24.13-q24.21	PPKP1B
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Keratoderma, palmoplantar, with deafness, 148350 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
Keratolytic winter erythema (2)	KWE	148370	8p23-p22	KWE
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	MBTPS2
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	S2P
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	IFAP
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	KFSDX
Keratosis follicularis spinulosa decalvans, X-linked, 308800 (3)	MBTPS2, S2P, IFAP, KFSDX, OLMSX	300294	Xp22.12	OLMSX
Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	POMP, UMP1	613386	13q12.3	POMP
Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3)	POMP, UMP1	613386	13q12.3	UMP1
Keratosis palmoplantaris striata I, AD, 148700 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	DSG1
Keratosis palmoplantaris striata I, AD, 148700 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	PPKS1
Keratosis palmoplantaris striata I, AD, 148700 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	SPPK1
Keratosis palmoplantaris striata I, AD, 148700 (3)	DSG1, PPKS1, SPPK1, EPKHE	125670	18q12.1	EPKHE
Keratosis palmoplantaris striata II, 612908 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Keratosis palmoplantaris striata II, 612908 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Keratosis palmoplantaris striata II, 612908 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Keratosis palmoplantaris striata II, 612908 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Keratosis palmoplantaris striata III, 607654 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Keratosis palmoplantaris striata III, 607654 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Keratosis palmoplantaris striata III, 607654 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Keratosis palmoplantaris striata III, 607654 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Keratosis, seborrheic, somatic, 182000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Keutel syndrome, 245150 (3)	MGP	154870	12p12.3	MGP
Kindler syndrome, 173650 (3)	KIND1, URP1, C20orf42	607900	20p12.3	KIND1
Kindler syndrome, 173650 (3)	KIND1, URP1, C20orf42	607900	20p12.3	URP1
Kindler syndrome, 173650 (3)	KIND1, URP1, C20orf42	607900	20p12.3	C20orf42
King-Denborough syndrome, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
King-Denborough syndrome, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	MHS
King-Denborough syndrome, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	CCO
Kleefstra syndrome, 610253 (3)	EHMT1, EUHMTASE1, DEL9q34	607001	9q34.3	EHMT1
Kleefstra syndrome, 610253 (3)	EHMT1, EUHMTASE1, DEL9q34	607001	9q34.3	EUHMTASE1
Kleefstra syndrome, 610253 (3)	EHMT1, EUHMTASE1, DEL9q34	607001	9q34.3	DEL9q34
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOP4
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	KFS1
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOPCB6
Klippel-Feil syndrome 1, autosomal dominant, 118100 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	LCA17
Klippel-Feil syndrome 2, 214300 (3)	MEOX1, MOX1, KFS2	600147	17q21.31	MEOX1
Klippel-Feil syndrome 2, 214300 (3)	MEOX1, MOX1, KFS2	600147	17q21.31	MOX1
Klippel-Feil syndrome 2, 214300 (3)	MEOX1, MOX1, KFS2	600147	17q21.31	KFS2
Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	KFS3
Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOPCB6
Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOP7
Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	MYO18B, KFS4	607295	22q12.1	MYO18B
Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3)	MYO18B, KFS4	607295	22q12.1	KFS4
Klippel-Trenaunay-Weber syndrome (2)	KTWS, KTS	149000	8q22.3	KTWS
Klippel-Trenaunay-Weber syndrome (2)	KTWS, KTS	149000	8q22.3	KTS
Kniest dysplasia, 156550 (3)	COL2A1	120140	12q13.11	COL2A1
Knobloch syndrome, type 1, 267750 (3)	COL18A1, KNO1	120328	21q22.3	COL18A1
Knobloch syndrome, type 1, 267750 (3)	COL18A1, KNO1	120328	21q22.3	KNO1
Kohlschutter-Tonz syndrome, 226750 (3)	ROGDI, KTZS	614574	16p13.3	ROGDI
Kohlschutter-Tonz syndrome, 226750 (3)	ROGDI, KTZS	614574	16p13.3	KTZS
Kondoh syndrome (2)	KONDS	606242	1p36.32-p35.3	KONDS
Koolen-De Vries syndrome, 610443 (3)	KANSL1, KIAA1267, MSL1V1, KDVS	612452	17q21.31	KANSL1
Koolen-De Vries syndrome, 610443 (3)	KANSL1, KIAA1267, MSL1V1, KDVS	612452	17q21.31	KIAA1267
Koolen-De Vries syndrome, 610443 (3)	KANSL1, KIAA1267, MSL1V1, KDVS	612452	17q21.31	MSL1V1
Koolen-De Vries syndrome, 610443 (3)	KANSL1, KIAA1267, MSL1V1, KDVS	612452	17q21.31	KDVS
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFR
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IBGC4
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IMF1
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PENTT
Kosaki overgrowth syndrome, 616592 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	KOGS
Kowarski syndrome, 262650 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GH1
Kowarski syndrome, 262650 (3)	GH1, GHN, IGHD1B	139250	17q23.3	GHN
Kowarski syndrome, 262650 (3)	GH1, GHN, IGHD1B	139250	17q23.3	IGHD1B
Krabbe disease, 245200 (3)	GALC	606890	14q31.3	GALC
Krabbe disease, atypical, 611722 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Krabbe disease, atypical, 611722 (3)	PSAP, SAP1	176801	10q22.1	SAP1
Kufor-Rakeb syndrome, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	ATP13A2
Kufor-Rakeb syndrome, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	PARK9
Kufor-Rakeb syndrome, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	KRPPD
Kufor-Rakeb syndrome, 606693 (3)	ATP13A2, PARK9, KRPPD, CLN12	610513	1p36.13	CLN12
Kyphoscoliosis 1 (2)	KYPSC1	610170	5p13	KYPSC1
L-2-hydroxyglutaric aciduria, 236792 (3)	L2HGDH, C14orf160, L2HGA	609584	14q21.3	L2HGDH
L-2-hydroxyglutaric aciduria, 236792 (3)	L2HGDH, C14orf160, L2HGA	609584	14q21.3	C14orf160
L-2-hydroxyglutaric aciduria, 236792 (3)	L2HGDH, C14orf160, L2HGA	609584	14q21.3	L2HGA
L-ferritin deficiency, dominant and recessive, 615604 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
L-ferritin deficiency, dominant and recessive, 615604 (3)	FTL, NBIA3, LFTD	134790	19q13.33	NBIA3
L-ferritin deficiency, dominant and recessive, 615604 (3)	FTL, NBIA3, LFTD	134790	19q13.33	LFTD
LADD syndrome, 149730 (3)	FGF10	602115	5p12	FGF10
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
LADD syndrome, 149730 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
LADD syndrome, 149730 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
LADD syndrome, 149730 (3)	FGFR3, ACH	134934	4p16.3	ACH
LCHAD deficiency, 609016 (3)	HADHA, MTPA	600890	2p23.3	HADHA
LCHAD deficiency, 609016 (3)	HADHA, MTPA	600890	2p23.3	MTPA
LDL cholesterol level QTL2, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLR
LDL cholesterol level QTL2, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	FHC
LDL cholesterol level QTL2, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	FH
LDL cholesterol level QTL2, 143890 (3)	LDLR, FHC, FH, LDLCQ2	606945	19p13.2	LDLCQ2
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTP2C
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	SHP2
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	NS1
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	JMML
LEOPARD syndrome 1, 151100 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	METCDS
LEOPARD syndrome 2, 611554 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
LEOPARD syndrome 2, 611554 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CRAF
LEOPARD syndrome 2, 611554 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	NS5
LEOPARD syndrome 2, 611554 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CMD1NN
LEOPARD syndrome 3, 613707 (3)	BRAF, NS7	164757	7q34	BRAF
LEOPARD syndrome 3, 613707 (3)	BRAF, NS7	164757	7q34	NS7
LIG4 syndrome, 606593 (3)	LIG4, LIG4S	601837	13q33.3	LIG4
LIG4 syndrome, 606593 (3)	LIG4, LIG4S	601837	13q33.3	LIG4S
Lactase deficiency, congenital, 223000 (3)	LCT, LAC, LPH	603202	2q21.3	LCT
Lactase deficiency, congenital, 223000 (3)	LCT, LAC, LPH	603202	2q21.3	LAC
Lactase deficiency, congenital, 223000 (3)	LCT, LAC, LPH	603202	2q21.3	LPH
Lactase persistence/nonpersistence, 223100 (3)	MCM6	601806	2q21.3	MCM6
Lacticacidemia due to PDX1 deficiency, 245349 (3)	PDX1	608769	11p13	PDX1
Lamb-Shaffer syndrome, 616803 (3)	SOX5, LAMSHF	604975	12p12.1	SOX5
Lamb-Shaffer syndrome, 616803 (3)	SOX5, LAMSHF	604975	12p12.1	LAMSHF
Langer mesomelic dysplasia, 249700 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Langer mesomelic dysplasia, 249700 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	GCFX
Langer mesomelic dysplasia, 249700 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SS
Langer mesomelic dysplasia, 249700 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	PHOG
Langer mesomelic dysplasia, 249700 (3)	SHOXY	400020	Yp11.2	SHOXY
Laron dwarfism, 262500 (3)	GHR, GHIP	600946	5p13-p12	GHR
Laron dwarfism, 262500 (3)	GHR, GHIP	600946	5p13-p12	GHIP
Larsen syndrome, 150250 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Larsen syndrome, 150250 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	SCT
Larsen syndrome, 150250 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	AOI
Larsen syndrome, 150250 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	LRS1
Larsen-like syndrome (2)	LRSL	608545	6p25	LRSL
Laryngoonychocutaneous syndrome, 245660 (3)	LAMA3, LOCS	600805	18q11.2	LAMA3
Laryngoonychocutaneous syndrome, 245660 (3)	LAMA3, LOCS	600805	18q11.2	LOCS
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	NOTCH3
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CADASIL1
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	CASIL
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	IMF2
Lateral meningocele syndrome, 130720 (3)	NOTCH3, CADASIL1, CASIL, IMF2, LMNS	600276	19p13.12	LMNS
Lathosterolosis, 607330 (3)	SC5DL, ERG3	602286	11q23.3-q24.1	SC5DL
Lathosterolosis, 607330 (3)	SC5DL, ERG3	602286	11q23.3-q24.1	ERG3
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Laurin-Sandrow syndrome, 135750 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	GUCY2D
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	GUC2D
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	LCA1
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	CORD6
Leber congenital amaurosis 1, 204000 (3)	GUCY2D, GUC2D, LCA1, CORD6, RCD2	600179	17p13.1	RCD2
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	KIAA0373
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	3H11AG
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	JBTS5
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	SLSN6
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	LCA10
Leber congenital amaurosis 10, 611755 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	BBS14
Leber congenital amaurosis 11, 613837 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	IMPDH1
Leber congenital amaurosis 11, 613837 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	RP10
Leber congenital amaurosis 11, 613837 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	LCA11
Leber congenital amaurosis 12, 610612 (3)	RD3, LCA12, C1orf36	180040	1q32.3	RD3
Leber congenital amaurosis 12, 610612 (3)	RD3, LCA12, C1orf36	180040	1q32.3	LCA12
Leber congenital amaurosis 12, 610612 (3)	RD3, LCA12, C1orf36	180040	1q32.3	C1orf36
Leber congenital amaurosis 13, 612712 (3)	RDH12, LCA13	608830	14q24.1	RDH12
Leber congenital amaurosis 13, 612712 (3)	RDH12, LCA13	608830	14q24.1	LCA13
Leber congenital amaurosis 14, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Leber congenital amaurosis 14, 613341 (3)	LRAT, LCA14	604863	4q32.1	LCA14
Leber congenital amaurosis 15, 613843 (3)	TULP1, RP14, LCA15	602280	6p21.31	TULP1
Leber congenital amaurosis 15, 613843 (3)	TULP1, RP14, LCA15	602280	6p21.31	RP14
Leber congenital amaurosis 15, 613843 (3)	TULP1, RP14, LCA15	602280	6p21.31	LCA15
Leber congenital amaurosis 16, 614186 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	KCNJ13
Leber congenital amaurosis 16, 614186 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	SVD
Leber congenital amaurosis 16, 614186 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	LCA16
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOP4
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	KFS1
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOPCB6
Leber congenital amaurosis 17, 615360 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	LCA17
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Leber congenital amaurosis 18, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Leber congenital amaurosis 2, 204100 (3)	RPE65, RP20, LCA2	180069	1p31.3	RPE65
Leber congenital amaurosis 2, 204100 (3)	RPE65, RP20, LCA2	180069	1p31.3	RP20
Leber congenital amaurosis 2, 204100 (3)	RPE65, RP20, LCA2	180069	1p31.3	LCA2
Leber congenital amaurosis 3, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	SPATA7
Leber congenital amaurosis 3, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	HSD3
Leber congenital amaurosis 3, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	LCA3
Leber congenital amaurosis 4, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Leber congenital amaurosis 4, 604393 (3)	AIPL1, LCA4	604392	17p13.2	LCA4
Leber congenital amaurosis 5, 604537 (3)	LCA5, C6orf152	611408	6q14.1	LCA5
Leber congenital amaurosis 5, 604537 (3)	LCA5, C6orf152	611408	6q14.1	C6orf152
Leber congenital amaurosis 6, 613826 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	RPGRIP1
Leber congenital amaurosis 6, 613826 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	LCA6
Leber congenital amaurosis 6, 613826 (3)	RPGRIP1, LCA6, CORD13	605446	14q11.2	CORD13
Leber congenital amaurosis 7, 613829 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRX
Leber congenital amaurosis 7, 613829 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CORD2
Leber congenital amaurosis 7, 613829 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	CRD
Leber congenital amaurosis 7, 613829 (3)	CRX, CORD2, CRD, LCA7	602225	19q13.33	LCA7
Leber congenital amaurosis 8, 613835 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Leber congenital amaurosis 8, 613835 (3)	CRB1, RP12, LCA8	604210	1q31.3	RP12
Leber congenital amaurosis 8, 613835 (3)	CRB1, RP12, LCA8	604210	1q31.3	LCA8
Leber congenital amaurosis 9, 608553 (3)	NMNAT1, NMNAT, PNAT1, LCA9	608700	1p36.22	NMNAT1
Leber congenital amaurosis 9, 608553 (3)	NMNAT1, NMNAT, PNAT1, LCA9	608700	1p36.22	NMNAT
Leber congenital amaurosis 9, 608553 (3)	NMNAT1, NMNAT, PNAT1, LCA9	608700	1p36.22	PNAT1
Leber congenital amaurosis 9, 608553 (3)	NMNAT1, NMNAT, PNAT1, LCA9	608700	1p36.22	LCA9
Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1	DTNA
Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1	D18S892E
Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1	DRP3
Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3)	DTNA, D18S892E, DRP3, LVNC1	601239	18q12.1	LVNC1
Left ventricular noncompaction 10, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	MYBPC3
Left ventricular noncompaction 10, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMH4
Left ventricular noncompaction 10, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	CMD1MM
Left ventricular noncompaction 10, 615396 (3)	MYBPC3, CMH4, CMD1MM, LVNC10	600958	11p11.2	LVNC10
Left ventricular noncompaction 2 (2)	LVNC2	609470	11p15	LVNC2
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	ZASP
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CYPHER
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	KIAA01613
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	MFM4
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMD1C
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMH24
Left ventricular noncompaction 3, 601493 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LVNC3
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ACTC1
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMD1R
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	CMH11
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	ASD5
Left ventricular noncompaction 4, 613424 (3)	ACTC1, CMD1R, CMH11, ASD5, LVNC4	102540	15q14	LVNC4
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Left ventricular noncompaction 5, 613426 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	TNNT2
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMH2
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	CMD1D
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	RCM3
Left ventricular noncompaction 6, 601494 (3)	TNNT2, CMH2, CMD1D, RCM3, LVNC6	191045	1q32.1	LVNC6
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	MIB1
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	MIB
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	DIP1
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	KIAA1323
Left ventricular noncompaction 7, 615092 (3)	MIB1, MIB, DIP1, KIAA1323, LVNC7	608677	18q11.2	LVNC7
Left ventricular noncompaction 8, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	PRDM16
Left ventricular noncompaction 8, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	MEL1
Left ventricular noncompaction 8, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	LVNC8
Left ventricular noncompaction 8, 615373 (3)	PRDM16, MEL1, LVNC8, CMD1LL	605557	1p36.32	CMD1LL
Left ventricular noncompaction 9, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	TPM1
Left ventricular noncompaction 9, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMH3
Left ventricular noncompaction 9, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	CMD1Y
Left ventricular noncompaction 9, 611878 (3)	TPM1, CMH3, CMD1Y , LVNC9	191010	15q22.2	LVNC9
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	EBAF
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	TGFB4
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	LEFTY2
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	LEFTA
Left-right axis malformations (3)	EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA	601877	1q42.12	LEFTYA
Legg-Calve-Perthes disease, 150600 (3)	COL2A1	120140	12q13.11	COL2A1
Legius syndrome, 611431 (3)	SPRED1, NFLS	609291	15q14	SPRED1
Legius syndrome, 611431 (3)	SPRED1, NFLS	609291	15q14	NFLS
Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)	COX15, CEMCOX2	603646	10q24.2	COX15
Leigh syndrome due to cytochrome c oxidase deficiency, 256000 (3)	COX15, CEMCOX2	603646	10q24.2	CEMCOX2
Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3)	COX10	602125	17p12	COX10
Leigh syndrome due to mitochondrial complex 1 deficiency, 256000 (3)	NDUFA12	614530	12q22	NDUFA12
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	FOXRED1	613622	11q24.2	FOXRED1
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFA2	602137	5q31.3	NDUFA2
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFA9	603834	12p13.32	NDUFA9
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFAF6, C8orf38	612392	8q22.1	NDUFAF6
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFAF6, C8orf38	612392	8q22.1	C8orf38
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFS3	603846	11p11.2	NDUFS3
Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)	NDUFS8	602141	11q13.2	NDUFS8
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	FLNMS
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	GRACILE
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BJS
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	PTD
Leigh syndrome, 256000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	MC3DN1
Leigh syndrome, 256000 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFAF2
Leigh syndrome, 256000 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFA12L
Leigh syndrome, 256000 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	MMTN
Leigh syndrome, 256000 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	B17.2L
Leigh syndrome, 256000 (3)	NDUFS4, AQDQ	602694	5q11.2	NDUFS4
Leigh syndrome, 256000 (3)	NDUFS4, AQDQ	602694	5q11.2	AQDQ
Leigh syndrome, 256000 (3)	NDUFS7, PSST	601825	19p13.3	NDUFS7
Leigh syndrome, 256000 (3)	NDUFS7, PSST	601825	19p13.3	PSST
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDH1
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHF
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	CMD1GG
Leigh syndrome, 256000 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	PGL5
Leigh syndrome, French-Canadian type, 220111 (3)	LRPPRC, LRP130, LSFC	607544	2p21	LRPPRC
Leigh syndrome, French-Canadian type, 220111 (3)	LRPPRC, LRP130, LSFC	607544	2p21	LRP130
Leigh syndrome, French-Canadian type, 220111 (3)	LRPPRC, LRP130, LSFC	607544	2p21	LSFC
Leigh syndrome, due to COX IV deficiency, 256000 (3)	SURF1, CMT4K	185620	9q34.2	SURF1
Leigh syndrome, due to COX IV deficiency, 256000 (3)	SURF1, CMT4K	185620	9q34.2	CMT4K
Leiomyoma, uterine, somatic, 150699 (1)	HMGA2, HMGIC, BABL	600698	12q14.3	HMGA2
Leiomyoma, uterine, somatic, 150699 (1)	HMGA2, HMGIC, BABL	600698	12q14.3	HMGIC
Leiomyoma, uterine, somatic, 150699 (1)	HMGA2, HMGIC, BABL	600698	12q14.3	BABL
Leiomyomatosis and renal cell cancer, 150800 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FH
Leiomyomatosis and renal cell cancer, 150800 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	HLRCC
Leiomyomatosis and renal cell cancer, 150800 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	MCUL1
Leiomyomatosis and renal cell cancer, 150800 (3)	FH, HLRCC, MCUL1, FMRD	136850	1q43	FMRD
Lenz-Majewski hyperostotic dwarfism, 151050 (3)	PTDSS1, PSS1, KIAA0024, LMHD	612792	8q22.1	PTDSS1
Lenz-Majewski hyperostotic dwarfism, 151050 (3)	PTDSS1, PSS1, KIAA0024, LMHD	612792	8q22.1	PSS1
Lenz-Majewski hyperostotic dwarfism, 151050 (3)	PTDSS1, PSS1, KIAA0024, LMHD	612792	8q22.1	KIAA0024
Lenz-Majewski hyperostotic dwarfism, 151050 (3)	PTDSS1, PSS1, KIAA0024, LMHD	612792	8q22.1	LMHD
Leprechaunism, 246200 (3)	INSR, HHF5	147670	19p13.2	INSR
Leprechaunism, 246200 (3)	INSR, HHF5	147670	19p13.2	HHF5
Leri pleonosteosis chromosome duplication syndrome (4)	DUP8q22.1, C8DUPq22.1	151200	8q22.1	DUP8q22.1
Leri pleonosteosis chromosome duplication syndrome (4)	DUP8q22.1, C8DUPq22.1	151200	8q22.1	C8DUPq22.1
Leri-Weill dyschondrosteosis, 127300 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Leri-Weill dyschondrosteosis, 127300 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	GCFX
Leri-Weill dyschondrosteosis, 127300 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SS
Leri-Weill dyschondrosteosis, 127300 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	PHOG
Leri-Weill dyschondrosteosis, 127300 (3)	SHOXY	400020	Yp11.2	SHOXY
Lesch-Nyhan syndrome, 300322 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT1
Lesch-Nyhan syndrome, 300322 (3)	HPRT1, HPRT	308000	Xq26.2-q26.3	HPRT
Lethal congenital contractural syndrome 2, 607598 (3)	ERBB3, LCCS2	190151	12q13.2	ERBB3
Lethal congenital contractural syndrome 2, 607598 (3)	ERBB3, LCCS2	190151	12q13.2	LCCS2
Lethal congenital contractural syndrome 3, 611369 (3)	PIP5K1C, LCCS3	606102	19p13.3	PIP5K1C
Lethal congenital contractural syndrome 3, 611369 (3)	PIP5K1C, LCCS3	606102	19p13.3	LCCS3
Lethal congenital contracture syndrome 1, 253310 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1
Lethal congenital contracture syndrome 1, 253310 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	GLE1L
Lethal congenital contracture syndrome 1, 253310 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	LCCS
Lethal congenital contracture syndrome 1, 253310 (3)	GLE1, GLE1L, LCCS, LCCS1	603371	9q34.11	LCCS1
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NERCC1
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	LCCS10
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	APUG
Lethal congenital contracture syndrome 10, 617022 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NC
Lethal congenital contracture syndrome 4, 614915 (3)	MYBPC1, LCCS4	160794	12q23.2	MYBPC1
Lethal congenital contracture syndrome 4, 614915 (3)	MYBPC1, LCCS4	160794	12q23.2	LCCS4
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDIB
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDI1
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMT2M
Lethal congenital contracture syndrome 5, 615368 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	LCCS5
Lethal congenital contracture syndrome 7, 616286 (3)	CNTNAP1, CASPR, P190	602346	17q21.2	CNTNAP1
Lethal congenital contracture syndrome 7, 616286 (3)	CNTNAP1, CASPR, P190	602346	17q21.2	CASPR
Lethal congenital contracture syndrome 7, 616286 (3)	CNTNAP1, CASPR, P190	602346	17q21.2	P190
Lethal congenital contracture syndrome 9, 616503 (3)	GPR126, VIGR, LCCS9	612243	6q24.2	GPR126
Lethal congenital contracture syndrome 9, 616503 (3)	GPR126, VIGR, LCCS9	612243	6q24.2	VIGR
Lethal congenital contracture syndrome 9, 616503 (3)	GPR126, VIGR, LCCS9	612243	6q24.2	LCCS9
Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)	ABL1	189980	9q34.12	ABL1
Leukemia, T-cell acute lymphoblastic (2)	LMO1, RBTN1, RHOM1	186921	11p15.4	LMO1
Leukemia, T-cell acute lymphoblastic (2)	LMO1, RBTN1, RHOM1	186921	11p15.4	RBTN1
Leukemia, T-cell acute lymphoblastic (2)	LMO1, RBTN1, RHOM1	186921	11p15.4	RHOM1
Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	NUP214
Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	D9S46E
Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	CAN
Leukemia, T-cell acute lymphoblastic, somatic, 613065 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	CAIN
Leukemia, T-cell acute lymphoblastoid (2)	LYL1	151440	19p13.13	LYL1
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL1, TCL5, SCL	187040	1p33	TAL1
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL1, TCL5, SCL	187040	1p33	TCL5
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL1, TCL5, SCL	187040	1p33	SCL
Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)	TAL2	186855	9q31.2	TAL2
Leukemia, acute T-cell (2)	LMO2, RBTNL1, RHOM2, TTG2	180385	11p13	LMO2
Leukemia, acute T-cell (2)	LMO2, RBTNL1, RHOM2, TTG2	180385	11p13	RBTNL1
Leukemia, acute T-cell (2)	LMO2, RBTNL1, RHOM2, TTG2	180385	11p13	RHOM2
Leukemia, acute T-cell (2)	LMO2, RBTNL1, RHOM2, TTG2	180385	11p13	TTG2
Leukemia, acute lymphoblastic (2)	LALL	247640	9p22-p21	LALL
Leukemia, acute lymphoblastic, 613065 (3)	NBN, NBS1	602667	8q21.3	NBN
Leukemia, acute lymphoblastic, 613065 (3)	NBN, NBS1	602667	8q21.3	NBS1
Leukemia, acute lymphoblastic, somatic, 613065 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute lymphoblastic, somatic, 613065 (3)	GNB1, MRD42	139380	1p36.33	GNB1
Leukemia, acute lymphoblastic, somatic, 613065 (3)	GNB1, MRD42	139380	1p36.33	MRD42
Leukemia, acute lymphocytic, somatic, 613065 (3)	BCR, CML, PHL, ALL	151410	22q11.23	BCR
Leukemia, acute lymphocytic, somatic, 613065 (3)	BCR, CML, PHL, ALL	151410	22q11.23	CML
Leukemia, acute lymphocytic, somatic, 613065 (3)	BCR, CML, PHL, ALL	151410	22q11.23	PHL
Leukemia, acute lymphocytic, somatic, 613065 (3)	BCR, CML, PHL, ALL	151410	22q11.23	ALL
Leukemia, acute myeloid, 601626 (1)	MLF1	601402	3q25.32	MLF1
Leukemia, acute myeloid, 601626 (1)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	NSD1
Leukemia, acute myeloid, 601626 (1)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	ARA267
Leukemia, acute myeloid, 601626 (1)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	STO
Leukemia, acute myeloid, 601626 (1)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	SOTOS1
Leukemia, acute myeloid, 601626 (1)	SH3GL1, EEN	601768	19p13.3	SH3GL1
Leukemia, acute myeloid, 601626 (1)	SH3GL1, EEN	601768	19p13.3	EEN
Leukemia, acute myeloid, 601626 (3)	AF10	602409	10p12.31	AF10
Leukemia, acute myeloid, 601626 (3)	KIT, PBT	164920	4q12	KIT
Leukemia, acute myeloid, 601626 (3)	KIT, PBT	164920	4q12	PBT
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Leukemia, acute myeloid, 601626 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Leukemia, acute myeloid, 601626 (3)	LPP	600700	3q27-q28	LPP
Leukemia, acute myeloid, 601626 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	RUNX1
Leukemia, acute myeloid, 601626 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	CBFA2
Leukemia, acute myeloid, 601626 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	AML1
Leukemia, acute myeloid, 601626 (3)	WHSC1L1, NSD3	607083	8p11.23	WHSC1L1
Leukemia, acute myeloid, 601626 (3)	WHSC1L1, NSD3	607083	8p11.23	NSD3
Leukemia, acute myeloid, reduced survival in, somatic, 601626 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute myeloid, somatic, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBPA
Leukemia, acute myeloid, somatic, 601626 (3)	CEBPA, CEBP	116897	19q13.11	CEBP
Leukemia, acute myeloid, somatic, 601626 (3)	ETV6, TEL, THC5	600618	12p13.2	ETV6
Leukemia, acute myeloid, somatic, 601626 (3)	ETV6, TEL, THC5	600618	12p13.2	TEL
Leukemia, acute myeloid, somatic, 601626 (3)	ETV6, TEL, THC5	600618	12p13.2	THC5
Leukemia, acute myeloid, somatic, 601626 (3)	FLT3	136351	13q12.2	FLT3
Leukemia, acute myeloid, somatic, 601626 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Leukemia, acute myeloid, somatic, 601626 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
Leukemia, acute myeloid, somatic, 601626 (3)	NPM1	164040	5q35.1	NPM1
Leukemia, acute myeloid, somatic, 601626 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	NUP214
Leukemia, acute myeloid, somatic, 601626 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	D9S46E
Leukemia, acute myeloid, somatic, 601626 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	CAN
Leukemia, acute myeloid, somatic, 601626 (3)	NUP214, D9S46E, CAN, CAIN	114350	9q34.13	CAIN
Leukemia, acute myeloid, somatic, 601626 (3)	PICALM, CALM, CLTH, LAP	603025	11q14.2	PICALM
Leukemia, acute myeloid, somatic, 601626 (3)	PICALM, CALM, CLTH, LAP	603025	11q14.2	CALM
Leukemia, acute myeloid, somatic, 601626 (3)	PICALM, CALM, CLTH, LAP	603025	11q14.2	CLTH
Leukemia, acute myeloid, somatic, 601626 (3)	PICALM, CALM, CLTH, LAP	603025	11q14.2	LAP
Leukemia, acute myeloid, therapy-related (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Leukemia, acute myeloid, therapy-related (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF
Leukemia, acute myeloid, therapy-related (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF1
Leukemia, acute myeloid, therapy-related (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	NAPB
Leukemia, acute myeloid, with eosinophilia (1)	ABL2, ABLL, ARG	164690	1q25.2	ABL2
Leukemia, acute myeloid, with eosinophilia (1)	ABL2, ABLL, ARG	164690	1q25.2	ABLL
Leukemia, acute myeloid, with eosinophilia (1)	ABL2, ABLL, ARG	164690	1q25.2	ARG
Leukemia, acute nonlymphocytic (2)	DEK, D6S231E	125264	6p22.3	DEK
Leukemia, acute nonlymphocytic (2)	DEK, D6S231E	125264	6p22.3	D6S231E
Leukemia, acute pre-B-cell (2)	PBX1	176310	1q23.3	PBX1
Leukemia, acute promyelocytic, 612376 (1)	RARA	180240	17q21.2	RARA
Leukemia, acute promyelocytic, PL2F/RARA type (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZBTB16
Leukemia, acute promyelocytic, PL2F/RARA type (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZNF145
Leukemia, acute promyelocytic, PL2F/RARA type (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	PLZF
Leukemia, acute promyelocytic, PML/RARA type (3)	PML, MYL	102578	15q24.1	PML
Leukemia, acute promyelocytic, PML/RARA type (3)	PML, MYL	102578	15q24.1	MYL
Leukemia, acute promyelocytic, somatic, 102578 (3)	STAT5B	604260	17q21.2	STAT5B
Leukemia, acute promyelocytic, somatic, 612376 (3)	NUMA1	164009	11q13.4	NUMA1
Leukemia, chronic myeloid, somatic, 608232 (3)	BCR, CML, PHL, ALL	151410	22q11.23	BCR
Leukemia, chronic myeloid, somatic, 608232 (3)	BCR, CML, PHL, ALL	151410	22q11.23	CML
Leukemia, chronic myeloid, somatic, 608232 (3)	BCR, CML, PHL, ALL	151410	22q11.23	PHL
Leukemia, chronic myeloid, somatic, 608232 (3)	BCR, CML, PHL, ALL	151410	22q11.23	ALL
Leukemia, juvenile myelomonocytic, 607785 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Leukemia, juvenile myelomonocytic, 607785 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	VRNF
Leukemia, juvenile myelomonocytic, 607785 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	WSS
Leukemia, juvenile myelomonocytic, 607785 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NFNS
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	ARHGAP26, GRAF	605370	5q31.3	ARHGAP26
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	ARHGAP26, GRAF	605370	5q31.3	GRAF
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTP2C
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	SHP2
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	NS1
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	JMML
Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	METCDS
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GF1
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	ERYF1
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	NFE1
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTDA
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTT
Leukemia, megakaryoblastic, with or without Down syndrome, somatic, 190685 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLANP
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	KMT2A
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	MLL
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	HRX
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	HTRX1
Leukemia, myeloid/lymphoid or mixed-lineage (2)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	WDSTS
Leukemia, transient, of Down syndrome (2)	TAM, MST	159595	21q11.2	TAM
Leukemia, transient, of Down syndrome (2)	TAM, MST	159595	21q11.2	MST
Leukemia/lymphoma, B-cell, 2 (3)	BCL2	151430	18q21.33	BCL2
Leukemia/lymphoma, B-cell, 3 (2)	BCL3	109560	19q13.32	BCL3
Leukemia/lymphoma, T-cell (2)	TCL1A, TCL1	186960	14q32.13	TCL1A
Leukemia/lymphoma, T-cell (2)	TCL1A, TCL1	186960	14q32.13	TCL1
Leukemia/lymphoma, T-cell (2)	TCL1B, TML1	603769	14q32.13	TCL1B
Leukemia/lymphoma, T-cell (2)	TCL1B, TML1	603769	14q32.13	TML1
Leukemia/lymphoma, T-cell (2)	TCL4	186860	2q34	TCL4
Leukocyte adhesion deficiency, 116920 (3)	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	ITGB2
Leukocyte adhesion deficiency, 116920 (3)	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	CD18
Leukocyte adhesion deficiency, 116920 (3)	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	LCAMB
Leukocyte adhesion deficiency, 116920 (3)	ITGB2, CD18, LCAMB, LAD	600065	21q22.3	LAD
Leukocyte adhesion deficiency, type III, 612840 (3)	KIND3, URP2, MIG2B, FERMT3	607901	11q13.1	KIND3
Leukocyte adhesion deficiency, type III, 612840 (3)	KIND3, URP2, MIG2B, FERMT3	607901	11q13.1	URP2
Leukocyte adhesion deficiency, type III, 612840 (3)	KIND3, URP2, MIG2B, FERMT3	607901	11q13.1	MIG2B
Leukocyte adhesion deficiency, type III, 612840 (3)	KIND3, URP2, MIG2B, FERMT3	607901	11q13.1	FERMT3
Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	PLEKHG2, CLG, LDAMD	611893	19q13.2	PLEKHG2
Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	PLEKHG2, CLG, LDAMD	611893	19q13.2	CLG
Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3)	PLEKHG2, CLG, LDAMD	611893	19q13.2	LDAMD
Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	LMNB1, ADLD	150340	5q23.2	LMNB1
Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)	LMNB1, ADLD	150340	5q23.2	ADLD
Leukodystrophy, hypomyelinating, 10, 616420 (3)	PYCR2, HLD10	616406	1q42.12	PYCR2
Leukodystrophy, hypomyelinating, 10, 616420 (3)	PYCR2, HLD10	616406	1q42.12	HLD10
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	POLR1C
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA39
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA40
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPAC1
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA5
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	TCS3
Leukodystrophy, hypomyelinating, 11, 616494 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	HLD11
Leukodystrophy, hypomyelinating, 12, 616683 (3)	VPS11, HLD12	608549	11q23.3	VPS11
Leukodystrophy, hypomyelinating, 12, 616683 (3)	VPS11, HLD12	608549	11q23.3	HLD12
Leukodystrophy, hypomyelinating, 13, 616881 (3)	C11orf73, HIKESHI, HLD13	614908	11q14.2	C11orf73
Leukodystrophy, hypomyelinating, 13, 616881 (3)	C11orf73, HIKESHI, HLD13	614908	11q14.2	HIKESHI
Leukodystrophy, hypomyelinating, 13, 616881 (3)	C11orf73, HIKESHI, HLD13	614908	11q14.2	HLD13
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJA12
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	CX47
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	PMLDAR
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	HLD2
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	SPG44
Leukodystrophy, hypomyelinating, 2, 608804 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	LMPH1C
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	AIMP1
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	SCYE1
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	EMAP2
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	EMAPII
Leukodystrophy, hypomyelinating, 3, 260600 (3)	AIMP1, SCYE1, EMAP2, EMAPII, HLD3	603605	4q24	HLD3
Leukodystrophy, hypomyelinating, 4, 612233 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSPD1
Leukodystrophy, hypomyelinating, 4, 612233 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	SPG13
Leukodystrophy, hypomyelinating, 4, 612233 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSP60
Leukodystrophy, hypomyelinating, 4, 612233 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HLD4
Leukodystrophy, hypomyelinating, 5, 610532 (3)	FAM126A, DRCTNNB1A, HLD5	610531	7p15.3	FAM126A
Leukodystrophy, hypomyelinating, 5, 610532 (3)	FAM126A, DRCTNNB1A, HLD5	610531	7p15.3	DRCTNNB1A
Leukodystrophy, hypomyelinating, 5, 610532 (3)	FAM126A, DRCTNNB1A, HLD5	610531	7p15.3	HLD5
Leukodystrophy, hypomyelinating, 6, 612438 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	TUBB4A
Leukodystrophy, hypomyelinating, 6, 612438 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	DYT4
Leukodystrophy, hypomyelinating, 6, 612438 (3)	TUBB4A, DYT4, HLD6	602662	19p13.3	HLD6
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	POLR3A
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	RPC1
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	RPC155
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	ADDH
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3)	POLR3A, RPC1, RPC155, ADDH, HLD7	614258	10q22.3	HLD7
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	POLR3B, RPC2, C128, HLD8	614366	12q23.3	POLR3B
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	POLR3B, RPC2, C128, HLD8	614366	12q23.3	RPC2
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	POLR3B, RPC2, C128, HLD8	614366	12q23.3	C128
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3)	POLR3B, RPC2, C128, HLD8	614366	12q23.3	HLD8
Leukodystrophy, hypomyelinating, 9, 616140 (3)	RARS, HLD9	107820	5q34	RARS
Leukodystrophy, hypomyelinating, 9, 616140 (3)	RARS, HLD9	107820	5q34	HLD9
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGMA
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	ECA2
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGI11
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EJM8
Leukoencephalopathy with ataxia, 615651 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	LKPAT
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	DARS2, ASPRS. LBSL	610956	1q25.1	DARS2
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3)	DARS2, ASPRS. LBSL	610956	1q25.1	ASPRS.LBSL
Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)	SCP2	184755	1p32.3	SCP2
Leukoencephalopathy with metaphyseal chondrodysplasia (2)	LKMCD	300660	Xq25-q27	LKMCD
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B1, EIF2BA	606686	12q24.31	EIF2B1
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B1, EIF2BA	606686	12q24.31	EIF2BA
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B2	606454	14q24.3	EIF2B2
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B3	606273	1p34.1	EIF2B3
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	EIF2B5
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	LVWM
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	CACH
Leukoencephalopathy with vanishing white matter, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	CLE
Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	RNASET2, RNASE6PL	612944	6q27	RNASET2
Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)	RNASET2, RNASE6PL	612944	6q27	RNASE6PL
Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	CSF1R, FMS, HDLS	164770	5q32	CSF1R
Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	CSF1R, FMS, HDLS	164770	5q32	FMS
Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)	CSF1R, FMS, HDLS	164770	5q32	HDLS
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	AARS2
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	KIAA1270
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	MTALARS
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	COXPD8
Leukoencephalopathy, progressive, with ovarian failure, 615889 (3)	AARS2, KIAA1270, MTALARS, COXPD8, LKENP	612035	6p21.1	LKENP
Leukoencephaly with vanishing white matter, 603896 (3)	EIF2B4	606687	2p23.3	EIF2B4
Leukotriene C4 synthase deficiency, 614037 (1)	LTC4S	246530	5q35.3	LTC4S
Levy-Shanske syndrome (4)	LVSKS	614846	15q26-qter	LVSKS
Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHR
Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LCGR
Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHR
Leydig cell hypoplasia with hypergonadotropic hypogonadism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LCGR
Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHR
Leydig cell hypoplasia with pseudohermaphroditism, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LCGR
Lhermitte-Duclos syndrome, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Lhermitte-Duclos syndrome, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Lhermitte-Duclos syndrome, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Lhermitte-Duclos syndrome, 158350 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Li-Fraumeni syndrome 3 (2)	LFS3	609266	1q23	LFS3
Li-Fraumeni syndrome, 151623 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Li-Fraumeni syndrome, 151623 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Li-Fraumeni syndrome, 151623 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Li-Fraumeni syndrome, 151623 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	RAD53
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHK2
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CDS1
Li-Fraumeni syndrome, 609265 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	LFS2
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Liang distal myopathy, 160500 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Liddle syndrome, 177200 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Liddle syndrome, 177200 (3)	SCNN1B, BESC1	600760	16p12.2	BESC1
Liddle syndrome, 177200 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Liddle syndrome, 177200 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	PHA1
Liddle syndrome, 177200 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	BESC3
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PITX1
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	PTX1
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	BFT
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	POTX
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	CCF
Liebenberg syndrome, 186550 (4)	PITX1, PTX1, BFT, POTX, CCF, LBNBG	602149	5q31.1	LBNBG
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Limb-mammary syndrome, 603543 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Linear skin defects with multiple congenital anomalies 1, 309801 (3)	HCCS, MCOPS7, LSDMCA1	300056	Xp22.2	HCCS
Linear skin defects with multiple congenital anomalies 1, 309801 (3)	HCCS, MCOPS7, LSDMCA1	300056	Xp22.2	MCOPS7
Linear skin defects with multiple congenital anomalies 1, 309801 (3)	HCCS, MCOPS7, LSDMCA1	300056	Xp22.2	LSDMCA1
Linear skin defects with multiple congenital anomalies 3, 300952 (3)	NDUFB11, LSDMCA3	300403	Xp11.3	NDUFB11
Linear skin defects with multiple congenital anomalies 3, 300952 (3)	NDUFB11, LSDMCA3	300403	Xp11.3	LSDMCA3
Linear skin defects with multiple congenital anomalies, 300887 (3)	COX7B, LSDMCA2	300885	Xq21.1	COX7B
Linear skin defects with multiple congenital anomalies, 300887 (3)	COX7B, LSDMCA2	300885	Xq21.1	LSDMCA2
Lipase deficiency, combined, 246650 (3)	LMF1, TMEM112	611761	16p13.3	LMF1
Lipase deficiency, combined, 246650 (3)	LMF1, TMEM112	611761	16p13.3	TMEM112
Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	FLAD1, FADS, LSMFLAD	610595	1q21.3	FLAD1
Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	FLAD1, FADS, LSMFLAD	610595	1q21.3	FADS
Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3)	FLAD1, FADS, LSMFLAD	610595	1q21.3	LSMFLAD
Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	AGPAT2
Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	LPAAB
Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	BSCL
Lipodystrophy, congenital generalized, type 1, 608594 (3)	AGPAT2, LPAAB, BSCL, BSCL1	603100	9q34.3	BSCL1
Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	SPG17
Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	HMN5
Lipodystrophy, congenital generalized, type 2, 269700 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	PELD
Lipodystrophy, congenital generalized, type 4, 613327 (3)	PTRF, CAVIN, CGL4	603198	17q21.2	PTRF
Lipodystrophy, congenital generalized, type 4, 613327 (3)	PTRF, CAVIN, CGL4	603198	17q21.2	CAVIN
Lipodystrophy, congenital generalized, type 4, 613327 (3)	PTRF, CAVIN, CGL4	603198	17q21.2	CGL4
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Lipodystrophy, familial partial, type 2, 151660 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
Lipodystrophy, familial partial, type 3, 604367 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
Lipodystrophy, familial partial, type 4, 613877 (3)	PLIN1, PLIN, FPLD4	170290	15q26.1	PLIN1
Lipodystrophy, familial partial, type 4, 613877 (3)	PLIN1, PLIN, FPLD4	170290	15q26.1	PLIN
Lipodystrophy, familial partial, type 4, 613877 (3)	PLIN1, PLIN, FPLD4	170290	15q26.1	FPLD4
Lipodystrophy, familial partial, type 6, 615980 (3)	LIPE, LHS, FPLD6	151750	19q13.2	LIPE
Lipodystrophy, familial partial, type 6, 615980 (3)	LIPE, LHS, FPLD6	151750	19q13.2	LHS
Lipodystrophy, familial partial, type 6, 615980 (3)	LIPE, LHS, FPLD6	151750	19q13.2	FPLD6
Lipoid adrenal hyperplasia, 201710 (3)	STAR	600617	8p11.23	STAR
Lipoma (3)	LPP	600700	3q27-q28	LPP
Lipoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Lipoprotein glomerulopathy, 611771 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Lipoprotein glomerulopathy, 611771 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
Lipoprotein glomerulopathy, 611771 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
Lipoprotein glomerulopathy, 611771 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
Lipoprotein lipase deficiency, 238600 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
Lipoprotein lipase deficiency, 238600 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LIPD
Lipoprotein lipase deficiency, 238600 (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	HDLCQ11
Liposarcoma (1)	LPSA, D19S381E	164953	19p13.2-q13.3	LPSA
Liposarcoma (1)	LPSA, D19S381E	164953	19p13.2-q13.3	D19S381E
Lipoyltransferase 1 deficiency, 616299 (3)	LIPT1, LIPT1D	610284	2q11.2	LIPT1
Lipoyltransferase 1 deficiency, 616299 (3)	LIPT1, LIPT1D	610284	2q11.2	LIPT1D
Lissencephaly 1, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	PAFAH1B1
Lissencephaly 1, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	LIS1
Lissencephaly 2 (Norman-Roberts type), 257320 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RELN
Lissencephaly 2 (Norman-Roberts type), 257320 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RL
Lissencephaly 2 (Norman-Roberts type), 257320 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	LIS2
Lissencephaly 2 (Norman-Roberts type), 257320 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	ETL7
Lissencephaly 3, 611603 (3)	TUBA1A, TUBA3, LIS3	602529	12q13.12	TUBA1A
Lissencephaly 3, 611603 (3)	TUBA1A, TUBA3, LIS3	602529	12q13.12	TUBA3
Lissencephaly 3, 611603 (3)	TUBA1A, TUBA3, LIS3	602529	12q13.12	LIS3
Lissencephaly 4 (with microcephaly), 614019 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NDE1
Lissencephaly 4 (with microcephaly), 614019 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	NUDE
Lissencephaly 4 (with microcephaly), 614019 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	LIS4
Lissencephaly 4 (with microcephaly), 614019 (3)	NDE1, NUDE, LIS4, MHAC	609449	16p13.11	MHAC
Lissencephaly 5, 615191 (3)	LAMB1, LIS5	150240	7q31.1	LAMB1
Lissencephaly 5, 615191 (3)	LAMB1, LIS5	150240	7q31.1	LIS5
Lissencephaly 6, with microcephaly, 616212 (3)	KATNB1, LIS6	602703	16q21	KATNB1
Lissencephaly 6, with microcephaly, 616212 (3)	KATNB1, LIS6	602703	16q21	LIS6
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Lissencephaly, X-linked 2, 300215 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Lissencephaly, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DCX
Lissencephaly, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DBCN
Lissencephaly, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	LISX
Liver failure, transient infantile, 613070 (3)	TRMU, MTO2	610230	22q13.31	TRMU
Liver failure, transient infantile, 613070 (3)	TRMU, MTO2	610230	22q13.31	MTO2
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	TGFBR1
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	ALK5
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	AAT5
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	LDS1
Loeys-Dietz syndrome 1, 609192 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	MSSE
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	TGFBR2
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	HNPCC6
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	AAT3
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	MFS2
Loeys-Dietz syndrome 2, 610168 (3)	TGFBR2, HNPCC6, AAT3, MFS2, LDS2	190182	3p24.1	LDS2
Loeys-Dietz syndrome 3, 613795 (3)	SMAD3, MADH3, LDS3	603109	15q22.33	SMAD3
Loeys-Dietz syndrome 3, 613795 (3)	SMAD3, MADH3, LDS3	603109	15q22.33	MADH3
Loeys-Dietz syndrome 3, 613795 (3)	SMAD3, MADH3, LDS3	603109	15q22.33	LDS3
Loeys-Dietz syndrome 4, 614816 (3)	TGFB2, LDS4	190220	1q41	TGFB2
Loeys-Dietz syndrome 4, 614816 (3)	TGFB2, LDS4	190220	1q41	LDS4
Loeys-Dietz syndrome 5, 615582 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	TGFB3
Loeys-Dietz syndrome 5, 615582 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	ARVD1
Loeys-Dietz syndrome 5, 615582 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	RNHF
Loeys-Dietz syndrome 5, 615582 (3)	TGFB3, ARVD1, RNHF, LDS5	190230	14q24.3	LDS5
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNA9
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	LQT1
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KVLQT1
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	ATFB3
Long QT syndrome 1, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	SQT2
Long QT syndrome 12, 612955 (3)	SNTA1, SNT1, TACIP1, LQT12	601017	20q11.21	SNTA1
Long QT syndrome 12, 612955 (3)	SNTA1, SNT1, TACIP1, LQT12	601017	20q11.21	SNT1
Long QT syndrome 12, 612955 (3)	SNTA1, SNT1, TACIP1, LQT12	601017	20q11.21	TACIP1
Long QT syndrome 12, 612955 (3)	SNTA1, SNT1, TACIP1, LQT12	601017	20q11.21	LQT12
Long QT syndrome 13, 613485 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KCNJ5
Long QT syndrome 13, 613485 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	GIRK4
Long QT syndrome 13, 613485 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	KATP1
Long QT syndrome 13, 613485 (3)	KCNJ5, GIRK4, KATP1, LQT13	600734	11q24.3	LQT13
Long QT syndrome 14, 616247 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CALM1
Long QT syndrome 14, 616247 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	PHKD
Long QT syndrome 14, 616247 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CPVT4
Long QT syndrome 14, 616247 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	LQT14
Long QT syndrome 15, 616249 (3)	CALM2, LQT15	114182	2p21	CALM2
Long QT syndrome 15, 616249 (3)	CALM2, LQT15	114182	2p21	LQT15
Long QT syndrome 2, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
Long QT syndrome 2, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	LQT2
Long QT syndrome 2, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	HERG
Long QT syndrome 2, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	SQT1
Long QT syndrome 4, 600919 (3)	ANK2, LQT4	106410	4q25-q26	ANK2
Long QT syndrome 4, 600919 (3)	ANK2, LQT4	106410	4q25-q26	LQT4
Long QT syndrome 5, 613695 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	KCNE1
Long QT syndrome 5, 613695 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	JLNS
Long QT syndrome 5, 613695 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	LQT5
Long QT syndrome 5, 613695 (3)	KCNE1, JLNS, LQT5, JLNS2	176261	21q22.12	JLNS2
Long QT syndrome 6, 613693 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	KCNE2
Long QT syndrome 6, 613693 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	MIRP1
Long QT syndrome 6, 613693 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	LQT6
Long QT syndrome 6, 613693 (3)	KCNE2, MIRP1, LQT6, ATFB4	603796	21q22.11	ATFB4
Long QT syndrome 9, 611818 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Long QT syndrome 9, 611818 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Long QT syndrome 9, 611818 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Long QT syndrome-10, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	SCN4B
Long QT syndrome-10, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	LQT10
Long QT syndrome-10, 611819 (3)	SCN4B, LQT10, ATFB17	608256	11q23.3	ATFB17
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Long QT syndrome-3, 603830 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Lowe syndrome, 309000 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL
Lowe syndrome, 309000 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	LOCR
Lowe syndrome, 309000 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	OCRL1
Lowe syndrome, 309000 (3)	OCRL, LOCR, OCRL1, NPHL2	300535	Xq26.1	NPHL2
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TNRC11
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TRAP230
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	HOPA
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	KIAA0192
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OKS
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	FGS1
Lujan-Fryns syndrome, 309520 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OHDOX
Lung cancer, 211980 (1)	DLEC1, DLC1	604050	3p22.2	DLEC1
Lung cancer, 211980 (1)	DLEC1, DLC1	604050	3p22.2	DLC1
Lung cancer, 211980 (2)	RASSF1	605082	3p21.31	RASSF1
Lung cancer, 211980 (3)	PPP2R1B	603113	11q23.1	PPP2R1B
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Lung cancer, somatic, 211980 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Lung cancer, somatic, 211980 (3)	MAP3K8, COT, EST, TPL2	191195	10p11.23	MAP3K8
Lung cancer, somatic, 211980 (3)	MAP3K8, COT, EST, TPL2	191195	10p11.23	COT
Lung cancer, somatic, 211980 (3)	MAP3K8, COT, EST, TPL2	191195	10p11.23	EST
Lung cancer, somatic, 211980 (3)	MAP3K8, COT, EST, TPL2	191195	10p11.23	TPL2
Lung cancer, somatic, 211980 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Lung cancer, somatic, 211980 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	BWSCR1A
Lung cancer, somatic, 211980 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	IMPT1
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	SETD2
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	SET2
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	HYPB
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	HBP231
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	KIAA1732
Luscan-Lumish syndrome, 616831 (3)	SETD2, SET2, HYPB, HBP231, KIAA1732, LLS	612778	3p21.31	LLS
Luteinizing hormone resistance, female, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Luteinizing hormone resistance, female, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHR
Luteinizing hormone resistance, female, 238320 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LCGR
Lymphangioleiomyomatosis, 606690 (3)	TSC1, LAM	605284	9q34.13	TSC1
Lymphangioleiomyomatosis, 606690 (3)	TSC1, LAM	605284	9q34.13	LAM
Lymphangioleiomyomatosis, somatic, 606690 (3)	TSC2, LAM	191092	16p13.3	TSC2
Lymphangioleiomyomatosis, somatic, 606690 (3)	TSC2, LAM	191092	16p13.3	LAM
Lymphedema, hereditary, IA, 153100 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	FLT4
Lymphedema, hereditary, IA, 153100 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	VEGFR3
Lymphedema, hereditary, IA, 153100 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	PCL
Lymphedema, hereditary, IA, 153100 (3)	FLT4, VEGFR3, PCL, LMPH1A	136352	5q35.3	LMPH1A
Lymphedema, hereditary, IB (2)	LMPH1B	611944	6q16.2-q22.1	LMPH1B
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJA12
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	CX47
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	PMLDAR
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	HLD2
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	SPG44
Lymphedema, hereditary, IC, 613480 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	LMPH1C
Lymphedema, hereditary, ID, 615907 (3)	VEGFC, VRP, LMPH1D	601528	4q34.3	VEGFC
Lymphedema, hereditary, ID, 615907 (3)	VEGFC, VRP, LMPH1D	601528	4q34.3	VRP
Lymphedema, hereditary, ID, 615907 (3)	VEGFC, VRP, LMPH1D	601528	4q34.3	LMPH1D
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	PIEZO1
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	FAM38A
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	MIB
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	DHS
Lymphedema, hereditary, III, 616843 (3)	PIEZO1, FAM38A, MIB, DHS, LMPH3	611184	16q24.3	LMPH3
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FOXC2
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FKHL14
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	MFH1
Lymphedema-distichiasis syndrome, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FOXC2
Lymphedema-distichiasis syndrome, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	FKHL14
Lymphedema-distichiasis syndrome, 153400 (3)	FOXC2, FKHL14, MFH1	602402	16q24.1	MFH1
Lymphocytic leukemia, acute T-cell (3)	RAP1GDS1	179502	4q23	RAP1GDS1
Lymphoma, B-cell (2)	BCL6	109565	3q27.3	BCL6
Lymphoma, B-cell non-Hodgkin, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Lymphoma, B-cell non-Hodgkin, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATA
Lymphoma, B-cell non-Hodgkin, somatic (3)	ATM, ATA, AT1	607585	11q22.3	AT1
Lymphoma, MALT, somatic, 137245 (3)	BCL10, IMD37	603517	1p22.3	BCL10
Lymphoma, MALT, somatic, 137245 (3)	BCL10, IMD37	603517	1p22.3	IMD37
Lymphoma, mantle cell, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
Lymphoma, mantle cell, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATA
Lymphoma, mantle cell, somatic (3)	ATM, ATA, AT1	607585	11q22.3	AT1
Lymphoma, non-Hodgkin, 605027 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	PRF1
Lymphoma, non-Hodgkin, 605027 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	HPLH2
Lymphoma, non-Hodgkin, 605027 (3)	PRF1, HPLH2, FLH2	170280	10q22.1	FLH2
Lymphoma, non-Hodgkin, somatic, 605027 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	CASP10
Lymphoma, non-Hodgkin, somatic, 605027 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	MCH4
Lymphoma, non-Hodgkin, somatic, 605027 (3)	CASP10, MCH4, ALPS2	601762	2q33.1	ALPS2
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54B	604289	8q22.1	RAD54B
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HR54
Lymphoma, non-Hodgkin, somatic, 605027 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HRAD54
Lymphoma, somatic (3)	MAD1L1, TXBP181	602686	7p22.3	MAD1L1
Lymphoma, somatic (3)	MAD1L1, TXBP181	602686	7p22.3	TXBP181
Lymphoma/leukemia, B-cell, variant (1)	FVT1	136440	18q21.33	FVT1
Lymphoproliferative syndrome 1, 613011 (3)	ITK, EMT, LPFS1	186973	5q33.3	ITK
Lymphoproliferative syndrome 1, 613011 (3)	ITK, EMT, LPFS1	186973	5q33.3	EMT
Lymphoproliferative syndrome 1, 613011 (3)	ITK, EMT, LPFS1	186973	5q33.3	LPFS1
Lymphoproliferative syndrome 2, 615122 (3)	TNFRSF7, CD27, S152. LPFS2	186711	12p13.31	TNFRSF7
Lymphoproliferative syndrome 2, 615122 (3)	TNFRSF7, CD27, S152. LPFS2	186711	12p13.31	CD27
Lymphoproliferative syndrome 2, 615122 (3)	TNFRSF7, CD27, S152. LPFS2	186711	12p13.31	S152.LPFS2
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	SH2D1A
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	LYP
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	IMD5
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	XLP
Lymphoproliferative syndrome, X-linked, 1, 308240 (3)	SH2D1A, LYP, IMD5, XLP, XLPD1	300490	Xq25	XLPD1
Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	XIAP, BIRC4, API3, XLP2	300079	Xq25	XIAP
Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	XIAP, BIRC4, API3, XLP2	300079	Xq25	BIRC4
Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	XIAP, BIRC4, API3, XLP2	300079	Xq25	API3
Lymphoproliferative syndrome, X-linked, 2, 300635 (3)	XIAP, BIRC4, API3, XLP2	300079	Xq25	XLP2
Lysinuric protein intolerance, 222700 (3)	SLC7A7, LPI	603593	14q11.2	SLC7A7
Lysinuric protein intolerance, 222700 (3)	SLC7A7, LPI	603593	14q11.2	LPI
Lysyl hydroxylase 3 deficiency, 612394 (3)	PLOD3, LH3	603066	7q22.1	PLOD3
Lysyl hydroxylase 3 deficiency, 612394 (3)	PLOD3, LH3	603066	7q22.1	LH3
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	L1CAM
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	CAML1
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	HSAS1
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	MASA
MASA syndrome, 303350 (3)	L1CAM, CAML1, HSAS1, MASA, SPG1	308840	Xq28	SPG1
MASP2 deficiency, 613791 (3)	MASP2	605102	1p36.22	MASP2
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
MASS syndrome, 604308 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
MEDNIK syndrome, 609313 (3)	AP1S1, CLAPS1, AP19, MEDNIK	603531	7q22.1	AP1S1
MEDNIK syndrome, 609313 (3)	AP1S1, CLAPS1, AP19, MEDNIK	603531	7q22.1	CLAPS1
MEDNIK syndrome, 609313 (3)	AP1S1, CLAPS1, AP19, MEDNIK	603531	7q22.1	AP19
MEDNIK syndrome, 609313 (3)	AP1S1, CLAPS1, AP19, MEDNIK	603531	7q22.1	MEDNIK
MEHMO syndrome (2)	MEHMO	300148	Xp22.13-p21.1	MEHMO
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	EBP
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CDPX2
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CPXD
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	CPX
MEND syndrome, 300960 (3)	EBP, CDPX2, CPXD, CPX, MEND	300205	Xp11.23	MEND
MHC class II deficiency, complementation group B, 209920 (3)	RFXANK	603200	19p13.11	RFXANK
MIRAGE syndrome, 617053 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	SAMD9
MIRAGE syndrome, 617053 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	NFTC
MIRAGE syndrome, 617053 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	MIRAGE
MODY, type I, 125850 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
MODY, type I, 125850 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	TCF14
MODY, type I, 125850 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	MODY1
MODY, type I, 125850 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	FRTS4
MODY, type II, 125851 (3)	GCK, HHF3	138079	7p13	GCK
MODY, type II, 125851 (3)	GCK, HHF3	138079	7p13	HHF3
MODY, type III, 600496 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
MODY, type III, 600496 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
MODY, type III, 600496 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
MODY, type III, 600496 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
MODY, type IV, 606392 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	IPF1
MODY, type IV, 606392 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	MODY4
MODY, type IV, 606392 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	PAGEN1
Machado-Joseph disease, 109150 (3)	ATXN3, MJD, SCA3	607047	14q32.12	ATXN3
Machado-Joseph disease, 109150 (3)	ATXN3, MJD, SCA3	607047	14q32.12	MJD
Machado-Joseph disease, 109150 (3)	ATXN3, MJD, SCA3	607047	14q32.12	SCA3
Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	RIN2, MACS	610222	20p11.23	RIN2
Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)	RIN2, MACS	610222	20p11.23	MACS
Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	HERC1, MDFPMR	605109	15q22.31	HERC1
Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3)	HERC1, MDFPMR	605109	15q22.31	MDFPMR
Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	RNF135, MMFD	611358	17q11.2	RNF135
Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)	RNF135, MMFD	611358	17q11.2	MMFD
Macrocephaly/autism syndrome, 605309 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Macrocephaly/autism syndrome, 605309 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Macrocephaly/autism syndrome, 605309 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Macrocephaly/autism syndrome, 605309 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	TBC1D7, PIG51, TBC7, MGCPH	612655	6p24.1	TBC1D7
Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	TBC1D7, PIG51, TBC7, MGCPH	612655	6p24.1	PIG51
Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	TBC1D7, PIG51, TBC7, MGCPH	612655	6p24.1	TBC7
Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3)	TBC1D7, PIG51, TBC7, MGCPH	612655	6p24.1	MGCPH
Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	RPS14, EMTB	130620	5q33.1	RPS14
Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)	RPS14, EMTB	130620	5q33.1	EMTB
Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	MYD88, MYD88D	602170	3p22.2	MYD88
Macroglobulinemia, Waldenstrom, somatic, 153600 (3)	MYD88, MYD88D	602170	3p22.2	MYD88D
Macrostomia (2)	MACST	613545	1p34-p32	MACST
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
Macrothrombocytopenia and progressive sensorineural deafness, 600208 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)	TUBB1	612901	20q13.32	TUBB1
Macular corneal dystrophy, 217800 (3)	CHST6, MCDC1	605294	16q23.1	CHST6
Macular corneal dystrophy, 217800 (3)	CHST6, MCDC1	605294	16q23.1	MCDC1
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP3
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CRD
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP15
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	COD1
Macular degeneration, X-linked atrophic, 300834 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CORDX1
Macular degeneration, age-related, 10 (2)	ARMD10	611488	9q32-q33	ARMD10
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARMD3
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ADCL2
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARCL1A
Macular degeneration, age-related, 3, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	HNARMD
Macular degeneration, early-onset, 616118 (3)	FBN2, CCA, EOMD	612570	5q23.3	FBN2
Macular degeneration, early-onset, 616118 (3)	FBN2, CCA, EOMD	612570	5q23.3	CCA
Macular degeneration, early-onset, 616118 (3)	FBN2, CCA, EOMD	612570	5q23.3	EOMD
Macular degeneration, juvenile, 248200 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	CNGB3
Macular degeneration, juvenile, 248200 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	ACHM3
Macular degeneration, juvenile, 248200 (3)	CNGB3, ACHM3, ACHM1	605080	8q21.3	ACHM1
Macular dystrophy with central cone involvement, 616170 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MFSD8
Macular dystrophy with central cone involvement, 616170 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	MGC33302
Macular dystrophy with central cone involvement, 616170 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	CLN7
Macular dystrophy with central cone involvement, 616170 (3)	MFSD8, MGC33302, CLN7, CCMD	611124	4q28.2	CCMD
Macular dystrophy, North Carolina type, 136550 (3)	DHS6S1, MCDR1	616842	6q16.2	DHS6S1
Macular dystrophy, North Carolina type, 136550 (3)	DHS6S1, MCDR1	616842	6q16.2	MCDR1
Macular dystrophy, butterfly-shaped pigmentary, 2 (2)	MDBS2	608970	5q21.3-q33.2	MDBS2
Macular dystrophy, dominant cystoid (2)	MDDC	153880	7p21-p15	MDDC
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Macular dystrophy, patterned, 1, 169150 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Macular dystrophy, patterned, 2, 608970 (3)	CTNNA1, MDPT2	116805	5q31.2	CTNNA1
Macular dystrophy, patterned, 2, 608970 (3)	CTNNA1, MDPT2	116805	5q31.2	MDPT2
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROML1
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	AC133
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	RP41
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CORD12
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CD133
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	MCDR2
Macular dystrophy, retinal, 2, 608051 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	STGD4
Macular dystrophy, retinal, 3 (2)	MCDR3	608850	5p15.33-p13.1	MCDR3
Macular dystrophy, vitelliform, 2, 153700 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Macular dystrophy, vitelliform, 2, 153700 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Macular dystrophy, vitelliform, 2, 153700 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Macular dystrophy, vitelliform, 2, 153700 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Macular dystrophy, vitelliform, 3, 608161 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Macular dystrophy, vitelliform, 4, 616151 (3)	IMPG1, IPM150, VMD4	602870	6q14.1	IMPG1
Macular dystrophy, vitelliform, 4, 616151 (3)	IMPG1, IPM150, VMD4	602870	6q14.1	IPM150
Macular dystrophy, vitelliform, 4, 616151 (3)	IMPG1, IPM150, VMD4	602870	6q14.1	VMD4
Macular dystrophy, vitelliform, 5, 616152 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IMPG2
Macular dystrophy, vitelliform, 5, 616152 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IPM200
Macular dystrophy, vitelliform, 5, 616152 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	RP56
Macular dystrophy, vitelliform, 5, 616152 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	VMD5
Majeed syndrome, 609628 (3)	LPIN2	605519	18p11.31	LPIN2
Major affective disorder 4 (2)	MAFD4, BPAD	611247	16p12	MAFD4
Major affective disorder 4 (2)	MAFD4, BPAD	611247	16p12	BPAD
Major depressive disorder 1, 608516 (2)	MDD1	608520	12q22-q23.2	MDD1
Major depressive disorder 2, 608516 (2)	MDD2	608691	15q25.3-q26.2	MDD2
Male germ cell tumor (2)	MGCT	273300	12q22	MGCT
Malignant fibrous histiocytoma (2)	MFHAS1, MASL1	605352	8p23.1	MFHAS1
Malignant fibrous histiocytoma (2)	MFHAS1, MASL1	605352	8p23.1	MASL1
Malignant melanoma, somatic, 155600 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Malignant melanoma, somatic, 155600 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Malignant melanoma, somatic, 155600 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Malignant melanoma, somatic, 155600 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Malonyl-CoA decarboxylase deficiency, 248360 (3)	MLYCD, MCD	606761	16q23.3	MLYCD
Malonyl-CoA decarboxylase deficiency, 248360 (3)	MLYCD, MCD	606761	16q23.3	MCD
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Malouf syndrome, 212112 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Mammary-digital-nail syndrome (2)	MDNS	613689	22q12.3-q13.1	MDNS
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	POLD1
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	CRCS10
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome, 615381 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	MDPL
Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	ZMPSTE24
Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	FACE1
Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	STE24
Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	MADB
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Mandibuloacral dysplasia, 248370 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Mandibulofacial dysostosis with alopecia, 616367 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	EDNRA
Mandibulofacial dysostosis with alopecia, 616367 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	MFDA
Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	EFTUD2, KIAA0031, MFDGA	603892	17q21.31	EFTUD2
Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	EFTUD2, KIAA0031, MFDGA	603892	17q21.31	KIAA0031
Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3)	EFTUD2, KIAA0031, MFDGA	603892	17q21.31	MFDGA
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	C9orf154
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	BNAR
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	MOTA
Manitoba oculotrichoanal syndrome, 248450 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	TRIGNO2
Mannosidosis, alpha-, types I and II, 248500 (3)	MAN2B1, MANB	609458	19p13.13	MAN2B1
Mannosidosis, alpha-, types I and II, 248500 (3)	MAN2B1, MANB	609458	19p13.13	MANB
Mannosidosis, beta, 248510 (3)	MANBA, MANB1	609489	4q24	MANBA
Mannosidosis, beta, 248510 (3)	MANBA, MANB1	609489	4q24	MANB1
Maple syrup urine disease, type II, 248600 (3)	DBT, BCATE2	248610	1p21.2	DBT
Maple syrup urine disease, type II, 248600 (3)	DBT, BCATE2	248610	1p21.2	BCATE2
Maple syrup urine disease, type Ia, 248600 (3)	BCKDHA, MSUD1	608348	19q13.2	BCKDHA
Maple syrup urine disease, type Ia, 248600 (3)	BCKDHA, MSUD1	608348	19q13.2	MSUD1
Maple syrup urine disease, type Ib, 248600 (3)	BCKDHB, E1B	248611	6q14.1	BCKDHB
Maple syrup urine disease, type Ib, 248600 (3)	BCKDHB, E1B	248611	6q14.1	E1B
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Marfan lipodystrophy syndrome, 616914 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Marfan syndrome, 154700 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Marinesco-Sjogren syndrome, 248800 (3)	SIL1, BAP, MSS	608005	5q31.2	SIL1
Marinesco-Sjogren syndrome, 248800 (3)	SIL1, BAP, MSS	608005	5q31.2	BAP
Marinesco-Sjogren syndrome, 248800 (3)	SIL1, BAP, MSS	608005	5q31.2	MSS
Marshall syndrome, 154780 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Marshall syndrome, 154780 (3)	COL11A1, STL2	120280	1p21.1	STL2
Marshall-Smith syndrome, 602535 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NFIX
Marshall-Smith syndrome, 602535 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NF1A
Marshall-Smith syndrome, 602535 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	SOTOS2
Marshall-Smith syndrome, 602535 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	MRSHSS
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP2
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP150
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	p150
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	KIAA0839
Martsolf syndrome, 212720 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	WARBM2
Mast cell disease, 154800 (3)	KIT, PBT	164920	4q12	KIT
Mast cell disease, 154800 (3)	KIT, PBT	164920	4q12	PBT
Mast syndrome, 248900 (3)	ACP33, MAST, SPG21	608181	15q22.31	ACP33
Mast syndrome, 248900 (3)	ACP33, MAST, SPG21	608181	15q22.31	MAST
Mast syndrome, 248900 (3)	ACP33, MAST, SPG21	608181	15q22.31	SPG21
Maturity-onset diabetes of the young 6, 606394 (3)	NEUROD1, NIDDM	601724	2q31.3	NEUROD1
Maturity-onset diabetes of the young 6, 606394 (3)	NEUROD1, NIDDM	601724	2q31.3	NIDDM
Maturity-onset diabetes of the young, type 10, 613370 (3)	INS, MODY10, IDDM2	176730	11p15.5	INS
Maturity-onset diabetes of the young, type 10, 613370 (3)	INS, MODY10, IDDM2	176730	11p15.5	MODY10
Maturity-onset diabetes of the young, type 10, 613370 (3)	INS, MODY10, IDDM2	176730	11p15.5	IDDM2
Maturity-onset diabetes of the young, type 11, 613375 (3)	BLK, MODY11	191305	8p23.1	BLK
Maturity-onset diabetes of the young, type 11, 613375 (3)	BLK, MODY11	191305	8p23.1	MODY11
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
Maturity-onset diabetes of the young, type 13, 616329 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
Maturity-onset diabetes of the young, type IX, 612225 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
Maturity-onset diabetes of the young, type IX, 612225 (3)	PAX4, MODY9, KPD	167413	7q32.1	MODY9
Maturity-onset diabetes of the young, type IX, 612225 (3)	PAX4, MODY9, KPD	167413	7q32.1	KPD
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	KLF11
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	TIEG2
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	FKLF1
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	FKLF
Maturity-onset diabetes of the young, type VII, 610508 (3)	KLF11, TIEG2, FKLF1, FKLF, MODY7	603301	2p25.1	MODY7
Maturity-onset diabetes of the young, type VIII, 609812 (3)	CEL, BSSL, CELL, MODY8	114840	9q34.13	CEL
Maturity-onset diabetes of the young, type VIII, 609812 (3)	CEL, BSSL, CELL, MODY8	114840	9q34.13	BSSL
Maturity-onset diabetes of the young, type VIII, 609812 (3)	CEL, BSSL, CELL, MODY8	114840	9q34.13	CELL
Maturity-onset diabetes of the young, type VIII, 609812 (3)	CEL, BSSL, CELL, MODY8	114840	9q34.13	MODY8
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
May-Hegglin anomaly, 155100 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
McArdle disease, 232600 (3)	PYGM	608455	11q13.1	PYGM
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
McCune-Albright syndrome, somatic, mosaic 174800 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKKS
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	HMCS
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	KMS
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	MKS
McKusick-Kaufman syndrome, 236700 (3)	MKKS, HMCS, KMS, MKS, BBS6	604896	20p12.2	BBS6
McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	XK, MCLDS	314850	Xp21.1	XK
McLeod syndrome with or without chronic granulomatous disease, 300842 (3)	XK, MCLDS	314850	Xp21.1	MCLDS
Meacham syndrome, 608978 (3)	WT1, NPHS4	607102	11p13	WT1
Meacham syndrome, 608978 (3)	WT1, NPHS4	607102	11p13	NPHS4
Mean platelet volume QTL4 (2)	MPVQTL4	614644	6p21.3-p21.2	MPVQTL4
Mean platelet volume QTL5 (2)	MPVQTL5	614645	6q23.3	MPVQTL5
Mean platelet volume QTL6 (2)	MPVQTL6	614646	7q22.3	MPVQTL6
Meckel syndrome 1, 249000 (3)	MKS1, MKS, BBS13	609883	17q22	MKS1
Meckel syndrome 1, 249000 (3)	MKS1, MKS, BBS13	609883	17q22	MKS
Meckel syndrome 1, 249000 (3)	MKS1, MKS, BBS13	609883	17q22	BBS13
Meckel syndrome 10, 614175 (3)	B9D2, MKS10	611951	19q13.2	B9D2
Meckel syndrome 10, 614175 (3)	B9D2, MKS10	611951	19q13.2	MKS10
Meckel syndrome 11, 615397 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	TMEM231
Meckel syndrome 11, 615397 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	JBTS20
Meckel syndrome 11, 615397 (3)	TMEM231, JBTS20, MKS11	614949	16q23.1	MKS11
Meckel syndrome 2, 603194 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	TMEM216
Meckel syndrome 2, 603194 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	JBTS2
Meckel syndrome 2, 603194 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	CORS2
Meckel syndrome 2, 603194 (3)	TMEM216, JBTS2, CORS2, MKS2	613277	11q12.2	MKS2
Meckel syndrome 3, 607361 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Meckel syndrome 3, 607361 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	MKS3
Meckel syndrome 3, 607361 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	JBTS6
Meckel syndrome 3, 607361 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	NPHP11
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	KIAA0373
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	3H11AG
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	JBTS5
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	SLSN6
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	LCA10
Meckel syndrome 4, 611134 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	BBS14
Meckel syndrome 5, 611561 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	RPGRIP1L
Meckel syndrome 5, 611561 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	KIAA1005
Meckel syndrome 5, 611561 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	JBTS7
Meckel syndrome 5, 611561 (3)	RPGRIP1L, KIAA1005, JBTS7, MKS5	610937	16q12.2	MKS5
Meckel syndrome 6, 612284 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	CC2D2A
Meckel syndrome 6, 612284 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	KIAA1345
Meckel syndrome 6, 612284 (3)	CC2D2A, KIAA1345, MKS6	612013	4p15.32	MKS6
Meckel syndrome 7, 267010 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Meckel syndrome 7, 267010 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPH3
Meckel syndrome 7, 267010 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	RHPD1
Meckel syndrome 7, 267010 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	MKS7
Meconium ileus, 614665 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUCY2C
Meconium ileus, 614665 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	GUC2C
Meconium ileus, 614665 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	DIAR6
Meconium ileus, 614665 (3)	GUCY2C, GUC2C, DIAR6, MECIL	601330	12p12.3	MECIL
Medullary cystic kidney disease 1, 174000 (3)	MUC1, PUM, MCKD1	158340	1q22	MUC1
Medullary cystic kidney disease 1, 174000 (3)	MUC1, PUM, MCKD1	158340	1q22	PUM
Medullary cystic kidney disease 1, 174000 (3)	MUC1, PUM, MCKD1	158340	1q22	MCKD1
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	UMOD
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	HNFJ1
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	FJHN
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	MCKD2
Medullary cystic kidney disease 2, 603860 (3)	UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2	191845	16p12.3	ADMCKD2
Medullary thyroid carcinoma, 155240 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Medullary thyroid carcinoma, 155240 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
Medullary thyroid carcinoma, 155240 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
Medullary thyroid carcinoma, familial, 155240 (3)	NTRK1, TRKA, MTC	191315	1q23.1	NTRK1
Medullary thyroid carcinoma, familial, 155240 (3)	NTRK1, TRKA, MTC	191315	1q23.1	TRKA
Medullary thyroid carcinoma, familial, 155240 (3)	NTRK1, TRKA, MTC	191315	1q23.1	MTC
Medulloblastoma, 155255 (3)	PTCH2	603673	1p34.1	PTCH2
Medulloblastoma, desmoplastic, 155255 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFU
Medulloblastoma, desmoplastic, 155255 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUXL
Medulloblastoma, desmoplastic, 155255 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUH
Meesmann corneal dystrophy, 122100 (3)	KRT12	601687	17q21.2	KRT12
Meesmann corneal dystrophy, 122100 (3)	KRT3	148043	12q13.13	KRT3
Megakaryoblastic leukemia, acute (2)	RBM15, SPEN, OTT	606077	1p13.3	RBM15
Megakaryoblastic leukemia, acute (2)	RBM15, SPEN, OTT	606077	1p13.3	SPEN
Megakaryoblastic leukemia, acute (2)	RBM15, SPEN, OTT	606077	1p13.3	OTT
Megakaryoblastic leukemia, acute (3)	MKL1, AMKL, MAL	606078	22q13.1-q13.2	MKL1
Megakaryoblastic leukemia, acute (3)	MKL1, AMKL, MAL	606078	22q13.1-q13.2	AMKL
Megakaryoblastic leukemia, acute (3)	MKL1, AMKL, MAL	606078	22q13.1-q13.2	MAL
Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	HEPACAM
Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	MLC2A
Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	MLC2B
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	HEPACAM
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	MLC2A
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3)	HEPACAM, MLC2A, MLC2B	611642	11q24.2	MLC2B
Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	MLC1, LVM, VL	605908	22q13.33	MLC1
Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	MLC1, LVM, VL	605908	22q13.33	LVM
Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3)	MLC1, LVM, VL	605908	22q13.33	VL
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic, 602501 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	PIK3R2, MPPH1	603157	19p13.11	PIK3R2
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3)	PIK3R2, MPPH1	603157	19p13.11	MPPH1
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	AKT3, PKBG, MPPH2	611223	1q43-q44	AKT3
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	AKT3, PKBG, MPPH2	611223	1q43-q44	PKBG
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3)	AKT3, PKBG, MPPH2	611223	1q43-q44	MPPH2
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	CCND2, MPPH3	123833	12p13.32	CCND2
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3)	CCND2, MPPH3	123833	12p13.32	MPPH3
Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3)	DHFR	126060	5q14.1	DHFR
Megaloblastic anemia-1, Finnish type, 261100 (3)	CUBN, IFCR, MGA1	602997	10p13	CUBN
Megaloblastic anemia-1, Finnish type, 261100 (3)	CUBN, IFCR, MGA1	602997	10p13	IFCR
Megaloblastic anemia-1, Finnish type, 261100 (3)	CUBN, IFCR, MGA1	602997	10p13	MGA1
Megaloblastic anemia-1, Norwegian type, 261100 (3)	AMN	605799	14q32.32	AMN
Megalocornea 1, X-linked 309300 (3)	CHRDL1, VOPT, MGC1	300350	Xq23	CHRDL1
Megalocornea 1, X-linked 309300 (3)	CHRDL1, VOPT, MGC1	300350	Xq23	VOPT
Megalocornea 1, X-linked 309300 (3)	CHRDL1, VOPT, MGC1	300350	Xq23	MGC1
Meier-Gorlin syndrome 1, 224690 (3)	ORC1, ORC1L	601902	1p32.3	ORC1
Meier-Gorlin syndrome 1, 224690 (3)	ORC1, ORC1L	601902	1p32.3	ORC1L
Meier-Gorlin syndrome 2, 613800 (3)	ORC4, ORC4L	603056	2q23.1	ORC4
Meier-Gorlin syndrome 2, 613800 (3)	ORC4, ORC4L	603056	2q23.1	ORC4L
Meier-Gorlin syndrome 3, 613803 (3)	ORC6, ORC6L	607213	16q11.2	ORC6
Meier-Gorlin syndrome 3, 613803 (3)	ORC6, ORC6L	607213	16q11.2	ORC6L
Meier-Gorlin syndrome 4, 613804 (3)	CDT1	605525	16q24.3	CDT1
Meier-Gorlin syndrome 6, 616835 (3)	GMNN, MGORS6	602842	6p22.3	GMNN
Meier-Gorlin syndrome 6, 616835 (3)	GMNN, MGORS6	602842	6p22.3	MGORS6
Meier-Gorlin syndrome 7, 617063 (3)	CDC45L, CDC45L2, MGORS7	603465	22q11.21	CDC45L
Meier-Gorlin syndrome 7, 617063 (3)	CDC45L, CDC45L2, MGORS7	603465	22q11.21	CDC45L2
Meier-Gorlin syndrome 7, 617063 (3)	CDC45L, CDC45L2, MGORS7	603465	22q11.21	MGORS7
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Melanocytic nevus syndrome, congenital, somatic, 137550 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MTS1
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	P16
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MLM
Melanoma and neural system tumor syndrome, 155755 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CMM2
Melanoma, malignant, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Melanoma, malignant, somatic (3)	BRAF, NS7	164757	7q34	NS7
Melanoma, malignant, somatic (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Melanoma, malignant, somatic (3)	STK11, PJS, LKB1	602216	19p13.3	PJS
Melanoma, malignant, somatic (3)	STK11, PJS, LKB1	602216	19p13.3	LKB1
Meleda disease, 248300 (3)	SLURP1, MDM	606119	8q24.3	SLURP1
Meleda disease, 248300 (3)	SLURP1, MDM	606119	8q24.3	MDM
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Melnick-Needles syndrome, 309350 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Melorheostosis with osteopoikilosis, 155950 (3)	LEMD3, MAN1	607844	12q14.3	LEMD3
Melorheostosis with osteopoikilosis, 155950 (3)	LEMD3, MAN1	607844	12q14.3	MAN1
Meningioma, 607174 (3)	MN1, MGCR	156100	22q12.1	MN1
Meningioma, 607174 (3)	MN1, MGCR	156100	22q12.1	MGCR
Meningioma, NF2-related, somatic, 607174 (3)	NF2	607379	22q12.2	NF2
Meningioma, SIS-related, 607174 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	PDGFB
Meningioma, SIS-related, 607174 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	SIS
Meningioma, SIS-related, 607174 (3)	PDGFB, SIS, IBGC5	190040	22q13.1	IBGC5
Meningioma, radiation-induced (2)	MNRI	606190	1p11	MNRI
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MNK
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MK
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	OHS
Menkes disease, 309400 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	SMAX3
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MED13L
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	THRAP2
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	PROSIT240
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	TRAP240L
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	KIAA1025
Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MRFACD
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MICPCH
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	FGS4
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CMG
Mental retardation and microcephaly with pontine and cerebellar hypoplasia, 300749 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MRXSNA
Mental retardation syndrome, X-linked, Armfield type (2)	MRXSA	300261	Xq28	MRXSA
Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	PHF8, ZNF422, KIAA1111, MRXSSD	300560	Xp11.22	PHF8
Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	PHF8, ZNF422, KIAA1111, MRXSSD	300560	Xp11.22	ZNF422
Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	PHF8, ZNF422, KIAA1111, MRXSSD	300560	Xp11.22	KIAA1111
Mental retardation syndrome, X-linked, Siderius type, 300263 (3)	PHF8, ZNF422, KIAA1111, MRXSSD	300560	Xp11.22	MRXSSD
Mental retardation with language impairment and with or without autistic features, 613670 (3)	FOXP1, QRF1	605515	3p13	FOXP1
Mental retardation with language impairment and with or without autistic features, 613670 (3)	FOXP1, QRF1	605515	3p13	QRF1
Mental retardation, FRA12A type, 136630 (3)	DIP2B, KIAA1463	611379	12q13.12	DIP2B
Mental retardation, FRA12A type, 136630 (3)	DIP2B, KIAA1463	611379	12q13.12	KIAA1463
Mental retardation, X-linked 1/78, 309530 (3)	IQSEC2, KIAA0522, MRX1, MRX78	300522	Xp11.22	IQSEC2
Mental retardation, X-linked 1/78, 309530 (3)	IQSEC2, KIAA0522, MRX1, MRX78	300522	Xp11.22	KIAA0522
Mental retardation, X-linked 1/78, 309530 (3)	IQSEC2, KIAA0522, MRX1, MRX78	300522	Xp11.22	MRX1
Mental retardation, X-linked 1/78, 309530 (3)	IQSEC2, KIAA0522, MRX1, MRX78	300522	Xp11.22	MRX78
Mental retardation, X-linked 102, 300958 (3)	DDX3X, DDX3, DBX, MRX102	300160	Xp11.4	DDX3X
Mental retardation, X-linked 102, 300958 (3)	DDX3X, DDX3, DBX, MRX102	300160	Xp11.4	DDX3
Mental retardation, X-linked 102, 300958 (3)	DDX3X, DDX3, DBX, MRX102	300160	Xp11.4	DBX
Mental retardation, X-linked 102, 300958 (3)	DDX3X, DDX3, DBX, MRX102	300160	Xp11.4	MRX102
Mental retardation, X-linked 12/35, 300957 (3)	THOC2, THO2, MRX12, MRX35	300395	Xq25	THOC2
Mental retardation, X-linked 12/35, 300957 (3)	THOC2, THO2, MRX12, MRX35	300395	Xq25	THO2
Mental retardation, X-linked 12/35, 300957 (3)	THOC2, THO2, MRX12, MRX35	300395	Xq25	MRX12
Mental retardation, X-linked 12/35, 300957 (3)	THOC2, THO2, MRX12, MRX35	300395	Xq25	MRX35
Mental retardation, X-linked 14 (2)	MRX14	300062	Xp11.3-q13.3	MRX14
Mental retardation, X-linked 19, 300844 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RPS6KA3
Mental retardation, X-linked 19, 300844 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	RSK2
Mental retardation, X-linked 19, 300844 (3)	RPS6KA3, RSK2, MRX19	300075	Xp22.12	MRX19
Mental retardation, X-linked 2 (2)	MRX2	300428	Xp22.3	MRX2
Mental retardation, X-linked 20 (2)	MRX20	300047	Xp11-q21	MRX20
Mental retardation, X-linked 21/34, 300143 (3)	IL1RAPL1, IL1R8, MRX21, MRX34	300206	Xp21.3-p21.2	IL1RAPL1
Mental retardation, X-linked 21/34, 300143 (3)	IL1RAPL1, IL1R8, MRX21, MRX34	300206	Xp21.3-p21.2	IL1R8
Mental retardation, X-linked 21/34, 300143 (3)	IL1RAPL1, IL1R8, MRX21, MRX34	300206	Xp21.3-p21.2	MRX21
Mental retardation, X-linked 21/34, 300143 (3)	IL1RAPL1, IL1R8, MRX21, MRX34	300206	Xp21.3-p21.2	MRX34
Mental retardation, X-linked 23 (2)	MRX23	300046	Xq23-q24	MRX23
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Mental retardation, X-linked 29 and others, 300419 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	HCFC1, HCF1, MRX3	300019	Xq28	HCFC1
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	HCFC1, HCF1, MRX3	300019	Xq28	HCF1
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3)	HCFC1, HCF1, MRX3	300019	Xq28	MRX3
Mental retardation, X-linked 30/47, 300558 (3)	PAK3, MRX30, MRX47	300142	Xq23	PAK3
Mental retardation, X-linked 30/47, 300558 (3)	PAK3, MRX30, MRX47	300142	Xq23	MRX30
Mental retardation, X-linked 30/47, 300558 (3)	PAK3, MRX30, MRX47	300142	Xq23	MRX47
Mental retardation, X-linked 41, 300849 (3)	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	GDI1
Mental retardation, X-linked 41, 300849 (3)	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	RABGD1A
Mental retardation, X-linked 41, 300849 (3)	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	MRX41
Mental retardation, X-linked 41, 300849 (3)	GDI1, RABGD1A, MRX41, MRX48	300104	Xq28	MRX48
Mental retardation, X-linked 42 (2)	MRX42	300372	Xq26	MRX42
Mental retardation, X-linked 45, 300498 (3)	ZNF81, MRX45	314998	Xp11.23	ZNF81
Mental retardation, X-linked 45, 300498 (3)	ZNF81, MRX45	314998	Xp11.23	MRX45
Mental retardation, X-linked 46, 300436 (3)	ARHGEF6, MRX46, COOL2	300267	Xq26.3	ARHGEF6
Mental retardation, X-linked 46, 300436 (3)	ARHGEF6, MRX46, COOL2	300267	Xq26.3	MRX46
Mental retardation, X-linked 46, 300436 (3)	ARHGEF6, MRX46, COOL2	300267	Xq26.3	COOL2
Mental retardation, X-linked 49/15, 300114 (3)	CLCN4, MRX49, MRX15	302910	Xp22.2	CLCN4
Mental retardation, X-linked 49/15, 300114 (3)	CLCN4, MRX49, MRX15	302910	Xp22.2	MRX49
Mental retardation, X-linked 49/15, 300114 (3)	CLCN4, MRX49, MRX15	302910	Xp22.2	MRX15
Mental retardation, X-linked 50 (2)	MRX50	300115	Xp11.3-p11.21	MRX50
Mental retardation, X-linked 52 (2)	MRX52	300504	Xp11.21-q22.3	MRX52
Mental retardation, X-linked 53 (2)	MRX53	300324	Xq22.2-q26	MRX53
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	TSPAN7
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	TM4SF2
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	MXS1
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	A15
Mental retardation, X-linked 58, 300210 (3)	TSPAN7, TM4SF2, MXS1, A15, MRX58	300096	Xp11.4	MRX58
Mental retardation, X-linked 61, 300978 (3)	RNF12, RLIM, MRX61	300379	Xq13.2	RNF12
Mental retardation, X-linked 61, 300978 (3)	RNF12, RLIM, MRX61	300379	Xq13.2	RLIM
Mental retardation, X-linked 61, 300978 (3)	RNF12, RLIM, MRX61	300379	Xq13.2	MRX61
Mental retardation, X-linked 63, 300387 (3)	ACSL4, FACL4, ACS4, MRX63	300157	Xq23	ACSL4
Mental retardation, X-linked 63, 300387 (3)	ACSL4, FACL4, ACS4, MRX63	300157	Xq23	FACL4
Mental retardation, X-linked 63, 300387 (3)	ACSL4, FACL4, ACS4, MRX63	300157	Xq23	ACS4
Mental retardation, X-linked 63, 300387 (3)	ACSL4, FACL4, ACS4, MRX63	300157	Xq23	MRX63
Mental retardation, X-linked 72, 300271 (3)	RAB39B, MRX72, WSMN	300774	Xq28	RAB39B
Mental retardation, X-linked 72, 300271 (3)	RAB39B, MRX72, WSMN	300774	Xq28	MRX72
Mental retardation, X-linked 72, 300271 (3)	RAB39B, MRX72, WSMN	300774	Xq28	WSMN
Mental retardation, X-linked 73 (2)	MRX73	300355	Xp22.2	MRX73
Mental retardation, X-linked 77 (2)	MRX77	300454	Xq12-q21.3	MRX77
Mental retardation, X-linked 78 (2)	MRX78	300551	Xp11.4-q21.1	MRX78
Mental retardation, X-linked 81 (2)	MRX81	300433	Xp11.2-q12	MRX81
Mental retardation, X-linked 82 (2)	MRX82	300518	Xq24-q25	MRX82
Mental retardation, X-linked 84 (2)	MRX84	300505	Xp11.3-q22.3	MRX84
Mental retardation, X-linked 88 (2)	MRX88	300852	Xq24	MRX88
Mental retardation, X-linked 89 (2)	MRX89	300848	Xp11.3	MRX89
Mental retardation, X-linked 9, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	FTSJ1
Mental retardation, X-linked 9, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	JM23
Mental retardation, X-linked 9, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	SPB1
Mental retardation, X-linked 9, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	MRX44
Mental retardation, X-linked 9, 309549 (3)	FTSJ1, JM23, SPB1, MRX44, MRX9	300499	Xp11.23	MRX9
Mental retardation, X-linked 90, 300850 (3)	DLG3, NEDLG, SAP102, MRX90	300189	Xq13.1	DLG3
Mental retardation, X-linked 90, 300850 (3)	DLG3, NEDLG, SAP102, MRX90	300189	Xq13.1	NEDLG
Mental retardation, X-linked 90, 300850 (3)	DLG3, NEDLG, SAP102, MRX90	300189	Xq13.1	SAP102
Mental retardation, X-linked 90, 300850 (3)	DLG3, NEDLG, SAP102, MRX90	300189	Xq13.1	MRX90
Mental retardation, X-linked 92 (2)	MRX92	300851	Xp11.3	MRX92
Mental retardation, X-linked 93, 300659 (3)	BRWD3, MRX93	300553	Xq21.1	BRWD3
Mental retardation, X-linked 93, 300659 (3)	BRWD3, MRX93	300553	Xq21.1	MRX93
Mental retardation, X-linked 94, 300699 (3)	GRIA3, GLUR3, MRX94	305915	Xq25	GRIA3
Mental retardation, X-linked 94, 300699 (3)	GRIA3, GLUR3, MRX94	305915	Xq25	GLUR3
Mental retardation, X-linked 94, 300699 (3)	GRIA3, GLUR3, MRX94	305915	Xq25	MRX94
Mental retardation, X-linked 95 (2)	MRX95	300716	Chr.X	MRX95
Mental retardation, X-linked 96, 300802 (3)	SYP, MRXSYP	313475	Xp11.23	SYP
Mental retardation, X-linked 96, 300802 (3)	SYP, MRXSYP	313475	Xp11.23	MRXSYP
Mental retardation, X-linked 97, 300803 (3)	ZNF711, ZNF6, CMPX1, MRX97	314990	Xq21.1	ZNF711
Mental retardation, X-linked 97, 300803 (3)	ZNF711, ZNF6, CMPX1, MRX97	314990	Xq21.1	ZNF6
Mental retardation, X-linked 97, 300803 (3)	ZNF711, ZNF6, CMPX1, MRX97	314990	Xq21.1	CMPX1
Mental retardation, X-linked 97, 300803 (3)	ZNF711, ZNF6, CMPX1, MRX97	314990	Xq21.1	MRX97
Mental retardation, X-linked 98, 300912 (3)	KIAA2022, MRX98	300524	Xq13.3	KIAA2022
Mental retardation, X-linked 98, 300912 (3)	KIAA2022, MRX98	300524	Xq13.3	MRX98
Mental retardation, X-linked 99, 300919 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	USP9X
Mental retardation, X-linked 99, 300919 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	DFFRX
Mental retardation, X-linked 99, 300919 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	MRX99
Mental retardation, X-linked 99, 300919 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	MRXS99F
Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	USP9X
Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	DFFRX
Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	MRX99
Mental retardation, X-linked 99, syndromic, female-restricted, 300968 (3)	USP9X, DFFRX, MRX99, MRXS99F	300072	Xp11.4	MRXS99F
Mental retardation, X-linked syndromic 16, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGD1
Mental retardation, X-linked syndromic 16, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	FGDY
Mental retardation, X-linked syndromic 16, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	AAS
Mental retardation, X-linked syndromic 16, 305400 (3)	FGD1, FGDY, AAS, MRXS16	300546	Xp11.22	MRXS16
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	AP1S2
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	MRX59
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	MRXSF
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	MRXS21
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	MRXS5
Mental retardation, X-linked syndromic 5, 304340 (3)	AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS	300629	Xp22.2	PGS
Mental retardation, X-linked syndromic 7 (2)	MRXS7	300218	Xp11.3-q22	MRXS7
Mental retardation, X-linked syndromic, Abidi type (2)	MRXSAB	300262	Xq13.2	MRXSAB
Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	SLC9A6, NHE6	300231	Xq26.3	SLC9A6
Mental retardation, X-linked syndromic, Christianson type, 300243 (3)	SLC9A6, NHE6	300231	Xq26.3	NHE6
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Mental retardation, X-linked syndromic, Lubs type, 300260 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	UBE2A, RAD6A, MRXSN, MRXS30	312180	Xq24	UBE2A
Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	UBE2A, RAD6A, MRXSN, MRXS30	312180	Xq24	RAD6A
Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	UBE2A, RAD6A, MRXSN, MRXS30	312180	Xq24	MRXSN
Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)	UBE2A, RAD6A, MRXSN, MRXS30	312180	Xq24	MRXS30
Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	ZDHHC9, DHHC9, MRXSZ	300646	Xq26.1	ZDHHC9
Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	ZDHHC9, DHHC9, MRXSZ	300646	Xq26.1	DHHC9
Mental retardation, X-linked syndromic, Raymond type, 300799 (3)	ZDHHC9, DHHC9, MRXSZ	300646	Xq26.1	MRXSZ
Mental retardation, X-linked syndromic, Turner type, 300706 (3)	HUWE1, UREB1, KIAA0312, LASU1	300697	Xp11.22	HUWE1
Mental retardation, X-linked syndromic, Turner type, 300706 (3)	HUWE1, UREB1, KIAA0312, LASU1	300697	Xp11.22	UREB1
Mental retardation, X-linked syndromic, Turner type, 300706 (3)	HUWE1, UREB1, KIAA0312, LASU1	300697	Xp11.22	KIAA0312
Mental retardation, X-linked syndromic, Turner type, 300706 (3)	HUWE1, UREB1, KIAA0312, LASU1	300697	Xp11.22	LASU1
Mental retardation, X-linked, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
Mental retardation, X-linked, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	KIAA1260
Mental retardation, X-linked, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	AUTSX2
Mental retardation, X-linked, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	ASPGX2
Mental retardation, X-linked, FRAXE type, 309548 (3)	AFF2, FMR2, FRAXE, MRX2	300806	Xq28	AFF2
Mental retardation, X-linked, FRAXE type, 309548 (3)	AFF2, FMR2, FRAXE, MRX2	300806	Xq28	FMR2
Mental retardation, X-linked, FRAXE type, 309548 (3)	AFF2, FMR2, FRAXE, MRX2	300806	Xq28	FRAXE
Mental retardation, X-linked, FRAXE type, 309548 (3)	AFF2, FMR2, FRAXE, MRX2	300806	Xq28	MRX2
Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	SMS, SRS, MRSR	300105	Xp22.11	SMS
Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	SMS, SRS, MRSR	300105	Xp22.11	SRS
Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)	SMS, SRS, MRSR	300105	Xp22.11	MRSR
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Mental retardation, X-linked, syndromic 13, 300055 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Mental retardation, X-linked, syndromic 14, 300676 (3)	UPF3B, RENT3B, MRXS14	300298	Xq24	UPF3B
Mental retardation, X-linked, syndromic 14, 300676 (3)	UPF3B, RENT3B, MRXS14	300298	Xq24	RENT3B
Mental retardation, X-linked, syndromic 14, 300676 (3)	UPF3B, RENT3B, MRXS14	300298	Xq24	MRXS14
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	CUL4B
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	MRXSC
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	MRXHF2
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	SFM2
Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)	CUL4B, MRXSC, MRXHF2, SFM2, MRXS15	300304	Xq24	MRXS15
Mental retardation, X-linked, syndromic 17 (2)	MRXS17	300858	Xp21.1-p11.23	MRXS17
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF1
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	TAF2A
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	CCG1
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	BA2R
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	DYT3
Mental retardation, X-linked, syndromic 33, 300966 (3)	TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33	313650	Xq13.1	MRXS33
Mental retardation, X-linked, syndromic 34, 300967 (3)	NONO, NRB54, MRXS34	300084	Xq13.1	NONO
Mental retardation, X-linked, syndromic 34, 300967 (3)	NONO, NRB54, MRXS34	300084	Xq13.1	NRB54
Mental retardation, X-linked, syndromic 34, 300967 (3)	NONO, NRB54, MRXS34	300084	Xq13.1	MRXS34
Mental retardation, X-linked, syndromic 9 (2)	MRXS9	300709	Xq12-q21.31	MRXS9
Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)	MRXSCS	300861	Xq21.33-q23	MRXSCS
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	KDM5C
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	JARID1C
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	SMCX
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	DXS1272E
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	XE169
Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3)	KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ	314690	Xp11.22	MRXSCJ
Mental retardation, X-linked, syndromic, Martin-Probst type (2)	MRXSMP	300519	Chr.X	MRXSMP
Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	OPHN1, MRX60	300127	Xq12	OPHN1
Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3)	OPHN1, MRX60	300127	Xq12	MRX60
Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)	SOX3, MRGH	313430	Xq27.1	SOX3
Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)	SOX3, MRGH	313430	Xq27.1	MRGH
Mental retardation, X-linked, with short stature (2)	MRSS	300360	Xq24	MRSS
Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	SOBP, JXC1, MRAMS	613667	6q21	SOBP
Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	SOBP, JXC1, MRAMS	613667	6q21	JXC1
Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3)	SOBP, JXC1, MRAMS	613667	6q21	MRAMS
Mental retardation, autosomal dominant 1, 156200 (3)	MBD5, KIAA1461, MRD1	611472	2q23.1	MBD5
Mental retardation, autosomal dominant 1, 156200 (3)	MBD5, KIAA1461, MRD1	611472	2q23.1	KIAA1461
Mental retardation, autosomal dominant 1, 156200 (3)	MBD5, KIAA1461, MRD1	611472	2q23.1	MRD1
Mental retardation, autosomal dominant 10, 614256 (3)	CACNG2, MRD10	602911	22q12.3	CACNG2
Mental retardation, autosomal dominant 10, 614256 (3)	CACNG2, MRD10	602911	22q12.3	MRD10
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNCL
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNECL
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	CMT20
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	MRD13
Mental retardation, autosomal dominant 13, 614563 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	SMALED1
Mental retardation, autosomal dominant 18, 615074 (3)	GATAD2B, KIAA1150, p68, MRD18	614998	1q21.3	GATAD2B
Mental retardation, autosomal dominant 18, 615074 (3)	GATAD2B, KIAA1150, p68, MRD18	614998	1q21.3	KIAA1150
Mental retardation, autosomal dominant 18, 615074 (3)	GATAD2B, KIAA1150, p68, MRD18	614998	1q21.3	p68
Mental retardation, autosomal dominant 18, 615074 (3)	GATAD2B, KIAA1150, p68, MRD18	614998	1q21.3	MRD18
Mental retardation, autosomal dominant 19, 615075 (3)	CTNNB1, MRD19	116806	3p22.1	CTNNB1
Mental retardation, autosomal dominant 19, 615075 (3)	CTNNB1, MRD19	116806	3p22.1	MRD19
Mental retardation, autosomal dominant 2 (4)	MRD2	614113	9p24	MRD2
Mental retardation, autosomal dominant 21, 615502 (3)	CTCF, MRD21	604167	16q22.1	CTCF
Mental retardation, autosomal dominant 21, 615502 (3)	CTCF, MRD21	604167	16q22.1	MRD21
Mental retardation, autosomal dominant 23, 615761 (3)	SETD5, KIAA1757	615743	3p25.3	SETD5
Mental retardation, autosomal dominant 23, 615761 (3)	SETD5, KIAA1757	615743	3p25.3	KIAA1757
Mental retardation, autosomal dominant 24, 615828 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	DEAF1
Mental retardation, autosomal dominant 24, 615828 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	SPN
Mental retardation, autosomal dominant 24, 615828 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	ZMYND5
Mental retardation, autosomal dominant 24, 615828 (3)	DEAF1, SPN, ZMYND5, MRD24	602635	11p15.5	MRD24
Mental retardation, autosomal dominant 26, 615834 (3)	KIAA0442, MRD26	607270	7q11.22	KIAA0442
Mental retardation, autosomal dominant 26, 615834 (3)	KIAA0442, MRD26	607270	7q11.22	MRD26
Mental retardation, autosomal dominant 29, 616078 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SETBP1
Mental retardation, autosomal dominant 29, 616078 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	KIAA0437
Mental retardation, autosomal dominant 29, 616078 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SEB
Mental retardation, autosomal dominant 29, 616078 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	MRD29
Mental retardation, autosomal dominant 3, 612580 (3)	CDH15, CDH14, CDH3, MRD3	114019	16q24.3	CDH15
Mental retardation, autosomal dominant 3, 612580 (3)	CDH15, CDH14, CDH3, MRD3	114019	16q24.3	CDH14
Mental retardation, autosomal dominant 3, 612580 (3)	CDH15, CDH14, CDH3, MRD3	114019	16q24.3	CDH3
Mental retardation, autosomal dominant 3, 612580 (3)	CDH15, CDH14, CDH3, MRD3	114019	16q24.3	MRD3
Mental retardation, autosomal dominant 30, 616083 (3)	ZMYND11, BS69, BRAM1, MRD30	608668	10p15.3	ZMYND11
Mental retardation, autosomal dominant 30, 616083 (3)	ZMYND11, BS69, BRAM1, MRD30	608668	10p15.3	BS69
Mental retardation, autosomal dominant 30, 616083 (3)	ZMYND11, BS69, BRAM1, MRD30	608668	10p15.3	BRAM1
Mental retardation, autosomal dominant 30, 616083 (3)	ZMYND11, BS69, BRAM1, MRD30	608668	10p15.3	MRD30
Mental retardation, autosomal dominant 31, 616158 (3)	PURA, PUR1, MRD31	600473	5q31.3	PURA
Mental retardation, autosomal dominant 31, 616158 (3)	PURA, PUR1, MRD31	600473	5q31.3	PUR1
Mental retardation, autosomal dominant 31, 616158 (3)	PURA, PUR1, MRD31	600473	5q31.3	MRD31
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	KAT6A
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	MYST3
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	MOZ
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	ZNF220
Mental retardation, autosomal dominant 32, 616268 (3)	KAT6A, MYST3, MOZ, ZNF220, MRD32	601408	8p11.21	MRD32
Mental retardation, autosomal dominant 33, 616311 (3)	DPP6, VF2, MRD33	126141	7q36.2	DPP6
Mental retardation, autosomal dominant 33, 616311 (3)	DPP6, VF2, MRD33	126141	7q36.2	VF2
Mental retardation, autosomal dominant 33, 616311 (3)	DPP6, VF2, MRD33	126141	7q36.2	MRD33
Mental retardation, autosomal dominant 34, 616351 (3)	COL4A3BP, GPBP, CERT, MRD34	604677	5q13.3	COL4A3BP
Mental retardation, autosomal dominant 34, 616351 (3)	COL4A3BP, GPBP, CERT, MRD34	604677	5q13.3	GPBP
Mental retardation, autosomal dominant 34, 616351 (3)	COL4A3BP, GPBP, CERT, MRD34	604677	5q13.3	CERT
Mental retardation, autosomal dominant 34, 616351 (3)	COL4A3BP, GPBP, CERT, MRD34	604677	5q13.3	MRD34
Mental retardation, autosomal dominant 35, 616355 (3)	PPP2R5D, MRD35	601646	6p21.1	PPP2R5D
Mental retardation, autosomal dominant 35, 616355 (3)	PPP2R5D, MRD35	601646	6p21.1	MRD35
Mental retardation, autosomal dominant 36, 616362 (3)	PPP2R1A, MRD36	605983	19q13.41	PPP2R1A
Mental retardation, autosomal dominant 36, 616362 (3)	PPP2R1A, MRD36	605983	19q13.41	MRD36
Mental retardation, autosomal dominant 38, 616393 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EEF1A2
Mental retardation, autosomal dominant 38, 616393 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	EIEE33
Mental retardation, autosomal dominant 38, 616393 (3)	EEF1A2, EIEE33, MRD38	602959	20q13.33	MRD38
Mental retardation, autosomal dominant 39, 616521 (3)	MYT1L, KIAA1106, MRD39	613084	2p25.3	MYT1L
Mental retardation, autosomal dominant 39, 616521 (3)	MYT1L, KIAA1106, MRD39	613084	2p25.3	KIAA1106
Mental retardation, autosomal dominant 39, 616521 (3)	MYT1L, KIAA1106, MRD39	613084	2p25.3	MRD39
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	KIRREL3
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	NEPH2
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	KIAA1867
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	KIRRE
Mental retardation, autosomal dominant 4, 612581 (3)	KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4	607761	11q24.2	MRD4
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	CHAMP1
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	ZNF828
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	C13orf8
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	KIAA1802
Mental retardation, autosomal dominant 40, 616579 (3)	CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40	616327	13q34	MRD40
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBL1XR1
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBLR1
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	IRA1
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	C21
Mental retardation, autosomal dominant 41 , 616944 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	MRD41
Mental retardation, autosomal dominant 42, 616973 (3)	GNB1, MRD42	139380	1p36.33	GNB1
Mental retardation, autosomal dominant 42, 616973 (3)	GNB1, MRD42	139380	1p36.33	MRD42
Mental retardation, autosomal dominant 43, 616977 (3)	HIVEP2, MRD43	143054	6q24.2	HIVEP2
Mental retardation, autosomal dominant 43, 616977 (3)	HIVEP2, MRD43	143054	6q24.2	MRD43
Mental retardation, autosomal dominant 5, 612621 (3)	SYNGAP1, MRD5	603384	6p21.32	SYNGAP1
Mental retardation, autosomal dominant 5, 612621 (3)	SYNGAP1, MRD5	603384	6p21.32	MRD5
Mental retardation, autosomal dominant 6, 613970 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	GRIN2B
Mental retardation, autosomal dominant 6, 613970 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	NMDAR2B
Mental retardation, autosomal dominant 6, 613970 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	MRD6
Mental retardation, autosomal dominant 6, 613970 (3)	GRIN2B, NMDAR2B, MRD6, EIEE27	138252	12p13.1	EIEE27
Mental retardation, autosomal dominant 7, 614104 (3)	DYRK1A, MNBH, MNB, MRD7	600855	21q22.13	DYRK1A
Mental retardation, autosomal dominant 7, 614104 (3)	DYRK1A, MNBH, MNB, MRD7	600855	21q22.13	MNBH
Mental retardation, autosomal dominant 7, 614104 (3)	DYRK1A, MNBH, MNB, MRD7	600855	21q22.13	MNB
Mental retardation, autosomal dominant 7, 614104 (3)	DYRK1A, MNBH, MNB, MRD7	600855	21q22.13	MRD7
Mental retardation, autosomal dominant 8, 614254 (3)	GRIN1, NMDAR1, MRD8	138249	9q34.3	GRIN1
Mental retardation, autosomal dominant 8, 614254 (3)	GRIN1, NMDAR1, MRD8	138249	9q34.3	NMDAR1
Mental retardation, autosomal dominant 8, 614254 (3)	GRIN1, NMDAR1, MRD8	138249	9q34.3	MRD8
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	ATSV
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	UNC104
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	SPG30
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	HSN2C
Mental retardation, autosomal dominant 9, 614255 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	MRD9
Mental retardation, autosomal dominant, 27, 615866 (3)	SOX11, MRD27	600898	2p25.2	SOX11
Mental retardation, autosomal dominant, 27, 615866 (3)	SOX11, MRD27	600898	2p25.2	MRD27
Mental retardation, autosomal recessive 1, 249500 (3)	PRSS12, BSSP3, MRT1	606709	4q26	PRSS12
Mental retardation, autosomal recessive 1, 249500 (3)	PRSS12, BSSP3, MRT1	606709	4q26	BSSP3
Mental retardation, autosomal recessive 1, 249500 (3)	PRSS12, BSSP3, MRT1	606709	4q26	MRT1
Mental retardation, autosomal recessive 10/20 (2)	MRT10, MRT20	611096	16p12.2-q12.1	MRT10
Mental retardation, autosomal recessive 10/20 (2)	MRT10, MRT20	611096	16p12.2-q12.1	MRT20
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GAL3
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	SIAT6
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	ST3GALII
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	MRT12
Mental retardation, autosomal recessive 12, 611090 (3)	ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15	606494	1p34.1	EIEE15
Mental retardation, autosomal recessive 13, 613192 (3)	TRAPPC9, NIBP, KIAA1882, MRT13	611966	8q24.3	TRAPPC9
Mental retardation, autosomal recessive 13, 613192 (3)	TRAPPC9, NIBP, KIAA1882, MRT13	611966	8q24.3	NIBP
Mental retardation, autosomal recessive 13, 613192 (3)	TRAPPC9, NIBP, KIAA1882, MRT13	611966	8q24.3	KIAA1882
Mental retardation, autosomal recessive 13, 613192 (3)	TRAPPC9, NIBP, KIAA1882, MRT13	611966	8q24.3	MRT13
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	TECR
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	GPSN2
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	TER
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	SC2
Mental retardation, autosomal recessive 14, 614020 (3)	TECR, GPSN2, TER, SC2, MRT14	610057	19p13.12	MRT14
Mental retardation, autosomal recessive 15, 614202 (3)	MAN1B1, MRT15	604346	9q34.3	MAN1B1
Mental retardation, autosomal recessive 15, 614202 (3)	MAN1B1, MRT15	604346	9q34.3	MRT15
Mental retardation, autosomal recessive 16 (2)	MRT16	614208	9p23-p13.3	MRT16
Mental retardation, autosomal recessive 18, 614249 (3)	MED23, MRT18	605042	6q23.2	MED23
Mental retardation, autosomal recessive 18, 614249 (3)	MED23, MRT18	605042	6q23.2	MRT18
Mental retardation, autosomal recessive 19 (2)	MRT19	614343	18p11.3	MRT19
Mental retardation, autosomal recessive 2, 607417 (3)	CRBN, MRT2	609262	3p26.2	CRBN
Mental retardation, autosomal recessive 2, 607417 (3)	CRBN, MRT2	609262	3p26.2	MRT2
Mental retardation, autosomal recessive 23 (2)	MRT23	614344	11p13-q14.1	MRT23
Mental retardation, autosomal recessive 24 (2)	MRT24	614345	6p12.2-q12	MRT24
Mental retardation, autosomal recessive 25 (2)	MRT25	614346	12q13.11-q15	MRT25
Mental retardation, autosomal recessive 27, 614340 (3)	LINS1, WINS1, FLJ10583, MRT27	610350	15q26.3	LINS1
Mental retardation, autosomal recessive 27, 614340 (3)	LINS1, WINS1, FLJ10583, MRT27	610350	15q26.3	WINS1
Mental retardation, autosomal recessive 27, 614340 (3)	LINS1, WINS1, FLJ10583, MRT27	610350	15q26.3	FLJ10583
Mental retardation, autosomal recessive 27, 614340 (3)	LINS1, WINS1, FLJ10583, MRT27	610350	15q26.3	MRT27
Mental retardation, autosomal recessive 28 (2)	MRT28	614347	6q26-q27	MRT28
Mental retardation, autosomal recessive 29 (2)	MRT29	614333	4q27-q28.2	MRT29
Mental retardation, autosomal recessive 3, 608443 (3)	CC2D1A, MRT3	610055	19p13.12	CC2D1A
Mental retardation, autosomal recessive 3, 608443 (3)	CC2D1A, MRT3	610055	19p13.12	MRT3
Mental retardation, autosomal recessive 30 (2)	MRT30	614342	6q12-q15	MRT30
Mental retardation, autosomal recessive 31 (2)	MRT31	614329	4q12-q13.1	MRT31
Mental retardation, autosomal recessive 32 (2)	MRT32	614339	14q32.13-q32.2	MRT32
Mental retardation, autosomal recessive 33 (2)	MRT33	614341	17p13.2-p13.1	MRT33
Mental retardation, autosomal recessive 34, 614499 (3)	CRADD, RAIDD, MRT34	603454	12q22	CRADD
Mental retardation, autosomal recessive 34, 614499 (3)	CRADD, RAIDD, MRT34	603454	12q22	RAIDD
Mental retardation, autosomal recessive 34, 614499 (3)	CRADD, RAIDD, MRT34	603454	12q22	MRT34
Mental retardation, autosomal recessive 35 (2)	MRT35	615162	17q21.31-q22	MRT35
Mental retardation, autosomal recessive 36, 615286 (3)	ADAT3, TAD3, MRT36	615302	19p13.3	ADAT3
Mental retardation, autosomal recessive 36, 615286 (3)	ADAT3, TAD3, MRT36	615302	19p13.3	TAD3
Mental retardation, autosomal recessive 36, 615286 (3)	ADAT3, TAD3, MRT36	615302	19p13.3	MRT36
Mental retardation, autosomal recessive 38, 615516 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
Mental retardation, autosomal recessive 38, 615516 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	SHEP1
Mental retardation, autosomal recessive 38, 615516 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	MRT38
Mental retardation, autosomal recessive 39, 615541 (3)	TTI2, C8orf41, MRT39	614426	8p12	TTI2
Mental retardation, autosomal recessive 39, 615541 (3)	TTI2, C8orf41, MRT39	614426	8p12	C8orf41
Mental retardation, autosomal recessive 39, 615541 (3)	TTI2, C8orf41, MRT39	614426	8p12	MRT39
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	TAF2
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	TAF2B
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	TAFII150
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	CIF150
Mental retardation, autosomal recessive 40, 615599 (3)	TAF2, TAF2B, TAFII150, CIF150, MRT40	604912	8q24.12	MRT40
Mental retardation, autosomal recessive 41, 615637 (3)	KPTN, 2E4, MRT41	615620	19q13.32	KPTN
Mental retardation, autosomal recessive 41, 615637 (3)	KPTN, 2E4, MRT41	615620	19q13.32	2E4
Mental retardation, autosomal recessive 41, 615637 (3)	KPTN, 2E4, MRT41	615620	19q13.32	MRT41
Mental retardation, autosomal recessive 42, 615802 (3)	PGAP1, MRT42	611655	2q33.1	PGAP1
Mental retardation, autosomal recessive 42, 615802 (3)	PGAP1, MRT42	611655	2q33.1	MRT42
Mental retardation, autosomal recessive 44, 615942 (3)	METTL23, C17orf95, MRT44	615262	17q25.1	METTL23
Mental retardation, autosomal recessive 44, 615942 (3)	METTL23, C17orf95, MRT44	615262	17q25.1	C17orf95
Mental retardation, autosomal recessive 44, 615942 (3)	METTL23, C17orf95, MRT44	615262	17q25.1	MRT44
Mental retardation, autosomal recessive 46, 616116 (3)	NDST1, HSST, MRT46	600853	5q33.1	NDST1
Mental retardation, autosomal recessive 46, 616116 (3)	NDST1, HSST, MRT46	600853	5q33.1	HSST
Mental retardation, autosomal recessive 46, 616116 (3)	NDST1, HSST, MRT46	600853	5q33.1	MRT46
Mental retardation, autosomal recessive 47, 616193 (3)	FMN2, MRT47	606373	1q43	FMN2
Mental retardation, autosomal recessive 47, 616193 (3)	FMN2, MRT47	606373	1q43	MRT47
Mental retardation, autosomal recessive 48, 616269 (3)	SLC6A17, NTT4, MRT48	610299	1p13.3	SLC6A17
Mental retardation, autosomal recessive 48, 616269 (3)	SLC6A17, NTT4, MRT48	610299	1p13.3	NTT4
Mental retardation, autosomal recessive 48, 616269 (3)	SLC6A17, NTT4, MRT48	610299	1p13.3	MRT48
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	NSUN2
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	TRM4
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	SAKI
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	MISU
Mental retardation, autosomal recessive 5, 611091 (3)	NSUN2, TRM4, SAKI, MISU, MRT5	610916	5p15.31	MRT5
Mental retardation, autosomal recessive 51, 616739 (3)	HNMT, MRT51	605238	2q22.1	HNMT
Mental retardation, autosomal recessive 51, 616739 (3)	HNMT, MRT51	605238	2q22.1	MRT51
Mental retardation, autosomal recessive 53, 616917 (3)	PIGG, GPI7, MRT53	616918	4p16.3	PIGG
Mental retardation, autosomal recessive 53, 616917 (3)	PIGG, GPI7, MRT53	616918	4p16.3	GPI7
Mental retardation, autosomal recessive 53, 616917 (3)	PIGG, GPI7, MRT53	616918	4p16.3	MRT53
Mental retardation, autosomal recessive 54, 617028 (3)	TNIK, KIAA0551, MRT54	610005	3q26.2-q26.3	TNIK
Mental retardation, autosomal recessive 54, 617028 (3)	TNIK, KIAA0551, MRT54	610005	3q26.2-q26.3	KIAA0551
Mental retardation, autosomal recessive 54, 617028 (3)	TNIK, KIAA0551, MRT54	610005	3q26.2-q26.3	MRT54
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	TUSC3
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	M33
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	D8S1992
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	MRT7
Mental retardation, autosomal recessive 7, 611093 (3)	TUSC3, M33, D8S1992, MRT7, MRT22	601385	8p22	MRT22
Mental retardation, autosomal recessive, 11 (2)	MRT11	611097	19q13.2-q13.3	MRT11
Mental retardation, autosomal recessive, 4 (2)	MRT4	611107	1p21.1-p13.3	MRT4
Mental retardation, autosomal recessive, 6, 611092 (3)	GRIK2, GLUR6, MRT6	138244	6q16.3	GRIK2
Mental retardation, autosomal recessive, 6, 611092 (3)	GRIK2, GLUR6, MRT6	138244	6q16.3	GLUR6
Mental retardation, autosomal recessive, 6, 611092 (3)	GRIK2, GLUR6, MRT6	138244	6q16.3	MRT6
Mental retardation, autosomal recessive, 8 (2)	MRT8	611094	10q22	MRT8
Mental retardation, autosomal recessive, 9/26 (2)	MRT9, MRT26	611095	14q11.2-q12	MRT9
Mental retardation, autosomal recessive, 9/26 (2)	MRT9, MRT26	611095	14q11.2-q12	MRT26
Mental retardation, severe, with spasticity and tapetoretinal degeneration (2)	MRST	602685	15q24	MRST
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	MEF2C
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	C5DELq14.3
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3)	MEF2C, C5DELq14.3, DEL5q14.3	600662	5q14.3	DEL5q14.3
Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	INPP5E
Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	MORMS
Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	JBTS1
Mental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3)	INPP5E, MORMS, JBTS1, CORS1	613037	9q34.3	CORS1
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CASK
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MICPCH
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	FGS4
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	CMG
Mental retardation, with or without nystagmus, 300422 (3)	CASK, MICPCH, FGS4, CMG, MRXSNA	300172	Xp11.4	MRXSNA
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	ATRX
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XH2
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	XNP
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SHS
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	SFM1
Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)	ATRX, XH2, XNP, SHS, SFM1, MRXHF1	300032	Xq21.1	MRXHF1
Mental retardation-skeletal dysplasia (2)	MRSD, CHRS	309620	Xq28	MRSD
Mental retardation-skeletal dysplasia (2)	MRSD, CHRS	309620	Xq28	CHRS
Mephenytoin poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Mephenytoin poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C19
Mercer-Ba syndrome, 617061 (3)	TRIO, MEBAS	601893	5p15.2	TRIO
Mercer-Ba syndrome, 617061 (3)	TRIO, MEBAS	601893	5p15.2	MEBAS
Merkel cell carcinoma, somatic (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Merkel cell carcinoma, somatic (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Merkel cell carcinoma, somatic (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Mesomelia-synostoses syndrome (4)	DEL8q13, C8DELq13	600383	8q13	DEL8q13
Mesomelia-synostoses syndrome (4)	DEL8q13, C8DELq13	600383	8q13	C8DELq13
Mesomelic dysplasia, Kantaputra type (2)	MMDK, MDK	156232	2q24-q32	MMDK
Mesomelic dysplasia, Kantaputra type (2)	MMDK, MDK	156232	2q24-q32	MDK
Mesothelioma, somatic, 156240 (3)	WT1, NPHS4	607102	11p13	WT1
Mesothelioma, somatic, 156240 (3)	WT1, NPHS4	607102	11p13	NPHS4
Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	TANGO2, C22orf25, MECRCN	616830	22q11.21	TANGO2
Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	TANGO2, C22orf25, MECRCN	616830	22q11.21	C22orf25
Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3)	TANGO2, C22orf25, MECRCN	616830	22q11.21	MECRCN
Metacarpal 4-5 fusion, 309630 (3)	FGF16, MF4	300827	Xq21.1	FGF16
Metacarpal 4-5 fusion, 309630 (3)	FGF16, MF4	300827	Xq21.1	MF4
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTP2C
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	SHP2
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	NS1
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	JMML
Metachondromatosis, 156250 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	METCDS
Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)	PSAP, SAP1	176801	10q22.1	PSAP
Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3)	PSAP, SAP1	176801	10q22.1	SAP1
Metachromatic leukodystrophy, 250100 (3)	ARSA	607574	22q13.33	ARSA
Metaphyseal anadysplasia 1, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Metaphyseal anadysplasia 1, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	CLG3
Metaphyseal anadysplasia 1, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MANDP1
Metaphyseal anadysplasia 1, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MDST
Metaphyseal anadysplasia 2, 613073 (3)	MMP9, CLG4B, MANDP2	120361	20q13.12	MMP9
Metaphyseal anadysplasia 2, 613073 (3)	MMP9, CLG4B, MANDP2	120361	20q13.12	CLG4B
Metaphyseal anadysplasia 2, 613073 (3)	MMP9, CLG4B, MANDP2	120361	20q13.12	MANDP2
Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR1
Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PTHR
Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3)	PTHR1, PTHR, PFE	168468	3p21.31	PFE
Metaphyseal chondrodysplasia, Schmid type, 156500 (3)	COL10A1	120110	6q22.1	COL10A1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	RUNX2
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CBFA1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	PEBP2A1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	AML3
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CCD
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3)	RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD	600211	6p21.1	CLCD
Metaphyseal dysplasia without hypotrichosis, 250460 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRP
Metaphyseal dysplasia without hypotrichosis, 250460 (3)	RMRP, RMRPR, CHH	157660	9p13.3	RMRPR
Metaphyseal dysplasia without hypotrichosis, 250460 (3)	RMRP, RMRPR, CHH	157660	9p13.3	CHH
Metaphyseal dysplasia, Spahr type, 250400 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Metaphyseal dysplasia, Spahr type, 250400 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	CLG3
Metaphyseal dysplasia, Spahr type, 250400 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MANDP1
Metaphyseal dysplasia, Spahr type, 250400 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MDST
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Metatropic dysplasia, 156530 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Methemoglobinemia, type I, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	CYB5R3
Methemoglobinemia, type I, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	DIA1
Methemoglobinemia, type I, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	B5R
Methemoglobinemia, type II, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	CYB5R3
Methemoglobinemia, type II, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	DIA1
Methemoglobinemia, type II, 250800 (3)	CYB5R3, DIA1, B5R	613213	22q13.2	B5R
Methemoglobinemia, type IV, 250790 (3)	CYB5A, MCB5	613218	18q22.3	CYB5A
Methemoglobinemia, type IV, 250790 (3)	CYB5A, MCB5	613218	18q22.3	MCB5
Methemoglobinemias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBA1
Methemoglobinemias, alpha- (3)	HBA1, HBH	141800	16p13.3	HBH
Methemoglobinemias, beta- (3)	HBB	141900	11p15.4	HBB
Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MAT1A
Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	MATA1
Methionine adenosyltransferase deficiency, autosomal recessive, 250850 (3)	MAT1A, MATA1, SAMS1	610550	10q22.3	SAMS1
Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	ALDH6A1, MMSDH	603178	14q24.3	ALDH6A1
Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)	ALDH6A1, MMSDH	603178	14q24.3	MMSDH
Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)	MMACHC	609831	1p34.1	MMACHC
Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Methylmalonic aciduria and homocystinuria, cblD type, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	MMADHC
Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	LMBRD1, LMBD1, NESI, MAHCF	612625	6q13	LMBRD1
Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	LMBRD1, LMBD1, NESI, MAHCF	612625	6q13	LMBD1
Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	LMBRD1, LMBD1, NESI, MAHCF	612625	6q13	NESI
Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)	LMBRD1, LMBD1, NESI, MAHCF	612625	6q13	MAHCF
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	ABCD4
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	PXMP1L
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	P79R
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	PMP69
Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3)	ABCD4, PXMP1L, P79R, PMP69, MAHCJ	603214	14q24.3	MAHCJ
Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	CD320, 8D6, 8D6A, TCBLR	606475	19p13.2	CD320
Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	CD320, 8D6, 8D6A, TCBLR	606475	19p13.2	8D6
Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	CD320, 8D6, 8D6A, TCBLR	606475	19p13.2	8D6A
Methylmalonic aciduria due to transcobalamin receptor defect, 613646 (3)	CD320, 8D6, 8D6A, TCBLR	606475	19p13.2	TCBLR
Methylmalonic aciduria, cblD type, variant 2, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	C2orf25
Methylmalonic aciduria, cblD type, variant 2, 277410 (3)	C2orf25, MMADHC	611935	2q23.2	MMADHC
Methylmalonic aciduria, mut(0) type, 251000 (3)	MUT, MCM	609058	6p12.3	MUT
Methylmalonic aciduria, mut(0) type, 251000 (3)	MUT, MCM	609058	6p12.3	MCM
Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)	MMAA	607481	4q31.21	MMAA
Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3)	MMAB	607568	12q24.11	MMAB
Methylmalonyl-CoA epimerase deficiency, 251120 (3)	MCEE	608419	2p13.3	MCEE
Mevalonic aciduria, 610377 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Mevalonic aciduria, 610377 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVLK
Mevalonic aciduria, 610377 (3)	MVK, MVLK, POROK3	251170	12q24.11	POROK3
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RNU4ATAC
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	U4ATAC
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	MOPD1
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	TALS
Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RFMN
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	PCNT
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	PCNT2
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	KEN
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	SCKL4
Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3)	PCNT, PCNT2, KEN, SCKL4, MOPD2	605925	21q22.3	MOPD2
Microcephaly 1, primary, autosomal recessive, 251200 (3)	MCPH1	607117	8p23.1	MCPH1
Microcephaly 15, primary, autosomal recessive, 616486 (3)	MFSD2A, MCPH15	614397	1p34.2	MFSD2A
Microcephaly 15, primary, autosomal recessive, 616486 (3)	MFSD2A, MCPH15	614397	1p34.2	MCPH15
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	WDR62, C19orf14, MCPH2	613583	19q13.12	WDR62
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	WDR62, C19orf14, MCPH2	613583	19q13.12	C19orf14
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3)	WDR62, C19orf14, MCPH2	613583	19q13.12	MCPH2
Microcephaly 3, primary, autosomal recessive, 604804 (3)	CDK5RAP2, KIAA1633, MCPH3	608201	9q33.2	CDK5RAP2
Microcephaly 3, primary, autosomal recessive, 604804 (3)	CDK5RAP2, KIAA1633, MCPH3	608201	9q33.2	KIAA1633
Microcephaly 3, primary, autosomal recessive, 604804 (3)	CDK5RAP2, KIAA1633, MCPH3	608201	9q33.2	MCPH3
Microcephaly 4, primary, autosomal recessive, 604321 (3)	CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	CASC5
Microcephaly 4, primary, autosomal recessive, 604321 (3)	CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	AF15Q14
Microcephaly 4, primary, autosomal recessive, 604321 (3)	CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	KIAA1570
Microcephaly 4, primary, autosomal recessive, 604321 (3)	CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	D40
Microcephaly 4, primary, autosomal recessive, 604321 (3)	CASC5, AF15Q14, KIAA1570, D40, MCPH4	609173	15q15.1	MCPH4
Microcephaly 5, primary, autosomal recessive, 608716 (3)	ASPM, MCPH5	605481	1q31.3	ASPM
Microcephaly 5, primary, autosomal recessive, 608716 (3)	ASPM, MCPH5	605481	1q31.3	MCPH5
Microcephaly 6, primary, autosomal recessive, 608393 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CENPJ
Microcephaly 6, primary, autosomal recessive, 608393 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	CPAP
Microcephaly 6, primary, autosomal recessive, 608393 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	MCPH6
Microcephaly 6, primary, autosomal recessive, 608393 (3)	CENPJ, CPAP, MCPH6, SCKL4	609279	13q12.12-q12.13	SCKL4
Microcephaly 7, primary, autosomal recessive, 612703 (3)	STIL, SIL, MCPH7	181590	1p33	STIL
Microcephaly 7, primary, autosomal recessive, 612703 (3)	STIL, SIL, MCPH7	181590	1p33	SIL
Microcephaly 7, primary, autosomal recessive, 612703 (3)	STIL, SIL, MCPH7	181590	1p33	MCPH7
Microcephaly 9, primary, autosomal recessive, 614852 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	CEP152
Microcephaly 9, primary, autosomal recessive, 614852 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	KIAA0912
Microcephaly 9, primary, autosomal recessive, 614852 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	MCPH9
Microcephaly 9, primary, autosomal recessive, 614852 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	SCKL5
Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	TUBGCP6, GCP6, KIAA1669, MCCRP1	610053	22q13.33	TUBGCP6
Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	TUBGCP6, GCP6, KIAA1669, MCCRP1	610053	22q13.33	GCP6
Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	TUBGCP6, GCP6, KIAA1669, MCCRP1	610053	22q13.33	KIAA1669
Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3)	TUBGCP6, GCP6, KIAA1669, MCCRP1	610053	22q13.33	MCCRP1
Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	PLK4, STK18, SAK, MCCRP2	605031	4q28.1	PLK4
Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	PLK4, STK18, SAK, MCCRP2	605031	4q28.1	STK18
Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	PLK4, STK18, SAK, MCCRP2	605031	4q28.1	SAK
Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3)	PLK4, STK18, SAK, MCCRP2	605031	4q28.1	MCCRP2
Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	TUBGCP4, GCP4, MCCRP3	609610	15q15.3	TUBGCP4
Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	TUBGCP4, GCP4, MCCRP3	609610	15q15.3	GCP4
Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3)	TUBGCP4, GCP4, MCCRP3	609610	15q15.3	MCCRP3
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	KIF11, KNSL1, MCLMR	148760	10q23.33	KIF11
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	KIF11, KNSL1, MCLMR	148760	10q23.33	KNSL1
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3)	KIF11, KNSL1, MCLMR	148760	10q23.33	MCLMR
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	SLC25A19
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	DNC
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	MUP1
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	MCPHA
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	THMD3
Microcephaly, Amish type, 607196 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	THMD4
Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	MSMO1, SC4MOL, ERG25, MCCPD	607545	4q32.3	MSMO1
Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	MSMO1, SC4MOL, ERG25, MCCPD	607545	4q32.3	SC4MOL
Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	MSMO1, SC4MOL, ERG25, MCCPD	607545	4q32.3	ERG25
Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3)	MSMO1, SC4MOL, ERG25, MCCPD	607545	4q32.3	MCCPD
Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	IER3IP1, MEDS	609382	18q21.1	IER3IP1
Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)	IER3IP1, MEDS	609382	18q21.1	MEDS
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	MED17
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	CRSP6
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	CRSP77
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	TRAP80
Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3)	MED17, CRSP6, CRSP77, TRAP80, DRIP80	603810	11q21	DRIP80
Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	QARS, GLNRS, MSCCA	603727	3p21.31	QARS
Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	QARS, GLNRS, MSCCA	603727	3p21.31	GLNRS
Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3)	QARS, GLNRS, MSCCA	603727	3p21.31	MSCCA
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	PNKP
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	PNK
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	MCSZ
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	EIEE10
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	MCSZ
Microcephaly, seizures, and developmental delay, 613402 (3)	PNKP, PNK, MCSZ, EIEE10, MCSZ, AOA4	605610	19q13.33	AOA4
Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	TRMT10A, RG9MTD2, MSSGM1	616013	4q23	TRMT10A
Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	TRMT10A, RG9MTD2, MSSGM1	616013	4q23	RG9MTD2
Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3)	TRMT10A, RG9MTD2, MSSGM1	616013	4q23	MSSGM1
Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	PPP1R15B, CREP, MSSGM2	613257	1q32.1	PPP1R15B
Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	PPP1R15B, CREP, MSSGM2	613257	1q32.1	CREP
Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3)	PPP1R15B, CREP, MSSGM2	613257	1q32.1	MSSGM2
Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	RTTN, MSSP	610436	18q22.2	RTTN
Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3)	RTTN, MSSP	610436	18q22.2	MSSP
Microcephaly-capillary malformation syndrome, 614261 (3)	STAMBP, AMSH, MICCAP	606247	2p13.1	STAMBP
Microcephaly-capillary malformation syndrome, 614261 (3)	STAMBP, AMSH, MICCAP	606247	2p13.1	AMSH
Microcephaly-capillary malformation syndrome, 614261 (3)	STAMBP, AMSH, MICCAP	606247	2p13.1	MICCAP
Microcoria, congenital (4)	MCOR, C13DELq32, DEL13q32	156600	13q32	MCOR
Microcoria, congenital (4)	MCOR, C13DELq32, DEL13q32	156600	13q32	C13DELq32
Microcoria, congenital (4)	MCOR, C13DELq32, DEL13q32	156600	13q32	DEL13q32
Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	ADAMTS18, MMCAT	607512	16q23.1	ADAMTS18
Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3)	ADAMTS18, MMCAT	607512	16q23.1	MMCAT
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Microphthalmia with cataract 1 (2)	MCOPCT1	156850	16p13.3	MCOPCT1
Microphthalmia with coloboma 1 (2)	MCOPCB1	300345	Chr.X	MCOPCB1
Microphthalmia with coloboma 2 (2)	MCOPCB2	605738	15q12-q15	MCOPCB2
Microphthalmia with coloboma 3, 610092 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	CHX10
Microphthalmia with coloboma 3, 610092 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	HOX10
Microphthalmia with coloboma 3, 610092 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	MCOP2
Microphthalmia with coloboma 3, 610092 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	MCOPCB3
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HPE3
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HLP3
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SMMCI
Microphthalmia with coloboma 5, 611638 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	MCOPCB5
Microphthalmia with coloboma 6, 613703 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Microphthalmia with coloboma 6, 613703 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	KFS3
Microphthalmia with coloboma 6, 613703 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOPCB6
Microphthalmia with coloboma 6, 613703 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOP7
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOP4
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	KFS1
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOPCB6
Microphthalmia with coloboma 6, digenic, 613703 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	LCA17
Microphthalmia with limb anomalies, 206920 (3)	SMOC1, OAS	608488	14q24.2	SMOC1
Microphthalmia with limb anomalies, 206920 (3)	SMOC1, OAS	608488	14q24.2	OAS
Microphthalmia, isolated 1 (2)	MCOP1	251600	14q32	MCOP1
Microphthalmia, isolated 2, 610093 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	CHX10
Microphthalmia, isolated 2, 610093 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	HOX10
Microphthalmia, isolated 2, 610093 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	MCOP2
Microphthalmia, isolated 2, 610093 (3)	CHX10, HOX10, MCOP2, MCOPCB3	142993	14q24.3	MCOPCB3
Microphthalmia, isolated 3, 611038 (3)	RAX, RX, MCOP3	601881	18q21.32	RAX
Microphthalmia, isolated 3, 611038 (3)	RAX, RX, MCOP3	601881	18q21.32	RX
Microphthalmia, isolated 3, 611038 (3)	RAX, RX, MCOP3	601881	18q21.32	MCOP3
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	GDF6
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOP4
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	KFS1
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	MCOPCB6
Microphthalmia, isolated 4, 613094 (3)	GDF6, MCOP4, KFS1, MCOPCB6, LCA17	601147	8q22.1	LCA17
Microphthalmia, isolated 5, 611040 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MFRP
Microphthalmia, isolated 5, 611040 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MCOP5
Microphthalmia, isolated 5, 611040 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	NNO2
Microphthalmia, isolated 6, 613517 (3)	PRSS56, MCOP6	613858	2q37.1	PRSS56
Microphthalmia, isolated 6, 613517 (3)	PRSS56, MCOP6	613858	2q37.1	MCOP6
Microphthalmia, isolated 7, 613704 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	GDF3
Microphthalmia, isolated 7, 613704 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	KFS3
Microphthalmia, isolated 7, 613704 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOPCB6
Microphthalmia, isolated 7, 613704 (3)	GDF3, KFS3, MCOPCB6, MCOP7	606522	12p13.31	MCOP7
Microphthalmia, isolated 8, 615113 (3)	ALDH1A3, ALDH6, MCOP8	600463	15q26.3	ALDH1A3
Microphthalmia, isolated 8, 615113 (3)	ALDH1A3, ALDH6, MCOP8	600463	15q26.3	ALDH6
Microphthalmia, isolated 8, 615113 (3)	ALDH1A3, ALDH6, MCOP8	600463	15q26.3	MCOP8
Microphthalmia, isolated, with coloboma 10, 616428 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RBP4
Microphthalmia, isolated, with coloboma 10, 616428 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RDCCAS
Microphthalmia, isolated, with coloboma 10, 616428 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	MCOPCB10
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MTABC3
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MCOPCB7
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	LAN
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	DUH3
Microphthalmia, isolated, with coloboma 7, 614497 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	PSHK2
Microphthalmia, isolated, with coloboma 8, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	STRA6
Microphthalmia, isolated, with coloboma 8, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	MCOPS9
Microphthalmia, isolated, with coloboma 8, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	MCOPCB8
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	TENM3
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	ODZ3
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	TNM3
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	KIAA1455
Microphthalmia, isolated, with coloboma 9, 615145 (3)	TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9	610083	4q34.3-q35.1	MCOPCB9
Microphthalmia, syndromic 12, 615524 (3)	RARB, HAP, MCOPS12	180220	3p24.2	RARB
Microphthalmia, syndromic 12, 615524 (3)	RARB, HAP, MCOPS12	180220	3p24.2	HAP
Microphthalmia, syndromic 12, 615524 (3)	RARB, HAP, MCOPS12	180220	3p24.2	MCOPS12
Microphthalmia, syndromic 14, 615877 (3)	MAB21L2, MCOPS14	604357	4q31.3	MAB21L2
Microphthalmia, syndromic 14, 615877 (3)	MAB21L2, MCOPS14	604357	4q31.3	MCOPS14
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	BCOR
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	KIAA1575
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	MCOPS2
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	MAA2
Microphthalmia, syndromic 2, 300166 (3)	BCOR, KIAA1575, MCOPS2, MAA2, ANOP2	300485	Xp11.4	ANOP2
Microphthalmia, syndromic 3, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	SOX2
Microphthalmia, syndromic 3, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	MCOPS3
Microphthalmia, syndromic 5, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Microphthalmia, syndromic 5, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	MCOPS5
Microphthalmia, syndromic 5, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	CPHD6
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP4
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP2B1
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP2B
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	MCOPS6
Microphthalmia, syndromic 6, 607932 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	OFC11
Microphthalmia, syndromic 8 (2)	MCOPS8, MMEP	601349	6q21	MCOPS8
Microphthalmia, syndromic 8 (2)	MCOPS8, MMEP	601349	6q21	MMEP
Microphthalmia, syndromic 9, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	STRA6
Microphthalmia, syndromic 9, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	MCOPS9
Microphthalmia, syndromic 9, 601186 (3)	STRA6, MCOPS9, MCOPCB8	610745	15q24.1	MCOPCB8
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP3
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	GLC3D
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	MSPKA
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	WMS3
Microtia with nasolacrimal duct imperforation and eye coloboma (1)	MNDEC	611863	4p16-p15	MNDEC
Microvillus inclusion disease, 251850 (3)	MYO5B, KIAA1119	606540	18q21.1	MYO5B
Microvillus inclusion disease, 251850 (3)	MYO5B, KIAA1119	606540	18q21.1	KIAA1119
Migraine, familial basilar, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Migraine, familial basilar, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	FHM2
Migraine, familial basilar, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	MHP2
Migraine, familial hemiplegic, 1, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNA1A
Migraine, familial hemiplegic, 1, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNL1A4
Migraine, familial hemiplegic, 1, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	SCA6
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNA1A
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNL1A4
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia, 141500 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	SCA6
Migraine, familial hemiplegic, 2, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	ATP1A2
Migraine, familial hemiplegic, 2, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	FHM2
Migraine, familial hemiplegic, 2, 602481 (3)	ATP1A2, FHM2, MHP2	182340	1q23.2	MHP2
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SCN1A
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	GEFSP2
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	SMEI
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FEB3A
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	EIEE6
Migraine, familial hemiplegic, 3, 609634 (3)	SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3	182389	2q24.3	FHM3
Miles-Carpenter syndrome (2)	MCS, MRXS4	309605	Xq13-q22	MCS
Miles-Carpenter syndrome (2)	MCS, MRXS4	309605	Xq13-q22	MRXS4
Miller syndrome, 263750 (3)	DHODH, URA1, POADS	126064	16q22.2	DHODH
Miller syndrome, 263750 (3)	DHODH, URA1, POADS	126064	16q22.2	URA1
Miller syndrome, 263750 (3)	DHODH, URA1, POADS	126064	16q22.2	POADS
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	MDLS
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	MDS
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	MDCR
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	DEL17p13.3
Miller-Dieker lissencephaly syndrome (4)	MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3	247200	17p13.3	C17DELp13.3
Minicore myopathy with external ophthalmoplegia, 255320 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Minicore myopathy with external ophthalmoplegia, 255320 (3)	RYR1, MHS, CCO	180901	19q13.2	MHS
Minicore myopathy with external ophthalmoplegia, 255320 (3)	RYR1, MHS, CCO	180901	19q13.2	CCO
Mirror movements 1, 157600 (3)	DCC, MRMV1	120470	18q21.2	DCC
Mirror movements 1, 157600 (3)	DCC, MRMV1	120470	18q21.2	MRMV1
Mirror movements 2, 614508 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	RAD51A
Mirror movements 2, 614508 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	RECA
Mirror movements 2, 614508 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	MRMV2
Mismatch repair cancer syndrome, 276300 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Mismatch repair cancer syndrome, 276300 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	COCA2
Mismatch repair cancer syndrome, 276300 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	HNPCC2
Mismatch repair cancer syndrome, 276300 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Mismatch repair cancer syndrome, 276300 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	COCA1
Mismatch repair cancer syndrome, 276300 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	FCC1
Mismatch repair cancer syndrome, 276300 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	HNPCC1
Mismatch repair cancer syndrome, 276300 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	MSH6
Mismatch repair cancer syndrome, 276300 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	GTBP
Mismatch repair cancer syndrome, 276300 (3)	MSH6, GTBP, HNPCC5	600678	2p16.3	HNPCC5
Mismatch repair cancer syndrome, 276300 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMS2
Mismatch repair cancer syndrome, 276300 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	PMSL2
Mismatch repair cancer syndrome, 276300 (3)	PMS2, PMSL2, HNPCC4	600259	7p22.1	HNPCC4
Mitchell-Riley syndrome, 615710 (3)	RFX6, RFXDC1, MTCHRS	612659	6q22.1	RFX6
Mitchell-Riley syndrome, 615710 (3)	RFX6, RFXDC1, MTCHRS	612659	6q22.1	RFXDC1
Mitchell-Riley syndrome, 615710 (3)	RFX6, RFXDC1, MTCHRS	612659	6q22.1	MTCHRS
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	TYMP
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	ECGF1
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	MNGIE
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	PDECGF
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	MEDPS1
Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)	TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1	131222	22q13.33	MTDPS1
Mitochondrial DNA depletion syndrome 11, 615084 (3)	MGME1, C20orf72, MTDPS11	615076	20p11.23	MGME1
Mitochondrial DNA depletion syndrome 11, 615084 (3)	MGME1, C20orf72, MTDPS11	615076	20p11.23	C20orf72
Mitochondrial DNA depletion syndrome 11, 615084 (3)	MGME1, C20orf72, MTDPS11	615076	20p11.23	MTDPS11
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	SLC25A4
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	ANT1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	T1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEO3
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEO2
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	MTDPS12
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type), 615418 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEOA2
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	FBXL4, FBL4, MTDPS13	605654	6q16.1-q16.2	FBXL4
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	FBXL4, FBL4, MTDPS13	605654	6q16.1-q16.2	FBL4
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3)	FBXL4, FBL4, MTDPS13	605654	6q16.1-q16.2	MTDPS13
Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	TK2, MTDPS2	188250	16q21	TK2
Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)	TK2, MTDPS2	188250	16q21	MTDPS2
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	DGUOK, DGK, MTDPS3	601465	2p13.1	DGUOK
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	DGUOK, DGK, MTDPS3	601465	2p13.1	DGK
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3)	DGUOK, DGK, MTDPS3	601465	2p13.1	MTDPS3
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG1
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLGA
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	PEO
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SANDO
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SCAE
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4A
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4B
Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MIRAS
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG1
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLGA
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	PEO
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SANDO
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SCAE
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4A
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4B
Mitochondrial DNA depletion syndrome 4B (MNGIE type), 613662 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MIRAS
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	SUCLA2, MTDPS5	603921	13q14.2	SUCLA2
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3)	SUCLA2, MTDPS5	603921	13q14.2	MTDPS5
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	MPV17, MTDPS6	137960	2p23.3	MPV17
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3)	MPV17, MTDPS6	137960	2p23.3	MTDPS6
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	C10orf2
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWINKLE
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PEOA3
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	IOSCA
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	MTDPS7
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PRLTS5
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	P53R2
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	PEOA5
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8A
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8B
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	P53R2
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	PEOA5
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8A
Mitochondrial DNA depletion syndrome 8B (MNGIE type), 612075 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8B
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	SUCLG1, SUCLA1, MTDPS9	611224	2p11.2	SUCLG1
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	SUCLG1, SUCLA1, MTDPS9	611224	2p11.2	SUCLA1
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3)	SUCLG1, SUCLA1, MTDPS9	611224	2p11.2	MTDPS9
Mitochondrial complex 1 deficiency, 252010 (3)	NDUFAF5, C20orf7	612360	20p12.1	NDUFAF5
Mitochondrial complex 1 deficiency, 252010 (3)	NDUFAF5, C20orf7	612360	20p12.1	C20orf7
Mitochondrial complex I deficiency due to ACAD9 deficiency, 611126 (3)	ACAD9	611103	3q21.3	ACAD9
Mitochondrial complex I deficiency, 252010 (3)	FOXRED1	613622	11q24.2	FOXRED1
Mitochondrial complex I deficiency, 252010 (3)	NDUFA1, MWFE	300078	Xq24	NDUFA1
Mitochondrial complex I deficiency, 252010 (3)	NDUFA1, MWFE	300078	Xq24	MWFE
Mitochondrial complex I deficiency, 252010 (3)	NDUFA11	612638	19p13.3	NDUFA11
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF1, CIA30, CGI65	606934	15q15.1	NDUFAF1
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF1, CIA30, CGI65	606934	15q15.1	CIA30
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF1, CIA30, CGI65	606934	15q15.1	CGI65
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFAF2
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	NDUFA12L
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	MMTN
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF2, NDUFA12L, MMTN, B17.2L	609653	5q12.1	B17.2L
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF3	612911	3p21.31	NDUFAF3
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF4, HRPAP20, C6orf66	611776	6q16.1	NDUFAF4
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF4, HRPAP20, C6orf66	611776	6q16.1	HRPAP20
Mitochondrial complex I deficiency, 252010 (3)	NDUFAF4, HRPAP20, C6orf66	611776	6q16.1	C6orf66
Mitochondrial complex I deficiency, 252010 (3)	NDUFB3	603839	2q33.1	NDUFB3
Mitochondrial complex I deficiency, 252010 (3)	NDUFS1	157655	2q33.3	NDUFS1
Mitochondrial complex I deficiency, 252010 (3)	NDUFS2	602985	1q23.3	NDUFS2
Mitochondrial complex I deficiency, 252010 (3)	NDUFS3	603846	11p11.2	NDUFS3
Mitochondrial complex I deficiency, 252010 (3)	NDUFS4, AQDQ	602694	5q11.2	NDUFS4
Mitochondrial complex I deficiency, 252010 (3)	NDUFS4, AQDQ	602694	5q11.2	AQDQ
Mitochondrial complex I deficiency, 252010 (3)	NDUFS6	603848	5p15.33	NDUFS6
Mitochondrial complex I deficiency, 252010 (3)	NDUFV1, UQOR1	161015	11q13.2	NDUFV1
Mitochondrial complex I deficiency, 252010 (3)	NDUFV1, UQOR1	161015	11q13.2	UQOR1
Mitochondrial complex I deficiency, 252010 (3)	NDUFV2	600532	18p11.22	NDUFV2
Mitochondrial complex I deficiency, 252010 (3)	NUBPL, IND1	613621	14q12	NUBPL
Mitochondrial complex I deficiency, 252010 (3)	NUBPL, IND1	613621	14q12	IND1
Mitochondrial complex I deficiency, 252010 (3)	TMEM126B	615533	11q14.1	TMEM126B
Mitochondrial complex II deficiency, 252011 (3)	SDHAF1	612848	19q13.12	SDHAF1
Mitochondrial complex II deficiency, 252011 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Mitochondrial complex II deficiency, 252011 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Mitochondrial complex II deficiency, 252011 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BCS1L
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	FLNMS
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	GRACILE
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	BJS
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	PTD
Mitochondrial complex III deficiency, nuclear type 1, 124000 (3)	BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1	603647	2q35	MC3DN1
Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	TTC19, MC3DN2	613814	17p12	TTC19
Mitochondrial complex III deficiency, nuclear type 2, 615157 (3)	TTC19, MC3DN2	613814	17p12	MC3DN2
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	UQCRB, UQBP, QPC, MC3DN3	191330	8q22.1	UQCRB
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	UQCRB, UQBP, QPC, MC3DN3	191330	8q22.1	UQBP
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	UQCRB, UQBP, QPC, MC3DN3	191330	8q22.1	QPC
Mitochondrial complex III deficiency, nuclear type 3, 615158 (3)	UQCRB, UQBP, QPC, MC3DN3	191330	8q22.1	MC3DN3
Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	UQCRQ, QPC, MC3DN4	612080	5q31.1	UQCRQ
Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	UQCRQ, QPC, MC3DN4	612080	5q31.1	QPC
Mitochondrial complex III deficiency, nuclear type 4, 615159 (3)	UQCRQ, QPC, MC3DN4	612080	5q31.1	MC3DN4
Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	UQCRC2, MC3DN5	191329	16p12.2	UQCRC2
Mitochondrial complex III deficiency, nuclear type 5, 615160 (3)	UQCRC2, MC3DN5	191329	16p12.2	MC3DN5
Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	CYC1, MC3DN6	123980	8q24.3	CYC1
Mitochondrial complex III deficiency, nuclear type 6, 615453 (3)	CYC1, MC3DN6	123980	8q24.3	MC3DN6
Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	LYRM7, MZM1L, MC3DN8	615831	5q23.3-q31.1	LYRM7
Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	LYRM7, MZM1L, MC3DN8	615831	5q23.3-q31.1	MZM1L
Mitochondrial complex III deficiency, nuclear type 8, 615838 (3)	LYRM7, MZM1L, MC3DN8	615831	5q23.3-q31.1	MC3DN8
Mitochondrial complex IV deficiency, 220110 (3)	APOPT1, APOP	616003	14q32.33	APOPT1
Mitochondrial complex IV deficiency, 220110 (3)	APOPT1, APOP	616003	14q32.33	APOP
Mitochondrial complex IV deficiency, 220110 (3)	COX10	602125	17p12	COX10
Mitochondrial complex IV deficiency, 220110 (3)	COX20, FAM36A	614698	1q44	COX20
Mitochondrial complex IV deficiency, 220110 (3)	COX20, FAM36A	614698	1q44	FAM36A
Mitochondrial complex IV deficiency, 220110 (3)	COX6B1	124089	19q13.12	COX6B1
Mitochondrial complex IV deficiency, 220110 (3)	PET100, C19orf79	614770	19p13.2	PET100
Mitochondrial complex IV deficiency, 220110 (3)	PET100, C19orf79	614770	19p13.2	C19orf79
Mitochondrial complex IV deficiency, 220110 (3)	SCO1, SCOD1	603644	17p13.1	SCO1
Mitochondrial complex IV deficiency, 220110 (3)	SCO1, SCOD1	603644	17p13.1	SCOD1
Mitochondrial complex IV deficiency, 220110 (3)	TACO1, CCDC44	612958	17q23.3	TACO1
Mitochondrial complex IV deficiency, 220110 (3)	TACO1, CCDC44	612958	17q23.3	CCDC44
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	ATPAF2, ATP12, MC5DN1	608918	17p11.2	ATPAF2
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	ATPAF2, ATP12, MC5DN1	608918	17p11.2	ATP12
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3)	ATPAF2, ATP12, MC5DN1	608918	17p11.2	MC5DN1
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	TMEM70, MC5DN2	612418	8q21.11	TMEM70
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3)	TMEM70, MC5DN2	612418	8q21.11	MC5DN2
Mitochondrial phosphate carrier deficiency, 610773 (3)	SLC25A3, PHC	600370	12q23.1	SLC25A3
Mitochondrial phosphate carrier deficiency, 610773 (3)	SLC25A3, PHC	600370	12q23.1	PHC
Mitochondrial pyruvate carrier deficiency, 614741 (3)	BRP44L, MPC1, MPYCD	614738	6q27	BRP44L
Mitochondrial pyruvate carrier deficiency, 614741 (3)	BRP44L, MPC1, MPYCD	614738	6q27	MPC1
Mitochondrial pyruvate carrier deficiency, 614741 (3)	BRP44L, MPC1, MPYCD	614738	6q27	MPYCD
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLGA
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	PEO
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SANDO
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SCAE
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4A
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4B
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE), 607459 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MIRAS
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDH1
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHF
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	CMD1GG
Mitochondrial respiratory chain complex II deficiency, 252011 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	PGL5
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	ECHS1, SCEH, ECHS1D	602292	10q26.3	ECHS1
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	ECHS1, SCEH, ECHS1D	602292	10q26.3	SCEH
Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3)	ECHS1, SCEH, ECHS1D	602292	10q26.3	ECHS1D
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	DCHS1
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	PCDH16
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	FIB1
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	CDH19
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	VMLDS1
Mitral valve prolapse 2, 607829 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	MVP2
Mitral valve prolapse, myxomatous 1 (2)	MMVP1, MVP, PMV	157700	16p12.1-p11.2	MMVP1
Mitral valve prolapse, myxomatous 1 (2)	MMVP1, MVP, PMV	157700	16p12.1-p11.2	MVP
Mitral valve prolapse, myxomatous 1 (2)	MMVP1, MVP, PMV	157700	16p12.1-p11.2	PMV
Mitral valve prolapse, myxomatous 3 (2)	MMVP3	610840	13q31.3-q32.1	MMVP3
Miyoshi muscular dystrophy 1, 254130 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Miyoshi muscular dystrophy 1, 254130 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	LGMD2B
Miyoshi muscular dystrophy 1, 254130 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	MMD1
Miyoshi muscular dystrophy 2 (2)	MMD2	613318	8q22.3	MMD2
Miyoshi muscular dystrophy 3, 613319 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Miyoshi muscular dystrophy 3, 613319 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	TMEM16E
Miyoshi muscular dystrophy 3, 613319 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	GDD1
Miyoshi muscular dystrophy 3, 613319 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	LGMD2L
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	TIMM8A
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	DFN1
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	DDP
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	MTS
Mohr-Tranebjaerg syndrome, 304700 (3)	TIMM8A, DFN1, DDP, MTS, DDP1	300356	Xq22.1	DDP1
Molybdenum cofactor deficiency A, 252150 (3)	MOCS1, MOCODA	603707	6p21.2	MOCS1
Molybdenum cofactor deficiency A, 252150 (3)	MOCS1, MOCODA	603707	6p21.2	MOCODA
Molybdenum cofactor deficiency B, 252160 (3)	MOCS2, MPTS, MOCODB	603708	5q11.2	MOCS2
Molybdenum cofactor deficiency B, 252160 (3)	MOCS2, MPTS, MOCODB	603708	5q11.2	MPTS
Molybdenum cofactor deficiency B, 252160 (3)	MOCS2, MPTS, MOCODB	603708	5q11.2	MOCODB
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	GPHN
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	GPH
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	KIAA1385
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	GEPH
Molybdenum cofactor deficiency C, 615501 (3)	GPHN, GPH, KIAA1385, GEPH, MOCODC	603930	14q23.3-q24.1	MOCODC
Monilethrix, 158000 (3)	KRT81, KRTHB1, HB1	602153	12q13.13	KRT81
Monilethrix, 158000 (3)	KRT81, KRTHB1, HB1	602153	12q13.13	KRTHB1
Monilethrix, 158000 (3)	KRT81, KRTHB1, HB1	602153	12q13.13	HB1
Monilethrix, 158000 (3)	KRT86, KRTHB6, HB6	601928	12q13.13	KRT86
Monilethrix, 158000 (3)	KRT86, KRTHB6, HB6	601928	12q13.13	KRTHB6
Monilethrix, 158000 (3)	KRT86, KRTHB6, HB6	601928	12q13.13	HB6
Monocarboxylate transporter 1 deficiency, 616095 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	SLC16A1
Monocarboxylate transporter 1 deficiency, 616095 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1
Monocarboxylate transporter 1 deficiency, 616095 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	HHF7
Monocarboxylate transporter 1 deficiency, 616095 (3)	SLC16A1, MCT1, HHF7, MCT1D	600682	1p13.2	MCT1D
Mononeuropathy of the median nerve, mild, 613353 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	SH3TC2
Mononeuropathy of the median nerve, mild, 613353 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	KIAA1985
Mononeuropathy of the median nerve, mild, 613353 (3)	SH3TC2, KIAA1985, MNMN	608206	5q32	MNMN
Morbid obesity and spermatogenic failure, 615703 (3)	CEP19, C3orf34, MOSPGF	615586	3q29	CEP19
Morbid obesity and spermatogenic failure, 615703 (3)	CEP19, C3orf34, MOSPGF	615586	3q29	C3orf34
Morbid obesity and spermatogenic failure, 615703 (3)	CEP19, C3orf34, MOSPGF	615586	3q29	MOSPGF
Mosaic variegated aneuploidy syndrome 1, 257300 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
Mosaic variegated aneuploidy syndrome 1, 257300 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUBR1
Mosaic variegated aneuploidy syndrome 1, 257300 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	MVA1
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	CEP57
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	PIG8
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	TSP57
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	KIAA0092
Mosaic variegated aneuploidy syndrome 2, 614114 (3)	CEP57, PIG8, TSP57, KIAA0092, MVA2	607951	11q21	MVA2
Mowat-Wilson syndrome, 235730 (3)	ZEB2, ZFHX1B, SMADIP1, SIP1	605802	2q22.3	ZEB2
Mowat-Wilson syndrome, 235730 (3)	ZEB2, ZFHX1B, SMADIP1, SIP1	605802	2q22.3	ZFHX1B
Mowat-Wilson syndrome, 235730 (3)	ZEB2, ZFHX1B, SMADIP1, SIP1	605802	2q22.3	SMADIP1
Mowat-Wilson syndrome, 235730 (3)	ZEB2, ZFHX1B, SMADIP1, SIP1	605802	2q22.3	SIP1
Moyamoya 6 with achalasia, 615750 (3)	GUCY1A3, GUC1A3, GUCSA3, MYMY6	139396	4q32.1	GUCY1A3
Moyamoya 6 with achalasia, 615750 (3)	GUCY1A3, GUC1A3, GUCSA3, MYMY6	139396	4q32.1	GUC1A3
Moyamoya 6 with achalasia, 615750 (3)	GUCY1A3, GUC1A3, GUCSA3, MYMY6	139396	4q32.1	GUCSA3
Moyamoya 6 with achalasia, 615750 (3)	GUCY1A3, GUC1A3, GUCSA3, MYMY6	139396	4q32.1	MYMY6
Moyamoya disease (2)	MYMY1, MYMY	252350	3p26-p24.2	MYMY1
Moyamoya disease (2)	MYMY1, MYMY	252350	3p26-p24.2	MYMY
Moyamoya disease 3 (2)	MYMY3	608796	8q23	MYMY3
Moyamoya disease 4 (4)	MYMY4, CXDELq38	300845	Xq28	MYMY4
Moyamoya disease 4 (4)	MYMY4, CXDELq38	300845	Xq28	CXDELq38
Moyamoya disease 5, 614042 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Moyamoya disease 5, 614042 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTSA
Moyamoya disease 5, 614042 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	AAT6
Moyamoya disease 5, 614042 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	MYMY5
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NLRP3
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	CIAS1
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCU
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	FCAS1
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	NALP3
Muckle-Wells syndrome, 191900 (3)	NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1	606416	1q44	PYPAF1
Mucoepidermoid salivary gland carcinoma (3)	CRTC1, MECT1, KIAA0616, FLJ14027	607536	19p13.11	CRTC1
Mucoepidermoid salivary gland carcinoma (3)	CRTC1, MECT1, KIAA0616, FLJ14027	607536	19p13.11	MECT1
Mucoepidermoid salivary gland carcinoma (3)	CRTC1, MECT1, KIAA0616, FLJ14027	607536	19p13.11	KIAA0616
Mucoepidermoid salivary gland carcinoma (3)	CRTC1, MECT1, KIAA0616, FLJ14027	607536	19p13.11	FLJ14027
Mucoepidermoid salivary gland carcinoma (3)	MAML2, MAM3	607537	11q21	MAML2
Mucoepidermoid salivary gland carcinoma (3)	MAML2, MAM3	607537	11q21	MAM3
Mucolipidosis II alpha/beta, 252500 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTAB
Mucolipidosis II alpha/beta, 252500 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTA
Mucolipidosis III alpha/beta, 252600 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTAB
Mucolipidosis III alpha/beta, 252600 (3)	GNPTAB, GNPTA	607840	12q23.2	GNPTA
Mucolipidosis III gamma, 252605 (3)	GNPTAG	607838	16p13.3	GNPTAG
Mucolipidosis IV, 252650 (3)	MCOLN1, ML4	605248	19p13.2	MCOLN1
Mucolipidosis IV, 252650 (3)	MCOLN1, ML4	605248	19p13.2	ML4
Mucopolysaccharidosis II, 309900 (3)	IDS, MPS2, SIDS	300823	Xq28	IDS
Mucopolysaccharidosis II, 309900 (3)	IDS, MPS2, SIDS	300823	Xq28	MPS2
Mucopolysaccharidosis II, 309900 (3)	IDS, MPS2, SIDS	300823	Xq28	SIDS
Mucopolysaccharidosis IVA, 253000 (3)	GALNS, MPS4A	612222	16q24.3	GALNS
Mucopolysaccharidosis IVA, 253000 (3)	GALNS, MPS4A	612222	16q24.3	MPS4A
Mucopolysaccharidosis Ih, 607014 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis Ih, 607014 (3)	IDUA, IDA	252800	4p16.3	IDA
Mucopolysaccharidosis Ih/s, 607015 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis Ih/s, 607015 (3)	IDUA, IDA	252800	4p16.3	IDA
Mucopolysaccharidosis Is, 607016 (3)	IDUA, IDA	252800	4p16.3	IDUA
Mucopolysaccharidosis Is, 607016 (3)	IDUA, IDA	252800	4p16.3	IDA
Mucopolysaccharidosis VII, 253220 (3)	GUSB, MPS7	611499	7q11.21	GUSB
Mucopolysaccharidosis VII, 253220 (3)	GUSB, MPS7	611499	7q11.21	MPS7
Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	SGSH, MPS3A, SFMD	605270	17q25.3	SGSH
Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	SGSH, MPS3A, SFMD	605270	17q25.3	MPS3A
Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3)	SGSH, MPS3A, SFMD	605270	17q25.3	SFMD
Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	NAGLU
Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	MPS3B
Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)	NAGLU, MPS3B, CMT2V	609701	17q21.2	CMT2V
Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	HGSNAT
Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	TMEM76
Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	MPS3C
Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	RP73
Mucopolysaccharidosis type IIID, 252940 (3)	GNS, G6S	607664	12q14.3	GNS
Mucopolysaccharidosis type IIID, 252940 (3)	GNS, G6S	607664	12q14.3	G6S
Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	GLB1, MPS4B	611458	3p22.3	GLB1
Mucopolysaccharidosis type IVB (Morquio), 253010 (3)	GLB1, MPS4B	611458	3p22.3	MPS4B
Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	ARSB, MPS6	611542	5q14.1	ARSB
Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)	ARSB, MPS6	611542	5q14.1	MPS6
Muenke syndrome, 602849 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Muenke syndrome, 602849 (3)	FGFR3, ACH	134934	4p16.3	ACH
Muir-Torre syndrome, 158320 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	MLH1
Muir-Torre syndrome, 158320 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	COCA2
Muir-Torre syndrome, 158320 (3)	MLH1, COCA2, HNPCC2	120436	3p22.2	HNPCC2
Muir-Torre syndrome, 158320 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	MSH2
Muir-Torre syndrome, 158320 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	COCA1
Muir-Torre syndrome, 158320 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	FCC1
Muir-Torre syndrome, 158320 (3)	MSH2, COCA1, FCC1, HNPCC1	609309	2p21-p16	HNPCC1
Mulibrey nanism, 253250 (3)	TRIM37, MUL, KIAA0898	605073	17q22	TRIM37
Mulibrey nanism, 253250 (3)	TRIM37, MUL, KIAA0898	605073	17q22	MUL
Mulibrey nanism, 253250 (3)	TRIM37, MUL, KIAA0898	605073	17q22	KIAA0898
Mullerian aplasia and hyperandrogenism, 158330 (3)	WNT4, SERKAL	603490	1p36.12	WNT4
Mullerian aplasia and hyperandrogenism, 158330 (3)	WNT4, SERKAL	603490	1p36.12	SERKAL
Multicentric carpotarsal osteolysis syndrome, 166300 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MAFB
Multicentric carpotarsal osteolysis syndrome, 166300 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	KRML
Multicentric carpotarsal osteolysis syndrome, 166300 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	MCTO
Multicentric carpotarsal osteolysis syndrome, 166300 (3)	MAFB, KRML, MCTO, DURS3	608968	20q12	DURS3
Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	MMP2, CLG4A, MONA	120360	16q12.2	MMP2
Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	MMP2, CLG4A, MONA	120360	16q12.2	CLG4A
Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3)	MMP2, CLG4A, MONA	120360	16q12.2	MONA
Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	PIGN, MCAHS1	606097	18q21.33	PIGN
Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3)	PIGN, MCAHS1	606097	18q21.33	MCAHS1
Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PIGA
Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PNH1
Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	MCAHS2
Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PIGT
Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	NDAP
Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	PNH2
Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3)	PIGT, NDAP, PNH2, MCAHS3	610272	20q13.12	MCAHS3
Multiple endocrine neoplasia 1, 131100 (3)	MEN1	613733	11q13.1	MEN1
Multiple endocrine neoplasia IIA, 171400 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Multiple endocrine neoplasia IIA, 171400 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
Multiple endocrine neoplasia IIA, 171400 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
Multiple endocrine neoplasia IIB, 162300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Multiple endocrine neoplasia IIB, 162300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
Multiple endocrine neoplasia IIB, 162300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
Multiple endocrine neoplasia, type IV, 610755 (3)	CDKN1B, KIP1, CDKN4, MEN4	600778	12p13.1	CDKN1B
Multiple endocrine neoplasia, type IV, 610755 (3)	CDKN1B, KIP1, CDKN4, MEN4	600778	12p13.1	KIP1
Multiple endocrine neoplasia, type IV, 610755 (3)	CDKN1B, KIP1, CDKN4, MEN4	600778	12p13.1	CDKN4
Multiple endocrine neoplasia, type IV, 610755 (3)	CDKN1B, KIP1, CDKN4, MEN4	600778	12p13.1	MEN4
Multiple fibroadenomas of the breast, 615554 (3)	PRLR, MFAB, HPRL	176761	5p13.2	PRLR
Multiple fibroadenomas of the breast, 615554 (3)	PRLR, MFAB, HPRL	176761	5p13.2	MFAB
Multiple fibroadenomas of the breast, 615554 (3)	PRLR, MFAB, HPRL	176761	5p13.2	HPRL
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	B3GAT3, GLCATI, JDSCD	606374	11q12.3	B3GAT3
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	B3GAT3, GLCATI, JDSCD	606374	11q12.3	GLCATI
Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3)	B3GAT3, GLCATI, JDSCD	606374	11q12.3	JDSCD
Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	NFU1, HIRIP, MMDS1	608100	2p13.3	NFU1
Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	NFU1, HIRIP, MMDS1	608100	2p13.3	HIRIP
Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)	NFU1, HIRIP, MMDS1	608100	2p13.3	MMDS1
Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	BOLA3, MMDS2	613183	2p13.1	BOLA3
Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3)	BOLA3, MMDS2	613183	2p13.1	MMDS2
Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	ISCA2, MMDS4	615317	14q24.3	ISCA2
Multiple mitochondrial dysfunctions syndrome 4, 616370 (3)	ISCA2, MMDS4	615317	14q24.3	MMDS4
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	ACHRD
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1B
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1A
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	ACHRD
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	SCCMS
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3A
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3B
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3C
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNG, ACHRG	100730	2q37.1	CHRNG
Multiple pterygium syndrome, lethal type, 253290 (3)	CHRNG, ACHRG	100730	2q37.1	ACHRG
Multiple sulfatase deficiency, 272200 (3)	SUMF1, FGE	607939	3p26.1	SUMF1
Multiple sulfatase deficiency, 272200 (3)	SUMF1, FGE	607939	3p26.1	FGE
Multiple synostoses syndrome 1, 186500 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Multiple synostoses syndrome 1, 186500 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYM1
Multiple synostoses syndrome 1, 186500 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYNS1A
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Multiple synostoses syndrome 2, 610017 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTA2
Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	ACTSA
Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	AAT6
Multisystemic smooth muscle dysfunction syndrome, 613834 (3)	ACTA2, ACTSA, AAT6, MYMY5	102620	10q23.31	MYMY5
Mungan syndrome (2)	MGS	611376	8q23-q24	MGS
Muscle glycogenosis, 300559 (3)	PHKA1	311870	Xq13.1	PHKA1
Muscle hypertrophy, 614160 (3)	GDF8, MSTN, MSLHP	601788	2q32.2	GDF8
Muscle hypertrophy, 614160 (3)	GDF8, MSTN, MSLHP	601788	2q32.2	MSTN
Muscle hypertrophy, 614160 (3)	GDF8, MSTN, MSLHP	601788	2q32.2	MSLHP
Muscle strength quantitative trait locus 1 (2)	MUSTQTL1	612083	14q24.3	MUSTQTL1
Muscular dystrophy with rimmed vacuoles (2)	MDRV	601846	19p13.3	MDRV
Muscular dystrophy, congenital merosin-deficient, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMA2
Muscular dystrophy, congenital merosin-deficient, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMM
Muscular dystrophy, congenital, 1B (2)	MDC1B	604801	1q42	MDC1B
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Muscular dystrophy, congenital, 613205 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)	ITGA7	600536	12q13.2	ITGA7
Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMA2
Muscular dystrophy, congenital, due to partial LAMA2 deficiency, 607855 (3)	LAMA2, LAMM	156225	6q22.33	LAMM
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	CHKB
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	CHKL
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	CKEKB
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	EKB
Muscular dystrophy, congenital, megaconial type, 602541 (3)	CHKB, CHKL, CKEKB, EKB, MDCMC	612395	22q13.33	MDCMC
Muscular dystrophy, congenital, merosin-positive (2)	MDCMP	609456	4p16.3	MDCMP
Muscular dystrophy, limb-girdle, type 1A, 159000 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Muscular dystrophy, limb-girdle, type 1A, 159000 (3)	MYOT, TTOD, MFM3	604103	5q31.2	TTOD
Muscular dystrophy, limb-girdle, type 1A, 159000 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MFM3
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Muscular dystrophy, limb-girdle, type 1B, 159001 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	DNAJB6, MRJ, DJ4, LGMD1E	611332	7q36.3	DNAJB6
Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	DNAJB6, MRJ, DJ4, LGMD1E	611332	7q36.3	MRJ
Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	DNAJB6, MRJ, DJ4, LGMD1E	611332	7q36.3	DJ4
Muscular dystrophy, limb-girdle, type 1E, 603511 (3)	DNAJB6, MRJ, DJ4, LGMD1E	611332	7q36.3	LGMD1E
Muscular dystrophy, limb-girdle, type 1F, 608423 (3)	TNPO3, TRNSR, LGMD1F	610032	7q32.1	TNPO3
Muscular dystrophy, limb-girdle, type 1F, 608423 (3)	TNPO3, TRNSR, LGMD1F	610032	7q32.1	TRNSR
Muscular dystrophy, limb-girdle, type 1F, 608423 (3)	TNPO3, TRNSR, LGMD1F	610032	7q32.1	LGMD1F
Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	HNRNPDL, HNRPDL, JKTBP, LGMD1G	607137	4q21.22	HNRNPDL
Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	HNRNPDL, HNRPDL, JKTBP, LGMD1G	607137	4q21.22	HNRPDL
Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	HNRNPDL, HNRPDL, JKTBP, LGMD1G	607137	4q21.22	JKTBP
Muscular dystrophy, limb-girdle, type 1G, 609115 (3)	HNRNPDL, HNRPDL, JKTBP, LGMD1G	607137	4q21.22	LGMD1G
Muscular dystrophy, limb-girdle, type 1H (2)	LGMD1H	613530	3p25.1-p23	LGMD1H
Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	CAPN3, CANP3	114240	15q15.1	CAPN3
Muscular dystrophy, limb-girdle, type 2A, 253600 (3)	CAPN3, CANP3	114240	15q15.1	CANP3
Muscular dystrophy, limb-girdle, type 2B, 253601 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Muscular dystrophy, limb-girdle, type 2B, 253601 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	LGMD2B
Muscular dystrophy, limb-girdle, type 2B, 253601 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	MMD1
Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12.12	SGCG
Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12.12	LGMD2C
Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12.12	DMDA1
Muscular dystrophy, limb-girdle, type 2C, 253700 (3)	SGCG, LGMD2C, DMDA1, SCG3	608896	13q12.12	SCG3
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	SGCA
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	ADL
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	DAG2
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	LGMD2D
Muscular dystrophy, limb-girdle, type 2D, 608099 (3)	SGCA, ADL, DAG2, LGMD2D, DMDA2	600119	17q21.33	DMDA2
Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	SGCB, LGMD2E	600900	4q12	SGCB
Muscular dystrophy, limb-girdle, type 2E, 604286 (3)	SGCB, LGMD2E	600900	4q12	LGMD2E
Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGCD
Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	SGD
Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	LGMD2F
Muscular dystrophy, limb-girdle, type 2F, 601287 (3)	SGCD, SGD, LGMD2F, CMD1L	601411	5q33.2-q33.3	CMD1L
Muscular dystrophy, limb-girdle, type 2G, 601954 (3)	TCAP, LGMD2G, CMH25	604488	17q12	TCAP
Muscular dystrophy, limb-girdle, type 2G, 601954 (3)	TCAP, LGMD2G, CMH25	604488	17q12	LGMD2G
Muscular dystrophy, limb-girdle, type 2G, 601954 (3)	TCAP, LGMD2G, CMH25	604488	17q12	CMH25
Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	TRIM32
Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	HT2A
Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	LGMD2H
Muscular dystrophy, limb-girdle, type 2H, 254110 (3)	TRIM32, HT2A, LGMD2H, BBS11	602290	9q33.1	BBS11
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Muscular dystrophy, limb-girdle, type 2J, 608807 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Muscular dystrophy, limb-girdle, type 2L, 611307 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	ANO5
Muscular dystrophy, limb-girdle, type 2L, 611307 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	TMEM16E
Muscular dystrophy, limb-girdle, type 2L, 611307 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	GDD1
Muscular dystrophy, limb-girdle, type 2L, 611307 (3)	ANO5, TMEM16E, GDD1, LGMD2L	608662	11p14.3	LGMD2L
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC1
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLEC
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	PLTN
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBS1
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	LGMD2Q
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSOG
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSPA
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSMD
Muscular dystrophy, limb-girdle, type 2Q, 613723 (3)	PLEC1, PLEC, PLTN, EBS1, LGMD2Q, EBSOG, EBSPA, EBSMD, EBSND	601282	8q24.3	EBSND
Muscular dystrophy, limb-girdle, type 2S, 615356 (3)	TRAPPC11, C4orf41, LGMD2S	614138	4q35.1	TRAPPC11
Muscular dystrophy, limb-girdle, type 2S, 615356 (3)	TRAPPC11, C4orf41, LGMD2S	614138	4q35.1	C4orf41
Muscular dystrophy, limb-girdle, type 2S, 615356 (3)	TRAPPC11, C4orf41, LGMD2S	614138	4q35.1	LGMD2S
Muscular dystrophy, limb-girdle, type 2W, 616827 (3)	LIMS2, PINCH2, LGMD2W	607908	2q14.3	LIMS2
Muscular dystrophy, limb-girdle, type 2W, 616827 (3)	LIMS2, PINCH2, LGMD2W	607908	2q14.3	PINCH2
Muscular dystrophy, limb-girdle, type 2W, 616827 (3)	LIMS2, PINCH2, LGMD2W	607908	2q14.3	LGMD2W
Muscular dystrophy, limb-girdle, type IC, 607801 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Muscular dystrophy, limb-girdle, type IC, 607801 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Muscular dystrophy, limb-girdle, type IC, 607801 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Muscular dystrophy, rigid spine, 1, 602771 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SEPN1
Muscular dystrophy, rigid spine, 1, 602771 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SELN
Muscular dystrophy, rigid spine, 1, 602771 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	RSMD1
Muscular dystrophy, rigid spine, 1, 602771 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	CFTD
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGA1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGB1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGC1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	TMEM5, MDDGA10	605862	12q14.2	TMEM5
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3)	TMEM5, MDDGA10	605862	12q14.2	MDDGA10
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	POMK
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	SGK196
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	MDDGA12
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3)	POMK, SGK196, MDDGA12, MDDGC12	615247	8p11.21	MDDGC12
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	B3GNT1, IGNT, IGAT, MDDGA13	605517	11q13.2	B3GNT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	B3GNT1, IGNT, IGAT, MDDGA13	605517	11q13.2	IGNT
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	B3GNT1, IGNT, IGAT, MDDGA13	605517	11q13.2	IGAT
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3)	B3GNT1, IGNT, IGAT, MDDGA13	605517	11q13.2	MDDGA13
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	KIAA1851
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGA14
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGB14
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGC14
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGA2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGB2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGC2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MEB
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGA3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGB3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGC3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FCMD
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	CMD1X
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	LGMD2M
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGA4
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGB4
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGC4
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDC1C
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	LGMD2I
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGA5
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGB5
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGC5
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	LARGE
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	KIAA0609
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDC1D
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDDGA6
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDDGB6
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	ISPD
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	MDDGA7
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	MDDGC7
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	MDDGC9
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	MDDGA9
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	B3GALNT2, MGC39558, MDDGA11	610194	1q42.3	B3GALNT2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	B3GALNT2, MGC39558, MDDGA11	610194	1q42.3	MGC39558
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3)	B3GALNT2, MGC39558, MDDGA11	610194	1q42.3	MDDGA11
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	POMGNT2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	GTDC2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	C3orf39
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	AGO61
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3)	POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8	614828	3p22.1	MDDGA8
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGA1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGB1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1, 613155 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGC1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	KIAA1851
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGA14
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGB14
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14, 615351 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGC14
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGA2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGB2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2, 613156 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGC2
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MEB
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGA3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGB3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3, 613151 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGC3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	LARGE
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	KIAA0609
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDC1D
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDDGA6
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3)	LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6	603590	22q12.3	MDDGB6
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDC1C
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	LGMD2I
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGA5
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGB5
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5, 606612 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGC5
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FCMD
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	CMD1X
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	LGMD2M
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGA4
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGB4
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGC4
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	POMT1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGA1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGB1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3)	POMT1, MDDGA1, MDDGB1, MDDGC1	607423	9q34.13	MDDGC1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	GMPPB
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	KIAA1851
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGA14
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGB14
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3)	GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14	615320	3p21.31	MDDGC14
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	POMT2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGA2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGB2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3)	POMT2, MDDGA2, MDDGB2, MDDGC2	607439	14q24.3	MDDGC2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	POMGNT1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MEB
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGA3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGB3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3)	POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3	606822	1p34.1	MDDGC3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FKTN
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	FCMD
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	CMD1X
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	LGMD2M
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGA4
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGB4
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3)	FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4	607440	9q31.2	MDDGC4
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	FKRP
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDC1C
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	LGMD2I
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGA5
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGB5
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3)	FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5	606596	19q13.32	MDDGC5
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	ISPD
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	MDDGA7
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3)	ISPD, MDDGA7, MDDGC7	614631	7p21.2	MDDGC7
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	DAG
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	MDDGC9
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3)	DAG1, DAG, MDDGC9, MDDGA9	128239	3p21.31	MDDGA9
Myasthenia gravis with thymus hyperplasia (2)	MYAS1	607085	6p21.3	MYAS1
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	GFPT1
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	GFAT1
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	GFPT1L
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	MSLG
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	CMS12
Myasthenia, congenital, 12, with tubular aggregates, 610542 (3)	GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1	138292	2p13.3	CMSTA1
Myasthenic syndrome, congenital, 10, 254300 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	DOK7
Myasthenic syndrome, congenital, 10, 254300 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	C4orf25
Myasthenic syndrome, congenital, 10, 254300 (3)	DOK7, C4orf25, CMS10	610285	4p16.3	CMS10
Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	RAPSN
Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	CMS1D
Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	CMS11
Myasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3)	RAPSN, CMS1D, CMS11, FADS	601592	11p11.2	FADS
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT1
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DPAGT2
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	DGPT
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CDG1J
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CMSTA2
Myasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3)	DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13	191350	11q23.3	CMS13
Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	ALG2
Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CDGII
Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CMSTA3
Myasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3)	ALG2, CDGII, CMSTA3, CMS14	607905	9q22.33	CMS14
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HYPP
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	NAC1A
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HOKPP2
Myasthenic syndrome, congenital, 16, 614198 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	CMS16
Myasthenic syndrome, congenital, 19, 616720 (3)	COL13A1, CMS19	120350	10q22.1	COL13A1
Myasthenic syndrome, congenital, 19, 616720 (3)	COL13A1, CMS19	120350	10q22.1	CMS19
Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	ACHRD
Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1B
Myasthenic syndrome, congenital, 1A, slow-channel, 601462 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1A
Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CHRNA1
Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	ACHRD
Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1B
Myasthenic syndrome, congenital, 1B, fast-channel, 608930 (3)	CHRNA1, ACHRD, CMS1B, CMS1A	100690	2q31.1	CMS1A
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CHRNB1
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	ACHRB
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	SCCMS
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CMS2A
Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3)	CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C	100710	17p13.1	CMS2C
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CHRND
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	ACHRD
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	SCCMS
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3A
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3B
Myasthenic syndrome, congenital, 3B, fast-channel, 616322 (3)	CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C	100720	2q37.1	CMS3C
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	SCCMS
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4A
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4B
Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4C
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	SCCMS
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4A
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4B
Myasthenic syndrome, congenital, 4B, fast-channel, 616324 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4C
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CHRNE
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	SCCMS
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4A
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4B
Myasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3)	CHRNE, SCCMS, CMS4A, CMS4B, CMS4C	100725	17p13.2	CMS4C
Myasthenic syndrome, congenital, 5, 603034 (3)	COLQ, EAD, CMS5	603033	3p25.1	COLQ
Myasthenic syndrome, congenital, 5, 603034 (3)	COLQ, EAD, CMS5	603033	3p25.1	EAD
Myasthenic syndrome, congenital, 5, 603034 (3)	COLQ, EAD, CMS5	603033	3p25.1	CMS5
Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	CHAT, CMS6	118490	10q11.23	CHAT
Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3)	CHAT, CMS6	118490	10q11.23	CMS6
Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	SYT2, CMS7, MYSPC	600104	1q32.1	SYT2
Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	SYT2, CMS7, MYSPC	600104	1q32.1	CMS7
Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3)	SYT2, CMS7, MYSPC	600104	1q32.1	MYSPC
Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	AGRN, CMS8	103320	1p36.33	AGRN
Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3)	AGRN, CMS8	103320	1p36.33	CMS8
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3)	MUSK, CMS9, FADS	601296	9q31.3	MUSK
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3)	MUSK, CMS9, FADS	601296	9q31.3	CMS9
Myasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3)	MUSK, CMS9, FADS	601296	9q31.3	FADS
Myelodysplasia and leukemia syndrome with monosomy 7 (4)	MLSM7, DEL7q, C7DELq	252270	7q	MLSM7
Myelodysplasia and leukemia syndrome with monosomy 7 (4)	MLSM7, DEL7q, C7DELq	252270	7q	DEL7q
Myelodysplasia and leukemia syndrome with monosomy 7 (4)	MLSM7, DEL7q, C7DELq	252270	7q	C7DELq
Myelodysplasia syndrome-1 (3)	MDS1	600049	3q26	MDS1
Myelodysplastic syndrome (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACSL6
Myelodysplastic syndrome (3)	ACSL6, FACL6, ACS2	604443	5q31.1	FACL6
Myelodysplastic syndrome (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACS2
Myelodysplastic syndrome, preleukemic (3)	IRF1, MAR	147575	5q31.1	IRF1
Myelodysplastic syndrome, preleukemic (3)	IRF1, MAR	147575	5q31.1	MAR
Myelodysplastic syndrome, somatic, 614286 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	ASXL1
Myelodysplastic syndrome, somatic, 614286 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	KIAA0978
Myelodysplastic syndrome, somatic, 614286 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	BOPS
Myelodysplastic syndrome, somatic, 614286 (3)	ASXL1, KIAA0978, BOPS, MDS	612990	20q11.21	MDS
Myelodysplastic syndrome, somatic, 614286 (3)	SF3B1, SF3B155, SAP155, MDS	605590	2q33.1	SF3B1
Myelodysplastic syndrome, somatic, 614286 (3)	SF3B1, SF3B155, SAP155, MDS	605590	2q33.1	SF3B155
Myelodysplastic syndrome, somatic, 614286 (3)	SF3B1, SF3B155, SAP155, MDS	605590	2q33.1	SAP155
Myelodysplastic syndrome, somatic, 614286 (3)	SF3B1, SF3B155, SAP155, MDS	605590	2q33.1	MDS
Myelodysplastic syndrome, somatic, 614286 (3)	TET2, KIAA1546, MDS	612839	4q24	TET2
Myelodysplastic syndrome, somatic, 614286 (3)	TET2, KIAA1546, MDS	612839	4q24	KIAA1546
Myelodysplastic syndrome, somatic, 614286 (3)	TET2, KIAA1546, MDS	612839	4q24	MDS
Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	TPOR
Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPLV
Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	THCYT2
Myelofibrosis, somatic, 254450 (3)	CALR, SSA	109091	19p13.13	CALR
Myelofibrosis, somatic, 254450 (3)	CALR, SSA	109091	19p13.13	SSA
Myelofibrosis, somatic, 254450 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Myelofibrosis, somatic, 254450 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
Myelofibrosis, somatic, 254450 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Myelofibrosis, somatic, 254450 (3)	SH2B3, LNK	605093	12q24.12	LNK
Myelogenous leukemia, acute (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACSL6
Myelogenous leukemia, acute (3)	ACSL6, FACL6, ACS2	604443	5q31.1	FACL6
Myelogenous leukemia, acute (3)	ACSL6, FACL6, ACS2	604443	5q31.1	ACS2
Myelogenous leukemia, acute (3)	IRF1, MAR	147575	5q31.1	IRF1
Myelogenous leukemia, acute (3)	IRF1, MAR	147575	5q31.1	MAR
Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	CBFB, PEBP2B	121360	16q22.1	CBFB
Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1)	CBFB, PEBP2B	121360	16q22.1	PEBP2B
Myelokathexis, isolated (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	CXCR4
Myelokathexis, isolated (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	D2S201E
Myelokathexis, isolated (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	NPY3R
Myelokathexis, isolated (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	WHIMS
Myeloperoxidase deficiency, 254600 (3)	MPO	606989	17q22	MPO
Myeloproliferative disorder (2)	FGFR1OP, FOP	605392	6q27	FGFR1OP
Myeloproliferative disorder (2)	FGFR1OP, FOP	605392	6q27	FOP
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFR
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IBGC4
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IMF1
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PENTT
Myeloproliferative disorder with eosinophilia, 131440 (4)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	KOGS
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MADH4
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	DPC4
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	JIP
Myhre syndrome, 139210 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MYHRS
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	TBC1D24
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	KIAA1171
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	FIME
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	EIEE16
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DOORS
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNB86
Myoclonic epilepsy, infantile, familial, 605021 (3)	TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65	613577	16p13.3	DFNA65
Myoclonic epilepsy, juvenile, 4 (2)	EJM4	611364	5q12-q14	EJM4
Myoclonic-atonic epilepsy, 616421 (3)	SLC6A1, GABATR, MAE	137165	3p25.3	SLC6A1
Myoclonic-atonic epilepsy, 616421 (3)	SLC6A1, GABATR, MAE	137165	3p25.3	GABATR
Myoclonic-atonic epilepsy, 616421 (3)	SLC6A1, GABATR, MAE	137165	3p25.3	MAE
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	NOL3
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	NOP
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	MYC
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	ARC
Myoclonus, familial cortical, 614937 (3)	NOL3, NOP, MYC, ARC, FCM	605235	16q22.1	FCM
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFR
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IBGC4
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IMF1
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PENTT
Myofibromatosis, infantile, 1, 228550 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	KOGS
Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)	LPIN1	605518	2p25.1	LPIN1
Myokymia, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Myokymia, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EBN1
Myokymia, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EIEE7
Myokymia, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	BFNS1
Myopathy due to CPT II deficiency, 255110 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
Myopathy due to CPT II deficiency, 255110 (3)	CPT2, IIAE4	600650	1p32.3	IIAE4
Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	AMPD1, MMDD	102770	1p13.2	AMPD1
Myopathy due to myoadenylate deaminase deficiency, 615511 (3)	AMPD1, MMDD	102770	1p13.2	MMDD
Myopathy with extrapyramidal signs, 615673 (3)	MICU1, CBARA1, MPXPS	605084	10q22.1	MICU1
Myopathy with extrapyramidal signs, 615673 (3)	MICU1, CBARA1, MPXPS	605084	10q22.1	CBARA1
Myopathy with extrapyramidal signs, 615673 (3)	MICU1, CBARA1, MPXPS	605084	10q22.1	MPXPS
Myopathy with lactic acidosis, hereditary, 255125 (3)	ISCU, HML	611911	12q23.3	ISCU
Myopathy with lactic acidosis, hereditary, 255125 (3)	ISCU, HML	611911	12q23.3	HML
Myopathy, X-linked, with excessive autophagy, 310440 (3)	VMA21, XMEA	300913	Xq28	VMA21
Myopathy, X-linked, with excessive autophagy, 310440 (3)	VMA21, XMEA	300913	Xq28	XMEA
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	SLIM1
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	XMPMA
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	KYOT
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1A
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1B
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1A
Myopathy, X-linked, with postural muscle atrophy, 300696 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1B
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ASMA
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	NEM3
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	CFTD1
Myopathy, actin, congenital, with cores, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	SHPM
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ASMA
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	NEM3
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	CFTD1
Myopathy, actin, congenital, with excess of thin myofilaments, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	SHPM
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	MEGF10
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	KIAA1780
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	EMARDD
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	MEGF10
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	KIAA1780
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3)	MEGF10, KIAA1780, EMARDD	612453	5q23.2	EMARDD
Myopathy, centronuclear, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	DNM2
Myopathy, centronuclear, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDIB
Myopathy, centronuclear, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMTDI1
Myopathy, centronuclear, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	CMT2M
Myopathy, centronuclear, 160150 (3)	DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5	602378	19p13.2	LCCS5
Myopathy, centronuclear, 3, 614408 (3)	MYF6, CNM3	159991	12q21.31	MYF6
Myopathy, centronuclear, 3, 614408 (3)	MYF6, CNM3	159991	12q21.31	CNM3
Myopathy, centronuclear, 4, 614807 (3)	CCDC78, C16orf25, CNM4	614666	16p13.3	CCDC78
Myopathy, centronuclear, 4, 614807 (3)	CCDC78, C16orf25, CNM4	614666	16p13.3	C16orf25
Myopathy, centronuclear, 4, 614807 (3)	CCDC78, C16orf25, CNM4	614666	16p13.3	CNM4
Myopathy, centronuclear, autosomal recessive, 255200 (3)	BIN1, AMPHL	601248	2q14.3	BIN1
Myopathy, centronuclear, autosomal recessive, 255200 (3)	BIN1, AMPHL	601248	2q14.3	AMPHL
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ASMA
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	NEM3
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	CFTD1
Myopathy, congenital, with fiber-type disproportion 1, 255310 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	SHPM
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SEPN1
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	SELN
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	RSMD1
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	SEPN1, SELN, RSMD1, CFTD	606210	1p36.11	CFTD
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	NEM1
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CFTD
Myopathy, congenital, with fiber-type disproportion, 255310 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CAPM1
Myopathy, congenital, with fiber-type disproportion, X-linked (2)	CFTDX	300580	Xq13.1-q22.1	CFTDX
Myopathy, distal 3 (2)	MPD3	610099	8p22-q11	MPD3
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLN2
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPA
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPL
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MFM5
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MPD4
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	CMH26
Myopathy, distal, 4, 614065 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	RCM5
Myopathy, distal, 5, 617030 (3)	ADSL1, MPD5	612498	14q32.33	ADSL1
Myopathy, distal, 5, 617030 (3)	ADSL1, MPD5	612498	14q32.33	MPD5
Myopathy, distal, Tateyama type, 614321 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Myopathy, distal, Tateyama type, 614321 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Myopathy, distal, Tateyama type, 614321 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Myopathy, distal, with anterior tibial onset, 606768 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	DYSF
Myopathy, distal, with anterior tibial onset, 606768 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	LGMD2B
Myopathy, distal, with anterior tibial onset, 606768 (3)	DYSF, LGMD2B, MMD1	603009	2p13.2	MMD1
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Myopathy, early-onset, with fatal cardiomyopathy, 611705 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	PUS1, MLASA1	608109	12q24.33	PUS1
Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3)	PUS1, MLASA1	608109	12q24.33	MLASA1
Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	YARS2, TYRRS, MLASA2	610957	12p11.21	YARS2
Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	YARS2, TYRRS, MLASA2	610957	12p11.21	TYRRS
Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)	YARS2, TYRRS, MLASA2	610957	12p11.21	MLASA2
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	GFER, ERV1, ALR	600924	16p13.3	GFER
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	GFER, ERV1, ALR	600924	16p13.3	ERV1
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)	GFER, ERV1, ALR	600924	16p13.3	ALR
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	CMD1I
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	MFM1
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	SCPNK
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVD7
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVC7
Myopathy, myofibrillar, 1, 601419 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	LGMD2R
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYA2
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTPP2
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CMD1II
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTRCT16
Myopathy, myofibrillar, 2, 608810 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	MFM2
Myopathy, myofibrillar, 3, 609200 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Myopathy, myofibrillar, 3, 609200 (3)	MYOT, TTOD, MFM3	604103	5q31.2	TTOD
Myopathy, myofibrillar, 3, 609200 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MFM3
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LDB3
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	ZASP
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CYPHER
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	KIAA01613
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	MFM4
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMD1C
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	CMH24
Myopathy, myofibrillar, 4, 609452 (3)	LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3	605906	10q23.2	LVNC3
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLNC
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	FLN2
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPA
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	ABPL
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MFM5
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	MPD4
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	CMH26
Myopathy, myofibrillar, 5, 609524 (3)	FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5	102565	7q32.1	RCM5
Myopathy, myofibrillar, 6, 612954 (3)	BAG3, MFM6	603883	10q26.11	BAG3
Myopathy, myofibrillar, 6, 612954 (3)	BAG3, MFM6	603883	10q26.11	MFM6
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYAB
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CRYA2
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTPP2
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CMD1II
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	CTRCT16
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related, 613869 (3)	CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2	123590	11q23.1	MFM2
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Myopathy, myosin storage, autosomal dominant, 608358 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Myopathy, myosin storage, autosomal recessive, 255160 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Myopathy, proximal, with early respiratory muscle involvement, 603689 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Myopathy, spheroid body, 182920 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MYOT
Myopathy, spheroid body, 182920 (3)	MYOT, TTOD, MFM3	604103	5q31.2	TTOD
Myopathy, spheroid body, 182920 (3)	MYOT, TTOD, MFM3	604103	5q31.2	MFM3
Myopathy, tubular aggregate, 1 160565 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Myopathy, tubular aggregate, 1 160565 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	TAM1
Myopathy, tubular aggregate, 1 160565 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	IMD10
Myopathy, tubular aggregate, 1 160565 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STRMK
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	ORAI1
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	TMEM142A
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	CRACM1
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	IMD9
Myopathy, tubular aggregate, 2, 615883 (3)	ORAI1, TMEM142A, CRACM1, IMD9, TAM2	610277	12q24.31	TAM2
Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	CASQ1, VMCQA	114250	1q23.2	CASQ1
Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3)	CASQ1, VMCQA	114250	1q23.2	VMCQA
Myopia 10 (2)	MYP10	609259	8p23	MYP10
Myopia 11 (2)	MYP11	609994	4q22-q27	MYP11
Myopia 12 (2)	MYP12	609995	2q37.1	MYP12
Myopia 13 (2)	MYP13	300613	Xq23-q27.2	MYP13
Myopia 14 (2)	MYP14	610320	1p36	MYP14
Myopia 15 (2)	MYP15	612717	10q21.1	MYP15
Myopia 16 (2)	MYP16	612554	5p15.33-p15.2	MYP16
Myopia 17 (2)	MYP17, MYP4	608367	7p15	MYP17
Myopia 17 (2)	MYP17, MYP4	608367	7p15	MYP4
Myopia 18 (2)	MYP18	255500	14q22.1-q24.2	MYP18
Myopia 19 (2)	MYP19	613969	5p15.1-p13.3	MYP19
Myopia 20, autosomal dominant (2)	MYP20	614166	13q12.12	MYP20
Myopia 21, autosomal dominant, 614167 (3)	ZNF644, MYP21	614159	1p22.2	ZNF644
Myopia 21, autosomal dominant, 614167 (3)	ZNF644, MYP21	614159	1p22.2	MYP21
Myopia 22, autosomal dominant, 615420 (3)	CCDC111, MYP22	615421	4q35.1	CCDC111
Myopia 22, autosomal dominant, 615420 (3)	CCDC111, MYP22	615421	4q35.1	MYP22
Myopia 23, autosomal recessive, 615431 (3)	LRPAP1, A2MRAP, MYP23	104225	4p16.3	LRPAP1
Myopia 23, autosomal recessive, 615431 (3)	LRPAP1, A2MRAP, MYP23	104225	4p16.3	A2MRAP
Myopia 23, autosomal recessive, 615431 (3)	LRPAP1, A2MRAP, MYP23	104225	4p16.3	MYP23
Myopia 24, autosomal dominant, 615946 (3)	SLC39A5, MYP24	608730	12q13.3	SLC39A5
Myopia 24, autosomal dominant, 615946 (3)	SLC39A5, MYP24	608730	12q13.3	MYP24
Myopia 5 (2)	MYP5	608474	17q21-q22	MYP5
Myopia 6, 608908 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	SCO2
Myopia 6, 608908 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	CEMCOX1
Myopia 6, 608908 (3)	SCO2, CEMCOX1, MYP6	604272	22q13.33	MYP6
Myopia 7 (2)	MYP7	609256	11p13	MYP7
Myopia 8 (2)	MYP8	609257	3q26	MYP8
Myopia 9 (2)	MYP9	609258	4q12	MYP9
Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	P3H2, LEPREL1, MCVD	610341	3q28	P3H2
Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	P3H2, LEPREL1, MCVD	610341	3q28	LEPREL1
Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3)	P3H2, LEPREL1, MCVD	610341	3q28	MCVD
Myopia-1 (2)	MYP1	310460	Xq28	MYP1
Myopia-2 (2)	MYP2	160700	18p11.31	MYP2
Myopia-3 (2)	MYP3	603221	12q21-q23	MYP3
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HYPP
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	NAC1A
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HOKPP2
Myotonia congenita, atypical, acetazolamide-responsive, 608390 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	CMS16
Myotonia congenita, dominant, 160800 (3)	CLCN1	118425	7q34	CLCN1
Myotonia congenita, recessive, 255700 (3)	CLCN1	118425	7q34	CLCN1
Myotonia levior, recessive (3)	CLCN1	118425	7q34	CLCN1
Myotonic dystrophy 1, 160900 (3)	DMPK, DM, DMK	605377	19q13.32	DMPK
Myotonic dystrophy 1, 160900 (3)	DMPK, DM, DMK	605377	19q13.32	DM
Myotonic dystrophy 1, 160900 (3)	DMPK, DM, DMK	605377	19q13.32	DMK
Myotonic dystrophy 2, 602668 (3)	ZNF9, CNBP1, DM2, PROMM	116955	3q21.3	ZNF9
Myotonic dystrophy 2, 602668 (3)	ZNF9, CNBP1, DM2, PROMM	116955	3q21.3	CNBP1
Myotonic dystrophy 2, 602668 (3)	ZNF9, CNBP1, DM2, PROMM	116955	3q21.3	DM2
Myotonic dystrophy 2, 602668 (3)	ZNF9, CNBP1, DM2, PROMM	116955	3q21.3	PROMM
Myotubular myopathy, X-linked, 310400 (3)	MTM1, MTMX	300415	Xq28	MTM1
Myotubular myopathy, X-linked, 310400 (3)	MTM1, MTMX	300415	Xq28	MTMX
Myxoid liposarcoma, 613488 (1)	DDIT3, GADD153, CHOP10	126337	12q13.3	DDIT3
Myxoid liposarcoma, 613488 (1)	DDIT3, GADD153, CHOP10	126337	12q13.3	GADD153
Myxoid liposarcoma, 613488 (1)	DDIT3, GADD153, CHOP10	126337	12q13.3	CHOP10
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	TSE1
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CNC1
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CAR
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PPNAD1
Myxoma, intracardiac, 255960 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	ACRDYS1
N-acetylglutamate synthase deficiency, 237310 (3)	NAGS	608300	17q21.31	NAGS
NOR polyagglutination syndrome, 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
NOR polyagglutination syndrome, 111400 (3)	A4GALT, P1PK	607922	22q13.2	P1PK
Nablus mask-like facial syndrome (4)	NMLFS, DEL8q22.1, C8DELq22.1	608156	8q22.1	NMLFS
Nablus mask-like facial syndrome (4)	NMLFS, DEL8q22.1, C8DELq22.1	608156	8q22.1	DEL8q22.1
Nablus mask-like facial syndrome (4)	NMLFS, DEL8q22.1, C8DELq22.1	608156	8q22.1	C8DELq22.1
Naegeli-Franceschetti-Jadassohn syndrome, 161000 (3)	KRT14	148066	17q21.2	KRT14
Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	FZD6, NDNC10	603409	8q22.3	FZD6
Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3)	FZD6, NDNC10	603409	8q22.3	NDNC10
Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	PLCD1, NDNC3	602142	3p22.2	PLCD1
Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)	PLCD1, NDNC3	602142	3p22.2	NDNC3
Nail disorder, nonsyndromic congenital, 7 (2)	NDNC7	605779	17p13	NDNC7
Nail disorder, nonsyndromic congenital, 9 (2)	NDNC9	614149	17q25.1-q25.3	NDNC9
Nail-patella syndrome, 161200 (3)	LMX1B, NPS1	602575	9q33.3	LMX1B
Nail-patella syndrome, 161200 (3)	LMX1B, NPS1	602575	9q33.3	NPS1
Nance-Horan syndrome, 302350 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	NHS
Nance-Horan syndrome, 302350 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	CXN
Nance-Horan syndrome, 302350 (3)	NHS, CXN, CTRCT40	300457	Xp22.2-p22.1	CTRCT40
Nanophthalmos 2, 609549 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MFRP
Nanophthalmos 2, 609549 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	MCOP5
Nanophthalmos 2, 609549 (3)	MFRP, MCOP5, NNO2	606227	11q23.3	NNO2
Nanophthalmos 3 (2)	NNO3	611897	2q11-q14	NNO3
Nanophthalmos 4, 615972 (3)	TMEM98, NNO4	615949	17q11.2	TMEM98
Nanophthalmos 4, 615972 (3)	TMEM98, NNO4	615949	17q11.2	NNO4
Nanophthalmos-1 (2)	NNO1	600165	11p	NNO1
Narcolepsy 2 (2)	NRCLP2	605841	4p13-q21	NRCLP2
Narcolepsy 3 (2)	NRCLP3	609039	21q11.2	NRCLP3
Narcolepsy 6 (2)	NRCLP6	614223	19p13.2	NRCLP6
Nasopharyngeal carcinoma, 607107 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Nasopharyngeal carcinoma, 607107 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Nasopharyngeal carcinoma, 607107 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Nasopharyngeal carcinoma, 607107 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Nasu-Hakola disease, 221770 (3)	TREM2	605086	6p21.1	TREM2
Nasu-Hakola disease, 221770 (3)	TYROBP, PLOSL, DAP12	604142	19q13.12	TYROBP
Nasu-Hakola disease, 221770 (3)	TYROBP, PLOSL, DAP12	604142	19q13.12	PLOSL
Nasu-Hakola disease, 221770 (3)	TYROBP, PLOSL, DAP12	604142	19q13.12	DAP12
Native American myopathy, 255995 (3)	STAC3, NAM	615521	12q13.3	STAC3
Native American myopathy, 255995 (3)	STAC3, NAM	615521	12q13.3	NAM
Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)	MCM4, NKGCD, NKCD	602638	8q11.21	MCM4
Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)	MCM4, NKGCD, NKCD	602638	8q11.21	NKGCD
Natural killer cell and glucocorticoid deficiency with DNA repair defect, 609981 (3)	MCM4, NKGCD, NKCD	602638	8q11.21	NKCD
Naxos disease, 601214 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	JUP
Naxos disease, 601214 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	DP3
Naxos disease, 601214 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	PDGB
Naxos disease, 601214 (3)	JUP, DP3, PDGB, ARVD12	173325	17q21.2	ARVD12
Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	TPM3
Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	NEM1
Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CFTD
Nemaline myopathy 1, autosomal dominant or recessive, 609284 (3)	TPM3, NEM1, CFTD, CAPM1	191030	1q21.3	CAPM1
Nemaline myopathy 10, 616165 (3)	LMOD3, NEM10	616112	3p14.1	LMOD3
Nemaline myopathy 10, 616165 (3)	LMOD3, NEM10	616112	3p14.1	NEM10
Nemaline myopathy 2, autosomal recessive, 256030 (3)	NEB, NEM2	161650	2q23.3	NEB
Nemaline myopathy 2, autosomal recessive, 256030 (3)	NEB, NEM2	161650	2q23.3	NEM2
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ACTA1
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	ASMA
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	NEM3
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	CFTD1
Nemaline myopathy 3, autosomal dominant or recessive, 161800 (3)	ACTA1, ASMA, NEM3, CFTD1, SHPM	102610	1q42.13	SHPM
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TPM2
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	TMSB
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	AMCD1
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA1
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	DA2B
Nemaline myopathy 4, autosomal dominant, 609285 (3)	TPM2, TMSB, AMCD1, DA1, DA2B, NEM4	190990	9p13.3	NEM4
Nemaline myopathy 5, Amish type, 605355 (3)	TNNT1, ANM, NEM5	191041	19q13.42	TNNT1
Nemaline myopathy 5, Amish type, 605355 (3)	TNNT1, ANM, NEM5	191041	19q13.42	ANM
Nemaline myopathy 5, Amish type, 605355 (3)	TNNT1, ANM, NEM5	191041	19q13.42	NEM5
Nemaline myopathy 6, autosomal dominant, 609273 (3)	KBTBD13, NEM6	613727	15q22.31	KBTBD13
Nemaline myopathy 6, autosomal dominant, 609273 (3)	KBTBD13, NEM6	613727	15q22.31	NEM6
Nemaline myopathy 7, autosomal recessive, 610687 (3)	CFL2, NEM7	601443	14q13.1	CFL2
Nemaline myopathy 7, autosomal recessive, 610687 (3)	CFL2, NEM7	601443	14q13.1	NEM7
Nemaline myopathy 8, autosomal recessive, 615348 (3)	KLHL40, SYRP, KBTBD5, NEM8	615340	3p22.1	KLHL40
Nemaline myopathy 8, autosomal recessive, 615348 (3)	KLHL40, SYRP, KBTBD5, NEM8	615340	3p22.1	SYRP
Nemaline myopathy 8, autosomal recessive, 615348 (3)	KLHL40, SYRP, KBTBD5, NEM8	615340	3p22.1	KBTBD5
Nemaline myopathy 8, autosomal recessive, 615348 (3)	KLHL40, SYRP, KBTBD5, NEM8	615340	3p22.1	NEM8
Nemaline myopathy 9, 615731 (3)	KLHL41, KBTBD10, SARCOSIN, NEM9	607701	2q31.1	KLHL41
Nemaline myopathy 9, 615731 (3)	KLHL41, KBTBD10, SARCOSIN, NEM9	607701	2q31.1	KBTBD10
Nemaline myopathy 9, 615731 (3)	KLHL41, KBTBD10, SARCOSIN, NEM9	607701	2q31.1	SARCOSIN
Nemaline myopathy 9, 615731 (3)	KLHL41, KBTBD10, SARCOSIN, NEM9	607701	2q31.1	NEM9
Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	AVPR2
Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	DIR
Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	DI1
Nephrogenic syndrome of inappropriate antidiuresis, 300539 (3)	AVPR2, DIR, DI1, ADHR	300538	Xq28	ADHR
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCK2
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL2
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	DENTS
Nephrolithiasis, type I, 310468 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL1
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC34A1
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	SLC17A2
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPT2
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	NPHLOP1
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	FRTS2
Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3)	SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2	182309	5q35.3	HCINF2
Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	SLC9A3R1, EBP50, NHERF1, NPHLOP2	604990	17q25.1	SLC9A3R1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	SLC9A3R1, EBP50, NHERF1, NPHLOP2	604990	17q25.1	EBP50
Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	SLC9A3R1, EBP50, NHERF1, NPHLOP2	604990	17q25.1	NHERF1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)	SLC9A3R1, EBP50, NHERF1, NPHLOP2	604990	17q25.1	NPHLOP2
Nephronophthisis 1, juvenile, 256100 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Nephronophthisis 1, juvenile, 256100 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPH1
Nephronophthisis 1, juvenile, 256100 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	SLSN1
Nephronophthisis 1, juvenile, 256100 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	JBTS4
Nephronophthisis 11, 613550 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
Nephronophthisis 11, 613550 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	MKS3
Nephronophthisis 11, 613550 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	JBTS6
Nephronophthisis 11, 613550 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	NPHP11
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	TTC21B
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	THM1
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	NPHP12
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	SRTD4
Nephronophthisis 12, 613820 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	ATD4
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	SRTD5
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	ATD5
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	NPHP13
Nephronophthisis 13, 614377 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	CED4
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZNF423
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	ZFP423
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	OAZ
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	KIAA0760
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	NPHP14
Nephronophthisis 14, 614844 (3)	ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19	604557	16q12.1	JBTS19
Nephronophthisis 15, 614845 (3)	CEP164, KIAA1052	614848	11q23.3	CEP164
Nephronophthisis 15, 614845 (3)	CEP164, KIAA1052	614848	11q23.3	KIAA1052
Nephronophthisis 16, 615382 (3)	ANKS6, PKDR1, NPHP16	615370	9q22.33	ANKS6
Nephronophthisis 16, 615382 (3)	ANKS6, PKDR1, NPHP16	615370	9q22.33	PKDR1
Nephronophthisis 16, 615382 (3)	ANKS6, PKDR1, NPHP16	615370	9q22.33	NPHP16
Nephronophthisis 18, 615862 (3)	CEP83, CCDC41, NPHP18	615847	12q22	CEP83
Nephronophthisis 18, 615862 (3)	CEP83, CCDC41, NPHP18	615847	12q22	CCDC41
Nephronophthisis 18, 615862 (3)	CEP83, CCDC41, NPHP18	615847	12q22	NPHP18
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	DCDC2
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	RU2
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	KIAA1154
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	NPHP19
Nephronophthisis 19, 616217 (3)	DCDC2, RU2, KIAA1154, NPHP19, DFNB66	605755	6p22.3	DFNB66
Nephronophthisis 2, infantile, 602088 (3)	INVS, INV, NPHP2, NPH2	243305	9q31.1	INVS
Nephronophthisis 2, infantile, 602088 (3)	INVS, INV, NPHP2, NPH2	243305	9q31.1	INV
Nephronophthisis 2, infantile, 602088 (3)	INVS, INV, NPHP2, NPH2	243305	9q31.1	NPHP2
Nephronophthisis 2, infantile, 602088 (3)	INVS, INV, NPHP2, NPH2	243305	9q31.1	NPH2
Nephronophthisis 3, 604387 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Nephronophthisis 3, 604387 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPH3
Nephronophthisis 3, 604387 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	RHPD1
Nephronophthisis 3, 604387 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	MKS7
Nephronophthisis 4, 606966 (3)	NPHP4, SLSN4	607215	1p36.31	NPHP4
Nephronophthisis 4, 606966 (3)	NPHP4, SLSN4	607215	1p36.31	SLSN4
Nephronophthisis 7, 611498 (3)	GLIS2, NPHP7	608539	16p13.3	GLIS2
Nephronophthisis 7, 611498 (3)	GLIS2, NPHP7	608539	16p13.3	NPHP7
Nephronophthisis-like nephropathy 1, 613159 (3)	XPNPEP3, APP3, NPHPL1	613553	22q13.2	XPNPEP3
Nephronophthisis-like nephropathy 1, 613159 (3)	XPNPEP3, APP3, NPHPL1	613553	22q13.2	APP3
Nephronophthisis-like nephropathy 1, 613159 (3)	XPNPEP3, APP3, NPHPL1	613553	22q13.2	NPHPL1
Nephropathy due to CFHR5 deficiency, 614809 (3)	CFHR5, CFHL5, FHR5, CFHR5D	608593	1q31.3	CFHR5
Nephropathy due to CFHR5 deficiency, 614809 (3)	CFHR5, CFHL5, FHR5, CFHR5D	608593	1q31.3	CFHL5
Nephropathy due to CFHR5 deficiency, 614809 (3)	CFHR5, CFHL5, FHR5, CFHR5D	608593	1q31.3	FHR5
Nephropathy due to CFHR5 deficiency, 614809 (3)	CFHR5, CFHL5, FHR5, CFHR5D	608593	1q31.3	CFHR5D
Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	CD151
Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	PETA3
Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	SFA1
Nephropathy with pretibial epidermolysis bullosa and deafness, 609057 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	MER2
Nephropathy, progressive, with deafness (2)	NEDE	609469	11q24	NEDE
Nephropathy-hypertension (2)	RFH1, AORF	161900	1q21	RFH1
Nephropathy-hypertension (2)	RFH1, AORF	161900	1q21	AORF
Nephrotic syndrome, type 1, 256300 (3)	NPHS1, NPHN	602716	19q13.12	NPHS1
Nephrotic syndrome, type 1, 256300 (3)	NPHS1, NPHN	602716	19q13.12	NPHN
Nephrotic syndrome, type 10, 615861 (3)	EMP2, NPHS10	602334	16p13.13	EMP2
Nephrotic syndrome, type 10, 615861 (3)	EMP2, NPHS10	602334	16p13.13	NPHS10
Nephrotic syndrome, type 11, 616730 (3)	NUP107, NUP84, NPHS11	607617	12q15	NUP107
Nephrotic syndrome, type 11, 616730 (3)	NUP107, NUP84, NPHS11	607617	12q15	NUP84
Nephrotic syndrome, type 11, 616730 (3)	NUP107, NUP84, NPHS11	607617	12q15	NPHS11
Nephrotic syndrome, type 12, 616892 (3)	NUP93, NIC96, KIAA0095, NPHS12	614351	16q13	NUP93
Nephrotic syndrome, type 12, 616892 (3)	NUP93, NIC96, KIAA0095, NPHS12	614351	16q13	NIC96
Nephrotic syndrome, type 12, 616892 (3)	NUP93, NIC96, KIAA0095, NPHS12	614351	16q13	KIAA0095
Nephrotic syndrome, type 12, 616892 (3)	NUP93, NIC96, KIAA0095, NPHS12	614351	16q13	NPHS12
Nephrotic syndrome, type 2, 600995 (3)	PDCN, NPHS2, SRN1	604766	1q25.2	PDCN
Nephrotic syndrome, type 2, 600995 (3)	PDCN, NPHS2, SRN1	604766	1q25.2	NPHS2
Nephrotic syndrome, type 2, 600995 (3)	PDCN, NPHS2, SRN1	604766	1q25.2	SRN1
Nephrotic syndrome, type 3, 610725 (3)	PLCE1, KIAA1516, NPHS3	608414	10q23.33	PLCE1
Nephrotic syndrome, type 3, 610725 (3)	PLCE1, KIAA1516, NPHS3	608414	10q23.33	KIAA1516
Nephrotic syndrome, type 3, 610725 (3)	PLCE1, KIAA1516, NPHS3	608414	10q23.33	NPHS3
Nephrotic syndrome, type 4, 256370 (3)	WT1, NPHS4	607102	11p13	WT1
Nephrotic syndrome, type 4, 256370 (3)	WT1, NPHS4	607102	11p13	NPHS4
Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMB2
Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMS
Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	NPHS5
Nephrotic syndrome, type 6, 614196 (3)	PTPRO, GLEPP1, NPHS6	600579	12p12.3	PTPRO
Nephrotic syndrome, type 6, 614196 (3)	PTPRO, GLEPP1, NPHS6	600579	12p12.3	GLEPP1
Nephrotic syndrome, type 6, 614196 (3)	PTPRO, GLEPP1, NPHS6	600579	12p12.3	NPHS6
Nephrotic syndrome, type 7, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	DGKE
Nephrotic syndrome, type 7, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	NPHS7
Nephrotic syndrome, type 7, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	AHUS7
Nephrotic syndrome, type 8, 615244 (3)	ARHGDIA, GDIA1, NPHS8	601925	17q25.3	ARHGDIA
Nephrotic syndrome, type 8, 615244 (3)	ARHGDIA, GDIA1, NPHS8	601925	17q25.3	GDIA1
Nephrotic syndrome, type 8, 615244 (3)	ARHGDIA, GDIA1, NPHS8	601925	17q25.3	NPHS8
Nephrotic syndrome, type 9, 615573 (3)	ADCK4, NPHS9	615567	19q13.2	ADCK4
Nephrotic syndrome, type 9, 615573 (3)	ADCK4, NPHS9	615567	19q13.2	NPHS9
Nestor-Guillermo progeria syndrome, 614008 (3)	BANF1, BAF, NGPS	603811	11q13.1	BANF1
Nestor-Guillermo progeria syndrome, 614008 (3)	BANF1, BAF, NGPS	603811	11q13.1	BAF
Nestor-Guillermo progeria syndrome, 614008 (3)	BANF1, BAF, NGPS	603811	11q13.1	NGPS
Netherton syndrome, 256500 (3)	SPINK5, LEKTI	605010	5q32	SPINK5
Netherton syndrome, 256500 (3)	SPINK5, LEKTI	605010	5q32	LEKTI
Neu-Laxova syndrome 1, 256520 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDH
Neu-Laxova syndrome 1, 256520 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	NLS1
Neu-Laxova syndrome 1, 256520 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDHD
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT1
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSAT
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	EPIP
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	PSATD
Neu-Laxova syndrome 2, 616038 (3)	PSAT1, PSAT, EPIP, PSATD, NLS2	610936	9q21.2	NLS2
Neural tube defects, 182940 (3)	FUZ, NTD	610622	19q13.33	FUZ
Neural tube defects, 182940 (3)	FUZ, NTD	610622	19q13.33	NTD
Neural tube defects, 182940 (3)	VANGL2, LTAP	600533	1q23.2	VANGL2
Neural tube defects, 182940 (3)	VANGL2, LTAP	600533	1q23.2	LTAP
Neuroblastoma with Hirschsprung disease, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
Neuroblastoma with Hirschsprung disease, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBPHOX
Neuroblastoma with Hirschsprung disease, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PHOX2B
Neuroblastoma with Hirschsprung disease, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBLST2
Neuroblastoma, 256700 (3)	NME1, NM23	156490	17q21.33	NME1
Neuroblastoma, 256700 (3)	NME1, NM23	156490	17q21.33	NM23
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Neurocutaneous melanosis, somatic, 249400 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Neurodegeneration due to cerebral folate transport deficiency, 613068 (3)	FOLR1	136430	11q13.4	FOLR1
Neurodegeneration with brain iron accululation 5, 300894 (3)	WDR45, WIPI4, NBIA5	300526	Xp11.23	WDR45
Neurodegeneration with brain iron accululation 5, 300894 (3)	WDR45, WIPI4, NBIA5	300526	Xp11.23	WIPI4
Neurodegeneration with brain iron accululation 5, 300894 (3)	WDR45, WIPI4, NBIA5	300526	Xp11.23	NBIA5
Neurodegeneration with brain iron accumulation 1, 234200 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PANK2
Neurodegeneration with brain iron accumulation 1, 234200 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	NBIA1
Neurodegeneration with brain iron accumulation 1, 234200 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	PKAN
Neurodegeneration with brain iron accumulation 1, 234200 (3)	PANK2, NBIA1, PKAN, HARP	606157	20p13	HARP
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	IPLA2
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	INAD1
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2B
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2A
Neurodegeneration with brain iron accumulation 2B, 610217 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PARK14
Neurodegeneration with brain iron accumulation 3, 606159 (3)	FTL, NBIA3, LFTD	134790	19q13.33	FTL
Neurodegeneration with brain iron accumulation 3, 606159 (3)	FTL, NBIA3, LFTD	134790	19q13.33	NBIA3
Neurodegeneration with brain iron accumulation 3, 606159 (3)	FTL, NBIA3, LFTD	134790	19q13.33	LFTD
Neurodegeneration with brain iron accumulation 4, 614298 (3)	C19orf12, NBIA4, SPG43	614297	19q12	C19orf12
Neurodegeneration with brain iron accumulation 4, 614298 (3)	C19orf12, NBIA4, SPG43	614297	19q12	NBIA4
Neurodegeneration with brain iron accumulation 4, 614298 (3)	C19orf12, NBIA4, SPG43	614297	19q12	SPG43
Neurodegeneration with brain iron accumulation 6, 615643 (3)	COASY, NBIA6	609855	17q21.2	COASY
Neurodegeneration with brain iron accumulation 6, 615643 (3)	COASY, NBIA6	609855	17q21.2	NBIA6
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	RERE, NEDBEH	605226	1p36.23	RERE
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3)	RERE, NEDBEH	605226	1p36.23	NEDBEH
Neuroepithelioma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWSR1
Neuroepithelioma, 612219 (3)	EWSR1, EWS	133450	22q12.2	EWS
Neurofibromatosis, familial spinal, 162210 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibromatosis, familial spinal, 162210 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	VRNF
Neurofibromatosis, familial spinal, 162210 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	WSS
Neurofibromatosis, familial spinal, 162210 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NFNS
Neurofibromatosis, type 1, 162200 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibromatosis, type 1, 162200 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	VRNF
Neurofibromatosis, type 1, 162200 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	WSS
Neurofibromatosis, type 1, 162200 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NFNS
Neurofibromatosis, type 2, 101000 (3)	NF2	607379	22q12.2	NF2
Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	VRNF
Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	WSS
Neurofibromatosis-Noonan syndrome, 601321 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NFNS
Neurofibrosarcoma (3)	MXI1	600020	10q25.2	MXI1
Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	MHS
Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3)	RYR1, MHS, CCO	180901	19q13.2	CCO
Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	HINT1, PRKCNH1, NMAN	601314	5q23.3	HINT1
Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	HINT1, PRKCNH1, NMAN	601314	5q23.3	PRKCNH1
Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3)	HINT1, PRKCNH1, NMAN	601314	5q23.3	NMAN
Neuronopathy, distal hereditary motor, type I (2)	DHMN1	182960	7q34-q36	DHMN1
Neuronopathy, distal hereditary motor, type IID, 615575 (3)	FBXO38, FBX38, MOKA, HMN2D	608533	5q32	FBXO38
Neuronopathy, distal hereditary motor, type IID, 615575 (3)	FBXO38, FBX38, MOKA, HMN2D	608533	5q32	FBX38
Neuronopathy, distal hereditary motor, type IID, 615575 (3)	FBXO38, FBX38, MOKA, HMN2D	608533	5q32	MOKA
Neuronopathy, distal hereditary motor, type IID, 615575 (3)	FBXO38, FBX38, MOKA, HMN2D	608533	5q32	HMN2D
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	IGHMBP2
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	SMUBP2
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	CATF1
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	SMARD1
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	HMN6
Neuronopathy, distal hereditary motor, type VI, 604320 (3)	IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S	600502	11q13.3	CMT2S
Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)	SLC5A7, CHT1, HMN7A	608761	2q12.3	SLC5A7
Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)	SLC5A7, CHT1, HMN7A	608761	2q12.3	CHT1
Neuronopathy, distal hereditary motor, type VIIA, 158580 (3)	SLC5A7, CHT1, HMN7A	608761	2q12.3	HMN7A
Neuropathy, congenital hypomyelinating, 1, 605253 (3)	EGR2, KROX20	129010	10q21.3	EGR2
Neuropathy, congenital hypomyelinating, 1, 605253 (3)	EGR2, KROX20	129010	10q21.3	KROX20
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Neuropathy, congenital hypomyelinating, 605253 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HSPB8
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	H11
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	E2IG1
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	DHMN2
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	CMT2L
Neuropathy, distal hereditary motor, type IIA, 158590 (3)	HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A	608014	12q24.23	HMN2A
Neuropathy, distal hereditary motor, type IIB, 608634 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSPB1
Neuropathy, distal hereditary motor, type IIB, 608634 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HSP27
Neuropathy, distal hereditary motor, type IIB, 608634 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	CMT2F
Neuropathy, distal hereditary motor, type IIB, 608634 (3)	HSPB1, HSP27, CMT2F, HMN2B	602195	7q11.23	HMN2B
Neuropathy, distal hereditary motor, type VA, 600794 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Neuropathy, distal hereditary motor, type VA, 600794 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	SPG17
Neuropathy, distal hereditary motor, type VA, 600794 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	HMN5
Neuropathy, distal hereditary motor, type VA, 600794 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	PELD
Neuropathy, distal hereditary motor, type VA, 600794 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	GARS
Neuropathy, distal hereditary motor, type VA, 600794 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	SMAD1
Neuropathy, distal hereditary motor, type VA, 600794 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	CMT2D
Neuropathy, distal hereditary motor, type VA, 600794 (3)	GARS, SMAD1, CMT2D, HMN5	600287	7p14.3	HMN5
Neuropathy, distal hereditary motor, type VIIB, 607641 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
Neuropathy, distal hereditary motor, type VIIB, 607641 (3)	DCTN1, HMN7B	601143	2p13.1	HMN7B
Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	HK1, HKD, HMSNR	142600	10q22.1	HK1
Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	HK1, HKD, HMSNR	142600	10q22.1	HKD
Neuropathy, hereditary motor and sensory, Russe type, 605285 (3)	HK1, HKD, HMSNR	142600	10q22.1	HMSNR
Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	SLC25A46, HMSN6B	610826	5q22.1	SLC25A46
Neuropathy, hereditary motor and sensory, type VIB, 616505 (3)	SLC25A46, HMSN6B	610826	5q22.1	HMSN6B
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	SPTLC1
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	LBC1
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	SPT1
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	HSN1
Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)	SPTLC1, LBC1, SPT1, HSN1, HSAN	605712	9q22.31	HSAN
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	SPTLC2
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	KIAA0526
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	SPT2
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	LCB2
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	HSN1C
Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)	SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C	605713	14q24.3	NSAN1C
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	WNK1
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	PRKWNK1
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	KDP
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	PHA2C
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	HSAN2
Neuropathy, hereditary sensory and autonomic, type II, 201300 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	HSN2
Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	FAM134B, HSAN2B	613114	5p15.1	FAM134B
Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)	FAM134B, HSAN2B	613114	5p15.1	HSAN2B
Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	NGF, NGFB, HSAN5	162030	1p13.2	NGF
Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	NGF, NGFB, HSAN5	162030	1p13.2	NGFB
Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)	NGF, NGFB, HSAN5	162030	1p13.2	HSAN5
Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	SCN11A
Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	HSAN7
Neuropathy, hereditary sensory and autonomic, type VII, 615548 (3)	SCN11A, HSAN7, FEPS3	604385	3p22.2	FEPS3
Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	PRDM12, HSAN8	616458	9q34.12	PRDM12
Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3)	PRDM12, HSAN8	616458	9q34.12	HSAN8
Neuropathy, hereditary sensory, type IB (2)	HSN1B	608088	3p24-p22	HSN1B
Neuropathy, hereditary sensory, type ID, 613708 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	ATL1
Neuropathy, hereditary sensory, type ID, 613708 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	SPG3A
Neuropathy, hereditary sensory, type ID, 613708 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	HSN1D
Neuropathy, hereditary sensory, type IE, 614116 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	DNMT1
Neuropathy, hereditary sensory, type IE, 614116 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	MCMT
Neuropathy, hereditary sensory, type IE, 614116 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	HSN1E
Neuropathy, hereditary sensory, type IE, 614116 (3)	DNMT1, MCMT, HSN1E, ADCADN	126375	19p13.2	ADCADN
Neuropathy, hereditary sensory, type IF, 615632 (3)	ATL3, HSN1F	609369	11q13.1	ATL3
Neuropathy, hereditary sensory, type IF, 615632 (3)	ATL3, HSN1F	609369	11q13.1	HSN1F
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	ATSV
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	UNC104
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	SPG30
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	HSN2C
Neuropathy, hereditary sensory, type IIC, 614213 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	MRD9
Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	CCT5, KIAA0098, CCTE	610150	5p15.2	CCT5
Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	CCT5, KIAA0098, CCTE	610150	5p15.2	KIAA0098
Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)	CCT5, KIAA0098, CCTE	610150	5p15.2	CCTE
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	FBLN5
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARMD3
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ADCL2
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	ARCL1A
Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3)	FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD	604580	14q32.12	HNARMD
Neuropathy, inflammatory demyelinating, 139393 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Neuropathy, inflammatory demyelinating, 139393 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Neuropathy, inflammatory demyelinating, 139393 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Neuropathy, inflammatory demyelinating, 139393 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Neuropathy, paraneoplastic sensory (1)	ELAVL4, HUD, PNEM	168360	1p33-p32	ELAVL4
Neuropathy, paraneoplastic sensory (1)	ELAVL4, HUD, PNEM	168360	1p33-p32	HUD
Neuropathy, paraneoplastic sensory (1)	ELAVL4, HUD, PNEM	168360	1p33-p32	PNEM
Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Neuropathy, recurrent, with pressure palsies, 162500 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Neutral lipid storage disease with myopathy, 610717 (3)	PNPLA2, TTS2, ATGL	609059	11p15.5	PNPLA2
Neutral lipid storage disease with myopathy, 610717 (3)	PNPLA2, TTS2, ATGL	609059	11p15.5	TTS2
Neutral lipid storage disease with myopathy, 610717 (3)	PNPLA2, TTS2, ATGL	609059	11p15.5	ATGL
Neutropenia, alloimmune neonatal (3)	FCGR3B	610665	1q23.3	FCGR3B
Neutropenia, cyclic, 162800 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELANE
Neutropenia, cyclic, 162800 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELA2
Neutropenia, cyclic, 162800 (3)	ELANE, ELA2, SCN1	130130	19p13.3	SCN1
Neutropenia, neonatal alloimmune (1)	LAG5	151450	Chr.4	LAG5
Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	GFI1
Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	ZNF163
Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	SCN2
Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELANE
Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	ELANE, ELA2, SCN1	130130	19p13.3	ELA2
Neutropenia, severe congenital 1, autosomal dominant, 202700 (3)	ELANE, ELA2, SCN1	130130	19p13.3	SCN1
Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	GFI1
Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	ZNF163
Neutropenia, severe congenital 2, autosomal dominant, 613107 (3)	GFI1, ZNF163, SCN2	600871	1p22.1	SCN2
Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	HAX1, SCN3	605998	1q21.3	HAX1
Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)	HAX1, SCN3	605998	1q21.3	SCN3
Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	G6PC3
Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	UGRP
Neutropenia, severe congenital 4, autosomal recessive, 612541 (3)	G6PC3, UGRP, SCN4	611045	17q21.31	SCN4
Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	VPS45A, VPS45, SCN5	610035	1q21.2	VPS45A
Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	VPS45A, VPS45, SCN5	610035	1q21.2	VPS45
Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3)	VPS45A, VPS45, SCN5	610035	1q21.2	SCN5
Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	JAGN1, SCN6	616012	3p25.3	JAGN1
Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3)	JAGN1, SCN6	616012	3p25.3	SCN6
Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	CSF3R, GCSFR, SCN7	138971	1p34.3	CSF3R
Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	CSF3R, GCSFR, SCN7	138971	1p34.3	GCSFR
Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3)	CSF3R, GCSFR, SCN7	138971	1p34.3	SCN7
Neutropenia, severe congenital, X-linked, 300299 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Neutropenia, severe congenital, X-linked, 300299 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	IMD2
Neutropenia, severe congenital, X-linked, 300299 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	THC1
Neutropenia, severe congenital, X-linked, 300299 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	SCNX
Neutrophil immunodeficiency syndrome, 608203 (3)	RAC2	602049	22q13.1	RAC2
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NEK9
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NERCC1
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	LCCS10
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	APUG
Nevus comedonicus, somatic, 617025 (3)	NEK9, NERCC1, LCCS10, APUG, NC	609798	14q24.3	NC
Nevus, epidermal, somatic, 162900 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Nevus, epidermal, somatic, 162900 (3)	FGFR3, ACH	134934	4p16.3	ACH
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Nevus, epidermal, somatic, 162900 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Newfoundland rod-cone dystrophy, 607476 (3)	RLBP1	180090	15q26.1	RLBP1
Nicolaides-Baraitser syndrome, 601358 (3)	SMARCA2, SNF2L2, NCBRS	600014	9p24.3	SMARCA2
Nicolaides-Baraitser syndrome, 601358 (3)	SMARCA2, SNF2L2, NCBRS	600014	9p24.3	SNF2L2
Nicolaides-Baraitser syndrome, 601358 (3)	SMARCA2, SNF2L2, NCBRS	600014	9p24.3	NCBRS
Niemann-Pick disease, type A, 257200 (3)	SMPD1, NPD	607608	11p15.4	SMPD1
Niemann-Pick disease, type A, 257200 (3)	SMPD1, NPD	607608	11p15.4	NPD
Niemann-Pick disease, type B, 607616 (3)	SMPD1, NPD	607608	11p15.4	SMPD1
Niemann-Pick disease, type B, 607616 (3)	SMPD1, NPD	607608	11p15.4	NPD
Niemann-Pick disease, type C1, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC1
Niemann-Pick disease, type C1, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC
Niemann-Pick disease, type D, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC1
Niemann-Pick disease, type D, 257220 (3)	NPC1, NPC	607623	18q11.2	NPC
Niemann-pick disease, type C2, 607625 (3)	NPC2, HE1	601015	14q24.3	NPC2
Niemann-pick disease, type C2, 607625 (3)	NPC2, HE1	601015	14q24.3	HE1
Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	NYX, CSNB1A, NBM1	300278	Xp11.4	NYX
Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	NYX, CSNB1A, NBM1	300278	Xp11.4	CSNB1A
Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3)	NYX, CSNB1A, NBM1	300278	Xp11.4	NBM1
Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	GRM6, MGLUR6, CSNB1B	604096	5q35.3	GRM6
Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	GRM6, MGLUR6, CSNB1B	604096	5q35.3	MGLUR6
Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3)	GRM6, MGLUR6, CSNB1B	604096	5q35.3	CSNB1B
Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	TRPM1, MLSN1, CSNB1C	603576	15q13.3	TRPM1
Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	TRPM1, MLSN1, CSNB1C	603576	15q13.3	MLSN1
Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)	TRPM1, MLSN1, CSNB1C	603576	15q13.3	CSNB1C
Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	SLC24A1, NCKX1, CSNB1D	603617	15q22.31	SLC24A1
Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	SLC24A1, NCKX1, CSNB1D	603617	15q22.31	NCKX1
Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3)	SLC24A1, NCKX1, CSNB1D	603617	15q22.31	CSNB1D
Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	GPR179, GPR158L, GPR158L1, CSNB1E	614515	17q12	GPR179
Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	GPR179, GPR158L, GPR158L1, CSNB1E	614515	17q12	GPR158L
Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	GPR179, GPR158L, GPR158L1, CSNB1E	614515	17q12	GPR158L1
Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3)	GPR179, GPR158L, GPR158L1, CSNB1E	614515	17q12	CSNB1E
Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	LRIT3, FIGLER4, CSNB1F	615004	4q25	LRIT3
Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	LRIT3, FIGLER4, CSNB1F	615004	4q25	FIGLER4
Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3)	LRIT3, FIGLER4, CSNB1F	615004	4q25	CSNB1F
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CACNA1F
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CORDX3
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	CSNB2A
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	AIED
Night blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3)	CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2	300110	Xp11.23	OA2
Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RP4
Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	OPN2
Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	CSNBAD1
Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDE6B
Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDEB
Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	RP40
Night blindness, congenital stationary, autosomal dominant 2, 163500 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	CSNBAD2
Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	GNAT1
Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	CSNBAD3
Night blindness, congenital stationary, autosomal dominant 3, 610444 (3)	GNAT1, CSNBAD3, CSNB1G	139330	3p21.31	CSNB1G
Night blindness, congenital stationary, type 1H, 617024 (3)	GNB3, CSNB1H	139130	12p13.31	GNB3
Night blindness, congenital stationary, type 1H, 617024 (3)	GNB3, CSNB1H	139130	12p13.31	CSNB1H
Nijmegen breakage syndrome, 251260 (3)	NBN, NBS1	602667	8q21.3	NBN
Nijmegen breakage syndrome, 251260 (3)	NBN, NBS1	602667	8q21.3	NBS1
Nijmegen breakage syndrome-like disorder, 613078 (3)	RAD50, NBSLD	604040	5q31.1	RAD50
Nijmegen breakage syndrome-like disorder, 613078 (3)	RAD50, NBSLD	604040	5q31.1	NBSLD
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GNE
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GLCNE
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	IBM2
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	DMRV
Nonaka myopathy, 605820 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	NM
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980 (3)	EGFR, NISBD2	131550	7p11.2	NISBD2
Nonsmall cell lung cancer, somatic (3)	BRAF, NS7	164757	7q34	BRAF
Nonsmall cell lung cancer, somatic (3)	BRAF, NS7	164757	7q34	NS7
Nonsmall cell lung cancer, somatic, 211980 (3)	IRF1, MAR	147575	5q31.1	IRF1
Nonsmall cell lung cancer, somatic, 211980 (3)	IRF1, MAR	147575	5q31.1	MAR
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Nonsmall cell lung cancer, somatic, 211980 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTPN11
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	PTP2C
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	SHP2
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	NS1
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	JMML
Noonan syndrome 1, 163950 (3)	PTPN11, PTP2C, SHP2, NS1, JMML, METCDS	176876	12q24.13	METCDS
Noonan syndrome 10, 616564 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	LZTR1
Noonan syndrome 10, 616564 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	SWNTS2
Noonan syndrome 10, 616564 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	NS10
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Noonan syndrome 3, 609942 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	SOS1
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	GINGF
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	GF1
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	HGF
Noonan syndrome 4, 610733 (3)	SOS1, GINGF, GF1, HGF, NS4	182530	2p22.1	NS4
Noonan syndrome 5, 611553 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	RAF1
Noonan syndrome 5, 611553 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CRAF
Noonan syndrome 5, 611553 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	NS5
Noonan syndrome 5, 611553 (3)	RAF1, CRAF, NS5, CMD1NN	164760	3p25.2	CMD1NN
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Noonan syndrome 6, 613224 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Noonan syndrome 7, 613706 (3)	BRAF, NS7	164757	7q34	BRAF
Noonan syndrome 7, 613706 (3)	BRAF, NS7	164757	7q34	NS7
Noonan syndrome 8, 615355 (3)	RIT1, RIT, ROC1, NS8	609591	1q22	RIT1
Noonan syndrome 8, 615355 (3)	RIT1, RIT, ROC1, NS8	609591	1q22	RIT
Noonan syndrome 8, 615355 (3)	RIT1, RIT, ROC1, NS8	609591	1q22	ROC1
Noonan syndrome 8, 615355 (3)	RIT1, RIT, ROC1, NS8	609591	1q22	NS8
Noonan syndrome 9, 616559 (3)	SOS2, NS9	601247	14q21.3	SOS2
Noonan syndrome 9, 616559 (3)	SOS2, NS9	601247	14q21.3	NS9
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3)	CBL, CBL2, NSLL	165360	11q23.3	CBL2
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3)	CBL, CBL2, NSLL	165360	11q23.3	NSLL
Noonan-like syndrome with loose anagen hair, 607721 (3)	SHOC2, SIAA0862, SOC2, SUR8	602775	10q25.2	SHOC2
Noonan-like syndrome with loose anagen hair, 607721 (3)	SHOC2, SIAA0862, SOC2, SUR8	602775	10q25.2	SIAA0862
Noonan-like syndrome with loose anagen hair, 607721 (3)	SHOC2, SIAA0862, SOC2, SUR8	602775	10q25.2	SOC2
Noonan-like syndrome with loose anagen hair, 607721 (3)	SHOC2, SIAA0862, SOC2, SUR8	602775	10q25.2	SUR8
Norrie disease, 310600 (3)	NDP, ND, EVR2	300658	Xp11.3	NDP
Norrie disease, 310600 (3)	NDP, ND, EVR2	300658	Xp11.3	ND
Norrie disease, 310600 (3)	NDP, ND, EVR2	300658	Xp11.3	EVR2
Norum disease, 245900 (3)	LCAT	606967	16q22.1	LCAT
Nystagmus 1, congenital, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	FRMD7
Nystagmus 1, congenital, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	NYS1
Nystagmus 1, congenital, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	XIPAN
Nystagmus 2, congenital, autosomal dominant (2)	NYS2, NYSA	164100	6p12	NYS2
Nystagmus 2, congenital, autosomal dominant (2)	NYS2, NYSA	164100	6p12	NYSA
Nystagmus 3, congenital, autosomal dominant (2)	NYS3	608345	7p11.2	NYS3
Nystagmus 4, congenital, autosomal dominant (2)	NYS4	193003	13q31-q33	NYS4
Nystagmus 5, congenital, X-linked (2)	NYS5	300589	Xp11.4	NYS5
Nystagmus 6, congenital, X-linked, 300814 (3)	GPR143, OA1, NYS6	300808	Xp22.2	GPR143
Nystagmus 6, congenital, X-linked, 300814 (3)	GPR143, OA1, NYS6	300808	Xp22.2	OA1
Nystagmus 6, congenital, X-linked, 300814 (3)	GPR143, OA1, NYS6	300808	Xp22.2	NYS6
Nystagmus 7, congenital, autosomal dominant (2)	NYS7	614826	1q31.3-q32.1	NYS7
Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	FRMD7
Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	NYS1
Nystagmus, infantile periodic alternating, X-linked, 310700 (3)	FRMD7, NYS1, XIPAN	300628	Xq26.2	XIPAN
OKT4 epitope deficiency, 613949 (3)	CD4	186940	12p13.31	CD4
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PCSK1
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	NEC1
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PC1
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PC3
Obesity with impaired prohormone processing, 600955 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	BMIQ12
Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3)	POMC	176830	2p23.3	POMC
Obesity, autosomal dominant, 601665 (3)	MC4R	155541	18q21.32	MC4R
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	AKR1C2
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	DDH2
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	DD2
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	HAKRD
Obesity, hyperphagia, and developmental delay (3)	AKR1C2, DDH2, DD2, HAKRD, SRXY8	600450	10p15.1	SRXY8
Obesity, mild, early-onset, 601665 (3)	NR0B2, SHP	604630	1p36.11	NR0B2
Obesity, mild, early-onset, 601665 (3)	NR0B2, SHP	604630	1p36.11	SHP
Obesity, morbid, due to leptin deficiency, 614962 (3)	LEP, OB, LEPD	164160	7q32.1	LEP
Obesity, morbid, due to leptin deficiency, 614962 (3)	LEP, OB, LEPD	164160	7q32.1	OB
Obesity, morbid, due to leptin deficiency, 614962 (3)	LEP, OB, LEPD	164160	7q32.1	LEPD
Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	LEPR, OBR, LEPRD	601007	1p31.3	LEPR
Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	LEPR, OBR, LEPRD	601007	1p31.3	OBR
Obesity, morbid, due to leptin receptor deficiency, 614963 (3)	LEPR, OBR, LEPRD	601007	1p31.3	LEPRD
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
Obesity, severe, 601665 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
Obesity, severe, 601665 (3)	SIM1	603128	6q16.3	SIM1
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MNK
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MK
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	OHS
Occipital horn syndrome, 304150 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	SMAX3
Occult macular dystrophy, 613587 (3)	RP1L1	608581	8p23.1	RP1L1
Ocular albinism with sensorineural deafness (2)	OASD	300650	Xp22.3	OASD
Ocular albinism, type I, Nettleship-Falls type, 300500 (3)	GPR143, OA1, NYS6	300808	Xp22.2	GPR143
Ocular albinism, type I, Nettleship-Falls type, 300500 (3)	GPR143, OA1, NYS6	300808	Xp22.2	OA1
Ocular albinism, type I, Nettleship-Falls type, 300500 (3)	GPR143, OA1, NYS6	300808	Xp22.2	NYS6
Oculoauricular syndrome, 612109 (3)	HMX1, H6	142992	4p16.1	HMX1
Oculoauricular syndrome, 612109 (3)	HMX1, H6	142992	4p16.1	H6
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Oculodentodigital dysplasia, 164200 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Oculodentodigital dysplasia, autosomal recessive, 257850 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Oculomotor apraxia, congenital, Cogan-type (2)	COMA	257550	2q13	COMA
Oculopharyngeal muscular dystrophy, 164300 (3)	PABPN1, PABP2, PAB2	602279	14q11.2	PABPN1
Oculopharyngeal muscular dystrophy, 164300 (3)	PABPN1, PABP2, PAB2	602279	14q11.2	PABP2
Oculopharyngeal muscular dystrophy, 164300 (3)	PABPN1, PABP2, PAB2	602279	14q11.2	PAB2
Odontohypophosphatasia, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	ALPL
Odontohypophosphatasia, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	HOPS
Odontohypophosphatasia, 146300 (3)	ALPL, HOPS, TNSALP	171760	1p36.12	TNSALP
Odontoonychodermal dysplasia, 257980 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Odontoonychodermal dysplasia, 257980 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	SSPS
Odontoonychodermal dysplasia, 257980 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	STHAG4
Odontoonychodermal dysplasia, 257980 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	OODD
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NAA10
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	ARD1A
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	ARD1
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	TE2
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	NATD
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	OGDNS
Ogden syndrome, 300855 (3)	NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1	300013	Xq28	MCOPS1
Oguchi disease-1, 258100 (3)	SAG, RP47	181031	2q37.1	SAG
Oguchi disease-1, 258100 (3)	SAG, RP47	181031	2q37.1	RP47
Oguchi disease-2, 613411 (3)	GRK1, RHOK, RK	180381	13q34	GRK1
Oguchi disease-2, 613411 (3)	GRK1, RHOK, RK	180381	13q34	RHOK
Oguchi disease-2, 613411 (3)	GRK1, RHOK, RK	180381	13q34	RK
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TNRC11
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TRAP230
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	HOPA
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	KIAA0192
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OKS
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	FGS1
Ohdo syndrome, X-linked, 300895 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OHDOX
Okur-Chung neurodevelopmental syndrome, 617062 (3)	CSNK2A1, CK2A1, OCNDS	115440	20p13	CSNK2A1
Okur-Chung neurodevelopmental syndrome, 617062 (3)	CSNK2A1, CK2A1, OCNDS	115440	20p13	CK2A1
Okur-Chung neurodevelopmental syndrome, 617062 (3)	CSNK2A1, CK2A1, OCNDS	115440	20p13	OCNDS
Oligodontia-colorectal cancer syndrome, 608615 (3)	AXIN2, ODCRCS	604025	17q24.1	AXIN2
Oligodontia-colorectal cancer syndrome, 608615 (3)	AXIN2, ODCRCS	604025	17q24.1	ODCRCS
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTE
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	SPG39
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTEMND
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	BNHS
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	LNMS
Oliver-McFarlane syndrome, 275400 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	OMCS
Olmsted syndrome, 614594 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	TRPV3
Olmsted syndrome, 614594 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	OLMS
Olmsted syndrome, 614594 (3)	TRPV3, OLMS, FNEPPK2	607066	17p13.2	FNEPPK2
Omenn syndrome, 603554 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	DCLRE1C
Omenn syndrome, 603554 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	ARTEMIS
Omenn syndrome, 603554 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	SCIDA
Omenn syndrome, 603554 (3)	RAG1	179615	11p12	RAG1
Omenn syndrome, 603554 (3)	RAG2	179616	11p12	RAG2
Omeprazole poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Omeprazole poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C19
Omodysplasia 1, 258315 (3)	GPC6, OMIMD1	604404	13q31.3-q32.1	GPC6
Omodysplasia 1, 258315 (3)	GPC6, OMIMD1	604404	13q31.3-q32.1	OMIMD1
Omphalocele due to duplication of 1p31.3 (4)	OPHLC, C1DUPp31.3, DUP1p31.3	164750	1p31.3	OPHLC
Omphalocele due to duplication of 1p31.3 (4)	OPHLC, C1DUPp31.3, DUP1p31.3	164750	1p31.3	C1DUPp31.3
Omphalocele due to duplication of 1p31.3 (4)	OPHLC, C1DUPp31.3, DUP1p31.3	164750	1p31.3	DUP1p31.3
Oocyte maturation defect 1, 615774 (3)	ZP1, OOMD1	195000	11q12.2	ZP1
Oocyte maturation defect 1, 615774 (3)	ZP1, OOMD1	195000	11q12.2	OOMD1
Oocyte maturation defect 2, 616780 (3)	TUBB8, OOMD2	616768	10p15.3	TUBB8
Oocyte maturation defect 2, 616780 (3)	TUBB8, OOMD2	616768	10p15.3	OOMD2
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	MID1
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	OGS1
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	BBBG1
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	FXY
Opitz GBBB syndrome, type I, 300000 (3)	MID1, OGS1, BBBG1, FXY, OSX	300552	Xp22.2	OSX
Opitz GBBB syndrome, type II, 145410 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	SPECC1L
Opitz GBBB syndrome, type II, 145410 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	KIAA0376
Opitz GBBB syndrome, type II, 145410 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	OBLFC1
Opitz GBBB syndrome, type II, 145410 (3)	SPECC1L, KIAA0376, OBLFC1, GBBB2	614140	22q11.23	GBBB2
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	MED12
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TNRC11
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	TRAP230
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	HOPA
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	KIAA0192
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OKS
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	FGS1
Opitz-Kaveggia syndrome, 305450 (3)	MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX	300188	Xq13.1	OHDOX
Opsismodysplasia, 258480 (3)	INPPL1, OPSMD	600829	11q13.4	INPPL1
Opsismodysplasia, 258480 (3)	INPPL1, OPSMD	600829	11q13.4	OPSMD
Optic atroph 8 (2)	OPA8	616648	16q21-q22	OPA8
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NTG
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NPG
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	BERHS
Optic atrophy 1, 165500 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	MTDPS14
Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	RTN4IP1, NIMP, OPA10	610502	6q21	RTN4IP1
Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	RTN4IP1, NIMP, OPA10	610502	6q21	NIMP
Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3)	RTN4IP1, NIMP, OPA10	610502	6q21	OPA10
Optic atrophy 2, X-linked (2)	OPA2	311050	Xp11.4-p11.21	OPA2
Optic atrophy 3 with cataract, 165300 (3)	OPA3, MGA3	606580	19q13.32	OPA3
Optic atrophy 3 with cataract, 165300 (3)	OPA3, MGA3	606580	19q13.32	MGA3
Optic atrophy 4 (2)	OPA4	605293	18q12.2-q12.3	OPA4
Optic atrophy 5 (2)	OPA5	610708	22q12.1-q13.1	OPA5
Optic atrophy 6 (2)	OPA6	258500	8q21-q22	OPA6
Optic atrophy 7, 612989 (3)	TMEM126A, OPA7	612988	11q14.1	TMEM126A
Optic atrophy 7, 612989 (3)	TMEM126A, OPA7	612988	11q14.1	OPA7
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NTG
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NPG
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	BERHS
Optic atrophy plus syndrome, 125250 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	MTDPS14
Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	SIX6, ODRMD	606326	14q23.1	SIX6
Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3)	SIX6, ODRMD	606326	14q23.1	ODRMD
Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	SOX2
Optic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3)	SOX2, MCOPS3	184429	3q26.33	MCOPS3
Optic nerve hypoplasia, 165550 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Optic nerve hypoplasia, 165550 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Optic nerve hypoplasia, 165550 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Optic nerve hypoplasia, 165550 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Ornithine transcarbamylase deficiency, 311250 (3)	OTC	300461	Xp11.4	OTC
Orofacial cleft 10, 613705 (3)	SUMO1, UBL1, SMT3, OFC10	601912	2q33.1	SUMO1
Orofacial cleft 10, 613705 (3)	SUMO1, UBL1, SMT3, OFC10	601912	2q33.1	UBL1
Orofacial cleft 10, 613705 (3)	SUMO1, UBL1, SMT3, OFC10	601912	2q33.1	SMT3
Orofacial cleft 10, 613705 (3)	SUMO1, UBL1, SMT3, OFC10	601912	2q33.1	OFC10
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP4
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP2B1
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	BMP2B
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	MCOPS6
Orofacial cleft 11, 600625 (3)	BMP4, BMP2B1, BMP2B, MCOPS6, OFC11	112262	14q22.2	OFC11
Orofacial cleft 12 (2)	OFC12	612858	8q24.3	OFC12
Orofacial cleft 13 (2)	OFC13	613857	1p33	OFC13
Orofacial cleft 14 (2)	OFC14	615892	1p31	OFC14
Orofacial cleft 4 (2)	OFC4	608371	4q21-q31	OFC4
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HOX7
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HYD1
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	OFC5
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	STHAG1
Orofacial cleft 5, 608874 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	ECTD3
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	NECTIN1
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PVRL1
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	HVEC
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PVRR1
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	PRR1
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	ED4
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	OFC7
Orofacial cleft 7, 225060 (3)	NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1	600644	11q23.3	CLPED1
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Orofacial cleft 8, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Orofacial cleft 9 (2)	OFC9	610361	13q33.1-q34	OFC9
Orofacial cleft-1 (2)	OFC1, CL	119530	6p24.3	OFC1
Orofacial cleft-1 (2)	OFC1, CL	119530	6p24.3	CL
Orofacial cleft-2 (2)	OFC2	602966	2p13	OFC2
Orofacial cleft-3 (2)	OFC3	600757	19q13	OFC3
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	CXorf5
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	SGBS2
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	JBTS10
Orofaciodigital syndrome I, 311200 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	RP23
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TCTN3
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	TECT3
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	C10orf61
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	OFD4
Orofaciodigital syndrome IV, 258860 (3)	TCTN3, TECT3, C10orf61, OFD4, JBTS18	613847	10q24.1	JBTS18
Orofaciodigital syndrome V, 174300 (3)	DDX59, OFD5	615464	1q32.1	DDX59
Orofaciodigital syndrome V, 174300 (3)	DDX59, OFD5	615464	1q32.1	OFD5
Orofaciodigital syndrome VI, 277170 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	C5orf42
Orofaciodigital syndrome VI, 277170 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	JBTS17
Orofaciodigital syndrome VI, 277170 (3)	C5orf42, JBTS17, OFD6	614571	5p13.2	OFD6
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MTS1
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	P16
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MLM
Orolaryngeal cancer, multiple, (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CMM2
Orotic aciduria, 258900 (3)	UMPS, OPRT	613891	3q21.2	UMPS
Orotic aciduria, 258900 (3)	UMPS, OPRT	613891	3q21.2	OPRT
Orthostatic hypotensive disorder of Streeten (2)	OHDS	143850	18q	OHDS
Orthostatic intolerance, 604715 (3)	SLC6A2, NAT1, NET1	163970	16q12.2	SLC6A2
Orthostatic intolerance, 604715 (3)	SLC6A2, NAT1, NET1	163970	16q12.2	NAT1
Orthostatic intolerance, 604715 (3)	SLC6A2, NAT1, NET1	163970	16q12.2	NET1
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Osseous heteroplasia, progressive, 166350 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Osteoarthritis with mild chondrodysplasia, 604864 (3)	COL2A1	120140	12q13.11	COL2A1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	ACAN
Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	AGC1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	CSPG1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	MSK16
Osteochondritis dissecans, short stature, and early-onset osteoarthritis, 165800 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	SEDK
Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	TAPT1, CMVFR, OCLSBG	612758	4p15.32	TAPT1
Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	TAPT1, CMVFR, OCLSBG	612758	4p15.32	CMVFR
Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3)	TAPT1, CMVFR, OCLSBG	612758	4p15.32	OCLSBG
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Osteogenesis imperfecta, type I, 166200 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Osteogenesis imperfecta, type II, 166210 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Osteogenesis imperfecta, type II, 166210 (3)	COL1A2	120160	7q21.3	COL1A2
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Osteogenesis imperfecta, type III, 259420 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Osteogenesis imperfecta, type III, 259420 (3)	COL1A2	120160	7q21.3	COL1A2
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
Osteogenesis imperfecta, type IV, 166220 (3)	COL1A2	120160	7q21.3	COL1A2
Osteogenesis imperfecta, type IX, 259440 (3)	PPIB, CYPB, OI9	123841	15q22.31	PPIB
Osteogenesis imperfecta, type IX, 259440 (3)	PPIB, CYPB, OI9	123841	15q22.31	CYPB
Osteogenesis imperfecta, type IX, 259440 (3)	PPIB, CYPB, OI9	123841	15q22.31	OI9
Osteogenesis imperfecta, type V, 610967 (3)	IFITM5, OI5	614757	11p15.5	IFITM5
Osteogenesis imperfecta, type V, 610967 (3)	IFITM5, OI5	614757	11p15.5	OI5
Osteogenesis imperfecta, type VI, 613982 (3)	SERPINF1, PEDF, OI6	172860	17p13.3	SERPINF1
Osteogenesis imperfecta, type VI, 613982 (3)	SERPINF1, PEDF, OI6	172860	17p13.3	PEDF
Osteogenesis imperfecta, type VI, 613982 (3)	SERPINF1, PEDF, OI6	172860	17p13.3	OI6
Osteogenesis imperfecta, type VII, 610682 (3)	CRTAP, CASP, OI7	605497	3p22.3	CRTAP
Osteogenesis imperfecta, type VII, 610682 (3)	CRTAP, CASP, OI7	605497	3p22.3	CASP
Osteogenesis imperfecta, type VII, 610682 (3)	CRTAP, CASP, OI7	605497	3p22.3	OI7
Osteogenesis imperfecta, type VIII, 610915 (3)	P3H1, LEPRE1, GROS1, OI8	610339	1p34.2	P3H1
Osteogenesis imperfecta, type VIII, 610915 (3)	P3H1, LEPRE1, GROS1, OI8	610339	1p34.2	LEPRE1
Osteogenesis imperfecta, type VIII, 610915 (3)	P3H1, LEPRE1, GROS1, OI8	610339	1p34.2	GROS1
Osteogenesis imperfecta, type VIII, 610915 (3)	P3H1, LEPRE1, GROS1, OI8	610339	1p34.2	OI8
Osteogenesis imperfecta, type XI, 610968 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP10
Osteogenesis imperfecta, type XI, 610968 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	FKBP65
Osteogenesis imperfecta, type XI, 610968 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	OI11
Osteogenesis imperfecta, type XI, 610968 (3)	FKBP10, FKBP65, OI11, BRKS1	607063	17q21.2	BRKS1
Osteogenesis imperfecta, type XIII, 614856 (3)	BMP1, OI13	112264	8p21.3	BMP1
Osteogenesis imperfecta, type XIII, 614856 (3)	BMP1, OI13	112264	8p21.3	OI13
Osteogenesis imperfecta, type XIV, 615066 (3)	TMEM38B, TRICB, OI14	611236	9q31.2	TMEM38B
Osteogenesis imperfecta, type XIV, 615066 (3)	TMEM38B, TRICB, OI14	611236	9q31.2	TRICB
Osteogenesis imperfecta, type XIV, 615066 (3)	TMEM38B, TRICB, OI14	611236	9q31.2	OI14
Osteogenesis imperfecta, type XV, 615220 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	WNT1
Osteogenesis imperfecta, type XV, 615220 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	INT1
Osteogenesis imperfecta, type XV, 615220 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	OI15
Osteogenesis imperfecta, type XV, 615220 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	BMND16
Osteogenesis imperfecta, type XVI (4)	OI16, C16DELp11.2, DEL16p11.2	616229	11p11.2	OI16
Osteogenesis imperfecta, type XVI (4)	OI16, C16DELp11.2, DEL16p11.2	616229	11p11.2	C16DELp11.2
Osteogenesis imperfecta, type XVI (4)	OI16, C16DELp11.2, DEL16p11.2	616229	11p11.2	DEL16p11.2
Osteogenesis imperfecta, type XVII, 616507 (3)	SPARC, ON, OI17	182120	5q33.1	SPARC
Osteogenesis imperfecta, type XVII, 616507 (3)	SPARC, ON, OI17	182120	5q33.1	ON
Osteogenesis imperfecta, type XVII, 616507 (3)	SPARC, ON, OI17	182120	5q33.1	OI17
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Osteoglophonic dysplasia, 166250 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	RANK
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	ODFR
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	FEO
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	OPTB7
Osteolysis, familial expansile, 174810 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	PDB2
Osteomalacia, tumor-induced (1)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Osteomalacia, tumor-induced (1)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	ADHR
Osteomalacia, tumor-induced (1)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	HPDR2
Osteomalacia, tumor-induced (1)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	PHPTC
Osteopathia striata with cranial sclerosis, 300373 (3)	AMER1, FAM123B, WTX, OSCS	300647	Xq11.2	AMER1
Osteopathia striata with cranial sclerosis, 300373 (3)	AMER1, FAM123B, WTX, OSCS	300647	Xq11.2	FAM123B
Osteopathia striata with cranial sclerosis, 300373 (3)	AMER1, FAM123B, WTX, OSCS	300647	Xq11.2	WTX
Osteopathia striata with cranial sclerosis, 300373 (3)	AMER1, FAM123B, WTX, OSCS	300647	Xq11.2	OSCS
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
Osteopetrosis, autosomal dominant 1, 607634 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
Osteopetrosis, autosomal dominant 2, 166600 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLCN7
Osteopetrosis, autosomal dominant 2, 166600 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLC7
Osteopetrosis, autosomal dominant 2, 166600 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	OPTA2
Osteopetrosis, autosomal dominant 2, 166600 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	OPTB4
Osteopetrosis, autosomal recessive 1, 259700 (3)	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.2	TCIRG1
Osteopetrosis, autosomal recessive 1, 259700 (3)	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.2	TIRC7
Osteopetrosis, autosomal recessive 1, 259700 (3)	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.2	OC116
Osteopetrosis, autosomal recessive 1, 259700 (3)	TCIRG1, TIRC7, OC116, OPTB1	604592	11q13.2	OPTB1
Osteopetrosis, autosomal recessive 2, 259710 (3)	TNFSF11, OPGL, TRANCE, OPTB2	602642	13q14.11	TNFSF11
Osteopetrosis, autosomal recessive 2, 259710 (3)	TNFSF11, OPGL, TRANCE, OPTB2	602642	13q14.11	OPGL
Osteopetrosis, autosomal recessive 2, 259710 (3)	TNFSF11, OPGL, TRANCE, OPTB2	602642	13q14.11	TRANCE
Osteopetrosis, autosomal recessive 2, 259710 (3)	TNFSF11, OPGL, TRANCE, OPTB2	602642	13q14.11	OPTB2
Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3)	CA2	611492	8q21.2	CA2
Osteopetrosis, autosomal recessive 4, 611490 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLCN7
Osteopetrosis, autosomal recessive 4, 611490 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	CLC7
Osteopetrosis, autosomal recessive 4, 611490 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	OPTA2
Osteopetrosis, autosomal recessive 4, 611490 (3)	CLCN7, CLC7, OPTA2, OPTB4	602727	16p13.3	OPTB4
Osteopetrosis, autosomal recessive 5, 259720 (3)	OSTM1, GL, OPTB5	607649	6q21	OSTM1
Osteopetrosis, autosomal recessive 5, 259720 (3)	OSTM1, GL, OPTB5	607649	6q21	GL
Osteopetrosis, autosomal recessive 5, 259720 (3)	OSTM1, GL, OPTB5	607649	6q21	OPTB5
Osteopetrosis, autosomal recessive 6, 611497 (3)	PLEKHM1, AP162, KIAA0356, OPTB6	611466	17q21.31	PLEKHM1
Osteopetrosis, autosomal recessive 6, 611497 (3)	PLEKHM1, AP162, KIAA0356, OPTB6	611466	17q21.31	AP162
Osteopetrosis, autosomal recessive 6, 611497 (3)	PLEKHM1, AP162, KIAA0356, OPTB6	611466	17q21.31	KIAA0356
Osteopetrosis, autosomal recessive 6, 611497 (3)	PLEKHM1, AP162, KIAA0356, OPTB6	611466	17q21.31	OPTB6
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	RANK
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	ODFR
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	FEO
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	OPTB7
Osteopetrosis, autosomal recessive 7, 612301 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	PDB2
Osteopetrosis, autosomal recessive 8, 615085 (3)	SNX10, OPTB8	614780	7p15.2	SNX10
Osteopetrosis, autosomal recessive 8, 615085 (3)	SNX10, OPTB8	614780	7p15.2	OPTB8
Osteopoikilosis, 166700 (3)	LEMD3, MAN1	607844	12q14.3	LEMD3
Osteopoikilosis, 166700 (3)	LEMD3, MAN1	607844	12q14.3	MAN1
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
Osteoporosis-pseudoglioma syndrome, 259770 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
Osteosarcoma, 259500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Osteosarcoma, 259500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Osteosarcoma, 259500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Osteosarcoma, 259500 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	RAD53
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHK2
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CDS1
Osteosarcoma, somatic, 259500 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	LFS2
Osteosarcoma, somatic, 259500 (3)	RB1	614041	13q14.2	RB1
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
Osteosclerosis, 144750 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
Otodental dysplasia chromsome deletion syndrome (4)	OTDD, DEL11q13, C11DELq13	166750	11q13	OTDD
Otodental dysplasia chromsome deletion syndrome (4)	OTDD, DEL11q13, C11DELq13	166750	11q13	DEL11q13
Otodental dysplasia chromsome deletion syndrome (4)	OTDD, DEL11q13, C11DELq13	166750	11q13	C11DELq13
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Otopalatodigital syndrome, type I, 311300 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Otopalatodigital syndrome, type II, 304120 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Otosclerosis 1 (2)	OTSC1, OTS	166800	15q26.1-qter	OTSC1
Otosclerosis 1 (2)	OTSC1, OTS	166800	15q26.1-qter	OTS
Otosclerosis 10 (2)	OTSC10	615589	1q41-q44	OTSC10
Otosclerosis 2 (2)	OTSC2	605727	7q34-q36	OTSC2
Otosclerosis 3 (2)	OTSC3	608244	6p22.3-p21.3	OTSC3
Otosclerosis 5 (2)	OTSC5	608787	3q22-q24	OTSC5
Otosclerosis 7 (2)	OTSC7	611572	6q13-q16.1	OTSC7
Otosclerosis 8 (2)	OTSC8	612096	9p13.1-q21.11	OTSC8
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Otospondylomegaepiphyseal dysplasia, 215150 (3)	COL2A1	120140	12q13.11	COL2A1
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
Ovalocytosis, SA type, 166900 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
Ovarian cancer, somatic, (3)	ERBB2, NGL, NEU, HER2	164870	17q12	ERBB2
Ovarian cancer, somatic, (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NGL
Ovarian cancer, somatic, (3)	ERBB2, NGL, NEU, HER2	164870	17q12	NEU
Ovarian cancer, somatic, (3)	ERBB2, NGL, NEU, HER2	164870	17q12	HER2
Ovarian cancer, somatic, 167000 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Ovarian cancer, somatic, 167000 (3)	AKT1, CWS6	164730	14q32.33	CWS6
Ovarian cancer, somatic, 167000 (3)	CTNNB1, MRD19	116806	3p22.1	CTNNB1
Ovarian cancer, somatic, 167000 (3)	CTNNB1, MRD19	116806	3p22.1	MRD19
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	PIK3CA
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CLOVE
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCAP
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCM
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	MCMTC
Ovarian cancer, somatic, 167000 (3)	PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5	171834	3q26.32	CWS5
Ovarian carcinoma (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	SEPT9
Ovarian carcinoma (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF
Ovarian carcinoma (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	MSF1
Ovarian carcinoma (1)	SEPT9, MSF, MSF1, NAPB	604061	17q25.3	NAPB
Ovarian carcinoma (3)	RRAS2, TC21	600098	11p15.2	RRAS2
Ovarian carcinoma (3)	RRAS2, TC21	600098	11p15.2	TC21
Ovarian carcinoma, somatic, 167000 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	CDH1
Ovarian carcinoma, somatic, 167000 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	UVO
Ovarian carcinoma, somatic, 167000 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	LCAM
Ovarian carcinoma, somatic, 167000 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	ECAD
Ovarian dysgenesis 1, 233300 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarian dysgenesis 1, 233300 (3)	FSHR, ODG1	136435	2p16.3	ODG1
Ovarian dysgenesis 2, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	BMP15
Ovarian dysgenesis 2, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	GDF9B
Ovarian dysgenesis 2, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	ODG2
Ovarian dysgenesis 2, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	POF4
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	PSMC3IP
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	TBPIP
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	GT198
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	HOP2
Ovarian dysgenesis 3, 614324 (3)	PSMC3IP, TBPIP, GT198, HOP2, ODG3	608665	17q21.2	ODG3
Ovarian dysgenesis 4, 616185 (3)	MCM9, MCMDC1, ODG4	610098	6q22.31	MCM9
Ovarian dysgenesis 4, 616185 (3)	MCM9, MCMDC1, ODG4	610098	6q22.31	MCMDC1
Ovarian dysgenesis 4, 616185 (3)	MCM9, MCMDC1, ODG4	610098	6q22.31	ODG4
Ovarian hyperstimulation syndrome, 608115 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarian hyperstimulation syndrome, 608115 (3)	FSHR, ODG1	136435	2p16.3	ODG1
Ovarian response to FSH stimulation, 276400 (3)	FSHR, ODG1	136435	2p16.3	FSHR
Ovarian response to FSH stimulation, 276400 (3)	FSHR, ODG1	136435	2p16.3	ODG1
Ovarioleukodystrophy, 603896 (3)	EIF2B2	606454	14q24.3	EIF2B2
Ovarioleukodystrophy, 603896 (3)	EIF2B4	606687	2p23.3	EIF2B4
Ovarioleukodystrophy, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	EIF2B5
Ovarioleukodystrophy, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	LVWM
Ovarioleukodystrophy, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	CACH
Ovarioleukodystrophy, 603896 (3)	EIF2B5, LVWM, CACH, CLE	603945	3q27.1	CLE
Overhydrated hereditary stomatocytosis, 185000 (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
Overhydrated hereditary stomatocytosis, 185000 (3)	RHAG, RH50A, OHST	180297	6p12.3	RH50A
Overhydrated hereditary stomatocytosis, 185000 (3)	RHAG, RH50A, OHST	180297	6p12.3	OHST
PCWH syndrome, 609136 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
PCWH syndrome, 609136 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4
PCWH syndrome, 609136 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4C
PCWH syndrome, 609136 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	PCWH
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	CCDC88A
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	KIAA1212
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	HKRP1
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	GIRDIN
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	APE
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	GIV
PEHO syndrome, 260565 (3)	CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHO	609736	2p16.1	PEHO
PEPCK deficiency, mitochondrial, 261650 (1)	PCK2, PEPCK2	614095	14q11-q12	PCK2
PEPCK deficiency, mitochondrial, 261650 (1)	PCK2, PEPCK2	614095	14q11-q12	PEPCK2
PTEN hamartoma tumor syndrome (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
PTEN hamartoma tumor syndrome (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
PTEN hamartoma tumor syndrome (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
PTEN hamartoma tumor syndrome (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Pachyonychia congenita 1, 167200 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	KRT16
Pachyonychia congenita 1, 167200 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	FNEPPK
Pachyonychia congenita 1, 167200 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	PC1
Pachyonychia congenita 2, 167210 (3)	KRT17, PC2, PCHC1	148069	17q21.2	KRT17
Pachyonychia congenita 2, 167210 (3)	KRT17, PC2, PCHC1	148069	17q21.2	PC2
Pachyonychia congenita 2, 167210 (3)	KRT17, PC2, PCHC1	148069	17q21.2	PCHC1
Pachyonychia congenita 3, 615726 (3)	KRT6A, PC3	148041	12q13.13	KRT6A
Pachyonychia congenita 3, 615726 (3)	KRT6A, PC3	148041	12q13.13	PC3
Pachyonychia congenita 4, 615728 (3)	KRT6B, PC4	148042	12q13.13	KRT6B
Pachyonychia congenita 4, 615728 (3)	KRT6B, PC4	148042	12q13.13	PC4
Paget disease of bone 3, 167250 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	SQSTM1
Paget disease of bone 3, 167250 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	P62
Paget disease of bone 3, 167250 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	PDB3
Paget disease of bone 3, 167250 (3)	SQSTM1, P62, PDB3, FTDALS3	601530	5q35.3	FTDALS3
Paget disease of bone 4 (2)	PDB4	606263	5q31	PDB4
Paget disease of bone 5, juvenile-onset, 239000 (3)	TNFRSF11B, OPG, OCIF, PDB5	602643	8q24.12	TNFRSF11B
Paget disease of bone 5, juvenile-onset, 239000 (3)	TNFRSF11B, OPG, OCIF, PDB5	602643	8q24.12	OPG
Paget disease of bone 5, juvenile-onset, 239000 (3)	TNFRSF11B, OPG, OCIF, PDB5	602643	8q24.12	OCIF
Paget disease of bone 5, juvenile-onset, 239000 (3)	TNFRSF11B, OPG, OCIF, PDB5	602643	8q24.12	PDB5
Paget disease of bone 6, 616833 (3)	ZNF687, KIAA1441, PDB6	610568	1q21.3	ZNF687
Paget disease of bone 6, 616833 (3)	ZNF687, KIAA1441, PDB6	610568	1q21.3	KIAA1441
Paget disease of bone 6, 616833 (3)	ZNF687, KIAA1441, PDB6	610568	1q21.3	PDB6
Pallister-Hall syndrome, 146510 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Pallister-Hall syndrome, 146510 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPA
Pallister-Hall syndrome, 146510 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPB
Pallister-Killian syndrome (4)	PKS	601803	12p	PKS
Palmoplantar carcinoma, multiple self-healing (2)	MSPC	616964	17p13.3-p12	MSPC
Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	RSPO1
Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	FLJ40906
Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	RSPO1
Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3)	RSPO1, FLJ40906	609595	1p34.3	FLJ40906
Palmoplantar keratoderma and woolly hair, 616099 (3)	KANK2, ANKRD25, KIAA1518, PPKWH	614610	19p13.2	KANK2
Palmoplantar keratoderma and woolly hair, 616099 (3)	KANK2, ANKRD25, KIAA1518, PPKWH	614610	19p13.2	ANKRD25
Palmoplantar keratoderma and woolly hair, 616099 (3)	KANK2, ANKRD25, KIAA1518, PPKWH	614610	19p13.2	KIAA1518
Palmoplantar keratoderma and woolly hair, 616099 (3)	KANK2, ANKRD25, KIAA1518, PPKWH	614610	19p13.2	PPKWH
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Palmoplantar keratoderma with congenital alopecia, 104100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Palmoplantar keratoderma, Bothnian type, 600231 (3)	AQP5, PPKB	600442	12q13.12	AQP5
Palmoplantar keratoderma, Bothnian type, 600231 (3)	AQP5, PPKB	600442	12q13.12	PPKB
Palmoplantar keratoderma, Nagashima type, 615598 (3)	SERPINB7, MEGSIN, PPKN	603357	18q21.33	SERPINB7
Palmoplantar keratoderma, Nagashima type, 615598 (3)	SERPINB7, MEGSIN, PPKN	603357	18q21.33	MEGSIN
Palmoplantar keratoderma, Nagashima type, 615598 (3)	SERPINB7, MEGSIN, PPKN	603357	18q21.33	PPKN
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT9, EPPK	607606	17q21.2	KRT9
Palmoplantar keratoderma, epidermolytic, 144200 (3)	KRT9, EPPK	607606	17q21.2	EPPK
Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	KRT1
Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EPPK
Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	NEPPK
Palmoplantar keratoderma, nonepidermolytic, 600962 (3)	KRT1, EPPK, NEPPK, EHK	139350	12q13.13	EHK
Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	KRT6C, PPKNEFD	612315	12q13.13	KRT6C
Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3)	KRT6C, PPKNEFD	612315	12q13.13	PPKNEFD
Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	KRT16
Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	FNEPPK
Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3)	KRT16, FNEPPK, PC1	148067	17q21.2	PC1
Panbronchiolitis, diffuse (2)	PBLT	604809	6p21.3	PBLT
Pancreatic agenesis 1, 260370 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	IPF1
Pancreatic agenesis 1, 260370 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	MODY4
Pancreatic agenesis 1, 260370 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	PAGEN1
Pancreatic agenesis 2, 615935 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PTF1A
Pancreatic agenesis 2, 615935 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PACA
Pancreatic agenesis 2, 615935 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PAGEN2
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	GATA6
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	ASD9
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Pancreatic agenesis and congenital heart defects, 600001 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	PACHD
Pancreatic and cerebellar agenesis, 609069 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PTF1A
Pancreatic and cerebellar agenesis, 609069 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PACA
Pancreatic and cerebellar agenesis, 609069 (3)	PTF1A, PACA, PAGEN2	607194	10p12.2	PAGEN2
Pancreatic cancer, 260350 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Pancreatic cancer, 260350 (3)	STK11, PJS, LKB1	602216	19p13.3	PJS
Pancreatic cancer, 260350 (3)	STK11, PJS, LKB1	602216	19p13.3	LKB1
Pancreatic cancer, 260350 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
Pancreatic cancer, 260350 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
Pancreatic cancer, 260350 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
Pancreatic cancer, 260350 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
Pancreatic cancer, somatic (3)	ACVR1B, ACVRLK4, ALK4	601300	12q13.13	ACVR1B
Pancreatic cancer, somatic (3)	ACVR1B, ACVRLK4, ALK4	601300	12q13.13	ACVRLK4
Pancreatic cancer, somatic (3)	ACVR1B, ACVRLK4, ALK4	601300	12q13.13	ALK4
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MADH4
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	DPC4
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	JIP
Pancreatic cancer, somatic, 260350 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MYHRS
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MTS1
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	P16
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MLM
Pancreatic cancer/melanoma syndrome, 606719 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CMM2
Pancreatic carcinoma, somatic (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Pancreatic carcinoma, somatic (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RIM
Pancreatic carcinoma, somatic (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	SCKL2
Pancreatic carcinoma, somatic (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	JWDS
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Pancreatic carcinoma, somatic, 260350 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Pancreatic lipase deficiency, 614338 (1)	PNLIP, PNLIPD	246600	10q25.3	PNLIP
Pancreatic lipase deficiency, 614338 (1)	PNLIP, PNLIPD	246600	10q25.3	PNLIPD
Pancreatitis, hereditary, 167800 (3)	PRSS1, TRY1	276000	7q34	PRSS1
Pancreatitis, hereditary, 167800 (3)	PRSS1, TRY1	276000	7q34	TRY1
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PSTI
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PCTT
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TATI
Pancreatitis, hereditary, 167800 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TCP
Panhypopituitarism, X-linked, 312000 (3)	SOX3, MRGH	313430	Xq27.1	SOX3
Panhypopituitarism, X-linked, 312000 (3)	SOX3, MRGH	313430	Xq27.1	MRGH
Panic disorder 2 (2)	PAND2	607853	9q31	PAND2
Panic disorder 3 (2)	PAND3	609985	4q31-q34	PAND3
Panic disorder syndrome 1 (2)	PAND1	167870	13q22-q32	PAND1
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CPPI
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PALS
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PLS
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	HMS
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PDON1
Papillon-Lefevre syndrome, 245000 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	JPD
Papillorenal syndrome, 120330 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAX2
Papillorenal syndrome, 120330 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	PAPRS
Papillorenal syndrome, 120330 (3)	PAX2, PAPRS, FSGS7	167409	10q24.31	FSGS7
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDH2
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHIP
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	PGL4
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	CWS2
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHC, PGL3	602413	1q23.3	PGL3
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Paraganglioma and gastric stromal sarcoma, 606864 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Paragangliomas 1, with or without deafness, 168000 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Paragangliomas 1, with or without deafness, 168000 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Paragangliomas 1, with or without deafness, 168000 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Paragangliomas 2, 601650 (3)	SDHAF2, SDH5, PGL2	613019	11q12.2	SDHAF2
Paragangliomas 2, 601650 (3)	SDHAF2, SDH5, PGL2	613019	11q12.2	SDH5
Paragangliomas 2, 601650 (3)	SDHAF2, SDH5, PGL2	613019	11q12.2	PGL2
Paragangliomas 3, 605373 (3)	SDHC, PGL3	602413	1q23.3	SDHC
Paragangliomas 3, 605373 (3)	SDHC, PGL3	602413	1q23.3	PGL3
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDH2
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHIP
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	PGL4
Paragangliomas 4, 115310 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	CWS2
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHA
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDH1
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	SDHF
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	CMD1GG
Paragangliomas 5, 614165 (3)	SDHA, SDH1, SDHF, CMD1GG, PGL5	600857	5p15.33	PGL5
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	SCN4A
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HYPP
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	NAC1A
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	HOKPP2
Paramyotonia congenita, 168300 (3)	SCN4A, HYPP, NAC1A, HOKPP2, CMS16	603967	17q23.3	CMS16
Parasomnia, sleepwalking type (2)	PSMNSW	613938	20q12-q13.12	PSMNSW
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Parastremmatic dwarfism, 168400 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Parathyroid adenoma with cystic changes, 145001 (3)	HRPT2, C1orf28	607393	1q31.2	HRPT2
Parathyroid adenoma with cystic changes, 145001 (3)	HRPT2, C1orf28	607393	1q31.2	C1orf28
Parathyroid adenoma, somatic (3)	MEN1	613733	11q13.1	MEN1
Parathyroid carcinoma, 608266 (3)	HRPT2, C1orf28	607393	1q31.2	HRPT2
Parathyroid carcinoma, 608266 (3)	HRPT2, C1orf28	607393	1q31.2	C1orf28
Parietal foramina 1, 168500 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Parietal foramina 1, 168500 (3)	MSX2, CRS2, HOX8	123101	5q35.2	CRS2
Parietal foramina 1, 168500 (3)	MSX2, CRS2, HOX8	123101	5q35.2	HOX8
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	PFM2
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FPP
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FND2
Parietal foramina 2, 609597 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	CRS5
Parietal foramina with cleidocranial dysplasia, 168550 (3)	MSX2, CRS2, HOX8	123101	5q35.2	MSX2
Parietal foramina with cleidocranial dysplasia, 168550 (3)	MSX2, CRS2, HOX8	123101	5q35.2	CRS2
Parietal foramina with cleidocranial dysplasia, 168550 (3)	MSX2, CRS2, HOX8	123101	5q35.2	HOX8
Parkes Weber syndrome, 608355 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	RASA1
Parkes Weber syndrome, 608355 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	GAP
Parkes Weber syndrome, 608355 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	CMAVM
Parkes Weber syndrome, 608355 (3)	RASA1, GAP, CMAVM, PKWS	139150	5q14.3	PKWS
Parkinson disease 1, 168601 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Parkinson disease 1, 168601 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	NACP
Parkinson disease 1, 168601 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK1
Parkinson disease 1, 168601 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK4
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PLA2G6
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	IPLA2
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	INAD1
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2B
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	NBIA2A
Parkinson disease 14, autosomal recessive, 612953 (3)	PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14	603604	22q13.1	PARK14
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	FBXO7
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	FBX7
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	FBX
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	PKPS
Parkinson disease 15, autosomal recessive, 260300 (3)	FBXO7, FBX7, FBX, PKPS, PARK15	605648	22q12.3	PARK15
Parkinson disease 19a, juvenile-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DNAJC6
Parkinson disease 19a, juvenile-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DJC6
Parkinson disease 19a, juvenile-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	KIAA0473
Parkinson disease 19a, juvenile-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	PARK19
Parkinson disease 19b, early-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DNAJC6
Parkinson disease 19b, early-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	DJC6
Parkinson disease 19b, early-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	KIAA0473
Parkinson disease 19b, early-onset, 615528 (3)	DNAJC6, DJC6, KIAA0473, PARK19	608375	1p31.3	PARK19
Parkinson disease 20, early-onset, 615530 (3)	SYNJ1, PARK20	604297	21q22.11	SYNJ1
Parkinson disease 20, early-onset, 615530 (3)	SYNJ1, PARK20	604297	21q22.11	PARK20
Parkinson disease 21 (2)	PARK21	616361	3q22	PARK21
Parkinson disease 22, autosomal dominant, 616710 (3)	CHCHD2, PARK22	616244	7p11.2	CHCHD2
Parkinson disease 22, autosomal dominant, 616710 (3)	CHCHD2, PARK22	616244	7p11.2	PARK22
Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	VPS13C, KIAA1421, PARK23	608879	15q22.2	VPS13C
Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	VPS13C, KIAA1421, PARK23	608879	15q22.2	KIAA1421
Parkinson disease 23, autosomal recessive, early onset, 616840 (3)	VPS13C, KIAA1421, PARK23	608879	15q22.2	PARK23
Parkinson disease 4, 605543 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	SNCA
Parkinson disease 4, 605543 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	NACP
Parkinson disease 4, 605543 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK1
Parkinson disease 4, 605543 (3)	SNCA, NACP, PARK1, PARK4	163890	4q22.1	PARK4
Parkinson disease 6, early onset, 605909 (3)	PINK1, PARK6	608309	1p36.12	PINK1
Parkinson disease 6, early onset, 605909 (3)	PINK1, PARK6	608309	1p36.12	PARK6
Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	DJ1, PARK7	602533	1p36.23	DJ1
Parkinson disease 7, autosomal recessive early-onset, 606324 (3)	DJ1, PARK7	602533	1p36.23	PARK7
Parkinson disease, juvenile, type 2, 600116 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
Parkinson disease, juvenile, type 2, 600116 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PARK2
Parkinson disease, juvenile, type 2, 600116 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PDJ
Parkinson disease, juvenile, type 2, 600116 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	LPRS2
Parkinsonism-dystonia, infantile, 613135 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	SLC6A3
Parkinsonism-dystonia, infantile, 613135 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	DAT1
Parkinsonism-dystonia, infantile, 613135 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	PKDYS
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Paroxysmal extreme pain disorder, 167400, (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PIGA
Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	PNH1
Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)	PIGA, PNH1, MCAHS2	311770	Xp22.2	MCAHS2
Paroxysmal nonkinesigenic dyskinesia 2 (2)	PNKD2	611147	2q31	PNKD2
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	MR1
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	TAHCCP2
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	KIPP1184
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	BRP17
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	PNKD
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	FPD1
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	PDC
Paroxysmal nonkinesigenic dyskinesia, 118800 (3)	MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8	609023	2q35	DYT8
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Partington syndrome, 309510 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Patella aplasia or hypoplasia (2)	PTLAH, FPAH	168860	17q21-q22	PTLAH
Patella aplasia or hypoplasia (2)	PTLAH, FPAH	168860	17q21-q22	FPAH
Patent ductus arteriosus 2, 617035 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	TFAP2B
Patent ductus arteriosus 2, 617035 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	CHAR
Patent ductus arteriosus 2, 617035 (3)	TFAP2B, CHAR, PDA2	601601	6p12.3	PDA2
Patent ductus arteriosus 3, 617039 (3)	PRDM6, PRISM, PDA3	616982	5q23.2	PRDM6
Patent ductus arteriosus 3, 617039 (3)	PRDM6, PRISM, PDA3	616982	5q23.2	PRISM
Patent ductus arteriosus 3, 617039 (3)	PRDM6, PRISM, PDA3	616982	5q23.2	PDA3
Peeling skin syndrome 1, 270300 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	CDSN
Peeling skin syndrome 1, 270300 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	HTSS1
Peeling skin syndrome 1, 270300 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	HYPT2
Peeling skin syndrome 1, 270300 (3)	CDSN, HTSS1, HYPT2, PSS1	602593	6p21.33	PSS1
Peeling skin syndrome 2, 609796 (3)	TGM5, TGX, PSS2	603805	15q15.2	TGM5
Peeling skin syndrome 2, 609796 (3)	TGM5, TGX, PSS2	603805	15q15.2	TGX
Peeling skin syndrome 2, 609796 (3)	TGM5, TGX, PSS2	603805	15q15.2	PSS2
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	CSTA
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	STFA
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	STF1
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	AREI
Peeling skin syndrome 4, 607936 (3)	CSTA, STFA, STF1, AREI, PSS4	184600	3q21.1	PSS4
Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	CAST, PLACK	114090	5q15	CAST
Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3)	CAST, PLACK	114090	5q15	PLACK
Pelger-Huet anomaly, 169400 (3)	LBR, PHA	600024	1q42.12	LBR
Pelger-Huet anomaly, 169400 (3)	LBR, PHA	600024	1q42.12	PHA
Pelizaeus-Merzbacher disease, 312080 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PLP1
Pelizaeus-Merzbacher disease, 312080 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PMD
Pelizaeus-Merzbacher disease, 312080 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	HLD1
Pelizaeus-Merzbacher disease, 312080 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	SPG2
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	SLC26A4
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	PDS
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	DFNB4
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	EVA
Pendred syndrome, 274600 (3)	SLC26A4, PDS, DFNB4, EVA, TDH2B	605646	7q22.3	TDH2B
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFRSF1A
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFR1
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFAR
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	FPF
Periodic fever, familial, 142680 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	MS5
Periodic fever, menstrual cycle dependent, 614674 (3)	HTR1A, ADRB2RL1, PFMCD	109760	5q12.3	HTR1A
Periodic fever, menstrual cycle dependent, 614674 (3)	HTR1A, ADRB2RL1, PFMCD	109760	5q12.3	ADRB2RL1
Periodic fever, menstrual cycle dependent, 614674 (3)	HTR1A, ADRB2RL1, PFMCD	109760	5q12.3	PFMCD
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CTSC
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	CPPI
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PALS
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PLS
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	HMS
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	PDON1
Periodontitis 1, juvenile, 170650 (3)	CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD	602365	11q14.2	JPD
Periodontitis, aggressive, 2 (2)	PDON2	608526	1q25	PDON2
Peripheral arterial occlusive disease 1 (2)	PAOD1	606787	1p31	PAOD1
Periventricular heterotopia with microcephaly, 608097 (3)	ARFGEF2, BIG2, PVNH2	605371	20q13.13	ARFGEF2
Periventricular heterotopia with microcephaly, 608097 (3)	ARFGEF2, BIG2, PVNH2	605371	20q13.13	BIG2
Periventricular heterotopia with microcephaly, 608097 (3)	ARFGEF2, BIG2, PVNH2	605371	20q13.13	PVNH2
Periventricular nodular heterotopia 3 (2)	PVNH3	608098	5p15.1	PVNH3
Periventricular nodular heterotopia 5 (4)	PVNH5	612881	5q14.3-q15	PVNH5
Perlman syndrome, 267000 (3)	DIS3L2, PRLMNS	614184	2q37.1	DIS3L2
Perlman syndrome, 267000 (3)	DIS3L2, PRLMNS	614184	2q37.1	PRLMNS
Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	ACOX1, ACOX, SCOX	609751	17q25.1	ACOX1
Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	ACOX1, ACOX, SCOX	609751	17q25.1	ACOX
Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)	ACOX1, ACOX, SCOX	609751	17q25.1	SCOX
Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	FAR1, MLSTD2, PFCRD	616107	11p15.3	FAR1
Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	FAR1, MLSTD2, PFCRD	616107	11p15.3	MLSTD2
Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3)	FAR1, MLSTD2, PFCRD	616107	11p15.3	PFCRD
Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3)	PEX3, PBD10A	603164	6q24.2	PEX3
Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3)	PEX3, PBD10A	603164	6q24.2	PBD10A
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PEX13
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	ZWS
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	NALD
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PBD11A
Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PBD11B
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PEX13
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	ZWS
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	NALD
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PBD11A
Peroxisome biogenesis disorder 11B, 614885 (3)	PEX13, ZWS, NALD, PBD11A, PBD11B	601789	2p15	PBD11B
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	PEX19
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	PXF
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	HK33
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	D1S2223E
Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3)	PEX19, PXF, HK33, D1S2223E, PBD12A	600279	1q23.2	PBD12A
Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	PEX14, PBD13A	601791	1p36.22	PEX14
Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3)	PEX14, PBD13A	601791	1p36.22	PBD13A
Peroxisome biogenesis disorder 14B, 614920 (3)	PEX11B, PEX14B	603867	1q21.1	PEX11B
Peroxisome biogenesis disorder 14B, 614920 (3)	PEX11B, PEX14B	603867	1q21.1	PEX14B
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	ZWS1
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1A
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1B
Peroxisome biogenesis disorder 1A (Zellweger), 214100 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	HMLR1
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PEX1
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	ZWS1
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1A
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	PBD1B
Peroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3)	PEX1, ZWS1, PBD1A, PBD1B, HMLR1	602136	7q21.2	HMLR1
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PXR1
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PTS1R
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2A
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2B
Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	RCDP5
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PXR1
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PTS1R
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2A
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2B
Peroxisome biogenesis disorder 2B, 202370 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	RCDP5
Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3)	PEX12, PBD3A	601758	17q12	PEX12
Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3)	PEX12, PBD3A	601758	17q12	PBD3A
Peroxisome biogenesis disorder 3B, 266510 (3)	PEX12, PBD3A	601758	17q12	PEX12
Peroxisome biogenesis disorder 3B, 266510 (3)	PEX12, PBD3A	601758	17q12	PBD3A
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PXAAA1
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PAF2
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PBD4A
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PDB4B
Peroxisome biogenesis disorder 4A (Zellweger), 614862 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	HMLR2
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PEX6
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PXAAA1
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PAF2
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PBD4A
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	PDB4B
Peroxisome biogenesis disorder 4B, 614863 (3)	PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2	601498	6p21.1	HMLR2
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PEX2
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PAF1
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PMP35
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PBD5A
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PBD5B
Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PXMP3
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PEX2
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PAF1
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PMP35
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PBD5A
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PBD5B
Peroxisome biogenesis disorder 5B, 614867 (3)	PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3	170993	8q21.13	PXMP3
Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PEX10
Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	NALD
Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PBD6A
Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PBD6B
Peroxisome biogenesis disorder 6B, 614871 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PEX10
Peroxisome biogenesis disorder 6B, 614871 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	NALD
Peroxisome biogenesis disorder 6B, 614871 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PBD6A
Peroxisome biogenesis disorder 6B, 614871 (3)	PEX10, NALD, PBD6A, PBD6B	602859	1p36.32	PBD6B
Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PEX26
Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PBD7A
Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PBD7B
Peroxisome biogenesis disorder 7B, 614873 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PEX26
Peroxisome biogenesis disorder 7B, 614873 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PBD7A
Peroxisome biogenesis disorder 7B, 614873 (3)	PEX26, PBD7A, PBD7B	608666	22q11.21	PBD7B
Peroxisome biogenesis disorder 8A, (Zellweger), 614876 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PEX16
Peroxisome biogenesis disorder 8A, (Zellweger), 614876 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PBD8A
Peroxisome biogenesis disorder 8A, (Zellweger), 614876 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PBD8B
Peroxisome biogenesis disorder 8B, 614877 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PEX16
Peroxisome biogenesis disorder 8B, 614877 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PBD8A
Peroxisome biogenesis disorder 8B, 614877 (3)	PEX16, PBD8A, PBD8B	603360	11p11.2	PBD8B
Peroxisome biogenesis disorder 9B, 614879 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PEX7
Peroxisome biogenesis disorder 9B, 614879 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	RCDP1
Peroxisome biogenesis disorder 9B, 614879 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PBD9B
Perrault syndrome 1, 233400 (3)	HSD17B4, PRLTS1	601860	5q23.1	HSD17B4
Perrault syndrome 1, 233400 (3)	HSD17B4, PRLTS1	601860	5q23.1	PRLTS1
Perrault syndrome 3, 614129 (3)	CLPP, PRLTS3, DFNB81	601119	19p13.3	CLPP
Perrault syndrome 3, 614129 (3)	CLPP, PRLTS3, DFNB81	601119	19p13.3	PRLTS3
Perrault syndrome 3, 614129 (3)	CLPP, PRLTS3, DFNB81	601119	19p13.3	DFNB81
Perrault syndrome 4, 615300 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	LARS2
Perrault syndrome 4, 615300 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	PRLTS4
Perrault syndrome 4, 615300 (3)	LARS2, PRLTS4, HLASA	604544	3p21.31	HLASA
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	C10orf2
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWINKLE
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PEOA3
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	IOSCA
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	MTDPS7
Perrault syndrome 5, 616138 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PRLTS5
Perry syndrome, 168605 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
Perry syndrome, 168605 (3)	DCTN1, HMN7B	601143	2p13.1	HMN7B
Persistent Mullerian duct syndrome, type I, 261550 (3)	AMH, MIF	600957	19p13.3	AMH
Persistent Mullerian duct syndrome, type I, 261550 (3)	AMH, MIF	600957	19p13.3	MIF
Persistent Mullerian duct syndrome, type II, 261550 (3)	AMHR2, AMHR	600956	12q13.13	AMHR2
Persistent Mullerian duct syndrome, type II, 261550 (3)	AMHR2, AMHR	600956	12q13.13	AMHR
Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	ATOH7, PHPVAR, NCRNA	609875	10q21.3	ATOH7
Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	ATOH7, PHPVAR, NCRNA	609875	10q21.3	PHPVAR
Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3)	ATOH7, PHPVAR, NCRNA	609875	10q21.3	NCRNA
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	GATA6
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	ASD9
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Persistent truncus arteriosus, 217095 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	PACHD
Persistent truncus arteriosus, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	NKX2-6
Persistent truncus arteriosus, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	CSX2
Persistent truncus arteriosus, 217095 (3)	NKX2-6, CSX2, CTHM	611770	8p21.2	CTHM
Peters anomaly, 604229 (3)	CYP1B1, GLC3A	601771	2p22.2	CYP1B1
Peters anomaly, 604229 (3)	CYP1B1, GLC3A	601771	2p22.2	GLC3A
Peters anomaly, 604229 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	PAX6
Peters anomaly, 604229 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	AN2
Peters anomaly, 604229 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	MGDA
Peters anomaly, 604229 (3)	PAX6, AN2, MGDA, FVH1	607108	11p13	FVH1
Peters anomaly, 604229 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	PITX2
Peters anomaly, 604229 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IDG2
Peters anomaly, 604229 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RIEG1
Peters anomaly, 604229 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RGS
Peters anomaly, 604229 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IGDS2
Peters-plus syndrome, 261540 (3)	B3GLCT, B3GALTL, B3GTL	610308	13q12.3	B3GLCT
Peters-plus syndrome, 261540 (3)	B3GLCT, B3GALTL, B3GTL	610308	13q12.3	B3GALTL
Peters-plus syndrome, 261540 (3)	B3GLCT, B3GALTL, B3GTL	610308	13q12.3	B3GTL
Peutz-Jeghers syndrome, 175200 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Peutz-Jeghers syndrome, 175200 (3)	STK11, PJS, LKB1	602216	19p13.3	PJS
Peutz-Jeghers syndrome, 175200 (3)	STK11, PJS, LKB1	602216	19p13.3	LKB1
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Pfeiffer syndrome, 101600 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Pfeiffer syndrome, 101600 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SHANK3
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	PSAP2
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	PROSAP2
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	KIAA1650
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	DEL22q13.3
Phelan-McDermid syndrome, 606232 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SCZD15
Phenylketonuria, 261600 (3)	PAH, PKU1	612349	12q23.2	PAH
Phenylketonuria, 261600 (3)	PAH, PKU1	612349	12q23.2	PKU1
Pheochromocytoma, 171300 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
Pheochromocytoma, 171300 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A
Pheochromocytoma, 171300 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A1
Pheochromocytoma, 171300 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	NBLST1
Pheochromocytoma, 171300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
Pheochromocytoma, 171300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
Pheochromocytoma, 171300 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHB
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDH2
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	SDHIP
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	PGL4
Pheochromocytoma, 171300 (3)	SDHB, SDH2, SDHIP, PGL4, CWS2	185470	1p36.13	CWS2
Pheochromocytoma, 171300 (3)	SDHD, PGL1, CWS3	602690	11q23.1	SDHD
Pheochromocytoma, 171300 (3)	SDHD, PGL1, CWS3	602690	11q23.1	PGL1
Pheochromocytoma, 171300 (3)	SDHD, PGL1, CWS3	602690	11q23.1	CWS3
Pheochromocytoma, 171300 (3)	VHL	608537	3p25.3	VHL
Phobia, specific (2)	PHOBS	608251	Chr.14	PHOBS
Phosphoglycerate dehydrogenase deficiency, 601815 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDH
Phosphoglycerate dehydrogenase deficiency, 601815 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	NLS1
Phosphoglycerate dehydrogenase deficiency, 601815 (3)	PHGDH, NLS1, PHGDHD	606879	1p12	PHGDHD
Phosphoglycerate kinase 1 deficiency, 300653 (3)	PGK1, PGKA	311800	Xq21.1	PGK1
Phosphoglycerate kinase 1 deficiency, 300653 (3)	PGK1, PGKA	311800	Xq21.1	PGKA
Phospholipase A2, group IV A, deficiency of (3)	PLA2G4A, PLA2G4	600522	1q31.1	PLA2G4A
Phospholipase A2, group IV A, deficiency of (3)	PLA2G4A, PLA2G4	600522	1q31.1	PLA2G4
Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	PRPS1
Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	CMTX5
Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFNX1
Phosphoribosylpyrophosphate synthetase superactivity, 300661 (3)	PRPS1, CMTX5, DFNX1, DFN2	311850	Xq22.3	DFN2
Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3)	PHKB	172490	16q12.1	PHKB
Phosphoserine phosphatase deficiency, 614023 (3)	PSPH, PSP, PSPHD	172480	7p11.2	PSPH
Phosphoserine phosphatase deficiency, 614023 (3)	PSPH, PSP, PSPHD	172480	7p11.2	PSP
Phosphoserine phosphatase deficiency, 614023 (3)	PSPH, PSP, PSPHD	172480	7p11.2	PSPHD
Photoparoxysmal response 1 (2)	PPR1	132100	6p21.1	PPR1
Photoparoxysmal response 2 (2)	PPR2	609572	13q31.3	PPR2
Photoparoxysmal response 3 (2)	PPR3	609573	7q32	PPR3
Pick disease, 172700 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Pick disease, 172700 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MTBT1
Pick disease, 172700 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	DDPAC
Pick disease, 172700 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MSTD
Pick disease, 172700 (3)	PSEN1, AD3	104311	14q24.2	PSEN1
Pick disease, 172700 (3)	PSEN1, AD3	104311	14q24.2	AD3
Piebaldism, 172800 (3)	KIT, PBT	164920	4q12	KIT
Piebaldism, 172800 (3)	KIT, PBT	164920	4q12	PBT
Piebaldism, 172800 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SNAI2
Piebaldism, 172800 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SLUG
Piebaldism, 172800 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	WS2D
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBL1XR1
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	TBLR1
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	IRA1
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	C21
Pierpont syndrome, 602342 (3)	TBL1XR1, TBLR1, IRA1, C21, MRD41	608628	3q26.32	MRD41
Pierre Robin syndrome (2)	PRBNS	261800	17q24.3-q25.1	PRBNS
Pierson syndrome, 609049 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMB2
Pierson syndrome, 609049 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	LAMS
Pierson syndrome, 609049 (3)	LAMB2, LAMS, NPHS5	150325	3p21.31	NPHS5
Pigment dispersion syndrome (2)	GPDS1, PDS1	600510	7q35-q36	GPDS1
Pigment dispersion syndrome (2)	GPDS1, PDS1	600510	7q35-q36	PDS1
Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3)	POLA1	312040	Xp22.1-p21.3	POLA1
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PRKAR1A
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	TSE1
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CNC1
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	CAR
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	PPNAD1
Pigmented nodular adrenocortical disease, primary, 1, 610489 (3)	PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1	188830	17q24.2	ACRDYS1
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PDE11A
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PDE11A1
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PDE11A2
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PDE11A3
Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)	PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2	604961	2q31.2	PPNAD2
Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PDE8B
Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PPNAD3
Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	ADSD
Pigmented nodular adrenocortical disease, primary, 4 (4)	PPNAD4	615830	19p13	PPNAD4
Pigmented paravenous chorioretinal atrophy, 172870 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Pigmented paravenous chorioretinal atrophy, 172870 (3)	CRB1, RP12, LCA8	604210	1q31.3	RP12
Pigmented paravenous chorioretinal atrophy, 172870 (3)	CRB1, RP12, LCA8	604210	1q31.3	LCA8
Pilomatricoma, somatic, 132600 (3)	CTNNB1, MRD19	116806	3p22.1	CTNNB1
Pilomatricoma, somatic, 132600 (3)	CTNNB1, MRD19	116806	3p22.1	MRD19
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CASPR2
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	NRXN4
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CDFE
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	AUTS15
Pitt-Hopkins like syndrome 1, 610042 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	PTHSL1
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	TCF4
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	SEF2
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	ITF2
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	PTHS
Pitt-Hopkins syndrome, 610954 (3)	TCF4, SEF2, ITF2, PTHS, FECD3	602272	18q21.2	FECD3
Pitt-Hopkins-like syndrome 2, 614325 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	NRXN1
Pitt-Hopkins-like syndrome 2, 614325 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	PTHSL2
Pitt-Hopkins-like syndrome 2, 614325 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	SCZD17
Pituitary ACTH-secreting adenoma (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2
Pituitary ACTH-secreting adenoma (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2B
Pituitary ACTH-secreting adenoma (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GIP
Pituitary adenoma, ACTH-secreting, 219090 (3)	AIP, XAP2, ARA9	605555	11q13.2	AIP
Pituitary adenoma, ACTH-secreting, 219090 (3)	AIP, XAP2, ARA9	605555	11q13.2	XAP2
Pituitary adenoma, ACTH-secreting, 219090 (3)	AIP, XAP2, ARA9	605555	11q13.2	ARA9
Pituitary adenoma, growth hormone-secreting 2, 300943 (3)	GPR101, PAGH2	300393	Xq26.3	GPR101
Pituitary adenoma, growth hormone-secreting 2, 300943 (3)	GPR101, PAGH2	300393	Xq26.3	PAGH2
Pituitary adenoma, growth hormone-secreting, 102200 (3)	AIP, XAP2, ARA9	605555	11q13.2	AIP
Pituitary adenoma, growth hormone-secreting, 102200 (3)	AIP, XAP2, ARA9	605555	11q13.2	XAP2
Pituitary adenoma, growth hormone-secreting, 102200 (3)	AIP, XAP2, ARA9	605555	11q13.2	ARA9
Pituitary adenoma, prolactin-secreting, 600634 (3)	AIP, XAP2, ARA9	605555	11q13.2	AIP
Pituitary adenoma, prolactin-secreting, 600634 (3)	AIP, XAP2, ARA9	605555	11q13.2	XAP2
Pituitary adenoma, prolactin-secreting, 600634 (3)	AIP, XAP2, ARA9	605555	11q13.2	ARA9
Pituitary hormone deficiency, combined, 1, 613038 (3)	POU1F1, PIT1, CPHD1	173110	3p11.2	POU1F1
Pituitary hormone deficiency, combined, 1, 613038 (3)	POU1F1, PIT1, CPHD1	173110	3p11.2	PIT1
Pituitary hormone deficiency, combined, 1, 613038 (3)	POU1F1, PIT1, CPHD1	173110	3p11.2	CPHD1
Pituitary hormone deficiency, combined, 2, 262600 (3)	PROP1, CPHD2	601538	5q35.3	PROP1
Pituitary hormone deficiency, combined, 2, 262600 (3)	PROP1, CPHD2	601538	5q35.3	CPHD2
Pituitary hormone deficiency, combined, 3, 221750 (3)	LHX3, CPHD3	600577	9q34.3	LHX3
Pituitary hormone deficiency, combined, 3, 221750 (3)	LHX3, CPHD3	600577	9q34.3	CPHD3
Pituitary hormone deficiency, combined, 4, 262700 (3)	LHX4, CPHD4	602146	1q25.2	LHX4
Pituitary hormone deficiency, combined, 4, 262700 (3)	LHX4, CPHD4	602146	1q25.2	CPHD4
Pituitary hormone deficiency, combined, 5, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Pituitary hormone deficiency, combined, 5, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	RPX
Pituitary hormone deficiency, combined, 5, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	CPHD5
Pituitary hormone deficiency, combined, 6, 613986 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Pituitary hormone deficiency, combined, 6, 613986 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	MCOPS5
Pituitary hormone deficiency, combined, 6, 613986 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	CPHD6
Pituitary tumor, invasive (3)	PRKCA, PKCA	176960	17q24.2	PRKCA
Pituitary tumor, invasive (3)	PRKCA, PKCA	176960	17q24.2	PKCA
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARD14
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARMA2
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	BIMP2
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PSORS2
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PSS1
Pityriasis rubra pilaris, 173200 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PRP
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FN1
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FN
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	LETS
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	FNZ
Plasma fibronectin deficiency, 614101 (1)	FN1, FN, LETS, FNZ, GFND2	135600	2q35	GFND2
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	ANGPTL4
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	PGAR
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	HFARP
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	FIAF
Plasma triglyceride level QTL, low, 615881 (3)	ANGPTL4, PGAR, HFARP, FIAF, TGQTL	605910	19p13.2	TGQTL
Plasminogen activator inhibitor-1 deficiency, 613329 (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PAI1
Plasminogen activator inhibitor-1 deficiency, 613329 (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PLANH1
Plasminogen activator inhibitor-1 deficiency, 613329 (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	SERPINE1
Plasminogen deficiency, type I, 217090 (3)	PLG	173350	6q26	PLG
Platelet PLC beta-2 deficiency (1)	PLCB2	604114	15q15.1	PLCB2
Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	RUNX1
Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	CBFA2
Platelet disorder, familial, with associated myeloid malignancy, 601399 (3)	RUNX1, CBFA2, AML1	151385	21q22.12	AML1
Platelet glycoprotein IV deficiency, 608404 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
Platelet glycoprotein IV deficiency, 608404 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CHDS7
Platelet glycoprotein IV deficiency, 608404 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	BDPLT10
Platelet-activating factor acetylhydrolase deficiency, 614278 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
Platelet-activating factor acetylhydrolase deficiency, 614278 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAH
Platelet-activating factor acetylhydrolase deficiency, 614278 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAD
Platyspondylic skeletal dysplasia, Torrance type, 151210 (3)	COL2A1	120140	12q13.11	COL2A1
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	HERNA
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	KIAA0928
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	MNG1
Pleuropulmonary blastoma, 601200 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	RMSE2
Pneumothorax, primary spontaneous, 173600 (3)	FLCN, BHD	607273	17p11.2	FLCN
Pneumothorax, primary spontaneous, 173600 (3)	FLCN, BHD	607273	17p11.2	BHD
Poikiloderma with neutropenia, 604173 (3)	C16orf57, PN	613276	16q21	C16orf57
Poikiloderma with neutropenia, 604173 (3)	C16orf57, PN	613276	16q21	PN
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	FAM111B, POIKTMP	615584	11q12.1	FAM111B
Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3)	FAM111B, POIKTMP	615584	11q12.1	POIKTMP
Polyarteritis nodosa, childhood-onset, 615688 (3)	CECR1, PAN, SNEDS	607575	22q11.1	CECR1
Polyarteritis nodosa, childhood-onset, 615688 (3)	CECR1, PAN, SNEDS	607575	22q11.1	PAN
Polyarteritis nodosa, childhood-onset, 615688 (3)	CECR1, PAN, SNEDS	607575	22q11.1	SNEDS
Polycyctic kidney disease 3, 600666 (3)	GANAB, PKD3	104160	11q12.3	GANAB
Polycyctic kidney disease 3, 600666 (3)	GANAB, PKD3	104160	11q12.3	PKD3
Polycystic kidney and hepatic disease, 263200 (3)	FCYT, PKHD1, ARPKD	606702	6p12.3-p12.2	FCYT
Polycystic kidney and hepatic disease, 263200 (3)	FCYT, PKHD1, ARPKD	606702	6p12.3-p12.2	PKHD1
Polycystic kidney and hepatic disease, 263200 (3)	FCYT, PKHD1, ARPKD	606702	6p12.3-p12.2	ARPKD
Polycystic kidney disease 2, 613095 (3)	PKD2	173910	4q22.1	PKD2
Polycystic kidney disease, adult type I, 173900 (3)	PKD1	601313	16p13.3	PKD1
Polycystic kidney disease, infantile severe, with tuberous sclerosis (4)	PKDTS	600273	16p13.3	PKDTS
Polycystic liver disease 1, 174050 (3)	PRKCSH, G19P1, PCLD1	177060	19p13.2	PRKCSH
Polycystic liver disease 1, 174050 (3)	PRKCSH, G19P1, PCLD1	177060	19p13.2	G19P1
Polycystic liver disease 1, 174050 (3)	PRKCSH, G19P1, PCLD1	177060	19p13.2	PCLD1
Polycystic liver disease 2, 617004 (3)	SEC63, PCLD2	608648	6q21	SEC63
Polycystic liver disease 2, 617004 (3)	SEC63, PCLD2	608648	6q21	PCLD2
Polycystic ovary syndrome 1 (2)	PCOS1, PCO1, PCO	184700	19p13.2	PCOS1
Polycystic ovary syndrome 1 (2)	PCOS1, PCO1, PCO	184700	19p13.2	PCO1
Polycystic ovary syndrome 1 (2)	PCOS1, PCO1, PCO	184700	19p13.2	PCO
Polycythemia vera, somatic, 263300 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Polycythemia vera, somatic, 263300 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
Polydactyly, postaxial, type A3 (2)	PAPA3	607324	19p13.2-p13.1	PAPA3
Polydactyly, postaxial, type A4 (2)	PAPA4	608562	7q22	PAPA4
Polydactyly, postaxial, type A5 (2)	PAPA5	263450	13q13.3-q21	PAPA5
Polydactyly, postaxial, types A1 and B, 174200 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Polydactyly, postaxial, types A1 and B, 174200 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPA
Polydactyly, postaxial, types A1 and B, 174200 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPB
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Polydactyly, preaxial type II, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Polydactyly, preaxial, type IV, 174700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
Polydactyly, preaxial, type IV, 174700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPA
Polydactyly, preaxial, type IV, 174700 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPB
Polyglucosan body disease, adult form, 263570 (3)	GBE1, GSD4, APBD	607839	3p12.2	GBE1
Polyglucosan body disease, adult form, 263570 (3)	GBE1, GSD4, APBD	607839	3p12.2	GSD4
Polyglucosan body disease, adult form, 263570 (3)	GBE1, GSD4, APBD	607839	3p12.2	APBD
Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	RBCK1, HOIL1, PGBM1, PBMEI	610924	20p13	RBCK1
Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	RBCK1, HOIL1, PGBM1, PBMEI	610924	20p13	HOIL1
Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	RBCK1, HOIL1, PGBM1, PBMEI	610924	20p13	PGBM1
Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3)	RBCK1, HOIL1, PGBM1, PBMEI	610924	20p13	PBMEI
Polyglucosan body myopathy 2, 616199 (3)	GYG1, GSD15	603942	3q24	GYG1
Polyglucosan body myopathy 2, 616199 (3)	GYG1, GSD15	603942	3q24	GSD15
Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	STRADA, STRAD, LYK5	608626	17q23.3	STRADA
Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	STRADA, STRAD, LYK5	608626	17q23.3	STRAD
Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)	STRADA, STRAD, LYK5	608626	17q23.3	LYK5
Polymicrogyria with optic nerve hypoplasia, 613180 (3)	TUBA8, TUBAL2	605742	22q11.21	TUBA8
Polymicrogyria with optic nerve hypoplasia, 613180 (3)	TUBA8, TUBAL2	605742	22q11.21	TUBAL2
Polymicrogyria, bilateral frontoparietal, 606854 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	GPR56
Polymicrogyria, bilateral frontoparietal, 606854 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	TM7XN1
Polymicrogyria, bilateral frontoparietal, 606854 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	BFPP
Polymicrogyria, bilateral frontoparietal, 606854 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	BPPR
Polymicrogyria, bilateral perisylvian (2)	BPP, PMGX, CBPS	300388	Xq27.2-q28	BPP
Polymicrogyria, bilateral perisylvian (2)	BPP, PMGX, CBPS	300388	Xq27.2-q28	PMGX
Polymicrogyria, bilateral perisylvian (2)	BPP, PMGX, CBPS	300388	Xq27.2-q28	CBPS
Polymicrogyria, bilateral perisylvian, 615752 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	GPR56
Polymicrogyria, bilateral perisylvian, 615752 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	TM7XN1
Polymicrogyria, bilateral perisylvian, 615752 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	BFPP
Polymicrogyria, bilateral perisylvian, 615752 (3)	GPR56, TM7XN1, BFPP, BPPR	604110	16q21	BPPR
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	PI4KA, PIK4CA, PMGYCHA	600286	22q11.21	PI4KA
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	PI4KA, PIK4CA, PMGYCHA	600286	22q11.21	PIK4CA
Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3)	PI4KA, PIK4CA, PMGYCHA	600286	22q11.21	PMGYCHA
Polymicrogyria, symmetric or asymmetric, 610031 (3)	TUBB2B, PMGYSA	612850	6p25.2	TUBB2B
Polymicrogyria, symmetric or asymmetric, 610031 (3)	TUBB2B, PMGYSA	612850	6p25.2	PMGYSA
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	ABHD12, PHARC	613599	20p11.21	ABHD12
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3)	ABHD12, PHARC	613599	20p11.21	PHARC
Polyposis syndrome, hereditary mixed, 2, 610069 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Polyposis syndrome, hereditary mixed, 2, 610069 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ACVRLK3
Polyposis syndrome, hereditary mixed, 2, 610069 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ALK3
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	HMPS1
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	CRAC1
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	CRCS4
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	DUP15q
Polyposis syndrome, mixed hereditary 1 (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	C15DUPq
Polyposis, juvenile intestinal, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	BMPR1A
Polyposis, juvenile intestinal, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ACVRLK3
Polyposis, juvenile intestinal, 174900 (3)	BMPR1A, ACVRLK3, ALK3	601299	10q23.2	ALK3
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MADH4
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	DPC4
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	SMAD4
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	JIP
Polyposis, juvenile intestinal, 174900 (3)	SMAD4, MADH4, DPC4, SMAD4, JIP, MYHRS	600993	18q21.2	MYHRS
Pontocerebellar hypoplasia type 1A, 607596 (3)	VRK1, PCH1A	602168	14q32.2	VRK1
Pontocerebellar hypoplasia type 1A, 607596 (3)	VRK1, PCH1A	602168	14q32.2	PCH1A
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	SEN54
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH2A
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH4
Pontocerebellar hypoplasia type 2A, 277470 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH5
Pontocerebellar hypoplasia type 2B, 612389 (3)	TSEN2, SEN2, PCH2B	608753	3p25.2	TSEN2
Pontocerebellar hypoplasia type 2B, 612389 (3)	TSEN2, SEN2, PCH2B	608753	3p25.2	SEN2
Pontocerebellar hypoplasia type 2B, 612389 (3)	TSEN2, SEN2, PCH2B	608753	3p25.2	PCH2B
Pontocerebellar hypoplasia type 2D, 613811 (3)	SEPSECS, SLA, LP, PCH2D	613009	4p15.2	SEPSECS
Pontocerebellar hypoplasia type 2D, 613811 (3)	SEPSECS, SLA, LP, PCH2D	613009	4p15.2	SLA
Pontocerebellar hypoplasia type 2D, 613811 (3)	SEPSECS, SLA, LP, PCH2D	613009	4p15.2	LP
Pontocerebellar hypoplasia type 2D, 613811 (3)	SEPSECS, SLA, LP, PCH2D	613009	4p15.2	PCH2D
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	TSEN54
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	SEN54
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH2A
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH4
Pontocerebellar hypoplasia type 4, 225753 (3)	TSEN54, SEN54, PCH2A, PCH4, PCH5	608755	17q25.1	PCH5
Pontocerebellar hypoplasia, type 10, 615803 (3)	CLP1, HEAB, PCH10	608757	11q12.1	CLP1
Pontocerebellar hypoplasia, type 10, 615803 (3)	CLP1, HEAB, PCH10	608757	11q12.1	HEAB
Pontocerebellar hypoplasia, type 10, 615803 (3)	CLP1, HEAB, PCH10	608757	11q12.1	PCH10
Pontocerebellar hypoplasia, type 1B, 614678 (3)	EXOSC3, RRP40, PCH1B	606489	9p13.2	EXOSC3
Pontocerebellar hypoplasia, type 1B, 614678 (3)	EXOSC3, RRP40, PCH1B	606489	9p13.2	RRP40
Pontocerebellar hypoplasia, type 1B, 614678 (3)	EXOSC3, RRP40, PCH1B	606489	9p13.2	PCH1B
Pontocerebellar hypoplasia, type 1C, 616081 (3)	EXOSC8, OIP2, RRP43, PCH1C	606019	13q13.3	EXOSC8
Pontocerebellar hypoplasia, type 1C, 616081 (3)	EXOSC8, OIP2, RRP43, PCH1C	606019	13q13.3	OIP2
Pontocerebellar hypoplasia, type 1C, 616081 (3)	EXOSC8, OIP2, RRP43, PCH1C	606019	13q13.3	RRP43
Pontocerebellar hypoplasia, type 1C, 616081 (3)	EXOSC8, OIP2, RRP43, PCH1C	606019	13q13.3	PCH1C
Pontocerebellar hypoplasia, type 2E, 615851 (3)	VPS53, HCCS1, PCH2E	615850	17p13.3	VPS53
Pontocerebellar hypoplasia, type 2E, 615851 (3)	VPS53, HCCS1, PCH2E	615850	17p13.3	HCCS1
Pontocerebellar hypoplasia, type 2E, 615851 (3)	VPS53, HCCS1, PCH2E	615850	17p13.3	PCH2E
Pontocerebellar hypoplasia, type 2F, 617026 (3)	TSEN15, SEN15, C1orf19, PCH2F	608756	1q25.3	TSEN15
Pontocerebellar hypoplasia, type 2F, 617026 (3)	TSEN15, SEN15, C1orf19, PCH2F	608756	1q25.3	SEN15
Pontocerebellar hypoplasia, type 2F, 617026 (3)	TSEN15, SEN15, C1orf19, PCH2F	608756	1q25.3	C1orf19
Pontocerebellar hypoplasia, type 2F, 617026 (3)	TSEN15, SEN15, C1orf19, PCH2F	608756	1q25.3	PCH2F
Pontocerebellar hypoplasia, type 6, 611523 (3)	RARS2, RARSL, PCH6	611524	6q15	RARS2
Pontocerebellar hypoplasia, type 6, 611523 (3)	RARS2, RARSL, PCH6	611524	6q15	RARSL
Pontocerebellar hypoplasia, type 6, 611523 (3)	RARS2, RARSL, PCH6	611524	6q15	PCH6
Pontocerebellar hypoplasia, type 8, 614961 (3)	CHMP1A, PCOLN3, PRSM1, PCH8	164010	16q24.3	CHMP1A
Pontocerebellar hypoplasia, type 8, 614961 (3)	CHMP1A, PCOLN3, PRSM1, PCH8	164010	16q24.3	PCOLN3
Pontocerebellar hypoplasia, type 8, 614961 (3)	CHMP1A, PCOLN3, PRSM1, PCH8	164010	16q24.3	PRSM1
Pontocerebellar hypoplasia, type 8, 614961 (3)	CHMP1A, PCOLN3, PRSM1, PCH8	164010	16q24.3	PCH8
Pontocerebellar hypoplasia, type 9, 615809 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	AMPD2
Pontocerebellar hypoplasia, type 9, 615809 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	SPG63
Pontocerebellar hypoplasia, type 9, 615809 (3)	AMPD2, SPG63, PCH9	102771	1p13.3	PCH9
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	VWS
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	LPS
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PIT
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PPS1
Popliteal pterygium syndrome 1, 119500 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	OFC6
Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	RIPK4, NKRD3, DIK, PPS2	605706	21q22.3	RIPK4
Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	RIPK4, NKRD3, DIK, PPS2	605706	21q22.3	NKRD3
Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	RIPK4, NKRD3, DIK, PPS2	605706	21q22.3	DIK
Popliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3)	RIPK4, NKRD3, DIK, PPS2	605706	21q22.3	PPS2
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	POREN1
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	HANAC
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	ICH
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	BSVD
Porencephaly 1, 175780 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	RATOR
Porencephaly 2, 614483 (3)	COL4A2, POREN2, ICH	120090	13q34	COL4A2
Porencephaly 2, 614483 (3)	COL4A2, POREN2, ICH	120090	13q34	POREN2
Porencephaly 2, 614483 (3)	COL4A2, POREN2, ICH	120090	13q34	ICH
Poretti-Boltshauser syndrome, 615960 (3)	LAMA1, PTBHS	150320	18p11.31	LAMA1
Poretti-Boltshauser syndrome, 615960 (3)	LAMA1, PTBHS	150320	18p11.31	PTBHS
Porokeratosis 1, multiple types, 175800 (3)	PMVK, PMK, POROK1	607622	1q21.3	PMVK
Porokeratosis 1, multiple types, 175800 (3)	PMVK, PMK, POROK1	607622	1q21.3	PMK
Porokeratosis 1, multiple types, 175800 (3)	PMVK, PMK, POROK1	607622	1q21.3	POROK1
Porokeratosis 2, palmar, plantar, and disseminated (2)	POROK2, PPPD1	175850	12q24.1-q24.2	POROK2
Porokeratosis 2, palmar, plantar, and disseminated (2)	POROK2, PPPD1	175850	12q24.1-q24.2	PPPD1
Porokeratosis 3, multiple types, 175900 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVK
Porokeratosis 3, multiple types, 175900 (3)	MVK, MVLK, POROK3	251170	12q24.11	MVLK
Porokeratosis 3, multiple types, 175900 (3)	MVK, MVLK, POROK3	251170	12q24.11	POROK3
Porokeratosis 4, disseminated superficial actinic (2)	POROK4, DSAP2	607728	15q25.1-q26.1	POROK4
Porokeratosis 4, disseminated superficial actinic (2)	POROK4, DSAP2	607728	15q25.1-q26.1	DSAP2
Porokeratosis 5, disseminated superficial actinic (2)	POROK5, DSAP3	612293	1p31.3-p31.1	POROK5
Porokeratosis 5, disseminated superficial actinic (2)	POROK5, DSAP3	612293	1p31.3-p31.1	DSAP3
Porokeratosis 6, multiple types (2)	POROK6, DSAP4	612353	18p11.3	POROK6
Porokeratosis 6, multiple types (2)	POROK6, DSAP4	612353	18p11.3	DSAP4
Porokeratosis 7, multiple types, 614714 (3)	MVD, MPD, POROK7	603236	16q24.2	MVD
Porokeratosis 7, multiple types, 614714 (3)	MVD, MPD, POROK7	603236	16q24.2	MPD
Porokeratosis 7, multiple types, 614714 (3)	MVD, MPD, POROK7	603236	16q24.2	POROK7
Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	SLC17A9, C20orf59, POROK8	612107	20q13.33	SLC17A9
Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	SLC17A9, C20orf59, POROK8	612107	20q13.33	C20orf59
Porokeratosis 8, disseminated superficial actinic type, 616063 (3)	SLC17A9, C20orf59, POROK8	612107	20q13.33	POROK8
Porokeratosis 9, multiple types, 616631 (3)	FDPS, FPS, POROK9	134629	1q22	FDPS
Porokeratosis 9, multiple types, 616631 (3)	FDPS, FPS, POROK9	134629	1q22	FPS
Porokeratosis 9, multiple types, 616631 (3)	FDPS, FPS, POROK9	134629	1q22	POROK9
Porphyria cutanea tarda, 176100 (3)	UROD	613521	1p34.1	UROD
Porphyria variegata, 176200 (3)	PPOX	600923	1q23.3	PPOX
Porphyria, acute hepatic, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALAD
Porphyria, acute hepatic, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALADH
Porphyria, acute hepatic, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	PBGS
Porphyria, acute intermittent, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	HMBS
Porphyria, acute intermittent, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	PBGD
Porphyria, acute intermittent, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	UPS
Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	HMBS
Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	PBGD
Porphyria, acute intermittent, nonerythroid variant, 176000 (3)	HMBS, PBGD, UPS	609806	11q23.3	UPS
Porphyria, congenital erythropoietic, 263700 (3)	UROS	606938	10q26.2	UROS
Porphyria, hepatoerythropoietic, 176100 (3)	UROD	613521	1p34.1	UROD
Postaxial polydactyly, type A2 (2)	PAPA2	602085	13q21-q32	PAPA2
Potocki-Lupski syndrome (4)	PTLS	610883	17p11.2	PTLS
Potocki-Shaffer syndrome (4)	PSS	601224	11p11.2	PSS
Prader-Willi syndrome, 176270 (3)	NDN	602117	15q11.2	NDN
Prader-Willi syndrome, 176270 (3)	SNRPN	182279	15q11.2	SNRPN
Preauricular tag, isolated, autosomal dominant, 1 (2)	PAURT1	610420	14q11.2-q12	PAURT1
Precocious puberty, central, 2, 615346 (3)	MKRN3, ZFP127, ZNF127, CPPB2	603856	15q11.2	MKRN3
Precocious puberty, central, 2, 615346 (3)	MKRN3, ZFP127, ZNF127, CPPB2	603856	15q11.2	ZFP127
Precocious puberty, central, 2, 615346 (3)	MKRN3, ZFP127, ZNF127, CPPB2	603856	15q11.2	ZNF127
Precocious puberty, central, 2, 615346 (3)	MKRN3, ZFP127, ZNF127, CPPB2	603856	15q11.2	CPPB2
Precocious puberty, male, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHCGR
Precocious puberty, male, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LHR
Precocious puberty, male, 176410 (3)	LHCGR, LHR, LCGR	152790	2p16.3	LCGR
Preeclampsia/eclampsia 1 (2)	PEE1, PREG1	189800	2p13	PEE1
Preeclampsia/eclampsia 1 (2)	PEE1, PREG1	189800	2p13	PREG1
Preeclampsia/eclampsia 2 (2)	PEE2	609402	2p25	PEE2
Preeclampsia/eclampsia 3 (2)	PEE3	609403	9p13	PEE3
Preeclampsia/eclampsia 4, 609404 (3)	STOX1, PEE4	609397	10q22.1	STOX1
Preeclampsia/eclampsia 4, 609404 (3)	STOX1, PEE4	609397	10q22.1	PEE4
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	CORIN
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	CRN
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	TMPRSS10
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	ATC2
Preeclampsia/eclampsia 5, 614595 (3)	CORIN, CRN, TMPRSS10, ATC2, PEE5	605236	4p12	PEE5
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SYCP3
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SCP3
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	COR1
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SPGF4
Pregnancy loss, recurrent, 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	RPRGL4
Preimplantation embryonic lethality, 616814 (3)	TLE6, GRG6, PREMBL	612399	19p13.3	TLE6
Preimplantation embryonic lethality, 616814 (3)	TLE6, GRG6, PREMBL	612399	19p13.3	GRG6
Preimplantation embryonic lethality, 616814 (3)	TLE6, GRG6, PREMBL	612399	19p13.3	PREMBL
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFRB
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PDGFR
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IBGC4
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	IMF1
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	PENTT
Premature aging syndrome, Penttinen type, 601812 (3)	PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS	173410	5q32	KOGS
Premature ovarian failure 1, 311360 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FMR1
Premature ovarian failure 1, 311360 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	FRAXA
Premature ovarian failure 1, 311360 (3)	FMR1, FRAXA, POF1	309550	Xq27.3	POF1
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
Premature ovarian failure 11, 616946 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
Premature ovarian failure 2B, 300604 (3)	FLJ22792, POF1B, POF2B	300603	Xq21.1	FLJ22792
Premature ovarian failure 2B, 300604 (3)	FLJ22792, POF1B, POF2B	300603	Xq21.1	POF1B
Premature ovarian failure 2B, 300604 (3)	FLJ22792, POF1B, POF2B	300603	Xq21.1	POF2B
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	FOXL2
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	BPES1
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	PFRK
Premature ovarian failure 3, 608996 (3)	FOXL2, BPES, BPES1, PFRK, POF3	605597	3q22.3	POF3
Premature ovarian failure 4, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	BMP15
Premature ovarian failure 4, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	GDF9B
Premature ovarian failure 4, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	ODG2
Premature ovarian failure 4, 300510 (3)	BMP15, GDF9B, ODG2, POF4	300247	Xp11.22	POF4
Premature ovarian failure 5, 611548 (3)	NOBOX, POF5	610934	7q35	NOBOX
Premature ovarian failure 5, 611548 (3)	NOBOX, POF5	610934	7q35	POF5
Premature ovarian failure 6, 612310 (3)	FIGLA, POF6	608697	2p13.3	FIGLA
Premature ovarian failure 6, 612310 (3)	FIGLA, POF6	608697	2p13.3	POF6
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	NR5A1
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZF1
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZ1
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SF1
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	AD4BP
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	POF7
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SRXY3
Premature ovarian failure 7, 612964 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SPGF8
Premature ovarian failure 8, 615723 (3)	STAG3, POF8	608489	7q22.1	STAG3
Premature ovarian failure 8, 615723 (3)	STAG3, POF8	608489	7q22.1	POF8
Premature ovarian failure 9, 615724 (3)	HFM1, MER3, POF9	615684	1p22.2	HFM1
Premature ovarian failure 9, 615724 (3)	HFM1, MER3, POF9	615684	1p22.2	MER3
Premature ovarian failure 9, 615724 (3)	HFM1, MER3, POF9	615684	1p22.2	POF9
Premature ovarian failure, 300511 (3)	DIAPH2, DIA, POF2	300108	Xq21.33	DIAPH2
Premature ovarian failure, 300511 (3)	DIAPH2, DIA, POF2	300108	Xq21.33	DIA
Premature ovarian failure, 300511 (3)	DIAPH2, DIA, POF2	300108	Xq21.33	POF2
Prieto syndrome (2)	PRS, MRXS2	309610	Xp11-q21	PRS
Prieto syndrome (2)	PRS, MRXS2	309610	Xp11-q21	MRXS2
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNA1D
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNL1A2
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CCHL1A2
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	SANDD
Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	PASNA
Primary lateral sclerosis, adult, 1 (2)	PLSA1, PLSA	611637	4p16	PLSA1
Primary lateral sclerosis, adult, 1 (2)	PLSA1, PLSA	611637	4p16	PLSA
Primary lateral sclerosis, juvenile, 606353 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Primary lateral sclerosis, juvenile, 606353 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALSJ
Primary lateral sclerosis, juvenile, 606353 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	PLSJ
Primary lateral sclerosis, juvenile, 606353 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	IAHSP
Primrose syndrome, 259050 (3)	ZBTB20, ZNF288, DPZF, PRIMS	606025	3q13.31	ZBTB20
Primrose syndrome, 259050 (3)	ZBTB20, ZNF288, DPZF, PRIMS	606025	3q13.31	ZNF288
Primrose syndrome, 259050 (3)	ZBTB20, ZNF288, DPZF, PRIMS	606025	3q13.31	DPZF
Primrose syndrome, 259050 (3)	ZBTB20, ZNF288, DPZF, PRIMS	606025	3q13.31	PRIMS
Prion disease with protracted course, 606688 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
Prion disease with protracted course, 606688 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
Prion disease with protracted course, 606688 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
Prion disease with protracted course, 606688 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	SLC25A4
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	ANT1
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	T1
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEO3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEO2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	MTDPS12
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3)	SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12, PEOA2	103220	4q35.1	PEOA2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	C10orf2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	TWINKLE
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PEOA3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	IOSCA
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	MTDPS7
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3)	C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5	606075	10q24.31	PRLTS5
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	POLG2, POLGB, PEOA4	604983	17q23.3	POLG2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	POLG2, POLGB, PEOA4	604983	17q23.3	POLGB
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3)	POLG2, POLGB, PEOA4	604983	17q23.3	PEOA4
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	RRM2B
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	P53R2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	PEOA5
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8A
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3)	RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B	604712	8q22.3	MTDPS8B
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	DNA2L
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	KIAA0083
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	PEOA6
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3)	DNA2, DNA2L, KIAA0083, PEOA6, SCKL8	601810	10q21.3	SCKL8
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	RNASEH1, PEOB2	604123	2p25.3	RNASEH1
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3)	RNASEH1, PEOB2	604123	2p25.3	PEOB2
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG1
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLGA
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	PEO
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SANDO
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SCAE
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4A
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4B
Progressive external ophthalmoplegia, autosomal dominant 1, 157640 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MIRAS
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLG1
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	POLGA
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	PEO
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SANDO
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	SCAE
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4A
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MTDPS4B
Progressive external ophthalmoplegia, autosomal recessive 1, 258450 (3)	POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS	174763	15q26.1	MIRAS
Progressive familial heart block, type IB, 604559 (3)	TRPM4, PFHB1B	606936	19q13.33	TRPM4
Progressive familial heart block, type IB, 604559 (3)	TRPM4, PFHB1B	606936	19q13.33	PFHB1B
Progressive familial heart block, type II (2)	PFHB2	140400	1q32	PFHB2
Proguanil poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C
Proguanil poor metabolizer, 609535 (3)	CYP2C, CYP2C19	124020	10q23.33	CYP2C19
Prolidase deficiency, 170100 (3)	PEPD	613230	19q13.11	PEPD
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	FLVCR2
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	C14orf58
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	CCT
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	PVHH
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome, 225790 (3)	FLVCR2, C14orf58, CCT, PVHH, EPV	610865	14q24.3	EPV
Properdin deficiency, X-linked, 312060 (3)	PFC, PFD	300383	Xp11.23	PFC
Properdin deficiency, X-linked, 312060 (3)	PFC, PFD	300383	Xp11.23	PFD
Propionicacidemia, 606054 (3)	PCCA	232000	13q32.3	PCCA
Propionicacidemia, 606054 (3)	PCCB	232050	3q22.3	PCCB
Prostate adenocarcinoma (2)	ST12, PAC1	601188	10pter-q11	ST12
Prostate adenocarcinoma (2)	ST12, PAC1	601188	10pter-q11	PAC1
Prostate cancer 1, 601518 (3)	RNASEL, RNS4, PRCA1, HPC1	180435	1q25.3	RNASEL
Prostate cancer 1, 601518 (3)	RNASEL, RNS4, PRCA1, HPC1	180435	1q25.3	RNS4
Prostate cancer 1, 601518 (3)	RNASEL, RNS4, PRCA1, HPC1	180435	1q25.3	PRCA1
Prostate cancer 1, 601518 (3)	RNASEL, RNS4, PRCA1, HPC1	180435	1q25.3	HPC1
Prostate cancer, hereditary, 176807 (3)	MSR1, SCARA1, SRA	153622	8p22	MSR1
Prostate cancer, hereditary, 176807 (3)	MSR1, SCARA1, SRA	153622	8p22	SCARA1
Prostate cancer, hereditary, 176807 (3)	MSR1, SCARA1, SRA	153622	8p22	SRA
Prostate cancer, somatic, 176807 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	KLF6
Prostate cancer, somatic, 176807 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	COPEB
Prostate cancer, somatic, 176807 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	BCD1
Prostate cancer, somatic, 176807 (3)	KLF6, COPEB, BCD1, ZF9	602053	10p15.2	ZF9
Prostate cancer, somatic, 176807 (3)	MAD1L1, TXBP181	602686	7p22.3	MAD1L1
Prostate cancer, somatic, 176807 (3)	MAD1L1, TXBP181	602686	7p22.3	TXBP181
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCN5
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	CLCK2
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL2
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	DENTS
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)	CLCN5, CLCK2, NPHL2, DENTS, NPHL1	300008	Xp11.23	NPHL1
Proteus syndrome, somatic, 176920 (3)	AKT1, CWS6	164730	14q32.33	AKT1
Proteus syndrome, somatic, 176920 (3)	AKT1, CWS6	164730	14q32.33	CWS6
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ALAS2
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ANH1
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ASB
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	XLEPP
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	XLSA
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	ANH1
Protoporphyria, erythropoietic, X-linked, 300752 (3)	ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1, SIDBA1	301300	Xp11.21	SIDBA1
Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)	FECH, FCE	612386	18q21.31	FECH
Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)	FECH, FCE	612386	18q21.31	FCE
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ARX
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	ISSX
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	PRTS
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRXS1
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX36
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX54
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX43
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX87
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX29
Proud syndrome, 300004 (3)	ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32	300382	Xp21.3	MRX32
Proximal myopathy and ophthalmoplegia, 605637 (3)	MYH2, MYPOP	160740	17p13.1	MYH2
Proximal myopathy and ophthalmoplegia, 605637 (3)	MYH2, MYPOP	160740	17p13.1	MYPOP
Pseudoachondroplasia, 177170 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	COMP
Pseudoachondroplasia, 177170 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	EDM1
Pseudoachondroplasia, 177170 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	MED
Pseudoachondroplasia, 177170 (3)	COMP, EDM1, MED, PSACH	600310	19p13.11	PSACH
Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	HSD17B3, EDH17B3	605573	9q22.32	HSD17B3
Pseudohermaphroditism, male, with gynecomastia, 264300 (3)	HSD17B3, EDH17B3	605573	9q22.32	EDH17B3
Pseudohyperkalemia, familial, 2, due to red cell leak (2)	PSHK2	609153	2q35-q36	PSHK2
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MTABC3
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MCOPCB7
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	LAN
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	DUH3
Pseudohyperkalemia, familial, 2, due to red cell leak, 609153 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	PSHK2
Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	NR3C2, MLR, MCR	600983	4q31.23	NR3C2
Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	NR3C2, MLR, MCR	600983	4q31.23	MLR
Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3)	NR3C2, MLR, MCR	600983	4q31.23	MCR
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1A, BESC2	600228	12p13.31	SCNN1A
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1A, BESC2	600228	12p13.31	BESC2
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1B, BESC1	600760	16p12.2	SCNN1B
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1B, BESC1	600760	16p12.2	BESC1
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	SCNN1G
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	PHA1
Pseudohypoaldosteronism, type I, 264350 (3)	SCNN1G, PHA1, BESC3	600761	16p12.2	BESC3
Pseudohypoaldosteronism, type IIA (2)	PHA2A, PHA2	145260	1q31-q42	PHA2A
Pseudohypoaldosteronism, type IIA (2)	PHA2A, PHA2	145260	1q31-q42	PHA2
Pseudohypoaldosteronism, type IIB, 614491 (3)	WNK4, PRKWNK4, PHA2B	601844	17q21.2	WNK4
Pseudohypoaldosteronism, type IIB, 614491 (3)	WNK4, PRKWNK4, PHA2B	601844	17q21.2	PRKWNK4
Pseudohypoaldosteronism, type IIB, 614491 (3)	WNK4, PRKWNK4, PHA2B	601844	17q21.2	PHA2B
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	WNK1
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	PRKWNK1
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	KDP
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	PHA2C
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	HSAN2
Pseudohypoaldosteronism, type IIC, 614492 (3)	WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2	605232	12p13.33	HSN2
Pseudohypoaldosteronism, type IID, 614495 (3)	KLHL3, PHA2D	605775	5q31.2	KLHL3
Pseudohypoaldosteronism, type IID, 614495 (3)	KLHL3, PHA2D	605775	5q31.2	PHA2D
Pseudohypoaldosteronism, type IIE, 614496 (3)	CUL3, PHA2E	603136	2q36.2	CUL3
Pseudohypoaldosteronism, type IIE, 614496 (3)	CUL3, PHA2E	603136	2q36.2	PHA2E
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Pseudohypoparathyroidism Ia, 103580 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Pseudohypoparathyroidism Ib, 603233 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Pseudohypoparathyroidism Ic, 612462 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Pseudohypoparathyroidism, type IB, 603233 (3)	GNASAS1, GNASAS, SANG, NESPAS	610540	20q13.32	GNASAS1
Pseudohypoparathyroidism, type IB, 603233 (3)	GNASAS1, GNASAS, SANG, NESPAS	610540	20q13.32	GNASAS
Pseudohypoparathyroidism, type IB, 603233 (3)	GNASAS1, GNASAS, SANG, NESPAS	610540	20q13.32	SANG
Pseudohypoparathyroidism, type IB, 603233 (3)	GNASAS1, GNASAS, SANG, NESPAS	610540	20q13.32	NESPAS
Pseudohypoparathyroidism, type IB, 603233 (3)	STX16, SYN16	603666	20q13.32	STX16
Pseudohypoparathyroidism, type IB, 603233 (3)	STX16, SYN16	603666	20q13.32	SYN16
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GNAS1
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	GPSA
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	POH
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1B
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1A
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	AHO
Pseudopseudohypoparathyroidism, 612463 (3)	GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C	139320	20q13.32	PHP1C
Pseudovaginal perineoscrotal hypospadias, 264600 (3)	SRD5A2	607306	2p23.1	SRD5A2
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ARA
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABC34
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	MLP1
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	PXE
Pseudoxanthoma elasticum, 264800 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	GACI2
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABCC6
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ARA
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	ABC34
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	MLP1
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	PXE
Pseudoxanthoma elasticum, forme fruste, 177850 (3)	ABCC6, ARA, ABC34, MLP1, PXE, GACI2	603234	16p13.11	GACI2
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	GGCX, VKCFD1	137167	2p11.2	GGCX
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)	GGCX, VKCFD1	137167	2p11.2	VKCFD1
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	IL36RN
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	IL1F5
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	FIL1D
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	IL1HY1
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	IL1RP3
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	PSORP
Psoriasis 14, pustular, 614204 (3)	IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14	605507	2q14.1	PSORS14
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARD14
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	CARMA2
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	BIMP2
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PSORS2
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PSS1
Psoriasis 2, 602723 (3)	CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP	607211	17q25.3	PRP
Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	SNIP1, PMRED	608241	1p34.3	SNIP1
Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3)	SNIP1, PMRED	608241	1p34.3	PMRED
Ptosis, hereditary congenital 2 (2)	PTOS2, PTOSX	300245	Xq24-q27.1	PTOS2
Ptosis, hereditary congenital 2 (2)	PTOS2, PTOSX	300245	Xq24-q27.1	PTOSX
Ptosis, hereditary congenital, 1 (2)	PTOS1	178300	1p34.1-p32	PTOS1
Pulmonary alveolar microlithiasis, 265100 (3)	SLC34A2	604217	4p15.2	SLC34A2
Pulmonary disease, chronic obstructive, severe early-onset (2)	COPD	606963	2q	COPD
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	RTEL1
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	C20orf41
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	NHL
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	KIAA1088
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCB5
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	DKCA4
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3)	RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3	608833	20q13.33	PFBMFT3
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PARN
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	DAN
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	DKCB6
Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3)	PARN, DAN, DKCB6, PFBMFT4	604212	16p13.12	PFBMFT4
Pulmonary fibrosis, idiopathic, 178500 (3)	SFTPA2, SPA2, COLEC5	178642	10q22.3	SFTPA2
Pulmonary fibrosis, idiopathic, 178500 (3)	SFTPA2, SPA2, COLEC5	178642	10q22.3	SPA2
Pulmonary fibrosis, idiopathic, 178500 (3)	SFTPA2, SPA2, COLEC5	178642	10q22.3	COLEC5
Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	PPH1
Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	POVD1
Pulmonary hypertension, primary, 2, 615342 (3)	MADH9, SMAD9, MADH6, PPH2	603295	13q13.3	MADH9
Pulmonary hypertension, primary, 2, 615342 (3)	MADH9, SMAD9, MADH6, PPH2	603295	13q13.3	SMAD9
Pulmonary hypertension, primary, 2, 615342 (3)	MADH9, SMAD9, MADH6, PPH2	603295	13q13.3	MADH6
Pulmonary hypertension, primary, 2, 615342 (3)	MADH9, SMAD9, MADH6, PPH2	603295	13q13.3	PPH2
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CAV1
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	BSCL3
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	CGL3
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	PPH3
Pulmonary hypertension, primary, 3, 615343 (3)	CAV1, BSCL3, CGL3, PPH3, LCCNS	601047	7q31.2	LCCNS
Pulmonary hypertension, primary, 4, 615344 (3)	KCNK3, TASK, PPH4	603220	2p23.3	KCNK3
Pulmonary hypertension, primary, 4, 615344 (3)	KCNK3, TASK, PPH4	603220	2p23.3	TASK
Pulmonary hypertension, primary, 4, 615344 (3)	KCNK3, TASK, PPH4	603220	2p23.3	PPH4
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	PPH1
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated, 178600 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	POVD1
Pulmonary venoocclusive disease 1, 265450 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	BMPR2
Pulmonary venoocclusive disease 1, 265450 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	PPH1
Pulmonary venoocclusive disease 1, 265450 (3)	BMPR2, PPH1, POVD1	600799	2q33.1-q33.2	POVD1
Pulmonary venoocclusive disease 2, 234810 (3)	EIF2AK4, GCN2, KIAA1338, PVOD2	609280	15q15.1	EIF2AK4
Pulmonary venoocclusive disease 2, 234810 (3)	EIF2AK4, GCN2, KIAA1338, PVOD2	609280	15q15.1	GCN2
Pulmonary venoocclusive disease 2, 234810 (3)	EIF2AK4, GCN2, KIAA1338, PVOD2	609280	15q15.1	KIAA1338
Pulmonary venoocclusive disease 2, 234810 (3)	EIF2AK4, GCN2, KIAA1338, PVOD2	609280	15q15.1	PVOD2
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GP3A
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GT
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT2
Purpura, posttransfusion (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT16
Pycnodysostosis, 265800 (3)	CTSK	601105	1q21.3	CTSK
Pyle disease, 265900 (3)	SFRP4, FRPHE, PYL	606570	7p14.1	SFRP4
Pyle disease, 265900 (3)	SFRP4, FRPHE, PYL	606570	7p14.1	FRPHE
Pyle disease, 265900 (3)	SFRP4, FRPHE, PYL	606570	7p14.1	PYL
Pyloric stenosis, infantile hypertrophic 1 (2)	IHPS1, IHPS	179010	12q	IHPS1
Pyloric stenosis, infantile hypertrophic 1 (2)	IHPS1, IHPS	179010	12q	IHPS
Pyloric stenosis, infantile hypertrophic, 2 (2)	IHPS2	610260	16p13-p12	IHPS2
Pyloric stenosis, infantile hypertrophic, 3 (2)	IHPS3	612017	11q14-q22	IHPS3
Pyloric stenosis, infantile hypertrophic, 4 (2)	IHPS4	300711	Xq23	IHPS4
Pyloric stenosis, infantile hypertrophic, 5 (2)	IHPS5	612525	16q24.3	IHPS5
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)	MYD88, MYD88D	602170	3p22.2	MYD88
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3)	MYD88, MYD88D	602170	3p22.2	MYD88D
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24.3	PSTPIP1
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24.3	PSTPIP
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24.3	CD2BP1
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3)	PSTPIP1, PSTPIP, CD2BP1, PAPAS	606347	15q24.3	PAPAS
Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)	PNPO	603287	17q21.32	PNPO
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	EL2
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPH3
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HS3
Pyropoikilocytosis, 266140 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HPP
Pyruvate carboxylase deficiency, 266150 (3)	PC	608786	11q13.2	PC
Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	PDHA1, PHE1A, PDHAD	300502	Xp22.12	PDHA1
Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	PDHA1, PHE1A, PDHAD	300502	Xp22.12	PHE1A
Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3)	PDHA1, PHE1A, PDHAD	300502	Xp22.12	PDHAD
Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	PDHB, PDHBD	179060	3p14.3	PDHB
Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)	PDHB, PDHBD	179060	3p14.3	PDHBD
Pyruvate dehydrogenase E2 deficiency, 245348 (3)	DLAT, PDCE2	608770	11q23.1	DLAT
Pyruvate dehydrogenase E2 deficiency, 245348 (3)	DLAT, PDCE2	608770	11q23.1	PDCE2
Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	PDP1, PPM2C, PDP1, PDPC	605993	8q22.1	PDP1
Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	PDP1, PPM2C, PDP1, PDPC	605993	8q22.1	PPM2C
Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	PDP1, PPM2C, PDP1, PDPC	605993	8q22.1	PDP1
Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)	PDP1, PPM2C, PDP1, PDPC	605993	8q22.1	PDPC
Pyruvate kinase deficiency, 266200 (3)	PKLR, PK1	609712	1q22	PKLR
Pyruvate kinase deficiency, 266200 (3)	PKLR, PK1	609712	1q22	PK1
Quebec platelet disorder, 601709 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	PLAU
Quebec platelet disorder, 601709 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	URK
Quebec platelet disorder, 601709 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	QPD
Quebec platelet disorder, 601709 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	BDPLT5
Question mark ears, isolated, 612798 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
Question mark ears, isolated, 612798 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	ARCND3
Question mark ears, isolated, 612798 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	QME
Question mark ears, isolated, 612798 (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	HDLCQ7
RAPADILINO syndrome, 266280 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
RAPADILINO syndrome, 266280 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RTS
RAPADILINO syndrome, 266280 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQ4
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
RAS-associated autoimmune leukoproliferative disorder, 614470 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
RIDDLE syndrome, 611943 (3)	RNF168	612688	3q29	RNF168
Rabson-Mendenhall syndrome, 262190 (3)	INSR, HHF5	147670	19p13.2	INSR
Rabson-Mendenhall syndrome, 262190 (3)	INSR, HHF5	147670	19p13.2	HHF5
Radial ray deficiency (2)	RRDX	300378	Xq24-q25	RRDX
Radiation sensitivity/chromosome instability syndrome, autosomal dominant (1)	RSCIS	605463	14q11.2	RSCIS
Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	HOXA11, HOX1I, RUSAT1	142958	7p15.2	HOXA11
Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	HOXA11, HOX1I, RUSAT1	142958	7p15.2	HOX1I
Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3)	HOXA11, HOX1I, RUSAT1	142958	7p15.2	RUSAT1
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	MECOM, EVI1, RUSAT2	165215	3q26.2	MECOM
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	MECOM, EVI1, RUSAT2	165215	3q26.2	EVI1
Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3)	MECOM, EVI1, RUSAT2	165215	3q26.2	RUSAT2
Raine syndrome, 259775 (3)	FAM20C, DMP4	611061	7p22.3	FAM20C
Raine syndrome, 259775 (3)	FAM20C, DMP4	611061	7p22.3	DMP4
Rajab syndrome (2)	RJBS	613658	2q36.2	RJBS
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Rapp-Hodgkin syndrome, 129400 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Recombination rate QTL 1, 612042 (3)	RNF212, ZHP3	612041	4p16.3	RNF212
Recombination rate QTL 1, 612042 (3)	RNF212, ZHP3	612041	4p16.3	ZHP3
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	SLIM1
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	XMPMA
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	KYOT
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1A
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1B
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1A
Reducing body myopathy, X-linked 1a, severe, infantile or early childhood onset, 300717 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1B
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	SLIM1
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	XMPMA
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	KYOT
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1A
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1B
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1A
Reducing body myopathy, X-linked 1b, with late childhood or adult onset, 300718 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1B
Refsum disease, 266500 (3)	PHYH, PAHX	602026	10p13	PHYH
Refsum disease, 266500 (3)	PHYH, PAHX	602026	10p13	PAHX
Renal carcinoma, chromophobe, somatic, 144700 (3)	FLCN, BHD	607273	17p11.2	FLCN
Renal carcinoma, chromophobe, somatic, 144700 (3)	FLCN, BHD	607273	17p11.2	BHD
Renal cell carcinoma, 144700 (1)	DIRC2, RCC4	602773	3q21.1	DIRC2
Renal cell carcinoma, 144700 (1)	DIRC2, RCC4	602773	3q21.1	RCC4
Renal cell carcinoma, 144700 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
Renal cell carcinoma, 144700 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
Renal cell carcinoma, 144700 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
Renal cell carcinoma, 144700 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
Renal cell carcinoma, 144700 (3)	RNF139, TRC8, RCA1	603046	8q24.13	RNF139
Renal cell carcinoma, 144700 (3)	RNF139, TRC8, RCA1	603046	8q24.13	TRC8
Renal cell carcinoma, 144700 (3)	RNF139, TRC8, RCA1	603046	8q24.13	RCA1
Renal cell carcinoma, clear cell, somatic, 144700 (3)	OGG1	601982	3p25.3	OGG1
Renal cell carcinoma, papillary, 1, 300854 (3)	TFE3, RCCX1	314310	Xp11.23	TFE3
Renal cell carcinoma, papillary, 1, 300854 (3)	TFE3, RCCX1	314310	Xp11.23	RCCX1
Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3)	MET, DFNB97, OSFD	164860	7q31.2	DFNB97
Renal cell carcinoma, papillary, 1, familial and somatic, 605074 (3)	MET, DFNB97, OSFD	164860	7q31.2	OSFD
Renal cell carcinoma, papillary, 605074 (3)	PRCC, RCCP1	179755	1q23.1	PRCC
Renal cell carcinoma, papillary, 605074 (3)	PRCC, RCCP1	179755	1q23.1	RCCP1
Renal cell carcinoma, somatic, 144700 (3)	VHL	608537	3p25.3	VHL
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	TCF2
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF2
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	MODY5
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	FJHN
Renal cysts and diabetes syndrome, 137920 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HPC11
Renal glucosuria, 233100 (3)	SLC5A2, SGLT2	182381	16p11.2	SLC5A2
Renal glucosuria, 233100 (3)	SLC5A2, SGLT2	182381	16p11.2	SGLT2
Renal hypodysplasia/aplasia 1, 191830 (3)	ITGA8, RHDA1	604063	10p13	ITGA8
Renal hypodysplasia/aplasia 1, 191830 (3)	ITGA8, RHDA1	604063	10p13	RHDA1
Renal tubular acidosis with deafness, 267300 (3)	ATP6B1, VPP3	192132	2p13.3	ATP6B1
Renal tubular acidosis with deafness, 267300 (3)	ATP6B1, VPP3	192132	2p13.3	VPP3
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
Renal tubular acidosis, distal, AD, 179800 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
Renal tubular acidosis, distal, AR, 611590 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	ATP6V0A4
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	ATP6N1B
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	VPP2
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	RTA1C
Renal tubular acidosis, distal, autosomal recessive, 602722 (3)	ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR	605239	7q34	RTADR
Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	SLC4A4, NBC1, KNBC	603345	4q13.3	SLC4A4
Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	SLC4A4, NBC1, KNBC	603345	4q13.3	NBC1
Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3)	SLC4A4, NBC1, KNBC	603345	4q13.3	KNBC
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
Renal tubular dysgenesis, 267430 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
Renal tubular dysgenesis, 267430 (3)	AGT, SERPINA8	106150	1q42.2	AGT
Renal tubular dysgenesis, 267430 (3)	AGT, SERPINA8	106150	1q42.2	SERPINA8
Renal tubular dysgenesis, 267430 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1
Renal tubular dysgenesis, 267430 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1A
Renal tubular dysgenesis, 267430 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AT2R1
Renal tubular dysgenesis, 267430 (3)	REN, HNFJ2	179820	1q32.1	REN
Renal tubular dysgenesis, 267430 (3)	REN, HNFJ2	179820	1q32.1	HNFJ2
Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPHP3
Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	NPH3
Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	RHPD1
Renal-hepatic-pancreatic dysplasia 1, 208540 (3)	NPHP3, NPH3, RHPD1, MKS7	608002	3q22.1	MKS7
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	PQBP1
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	NPW38
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	SHS
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	MRX55
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	MRXS3
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	RENS1
Renpenning syndrome, 309500 (3)	PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8	300463	Xp11.23	MRXS8
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMNA
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LMN1
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	EMD2
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	FPLD2
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	CMD1A
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	HGPS
Restrictive dermopathy, lethal, 275210 (3)	LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B	150330	1q22	LGMD1B
Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	ZMPSTE24
Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	FACE1
Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	STE24
Restrictive dermopathy, lethal, 275210 (3)	ZMPSTE24, FACE1, STE24, MADB	606480	1p34.2	MADB
Reticular dysgenesis, 267500 (3)	AK2	103020	1p35.1	AK2
Reticulate acropigmentation of Kitamura, 615537 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	ADAM10
Reticulate acropigmentation of Kitamura, 615537 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	MADM
Reticulate acropigmentation of Kitamura, 615537 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	RAK
Reticulate acropigmentation of Kitamura, 615537 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	AD18
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	IGFBP7, MAC25, RAMSVPS	602867	4q12	IGFBP7
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	IGFBP7, MAC25, RAMSVPS	602867	4q12	MAC25
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3)	IGFBP7, MAC25, RAMSVPS	602867	4q12	RAMSVPS
Retinal cone dystrophy 3, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	PDE6H
Retinal cone dystrophy 3, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	RCD3
Retinal cone dystrophy 3, 610024 (3)	PDE6H, RCD3, ACHM6	601190	12p12.3	ACHM6
Retinal cone dystrophy 3B, 610356 (3)	KCNV2, KV11.1, RCD3B	607604	9p24.2	KCNV2
Retinal cone dystrophy 3B, 610356 (3)	KCNV2, KV11.1, RCD3B	607604	9p24.2	KV11.1
Retinal cone dystrophy 3B, 610356 (3)	KCNV2, KV11.1, RCD3B	607604	9p24.2	RCD3B
Retinal cone dystrophy 4, 610478 (3)	CACNA2D4, RCD4	608171	12p13.33	CACNA2D4
Retinal cone dystrophy 4, 610478 (3)	CACNA2D4, RCD4	608171	12p13.33	RCD4
Retinal degeneration, autosomal recessive, clumped pigment type (3)	NRL, D14S46E, RP27	162080	14q11-q12	NRL
Retinal degeneration, autosomal recessive, clumped pigment type (3)	NRL, D14S46E, RP27	162080	14q11-q12	D14S46E
Retinal degeneration, autosomal recessive, clumped pigment type (3)	NRL, D14S46E, RP27	162080	14q11-q12	RP27
Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	C1QTNF5, CTRP5, LORD	608752	11q23.3	C1QTNF5
Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	C1QTNF5, CTRP5, LORD	608752	11q23.3	CTRP5
Retinal degeneration, late-onset, autosomal dominant, 605670 (3)	C1QTNF5, CTRP5, LORD	608752	11q23.3	LORD
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
Retinal dystrophy, early-onset severe, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
Retinal dystrophy, early-onset severe, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Retinal dystrophy, early-onset severe, 613341 (3)	LRAT, LCA14	604863	4q32.1	LCA14
Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	OTX2
Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	MCOPS5
Retinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3)	OTX2, MCOPS5, CPHD6	600037	14q22.3	CPHD6
Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RBP4
Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	RDCCAS
Retinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3)	RBP4, RDCCAS, MCOPCB10	180250	10q23.33	MCOPCB10
Retinitis pigmentosa 1, 180100 (3)	RP1, ORP1	603937	8q11.2-q12.1	RP1
Retinitis pigmentosa 1, 180100 (3)	RP1, ORP1	603937	8q11.2-q12.1	ORP1
Retinitis pigmentosa 10, 180105 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	IMPDH1
Retinitis pigmentosa 10, 180105 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	RP10
Retinitis pigmentosa 10, 180105 (3)	IMPDH1, RP10, LCA11	146690	7q32.1	LCA11
Retinitis pigmentosa 11, 600138 (3)	PRPF31, PRP31, RP11	606419	19q13.42	PRPF31
Retinitis pigmentosa 11, 600138 (3)	PRPF31, PRP31, RP11	606419	19q13.42	PRP31
Retinitis pigmentosa 11, 600138 (3)	PRPF31, PRP31, RP11	606419	19q13.42	RP11
Retinitis pigmentosa 13, 600059 (3)	PRPF8, PRPC8, RP13	607300	17p13.3	PRPF8
Retinitis pigmentosa 13, 600059 (3)	PRPF8, PRPC8, RP13	607300	17p13.3	PRPC8
Retinitis pigmentosa 13, 600059 (3)	PRPF8, PRPC8, RP13	607300	17p13.3	RP13
Retinitis pigmentosa 14, 600132 (3)	TULP1, RP14, LCA15	602280	6p21.31	TULP1
Retinitis pigmentosa 14, 600132 (3)	TULP1, RP14, LCA15	602280	6p21.31	RP14
Retinitis pigmentosa 14, 600132 (3)	TULP1, RP14, LCA15	602280	6p21.31	LCA15
Retinitis pigmentosa 17, 600852 (3)	CA4, RP17	114760	17q23.1	CA4
Retinitis pigmentosa 17, 600852 (3)	CA4, RP17	114760	17q23.1	RP17
Retinitis pigmentosa 18, 601414 (3)	PRPF3, HPRP3, RP18	607301	1q21.2	PRPF3
Retinitis pigmentosa 18, 601414 (3)	PRPF3, HPRP3, RP18	607301	1q21.2	HPRP3
Retinitis pigmentosa 18, 601414 (3)	PRPF3, HPRP3, RP18	607301	1q21.2	RP18
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
Retinitis pigmentosa 19, 601718 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
Retinitis pigmentosa 2, 312600 (3)	RP2	300757	Xp11.3	RP2
Retinitis pigmentosa 20, 613794 (3)	RPE65, RP20, LCA2	180069	1p31.3	RPE65
Retinitis pigmentosa 20, 613794 (3)	RPE65, RP20, LCA2	180069	1p31.3	RP20
Retinitis pigmentosa 20, 613794 (3)	RPE65, RP20, LCA2	180069	1p31.3	LCA2
Retinitis pigmentosa 22 (2)	RP22	602594	16p12.3-p12.1	RP22
Retinitis pigmentosa 24 (2)	RP24	300155	Xq26-q27	RP24
Retinitis pigmentosa 25, 602772 (3)	EYS, RP25	612424	6q12	EYS
Retinitis pigmentosa 25, 602772 (3)	EYS, RP25	612424	6q12	RP25
Retinitis pigmentosa 26, 608380 (3)	CERKL, RP26	608381	2q31.3	CERKL
Retinitis pigmentosa 26, 608380 (3)	CERKL, RP26	608381	2q31.3	RP26
Retinitis pigmentosa 27, 613750 (3)	NRL, D14S46E, RP27	162080	14q11-q12	NRL
Retinitis pigmentosa 27, 613750 (3)	NRL, D14S46E, RP27	162080	14q11-q12	D14S46E
Retinitis pigmentosa 27, 613750 (3)	NRL, D14S46E, RP27	162080	14q11-q12	RP27
Retinitis pigmentosa 28, 606068 (3)	FAM161A, RP28	613596	2p15	FAM161A
Retinitis pigmentosa 28, 606068 (3)	FAM161A, RP28	613596	2p15	RP28
Retinitis pigmentosa 29 (2)	RP29	612165	4q32-q34	RP29
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP3
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CRD
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP15
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	COD1
Retinitis pigmentosa 3, 300029 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CORDX1
Retinitis pigmentosa 30, 607921 (3)	FSCN2, RFSN, RP30	607643	17q25.3	FSCN2
Retinitis pigmentosa 30, 607921 (3)	FSCN2, RFSN, RP30	607643	17q25.3	RFSN
Retinitis pigmentosa 30, 607921 (3)	FSCN2, RFSN, RP30	607643	17q25.3	RP30
Retinitis pigmentosa 31, 609923 (3)	TOPORS, P53BP3, LUN, RP31	609507	9p21.1	TOPORS
Retinitis pigmentosa 31, 609923 (3)	TOPORS, P53BP3, LUN, RP31	609507	9p21.1	P53BP3
Retinitis pigmentosa 31, 609923 (3)	TOPORS, P53BP3, LUN, RP31	609507	9p21.1	LUN
Retinitis pigmentosa 31, 609923 (3)	TOPORS, P53BP3, LUN, RP31	609507	9p21.1	RP31
Retinitis pigmentosa 32 (2)	RP32	609913	1p21.3-p13.3	RP32
Retinitis pigmentosa 33, 610359 (3)	SNRNP200, ASCC3L1, KIAA0788, RP33	601664	2q11.2	SNRNP200
Retinitis pigmentosa 33, 610359 (3)	SNRNP200, ASCC3L1, KIAA0788, RP33	601664	2q11.2	ASCC3L1
Retinitis pigmentosa 33, 610359 (3)	SNRNP200, ASCC3L1, KIAA0788, RP33	601664	2q11.2	KIAA0788
Retinitis pigmentosa 33, 610359 (3)	SNRNP200, ASCC3L1, KIAA0788, RP33	601664	2q11.2	RP33
Retinitis pigmentosa 34 (2)	RP34	300605	Xq28	RP34
Retinitis pigmentosa 35, 610282 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMA4A
Retinitis pigmentosa 35, 610282 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	SEMB
Retinitis pigmentosa 35, 610282 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	RP35
Retinitis pigmentosa 35, 610282 (3)	SEMA4A, SEMB, RP35, CORD10	607292	1q22	CORD10
Retinitis pigmentosa 36, 610599 (3)	PRCD, RP36	610598	17q25.1	PRCD
Retinitis pigmentosa 36, 610599 (3)	PRCD, RP36	610598	17q25.1	RP36
Retinitis pigmentosa 37, 611131 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	NR2E3
Retinitis pigmentosa 37, 611131 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	PNR
Retinitis pigmentosa 37, 611131 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	ESCS
Retinitis pigmentosa 37, 611131 (3)	NR2E3, PNR, ESCS, RP37	604485	15q23	RP37
Retinitis pigmentosa 38, 613862 (3)	MERTK, RP38	604705	2q13	MERTK
Retinitis pigmentosa 38, 613862 (3)	MERTK, RP38	604705	2q13	RP38
Retinitis pigmentosa 39, 613809 (3)	USH2A, RP39	608400	1q41	USH2A
Retinitis pigmentosa 39, 613809 (3)	USH2A, RP39	608400	1q41	RP39
Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RP4
Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	OPN2
Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	CSNBAD1
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROML1
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	AC133
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	RP41
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CORD12
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CD133
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	MCDR2
Retinitis pigmentosa 41, 612095 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	STGD4
Retinitis pigmentosa 42, 612943 (3)	KLHL7, RP42, CISS3	611119	7p15.3	KLHL7
Retinitis pigmentosa 42, 612943 (3)	KLHL7, RP42, CISS3	611119	7p15.3	RP42
Retinitis pigmentosa 42, 612943 (3)	KLHL7, RP42, CISS3	611119	7p15.3	CISS3
Retinitis pigmentosa 43, 613810 (3)	PDE6A, PDEA, RP43	180071	5q32	PDE6A
Retinitis pigmentosa 43, 613810 (3)	PDE6A, PDEA, RP43	180071	5q32	PDEA
Retinitis pigmentosa 43, 613810 (3)	PDE6A, PDEA, RP43	180071	5q32	RP43
Retinitis pigmentosa 44, 613769 (3)	RGR, RP44	600342	10q23.1	RGR
Retinitis pigmentosa 44, 613769 (3)	RGR, RP44	600342	10q23.1	RP44
Retinitis pigmentosa 45, 613767 (3)	CNGB1, CNCG3L, CNCG2, RP45	600724	16q21	CNGB1
Retinitis pigmentosa 45, 613767 (3)	CNGB1, CNCG3L, CNCG2, RP45	600724	16q21	CNCG3L
Retinitis pigmentosa 45, 613767 (3)	CNGB1, CNCG3L, CNCG2, RP45	600724	16q21	CNCG2
Retinitis pigmentosa 45, 613767 (3)	CNGB1, CNCG3L, CNCG2, RP45	600724	16q21	RP45
Retinitis pigmentosa 46, 612572 (3)	IDH3B, RP46	604526	20p13	IDH3B
Retinitis pigmentosa 46, 612572 (3)	IDH3B, RP46	604526	20p13	RP46
Retinitis pigmentosa 47, 613758 (3)	SAG, RP47	181031	2q37.1	SAG
Retinitis pigmentosa 47, 613758 (3)	SAG, RP47	181031	2q37.1	RP47
Retinitis pigmentosa 48, 613827 (3)	GUCA1B, GCAP2, GUCA2, RP48	602275	6p21.1	GUCA1B
Retinitis pigmentosa 48, 613827 (3)	GUCA1B, GCAP2, GUCA2, RP48	602275	6p21.1	GCAP2
Retinitis pigmentosa 48, 613827 (3)	GUCA1B, GCAP2, GUCA2, RP48	602275	6p21.1	GUCA2
Retinitis pigmentosa 48, 613827 (3)	GUCA1B, GCAP2, GUCA2, RP48	602275	6p21.1	RP48
Retinitis pigmentosa 49, 613756 (3)	CNGA1, CNCG1, RP49	123825	4p12	CNGA1
Retinitis pigmentosa 49, 613756 (3)	CNGA1, CNCG1, RP49	123825	4p12	CNCG1
Retinitis pigmentosa 49, 613756 (3)	CNGA1, CNCG1, RP49	123825	4p12	RP49
Retinitis pigmentosa 54, 613428 (3)	C2orf71	613425	2p23.2	C2orf71
Retinitis pigmentosa 56, 613581 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IMPG2
Retinitis pigmentosa 56, 613581 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	IPM200
Retinitis pigmentosa 56, 613581 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	RP56
Retinitis pigmentosa 56, 613581 (3)	IMPG2, IPM200, RP56, VMD5	607056	3q12.3	VMD5
Retinitis pigmentosa 57, 613582 (3)	PDE6G, PDEG, RP57	180073	17q25.3	PDE6G
Retinitis pigmentosa 57, 613582 (3)	PDE6G, PDEG, RP57	180073	17q25.3	PDEG
Retinitis pigmentosa 57, 613582 (3)	PDE6G, PDEG, RP57	180073	17q25.3	RP57
Retinitis pigmentosa 58, 613617 (3)	ZNF513, RP58	613598	2p23.3	ZNF513
Retinitis pigmentosa 58, 613617 (3)	ZNF513, RP58	613598	2p23.3	RP58
Retinitis pigmentosa 59, 613861 (3)	DHDDS, HDS, RP59	608172	1p36.11	DHDDS
Retinitis pigmentosa 59, 613861 (3)	DHDDS, HDS, RP59	608172	1p36.11	HDS
Retinitis pigmentosa 59, 613861 (3)	DHDDS, HDS, RP59	608172	1p36.11	RP59
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	PRPF6
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	PRP6
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	ANT1
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	TOM
Retinitis pigmentosa 60, 613983 (3)	PRPF6, PRP6, ANT1, TOM, C20orf14	613979	20q13.33	C20orf14
Retinitis pigmentosa 61, 614180 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	CLRN1
Retinitis pigmentosa 61, 614180 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	USH3A
Retinitis pigmentosa 61, 614180 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	USH3
Retinitis pigmentosa 61, 614180 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	RP61
Retinitis pigmentosa 62, 614181 (3)	MAK, RP62	154235	6p24.2	MAK
Retinitis pigmentosa 62, 614181 (3)	MAK, RP62	154235	6p24.2	RP62
Retinitis pigmentosa 63 (2)	RP63	614494	6q23	RP63
Retinitis pigmentosa 64, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	C8orf37
Retinitis pigmentosa 64, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	CORD16
Retinitis pigmentosa 64, 614500 (3)	C8orf37, CORD16, RP64	614477	8q22.1	RP64
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CDHR1
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	PCDH21
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	PRCAD
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	CORD15
Retinitis pigmentosa 65, 613660 (3)	CDHR1, PCDH21, PRCAD, CORD15, RP65	609502	10q23.1	RP65
Retinitis pigmentosa 68, 615725 (3)	SLC7A14, KIAA1613, RP68	615720	3q26.2	SLC7A14
Retinitis pigmentosa 68, 615725 (3)	SLC7A14, KIAA1613, RP68	615720	3q26.2	KIAA1613
Retinitis pigmentosa 68, 615725 (3)	SLC7A14, KIAA1613, RP68	615720	3q26.2	RP68
Retinitis pigmentosa 69, 615780 (3)	KIZ, KIZUNA, C20orf19, RP69	615757	20p11.23	KIZ
Retinitis pigmentosa 69, 615780 (3)	KIZ, KIZUNA, C20orf19, RP69	615757	20p11.23	KIZUNA
Retinitis pigmentosa 69, 615780 (3)	KIZ, KIZUNA, C20orf19, RP69	615757	20p11.23	C20orf19
Retinitis pigmentosa 69, 615780 (3)	KIZ, KIZUNA, C20orf19, RP69	615757	20p11.23	RP69
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Retinitis pigmentosa 7 and digenic, 608133 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Retinitis pigmentosa 7, digenic, 608133 (3)	ROM1, ROSP1, RP7	180721	11q12.3	ROM1
Retinitis pigmentosa 7, digenic, 608133 (3)	ROM1, ROSP1, RP7	180721	11q12.3	ROSP1
Retinitis pigmentosa 7, digenic, 608133 (3)	ROM1, ROSP1, RP7	180721	11q12.3	RP7
Retinitis pigmentosa 70, 615922 (3)	PRPF4, PRP4, HPRP4, RP70	607795	9q32	PRPF4
Retinitis pigmentosa 70, 615922 (3)	PRPF4, PRP4, HPRP4, RP70	607795	9q32	PRP4
Retinitis pigmentosa 70, 615922 (3)	PRPF4, PRP4, HPRP4, RP70	607795	9q32	HPRP4
Retinitis pigmentosa 70, 615922 (3)	PRPF4, PRP4, HPRP4, RP70	607795	9q32	RP70
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	IFT172
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	SLB
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	KIAA1179
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	SRTD10
Retinitis pigmentosa 71, 616394 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	RP71
Retinitis pigmentosa 72, 616469 (3)	ZNF408, EVR6, RP72	616454	11p11.2	ZNF408
Retinitis pigmentosa 72, 616469 (3)	ZNF408, EVR6, RP72	616454	11p11.2	EVR6
Retinitis pigmentosa 72, 616469 (3)	ZNF408, EVR6, RP72	616454	11p11.2	RP72
Retinitis pigmentosa 73, 616544 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	HGSNAT
Retinitis pigmentosa 73, 616544 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	TMEM76
Retinitis pigmentosa 73, 616544 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	MPS3C
Retinitis pigmentosa 73, 616544 (3)	HGSNAT, TMEM76, MPS3C, RP73	610453	8p11.2-p11.1	RP73
Retinitis pigmentosa 74, 616562 (3)	BBS2, RP74	606151	16q13	BBS2
Retinitis pigmentosa 74, 616562 (3)	BBS2, RP74	606151	16q13	RP74
Retinitis pigmentosa 75, 617023 (3)	AGBL5, CCP5, RP75	615900	2p23.3	AGBL5
Retinitis pigmentosa 75, 617023 (3)	AGBL5, CCP5, RP75	615900	2p23.3	CCP5
Retinitis pigmentosa 75, 617023 (3)	AGBL5, CCP5, RP75	615900	2p23.3	RP75
Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	TRNT1
Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	SIFD
Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	RPEM
Retinitis pigmentosa with or without situs inversus, 615434 (3)	ARL2BP, BART	615407	16q13	ARL2BP
Retinitis pigmentosa with or without situs inversus, 615434 (3)	ARL2BP, BART	615407	16q13	BART
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RPGR
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP3
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CRD
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	RP15
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	COD1
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3)	RPGR, RP3, CRD, RP15, COD1, CORDX1	312610	Xp11.4	CORDX1
Retinitis pigmentosa, Y-linked (2)	RPY	400004	Chr.Y	RPY
Retinitis pigmentosa, concentric, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Retinitis pigmentosa, concentric, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Retinitis pigmentosa, concentric, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Retinitis pigmentosa, concentric, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Retinitis pigmentosa, juvenile, 604393 (3)	AIPL1, LCA4	604392	17p13.2	AIPL1
Retinitis pigmentosa, juvenile, 604393 (3)	AIPL1, LCA4	604392	17p13.2	LCA4
Retinitis pigmentosa, juvenile, 613341 (3)	LRAT, LCA14	604863	4q32.1	LRAT
Retinitis pigmentosa, juvenile, 613341 (3)	LRAT, LCA14	604863	4q32.1	LCA14
Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	SPATA7
Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	HSD3
Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3)	SPATA7, HSD3, LCA3	609868	14q31.3	LCA3
Retinitis pigmentosa-12, autosomal recessive, 600105 (3)	CRB1, RP12, LCA8	604210	1q31.3	CRB1
Retinitis pigmentosa-12, autosomal recessive, 600105 (3)	CRB1, RP12, LCA8	604210	1q31.3	RP12
Retinitis pigmentosa-12, autosomal recessive, 600105 (3)	CRB1, RP12, LCA8	604210	1q31.3	LCA8
Retinitis pigmentosa-40, 613801 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDE6B
Retinitis pigmentosa-40, 613801 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	PDEB
Retinitis pigmentosa-40, 613801 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	RP40
Retinitis pigmentosa-40, 613801 (3)	PDE6B, PDEB, RP40, CSNBAD2	180072	4p16.3	CSNBAD2
Retinitis pigmentosa-50, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Retinitis pigmentosa-50, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Retinitis pigmentosa-50, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Retinitis pigmentosa-50, 613194 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH2
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	DS
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	RP7
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	PRPH
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AVMD
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	AOFMD
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	CACD2
Retinitis punctata albescens, 136880 (3)	PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1	179605	6p21.1	MDBS1
Retinitis punctata albescens, 136880 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RHO
Retinitis punctata albescens, 136880 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	RP4
Retinitis punctata albescens, 136880 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	OPN2
Retinitis punctata albescens, 136880 (3)	RHO, RP4, OPN2, CSNBAD1	180380	3q22.1	CSNBAD1
Retinitis punctata albescens, 136880 (3)	RLBP1	180090	15q26.1	RLBP1
Retinoblastoma, 180200 (3)	RB1	614041	13q14.2	RB1
Retinoblastoma, trilateral, 180200 (3)	RB1	614041	13q14.2	RB1
Retinopathy of prematurity, 133780 (3)	FZD4, EVR1	604579	11q14.2	FZD4
Retinopathy of prematurity, 133780 (3)	FZD4, EVR1	604579	11q14.2	EVR1
Retinoschisis, 312700 (3)	RS1, XLRS1	300839	Xp22.13	RS1
Retinoschisis, 312700 (3)	RS1, XLRS1	300839	Xp22.13	XLRS1
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, atypical, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	FOXG1
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	FOXG1B
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	FKHL1
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	FKH2
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	QIN
Rett syndrome, congenital variant, 613454 (3)	FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1	164874	14q12	BF1
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
Rett syndrome, preserved speech variant, 312750 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
Revesz syndrome, 268130 (3)	TINF2, TIN2, DKCA3	604319	14q12	TINF2
Revesz syndrome, 268130 (3)	TINF2, TIN2, DKCA3	604319	14q12	TIN2
Revesz syndrome, 268130 (3)	TINF2, TIN2, DKCA3	604319	14q12	DKCA3
Rh-mod syndrome (3)	RHAG, RH50A, OHST	180297	6p12.3	RHAG
Rh-mod syndrome (3)	RHAG, RH50A, OHST	180297	6p12.3	RH50A
Rh-mod syndrome (3)	RHAG, RH50A, OHST	180297	6p12.3	OHST
Rh-null disease, amorph type (3)	RHCE	111700	1p36.11	RHCE
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SNF5
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	INI1
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RDT
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RTPS1
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	MRD15
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SWNTS1
Rhabdoid tumors, somatic, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	CSS3
Rhabdomyolysis, cerivastatin-induced (3)	CYP2C8	601129	10q23.33	CYP2C8
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS1
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	HUP2
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	CDHS
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS3
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX7, RMS2	167410	1p36.13	PAX7
Rhabdomyosarcoma 2, alveolar, 268220 (3)	PAX7, RMS2	167410	1p36.13	RMS2
Rhabdomyosarcoma, alveolar, 268220 (3)	FOXO1A, FKHR	136533	13q14.11	FOXO1A
Rhabdomyosarcoma, alveolar, 268220 (3)	FOXO1A, FKHR	136533	13q14.11	FKHR
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	DICER1
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	HERNA
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	KIAA0928
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	MNG1
Rhabdomyosarcoma, embryonal, 2, 180295 (3)	DICER1, HERNA, KIAA0928, MNG1, RMSE2	606241	14q32.13	RMSE2
Rhabdomyosarcoma, somatic, 268210 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	SLC22A1L
Rhabdomyosarcoma, somatic, 268210 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	BWSCR1A
Rhabdomyosarcoma, somatic, 268210 (3)	SLC22A1L, BWSCR1A, IMPT1	602631	11p15.4	IMPT1
Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PEX7
Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	RCDP1
Rhizomelic chondrodysplasia punctata, type 1, 215100 (3)	PEX7, RCDP1, PBD9B	601757	6q23.3	PBD9B
Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	GNPAT, DHAPAT, RCDP2	602744	1q42.2	GNPAT
Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	GNPAT, DHAPAT, RCDP2	602744	1q42.2	DHAPAT
Rhizomelic chondrodysplasia punctata, type 2, 222765 (3)	GNPAT, DHAPAT, RCDP2	602744	1q42.2	RCDP2
Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	AGPS, ADHAPS, RCDP3	603051	2q31.2	AGPS
Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	AGPS, ADHAPS, RCDP3	603051	2q31.2	ADHAPS
Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)	AGPS, ADHAPS, RCDP3	603051	2q31.2	RCDP3
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PEX5
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PXR1
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PTS1R
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2A
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	PBD2B
Rhizomelic chondrodysplasia punctata, type 5, 616716 (3)	PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5	600414	12p13.31	RCDP5
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	SLC52A1
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	GPR172B
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	GPCR42
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	PAR2
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	FLJ10060
Riboflavin deficiency, 615026 (3)	SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD	607883	17p13.2	RBFVD
Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)	CYP2R1	608713	11p15.2	CYP2R1
Rickets, vitamin D-resistant, type IIA, 277440 (3)	VDR	601769	12q13.11	VDR
Rieger or Axenfeld anomalies, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FOXC1
Rieger or Axenfeld anomalies, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FKHL7
Rieger or Axenfeld anomalies, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	FREAC3
Rieger or Axenfeld anomalies, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	IRID1
Rieger or Axenfeld anomalies, 602482 (3)	FOXC1, FKHL7, FREAC3, IRID1, RIEG3	601090	6p25.3	RIEG3
Rieger syndrome, type 2 (2)	RIEG2, RGS2	601499	13q14	RIEG2
Rieger syndrome, type 2 (2)	RIEG2, RGS2	601499	13q14	RGS2
Right atrial isomerism, 208530 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Right atrial isomerism, 208530 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DTGA3
Right atrial isomerism, 208530 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DORV
Right atrial isomerism, 208530 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	RAI
Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	BRAT1, BAAT1, C7orf27, RMFSL	614506	7p22.3	BRAT1
Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	BRAT1, BAAT1, C7orf27, RMFSL	614506	7p22.3	BAAT1
Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	BRAT1, BAAT1, C7orf27, RMFSL	614506	7p22.3	C7orf27
Rigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3)	BRAT1, BAAT1, C7orf27, RMFSL	614506	7p22.3	RMFSL
Ring chromosome 14 syndrome (4)	RC14S	616606	Chr.14	RC14S
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	PITX2
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IDG2
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RIEG1
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	RGS
Ring dermoid of cornea, 180550 (3)	PITX2, IDG2, RIEG1, RGS, IGDS2	601542	4q25	IGDS2
Rippling muscle disease, 606072 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	CAV3
Rippling muscle disease, 606072 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LGMD1C
Rippling muscle disease, 606072 (3)	CAV3, LGMD1C, LQT9	601253	3p25.3	LQT9
Rippling muscle disease-1 (2)	RMD1	600332	1q41	RMD1
Ritscher-Schinzel syndrome 1, 220210 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	KIAA0196
Ritscher-Schinzel syndrome 1, 220210 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	SPG8
Ritscher-Schinzel syndrome 1, 220210 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	RTSC1
Ritscher-Schinzel syndrome 2, 300963 (3)	CCDC22, RTSC2	300859	Xp11.23	CCDC22
Ritscher-Schinzel syndrome 2, 300963 (3)	CCDC22, RTSC2	300859	Xp11.23	RTSC2
Roberts syndrome, 268300 (3)	ESCO2	609353	8p21.1	ESCO2
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	DDX48
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	EIF4A3
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	MUK34
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	NMP265
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	KIAA0111
Robin sequence with cleft mandible and limb anomalies, 268305 (3)	DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS	608546	17q25.3	RCPS
Robinow syndrome, autosomal dominant 1, 180700 (3)	WNT5A	164975	3p14.3	WNT5A
Robinow syndrome, autosomal dominant 2, 616331 (3)	DVL1, DRS2	601365	1p36.33	DVL1
Robinow syndrome, autosomal dominant 2, 616331 (3)	DVL1, DRS2	601365	1p36.33	DRS2
Robinow syndrome, autosomal dominant 3, 616894 (3)	DVL3, DRS3	601368	3q27.1	DVL3
Robinow syndrome, autosomal dominant 3, 616894 (3)	DVL3, DRS3	601368	3q27.1	DRS3
Robinow syndrome, autosomal recessive, 268310 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	ROR2
Robinow syndrome, autosomal recessive, 268310 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	BDB1
Robinow syndrome, autosomal recessive, 268310 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	BDB
Robinow syndrome, autosomal recessive, 268310 (3)	ROR2, BDB1, BDB, NTRKR2	602337	9q22.31	NTRKR2
Robinow-Sorauf syndrome, 180750 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	TWIST1
Robinow-Sorauf syndrome, 180750 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	ACS3
Robinow-Sorauf syndrome, 180750 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	SCS
Robinow-Sorauf syndrome, 180750 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	CRS1
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RNU4ATAC
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	U4ATAC
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	MOPD1
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	TALS
Roifman syndrome, 616651 (3)	RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN	601428	2q14.2	RFMN
Rothmund-Thomson syndrome, 268400 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQL4
Rothmund-Thomson syndrome, 268400 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RTS
Rothmund-Thomson syndrome, 268400 (3)	RECQL4, RTS, RECQ4	603780	8q24.3	RECQ4
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	MPZ
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMT1B
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CMTDID
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	CHM
Roussy-Levy syndrome, 180800 (3)	MPZ, CMT1B, CMTDID, CHM, DSS	159440	1q23.3	DSS
Roussy-Levy syndrome, 180800 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	PMP22
Roussy-Levy syndrome, 180800 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1A
Roussy-Levy syndrome, 180800 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	CMT1E
Roussy-Levy syndrome, 180800 (3)	PMP22, CMT1A, CMT1E, DSS	601097	17p12	DSS
Rubinstein-Taybi syndrome 2, 613684 (3)	EP300, RSTS2	602700	22q13.2	EP300
Rubinstein-Taybi syndrome 2, 613684 (3)	EP300, RSTS2	602700	22q13.2	RSTS2
Rubinstein-Taybi syndrome, 180849 (3)	CREBBP, CBP, RSTS	600140	16p13.3	CREBBP
Rubinstein-Taybi syndrome, 180849 (3)	CREBBP, CBP, RSTS	600140	16p13.3	CBP
Rubinstein-Taybi syndrome, 180849 (3)	CREBBP, CBP, RSTS	600140	16p13.3	RSTS
Ruijs-Aalfs syndrome, 616200 (3)	SPRTN, DVC1, C1orf124, RJALS	616086	1q42.2	SPRTN
Ruijs-Aalfs syndrome, 616200 (3)	SPRTN, DVC1, C1orf124, RJALS	616086	1q42.2	DVC1
Ruijs-Aalfs syndrome, 616200 (3)	SPRTN, DVC1, C1orf124, RJALS	616086	1q42.2	C1orf124
Ruijs-Aalfs syndrome, 616200 (3)	SPRTN, DVC1, C1orf124, RJALS	616086	1q42.2	RJALS
SADDAN, 616482 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
SADDAN, 616482 (3)	FGFR3, ACH	134934	4p16.3	ACH
SARS infection, protection against (2)	CLEC4M, CD209L, LSIGN, DCSIGNR	605872	19p13.2	CLEC4M
SARS infection, protection against (2)	CLEC4M, CD209L, LSIGN, DCSIGNR	605872	19p13.2	CD209L
SARS infection, protection against (2)	CLEC4M, CD209L, LSIGN, DCSIGNR	605872	19p13.2	LSIGN
SARS infection, protection against (2)	CLEC4M, CD209L, LSIGN, DCSIGNR	605872	19p13.2	DCSIGNR
SBBYSS syndrome, 603736 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	KAT6B
SBBYSS syndrome, 603736 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	MYST4
SBBYSS syndrome, 603736 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	MORF
SBBYSS syndrome, 603736 (3)	KAT6B, MYST4, MORF, GTPTS	605880	10q22.2	GTPTS
SC phocomelia syndrome, 269000 (3)	ESCO2	609353	8p21.1	ESCO2
SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	JAK3, JAKL	600173	19p13.11	JAK3
SCID, autosomal recessive, T-negative/B-positive type, 600802 (3)	JAK3, JAKL	600173	19p13.11	JAKL
SED congenita, 183900 (3)	COL2A1	120140	12q13.11	COL2A1
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
SED, Maroteaux type, 184095 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
SERKAL syndrome, 611812 (3)	WNT4, SERKAL	603490	1p36.12	WNT4
SERKAL syndrome, 611812 (3)	WNT4, SERKAL	603490	1p36.12	SERKAL
SESAME syndrome, 612780 (3)	KCNJ10, SESAME	602208	1q23.2	KCNJ10
SESAME syndrome, 612780 (3)	KCNJ10, SESAME	602208	1q23.2	SESAME
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	PIK3R1
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	GRB1
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	AGM7
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	SHORT
SHORT syndrome, 269880 (3)	PIK3R1, GRB1, AGM7, SHORT, IMD36	171833	5q13.1	IMD36
SMED Strudwick type, 184250 (3)	COL2A1	120140	12q13.11	COL2A1
STAR syndrome, 300707 (3)	FAM58A, STAR	300708	Xq28	FAM58A
STAR syndrome, 300707 (3)	FAM58A, STAR	300708	Xq28	STAR
STING-associated vasculopathy, infantile-onset, 615934 (3)	TMEM173, STING, MPYS, SAVI	612374	5q31.2	TMEM173
STING-associated vasculopathy, infantile-onset, 615934 (3)	TMEM173, STING, MPYS, SAVI	612374	5q31.2	STING
STING-associated vasculopathy, infantile-onset, 615934 (3)	TMEM173, STING, MPYS, SAVI	612374	5q31.2	MPYS
STING-associated vasculopathy, infantile-onset, 615934 (3)	TMEM173, STING, MPYS, SAVI	612374	5q31.2	SAVI
Saccharopinuria, 268700 (1)	AASS	605113	7q31.32	AASS
Sacral agenesis with vertebral anomalies, 615709 (3)	T, TFT, SAVA	601397	6q27	T
Sacral agenesis with vertebral anomalies, 615709 (3)	T, TFT, SAVA	601397	6q27	TFT
Sacral agenesis with vertebral anomalies, 615709 (3)	T, TFT, SAVA	601397	6q27	SAVA
Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	TWIST1
Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	ACS3
Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	SCS
Saethre-Chotzen syndrome with eyelid anomalies, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	CRS1
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Saethre-Chotzen syndrome, 101400 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Saethre-Chotzen syndrome, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	TWIST1
Saethre-Chotzen syndrome, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	ACS3
Saethre-Chotzen syndrome, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	SCS
Saethre-Chotzen syndrome, 101400 (3)	TWIST1, ACS3, SCS, CRS1	601622	7p21.1	CRS1
Salla disease, 604369 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLC17A5
Salla disease, 604369 (3)	SLC17A5, SIASD, SLD	604322	6q13	SIASD
Salla disease, 604369 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLD
Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)	HEXB	606873	5q13.3	HEXB
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	NOD2
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CARD15
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	IBD1
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CD
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	ACUG
Sarcoidosis, early-onset, 609464 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	PSORAS1
Sarcoma, synovial (1)	SS18, SSXT, SYT	600192	18q11.2	SS18
Sarcoma, synovial (1)	SS18, SSXT, SYT	600192	18q11.2	SSXT
Sarcoma, synovial (1)	SS18, SSXT, SYT	600192	18q11.2	SYT
Scalp-ear-nipple syndrome, 181270 (3)	KCTD1, SENS	613420	18q11.2	KCTD1
Scalp-ear-nipple syndrome, 181270 (3)	KCTD1, SENS	613420	18q11.2	SENS
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Scaphocephaly and Axenfeld-Rieger anomaly (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	FGFR2
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BEK
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	CFD1
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	JWS
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	TK14
Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3)	FGFR2, BEK, CFD1, JWS, TK14, BBDS	176943	10q26.13	BBDS
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	SLIM1
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	XMPMA
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	KYOT
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1A
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	FHL1B
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1A
Scapuloperoneal myopathy, X-linked dominant, 300695 (3)	FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B	300163	Xq26.3	RBMX1B
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Scapuloperoneal spinal muscular atrophy, 181405 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MYH7
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMH1
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	MPD1
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	CMD1S
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMM
Scapuloperoneal syndrome, myopathic type, 181430 (3)	MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD	160760	14q11.2	SPMD
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	DES
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	CMD1I
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	MFM1
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	SCPNK
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVD7
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	ARVC7
Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3)	DES, CMD1I, MFM1, SCPNK, ARVD7, ARVC7, LGMD2R	125660	2q35	LGMD2R
Schaaf-Yang syndrome, 615547 (3)	MAGEL2, NDNL1, SHFYNG	605283	15q11.2	MAGEL2
Schaaf-Yang syndrome, 615547 (3)	MAGEL2, NDNL1, SHFYNG	605283	15q11.2	NDNL1
Schaaf-Yang syndrome, 615547 (3)	MAGEL2, NDNL1, SHFYNG	605283	15q11.2	SHFYNG
Schimke immunoosseous dysplasia, 242900 (3)	SMARCAL1, HARP, SIOD	606622	2q35	SMARCAL1
Schimke immunoosseous dysplasia, 242900 (3)	SMARCAL1, HARP, SIOD	606622	2q35	HARP
Schimke immunoosseous dysplasia, 242900 (3)	SMARCAL1, HARP, SIOD	606622	2q35	SIOD
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	HRAS	190020	11p15.5	HRAS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	KRAS2
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RASK2
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	NS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	CFC2
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	KRAS, KRAS2, RASK2, NS, CFC2, RALD	190070	12p12.1	RALD
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Schindler disease, type I, 609241 (3)	NAGA	104170	22q13.2	NAGA
Schindler disease, type III, 609241 (3)	NAGA	104170	22q13.2	NAGA
Schinzel-Giedion midface retraction syndrome, 269150 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SETBP1
Schinzel-Giedion midface retraction syndrome, 269150 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	KIAA0437
Schinzel-Giedion midface retraction syndrome, 269150 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	SEB
Schinzel-Giedion midface retraction syndrome, 269150 (3)	SETBP1, KIAA0437, SEB, MRD29	611060	18q12.3	MRD29
Schizencephaly, 269160 (3)	EMX2	600035	10q26.11	EMX2
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HPE3
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HLP3
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SMMCI
Schizencephaly, 269160 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	MCOPCB5
Schizencephaly, 269160 (3)	SIX3, HPE2	603714	2p21	SIX3
Schizencephaly, 269160 (3)	SIX3, HPE2	603714	2p21	HPE2
Schizophrenia 16 (4)	SCZD16, C16DUPq36.3, DUP7q36.3	613959	7q36.3	SCZD16
Schizophrenia 16 (4)	SCZD16, C16DUPq36.3, DUP7q36.3	613959	7q36.3	C16DUPq36.3
Schizophrenia 16 (4)	SCZD16, C16DUPq36.3, DUP7q36.3	613959	7q36.3	DUP7q36.3
Schizophrenia, 181500 (2)	DISC2	606271	1q42.2	DISC2
Schizophrenia, neurophysiologic defect in (2)	CHRNA7	118511	15q13.3	CHRNA7
Schneckenbecken dysplasia, 269250 (3)	SLC35D1, UGTREL7, KIAA0260	610804	1p31.3	SLC35D1
Schneckenbecken dysplasia, 269250 (3)	SLC35D1, UGTREL7, KIAA0260	610804	1p31.3	UGTREL7
Schneckenbecken dysplasia, 269250 (3)	SLC35D1, UGTREL7, KIAA0260	610804	1p31.3	KIAA0260
Schopf-Schulz-Passarge syndrome, 224750 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Schopf-Schulz-Passarge syndrome, 224750 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	SSPS
Schopf-Schulz-Passarge syndrome, 224750 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	STHAG4
Schopf-Schulz-Passarge syndrome, 224750 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	OODD
Schuss-Hoeijmakers sydnrome, 615009 (3)	PACS1, SHMS, MRD17	607492	11q13.1-q13.2	PACS1
Schuss-Hoeijmakers sydnrome, 615009 (3)	PACS1, SHMS, MRD17	607492	11q13.1-q13.2	SHMS
Schuss-Hoeijmakers sydnrome, 615009 (3)	PACS1, SHMS, MRD17	607492	11q13.1-q13.2	MRD17
Schwannomatosis, 162091 (3)	NF2	607379	22q12.2	NF2
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	HSPG2
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	PLC
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJS
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJA
Schwartz-Jampel syndrome, type 1, 255800 (3)	HSPG2, PLC, SJS, SJA, SJS1	142461	1p36.12	SJS1
Sclerosteosis 1, 269500 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Sclerosteosis 1, 269500 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	VBCH
Sclerosteosis 1, 269500 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	CDD
Sclerosteosis 1, 269500 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST1
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	LRP4
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	MEGF7
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CLSS
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	SOST2
Sclerosteosis 2, 614305 (3)	LRP4, MEGF7, CLSS, SOST2, CMS17	604270	11p11.2	CMS17
Scoliosis, idiopathic 1 (2)	IS1, AIS	181800	19p13.3	IS1
Scoliosis, idiopathic 1 (2)	IS1, AIS	181800	19p13.3	AIS
Scoliosis, idiopathic 2 (2)	IS2, AIS2	607354	17p11.2	IS2
Scoliosis, idiopathic 2 (2)	IS2, AIS2	607354	17p11.2	AIS2
Scott syndrome, 262890 (3)	ANO6, TMEM16F, SCTS, BDPLT7	608663	12q12	ANO6
Scott syndrome, 262890 (3)	ANO6, TMEM16F, SCTS, BDPLT7	608663	12q12	TMEM16F
Scott syndrome, 262890 (3)	ANO6, TMEM16F, SCTS, BDPLT7	608663	12q12	SCTS
Scott syndrome, 262890 (3)	ANO6, TMEM16F, SCTS, BDPLT7	608663	12q12	BDPLT7
Scurvy (3)	GULOP, GULO	240400	8p21.1	GULOP
Scurvy (3)	GULOP, GULO	240400	8p21.1	GULO
Sea-blue histiocyte disease, 269600 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
Sea-blue histiocyte disease, 269600 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
Sea-blue histiocyte disease, 269600 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
Sea-blue histiocyte disease, 269600 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
Sebaceous tumors, somatic (3)	LEF1	153245	4q25	LEF1
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MYH9
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	MHA
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	FTNS
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	DFNA17
Sebastian syndrome, 605249 (3)	MYH9, MHA, FTNS, DFNA17, BDPLT6	160775	22q12.3	BDPLT6
Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	ZNF750, FLJ13841	610226	17q25.3	ZNF750
Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)	ZNF750, FLJ13841	610226	17q25.3	FLJ13841
Seckel syndrome 1, 210600 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	ATR
Seckel syndrome 1, 210600 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	FRP1
Seckel syndrome 1, 210600 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	SCKL1
Seckel syndrome 1, 210600 (3)	ATR, FRP1, SCKL1, FCTCS	601215	3q23	FCTCS
Seckel syndrome 2, 606744 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RBBP8
Seckel syndrome 2, 606744 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	RIM
Seckel syndrome 2, 606744 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	SCKL2
Seckel syndrome 2, 606744 (3)	RBBP8, RIM, SCKL2, JWDS	604124	18q11.2	JWDS
Seckel syndrome 5, 613823 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	CEP152
Seckel syndrome 5, 613823 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	KIAA0912
Seckel syndrome 5, 613823 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	MCPH9
Seckel syndrome 5, 613823 (3)	CEP152, KIAA0912, MCPH9, SCKL5	613529	15q21.1	SCKL5
Seckel syndrome 9, 616777 (3)	TRAIP, TRIP, RNF206, SCKL9	605958	3p21.31	TRAIP
Seckel syndrome 9, 616777 (3)	TRAIP, TRIP, RNF206, SCKL9	605958	3p21.31	TRIP
Seckel syndrome 9, 616777 (3)	TRAIP, TRIP, RNF206, SCKL9	605958	3p21.31	RNF206
Seckel syndrome 9, 616777 (3)	TRAIP, TRIP, RNF206, SCKL9	605958	3p21.31	SCKL9
Segawa syndrome, recessive, 605407 (3)	TH, TYH	191290	11p15.5	TH
Segawa syndrome, recessive, 605407 (3)	TH, TYH	191290	11p15.5	TYH
Seizures, benign familial infantile, 1 (2)	BFIS1, BFIC1	601764	19q	BFIS1
Seizures, benign familial infantile, 1 (2)	BFIS1, BFIC1	601764	19q	BFIC1
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PRRT2
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	PKC
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	DYT10
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	EKD1
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIS2
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	BFIC2
Seizures, benign familial infantile, 2, 605751 (3)	PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA	614386	16p11.2	ICCA
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	SCN2A1
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFIC3
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	EIEE11
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFIS3
Seizures, benign familial infantile, 3, 607745 (3)	SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS	182390	2q24.3	BFNIS
Seizures, benign familial infantile, 4 (2)	BFIS4, BFIC4	612627	1p36.12-p35.1	BFIS4
Seizures, benign familial infantile, 4 (2)	BFIS4, BFIC4	612627	1p36.12-p35.1	BFIC4
Seizures, benign neonatal, 1, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	KCNQ2
Seizures, benign neonatal, 1, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EBN1
Seizures, benign neonatal, 1, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	EIEE7
Seizures, benign neonatal, 1, 121200 (3)	KCNQ2, EBN1, EIEE7, BFNS1	602235	20q13.33	BFNS1
Seizures, benign neonatal, type 2, 121201 (3)	KCNQ3, EBN2, BFNC2	602232	8q24.22	KCNQ3
Seizures, benign neonatal, type 2, 121201 (3)	KCNQ3, EBN2, BFNC2	602232	8q24.22	EBN2
Seizures, benign neonatal, type 2, 121201 (3)	KCNQ3, EBN2, BFNC2	602232	8q24.22	BFNC2
Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DIAPH1
Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	DFNA1
Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	LFHL1
Seizures, cortical blindness, microcephaly syndrome, 616632 (3)	DIAPH1, DFNA1, LFHL1, SCBMS	602121	5q31.3	SCBMS
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	AGK
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	MULK
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	MTDPS10
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	CATC5
Sengers syndrome, 212350 (3)	AGK, MULK, MTDPS10, CATC5, CTRCT38	610345	7q34	CTRCT38
Senior-Loken syndrome 3 (2)	SLSN3	606995	3q22	SLSN3
Senior-Loken syndrome 4, 606996 (3)	NPHP4, SLSN4	607215	1p36.31	NPHP4
Senior-Loken syndrome 4, 606996 (3)	NPHP4, SLSN4	607215	1p36.31	SLSN4
Senior-Loken syndrome 5, 609254 (3)	IQCB1, NPHP5, KIAA0036	609237	3q13.33	IQCB1
Senior-Loken syndrome 5, 609254 (3)	IQCB1, NPHP5, KIAA0036	609237	3q13.33	NPHP5
Senior-Loken syndrome 5, 609254 (3)	IQCB1, NPHP5, KIAA0036	609237	3q13.33	KIAA0036
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	CEP290
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	KIAA0373
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	3H11AG
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	JBTS5
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	SLSN6
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	LCA10
Senior-Loken syndrome 6, 610189 (3)	CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14	610142	12q21.32	BBS14
Senior-Loken syndrome 7, 613615 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SDCCAG8
Senior-Loken syndrome 7, 613615 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	CCCAP
Senior-Loken syndrome 7, 613615 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	SLSN7
Senior-Loken syndrome 7, 613615 (3)	SDCCAG8, CCCAP, SLSN7, BBS16	613524	1q43-q44	BBS16
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	WDR19
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	SRTD5
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	ATD5
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	NPHP13
Senior-Loken syndrome 8, 616307 (3)	WDR19, SRTD5, ATD5, NPHP13, CED4	608151	4p14	CED4
Senior-Loken syndrome 9, 616629 (3)	TRAF3IP1, MIPT3, SLSN9	607380	2q37.3	TRAF3IP1
Senior-Loken syndrome 9, 616629 (3)	TRAF3IP1, MIPT3, SLSN9	607380	2q37.3	MIPT3
Senior-Loken syndrome 9, 616629 (3)	TRAF3IP1, MIPT3, SLSN9	607380	2q37.3	SLSN9
Senior-Loken syndrome-1, 266900 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPHP1
Senior-Loken syndrome-1, 266900 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	NPH1
Senior-Loken syndrome-1, 266900 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	SLSN1
Senior-Loken syndrome-1, 266900 (3)	NPHP1, NPH1, SLSN1, JBTS4	607100	2q13	JBTS4
Sensorineural deafness with mild renal dysfunction, 602522 (3)	BSND	606412	1p32.3	BSND
Septooptic dysplasia, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	HESX1
Septooptic dysplasia, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	RPX
Septooptic dysplasia, 182230 (3)	HESX1, RPX, CPHD5	601802	3p14.3	CPHD5
Severe combined immunodeficiency due to ADA deficiency, 102700 (3)	ADA	608958	20q13.12	ADA
Severe combined immunodeficiency due to IL2 deficiency (1)	IL2	147680	4q27	IL2
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	NHEJ1, XLF	611290	2q35	NHEJ1
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)	NHEJ1, XLF	611290	2q35	XLF
Severe combined immunodeficiency, Athabascan type, 602450 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	DCLRE1C
Severe combined immunodeficiency, Athabascan type, 602450 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	ARTEMIS
Severe combined immunodeficiency, Athabascan type, 602450 (3)	DCLRE1C, ARTEMIS, SCIDA	605988	10p13	SCIDA
Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG1	179615	11p12	RAG1
Severe combined immunodeficiency, B cell-negative, 601457 (3)	RAG2	179616	11p12	RAG2
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	PTPRC
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	CD45
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive, 608971 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	LCA
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	IL7R, IL7RA, CD127	146661	5p13.2	IL7R
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	IL7R, IL7RA, CD127	146661	5p13.2	IL7RA
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3)	IL7R, IL7RA, CD127	146661	5p13.2	CD127
Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IL2RG
Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	SCIDX1
Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	SCIDX
Severe combined immunodeficiency, X-linked, 300400 (3)	IL2RG, SCIDX1, SCIDX, IMD4	308380	Xq13.1	IMD4
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COG6
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	COD2
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	KIAA1134
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	CDG2L
Shaheen syndrome, 615328 (3)	COG6, COD2, KIAA1134, CDG2L, SHNS	606977	13q14.11	SHNS
Short QT syndrome 1, 609620 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
Short QT syndrome 1, 609620 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	LQT2
Short QT syndrome 1, 609620 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	HERG
Short QT syndrome 1, 609620 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	SQT1
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNA9
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	LQT1
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KVLQT1
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	ATFB3
Short QT syndrome 2, 609621 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	SQT2
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KCNJ2
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	HHIRK1
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	KIR2.1
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	IRK1
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	LQT7
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	SQT3
Short QT syndrome 3, 609622 (3)	KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9	600681	17q24.3	ATFB9
Short stature with microcephaly and distinctive facies, 615789 (3)	CRIPT, SSMDF	604594	2p21	CRIPT
Short stature with microcephaly and distinctive facies, 615789 (3)	CRIPT, SSMDF	604594	2p21	SSMDF
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	NPR2
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ANPRB
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	AMDM
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	ECDM
Short stature with nonspecific skeletal abnormalities, 616255 (3)	NPR2, ANPRB, AMDM, ECDM, SNSK	108961	9p13.3	SNSK
Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	GSC, SAMS	138890	14q32.13	GSC
Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3)	GSC, SAMS	138890	14q32.13	SAMS
Short stature, developmental delay, and congenital heart defects, 617044 (3)	TKT, SDDHD	606781	3p21.1	TKT
Short stature, developmental delay, and congenital heart defects, 617044 (3)	TKT, SDDHD	606781	3p21.1	SDDHD
Short stature, idiopathic familial, 300582 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SHOX
Short stature, idiopathic familial, 300582 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	GCFX
Short stature, idiopathic familial, 300582 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	SS
Short stature, idiopathic familial, 300582 (3)	SHOX, GCFX, SS, PHOG	312865	Xp22.33	PHOG
Short stature, idiopathic familial, 300582 (3)	SHOXY	400020	Yp11.2	SHOXY
Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	XRCC4, SSMED	194363	5q14.2	XRCC4
Short stature, microcephaly, and endocrine dysfunction, 616541 (3)	XRCC4, SSMED	194363	5q14.2	SSMED
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	POC1A, PIX2, SOFT	614783	3p21.2	POC1A
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	POC1A, PIX2, SOFT	614783	3p21.2	PIX2
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3)	POC1A, PIX2, SOFT	614783	3p21.2	SOFT
Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NBAS
Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	NAG
Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	SOPH
Short stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3)	NBAS, NAG, SOPH, ILFS2	608025	2p24.3	ILFS2
Short-rib thoracic dysplasia 1 with or without polydactyly (2)	SRTD1, ATD1	208500	15q13	SRTD1
Short-rib thoracic dysplasia 1 with or without polydactyly (2)	SRTD1, ATD1	208500	15q13	ATD1
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	IFT172
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	SLB
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	KIAA1179
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	SRTD10
Short-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3)	IFT172, SLB, KIAA1179, SRTD10, RP71	607386	2p23.3	RP71
Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	WDR34, SRTD11	613363	9q34.11	WDR34
Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3)	WDR34, SRTD11	613363	9q34.11	SRTD11
Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	CEP120, CCDC100, SRTD13	613446	5q23.2	CEP120
Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	CEP120, CCDC100, SRTD13	613446	5q23.2	CCDC100
Short-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3)	CEP120, CCDC100, SRTD13	613446	5q23.2	SRTD13
Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	KIAA0586
Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	TALPID3
Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	JBTS23
Short-rib thoracic dysplasia 14 with polydactyly, 616546 (3)	KIAA0586, TALPID3, JBTS23, SRTD14	610178	14q23.1	SRTD14
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	IFT80
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	KIAA1374
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	WDR56
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	SRTD2
Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3)	IFT80, KIAA1374, WDR56, SRTD2, ATD2	611177	3q25.33	ATD2
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	DYNC2H1
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	DNCH2
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	DHC2
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	ATD3
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	SRPS2B
Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3)	DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3	603297	11q22.3	SRTD3
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	TTC21B
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	THM1
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	NPHP12
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	SRTD4
Short-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3)	TTC21B, THM1, NPHP12, SRTD4, ATD4	612014	2q24.3	ATD4
Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3)	NEK1, SRTD6, SRPS2A	604588	4q33	NEK1
Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3)	NEK1, SRTD6, SRPS2A	604588	4q33	SRTD6
Short-rib thoracic dysplasia 6 with or without polydactyly, 263520 (3)	NEK1, SRTD6, SRPS2A	604588	4q33	SRPS2A
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	WDR35
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	NAOFEN
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	KIAA1336
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	CED2
Short-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3)	WDR35, NAOFEN, KIAA1336, CED2, SRTD7	613602	2p24.1	SRTD7
Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	WDR60, SRTD8, SRPS6	615462	7q36.3	WDR60
Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	WDR60, SRTD8, SRPS6	615462	7q36.3	SRTD8
Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3)	WDR60, SRTD8, SRPS6	615462	7q36.3	SRPS6
Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	IFT140, KIAA0590, SRTD9, MZSDS	614620	16p13.3	IFT140
Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	IFT140, KIAA0590, SRTD9, MZSDS	614620	16p13.3	KIAA0590
Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	IFT140, KIAA0590, SRTD9, MZSDS	614620	16p13.3	SRTD9
Short-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3)	IFT140, KIAA0590, SRTD9, MZSDS	614620	16p13.3	MZSDS
Shprintzen-Goldberg syndrome, 182212 (3)	SKI, SGS	164780	1p36.33-p36.32	SKI
Shprintzen-Goldberg syndrome, 182212 (3)	SKI, SGS	164780	1p36.33-p36.32	SGS
Shwachman-Diamond syndrome, 260400 (3)	SBDS, SDS	607444	7q11.21	SBDS
Shwachman-Diamond syndrome, 260400 (3)	SBDS, SDS	607444	7q11.21	SDS
Sialic acid storage disorder, infantile, 269920 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLC17A5
Sialic acid storage disorder, infantile, 269920 (3)	SLC17A5, SIASD, SLD	604322	6q13	SIASD
Sialic acid storage disorder, infantile, 269920 (3)	SLC17A5, SIASD, SLD	604322	6q13	SLD
Sialidosis, type I, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU1
Sialidosis, type I, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU
Sialidosis, type I, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	SIAL1
Sialidosis, type II, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU1
Sialidosis, type II, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	NEU
Sialidosis, type II, 256550 (3)	NEU1, NEU, SIAL1	608272	6p21.33	SIAL1
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GNE
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	GLCNE
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	IBM2
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	DMRV
Sialuria, 269921 (3)	GNE, GLCNE, IBM2, DMRV, NM	603824	9p13.3	NM
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Sick sinus syndrome 1, 608567 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Sick sinus syndrome 2, 163800 (3)	HCN4, SSS2	605206	15q24.1	HCN4
Sick sinus syndrome 2, 163800 (3)	HCN4, SSS2	605206	15q24.1	SSS2
Sickle cell anemia, 603903 (3)	HBB	141900	11p15.4	HBB
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	TRNT1
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	SIFD
Sideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3)	TRNT1, SIFD, RPEM	612907	3p26.2	RPEM
Silver spastic paraplegia syndrome, 270685 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	BSCL2
Silver spastic paraplegia syndrome, 270685 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	SPG17
Silver spastic paraplegia syndrome, 270685 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	HMN5
Silver spastic paraplegia syndrome, 270685 (3)	BSCL2, SPG17, HMN5, PELD	606158	11q12.3	PELD
Silver-Russell syndrome (4)	SRS, RSS	180860	7p11.2	SRS
Silver-Russell syndrome (4)	SRS, RSS	180860	7p11.2	RSS
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	D11S813E
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	ASM1
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	BWS
Silver-Russell syndrome, 180860 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	WT2
Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	GPC3
Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	SDYS
Simpson-Golabi-Behmel syndrome, type 1, 312870 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	SGBS1
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	OFD1
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	CXorf5
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	SGBS2
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	JBTS10
Simpson-Golabi-Behmel syndrome, type 2, 300209 (3)	OFD1, CXorf5, SGBS2, JBTS10, RP23	300170	Xp22.2	RP23
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SHH
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HPE3
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	HLP3
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	SMMCI
Single median maxillary central incisor, 147250 (3)	SHH, HPE3, HLP3, SMMCI, MCOPCB5	600725	7q36.3	MCOPCB5
Singleton-Merten syndrome 1, 182250 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	IFIH1
Singleton-Merten syndrome 1, 182250 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	MDA5
Singleton-Merten syndrome 1, 182250 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	AGS7
Singleton-Merten syndrome 1, 182250 (3)	IFIH1, MDA5, AGS7, SGMRT1	606951	2q24.2	SGMRT1
Singleton-Merten syndrome 2, 616298 (3)	DDX58, RIGI, SGMRT2	609631	9p21.1	DDX58
Singleton-Merten syndrome 2, 616298 (3)	DDX58, RIGI, SGMRT2	609631	9p21.1	RIGI
Singleton-Merten syndrome 2, 616298 (3)	DDX58, RIGI, SGMRT2	609631	9p21.1	SGMRT2
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNA1D
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CACNL1A2
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	CCHL1A2
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	SANDD
Sinoatrial node dysfunction and deafness, 614896 (3)	CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA	114206	3p21.1	PASNA
Sitosterolemia, 210250 (3)	ABCG5	605459	2p21	ABCG5
Sitosterolemia, 210250 (3)	ABCG8, GBD4	605460	2p21	ABCG8
Sitosterolemia, 210250 (3)	ABCG8, GBD4	605460	2p21	GBD4
Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	ALDH3A2
Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	ALDH10
Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	SLS
Sjogren-Larsson syndrome, 270200 (3)	ALDH3A2, ALDH10, SLS, FALDH	609523	17p11.2	FALDH
Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZBTB16
Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	ZNF145
Skeletal defects, genital hypoplasia, and mental retardation, 612447 (3)	ZBTB16, ZNF145, PLZF	176797	11q23.2	PLZF
Skin fragility-woolly hair syndrome, 607655 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DSP
Skin fragility-woolly hair syndrome, 607655 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	KPPS2
Skin fragility-woolly hair syndrome, 607655 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	PPKS2
Skin fragility-woolly hair syndrome, 607655 (3)	DSP, KPPS2, PPKS2, DCWHKTA	125647	6p24.3	DCWHKTA
Small cell cancer of the lung, somatic, 182280 (3)	RB1	614041	13q14.2	RB1
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
Small fiber neuropathy, 133020 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
Small nucleolar RNA, H/ACA box, 2C, 615487 (3)	SNORA2C, SNORA34, ACA34, MIR1291	615487	12q13.11	SNORA2C
Small nucleolar RNA, H/ACA box, 2C, 615487 (3)	SNORA2C, SNORA34, ACA34, MIR1291	615487	12q13.11	SNORA34
Small nucleolar RNA, H/ACA box, 2C, 615487 (3)	SNORA2C, SNORA34, ACA34, MIR1291	615487	12q13.11	ACA34
Small nucleolar RNA, H/ACA box, 2C, 615487 (3)	SNORA2C, SNORA34, ACA34, MIR1291	615487	12q13.11	MIR1291
Small-cell cancer of lung (2)	SCLC1	182280	3p23-p21	SCLC1
Smith-Kingsmore syndrome, 616638 (3)	MTOR, FRAP1, SKS	601231	1p36.22	MTOR
Smith-Kingsmore syndrome, 616638 (3)	MTOR, FRAP1, SKS	601231	1p36.22	FRAP1
Smith-Kingsmore syndrome, 616638 (3)	MTOR, FRAP1, SKS	601231	1p36.22	SKS
Smith-Lemli-Opitz syndrome, 270400 (3)	DHCR7, SLOS	602858	11q13.4	DHCR7
Smith-Lemli-Opitz syndrome, 270400 (3)	DHCR7, SLOS	602858	11q13.4	SLOS
Smith-Magenis syndrome, 182290 (3)	RAI1, SMCR, SMS	607642	17p11.2	RAI1
Smith-Magenis syndrome, 182290 (3)	RAI1, SMCR, SMS	607642	17p11.2	SMCR
Smith-Magenis syndrome, 182290 (3)	RAI1, SMCR, SMS	607642	17p11.2	SMS
Smith-McCort dysplasia 2, 615222 (3)	RAB33B, SMC2	605950	4q31.1	RAB33B
Smith-McCort dysplasia 2, 615222 (3)	RAB33B, SMC2	605950	4q31.1	SMC2
Smith-McCort dysplasia, 607326 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DYM
Smith-McCort dysplasia, 607326 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	FLJ90130
Smith-McCort dysplasia, 607326 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	DMC
Smith-McCort dysplasia, 607326 (3)	DYM, FLJ90130, DMC, SMC	607461	18q21.1	SMC
Snowflake vitreoretinal degeneration, 193230 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	KCNJ13
Snowflake vitreoretinal degeneration, 193230 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	SVD
Snowflake vitreoretinal degeneration, 193230 (3)	KCNJ13, SVD, LCA16	603208	2q37.1	LCA16
Somatostatin analog, resistance to (3)	SSTR5	182455	16p13.3	SSTR5
Sorsby fundus dystrophy, 136900 (3)	TIMP3, SFD	188826	22q12.3	TIMP3
Sorsby fundus dystrophy, 136900 (3)	TIMP3, SFD	188826	22q12.3	SFD
Sotos syndrome 1, 117550 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	NSD1
Sotos syndrome 1, 117550 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	ARA267
Sotos syndrome 1, 117550 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	STO
Sotos syndrome 1, 117550 (3)	NSD1, ARA267, STO, SOTOS1	606681	5q35.3	SOTOS1
Sotos syndrome 2, 614753 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NFIX
Sotos syndrome 2, 614753 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	NF1A
Sotos syndrome 2, 614753 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	SOTOS2
Sotos syndrome 2, 614753 (3)	NFIX, NF1A, SOTOS2, MRSHSS	164005	19p13.13	MRSHSS
Spastic ataxia 1, autosomal dominant, 108600 (3)	VAMP1, SYB1, SPAX1	185880	12p13.31	VAMP1
Spastic ataxia 1, autosomal dominant, 108600 (3)	VAMP1, SYB1, SPAX1	185880	12p13.31	SYB1
Spastic ataxia 1, autosomal dominant, 108600 (3)	VAMP1, SYB1, SPAX1	185880	12p13.31	SPAX1
Spastic ataxia 2, autosomal recessive, 611302 (3)	KIF1C, LTXS1, KIAA0706, SPAX2	603060	17p13.2	KIF1C
Spastic ataxia 2, autosomal recessive, 611302 (3)	KIF1C, LTXS1, KIAA0706, SPAX2	603060	17p13.2	LTXS1
Spastic ataxia 2, autosomal recessive, 611302 (3)	KIF1C, LTXS1, KIAA0706, SPAX2	603060	17p13.2	KIAA0706
Spastic ataxia 2, autosomal recessive, 611302 (3)	KIF1C, LTXS1, KIAA0706, SPAX2	603060	17p13.2	SPAX2
Spastic ataxia 3, autosomal recessive, 611390 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	MARS2
Spastic ataxia 3, autosomal recessive, 611390 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	SPAX3
Spastic ataxia 3, autosomal recessive, 611390 (3)	MARS2, SPAX3, COXPD25	609728	2q33.1	COXPD25
Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	SACS, ARSACS	604490	13q12.12	SACS
Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)	SACS, ARSACS	604490	13q12.12	ARSACS
Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALS2
Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	ALSJ
Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	PLSJ
Spastic paralysis, infantile onset ascending, 607225 (3)	ALS2, ALSJ, PLSJ, IAHSP	606352	2q33.1	IAHSP
Spastic paraplegia 10, autosomal dominant, 604187 (3)	KIF5A, NKHC, SPG10	602821	12q13.3	KIF5A
Spastic paraplegia 10, autosomal dominant, 604187 (3)	KIF5A, NKHC, SPG10	602821	12q13.3	NKHC
Spastic paraplegia 10, autosomal dominant, 604187 (3)	KIF5A, NKHC, SPG10	602821	12q13.3	SPG10
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	SPG11
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	KIAA1840
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	FLJ21439
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	ALS5
Spastic paraplegia 11, autosomal recessive, 604360 (3)	SPG11, KIAA1840, FLJ21439, ALS5, CMT2X	610844	15q21.1	CMT2X
Spastic paraplegia 12, autosomal dominant, 604805 (3)	RTN2, NSPL1, SPG12	603183	19q13.32	RTN2
Spastic paraplegia 12, autosomal dominant, 604805 (3)	RTN2, NSPL1, SPG12	603183	19q13.32	NSPL1
Spastic paraplegia 12, autosomal dominant, 604805 (3)	RTN2, NSPL1, SPG12	603183	19q13.32	SPG12
Spastic paraplegia 13, autosomal dominant, 605280 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSPD1
Spastic paraplegia 13, autosomal dominant, 605280 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	SPG13
Spastic paraplegia 13, autosomal dominant, 605280 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HSP60
Spastic paraplegia 13, autosomal dominant, 605280 (3)	HSPD1, SPG13, HSP60, HLD4	118190	2q33.1	HLD4
Spastic paraplegia 14, autosomal recessive (2)	SPG14	605229	3q27-q28	SPG14
Spastic paraplegia 15, autosomal recessive, 270700 (3)	ZFYVE26, KIAA0321, SPG15	612012	14q24.1	ZFYVE26
Spastic paraplegia 15, autosomal recessive, 270700 (3)	ZFYVE26, KIAA0321, SPG15	612012	14q24.1	KIAA0321
Spastic paraplegia 15, autosomal recessive, 270700 (3)	ZFYVE26, KIAA0321, SPG15	612012	14q24.1	SPG15
Spastic paraplegia 16, X-linked, complicated (2)	SPG16	300266	Xq11.2	SPG16
Spastic paraplegia 18, autosomal recessive, 611225 (3)	ERLIN2, SPFH2, C8orf2, SPG18	611605	8p11.23	ERLIN2
Spastic paraplegia 18, autosomal recessive, 611225 (3)	ERLIN2, SPFH2, C8orf2, SPG18	611605	8p11.23	SPFH2
Spastic paraplegia 18, autosomal recessive, 611225 (3)	ERLIN2, SPFH2, C8orf2, SPG18	611605	8p11.23	C8orf2
Spastic paraplegia 18, autosomal recessive, 611225 (3)	ERLIN2, SPFH2, C8orf2, SPG18	611605	8p11.23	SPG18
Spastic paraplegia 19, autosomal dominant (2)	SPG19	607152	9q	SPG19
Spastic paraplegia 2, X-linked, 312920 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PLP1
Spastic paraplegia 2, X-linked, 312920 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	PMD
Spastic paraplegia 2, X-linked, 312920 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	HLD1
Spastic paraplegia 2, X-linked, 312920 (3)	PLP1, PMD, HLD1, SPG2	300401	Xq22.2	SPG2
Spastic paraplegia 23 (2)	SPG23	270750	2q24-q32	SPG23
Spastic paraplegia 24, autosomal recessive (2)	SPG24	607584	13q14	SPG24
Spastic paraplegia 25, autosomal recessive (2)	SPG25	608220	6q23-q24.1	SPG25
Spastic paraplegia 26, autosomal recessive, 609195 (3)	B4GALNT1, GALGT, GALNACT, SPG26	601873	12q13.3	B4GALNT1
Spastic paraplegia 26, autosomal recessive, 609195 (3)	B4GALNT1, GALGT, GALNACT, SPG26	601873	12q13.3	GALGT
Spastic paraplegia 26, autosomal recessive, 609195 (3)	B4GALNT1, GALGT, GALNACT, SPG26	601873	12q13.3	GALNACT
Spastic paraplegia 26, autosomal recessive, 609195 (3)	B4GALNT1, GALGT, GALNACT, SPG26	601873	12q13.3	SPG26
Spastic paraplegia 27, autosomal recessive (2)	SPG27	609041	10q22.1-q24.1	SPG27
Spastic paraplegia 28, autosomal recessive, 609340 (3)	DDHD1, PAPLA1, KIAA1705, SPG28	614603	14q22.1	DDHD1
Spastic paraplegia 28, autosomal recessive, 609340 (3)	DDHD1, PAPLA1, KIAA1705, SPG28	614603	14q22.1	PAPLA1
Spastic paraplegia 28, autosomal recessive, 609340 (3)	DDHD1, PAPLA1, KIAA1705, SPG28	614603	14q22.1	KIAA1705
Spastic paraplegia 28, autosomal recessive, 609340 (3)	DDHD1, PAPLA1, KIAA1705, SPG28	614603	14q22.1	SPG28
Spastic paraplegia 29, autosomal dominant (2)	SPG29	609727	1p31.1-p21.1	SPG29
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	KIF1A
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	ATSV
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	UNC104
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	SPG30
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	HSN2C
Spastic paraplegia 30, autosomal recessive, 610357 (3)	KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9	601255	2q37.3	MRD9
Spastic paraplegia 31, autosomal dominant, 610250 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	REEP1
Spastic paraplegia 31, autosomal dominant, 610250 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	C2ORF23
Spastic paraplegia 31, autosomal dominant, 610250 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	SPG31
Spastic paraplegia 31, autosomal dominant, 610250 (3)	REEP1, C2ORF23, SPG31, HMN5B	609139	2p11.2	HMN5B
Spastic paraplegia 32, autosomal recessive (2)	SPG32	611252	14q12-q21	SPG32
Spastic paraplegia 33, autosomal dominant, 610244 (3)	ZFYVE27, SPG33	610243	10q24.2	ZFYVE27
Spastic paraplegia 33, autosomal dominant, 610244 (3)	ZFYVE27, SPG33	610243	10q24.2	SPG33
Spastic paraplegia 34, X-linked (2)	SPG34	300750	Xq24-q25	SPG34
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	FA2H
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	FAAH
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	FAXDC1
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	FAH1
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	SCS7
Spastic paraplegia 35, autosomal recessive, 612319 (3)	FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35	611026	16q23.1	SPG35
Spastic paraplegia 36, autosomal dominant (2)	SPG36	613096	12q23-q24	SPG36
Spastic paraplegia 37, autosomal dominant (2)	SPG37	611945	8p21.1-q13.3	SPG37
Spastic paraplegia 38, autosomal dominant (2)	SPG38	612335	4p16-p15	SPG38
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	PNPLA6
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTE
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	SPG39
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	NTEMND
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	BNHS
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	LNMS
Spastic paraplegia 39, autosomal recessive, 612020 (3)	PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS	603197	19p13.2	OMCS
Spastic paraplegia 3A, autosomal dominant, 182600 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	ATL1
Spastic paraplegia 3A, autosomal dominant, 182600 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	SPG3A
Spastic paraplegia 3A, autosomal dominant, 182600 (3)	ATL1, SPG3A, HSN1D	606439	14q22.1	HSN1D
Spastic paraplegia 4, autosomal dominant, 182601 (3)	SPAST, SPG4	604277	2p22.3	SPAST
Spastic paraplegia 4, autosomal dominant, 182601 (3)	SPAST, SPG4	604277	2p22.3	SPG4
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SLC33A1
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	ACATN
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	AT1
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	SPG42
Spastic paraplegia 42, autosomal dominant, 612539 (3)	SLC33A1, ACATN, AT1, SPG42, CCHLND	603690	3q25.31	CCHLND
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJC2
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	GJA12
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	CX47
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	PMLDAR
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	HLD2
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	SPG44
Spastic paraplegia 44, autosomal recessive, 613206 (3)	GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C	608803	1q42.13	LMPH1C
Spastic paraplegia 45, autosomal recessive, 613162 (3)	NT5C2, NT5B, PNT5, SPG45	600417	10q24.32-q24.33	NT5C2
Spastic paraplegia 45, autosomal recessive, 613162 (3)	NT5C2, NT5B, PNT5, SPG45	600417	10q24.32-q24.33	NT5B
Spastic paraplegia 45, autosomal recessive, 613162 (3)	NT5C2, NT5B, PNT5, SPG45	600417	10q24.32-q24.33	PNT5
Spastic paraplegia 45, autosomal recessive, 613162 (3)	NT5C2, NT5B, PNT5, SPG45	600417	10q24.32-q24.33	SPG45
Spastic paraplegia 46, autosomal recessive, 614409 (3)	GBA2, KIAA1605, SPG46	609471	9p13.3	GBA2
Spastic paraplegia 46, autosomal recessive, 614409 (3)	GBA2, KIAA1605, SPG46	609471	9p13.3	KIAA1605
Spastic paraplegia 46, autosomal recessive, 614409 (3)	GBA2, KIAA1605, SPG46	609471	9p13.3	SPG46
Spastic paraplegia 47, autosomal recessive, 614066 (3)	AP4B1, SPG47, CPSQ5	607245	1p13.2	AP4B1
Spastic paraplegia 47, autosomal recessive, 614066 (3)	AP4B1, SPG47, CPSQ5	607245	1p13.2	SPG47
Spastic paraplegia 47, autosomal recessive, 614066 (3)	AP4B1, SPG47, CPSQ5	607245	1p13.2	CPSQ5
Spastic paraplegia 48, autosomal recessive, 613647 (3)	AP5Z1, KIAA0415, SPG48	613653	7p22.1	AP5Z1
Spastic paraplegia 48, autosomal recessive, 613647 (3)	AP5Z1, KIAA0415, SPG48	613653	7p22.1	KIAA0415
Spastic paraplegia 48, autosomal recessive, 613647 (3)	AP5Z1, KIAA0415, SPG48	613653	7p22.1	SPG48
Spastic paraplegia 49, autosomal recessive, 615031 (3)	TECPR2, KIAA0329, SPG49	615000	14q32.31	TECPR2
Spastic paraplegia 49, autosomal recessive, 615031 (3)	TECPR2, KIAA0329, SPG49	615000	14q32.31	KIAA0329
Spastic paraplegia 49, autosomal recessive, 615031 (3)	TECPR2, KIAA0329, SPG49	615000	14q32.31	SPG49
Spastic paraplegia 50, autosomal recessive, 612936 (3)	AP4M1, SPG50, CPSQ3	602296	7q22.1	AP4M1
Spastic paraplegia 50, autosomal recessive, 612936 (3)	AP4M1, SPG50, CPSQ3	602296	7q22.1	SPG50
Spastic paraplegia 50, autosomal recessive, 612936 (3)	AP4M1, SPG50, CPSQ3	602296	7q22.1	CPSQ3
Spastic paraplegia 51, autosomal recessive, 613744 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	AP4E1
Spastic paraplegia 51, autosomal recessive, 613744 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	SPG51
Spastic paraplegia 51, autosomal recessive, 613744 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	CPSQ4
Spastic paraplegia 51, autosomal recessive, 613744 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	STUT1
Spastic paraplegia 52, autosomal recessive, 614067 (3)	AP4S1, CPSQ6, SPG52	607243	14q12	AP4S1
Spastic paraplegia 52, autosomal recessive, 614067 (3)	AP4S1, CPSQ6, SPG52	607243	14q12	CPSQ6
Spastic paraplegia 52, autosomal recessive, 614067 (3)	AP4S1, CPSQ6, SPG52	607243	14q12	SPG52
Spastic paraplegia 53, autosomal recessive, 614898 (3)	VPS37A, HCRP1, SPG53	609927	8p22	VPS37A
Spastic paraplegia 53, autosomal recessive, 614898 (3)	VPS37A, HCRP1, SPG53	609927	8p22	HCRP1
Spastic paraplegia 53, autosomal recessive, 614898 (3)	VPS37A, HCRP1, SPG53	609927	8p22	SPG53
Spastic paraplegia 54, autosomal recessive, 615033 (3)	DDHD2, KIAA0725, SPG54	615003	8p11.23	DDHD2
Spastic paraplegia 54, autosomal recessive, 615033 (3)	DDHD2, KIAA0725, SPG54	615003	8p11.23	KIAA0725
Spastic paraplegia 54, autosomal recessive, 615033 (3)	DDHD2, KIAA0725, SPG54	615003	8p11.23	SPG54
Spastic paraplegia 55, autosomal recessive, 615035 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	C12orf65
Spastic paraplegia 55, autosomal recessive, 615035 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	COXPD7
Spastic paraplegia 55, autosomal recessive, 615035 (3)	C12orf65, COXPD7, SPG55	613541	12q24.31	SPG55
Spastic paraplegia 56, autosomal recessive, 615030 (3)	CYP2U1, SPG56	610670	4q25	CYP2U1
Spastic paraplegia 56, autosomal recessive, 615030 (3)	CYP2U1, SPG56	610670	4q25	SPG56
Spastic paraplegia 5A, autosomal recessive, 270800 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CYP7B1
Spastic paraplegia 5A, autosomal recessive, 270800 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	CBAS3
Spastic paraplegia 5A, autosomal recessive, 270800 (3)	CYP7B1, CBAS3, SPG5A	603711	8q12.3	SPG5A
Spastic paraplegia 6, autosomal dominant, 600363 (3)	NIPA1, SPG6	608145	15q11.2	NIPA1
Spastic paraplegia 6, autosomal dominant, 600363 (3)	NIPA1, SPG6	608145	15q11.2	SPG6
Spastic paraplegia 62, 615681 (3)	ERLIN1, SPG62	611604	10q24.31	ERLIN1
Spastic paraplegia 62, 615681 (3)	ERLIN1, SPG62	611604	10q24.31	SPG62
Spastic paraplegia 64, autosomal recessive, 615683 (3)	ENTPD1, CD39, SPG64	601752	10q24.1	ENTPD1
Spastic paraplegia 64, autosomal recessive, 615683 (3)	ENTPD1, CD39, SPG64	601752	10q24.1	CD39
Spastic paraplegia 64, autosomal recessive, 615683 (3)	ENTPD1, CD39, SPG64	601752	10q24.1	SPG64
Spastic paraplegia 7, autosomal recessive, 607259 (3)	PGN, SPG7, CMAR, CAR	602783	16q24.3	PGN
Spastic paraplegia 7, autosomal recessive, 607259 (3)	PGN, SPG7, CMAR, CAR	602783	16q24.3	SPG7
Spastic paraplegia 7, autosomal recessive, 607259 (3)	PGN, SPG7, CMAR, CAR	602783	16q24.3	CMAR
Spastic paraplegia 7, autosomal recessive, 607259 (3)	PGN, SPG7, CMAR, CAR	602783	16q24.3	CAR
Spastic paraplegia 75, autosomal recessive, 616680 (3)	MAG, GMA, SPG75	159460	19q13.12	MAG
Spastic paraplegia 75, autosomal recessive, 616680 (3)	MAG, GMA, SPG75	159460	19q13.12	GMA
Spastic paraplegia 75, autosomal recessive, 616680 (3)	MAG, GMA, SPG75	159460	19q13.12	SPG75
Spastic paraplegia 76, autosomal recessive, 616907 (3)	CAPN1, SPG76	114220	11q13.1	CAPN1
Spastic paraplegia 76, autosomal recessive, 616907 (3)	CAPN1, SPG76	114220	11q13.1	SPG76
Spastic paraplegia 8, autosomal dominant, 603563 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	KIAA0196
Spastic paraplegia 8, autosomal dominant, 603563 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	SPG8
Spastic paraplegia 8, autosomal dominant, 603563 (3)	KIAA0196, SPG8, RTSC1	610657	8q24.13	RTSC1
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	PYCS
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	GSAS
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ARCL3A
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9A
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9B
Spastic paraplegia 9A, autosomal dominant, 601162 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ADCL3
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ALDH18A1
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	PYCS
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	GSAS
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ARCL3A
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9A
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	SPG9B
Spastic paraplegia 9B, autosomal recessive, 616586 (3)	ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3	138250	10q24.1	ADCL3
Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	HACE1, KIAA1320, SPPRS	610876	6q16.3	HACE1
Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	HACE1, KIAA1320, SPPRS	610876	6q16.3	KIAA1320
Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3)	HACE1, KIAA1320, SPPRS	610876	6q16.3	SPPRS
Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	KLC2, SPOAN	611729	11q13.2	KLC2
Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3)	KLC2, SPOAN	611729	11q13.2	SPOAN
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	SLC1A4, SATT, ASCT1, SPATCCM	600229	2p14	SLC1A4
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	SLC1A4, SATT, ASCT1, SPATCCM	600229	2p14	SATT
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	SLC1A4, SATT, ASCT1, SPATCCM	600229	2p14	ASCT1
Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3)	SLC1A4, SATT, ASCT1, SPATCCM	600229	2p14	SPATCCM
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	GLRX5
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	C14orf87
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	PRO1238
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	FLB4739
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	PRSA
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	SIDBA3
Spasticity, childhood-onset, with hyperglycinemia, 616859 (3)	GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC	609588	14q32.13	SPAHGC
Specific granule deficiency, 245480 (3)	CEBPE, CRP1	600749	14q11.2	CEBPE
Specific granule deficiency, 245480 (3)	CEBPE, CRP1	600749	14q11.2	CRP1
Specific language impairment QTL, 1 (2)	SLI1	606711	16q	SLI1
Specific language impairment QTL, 2 (2)	SLI2	606712	19q	SLI2
Specific language impairment QTL, 3 (2)	SLI3	607134	13q21	SLI3
Speech-language disorder-1, 602081 (3)	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31.1	FOXP2
Speech-language disorder-1, 602081 (3)	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31.1	SPCH1
Speech-language disorder-1, 602081 (3)	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31.1	TNRC10
Speech-language disorder-1, 602081 (3)	FOXP2, SPCH1, TNRC10, CAGH44	605317	7q31.1	CAGH44
Spermatocytic seminoma, somatic, 273300 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Spermatocytic seminoma, somatic, 273300 (3)	FGFR3, ACH	134934	4p16.3	ACH
Spermatogenic failure 10, 614822 (3)	SEPT12, SPGF10	611562	16p13.3	SEPT12
Spermatogenic failure 10, 614822 (3)	SEPT12, SPGF10	611562	16p13.3	SPGF10
Spermatogenic failure 11, 615081 (3)	KLHL10, SPGF11	608778	17q21.2	KLHL10
Spermatogenic failure 11, 615081 (3)	KLHL10, SPGF11	608778	17q21.2	SPGF11
Spermatogenic failure 12, 615413 (3)	NANOS1, NOS1, SPGF12	608226	10q26.11	NANOS1
Spermatogenic failure 12, 615413 (3)	NANOS1, NOS1, SPGF12	608226	10q26.11	NOS1
Spermatogenic failure 12, 615413 (3)	NANOS1, NOS1, SPGF12	608226	10q26.11	SPGF12
Spermatogenic failure 2 (2)	SPGF2, ASG	108420	Chr.1	SPGF2
Spermatogenic failure 2 (2)	SPGF2, ASG	108420	Chr.1	ASG
Spermatogenic failure 3, 606766 (3)	SLC26A8, TAT1, SPGF3	608480	6p21.31	SLC26A8
Spermatogenic failure 3, 606766 (3)	SLC26A8, TAT1, SPGF3	608480	6p21.31	TAT1
Spermatogenic failure 3, 606766 (3)	SLC26A8, TAT1, SPGF3	608480	6p21.31	SPGF3
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SYCP3
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SCP3
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	COR1
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	SPGF4
Spermatogenic failure 4, 270960 (3)	SYCP3, SCP3, COR1, SPGF4, RPRGL4	604759	12q23.2	RPRGL4
Spermatogenic failure 5, 243060 (3)	AURKC, STK13, AIE2, SPGF5	603495	19q13.43	AURKC
Spermatogenic failure 5, 243060 (3)	AURKC, STK13, AIE2, SPGF5	603495	19q13.43	STK13
Spermatogenic failure 5, 243060 (3)	AURKC, STK13, AIE2, SPGF5	603495	19q13.43	AIE2
Spermatogenic failure 5, 243060 (3)	AURKC, STK13, AIE2, SPGF5	603495	19q13.43	SPGF5
Spermatogenic failure 7, 612997 (3)	CATSPER1, CATSPER, SPGF7	606389	11q13.1	CATSPER1
Spermatogenic failure 7, 612997 (3)	CATSPER1, CATSPER, SPGF7	606389	11q13.1	CATSPER
Spermatogenic failure 7, 612997 (3)	CATSPER1, CATSPER, SPGF7	606389	11q13.1	SPGF7
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	NR5A1
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZF1
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	FTZ1
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SF1
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	AD4BP
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	POF7
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SRXY3
Spermatogenic failure 8, 613957 (3)	NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8	184757	9q33.3	SPGF8
Spermatogenic failure 9, 613958 (3)	DPY19L2, SPGF9	613893	12q14.2	DPY19L2
Spermatogenic failure 9, 613958 (3)	DPY19L2, SPGF9	613893	12q14.2	SPGF9
Spermatogenic failure, X-linked, 2, 309120 (3)	TEX11, SPGFX2	300311	Xq13.1	TEX11
Spermatogenic failure, X-linked, 2, 309120 (3)	TEX11, SPGFX2	300311	Xq13.1	SPGFX2
Spermatogenic failure, Y-linked, 1 (4)	DELYq11, CYDELq11, SPGFY1	400042	Yq11	DELYq11
Spermatogenic failure, Y-linked, 1 (4)	DELYq11, CYDELq11, SPGFY1	400042	Yq11	CYDELq11
Spermatogenic failure, Y-linked, 1 (4)	DELYq11, CYDELq11, SPGFY1	400042	Yq11	SPGFY1
Spermatogenic failure, Y-linked, 2, 415000 (3)	USP9Y, DFFRY, SPGFY2	400005	Yq11.221	USP9Y
Spermatogenic failure, Y-linked, 2, 415000 (3)	USP9Y, DFFRY, SPGFY2	400005	Yq11.221	DFFRY
Spermatogenic failure, Y-linked, 2, 415000 (3)	USP9Y, DFFRY, SPGFY2	400005	Yq11.221	SPGFY2
Spherocytosis, type 1, 182900 (3)	ANK1, SPH1	612641	8p11.21	ANK1
Spherocytosis, type 1, 182900 (3)	ANK1, SPH1	612641	8p11.21	SPH1
Spherocytosis, type 2, 616649 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPTB
Spherocytosis, type 2, 616649 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	SPH2
Spherocytosis, type 2, 616649 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	EL3
Spherocytosis, type 2, 616649 (3)	SPTB, SPH2, EL3, HS2	182870	14q23.3	HS2
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPTA1
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	EL2
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	SPH3
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HS3
Spherocytosis, type 3, 270970 (3)	SPTA1, EL2, SPH3, HS3, HPP	182860	1q23.1	HPP
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
Spherocytosis, type 4, 612653 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
Spherocytosis, type 5, 612690 (3)	EPB42, SPH5	177070	15q15.2	EPB42
Spherocytosis, type 5, 612690 (3)	EPB42, SPH5	177070	15q15.2	SPH5
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	DHTR
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	TFM
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SBMA
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	KD
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SMAX1
Spinal and bulbar muscular atrophy of Kennedy, 313200 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	HYSP1
Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	TRIP4
Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	ASC1
Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	SMABF1
Spinal muscular atrophy with congenital bone fractures 1, 616866 (3)	TRIP4, ASC1, SMABF1, MDCDC	604501	15q22.31	MDCDC
Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	ASAH1, AC, SMAPME	613468	8p22	ASAH1
Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	ASAH1, AC, SMAPME	613468	8p22	AC
Spinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3)	ASAH1, AC, SMAPME	613468	8p22	SMAPME
Spinal muscular atrophy, Jokela type, 615048 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	CHCHD10
Spinal muscular atrophy, Jokela type, 615048 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	FTDALS2
Spinal muscular atrophy, Jokela type, 615048 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	SMAJ
Spinal muscular atrophy, Jokela type, 615048 (3)	CHCHD10, FTDALS2, SMAJ, IMMD	615903	22q11.23	IMMD
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	UBA1
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	UBE1
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	GXP1
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	A1ST
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	SMAX2
Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)	UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1	314370	Xp11.3	AMCX1
Spinal muscular atrophy, chronic distal, autosomal recessive (2)	SMAR	607088	11q13	SMAR
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	ATP7A
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MNK
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	MK
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	OHS
Spinal muscular atrophy, distal, X-linked 3, 300489 (3)	ATP7A, MNK, MK, OHS, SMAX3	300011	Xq21.1	SMAX3
Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	PLEKHG5
Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	KIAA0720
Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	DSMA4
Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)	PLEKHG5, KIAA0720, DSMA4, CMTRIC	611101	1p36.31	CMTRIC
Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	DNAJB2, HSJ1, HSPF3, DSMA5	604139	2q35	DNAJB2
Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	DNAJB2, HSJ1, HSPF3, DSMA5	604139	2q35	HSJ1
Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	DNAJB2, HSJ1, HSPF3, DSMA5	604139	2q35	HSPF3
Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3)	DNAJB2, HSJ1, HSPF3, DSMA5	604139	2q35	DSMA5
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Spinal muscular atrophy, distal, congenital nonprogressive, 600175 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPB
Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	VAPB, VAPC, ALS8	605704	20q13.32	VAPC
Spinal muscular atrophy, late-onset, Finkel type, 182980 (3)	VAPB, VAPC, ALS8	605704	20q13.32	ALS8
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DYNC1H1
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNCL
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	DNECL
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	CMT20
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	MRD13
Spinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3)	DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1	600112	14q32.31	SMALED1
Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	BICD2, KIAA0699, SMALED2	609797	9q22.31	BICD2
Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	BICD2, KIAA0699, SMALED2	609797	9q22.31	KIAA0699
Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3)	BICD2, KIAA0699, SMALED2	609797	9q22.31	SMALED2
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA1
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA2
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA3
Spinal muscular atrophy-1, 253300 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA4
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA1
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA2
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA3
Spinal muscular atrophy-2, 253550 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA4
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA1
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA2
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA3
Spinal muscular atrophy-3, 253400 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA4
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMN1
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA1
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA2
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA3
Spinal muscular atrophy-4, 271150 (3)	SMN1, SMA1, SMA2, SMA3, SMA4	600354	5q13.2	SMA4
Spinocerebellar ataxia 1, 164400 (3)	ATXN1, ATX1, SCA1	601556	6p22.3	ATXN1
Spinocerebellar ataxia 1, 164400 (3)	ATXN1, ATX1, SCA1	601556	6p22.3	ATX1
Spinocerebellar ataxia 1, 164400 (3)	ATXN1, ATX1, SCA1	601556	6p22.3	SCA1
Spinocerebellar ataxia 10, 603516 (3)	ATXN10, SCA10	611150	22q13.31	ATXN10
Spinocerebellar ataxia 10, 603516 (3)	ATXN10, SCA10	611150	22q13.31	SCA10
Spinocerebellar ataxia 11, 604432 (3)	TTBK2, SCA11	611695	15q15.2	TTBK2
Spinocerebellar ataxia 11, 604432 (3)	TTBK2, SCA11	611695	15q15.2	SCA11
Spinocerebellar ataxia 12, 604326 (3)	PPP2R2B	604325	5q32	PPP2R2B
Spinocerebellar ataxia 13, 605259 (3)	KCNC3, SCA13	176264	19q13.33	KCNC3
Spinocerebellar ataxia 13, 605259 (3)	KCNC3, SCA13	176264	19q13.33	SCA13
Spinocerebellar ataxia 14, 605361 (3)	PRKCG, PKCC, PKCG, SCA14	176980	19q13.42	PRKCG
Spinocerebellar ataxia 14, 605361 (3)	PRKCG, PKCC, PKCG, SCA14	176980	19q13.42	PKCC
Spinocerebellar ataxia 14, 605361 (3)	PRKCG, PKCC, PKCG, SCA14	176980	19q13.42	PKCG
Spinocerebellar ataxia 14, 605361 (3)	PRKCG, PKCC, PKCG, SCA14	176980	19q13.42	SCA14
Spinocerebellar ataxia 15, 606658 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Spinocerebellar ataxia 15, 606658 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA15
Spinocerebellar ataxia 15, 606658 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA16
Spinocerebellar ataxia 15, 606658 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA29
Spinocerebellar ataxia 17, 607136 (3)	TBP, SCA17, HDL4	600075	6q27	TBP
Spinocerebellar ataxia 17, 607136 (3)	TBP, SCA17, HDL4	600075	6q27	SCA17
Spinocerebellar ataxia 17, 607136 (3)	TBP, SCA17, HDL4	600075	6q27	HDL4
Spinocerebellar ataxia 18 (2)	SCA18, SMNA	607458	7q22-q32	SCA18
Spinocerebellar ataxia 18 (2)	SCA18, SMNA	607458	7q22-q32	SMNA
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3S
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	KCND3L
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	SCA19
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	SCA22
Spinocerebellar ataxia 19, 607346 (3)	KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9	605411	1p13.2	BRGDA9
Spinocerebellar ataxia 2, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
Spinocerebellar ataxia 2, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATX2
Spinocerebellar ataxia 2, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	SCA2
Spinocerebellar ataxia 2, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ASL13
Spinocerebellar ataxia 20 (4)	SCA20, DUP11q12, C11DUPq12	608687	11q12	SCA20
Spinocerebellar ataxia 20 (4)	SCA20, DUP11q12, C11DUPq12	608687	11q12	DUP11q12
Spinocerebellar ataxia 20 (4)	SCA20, DUP11q12, C11DUPq12	608687	11q12	C11DUPq12
Spinocerebellar ataxia 21, 607454 (3)	TMEM240, C1orf70, SCA21	616101	1p36.33	TMEM240
Spinocerebellar ataxia 21, 607454 (3)	TMEM240, C1orf70, SCA21	616101	1p36.33	C1orf70
Spinocerebellar ataxia 21, 607454 (3)	TMEM240, C1orf70, SCA21	616101	1p36.33	SCA21
Spinocerebellar ataxia 23, 610245 (3)	PDYN, SCA23	131340	20p13	PDYN
Spinocerebellar ataxia 23, 610245 (3)	PDYN, SCA23	131340	20p13	SCA23
Spinocerebellar ataxia 25 (2)	SCA25	608703	2p21-p13	SCA25
Spinocerebellar ataxia 27, 609307 (3)	FGF14, FHF4, SCA27	601515	13q33.1	FGF14
Spinocerebellar ataxia 27, 609307 (3)	FGF14, FHF4, SCA27	601515	13q33.1	FHF4
Spinocerebellar ataxia 27, 609307 (3)	FGF14, FHF4, SCA27	601515	13q33.1	SCA27
Spinocerebellar ataxia 28, 610246 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	AFG3L2
Spinocerebellar ataxia 28, 610246 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	SCA28
Spinocerebellar ataxia 28, 610246 (3)	AFG3L2, SCA28, SPAX5	604581	18p11.21	SPAX5
Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	ITPR1
Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA15
Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA16
Spinocerebellar ataxia 29, congenital nonprogressive, 117360 (3)	ITPR1, SCA15, SCA16, SCA29	147265	3p26.1	SCA29
Spinocerebellar ataxia 31, 117210 (3)	BEAN, SCA31	612051	16q21	BEAN
Spinocerebellar ataxia 31, 117210 (3)	BEAN, SCA31	612051	16q21	SCA31
Spinocerebellar ataxia 32 (2)	SCA32	613909	7q32-q33	SCA32
Spinocerebellar ataxia 35, 613908 (3)	TGM6, TG6, TGY, SCA35	613900	20p13	TGM6
Spinocerebellar ataxia 35, 613908 (3)	TGM6, TG6, TGY, SCA35	613900	20p13	TG6
Spinocerebellar ataxia 35, 613908 (3)	TGM6, TG6, TGY, SCA35	613900	20p13	TGY
Spinocerebellar ataxia 35, 613908 (3)	TGM6, TG6, TGY, SCA35	613900	20p13	SCA35
Spinocerebellar ataxia 36, 614153 (3)	NOP56, SCA36	614154	20p13	NOP56
Spinocerebellar ataxia 36, 614153 (3)	NOP56, SCA36	614154	20p13	SCA36
Spinocerebellar ataxia 37 (2)	SCA37	615945	1p32	SCA37
Spinocerebellar ataxia 38, 615957 (3)	ELOVL5, HELO1, SCA38	611805	6p12.1	ELOVL5
Spinocerebellar ataxia 38, 615957 (3)	ELOVL5, HELO1, SCA38	611805	6p12.1	HELO1
Spinocerebellar ataxia 38, 615957 (3)	ELOVL5, HELO1, SCA38	611805	6p12.1	SCA38
Spinocerebellar ataxia 4 (2)	SCA4	600223	16q22.1	SCA4
Spinocerebellar ataxia 42, 616795 (3)	CACNA1G, SCA42	604065	17q21.33	CACNA1G
Spinocerebellar ataxia 42, 616795 (3)	CACNA1G, SCA42	604065	17q21.33	SCA42
Spinocerebellar ataxia 5, 600224 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SPTBN2
Spinocerebellar ataxia 5, 600224 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SCA5
Spinocerebellar ataxia 5, 600224 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SCAR14
Spinocerebellar ataxia 6, 183086 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNA1A
Spinocerebellar ataxia 6, 183086 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	CACNL1A4
Spinocerebellar ataxia 6, 183086 (3)	CACNA1A, CACNL1A4, SCA6	601011	19p13.13	SCA6
Spinocerebellar ataxia 7, 164500 (3)	ATXN7, SCA7, OPCA3	607640	3p14.1	ATXN7
Spinocerebellar ataxia 7, 164500 (3)	ATXN7, SCA7, OPCA3	607640	3p14.1	SCA7
Spinocerebellar ataxia 7, 164500 (3)	ATXN7, SCA7, OPCA3	607640	3p14.1	OPCA3
Spinocerebellar ataxia 8, 608768 (3)	ATXN8	613289	13q21	ATXN8
Spinocerebellar ataxia 8, 608768 (3)	ATXN8OS, SCA8, KLHL1AS	603680	13q21.33	ATXN8OS
Spinocerebellar ataxia 8, 608768 (3)	ATXN8OS, SCA8, KLHL1AS	603680	13q21.33	SCA8
Spinocerebellar ataxia 8, 608768 (3)	ATXN8OS, SCA8, KLHL1AS	603680	13q21.33	KLHL1AS
Spinocerebellar ataxia, X-linked 5 (2)	SCAX5	300703	Xq25-q27.1	SCAX5
Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SETX
Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	SCAR1
Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	AOA2
Spinocerebellar ataxia, autosomal recessive 1, 606002 (3)	SETX, SCAR1, AOA2, ALS4	608465	9q34.13	ALS4
Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	ANO10, TMEM16K, SCAR10	613726	3p22.1-p21.3	ANO10
Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	ANO10, TMEM16K, SCAR10	613726	3p22.1-p21.3	TMEM16K
Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)	ANO10, TMEM16K, SCAR10	613726	3p22.1-p21.3	SCAR10
Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	SYT14, SCAR11	610949	1q32.2	SYT14
Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)	SYT14, SCAR11	610949	1q32.2	SCAR11
Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	GRM1, MGLUR1, GRM1A, SCAR13	604473	6q24.3	GRM1
Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	GRM1, MGLUR1, GRM1A, SCAR13	604473	6q24.3	MGLUR1
Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	GRM1, MGLUR1, GRM1A, SCAR13	604473	6q24.3	GRM1A
Spinocerebellar ataxia, autosomal recessive 13, 614831 (3)	GRM1, MGLUR1, GRM1A, SCAR13	604473	6q24.3	SCAR13
Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SPTBN2
Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SCA5
Spinocerebellar ataxia, autosomal recessive 14, 615386 (3)	SPTBN2, SCA5, SCAR14	604985	11q13.2	SCAR14
Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	STUB1, CHIP, SCAR16	607207	16p13.3	STUB1
Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	STUB1, CHIP, SCAR16	607207	16p13.3	CHIP
Spinocerebellar ataxia, autosomal recessive 16, 615768 (3)	STUB1, CHIP, SCAR16	607207	16p13.3	SCAR16
Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	GRID2, SCAR18	602368	4q22.1-q22.2	GRID2
Spinocerebellar ataxia, autosomal recessive 18, 616204 (3)	GRID2, SCAR18	602368	4q22.1-q22.2	SCAR18
Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	PMPCA, KIAA0123, SCAR2	613036	9q34.3	PMPCA
Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	PMPCA, KIAA0123, SCAR2	613036	9q34.3	KIAA0123
Spinocerebellar ataxia, autosomal recessive 2, 213200 (3)	PMPCA, KIAA0123, SCAR2	613036	9q34.3	SCAR2
Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	SNX14, SCAR20	616105	6q14.3	SNX14
Spinocerebellar ataxia, autosomal recessive 20, 616354 (3)	SNX14, SCAR20	616105	6q14.3	SCAR20
Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	SCYL1, NTKL, SCAR21	607982	11q13.1	SCYL1
Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	SCYL1, NTKL, SCAR21	607982	11q13.1	NTKL
Spinocerebellar ataxia, autosomal recessive 21, 616719 (3)	SCYL1, NTKL, SCAR21	607982	11q13.1	SCAR21
Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	TDP2, TTRAP	605764	6p22.3	TDP2
Spinocerebellar ataxia, autosomal recessive 23, 616949 (3)	TDP2, TTRAP	605764	6p22.3	TTRAP
Spinocerebellar ataxia, autosomal recessive 3 (2)	SCAR3, SCABD	271250	6p23-p21	SCAR3
Spinocerebellar ataxia, autosomal recessive 3 (2)	SCAR3, SCABD	271250	6p23-p21	SCABD
Spinocerebellar ataxia, autosomal recessive 4 (2)	SCAR4, SCASI	607317	1p36	SCAR4
Spinocerebellar ataxia, autosomal recessive 4 (2)	SCAR4, SCASI	607317	1p36	SCASI
Spinocerebellar ataxia, autosomal recessive 6 (2)	SCAR6, CLA3	608029	20q11-q13	SCAR6
Spinocerebellar ataxia, autosomal recessive 6 (2)	SCAR6, CLA3	608029	20q11-q13	CLA3
Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	TPP1
Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	CLN2
Spinocerebellar ataxia, autosomal recessive 7, 609270 (3)	TPP1, CLN2, SCAR7	607998	11p15.4	SCAR7
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SYNE1
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA0796
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA1756
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	KIAA1262
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	SCAR8
Spinocerebellar ataxia, autosomal recessive 8, 610743 (3)	SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4	608441	6q25.2	EDMD4
Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)	TDP1	607198	14q32.11	TDP1
Spinocrebellar ataxia, autosomal recessive 12, 614322 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	WWOX
Spinocrebellar ataxia, autosomal recessive 12, 614322 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	FOR
Spinocrebellar ataxia, autosomal recessive 12, 614322 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	SCAR12
Spinocrebellar ataxia, autosomal recessive 12, 614322 (3)	WWOX, FOR, SCAR12, EIEE28	605131	16q23.1-q23.2	EIEE28
Split hand/foot malformation 1 (4)	SHFM1, SHFD1, SHSF1	183600	7q21.2-q21.3	SHFM1
Split hand/foot malformation 1 (4)	SHFM1, SHFD1, SHSF1	183600	7q21.2-q21.3	SHFD1
Split hand/foot malformation 1 (4)	SHFM1, SHFD1, SHSF1	183600	7q21.2-q21.3	SHSF1
Split hand/foot malformation 2 (2)	SHFM2, SHFD2	313350	Xq26	SHFM2
Split hand/foot malformation 2 (2)	SHFM2, SHFD2	313350	Xq26	SHFD2
Split-foot malformation with mesoaxial polydactyly, 616890 (3)	ZAK, MLTK, MRK, SFMMP	609479	2q31.1	ZAK
Split-foot malformation with mesoaxial polydactyly, 616890 (3)	ZAK, MLTK, MRK, SFMMP	609479	2q31.1	MLTK
Split-foot malformation with mesoaxial polydactyly, 616890 (3)	ZAK, MLTK, MRK, SFMMP	609479	2q31.1	MRK
Split-foot malformation with mesoaxial polydactyly, 616890 (3)	ZAK, MLTK, MRK, SFMMP	609479	2q31.1	SFMMP
Split-hand/foot malformation 3, gene duplication syndrome (4)	SHFM3, SHSF3, DUP10q24, C10DUPq24	246560	10q24	SHFM3
Split-hand/foot malformation 3, gene duplication syndrome (4)	SHFM3, SHSF3, DUP10q24, C10DUPq24	246560	10q24	SHSF3
Split-hand/foot malformation 3, gene duplication syndrome (4)	SHFM3, SHSF3, DUP10q24, C10DUPq24	246560	10q24	DUP10q24
Split-hand/foot malformation 3, gene duplication syndrome (4)	SHFM3, SHSF3, DUP10q24, C10DUPq24	246560	10q24	C10DUPq24
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP63
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	TP73L
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	KET
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	EEC3
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	SHFM4
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	LMS
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	RHS
Split-hand/foot malformation 4, 605289 (3)	TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8	603273	3q28	OFC8
Split-hand/foot malformation 5 (2)	SHFM5	606708	2q31	SHFM5
Split-hand/foot malformation 6, 225300 (3)	WNT10B, SHFM6	601906	12q13.12	WNT10B
Split-hand/foot malformation 6, 225300 (3)	WNT10B, SHFM6	601906	12q13.12	SHFM6
Split-hand/foot malformation with long bone deficiency 1 (2)	SHFL1, SHFLD	119100	1q42.2-q43	SHFL1
Split-hand/foot malformation with long bone deficiency 1 (2)	SHFL1, SHFLD	119100	1q42.2-q43	SHFLD
Split-hand/foot malformation with long bone deficiency 2 (2)	SHFLD2	610685	6q14.1	SHFLD2
Split-hand/foot malformation with long bone deficiency 3 (4)	SHFLD3, DUP17p13.3, C17DUPp13.3	612576	17p13.3-p13.1	SHFLD3
Split-hand/foot malformation with long bone deficiency 3 (4)	SHFLD3, DUP17p13.3, C17DUPp13.3	612576	17p13.3-p13.1	DUP17p13.3
Split-hand/foot malformation with long bone deficiency 3 (4)	SHFLD3, DUP17p13.3, C17DUPp13.3	612576	17p13.3-p13.1	C17DUPp13.3
Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	NKX3-2, BAPX1, SMMD	602183	4p15.33	NKX3-2
Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	NKX3-2, BAPX1, SMMD	602183	4p15.33	BAPX1
Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)	NKX3-2, BAPX1, SMMD	602183	4p15.33	SMMD
Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	FLNB
Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	SCT
Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	AOI
Spondylocarpotarsal synostosis syndrome, 272460 (3)	FLNB, SCT, AOI, LRS1	603381	3p14.3	LRS1
Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)	SLC39A13	608735	11p11.2	SLC39A13
Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	DLL3, SCDO1	602768	19q13.2	DLL3
Spondylocostal dysostosis 1, autosomal recessive, 277300 (3)	DLL3, SCDO1	602768	19q13.2	SCDO1
Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	MESP2, SCDO2	605195	15q26.1	MESP2
Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)	MESP2, SCDO2	605195	15q26.1	SCDO2
Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	HES7, SCDO4	608059	17p13.1	HES7
Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)	HES7, SCDO4	608059	17p13.1	SCDO4
Spondylocostal dysostosis 5, 122600 (3)	TBX6, SCDO5	602427	16p11.2	TBX6
Spondylocostal dysostosis 5, 122600 (3)	TBX6, SCDO5	602427	16p11.2	SCDO5
Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	ACP5, SPENCDI	171640	19p13.2	ACP5
Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)	ACP5, SPENCDI	171640	19p13.2	SPENCDI
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	B3GALT6
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	SEMDJL1
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3)	B3GALT6, SEMDJL1, EDSP2	615291	1p36.33	EDSP2
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	KIF22
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	KNSL4
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	KID
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	OBP
Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3)	KIF22, KNSL4, KID, OBP, SEMDJL2	603213	16p11.2	SEMDJL2
Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	EDM5
Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	HOA
Spondyloepimetaphyseal dysplasia, 608728 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	OS2
Spondyloepimetaphyseal dysplasia, Genevieve type, 610442 (3)	NANS, SAS, SEMDG	605202	9q22.33	NANS
Spondyloepimetaphyseal dysplasia, Genevieve type, 610442 (3)	NANS, SAS, SEMDG	605202	9q22.33	SAS
Spondyloepimetaphyseal dysplasia, Genevieve type, 610442 (3)	NANS, SAS, SEMDG	605202	9q22.33	SEMDG
Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MMP13
Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	CLG3
Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MANDP1
Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3)	MMP13, CLG3, MANDP1, MDST	600108	11q22.2	MDST
Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3)	BGN, SEMDX	301870	Xq28	BGN
Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3)	BGN, SEMDX	301870	Xq28	SEMDX
Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	ACAN
Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	AGC1
Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	CSPG1
Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	MSK16
Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	SEDK
Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	WISP3
Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	PPAC
Spondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3)	WISP3, PPAC, PPD	603400	6q21	PPD
Spondyloepiphyseal dysplasia tarda, 313400 (3)	TRAPPC2, SEDL, SEDT	300202	Xp22.2	TRAPPC2
Spondyloepiphyseal dysplasia tarda, 313400 (3)	TRAPPC2, SEDL, SEDT	300202	Xp22.2	SEDL
Spondyloepiphyseal dysplasia tarda, 313400 (3)	TRAPPC2, SEDL, SEDT	300202	Xp22.2	SEDT
Spondyloepiphyseal dysplasia tarda, autosomal dominant (2)	SPDT	184100	12q13	SPDT
Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	CHST3, C6ST, C6ST1, HSD	603799	10q22.1	CHST3
Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	CHST3, C6ST, C6ST1, HSD	603799	10q22.1	C6ST
Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	CHST3, C6ST, C6ST1, HSD	603799	10q22.1	C6ST1
Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3)	CHST3, C6ST, C6ST1, HSD	603799	10q22.1	HSD
Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	ACAN
Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	AGC1
Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	CSPG1
Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	MSK16
Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3)	ACAN, AGC1, CSPG1, MSK16, SEDK	155760	15q26.1	SEDK
Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3)	COL2A1	120140	12q13.11	COL2A1
Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	DDR2, NTRKR3, TKT	191311	1q23.3	DDR2
Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	DDR2, NTRKR3, TKT	191311	1q23.3	NTRKR3
Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)	DDR2, NTRKR3, TKT	191311	1q23.3	TKT
Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	PCYT1A, CTPCT, PCYT1, SMDCRD	123695	3q29	PCYT1A
Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	PCYT1A, CTPCT, PCYT1, SMDCRD	123695	3q29	CTPCT
Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	PCYT1A, CTPCT, PCYT1, SMDCRD	123695	3q29	PCYT1
Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3)	PCYT1A, CTPCT, PCYT1, SMDCRD	123695	3q29	SMDCRD
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
Spondylometaphyseal dysplasia, Kozlowski type, 184252 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	PAM16, MAGMAS, SMDMDM	614336	16p13.3	PAM16
Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	PAM16, MAGMAS, SMDMDM	614336	16p13.3	MAGMAS
Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3)	PAM16, MAGMAS, SMDMDM	614336	16p13.3	SMDMDM
Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	GPX4, SMDS	138322	19p13.3	GPX4
Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3)	GPX4, SMDS	138322	19p13.3	SMDS
Spondyloocular syndrome, 605822 (3)	XYLT2, XT2, SOS	608125	17q21.33	XYLT2
Spondyloocular syndrome, 605822 (3)	XYLT2, XT2, SOS	608125	17q21.33	XT2
Spondyloocular syndrome, 605822 (3)	XYLT2, XT2, SOS	608125	17q21.33	SOS
Spondylopeimetaphyseal dsyplasia, Faden-Alkuraya type, 616723 (3)	RSPRY1, KIAA1972, SEMDFA	616585	16q13	RSPRY1
Spondylopeimetaphyseal dsyplasia, Faden-Alkuraya type, 616723 (3)	RSPRY1, KIAA1972, SEMDFA	616585	16q13	KIAA1972
Spondylopeimetaphyseal dsyplasia, Faden-Alkuraya type, 616723 (3)	RSPRY1, KIAA1972, SEMDFA	616585	16q13	SEMDFA
Spondyloperipheral dysplasia, 271700 (3)	COL2A1	120140	12q13.11	COL2A1
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	TNFRSF6
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	APT1
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	CD95
Squamous cell carcinoma, burn scar-related, somatic (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	ALPS1A
Squamous cell carcinoma, head and neck, 275355 (3)	TNFRSF10B, DR5, TRAILR2	603612	8p21.3	TNFRSF10B
Squamous cell carcinoma, head and neck, 275355 (3)	TNFRSF10B, DR5, TRAILR2	603612	8p21.3	DR5
Squamous cell carcinoma, head and neck, 275355 (3)	TNFRSF10B, DR5, TRAILR2	603612	8p21.3	TRAILR2
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	ING1	601566	13q34	ING1
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
Squamous cell carcinoma, head and neck, somatic, 275355 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
Stapes ankylosis with broad thumb and toes, 184460 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Stapes ankylosis with broad thumb and toes, 184460 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYM1
Stapes ankylosis with broad thumb and toes, 184460 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYNS1A
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
Stargardt disease 1, 248200 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ELOVL4
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ADMD
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD2
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	STGD3
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	ISQMR
Stargardt disease 3, 600110 (3)	ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34	605512	6q14.1	SCA34
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROM1
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	PROML1
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	AC133
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	RP41
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CORD12
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	CD133
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	MCDR2
Stargardt disease 4, 603786 (3)	PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4	604365	4p15.32	STGD4
Steatocystoma multiplex, 184500 (3)	KRT17, PC2, PCHC1	148069	17q21.2	KRT17
Steatocystoma multiplex, 184500 (3)	KRT17, PC2, PCHC1	148069	17q21.2	PC2
Steatocystoma multiplex, 184500 (3)	KRT17, PC2, PCHC1	148069	17q21.2	PCHC1
Stickler sydrome, type I, nonsyndromic ocular, 609508 (3)	COL2A1	120140	12q13.11	COL2A1
Stickler syndrome, type I, 108300 (3)	COL2A1	120140	12q13.11	COL2A1
Stickler syndrome, type II, 604841 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
Stickler syndrome, type II, 604841 (3)	COL11A1, STL2	120280	1p21.1	STL2
Stickler syndrome, type III, 184840 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Stickler syndrome, type III, 184840 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Stickler syndrome, type III, 184840 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Stickler syndrome, type III, 184840 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Stickler syndrome, type III, 184840 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Stickler syndrome, type IV, 614134 (3)	COL9A1, EDM6, STL4	120210	6q13	COL9A1
Stickler syndrome, type IV, 614134 (3)	COL9A1, EDM6, STL4	120210	6q13	EDM6
Stickler syndrome, type IV, 614134 (3)	COL9A1, EDM6, STL4	120210	6q13	STL4
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Stiff skin syndrome, 184900 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT18
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	PED
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1DS
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	EIG12
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT9
Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SDCHCN
Stormorken syndrome, 185070 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STIM1
Stormorken syndrome, 185070 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	TAM1
Stormorken syndrome, 185070 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	IMD10
Stormorken syndrome, 185070 (3)	STIM1, TAM1, IMD10, STRMK	605921	11p15.4	STRMK
Striatal degeneration, autosomal dominant, 609161 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PDE8B
Striatal degeneration, autosomal dominant, 609161 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	PPNAD3
Striatal degeneration, autosomal dominant, 609161 (3)	PDE8B, PPNAD3, ADSD	603390	5q13.3	ADSD
Striatal degeneration, autosomal dominant, 616922 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	PDE10A
Striatal degeneration, autosomal dominant, 616922 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	IOLOD
Striatal degeneration, autosomal dominant, 616922 (3)	PDE10A, IOLOD, ADSD2	610652	6q27	ADSD2
Striatonigral degeneration, childhood-onset, 617054 (3)	VAC14, TAX1BP2, TRX, SNDC	604632	16q22.1-q22.2	VAC14
Striatonigral degeneration, childhood-onset, 617054 (3)	VAC14, TAX1BP2, TRX, SNDC	604632	16q22.1-q22.2	TAX1BP2
Striatonigral degeneration, childhood-onset, 617054 (3)	VAC14, TAX1BP2, TRX, SNDC	604632	16q22.1-q22.2	TRX
Striatonigral degeneration, childhood-onset, 617054 (3)	VAC14, TAX1BP2, TRX, SNDC	604632	16q22.1-q22.2	SNDC
Striatonigral degeneration, infantile, 271930 (3)	NUP62, SNDI, IBSN	605815	19q13.33	NUP62
Striatonigral degeneration, infantile, 271930 (3)	NUP62, SNDI, IBSN	605815	19q13.33	SNDI
Striatonigral degeneration, infantile, 271930 (3)	NUP62, SNDI, IBSN	605815	19q13.33	IBSN
Stromme syndrome, 243605 (3)	CENPF, CILD31, STROMS	600236	1q41	CENPF
Stromme syndrome, 243605 (3)	CENPF, CILD31, STROMS	600236	1q41	CILD31
Stromme syndrome, 243605 (3)	CENPF, CILD31, STROMS	600236	1q41	STROMS
Sturge-Weber syndrome, somatic, mosaic, 185300 (3)	GNAQ, SWS, CMC1	600998	9q21.2	GNAQ
Sturge-Weber syndrome, somatic, mosaic, 185300 (3)	GNAQ, SWS, CMC1	600998	9q21.2	SWS
Sturge-Weber syndrome, somatic, mosaic, 185300 (3)	GNAQ, SWS, CMC1	600998	9q21.2	CMC1
Stuttering, familial persistent, 1, 184450 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	AP4E1
Stuttering, familial persistent, 1, 184450 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	SPG51
Stuttering, familial persistent, 1, 184450 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	CPSQ4
Stuttering, familial persistent, 1, 184450 (3)	AP4E1, SPG51, CPSQ4, STUT1	607244	15q21.2	STUT1
Stuttering, familial persistent, 2 (2)	STUT2	609261	12q24.1	STUT2
Stuttering, familial persistent, 3 (2)	STUT3	614655	3q13.2-q13.33	STUT3
Stuttering, familial persistent, 4 (2)	STUT4	614668	16q12.1-q23.1	STUT4
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR, STWS, SWS, SJS2	151443	5p13.1	LIFR
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR, STWS, SWS, SJS2	151443	5p13.1	STWS
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR, STWS, SWS, SJS2	151443	5p13.1	SWS
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)	LIFR, STWS, SWS, SJS2	151443	5p13.1	SJS2
Subcortical laminal heteropia, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DCX
Subcortical laminal heteropia, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	DBCN
Subcortical laminal heteropia, X-linked, 300067 (3)	DCX, DBCN, LISX	300121	Xq23	LISX
Subcortical laminar heterotopia, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	PAFAH1B1
Subcortical laminar heterotopia, 607432 (3)	PAFAH1B1, LIS1	601545	17p13.3	LIS1
Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	ALDH5A1, SSADH	610045	6p22.3	ALDH5A1
Succinic semialdehyde dehydrogenase deficiency, 271980 (3)	ALDH5A1, SSADH	610045	6p22.3	SSADH
Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	OXCT1, OXCT, SCOT	601424	5p13.1	OXCT1
Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	OXCT1, OXCT, SCOT	601424	5p13.1	OXCT
Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)	OXCT1, OXCT, SCOT	601424	5p13.1	SCOT
Sucrase-isomaltase deficiency, congenital, 222900 (3)	SI	609845	3q26.1	SI
Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	TSPYL1, TSPYL, SIDDT	604714	6q22.1	TSPYL1
Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	TSPYL1, TSPYL, SIDDT	604714	6q22.1	TSPYL
Sudden infant death with dysgenesis of the testes syndrome, 608800 (3)	TSPYL1, TSPYL, SIDDT	604714	6q22.1	SIDDT
Sulfite oxidase deficiency, 272300 (3)	SUOX	606887	12q13.2	SUOX
Supernumerary der(22)t(8-22) syndrome (4)	DER22t8-22	613700	22q11.2	DER22t8-22
Supranuclear palsy, progressive atypical, 260540 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Supranuclear palsy, progressive atypical, 260540 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MTBT1
Supranuclear palsy, progressive atypical, 260540 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	DDPAC
Supranuclear palsy, progressive atypical, 260540 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MSTD
Supranuclear palsy, progressive, 2 (2)	PSNP2	609454	1q31.1	PSNP2
Supranuclear palsy, progressive, 3 (2)	PSNP3	610898	11p12-p11	PSNP3
Supranuclear palsy, progressive, 601104 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
Supranuclear palsy, progressive, 601104 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MTBT1
Supranuclear palsy, progressive, 601104 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	DDPAC
Supranuclear palsy, progressive, 601104 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MSTD
Supravalvar aortic stenosis, 185500 (3)	ELN	130160	7q11.23	ELN
Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	SFTPB, SFTB3, SMDP1	178640	2p11.2	SFTPB
Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	SFTPB, SFTB3, SMDP1	178640	2p11.2	SFTB3
Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)	SFTPB, SFTB3, SMDP1	178640	2p11.2	SMDP1
Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	SFTPC, SFTP2, SMDP2	178620	8p21.3	SFTPC
Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	SFTPC, SFTP2, SMDP2	178620	8p21.3	SFTP2
Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)	SFTPC, SFTP2, SMDP2	178620	8p21.3	SMDP2
Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	ABCA3, ABC3, SMDP3	601615	16p13.3	ABCA3
Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	ABCA3, ABC3, SMDP3	601615	16p13.3	ABC3
Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)	ABCA3, ABC3, SMDP3	601615	16p13.3	SMDP3
Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	CSF2RA, SMDP4	306250	Xp22.33	CSF2RA
Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)	CSF2RA, SMDP4	306250	Xp22.33	SMDP4
Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	CSF2RB, SMDP5	138981	22q12.3	CSF2RB
Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)	CSF2RB, SMDP5	138981	22q12.3	SMDP5
Sveinsson chorioretinal atrophy, 108985 (3)	TEAD1, TCF13, REF1	189967	11p15.3	TEAD1
Sveinsson chorioretinal atrophy, 108985 (3)	TEAD1, TCF13, REF1	189967	11p15.3	TCF13
Sveinsson chorioretinal atrophy, 108985 (3)	TEAD1, TCF13, REF1	189967	11p15.3	REF1
Sweat chloride elevation without CF (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
Sweat chloride elevation without CF (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
Sweat chloride elevation without CF (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
Sweat chloride elevation without CF (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	TUBB5
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	M40
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	CDCBM6
Symmetric circumferential skin creases, congenital, 1, 156610 (3)	TUBB, TUBB5, M40, CDCBM6, CSCSC1	191130	6p21.33	CSCSC1
Symmetric circumferential skin creases, congenital, 2, 616734 (3)	MAPRE2, EB2, RP1, CSCSC2	605789	18q12.1-q12.2	MAPRE2
Symmetric circumferential skin creases, congenital, 2, 616734 (3)	MAPRE2, EB2, RP1, CSCSC2	605789	18q12.1-q12.2	EB2
Symmetric circumferential skin creases, congenital, 2, 616734 (3)	MAPRE2, EB2, RP1, CSCSC2	605789	18q12.1-q12.2	RP1
Symmetric circumferential skin creases, congenital, 2, 616734 (3)	MAPRE2, EB2, RP1, CSCSC2	605789	18q12.1-q12.2	CSCSC2
Symphalangism, proximal, 1A, 185800 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Symphalangism, proximal, 1A, 185800 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYM1
Symphalangism, proximal, 1A, 185800 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYNS1A
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
Symphalangism, proximal, 1B, 615298 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
Syncope, familial vasovagal (2)	VVS	609289	15q26	VVS
Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHA9
Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	BHLHF42
Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	MSSD
Syndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3)	BHLHA9, BHLHF42, MSSD, CCSPD	615416	17p13.3	CCSPD
Syndactyly, type 1, with or without craniosynostosis (4)	DUP2q35, C2DUPq35, SDTY1, SD1	185900	2q34-q36	DUP2q35
Syndactyly, type 1, with or without craniosynostosis (4)	DUP2q35, C2DUPq35, SDTY1, SD1	185900	2q34-q36	C2DUPq35
Syndactyly, type 1, with or without craniosynostosis (4)	DUP2q35, C2DUPq35, SDTY1, SD1	185900	2q34-q36	SDTY1
Syndactyly, type 1, with or without craniosynostosis (4)	DUP2q35, C2DUPq35, SDTY1, SD1	185900	2q34-q36	SD1
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	GJA1
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CX43
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODDD
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	SDTY3
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	ODOD
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HSS
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	AVSD3
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	HLHS1
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	CMDR
Syndactyly, type III, 186100 (3)	GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP	121014	6q22.31	EKVP
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Syndactyly, type IV, 186200 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Syndactyly, type V, 186300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Syndactyly, type V, 186300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOX4I
Syndactyly, type V, 186300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	SPD1
Syndactyly, type V, 186300 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	BDSD
Synesthesia (2)	SYNSTH	612759	2q24.1	SYNSTH
Synpolydactyly 1, 186000 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOXD13
Synpolydactyly 1, 186000 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	HOX4I
Synpolydactyly 1, 186000 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	SPD1
Synpolydactyly 1, 186000 (3)	HOXD13, HOX4I, SPD1, BDSD	142989	2q31.1	BDSD
Synpolydactyly 3 (2)	SPD3	610234	14q11.2-q12	SPD3
Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4)	FBLN1	135820	22q13.31	FBLN1
Systemic lupus erythematosus 16, 614420 (3)	DNASE1L3, SLEB16	602244	3p14.3	DNASE1L3
Systemic lupus erythematosus 16, 614420 (3)	DNASE1L3, SLEB16	602244	3p14.3	SLEB16
T-cell acute lymphoblastic leukemia, somatic, 613065 (3)	BAX	600040	19q13.33	BAX
T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	FOXN1, WHN	600838	17q11.2	FOXN1
T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3)	FOXN1, WHN	600838	17q11.2	WHN
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	STK4, MST1, KRS2, TIIAC	604965	20q13.12	STK4
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	STK4, MST1, KRS2, TIIAC	604965	20q13.12	MST1
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	STK4, MST1, KRS2, TIIAC	604965	20q13.12	KRS2
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)	STK4, MST1, KRS2, TIIAC	604965	20q13.12	TIIAC
T-cell prolymphocytic leukemia, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATM
T-cell prolymphocytic leukemia, somatic (3)	ATM, ATA, AT1	607585	11q22.3	ATA
T-cell prolymphocytic leukemia, somatic (3)	ATM, ATA, AT1	607585	11q22.3	AT1
TARP syndrome, 311900 (3)	RBM10, DXS8237E, KIAA0122, TARPS	300080	Xp11.3	RBM10
TARP syndrome, 311900 (3)	RBM10, DXS8237E, KIAA0122, TARPS	300080	Xp11.3	DXS8237E
TARP syndrome, 311900 (3)	RBM10, DXS8237E, KIAA0122, TARPS	300080	Xp11.3	KIAA0122
TARP syndrome, 311900 (3)	RBM10, DXS8237E, KIAA0122, TARPS	300080	Xp11.3	TARPS
Takenouchi-Kosaki syndrome, 616737 (3)	CDC42, TKS	116952	1p36.12	CDC42
Takenouchi-Kosaki syndrome, 616737 (3)	CDC42, TKS	116952	1p36.12	TKS
Tangier disease, 205400 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
Tangier disease, 205400 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABC1
Tangier disease, 205400 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	HDLDT1
Tangier disease, 205400 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	TGD
Tarsal-carpal coalition syndrome, 186570 (3)	NOG, SYM1, SYNS1A	602991	17q22	NOG
Tarsal-carpal coalition syndrome, 186570 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYM1
Tarsal-carpal coalition syndrome, 186570 (3)	NOG, SYM1, SYNS1A	602991	17q22	SYNS1A
Tatton-Brown-Rahman syndrome, 615879 (3)	DNMT3A, TBRS	602769	2p23.3	DNMT3A
Tatton-Brown-Rahman syndrome, 615879 (3)	DNMT3A, TBRS	602769	2p23.3	TBRS
Tay-Sachs disease, 272800 (3)	HEXA, TSD	606869	15q23	HEXA
Tay-Sachs disease, 272800 (3)	HEXA, TSD	606869	15q23	TSD
Telangiectasia, hereditary benign (2)	HBT	187260	5q14	HBT
Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	ENG, END, HHT1, ORW	131195	9q34.11	ENG
Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	ENG, END, HHT1, ORW	131195	9q34.11	END
Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	ENG, END, HHT1, ORW	131195	9q34.11	HHT1
Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)	ENG, END, HHT1, ORW	131195	9q34.11	ORW
Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q13.13	ACVRL1
Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q13.13	ACVRLK1
Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q13.13	ALK1
Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)	ACVRL1, ACVRLK1, ALK1, HHT2	601284	12q13.13	HHT2
Telangiectasia, hereditary hemorrhagic, type 3 (2)	HHT3, ORW3	601101	5q31.3-q32	HHT3
Telangiectasia, hereditary hemorrhagic, type 3 (2)	HHT3, ORW3	601101	5q31.3-q32	ORW3
Telangiectasia, hereditary hemorrhagic, type 4 (2)	HHT4	610655	7p14	HHT4
Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	GDF2, BMP9, HHT5	605120	10q11.22	GDF2
Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	GDF2, BMP9, HHT5	605120	10q11.22	BMP9
Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3)	GDF2, BMP9, HHT5	605120	10q11.22	HHT5
Temple syndrome (4)	TEMPS	616222	14q32	TEMPS
Temple-Baraitser syndrome, 611816 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	KCNH1
Temple-Baraitser syndrome, 611816 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	EAG
Temple-Baraitser syndrome, 611816 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	TMBTS
Temple-Baraitser syndrome, 611816 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	ZLS1
Temtamy preaxial brachydactyly syndrome, 605282 (3)	CHSY1, KIAA0990, TPBS	608183	15q26.3	CHSY1
Temtamy preaxial brachydactyly syndrome, 605282 (3)	CHSY1, KIAA0990, TPBS	608183	15q26.3	KIAA0990
Temtamy preaxial brachydactyly syndrome, 605282 (3)	CHSY1, KIAA0990, TPBS	608183	15q26.3	TPBS
Temtamy syndrome, 218340 (3)	C12orf57, C10, TEMTYS	615140	12p13.31	C12orf57
Temtamy syndrome, 218340 (3)	C12orf57, C10, TEMTYS	615140	12p13.31	C10
Temtamy syndrome, 218340 (3)	C12orf57, C10, TEMTYS	615140	12p13.31	TEMTYS
Tenorio syndrome, 616260 (3)	RNF125, TRAC1, TNORS	610432	18q12.1	RNF125
Tenorio syndrome, 616260 (3)	RNF125, TRAC1, TNORS	610432	18q12.1	TRAC1
Tenorio syndrome, 616260 (3)	RNF125, TRAC1, TNORS	610432	18q12.1	TNORS
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLNA
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FLN1
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	NHBP
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD1
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	OPD2
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	FMD
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	MNS
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CVD1
Terminal osseous dysplasia, 300244 (3)	FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS	300017	Xq28	CSBS
Testicular germ cell tumor (2)	TGCT1	300228	Xq27	TGCT1
Testicular tumor, somatic, 273300 (3)	STK11, PJS, LKB1	602216	19p13.3	STK11
Testicular tumor, somatic, 273300 (3)	STK11, PJS, LKB1	602216	19p13.3	PJS
Testicular tumor, somatic, 273300 (3)	STK11, PJS, LKB1	602216	19p13.3	LKB1
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	ASD2
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	VSD1
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TACHD
Tetralogy of Fallot, 187500 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TOF
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	GATA6
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	ASD9
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	AVSD5
Tetralogy of Fallot, 187500 (3)	GATA6, AVSD5, ASD9, AVSD5, PACHD	601656	18q11.2	PACHD
Tetralogy of Fallot, 187500 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Tetralogy of Fallot, 187500 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DTGA3
Tetralogy of Fallot, 187500 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DORV
Tetralogy of Fallot, 187500 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	RAI
Tetralogy of Fallot, 187500 (3)	JAG1, AGS, AHD	601920	20p12.2	JAG1
Tetralogy of Fallot, 187500 (3)	JAG1, AGS, AHD	601920	20p12.2	AGS
Tetralogy of Fallot, 187500 (3)	JAG1, AGS, AHD	601920	20p12.2	AHD
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGS
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CTHM
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CAFS
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TGA
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DORV
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	VCFS
Tetralogy of Fallot, 187500 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGCR
Tetralogy of Fallot, 187500 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	ZFPM2
Tetralogy of Fallot, 187500 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	FOG2
Tetralogy of Fallot, 187500 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	DIH3
Tetralogy of Fallot, 187500 (3)	ZFPM2, FOG2, DIH3, SRXY9	603693	8q23.1	SRXY9
Tetrasomy 18p (4)	TET18P	614290	18p	TET18P
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Tetrology of Fallot, 187500 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Thalassemia due to Hb Lepore (3)	HBD	142000	11p15.4	HBD
Thalassemia, Hispanic gamma-delta-beta, 613985 (3)	LCRB	152424	11p15.4	LCRB
Thalassemia, alpha-, 604131 (3)	HBA2, HBH	141850	16p13.3	HBA2
Thalassemia, alpha-, 604131 (3)	HBA2, HBH	141850	16p13.3	HBH
Thalassemia, delta- (3)	HBD	142000	11p15.4	HBD
Thalassemia-beta, dominant inclusion-body, 603902 (3)	HBB	141900	11p15.4	HBB
Thalassemias, alpha-, 604131 (3)	HBA1, HBH	141800	16p13.3	HBA1
Thalassemias, alpha-, 604131 (3)	HBA1, HBH	141800	16p13.3	HBH
Thalassemias, beta-, 613985 (3)	HBB	141900	11p15.4	HBB
Thanatophoric dysplasia, type I, 187600 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Thanatophoric dysplasia, type I, 187600 (3)	FGFR3, ACH	134934	4p16.3	ACH
Thanatophoric dysplasia, type II, 187601 (3)	FGFR3, ACH	134934	4p16.3	FGFR3
Thanatophoric dysplasia, type II, 187601 (3)	FGFR3, ACH	134934	4p16.3	ACH
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	SLC19A3, THMD2, BBGD	606152	2q36.3	SLC19A3
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	SLC19A3, THMD2, BBGD	606152	2q36.3	THMD2
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3)	SLC19A3, THMD2, BBGD	606152	2q36.3	BBGD
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	SLC25A19
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	DNC
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	MUP1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	MCPHA
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	THMD3
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3)	SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4	606521	17q25.1	THMD4
Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	TPK1, THMD5	606370	7q35	TPK1
Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3)	TPK1, THMD5	606370	7q35	THMD5
Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2, THTR1, TRMA, THMD1	603941	1q24.2	SLC19A2
Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2, THTR1, TRMA, THMD1	603941	1q24.2	THTR1
Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2, THTR1, TRMA, THMD1	603941	1q24.2	TRMA
Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)	SLC19A2, THTR1, TRMA, THMD1	603941	1q24.2	THMD1
Thoracoabdominal syndrome (2)	THAS, TAS	313850	Xq25-q26.1	THAS
Thoracoabdominal syndrome (2)	THAS, TAS	313850	Xq25-q26.1	TAS
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	THPO
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	MGDF
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	MPLLG
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	TPO
Thrombocythemia 1, 187950 (3)	THPO, MGDF, MPLLG, TPO, THCYT1	600044	3q27.1	THCYT1
Thrombocythemia 2, 601977 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Thrombocythemia 2, 601977 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	TPOR
Thrombocythemia 2, 601977 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPLV
Thrombocythemia 2, 601977 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	THCYT2
Thrombocythemia 3, 614521 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
Thrombocythemia 3, 614521 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
Thrombocythemia, X-linked (2)	THCYTX	300331	Chr.X	THCYTX
Thrombocythemia, somatic, 187950 (3)	CALR, SSA	109091	19p13.13	CALR
Thrombocythemia, somatic, 187950 (3)	CALR, SSA	109091	19p13.13	SSA
Thrombocythemia, somatic, 187950 (3)	SH2B3, LNK	605093	12q24.12	SH2B3
Thrombocythemia, somatic, 187950 (3)	SH2B3, LNK	605093	12q24.12	LNK
Thrombocytopenia 2, 188000 (3)	ANKRD26, KIAA1074, THC2	610855	10p12.1	ANKRD26
Thrombocytopenia 2, 188000 (3)	ANKRD26, KIAA1074, THC2	610855	10p12.1	KIAA1074
Thrombocytopenia 2, 188000 (3)	ANKRD26, KIAA1074, THC2	610855	10p12.1	THC2
Thrombocytopenia 4, 612004 (3)	CYCS, CYC, THC4	123970	7p15.3	CYCS
Thrombocytopenia 4, 612004 (3)	CYCS, CYC, THC4	123970	7p15.3	CYC
Thrombocytopenia 4, 612004 (3)	CYCS, CYC, THC4	123970	7p15.3	THC4
Thrombocytopenia 5, 616216 (3)	ETV6, TEL, THC5	600618	12p13.2	ETV6
Thrombocytopenia 5, 616216 (3)	ETV6, TEL, THC5	600618	12p13.2	TEL
Thrombocytopenia 5, 616216 (3)	ETV6, TEL, THC5	600618	12p13.2	THC5
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GF1
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	ERYF1
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	NFE1
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTDA
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTT
Thrombocytopenia with beta-thalassemia, X-linked, 314050 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLANP
Thrombocytopenia, X-linked, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Thrombocytopenia, X-linked, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	IMD2
Thrombocytopenia, X-linked, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	THC1
Thrombocytopenia, X-linked, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	SCNX
Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	IMD2
Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	THC1
Thrombocytopenia, X-linked, intermittent, 313900 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	SCNX
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GATA1
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	GF1
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	ERYF1
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	NFE1
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTDA
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLTT
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3)	GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP	305371	Xp11.23	XLANP
Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPL
Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	TPOR
Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	MPLV
Thrombocytopenia, congenital amegakaryocytic, 604498 (3)	MPL, TPOR, MPLV, THCYT2	159530	1p34.2	THCYT2
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GP3A
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GT
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT2
Thrombocytopenia, neonatal alloimmune (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT16
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	ITGA2B
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GP2B
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	CD41B
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	GT
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT2
Thrombocytopenia, neonatal alloimmune, BAK antigen related (3)	ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16	607759	17q21.31	BDPLT16
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	RBM8A
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	RBM8B
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	TAR
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	C1DELq21.1
Thrombocytopenia-absent radius syndrome, 274000 (3)	RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1	605313	1q21.1	DEL1q21.1
Thrombocytopenic purpura, autoimmune, 188030 (1)	FCGR2C, CD32C	612169	1q23.3	FCGR2C
Thrombocytopenic purpura, autoimmune, 188030 (1)	FCGR2C, CD32C	612169	1q23.3	CD32C
Thrombophilia due to HRG deficiency, 613116 (3)	HRG, THPH11	142640	3q27.3	HRG
Thrombophilia due to HRG deficiency, 613116 (3)	HRG, THPH11	142640	3q27.3	THPH11
Thrombophilia due to activated protein C resistance, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
Thrombophilia due to activated protein C resistance, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
Thrombophilia due to activated protein C resistance, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
Thrombophilia due to antithrombin III deficiency, 613118 (3)	SERPINC1, AT3, AT3D, THPH7	107300	1q25.1	SERPINC1
Thrombophilia due to antithrombin III deficiency, 613118 (3)	SERPINC1, AT3, AT3D, THPH7	107300	1q25.1	AT3
Thrombophilia due to antithrombin III deficiency, 613118 (3)	SERPINC1, AT3, AT3D, THPH7	107300	1q25.1	AT3D
Thrombophilia due to antithrombin III deficiency, 613118 (3)	SERPINC1, AT3, AT3D, THPH7	107300	1q25.1	THPH7
Thrombophilia due to elevated HRG, 613116 (1)	HRG, THPH11	142640	3q27.3	HRG
Thrombophilia due to elevated HRG, 613116 (1)	HRG, THPH11	142640	3q27.3	THPH11
Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	HCF2, HC2, SERPIND1, THPH10	142360	22q11.21	HCF2
Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	HCF2, HC2, SERPIND1, THPH10	142360	22q11.21	HC2
Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	HCF2, HC2, SERPIND1, THPH10	142360	22q11.21	SERPIND1
Thrombophilia due to heparin cofactor II deficiency, 612356 (3)	HCF2, HC2, SERPIND1, THPH10	142360	22q11.21	THPH10
Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PROC
Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PC
Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	THPH3
Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	THPH4
Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PROC
Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	PC
Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	THPH3
Thrombophilia due to protein C deficiency, autosomal recessive, 612304 (3)	PROC, PC, THPH3, THPH4	612283	2q14.3	THPH4
Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)	PROS1, THPH5, THPH6	176880	3q11.1	PROS1
Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)	PROS1, THPH5, THPH6	176880	3q11.1	THPH5
Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3)	PROS1, THPH5, THPH6	176880	3q11.1	THPH6
Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	PROS1, THPH5, THPH6	176880	3q11.1	PROS1
Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	PROS1, THPH5, THPH6	176880	3q11.1	THPH5
Thrombophilia due to protein S deficiency, autosomal recessive, 614514 (3)	PROS1, THPH5, THPH6	176880	3q11.1	THPH6
Thrombophilia due to thrombin defect, 188050 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
Thrombophilia due to thrombin defect, 188050 (3)	F2, THPH1, RPRGL2	176930	11p11.2	THPH1
Thrombophilia due to thrombin defect, 188050 (3)	F2, THPH1, RPRGL2	176930	11p11.2	RPRGL2
Thrombophilia due to thrombomodulin defect, 614486 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THBD
Thrombophilia due to thrombomodulin defect, 614486 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THRM
Thrombophilia due to thrombomodulin defect, 614486 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	AHUS6
Thrombophilia due to thrombomodulin defect, 614486 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THPH12
Thrombophilia, X-linked, due to factor IX defect, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
Thrombophilia, X-linked, due to factor IX defect, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	HEMB
Thrombophilia, X-linked, due to factor IX defect, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	THPH8
Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	PLAT
Thrombophilia, familial, due to decreased release of PLAT, 612348 (1)	PLAT, TPA	173370	8p11.21	TPA
Thrombosis, hyperhomocysteinemic, 236200 (3)	CBS	613381	21q22.3	CBS
Thrombotic thrombocytopenic purpura, familial, 274150 (3)	ADAMTS13, VWFCP, TTP	604134	9q34.2	ADAMTS13
Thrombotic thrombocytopenic purpura, familial, 274150 (3)	ADAMTS13, VWFCP, TTP	604134	9q34.2	VWFCP
Thrombotic thrombocytopenic purpura, familial, 274150 (3)	ADAMTS13, VWFCP, TTP	604134	9q34.2	TTP
Thryoid dyshormonogenesis 6, 607200 (3)	DUOX2, THOX2, TDH6	606759	15q21.1	DUOX2
Thryoid dyshormonogenesis 6, 607200 (3)	DUOX2, THOX2, TDH6	606759	15q21.1	THOX2
Thryoid dyshormonogenesis 6, 607200 (3)	DUOX2, THOX2, TDH6	606759	15q21.1	TDH6
Thyroid adenoma, hyperfunctioning, somatic (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Thyroid adenoma, hyperfunctioning, somatic (3)	TSHR, CHNG1	603372	14q31.1	CHNG1
Thyroid carcinoma with thyrotoxicosis (3)	TSHR, CHNG1	603372	14q31.1	TSHR
Thyroid carcinoma with thyrotoxicosis (3)	TSHR, CHNG1	603372	14q31.1	CHNG1
Thyroid carcinoma, follicular, 188470 (3)	MINPP1, HIPER1	605391	10q23.2	MINPP1
Thyroid carcinoma, follicular, 188470 (3)	MINPP1, HIPER1	605391	10q23.2	HIPER1
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NRAS
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	ALPS4
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NS6
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	CMNS
Thyroid carcinoma, follicular, somatic, 188470 (3)	NRAS, ALPS4, NS6, CMNS, NCMS	164790	1p13.2	NCMS
Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)	TCO	603386	19p13.2	TCO
Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	PTCPRN, PRN1	605642	1q21	PTCPRN
Thyroid carcinoma, papillary, with papillary renal neoplasia (2)	PTCPRN, PRN1	605642	1q21	PRN1
Thyroid dyshormonogenesis 1, 274400 (3)	SLC5A5, NIS, TDH1	601843	19p13.11	SLC5A5
Thyroid dyshormonogenesis 1, 274400 (3)	SLC5A5, NIS, TDH1	601843	19p13.11	NIS
Thyroid dyshormonogenesis 1, 274400 (3)	SLC5A5, NIS, TDH1	601843	19p13.11	TDH1
Thyroid dyshormonogenesis 2A, 274500 (3)	TPO, TPX, TDH2A	606765	2p25.3	TPO
Thyroid dyshormonogenesis 2A, 274500 (3)	TPO, TPX, TDH2A	606765	2p25.3	TPX
Thyroid dyshormonogenesis 2A, 274500 (3)	TPO, TPX, TDH2A	606765	2p25.3	TDH2A
Thyroid dyshormonogenesis 3, 274700 (3)	TG, AITD3, TDH3	188450	8q24.22	TG
Thyroid dyshormonogenesis 3, 274700 (3)	TG, AITD3, TDH3	188450	8q24.22	AITD3
Thyroid dyshormonogenesis 3, 274700 (3)	TG, AITD3, TDH3	188450	8q24.22	TDH3
Thyroid dyshormonogenesis 4, 274800 (3)	IYD, DEHAL1, TDH4	612025	6q25.1	IYD
Thyroid dyshormonogenesis 4, 274800 (3)	IYD, DEHAL1, TDH4	612025	6q25.1	DEHAL1
Thyroid dyshormonogenesis 4, 274800 (3)	IYD, DEHAL1, TDH4	612025	6q25.1	TDH4
Thyroid dyshormonogenesis 5, 274900 (3)	DUOXA2, TDH5	612772	15q21.1	DUOXA2
Thyroid dyshormonogenesis 5, 274900 (3)	DUOXA2, TDH5	612772	15q21.1	TDH5
Thyroid hormone metabolism, abnormal, 609698 (3)	SECISBP2, SBP2	607693	9q22.2	SECISBP2
Thyroid hormone metabolism, abnormal, 609698 (3)	SECISBP2, SBP2	607693	9q22.2	SBP2
Thyroid hormone resistance, 188570 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyroid hormone resistance, 188570 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	ERBA2
Thyroid hormone resistance, 188570 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THR1
Thyroid hormone resistance, 188570 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	PRTH
Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	ERBA2
Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THR1
Thyroid hormone resistance, autosomal recessive, 274300 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	PRTH
Thyroid hormone resistance, selective pituitary, 145650 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THRB
Thyroid hormone resistance, selective pituitary, 145650 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	ERBA2
Thyroid hormone resistance, selective pituitary, 145650 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	THR1
Thyroid hormone resistance, selective pituitary, 145650 (3)	THRB, ERBA2, THR1, PRTH	190160	3p24.2	PRTH
Thyrotropin-releasing hormone deficiency, 275120 (1)	TRH	613879	3q22.1	TRH
Thyrotropin-releasing hormone resistance, generalized (3)	TRHR	188545	8q23.1	TRHR
Thyroxine-binding globulin deficiency (3)	TBG	314200	Xq22.3	TBG
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TTN
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	CMD1G
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	TMD
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	LGMD2J
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	MPRM
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	HMERF
Tibial muscular dystrophy, tardive, 600334 (3)	TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC	188840	2q31.2	EOMFC
Tietz albinism-deafness syndrome, 103500 (3)	MITF, WS2A, CMM8	156845	3p13	MITF
Tietz albinism-deafness syndrome, 103500 (3)	MITF, WS2A, CMM8	156845	3p13	WS2A
Tietz albinism-deafness syndrome, 103500 (3)	MITF, WS2A, CMM8	156845	3p13	CMM8
Timothy syndrome, 601005 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNA1C
Timothy syndrome, 601005 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CACNL1A1
Timothy syndrome, 601005 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	CCHL1A1
Timothy syndrome, 601005 (3)	CACNA1C, CACNL1A1, CCHL1A1, TS	114205	12p13.33	TS
Tn polyagglutination syndrome, somatic, 300622 (3)	C1GALT1C1, COSMC, C1GALT2, TNPS	300611	Xq24	C1GALT1C1
Tn polyagglutination syndrome, somatic, 300622 (3)	C1GALT1C1, COSMC, C1GALT2, TNPS	300611	Xq24	COSMC
Tn polyagglutination syndrome, somatic, 300622 (3)	C1GALT1C1, COSMC, C1GALT2, TNPS	300611	Xq24	C1GALT2
Tn polyagglutination syndrome, somatic, 300622 (3)	C1GALT1C1, COSMC, C1GALT2, TNPS	300611	Xq24	TNPS
Toenail dystrophy, isolated, 607523 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Toenail dystrophy, isolated, 607523 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Tolbutamide poor metabolizer (3)	CYP2C9	601130	10q23.33	CYP2C9
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	MSX1
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HOX7
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	HYD1
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	OFC5
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	STHAG1
Tooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3)	MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3	142983	4p16.2	ECTD3
Tooth agenesis, selective, 2 (2)	STHAG2, HYD2	602639	16q12.1	STHAG2
Tooth agenesis, selective, 2 (2)	STHAG2, HYD2	602639	16q12.1	HYD2
Tooth agenesis, selective, 3, 604625 (3)	PAX9, STHAG3	167416	14q13.3	PAX9
Tooth agenesis, selective, 3, 604625 (3)	PAX9, STHAG3	167416	14q13.3	STHAG3
Tooth agenesis, selective, 4, 150400 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	WNT10A
Tooth agenesis, selective, 4, 150400 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	SSPS
Tooth agenesis, selective, 4, 150400 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	STHAG4
Tooth agenesis, selective, 4, 150400 (3)	WNT10A, SSPS, STHAG4, OODD	606268	2q35	OODD
Tooth agenesis, selective, 5 (2)	STHAG5	610926	10q11.2-q21	STHAG5
Tooth agenesis, selective, 7, 616724 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	LRP6
Tooth agenesis, selective, 7, 616724 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	ADCAD2
Tooth agenesis, selective, 7, 616724 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	STHAG7
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	EDA
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	ED1
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	ECTD1
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	EDA
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	HED1
Tooth agenesis, selective, X-linked 1, 313500 (3)	EDA, ED1, ECTD1, EDA, HED1, STHAGX1	300451	Xq13.1	STHAGX1
Total anomalous pulmonary venous return (2)	TAPVR1	106700	4q12	TAPVR1
Tourette syndrome (2)	GTS	137580	11q23	GTS
Tourette syndrome, 137580 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	SLITRK1
Tourette syndrome, 137580 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	KIAA1910
Tourette syndrome, 137580 (3)	SLITRK1, KIAA1910, TTM	609678	13q31.1	TTM
Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	SALL1
Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	HSAL1
Townes-Brocks branchiootorenal-like syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	TBS
Townes-Brocks syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	SALL1
Townes-Brocks syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	HSAL1
Townes-Brocks syndrome, 107480 (3)	SALL1, HSAL1, TBS	602218	16q12.1	TBS
Traboulsi syndrome, 601552 (3)	ASPH, HAAH, FDLAB	600582	8q12.3	ASPH
Traboulsi syndrome, 601552 (3)	ASPH, HAAH, FDLAB	600582	8q12.3	HAAH
Traboulsi syndrome, 601552 (3)	ASPH, HAAH, FDLAB	600582	8q12.3	FDLAB
Transaldolase deficiency, 606003 (3)	TALDO1	602063	11p15.5	TALDO1
Transcobalamin II deficiency, 275350 (3)	TCN2, TC2	613441	22q12.2	TCN2
Transcobalamin II deficiency, 275350 (3)	TCN2, TC2	613441	22q12.2	TC2
Transient bullous of the newborn, 131705 (3)	COL7A1, NDNC8	120120	3p21.31	COL7A1
Transient bullous of the newborn, 131705 (3)	COL7A1, NDNC8	120120	3p21.31	NDNC8
Transient erythroblastopenia of childhood (2)	TEC	227050	19q13.2	TEC
Transposition of great arteries, dextro-looped 3, 613854 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	GDF1
Transposition of great arteries, dextro-looped 3, 613854 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DTGA3
Transposition of great arteries, dextro-looped 3, 613854 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	DORV
Transposition of great arteries, dextro-looped 3, 613854 (3)	GDF1, DTGA3, DORV, RAI	602880	19p13.11	RAI
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MED13L
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	THRAP2
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	PROSIT240
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	TRAP240L
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	KIAA1025
Transposition of the great arteries, dextro-looped 1, 608808 (3)	MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD	608771	12q24.21	MRFACD
Treacher Collins syndrome 1, 154500 (3)	TCOF1, MFD1, TCS1	606847	5q32-q33	TCOF1
Treacher Collins syndrome 1, 154500 (3)	TCOF1, MFD1, TCS1	606847	5q32-q33	MFD1
Treacher Collins syndrome 1, 154500 (3)	TCOF1, MFD1, TCS1	606847	5q32-q33	TCS1
Treacher Collins syndrome 2, 613717 (3)	POLR1D, RPA16, RPAC2, TCS2	613715	13q12.2	POLR1D
Treacher Collins syndrome 2, 613717 (3)	POLR1D, RPA16, RPAC2, TCS2	613715	13q12.2	RPA16
Treacher Collins syndrome 2, 613717 (3)	POLR1D, RPA16, RPAC2, TCS2	613715	13q12.2	RPAC2
Treacher Collins syndrome 2, 613717 (3)	POLR1D, RPA16, RPAC2, TCS2	613715	13q12.2	TCS2
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	POLR1C
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA39
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA40
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPAC1
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	RPA5
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	TCS3
Treacher Collins syndrome 3, 248390 (3)	POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11	610060	6p21.1	HLD11
Trehalase deficiency, 612119 (1)	TREH	275360	11q23.3	TREH
Tremor, hereditary essential, 2 (2)	ETM2, ETM	602134	2p25-p22	ETM2
Tremor, hereditary essential, 2 (2)	ETM2, ETM	602134	2p25-p22	ETM
Tremor, hereditary essential, 3 (2)	ETM3	611456	6p23	ETM3
Tremor, hereditary essential, 4, 614782 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	FUS
Tremor, hereditary essential, 4, 614782 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	TLS
Tremor, hereditary essential, 4, 614782 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	ALS6
Tremor, hereditary essential, 4, 614782 (3)	FUS, TLS, ALS6, ETM4	137070	16p11.2	ETM4
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	TENM4
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	ODZ4
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	TNM4
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	DOC4
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	KIAA1302
Tremor, hereditary essential, 5, 616736 (3)	TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5	610084	11q14.1	ETM5
Trichilemmal cyst 1 (2)	TRICY1	609649	3p24-p21.2	TRICY1
Trichodontoosseous syndrome, 190320 (3)	DLX3, TDO, AI4	600525	17q21.33	DLX3
Trichodontoosseous syndrome, 190320 (3)	DLX3, TDO, AI4	600525	17q21.33	TDO
Trichodontoosseous syndrome, 190320 (3)	DLX3, TDO, AI4	600525	17q21.33	AI4
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CYLD
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	CDMT
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	EAC
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	MFT1
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	KIAA0849
Trichoepithelioma, multiple familial, 1, 601606 (3)	CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS	605018	16q12.1	BRSS
Trichoepithelioma, multiple familial, 2 (2)	MFT2, TEM	612099	9p21	MFT2
Trichoepithelioma, multiple familial, 2 (2)	MFT2, TEM	612099	9p21	TEM
Trichohepatoenteric syndrome 1, 222470 (3)	TTC37, KIAA0372	614589	5q15	TTC37
Trichohepatoenteric syndrome 1, 222470 (3)	TTC37, KIAA0372	614589	5q15	KIAA0372
Trichohepatoenteric syndrome 2, 614602 (3)	SKIV2L, SKI2, SKI2W, THES2	600478	6p21.33	SKIV2L
Trichohepatoenteric syndrome 2, 614602 (3)	SKIV2L, SKI2, SKI2W, THES2	600478	6p21.33	SKI2
Trichohepatoenteric syndrome 2, 614602 (3)	SKIV2L, SKI2, SKI2W, THES2	600478	6p21.33	SKI2W
Trichohepatoenteric syndrome 2, 614602 (3)	SKIV2L, SKI2, SKI2W, THES2	600478	6p21.33	THES2
Trichomegaly, 190330 (3)	FGF5, TCMGLY	165190	4q21.21	FGF5
Trichomegaly, 190330 (3)	FGF5, TCMGLY	165190	4q21.21	TCMGLY
Trichorhinophalangeal syndrome, type I, 190350 (3)	TRPS1	604386	8q23.3	TRPS1
Trichorhinophalangeal syndrome, type II (4)	TRPS2, LGCR, LGS	150230	8q24.11-q24.13	TRPS2
Trichorhinophalangeal syndrome, type II (4)	TRPS2, LGCR, LGS	150230	8q24.11-q24.13	LGCR
Trichorhinophalangeal syndrome, type II (4)	TRPS2, LGCR, LGS	150230	8q24.11-q24.13	LGS
Trichorhinophalangeal syndrome, type III, 190351 (3)	TRPS1	604386	8q23.3	TRPS1
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	EM9
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	XPD
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	COFS2
Trichothiodystrophy 1, photosensitive, 601675 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	TTD1
Trichothiodystrophy 2, photosensitive, 616390 (3)	ERCC3, XPB, TTD2	133510	2q14.3	ERCC3
Trichothiodystrophy 2, photosensitive, 616390 (3)	ERCC3, XPB, TTD2	133510	2q14.3	XPB
Trichothiodystrophy 2, photosensitive, 616390 (3)	ERCC3, XPB, TTD2	133510	2q14.3	TTD2
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	GTF2H5
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	TTD3
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	TFB5
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	C6orf175
Trichothiodystrophy 3, photosensitive, 616395 (3)	GTF2H5, TTD3, TFB5, C6orf175, TTDA	608780	6q25.3	TTDA
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	MPLKIP
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	C7orf11
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	ABHS
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	TTDN1
Trichothiodystrophy 4, nonphotosensitive, 234050 (3)	MPLKIP, C7orf11, ABHS, TTDN1, TTD4	609188	7p14.1	TTD4
Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	GTF2E2, TTD6	189964	8p12	GTF2E2
Trichothiodystrophy 6, nonphotosensitive, 616943 (3)	GTF2E2, TTD6	189964	8p12	TTD6
Trifunctional protein deficiency, 609015 (3)	HADHA, MTPA	600890	2p23.3	HADHA
Trifunctional protein deficiency, 609015 (3)	HADHA, MTPA	600890	2p23.3	MTPA
Trifunctional protein deficiency, 609015 (3)	HADHB	143450	2p23.3	HADHB
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FGFR1
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	FLT2
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	OGD
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	KAL2
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HH2
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	HRTFDS
Trigonocephaly 1, 190440 (3)	FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL	136350	8p11.23	ECCL
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	FREM1
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	C9orf154
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	BNAR
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	MOTA
Trigonocephaly 2, 614485 (3)	FREM1, C9orf154, BNAR, MOTA, TRIGNO2	608944	9p22.3	TRIGNO2
Trimethylaminuria, 602079 (3)	FMO3, TMAU	136132	1q24.3	FMO3
Trimethylaminuria, 602079 (3)	FMO3, TMAU	136132	1q24.3	TMAU
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Triphalangeal thumb, type I, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LMBR1
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	ACHP
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	C7orf2
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	PPD2
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	THYP
Triphalangeal thumb-polysyndactyly syndrome, 174500 (3)	LMBR1, ACHP, C7orf2, PPD2, THYP, LSS	605522	7q36.3	LSS
Trismus-pseudocamptodactyly syndrome, 158300 (3)	MYH8, DA7	160741	17p13.1	MYH8
Trismus-pseudocamptodactyly syndrome, 158300 (3)	MYH8, DA7	160741	17p13.1	DA7
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PSTI
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PCTT
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TATI
Tropical calcific pancreatitis, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TCP
Troyer syndrome, 275900 (3)	SPG20	607111	13q13.3	SPG20
Trypsinogen deficiency, 614044 (1)	PRSS1, TRY1	276000	7q34	PRSS1
Trypsinogen deficiency, 614044 (1)	PRSS1, TRY1	276000	7q34	TRY1
Tuberous sclerosis-1, 191100 (3)	TSC1, LAM	605284	9q34.13	TSC1
Tuberous sclerosis-1, 191100 (3)	TSC1, LAM	605284	9q34.13	LAM
Tuberous sclerosis-2, 613254 (3)	TSC2, LAM	191092	16p13.3	TSC2
Tuberous sclerosis-2, 613254 (3)	TSC2, LAM	191092	16p13.3	LAM
Tukel syndrome (2)	TUKLS	609428	21q22	TUKLS
Tumor predisposition syndrome, 614327 (3)	BAP1, TPDS	603089	3p21.1	BAP1
Tumor predisposition syndrome, 614327 (3)	BAP1, TPDS	603089	3p21.1	TPDS
Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	SAMD9
Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	NFTC
Tumoral calcinosis, familial, normophosphatemic, 610455 (3)	SAMD9, NFTC, MIRAGE	610456	7q21.2	MIRAGE
Tumoral calcinosis, hyperphosphatemic, 211900 (3)	KL, KLOTHO	604824	13q13.1	KL
Tumoral calcinosis, hyperphosphatemic, 211900 (3)	KL, KLOTHO	604824	13q13.1	KLOTHO
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	FGF23
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	ADHR
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	HPDR2
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	FGF23, ADHR, HPDR2, PHPTC	605380	12p13.32	PHPTC
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	GALNT3, HHS, HFTC	601756	2q24.3	GALNT3
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	GALNT3, HHS, HFTC	601756	2q24.3	HHS
Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)	GALNT3, HHS, HFTC	601756	2q24.3	HFTC
Turner syndrome-associated neurocognitive phenotype (2)	VSPA	313000	Xp22.33	VSPA
Tylosis with esophageal cancer, 148500 (3)	RHBDF2, IRHOM2, TOC	614404	17q25.1	RHBDF2
Tylosis with esophageal cancer, 148500 (3)	RHBDF2, IRHOM2, TOC	614404	17q25.1	IRHOM2
Tylosis with esophageal cancer, 148500 (3)	RHBDF2, IRHOM2, TOC	614404	17q25.1	TOC
Tyrosinemia, type I, 276700 (3)	FAH	613871	15q25.1	FAH
Tyrosinemia, type II, 276600 (3)	TAT	613018	16q22.2	TAT
Tyrosinemia, type III, 276710 (3)	HPD	609695	12q24.31	HPD
Tyrosinemia, type Ib (1)	GSTZ1, MAAI	603758	14q24.3	GSTZ1
Tyrosinemia, type Ib (1)	GSTZ1, MAAI	603758	14q24.3	MAAI
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
UV-sensitive syndrome 1, 600630 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
UV-sensitive syndrome 2, 614621 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	ERCC8
UV-sensitive syndrome 2, 614621 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	CKN1
UV-sensitive syndrome 2, 614621 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	CSA
UV-sensitive syndrome 2, 614621 (3)	ERCC8, CKN1, CSA, UVSS2	609412	5q12.1	UVSS2
UV-sensitive syndrome 3, 614640 (3)	UVSSA, KIAA1530, UVSS3	614632	4p16.3	UVSSA
UV-sensitive syndrome 3, 614640 (3)	UVSSA, KIAA1530, UVSS3	614632	4p16.3	KIAA1530
UV-sensitive syndrome 3, 614640 (3)	UVSSA, KIAA1530, UVSS3	614632	4p16.3	UVSS3
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	COL6A1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	BTHLM1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A1, BTHLM1, UCHMD1	120220	21q22.3	UCHMD1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	COL6A2
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	BTHLM1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A2, BTHLM1, UCMD1	120240	21q22.3	UCMD1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	COL6A3
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	DYT27
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	BTHLM1
Ullrich congenital muscular dystrophy 1, 254090 (3)	COL6A3, DYT27, BTHLM1, UCMD1	120250	2q37.3	UCMD1
Ulna and fibula, absence of, with severe limb deficiency, 276820 (3)	WNT7A	601570	3p25.1	WNT7A
Ulnar-mammary syndrome, 181450 (3)	TBX3	601621	12q24.21	TBX3
Urbach-Wiethe disease, 247100 (3)	ECM1, URBWD	602201	1q21.2	ECM1
Urbach-Wiethe disease, 247100 (3)	ECM1, URBWD	602201	1q21.2	URBWD
Urofacial syndrome 1, 236730 (3)	HPSE2, HPA2, UFS1	613469	10q24.2	HPSE2
Urofacial syndrome 1, 236730 (3)	HPSE2, HPA2, UFS1	613469	10q24.2	HPA2
Urofacial syndrome 1, 236730 (3)	HPSE2, HPA2, UFS1	613469	10q24.2	UFS1
Urofacial syndrome 2, 615112 (3)	LRIG2, LIG2, KIAA0806, UFS2	608869	1p13.2	LRIG2
Urofacial syndrome 2, 615112 (3)	LRIG2, LIG2, KIAA0806, UFS2	608869	1p13.2	LIG2
Urofacial syndrome 2, 615112 (3)	LRIG2, LIG2, KIAA0806, UFS2	608869	1p13.2	KIAA0806
Urofacial syndrome 2, 615112 (3)	LRIG2, LIG2, KIAA0806, UFS2	608869	1p13.2	UFS2
Usher syndrome type 3B, 614504 (3)	HARS, USH3B, CMT2W	142810	5q31.3	HARS
Usher syndrome type 3B, 614504 (3)	HARS, USH3B, CMT2W	142810	5q31.3	USH3B
Usher syndrome type 3B, 614504 (3)	HARS, USH3B, CMT2W	142810	5q31.3	CMT2W
Usher syndrome, type 1B, 276900 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	MYO7A
Usher syndrome, type 1B, 276900 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	USH1B
Usher syndrome, type 1B, 276900 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNB2
Usher syndrome, type 1B, 276900 (3)	MYO7A, USH1B, DFNB2, DFNA11	276903	11q13.5	DFNA11
Usher syndrome, type 1C, 276904 (3)	USH1C, DFNB18A	605242	11p15.1	USH1C
Usher syndrome, type 1C, 276904 (3)	USH1C, DFNB18A	605242	11p15.1	DFNB18A
Usher syndrome, type 1D, 601067 (3)	CDH23, USH1D	605516	10q22.1	CDH23
Usher syndrome, type 1D, 601067 (3)	CDH23, USH1D	605516	10q22.1	USH1D
Usher syndrome, type 1D/F digenic, 601067 (3)	CDH23, USH1D	605516	10q22.1	CDH23
Usher syndrome, type 1D/F digenic, 601067 (3)	CDH23, USH1D	605516	10q22.1	USH1D
Usher syndrome, type 1D/F digenic, 601067 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Usher syndrome, type 1D/F digenic, 601067 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	DFNB23
Usher syndrome, type 1D/F digenic, 601067 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	USH1F
Usher syndrome, type 1E (2)	USH1E	602097	21q21	USH1E
Usher syndrome, type 1F, 602083 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	PCDH15
Usher syndrome, type 1F, 602083 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	DFNB23
Usher syndrome, type 1F, 602083 (3)	PCDH15, DFNB23, USH1F	605514	10q21.1	USH1F
Usher syndrome, type 1G, 606943 (3)	SANS, USH1G	607696	17q25.1	SANS
Usher syndrome, type 1G, 606943 (3)	SANS, USH1G	607696	17q25.1	USH1G
Usher syndrome, type 1H (2)	USH1H	612632	15q22-q23	USH1H
Usher syndrome, type 2A, 276901 (3)	USH2A, RP39	608400	1q41	USH2A
Usher syndrome, type 2A, 276901 (3)	USH2A, RP39	608400	1q41	RP39
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	GPR98
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	MASS1
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	VLGR1
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	KIAA0686
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	FEB4
Usher syndrome, type 2C, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	USH2C
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	ADGRV1
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	GPR98
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	MASS1
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	VLGR1
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	KIAA0686
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	FEB4
Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3)	ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C	602851	5q14.3	USH2C
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	WHRN
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	CIP98
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	KIAA1526
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	DFNB31
Usher syndrome, type 2D, 611383 (3)	WHRN, CIP98, KIAA1526, DFNB31, USH2D	607928	9q32	USH2D
Usher syndrome, type 3A, 276902 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	CLRN1
Usher syndrome, type 3A, 276902 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	USH3A
Usher syndrome, type 3A, 276902 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	USH3
Usher syndrome, type 3A, 276902 (3)	CLRN1, USH3A, USH3, RP61	606397	3q25.1	RP61
Usher syndrome, type IIC, GPR98/PDZD7 digenic, 605472 (3)	PDZD7	612971	10q24.31	PDZD7
Usher syndrome, type IJ, 614869 (3)	CIB2, KIP2	605564	15q25.1	CIB2
Usher syndrome, type IJ, 614869 (3)	CIB2, KIP2	605564	15q25.1	KIP2
Usher syndrome, type IK (2)	USH1K	614990	10p11.21-q21.1	USH1K
VACTERL association, X-linked, 314390 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	ZIC3
VACTERL association, X-linked, 314390 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX1
VACTERL association, X-linked, 314390 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	HTX
VACTERL association, X-linked, 314390 (3)	ZIC3, HTX1, HTX, VACTERLX	300265	Xq26.3	VACTERLX
VATER association with macrocephaly and ventriculomegaly, 276950 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
VATER association with macrocephaly and ventriculomegaly, 276950 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
VATER association with macrocephaly and ventriculomegaly, 276950 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
VATER association with macrocephaly and ventriculomegaly, 276950 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
VLCAD deficiency, 201475 (3)	ACADVL, VLCAD	609575	17p13.1	ACADVL
VLCAD deficiency, 201475 (3)	ACADVL, VLCAD	609575	17p13.1	VLCAD
Van Buchem disease, 239100 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST
Van Buchem disease, 239100 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	VBCH
Van Buchem disease, 239100 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	CDD
Van Buchem disease, 239100 (3)	SOST, VBCH, CDD, SOST1	605740	17q21.31	SOST1
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	DCHS1
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	PCDH16
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	FIB1
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	CDH19
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	VMLDS1
Van Maldergem syndrome 1, 601390 (3)	DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2	603057	11p15.4	MVP2
Van Maldergem syndrome 2, 615546 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	FAT4
Van Maldergem syndrome 2, 615546 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	VMLDS2
Van Maldergem syndrome 2, 615546 (3)	FAT4, VMLDS2, HKLLS2	612411	4q28.1	HKLLS2
Van den Ende-Gupta syndrome, 600920 (3)	SCARF2, SREC2, VDEGS	613619	22q11.21	SCARF2
Van den Ende-Gupta syndrome, 600920 (3)	SCARF2, SREC2, VDEGS	613619	22q11.21	SREC2
Van den Ende-Gupta syndrome, 600920 (3)	SCARF2, SREC2, VDEGS	613619	22q11.21	VDEGS
Van der Woude syndrome 2, 606713 (3)	GRHL3, SOM, TFCP2L4, VWS2	608317	1p36.11	GRHL3
Van der Woude syndrome 2, 606713 (3)	GRHL3, SOM, TFCP2L4, VWS2	608317	1p36.11	SOM
Van der Woude syndrome 2, 606713 (3)	GRHL3, SOM, TFCP2L4, VWS2	608317	1p36.11	TFCP2L4
Van der Woude syndrome 2, 606713 (3)	GRHL3, SOM, TFCP2L4, VWS2	608317	1p36.11	VWS2
Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	AGS1
Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	CRV
Vasculopathy, retinal, with cerebral leukodystrophy, 192315 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	HERNS
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TBX1
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGS
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CTHM
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	CAFS
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	TGA
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DORV
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	VCFS
Velocardiofacial syndrome, 192430 (3)	TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR	602054	22q11.21	DGCR
Venous malformations, multiple cutaneous and mucosal, 600195 (3)	TEK, TIE2, VMCM	600221	9p21.2	TEK
Venous malformations, multiple cutaneous and mucosal, 600195 (3)	TEK, TIE2, VMCM	600221	9p21.2	TIE2
Venous malformations, multiple cutaneous and mucosal, 600195 (3)	TEK, TIE2, VMCM	600221	9p21.2	VMCM
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
Ventricular fibrillation, familial, 1, 603829 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	GATA4
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	ASD2
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	VSD1
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TACHD
Ventricular septal defect 1, 614429 (3)	GATA4, ASD2, VSD1, TACHD, TOF	600576	8p23.1	TOF
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	CITED2
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	MRG1
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	P35SRJ
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	VSD2
Ventricular septal defect 2, 614431 (3)	CITED2, MRG1, P35SRJ, VSD2, ASD8	602937	6q24.1	ASD8
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2-5
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	NKX2E
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CSX
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	CHNG5
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	VSD3
Ventricular septal defect 3, 614432 (3)	NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2	600584	5q35.1	HLHS2
Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	RYR2
Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	VTSIP
Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	ARVD2
Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3)	RYR2, VTSIP, ARVD2, ARVC2	180902	1q43	ARVC2
Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)	CASQ2	114251	1p13.1	CASQ2
Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)	CPVT3	614021	7p22-p14	CPVT3
Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CALM1
Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	PHKD
Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	CPVT4
Ventricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3)	CALM1, PHKD, CPVT4, LQT14	114180	14q32.11	LQT14
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	TRDN, TDN, CPVT5	603283	6q22.31	TRDN
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	TRDN, TDN, CPVT5	603283	6q22.31	TDN
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3)	TRDN, TDN, CPVT5	603283	6q22.31	CPVT5
Ventricular tachycardia, idiopathic, 192605 (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2
Ventricular tachycardia, idiopathic, 192605 (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GNAI2B
Ventricular tachycardia, idiopathic, 192605 (3)	GNAI2, GNAI2B, GIP	139360	3p21.31	GIP
Ventriculomegaly with cystic kidney disease, 219730 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	CRB2
Ventriculomegaly with cystic kidney disease, 219730 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	FSGS9
Ventriculomegaly with cystic kidney disease, 219730 (3)	CRB2, FSGS9, VMCKD	609720	9q33.3	VMCKD
Verheij syndrome, 615583 (3)	PUF60, FIR, SIAHBP1, VRJS	604819	8q24.3	PUF60
Verheij syndrome, 615583 (3)	PUF60, FIR, SIAHBP1, VRJS	604819	8q24.3	FIR
Verheij syndrome, 615583 (3)	PUF60, FIR, SIAHBP1, VRJS	604819	8q24.3	SIAHBP1
Verheij syndrome, 615583 (3)	PUF60, FIR, SIAHBP1, VRJS	604819	8q24.3	VRJS
Vertical talus, congenital, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOXD10
Vertical talus, congenital, 192950 (3)	HOXD10, HOX4D	142984	2q31.1	HOX4D
Vertigo, benign recurrent, 2 (2)	BRV2	613106	22q12	BRV2
Vesicoureteral reflux (2)	VUR	193000	1p13	VUR
Vesicoureteral reflux 2, 610878 (3)	ROBO2, SAX3, KIAA1568	602431	3p12.3	ROBO2
Vesicoureteral reflux 2, 610878 (3)	ROBO2, SAX3, KIAA1568	602431	3p12.3	SAX3
Vesicoureteral reflux 2, 610878 (3)	ROBO2, SAX3, KIAA1568	602431	3p12.3	KIAA1568
Vesicoureteral reflux 3, 613674 (3)	SOX17, VUR3	610928	8q11.23	SOX17
Vesicoureteral reflux 3, 613674 (3)	SOX17, VUR3	610928	8q11.23	VUR3
Vesicoureteral reflux 4 (2)	VUR4	614317	5q14.2	VUR4
Vesicoureteral reflux 5 (2)	VUR5	614318	13q33.2	VUR5
Vesicoureteral reflux 6 (2)	VUR6	614319	18q12.3	VUR6
Vesicoureteral reflux 7 (2)	VUR7	615390	12p11-q13	VUR7
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNX
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB1
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXBS
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	TNXB2
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	EDS3
Vesicoureteral reflux 8, 615963 (3)	TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3, VUR8	600985	6p21.33-p21.32	VUR8
Vestibulopathy, familial (2)	BPPV	193007	6q	BPPV
Vibratory urticaria, 125630 (3)	ADGRE2, EMR2, VBU	606100	19p13.12	ADGRE2
Vibratory urticaria, 125630 (3)	ADGRE2, EMR2, VBU	606100	19p13.12	EMR2
Vibratory urticaria, 125630 (3)	ADGRE2, EMR2, VBU	606100	19p13.12	VBU
Vici syndrome, 242840 (3)	EPG5, KIAA1632, HEEW1, VICIS	615068	18q12.3-q21.1	EPG5
Vici syndrome, 242840 (3)	EPG5, KIAA1632, HEEW1, VICIS	615068	18q12.3-q21.1	KIAA1632
Vici syndrome, 242840 (3)	EPG5, KIAA1632, HEEW1, VICIS	615068	18q12.3-q21.1	HEEW1
Vici syndrome, 242840 (3)	EPG5, KIAA1632, HEEW1, VICIS	615068	18q12.3-q21.1	VICIS
Visceral myopathy, 155310 (3)	ACTG2, ACTA3, VSCM	102545	2p13.1	ACTG2
Visceral myopathy, 155310 (3)	ACTG2, ACTA3, VSCM	102545	2p13.1	ACTA3
Visceral myopathy, 155310 (3)	ACTG2, ACTA3, VSCM	102545	2p13.1	VSCM
Vitamin D-dependent rickets, type I, 264700 (3)	CYP27B1, VDD1, PDDR	609506	12q14.1	CYP27B1
Vitamin D-dependent rickets, type I, 264700 (3)	CYP27B1, VDD1, PDDR	609506	12q14.1	VDD1
Vitamin D-dependent rickets, type I, 264700 (3)	CYP27B1, VDD1, PDDR	609506	12q14.1	PDDR
Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3)	GGCX, VKCFD1	137167	2p11.2	GGCX
Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3)	GGCX, VKCFD1	137167	2p11.2	VKCFD1
Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKORC1
Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKOR
Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKCFD2
Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	FLJ00289
Vitreoretinochoroidopathy, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	BEST1
Vitreoretinochoroidopathy, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	VMD2
Vitreoretinochoroidopathy, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	ARB
Vitreoretinochoroidopathy, 193220 (3)	BEST1, VMD2, ARB, RP50	607854	11q12.3	RP50
Vitreoretinopathy with phalangeal epiphyseal dysplasia (3)	COL2A1	120140	12q13.11	COL2A1
Vitreoretinopathy, neovascular inflammatory, 193235 (3)	CAPN5, HTRA3, VRNI	602537	11q13.5	CAPN5
Vitreoretinopathy, neovascular inflammatory, 193235 (3)	CAPN5, HTRA3, VRNI	602537	11q13.5	HTRA3
Vitreoretinopathy, neovascular inflammatory, 193235 (3)	CAPN5, HTRA3, VRNI	602537	11q13.5	VRNI
Vohwinkel syndrome with ichthyosis, 604117 (3)	LOR	152445	1q21.3	LOR
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	GJB2
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	CX26
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNB1A
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	PPK
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	DFNA3A
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	KID
Vohwinkel syndrome, 124500 (3)	GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID	121011	13q12.11	HID
WAGRO syndrome (4)	WAGRO, DEL11p14p12	612469	11p13-p12	WAGRO
WAGRO syndrome (4)	WAGRO, DEL11p14p12	612469	11p13-p12	DEL11p14p12
WHIM syndrome, 193670 (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	CXCR4
WHIM syndrome, 193670 (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	D2S201E
WHIM syndrome, 193670 (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	NPY3R
WHIM syndrome, 193670 (3)	CXCR4, D2S201E, NPY3R, WHIMS	162643	2q22.1	WHIMS
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS1
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	HUP2
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	CDHS
Waardenburg syndrome, type 1, 193500 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS3
Waardenburg syndrome, type 2A, 193510 (3)	MITF, WS2A, CMM8	156845	3p13	MITF
Waardenburg syndrome, type 2A, 193510 (3)	MITF, WS2A, CMM8	156845	3p13	WS2A
Waardenburg syndrome, type 2A, 193510 (3)	MITF, WS2A, CMM8	156845	3p13	CMM8
Waardenburg syndrome, type 2B (2)	WS2B	600193	1p21-p13.3	WS2B
Waardenburg syndrome, type 2C (2)	WS2C	606662	8p23	WS2C
Waardenburg syndrome, type 2D, 608890 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SNAI2
Waardenburg syndrome, type 2D, 608890 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	SLUG
Waardenburg syndrome, type 2D, 608890 (3)	SNAI2, SLUG, WS2D	602150	8q11.21	WS2D
Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4
Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4C
Waardenburg syndrome, type 2E, with or without neurologic involvement, 611584 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	PCWH
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	PAX3
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS1
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	HUP2
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	CDHS
Waardenburg syndrome, type 3, 148820 (3)	PAX3, WS1, HUP2, CDHS, WS3	606597	2q36.1	WS3
Waardenburg syndrome, type 4A, 277580 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
Waardenburg syndrome, type 4A, 277580 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	HSCR2
Waardenburg syndrome, type 4A, 277580 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	ABCDS
Waardenburg syndrome, type 4A, 277580 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	WS4A
Waardenburg syndrome, type 4B, 613265 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
Waardenburg syndrome, type 4B, 613265 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	WS4B
Waardenburg syndrome, type 4B, 613265 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	HSCR4
Waardenburg syndrome, type 4C, 613266 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	SOX10
Waardenburg syndrome, type 4C, 613266 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4
Waardenburg syndrome, type 4C, 613266 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	WS4C
Waardenburg syndrome, type 4C, 613266 (3)	SOX10, WS4, WS4C, PCWH	602229	22q13.1	PCWH
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
Waardenburg syndrome/albinism, digenic, 103470 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
Waardenburg syndrome/ocular albinism, digenic, 103470 (3)	MITF, WS2A, CMM8	156845	3p13	MITF
Waardenburg syndrome/ocular albinism, digenic, 103470 (3)	MITF, WS2A, CMM8	156845	3p13	WS2A
Waardenburg syndrome/ocular albinism, digenic, 103470 (3)	MITF, WS2A, CMM8	156845	3p13	CMM8
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	VCAN
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	CSPG2
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	WGN
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	WGN1
Wagner syndrome 1, 143200 (3)	VCAN, CSPG2, WGN, WGN1, ERVR	118661	5q14.2-q14.3	ERVR
Warburg micro syndrome 1, 600118 (3)	RAB3GAP1, WARBM1, P130	602536	2q21.3	RAB3GAP1
Warburg micro syndrome 1, 600118 (3)	RAB3GAP1, WARBM1, P130	602536	2q21.3	WARBM1
Warburg micro syndrome 1, 600118 (3)	RAB3GAP1, WARBM1, P130	602536	2q21.3	P130
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP2
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	RAB3GAP150
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	p150
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	KIAA0839
Warburg micro syndrome 2, 614225 (3)	RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2	609275	1q41	WARBM2
Warburg micro syndrome 3, 614222 (3)	RAB18, WARBM3	602207	10p12.1	RAB18
Warburg micro syndrome 3, 614222 (3)	RAB18, WARBM3	602207	10p12.1	WARBM3
Warburg micro syndrome 4, 615663 (3)	TBC1D20, C20orf140, WARBM4	611663	20p13	TBC1D20
Warburg micro syndrome 4, 615663 (3)	TBC1D20, C20orf140, WARBM4	611663	20p13	C20orf140
Warburg micro syndrome 4, 615663 (3)	TBC1D20, C20orf140, WARBM4	611663	20p13	WARBM4
Warfarin resistance, 122700 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKORC1
Warfarin resistance, 122700 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKOR
Warfarin resistance, 122700 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	VKCFD2
Warfarin resistance, 122700 (3)	VKORC1, VKOR, VKCFD2, FLJ00289	608547	16p11.2	FLJ00289
Warfarin sensitivity, 122700 (3)	CYP2C9	601130	10q23.33	CYP2C9
Warsaw breakage syndrome, 613398 (3)	DDX11, CHLR1, KRG2	601150	12p11.21	DDX11
Warsaw breakage syndrome, 613398 (3)	DDX11, CHLR1, KRG2	601150	12p11.21	CHLR1
Warsaw breakage syndrome, 613398 (3)	DDX11, CHLR1, KRG2	601150	12p11.21	KRG2
Watson syndrome, 193520 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NF1
Watson syndrome, 193520 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	VRNF
Watson syndrome, 193520 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	WSS
Watson syndrome, 193520 (3)	NF1, VRNF, WSS, NFNS	613113	17q11.2	NFNS
Weaver syndrome, 277590 (3)	EZH2, EZH1, WVS	601573	7q36.1	EZH2
Weaver syndrome, 277590 (3)	EZH2, EZH1, WVS	601573	7q36.1	EZH1
Weaver syndrome, 277590 (3)	EZH2, EZH1, WVS	601573	7q36.1	WVS
Wegener granulomatosis (2)	WG	608710	6p21.3	WG
Wegener-like granulomatosis (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	TAP2
Wegener-like granulomatosis (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	ABCB3
Wegener-like granulomatosis (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	PSF2
Wegener-like granulomatosis (3)	TAP2, ABCB3, PSF2, RING11	170261	6p21.32	RING11
Weill-Marchesani syndrome 1, recessive, 277600 (3)	ADAMTS10, WMS1	608990	19p13.2	ADAMTS10
Weill-Marchesani syndrome 1, recessive, 277600 (3)	ADAMTS10, WMS1	608990	19p13.2	WMS1
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	FBN1
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFS1
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	WMS2
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	SSKS
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	GPHYSD2
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ACMICD
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	ECTOL1
Weill-Marchesani syndrome 2, dominant, 608328 (3)	FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS	134797	15q21.1	MFLS
Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP2
Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	LTBP3
Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	GLC3D
Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	MSPKA
Weill-Marchesani syndrome 3, recessive, 614819 (3)	LTBP2, LTBP3, GLC3D, MSPKA, WMS3	602091	14q24.3	WMS3
Weill-Marchesani-like syndrome, 613195 (3)	ADAMTS17	607511	15q26.3	ADAMTS17
Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	COL11A2
Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	STL3
Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNA13
Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	DFNB53
Weissenbacher-Zweymuller syndrome, 277610 (3)	COL11A2, STL3, DFNA13, DFNB53, FBCG2	120290	6p21.32	FBCG2
Welander distal myopathy, 604454 (3)	TIA1, WDM	603518	2p13.3	TIA1
Welander distal myopathy, 604454 (3)	TIA1, WDM	603518	2p13.3	WDM
Werner syndrome, 277700 (3)	RECQL2, RECQ3, WRN	604611	8p12	RECQL2
Werner syndrome, 277700 (3)	RECQL2, RECQ3, WRN	604611	8p12	RECQ3
Werner syndrome, 277700 (3)	RECQL2, RECQ3, WRN	604611	8p12	WRN
Weyers acrodental dysostosis, 193530 (3)	EVC	604831	4p16.2	EVC
Weyers acrofacial dysostosis, 193530 (3)	LBN, EVC2, WAD	607261	4p16.2	LBN
Weyers acrofacial dysostosis, 193530 (3)	LBN, EVC2, WAD	607261	4p16.2	EVC2
Weyers acrofacial dysostosis, 193530 (3)	LBN, EVC2, WAD	607261	4p16.2	WAD
White sponge nevus 1, 193900 (3)	KRT4, CYK4, WSN1	123940	12q13.13	KRT4
White sponge nevus 1, 193900 (3)	KRT4, CYK4, WSN1	123940	12q13.13	CYK4
White sponge nevus 1, 193900 (3)	KRT4, CYK4, WSN1	123940	12q13.13	WSN1
White sponge nevus 2, 615785 (3)	KRT13, WSN2	148065	17q21.2	KRT13
White sponge nevus 2, 615785 (3)	KRT13, WSN2	148065	17q21.2	WSN2
White-Sutton syndrome, 616364 (3)	POGZ, KIAA0461, MRD37, WHSUS	614787	1q21.3	POGZ
White-Sutton syndrome, 616364 (3)	POGZ, KIAA0461, MRD37, WHSUS	614787	1q21.3	KIAA0461
White-Sutton syndrome, 616364 (3)	POGZ, KIAA0461, MRD37, WHSUS	614787	1q21.3	MRD37
White-Sutton syndrome, 616364 (3)	POGZ, KIAA0461, MRD37, WHSUS	614787	1q21.3	WHSUS
Wieacker-Wolff syndrome, 314580 (3)	ZC4H2, KIAA1166, WRWF	300897	Xq11.2	ZC4H2
Wieacker-Wolff syndrome, 314580 (3)	ZC4H2, KIAA1166, WRWF	300897	Xq11.2	KIAA1166
Wieacker-Wolff syndrome, 314580 (3)	ZC4H2, KIAA1166, WRWF	300897	Xq11.2	WRWF
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	KMT2A
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	MLL
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	HRX
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	HTRX1
Wiedemann-Steiner syndrome, 605130 (3)	KMT2A, MLL, HRX, HTRX1, WDSTS	159555	11q23.3	WDSTS
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	WBS
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	WMS
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	WS
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	DEL7q11
Williams-Beuren syndrome (4)	WBS, WMS, WS, DEL7q11, C7DELq11	194050	7q11.23	C7DELq11
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	H19
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	D11S813E
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	ASM1
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	BWS
Wilms tumor 2, 194071 (3)	H19, D11S813E, ASM1, BWS, WT2	103280	11p15.5	WT2
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
Wilms tumor, 194070 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	DEL11p13, C11DELp13, WAGR	194072	11p13	DEL11p13
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	DEL11p13, C11DELp13, WAGR	194072	11p13	C11DELp13
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome (4)	DEL11p13, C11DELp13, WAGR	194072	11p13	WAGR
Wilms tumor, somatic, 194070 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	GPC3
Wilms tumor, somatic, 194070 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	SDYS
Wilms tumor, somatic, 194070 (3)	GPC3, SDYS, SGBS1	300037	Xq26.2	SGBS1
Wilms tumor, type 1, 194070 (3)	WT1, NPHS4	607102	11p13	WT1
Wilms tumor, type 1, 194070 (3)	WT1, NPHS4	607102	11p13	NPHS4
Wilms tumor, type 3 (2)	WT3	194090	16q	WT3
Wilms tumor, type 4 (2)	WT4	601363	17q12-q21	WT4
Wilson disease, 277900 (3)	ATP7B, WND	606882	13q14.3	ATP7B
Wilson disease, 277900 (3)	ATP7B, WND	606882	13q14.3	WND
Wilson-Turner syndrome, 309585 (3)	LAS1L, WTS	300964	Xq12	LAS1L
Wilson-Turner syndrome, 309585 (3)	LAS1L, WTS	300964	Xq12	WTS
Wiskott-Aldrich syndrome, 301000 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	WAS
Wiskott-Aldrich syndrome, 301000 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	IMD2
Wiskott-Aldrich syndrome, 301000 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	THC1
Wiskott-Aldrich syndrome, 301000 (3)	WAS, IMD2, THC1, SCNX	300392	Xp11.23	SCNX
Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3, PEK, PERK, WRS	604032	2p11.2	EIF2AK3
Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3, PEK, PERK, WRS	604032	2p11.2	PEK
Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3, PEK, PERK, WRS	604032	2p11.2	PERK
Wolcott-Rallison syndrome, 226980 (3)	EIF2AK3, PEK, PERK, WRS	604032	2p11.2	WRS
Wolf-Hirschhorn syndrome (4)	WHS	194190	4p16.3	WHS
Wolff-Parkinson-White syndrome, 194200 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	PRKAG2
Wolff-Parkinson-White syndrome, 194200 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	WPWS
Wolff-Parkinson-White syndrome, 194200 (3)	PRKAG2, WPWS, CMH6	602743	7q36.1	CMH6
Wolfram syndrome 2, 604928 (3)	CISD2, WFS2, ZCD2, ERIS	611507	4q24	CISD2
Wolfram syndrome 2, 604928 (3)	CISD2, WFS2, ZCD2, ERIS	611507	4q24	WFS2
Wolfram syndrome 2, 604928 (3)	CISD2, WFS2, ZCD2, ERIS	611507	4q24	ZCD2
Wolfram syndrome 2, 604928 (3)	CISD2, WFS2, ZCD2, ERIS	611507	4q24	ERIS
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFRS
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA6
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA14
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA38
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFSL
Wolfram syndrome, 222300 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	CTRCT41
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFRS
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA6
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA14
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA38
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFSL
Wolfram-like syndrome, autosomal dominant, 614296 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	CTRCT41
Wolman disease, 278000 (3)	LIPA, CESD	613497	10q23.31	LIPA
Wolman disease, 278000 (3)	LIPA, CESD	613497	10q23.31	CESD
Wood neuroimmunologic syndrome (2)	INDX	300076	Xq26-qter	INDX
Woodhouse-Sakati syndrome, 241080 (3)	DCAF17, C20orf37	612515	2q31.1	DCAF17
Woodhouse-Sakati syndrome, 241080 (3)	DCAF17, C20orf37	612515	2q31.1	C20orf37
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT74
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	K6IRS4
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	KRT6IRS4
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HTSS2
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	HYPT3
Woolly hair, autosomal dominant, 194300 (3)	KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH	608248	12q13.13	ADWH
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LPAR6
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	P2RY5
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	P2Y5
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	LAH3
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	ARWH1
Woolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3)	LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8	609239	13q14.2	HYPT8
Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LIPH
Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	LAH2
Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	ARWH2
Woolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3)	LIPH, LAH2, ARWH2, HYPT7	607365	3q27.2	HYPT7
Woolly hair, autosomal recessive 3, 616760 (3)	KRT25, K25, KRT24IRS1, ARWH3	616646	17q21.2	KRT25
Woolly hair, autosomal recessive 3, 616760 (3)	KRT25, K25, KRT24IRS1, ARWH3	616646	17q21.2	K25
Woolly hair, autosomal recessive 3, 616760 (3)	KRT25, K25, KRT24IRS1, ARWH3	616646	17q21.2	KRT24IRS1
Woolly hair, autosomal recessive 3, 616760 (3)	KRT25, K25, KRT24IRS1, ARWH3	616646	17q21.2	ARWH3
Wrinkly skin syndrome, 278250 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ATP6V0A2
Wrinkly skin syndrome, 278250 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	WSS
Wrinkly skin syndrome, 278250 (3)	ATP6V0A2, WSS, ARCL2A	611716	12q24.31	ARCL2A
X inactivation, familial skewed, 2 (2)	SXI2	300179	Xq25-q26	SXI2
X-inactivation, familial skewed, 300087 (3)	XIC, XCE, XIST, SXI1	314670	Xq13.2	XIC
X-inactivation, familial skewed, 300087 (3)	XIC, XCE, XIST, SXI1	314670	Xq13.2	XCE
X-inactivation, familial skewed, 300087 (3)	XIC, XCE, XIST, SXI1	314670	Xq13.2	XIST
X-inactivation, familial skewed, 300087 (3)	XIC, XCE, XIST, SXI1	314670	Xq13.2	SXI1
Xanthinuria, type I, 278300 (3)	XDH, XAN1	607633	2p23.1	XDH
Xanthinuria, type I, 278300 (3)	XDH, XAN1	607633	2p23.1	XAN1
Xanthinuria, type II, 603592 (3)	MOCOS, MCS, XAN2	613274	18q12.2	MOCOS
Xanthinuria, type II, 603592 (3)	MOCOS, MCS, XAN2	613274	18q12.2	MCS
Xanthinuria, type II, 603592 (3)	MOCOS, MCS, XAN2	613274	18q12.2	XAN2
Xeroderma pigmentosum, group A, 278700 (3)	XPA, XPAC	611153	9q22.33	XPA
Xeroderma pigmentosum, group A, 278700 (3)	XPA, XPAC	611153	9q22.33	XPAC
Xeroderma pigmentosum, group B, 610651 (3)	ERCC3, XPB, TTD2	133510	2q14.3	ERCC3
Xeroderma pigmentosum, group B, 610651 (3)	ERCC3, XPB, TTD2	133510	2q14.3	XPB
Xeroderma pigmentosum, group B, 610651 (3)	ERCC3, XPB, TTD2	133510	2q14.3	TTD2
Xeroderma pigmentosum, group C, 278720 (3)	XPC, XPCC	613208	3p25.1	XPC
Xeroderma pigmentosum, group C, 278720 (3)	XPC, XPCC	613208	3p25.1	XPCC
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	ERCC2
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	EM9
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	XPD
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	COFS2
Xeroderma pigmentosum, group D, 278730 (3)	ERCC2, EM9, XPD, COFS2, TTD1	126340	19q13.32	TTD1
Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)	DDB2	600811	11p11.2	DDB2
Xeroderma pigmentosum, group F, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Xeroderma pigmentosum, group F, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XPF
Xeroderma pigmentosum, group F, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	FANCQ
Xeroderma pigmentosum, group F, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XFEPS
Xeroderma pigmentosum, group G, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Xeroderma pigmentosum, group G, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	XPG
Xeroderma pigmentosum, group G, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	COFS3
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	ERCC5
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	XPG
Xeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3)	ERCC5, XPG, COFS3	133530	13q33.1	COFS3
Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	ERCC4
Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XPF
Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	FANCQ
Xeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3)	ERCC4, XPF, FANCQ, XFEPS	133520	16p13.12	XFEPS
Xeroderma pigmentosum, variant type, 278750 (3)	POLH, XPV	603968	6p21.1	POLH
Xeroderma pigmentosum, variant type, 278750 (3)	POLH, XPV	603968	6p21.1	XPV
Xia-Gibbs syndrome, 615829 (3)	AHDC1, MRD25	615790	1p36.1-p35.3	AHDC1
Xia-Gibbs syndrome, 615829 (3)	AHDC1, MRD25	615790	1p36.1-p35.3	MRD25
Xp11.22 microduplication syndrome (4)	DUPXp11.22, MRX17, MRX31	300705	Xp11.22	DUPXp11.22
Xp11.22 microduplication syndrome (4)	DUPXp11.22, MRX17, MRX31	300705	Xp11.22	MRX17
Xp11.22 microduplication syndrome (4)	DUPXp11.22, MRX17, MRX31	300705	Xp11.22	MRX31
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	TELO2
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	TEL2
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	CLK2
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	KIAA0683
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	HCLK2
You-Hoover-Fong syndrome, 616954 (3)	TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS	611140	16p13.3	YHFS
Yuan-Harel-Lupski syndrome (4)	YUHAL	616652	17p12-p11.2	YUHAL
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	FIG4
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	KIAA0274
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	SAC3
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	ALS11
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	YVS
Yunis-Varon syndrome, 216340 (3)	FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP	609390	6q21	BTOP
Zimmermann-Laband syndrome 1, 135500 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	KCNH1
Zimmermann-Laband syndrome 1, 135500 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	EAG
Zimmermann-Laband syndrome 1, 135500 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	TMBTS
Zimmermann-Laband syndrome 1, 135500 (3)	KCNH1, EAG, TMBTS, ZLS1	603305	1q32.2	ZLS1
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6B1B2
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ATP6B2
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	VPP3
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	DOOD
Zimmermann-Laband syndrome 2, 616455 (3)	ATP6B1B2, ATP6B2, VPP3, DOOD, ZLS2	606939	8p21.3	ZLS2
Zinc deficiency, transient neonatal, 608118 (3)	SLC30A2, ZNT2, TNZD	609617	1p36.11	SLC30A2
Zinc deficiency, transient neonatal, 608118 (3)	SLC30A2, ZNT2, TNZD	609617	1p36.11	ZNT2
Zinc deficiency, transient neonatal, 608118 (3)	SLC30A2, ZNT2, TNZD	609617	1p36.11	TNZD
Zygodactyly 1 (2)	ZD1	609815	3p21.31	ZD1
[?Homosexuality, male] (2)	HMS1, GAY1	306995	Xq28	HMS1
[?Homosexuality, male] (2)	HMS1, GAY1	306995	Xq28	GAY1
[?Hyperproglucagonemia] (1)	GCG	138030	2q24.2	GCG
[?Phosphohydroxylysinuria], 615011 (3)	PHYKPL, AGXT2L2, PHLU	614683	5q35.3	PHYKPL
[?Phosphohydroxylysinuria], 615011 (3)	PHYKPL, AGXT2L2, PHLU	614683	5q35.3	AGXT2L2
[?Phosphohydroxylysinuria], 615011 (3)	PHYKPL, AGXT2L2, PHLU	614683	5q35.3	PHLU
[AMP deaminase deficiency, erythrocytic], 612874 (3)	AMPD3	102772	11p15.4	AMPD3
[Acetylation, slow], 243400 (3)	NAT2, AAC2	612182	8p22	NAT2
[Acetylation, slow], 243400 (3)	NAT2, AAC2	612182	8p22	AAC2
[Alpha-actinin-3 deficiency] (3)	ACTN3	102574	11q13.2	ACTN3
[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
[Analgesia from kappa-opioid receptor agonist, female-specific], 613098 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
[Angiotensin I-converting enzyme, benign serum increase] (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
[Anhaptoglobinemia], 614081 (3)	HP	140100	16q22.2	HP
[Aquaporin-1 deficiency] (3)	AQP1, CHIP28, CO	107776	7p14.3	AQP1
[Aquaporin-1 deficiency] (3)	AQP1, CHIP28, CO	107776	7p14.3	CHIP28
[Aquaporin-1 deficiency] (3)	AQP1, CHIP28, CO	107776	7p14.3	CO
[Axillary odor, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Axillary odor, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	MRP8
[Axillary odor, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	EWWD
[Axillary odor, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	WW
[Beta-glycopyranoside tasting] (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	RCBTB1
[Beta-glycopyranoside tasting] (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	CLLD7
[Beta-glycopyranoside tasting] (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	GLP
[Bilirubin, serum level of, QTL1], 601816 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
[Bilirubin, serum level of, QTL1], 601816 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1
[Bilirubin, serum level of, QTL1], 601816 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	GNT1
[Bilirubin, serum level of, QTL1], 601816 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	BILIQTL1
[Birth weight QTL 1] (2)	FGQTL2, BWQTL1	613219	7p15-p13	FGQTL2
[Birth weight QTL 1] (2)	FGQTL2, BWQTL1	613219	7p15-p13	BWQTL1
[Birth weight QTL 2] (2)	BWQTL2	613459	3q25.3	BWQTL2
[Birth weight QTL 3] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Birth weight QTL 3] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	BWQTL3
[Birth weight QTL 3] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	PGQTL1
[Birth weight QTL4] (2)	BWQTL4	615192	6p22.3	BWQTL4
[Blood group Cromer], 613793 (3)	CD55, DAF, CROM	125240	1q32.2	CD55
[Blood group Cromer], 613793 (3)	CD55, DAF, CROM	125240	1q32.2	DAF
[Blood group Cromer], 613793 (3)	CD55, DAF, CROM	125240	1q32.2	CROM
[Blood group GIL], 607457 (3)	AQP3	600170	9p13.3	AQP3
[Blood group, ABO system], 616093 (3)	ABO	110300	9q34.2	ABO
[Blood group, Auberger system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, Auberger system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	AU
[Blood group, Auberger system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	BCAM
[Blood group, Colton], 110450 (3)	AQP1, CHIP28, CO	107776	7p14.3	AQP1
[Blood group, Colton], 110450 (3)	AQP1, CHIP28, CO	107776	7p14.3	CHIP28
[Blood group, Colton], 110450 (3)	AQP1, CHIP28, CO	107776	7p14.3	CO
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Blood group, Diego], 110500 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Blood group, Dombrock], 616060 (3)	ART4, DO, DOK1	110600	12p12.3	ART4
[Blood group, Dombrock], 616060 (3)	ART4, DO, DOK1	110600	12p12.3	DO
[Blood group, Dombrock], 616060 (3)	ART4, DO, DOK1	110600	12p12.3	DOK1
[Blood group, Duffy system], 110700 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	DARC
[Blood group, Duffy system], 110700 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	FY
[Blood group, Duffy system], 110700 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	GPD
[Blood group, Duffy system], 110700 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	WBCQ1
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Blood group, Froese], 601551 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Blood group, Gerbich], 616089 (3)	GYPC, GE, GPC	110750	2q14.3	GYPC
[Blood group, Gerbich], 616089 (3)	GYPC, GE, GPC	110750	2q14.3	GE
[Blood group, Gerbich], 616089 (3)	GYPC, GE, GPC	110750	2q14.3	GPC
[Blood group, Ii], 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	GCNT2
[Blood group, Ii], 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	Ii
[Blood group, Ii], 110800 (3)	GCNT2, Ii, CTRCT13	600429	6p24.3-p24.2	CTRCT13
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	CD44
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	MDU2
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	MDU3
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	MIC4
[Blood group, Indian system], 609027 (3)	CD44, MDU2, MDU3, MIC4, IN	107269	11p13	IN
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	SEMA7A
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	SEMAL
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	SEMAK1
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	CDW108
[Blood group, John-Milton-Hagen system], 614745 (3)	SEMA7A, SEMAL, SEMAK1, CDW108, JMH	607961	15q24.1	JMH
[Blood group, Kell], 110900 (3)	KEL	613883	7q34	KEL
[Blood group, Kidd], 111000 (3)	SLC14A1, JK, UTE, UT1	613868	18q12.3	SLC14A1
[Blood group, Kidd], 111000 (3)	SLC14A1, JK, UTE, UT1	613868	18q12.3	JK
[Blood group, Kidd], 111000 (3)	SLC14A1, JK, UTE, UT1	613868	18q12.3	UTE
[Blood group, Kidd], 111000 (3)	SLC14A1, JK, UTE, UT1	613868	18q12.3	UT1
[Blood group, Knops system], 607486 (3)	CR1, C3BR	120620	1q32.2	CR1
[Blood group, Knops system], 607486 (3)	CR1, C3BR	120620	1q32.2	C3BR
[Blood group, Landsteiner-Wiener], 111250 (3)	ICAM4, CD242, LW	614088	19p13.2	ICAM4
[Blood group, Landsteiner-Wiener], 111250 (3)	ICAM4, CD242, LW	614088	19p13.2	CD242
[Blood group, Landsteiner-Wiener], 111250 (3)	ICAM4, CD242, LW	614088	19p13.2	LW
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	ABCB6
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MTABC3
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	MCOPCB7
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	LAN
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	DUH3
[Blood group, Langereis system], 111600 (3)	ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2	605452	2q35	PSHK2
[Blood group, Lewis] (3)	FUT3, LE	111100	19p13.3	FUT3
[Blood group, Lewis] (3)	FUT3, LE	111100	19p13.3	LE
[Blood group, Lutheran null], 247420 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, Lutheran null], 247420 (3)	LU, AU, BCAM	612773	19q13.32	AU
[Blood group, Lutheran null], 247420 (3)	LU, AU, BCAM	612773	19q13.32	BCAM
[Blood group, Lutheran system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	LU
[Blood group, Lutheran system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	AU
[Blood group, Lutheran system], 111200 (3)	LU, AU, BCAM	612773	19q13.32	BCAM
[Blood group, MN] (3)	GYPA, MN, GPA	111300	4q31.21	GYPA
[Blood group, MN] (3)	GYPA, MN, GPA	111300	4q31.21	MN
[Blood group, MN] (3)	GYPA, MN, GPA	111300	4q31.21	GPA
[Blood group, OK], 111380 (3)	BSG	109480	19p13.3	BSG
[Blood group, P1PK system, P(k) phenotype], 111400 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	B3GALT3
[Blood group, P1PK system, P(k) phenotype], 111400 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	GLCT3
[Blood group, P1PK system, P(k) phenotype], 111400 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	GLOB
[Blood group, P1Pk system, P(2) phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
[Blood group, P1Pk system, P(2) phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	P1PK
[Blood group, P1Pk system, p phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	A4GALT
[Blood group, P1Pk system, p phenotype], 111400 (3)	A4GALT, P1PK	607922	22q13.2	P1PK
[Blood group, Radin], 111620 (3)	ERMAP, SC, RD	609017	1p34.2	ERMAP
[Blood group, Radin], 111620 (3)	ERMAP, SC, RD	609017	1p34.2	SC
[Blood group, Radin], 111620 (3)	ERMAP, SC, RD	609017	1p34.2	RD
[Blood group, Raph], 179620 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	CD151
[Blood group, Raph], 179620 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	PETA3
[Blood group, Raph], 179620 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	SFA1
[Blood group, Raph], 179620 (3)	CD151, PETA3, SFA1, MER2	602243	11p15.5	MER2
[Blood group, Rhesus], 111690 (3)	RHCE	111700	1p36.11	RHCE
[Blood group, Rodgers], 614374 (3)	C4A, C4S, C4AD	120810	6p21.33	C4A
[Blood group, Rodgers], 614374 (3)	C4A, C4S, C4AD	120810	6p21.33	C4S
[Blood group, Rodgers], 614374 (3)	C4A, C4S, C4AD	120810	6p21.33	C4AD
[Blood group, Scianna system], 111750 (3)	ERMAP, SC, RD	609017	1p34.2	ERMAP
[Blood group, Scianna system], 111750 (3)	ERMAP, SC, RD	609017	1p34.2	SC
[Blood group, Scianna system], 111750 (3)	ERMAP, SC, RD	609017	1p34.2	RD
[Blood group, Ss] (3)	GYPB, SS, MNS	111740	4q31.21	GYPB
[Blood group, Ss] (3)	GYPB, SS, MNS	111740	4q31.21	SS
[Blood group, Ss] (3)	GYPB, SS, MNS	111740	4q31.21	MNS
[Blood group, Stoltzfus system] (2)	SF	111800	4q28-q31	SF
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Blood group, Swann], 601550 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Blood group, Vel system], 615264 (3)	SMIM1, VEL	615242	1p36.32	SMIM1
[Blood group, Vel system], 615264 (3)	SMIM1, VEL	615242	1p36.32	VEL
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Blood group, Waldner], 112010 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Blood group, Wright], 112050 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Blood group, XG system] (3)	XG	314700	Xpter-p22.32	XG
[Blood group, Yt system], 112100 (3)	ACHE, YT	100740	7q22.1	ACHE
[Blood group, Yt system], 112100 (3)	ACHE, YT	100740	7q22.1	YT
[Blood group, globoside system], 615021 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	B3GALT3
[Blood group, globoside system], 615021 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	GLCT3
[Blood group, globoside system], 615021 (3)	B3GALT3, GLCT3, GLOB	603094	3q26.1	GLOB
[Blood pressure regulation QTL], 145500 (2)	ATP1B1	182330	1q24.2	ATP1B1
[Blood pressure regulation QTL], 145500 (2)	RGS5	603276	1q23.3	RGS5
[Blood pressure regulation QTL], 145500 (2)	SELE, ELAM1	131210	1q24.2	SELE
[Blood pressure regulation QTL], 145500 (2)	SELE, ELAM1	131210	1q24.2	ELAM1
[Body mass index QTL 15] (2)	BMIQ15	612967	17q23.2-q25.1	BMIQ15
[Body mass index QTL13] (2)	BMIQ13	612459	2q14.1	BMIQ13
[Body mass index QTL16] (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	BMIQ16
[Body mass index QTL16] (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	DEL16p.11.2
[Body mass index QTL16] (4)	BMIQ16, DEL16p.11.2, C16DELp11.2	613444	16p11.2	C16DELp11.2
[Body mass index QTL1] (2)	BMIQ1	606641	7q32.3	BMIQ1
[Body mass index QTL2] (2)	BMIQ2	606643	13q14	BMIQ2
[Body mass index QTL3] (2)	BMIQ3	607446	6q23-q25	BMIQ3
[Body mass index QTL5] (2)	BMIQ5	608558	16p13	BMIQ5
[Body mass index QTL6] (2)	BMIQ6	608559	20pter-p11.2	BMIQ6
[Bombay phenotype] (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
[Bombay phenotype] (3)	FUT2, SE, B12QTL1	182100	19q13.33	SE
[Bombay phenotype] (3)	FUT2, SE, B12QTL1	182100	19q13.33	B12QTL1
[Bombay phenotype], 616754 (3)	FUT1, H, HH	211100	19q13.33	FUT1
[Bombay phenotype], 616754 (3)	FUT1, H, HH	211100	19q13.33	H
[Bombay phenotype], 616754 (3)	FUT1, H, HH	211100	19q13.33	HH
[Bone mineral density QTL 10] (2)	BMND10	612113	8q24	BMND10
[Bone mineral density QTL 11] (2)	BMND11	612114	6q25	BMND11
[Bone mineral density QTL 13] (2)	BMND13	612727	16q23	BMND13
[Bone mineral density QTL 14] (2)	BMND14	612728	1p33-p32	BMND14
[Bone mineral density QTL 15], 613418 (3)	MIR2861, MIRN2861, BMND15	613405	9q34.11	MIR2861
[Bone mineral density QTL 15], 613418 (3)	MIR2861, MIRN2861, BMND15	613405	9q34.11	MIRN2861
[Bone mineral density QTL 15], 613418 (3)	MIR2861, MIRN2861, BMND15	613405	9q34.11	BMND15
[Bone mineral density QTL 2] (2)	BMND2	605833	1q21-q23	BMND2
[Bone mineral density QTL 3] (2)	BMND3	606928	1p36	BMND3
[Bone mineral density QTL 4] (2)	BMND4	300536	Xq27	BMND4
[Bone mineral density QTL 5] (2)	BMND5	609354	11q23	BMND5
[Bone mineral density QTL 6] (2)	BMND6	609876	21q22.13-qter	BMND6
[Bone mineral density QTL 9] (2)	BMND9	612110	13q14	BMND9
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
[Bone mineral density variability 1], 601884 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
[Bone size quantitative trait locus 3] (2)	BSZQTL3	610649	8q24	BSZQTL3
[C-reactive protein QTL] (2)	CPROTQ	611920	10q23-q24	CPROTQ
[C3HEX, ability to smell], 615082 (3)	OR2J3, C3HEXS	615016	6p22.1	OR2J3
[C3HEX, ability to smell], 615082 (3)	OR2J3, C3HEXS	615016	6p22.1	C3HEXS
[Chitotriosidase deficiency], 614122 (3)	CHIT, CHITD	600031	1q32.1	CHIT
[Chitotriosidase deficiency], 614122 (3)	CHIT, CHITD	600031	1q32.1	CHITD
[Cholesterol level QTL 1] (2)	CLQTL1, CLF	604595	13q	CLQTL1
[Cholesterol level QTL 1] (2)	CLQTL1, CLF	604595	13q	CLF
[Cholesterol level QTL 2] (2)	CLQTL2	610760	2p24-p22	CLQTL2
[Cinnamon odor, pleasantness of] (2)	CINN	611109	4q32.3	CINN
[Colostrum secretion, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Colostrum secretion, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	MRP8
[Colostrum secretion, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	EWWD
[Colostrum secretion, variation in], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	WW
[Creatine kinase, brain type, ectopic expression of] (2)	CKBE	123270	14q32	CKBE
[Dopamine-beta-hydroxylase activity levels, plasma] (3)	DBH	609312	9q34.2	DBH
[Dysalbuminemic hyperthyroxinemia], 615999 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ALB
[Dysalbuminemic hyperthyroxinemia], 615999 (3)	ALB, ANALBA, FDAH	103600	4q13.3	ANALBA
[Dysalbuminemic hyperthyroxinemia], 615999 (3)	ALB, ANALBA, FDAH	103600	4q13.3	FDAH
[Dystransthyretinemic hyperthyroxinemia], 145680 (3)	TTR, PALB	176300	18q12.1	TTR
[Dystransthyretinemic hyperthyroxinemia], 145680 (3)	TTR, PALB	176300	18q12.1	PALB
[Earwax, wet/dry], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	ABCC11
[Earwax, wet/dry], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	MRP8
[Earwax, wet/dry], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	EWWD
[Earwax, wet/dry], 117800 (3)	ABCC11, MRP8, EWWD, WW	607040	16q12.1	WW
[Eculizumab, poor response to], 615749 (3)	C5, C5D, ECLZB	120900	9q33.2	C5
[Eculizumab, poor response to], 615749 (3)	C5, C5D, ECLZB	120900	9q33.2	C5D
[Eculizumab, poor response to], 615749 (3)	C5, C5D, ECLZB	120900	9q33.2	ECLZB
[Eosinophil peroxidase deficiency], 261500 (3)	EPX, EPXD	131399	17q22	EPX
[Eosinophil peroxidase deficiency], 261500 (3)	EPX, EPXD	131399	17q22	EPXD
[Erythrocytosis, familial, 1], 133100 (3)	EPOR	133171	19p13.2	EPOR
[Ezetimibe, nonresponse to] (3)	NPC1L1	608010	7p13	NPC1L1
[Fasting insulin level quantitative trait locus 1] (2)	FIQTL1	606035	6q22-q24	FIQTL1
[Fasting plasma glucose level QTL 1] (2)	FGQTL1	612108	2q24-q32	FGQTL1
[Fasting plasma glucose level QTL 2] (2)	FGQTL2, BWQTL1	613219	7p15-p13	FGQTL2
[Fasting plasma glucose level QTL 2] (2)	FGQTL2, BWQTL1	613219	7p15-p13	BWQTL1
[Fasting plasma glucose level QTL 3] (2)	FGQTL3	613233	11q21-q22	FGQTL3
[Fasting plasma glucose level QTL 4] (2)	FGQTL4	613462	7p21.2	FGQTL4
[Fasting plasma glucose level QTL 5], 613463 (3)	GCKR, GKRP, FGQTL5	600842	2p23.3	GCKR
[Fasting plasma glucose level QTL 5], 613463 (3)	GCKR, GKRP, FGQTL5	600842	2p23.3	GKRP
[Fasting plasma glucose level QTL 5], 613463 (3)	GCKR, GKRP, FGQTL5	600842	2p23.3	FGQTL5
[Fasting plasma glucose level QTL 6] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Fasting plasma glucose level QTL 6] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	BWQTL3
[Fasting plasma glucose level QTL 6] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	PGQTL1
[Fetal hemoglobin QTL5] (2)	HBFQTL5	142335	2p16.1	HBFQTL5
[Fleck retina, familial benign], 228980 (3)	PLA2G5, FRFB	601192	1p36.13	PLA2G5
[Fleck retina, familial benign], 228980 (3)	PLA2G5, FRFB	601192	1p36.13	FRFB
[Fructosuria], 229800 (3)	KHK	614058	2p23.3	KHK
[Gamma-glutamyltransferase, familial high serum] (2)	GGT2	137181	22q11.21	GGT2
[Gilbert syndrome], 143500 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1A1
[Gilbert syndrome], 143500 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	UGT1
[Gilbert syndrome], 143500 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	GNT1
[Gilbert syndrome], 143500 (3)	UGT1A1, UGT1, GNT1, BILIQTL1	191740	2q37.1	BILIQTL1
[Glycerol quantitative trait locus], 614411 (3)	AQP7, GLYCQTL	602974	9p13.3	AQP7
[Glycerol quantitative trait locus], 614411 (3)	AQP7, GLYCQTL	602974	9p13.3	GLYCQTL
[Glyoxalase II deficiency], 614033 (1)	HAGH, GLO2	138760	16p13.3	HAGH
[Glyoxalase II deficiency], 614033 (1)	HAGH, GLO2	138760	16p13.3	GLO2
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDAR
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	DL
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ED3
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	EDA3
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	HRM1
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10A
[Hair morphology 1, hair thickness], 612630 (3)	EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B	604095	2q13	ECTD10B
[Handedness] (2)	HSR	139900	2p12-q22	HSR
[Hematocrit/hemoglobin quantitative trait locus 1] (2)	HCHGQ1	609319	6q23	HCHGQ1
[Hematocrit/hemoglobin quantitative trait locus 2] (2)	HCHGQ2	609320	9q	HCHGQ2
[Hematocrit/hemoglobin quantitative trait locus 3] (2)	HCHGQ3	613284	22q12-q13	HCHGQ3
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	EGLN1
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	PHD2
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	HIFPH2
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	C1orf12
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	ZMYND6
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	SM20
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	ECYT3
[Hemoglobin, high altitude adaptation], 609070 (3)	EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH	606425	1q42.2	HALAH
[Hereditary persistence of alpha-fetoprotein], 615970 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFP
[Hereditary persistence of alpha-fetoprotein], 615970 (3)	AFP, HPAFP, AFPD	104150	4q13.3	HPAFP
[Hereditary persistence of alpha-fetoprotein], 615970 (3)	AFP, HPAFP, AFPD	104150	4q13.3	AFPD
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	KLF1
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	EKLF
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	INLU
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	HBFQTL6
[Hereditary persistence of fetal hemoglobin], 613566 (3)	KLF1, EKLF, INLU, HBFQTL6, CDAN4	600599	19p13.13	CDAN4
[Hex A pseudodeficiency], 272800 (3)	HEXA, TSD	606869	15q23	HEXA
[Hex A pseudodeficiency], 272800 (3)	HEXA, TSD	606869	15q23	TSD
[High density lipoprotein cholesterol level QTL 10], 143470 (3)	CETP, HDLCQ10	118470	16q13	CETP
[High density lipoprotein cholesterol level QTL 10], 143470 (3)	CETP, HDLCQ10	118470	16q13	HDLCQ10
[High density lipoprotein cholesterol level QTL 11] (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LPL
[High density lipoprotein cholesterol level QTL 11] (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	LIPD
[High density lipoprotein cholesterol level QTL 11] (3)	LPL, LIPD, HDLCQ11	609708	8p21.3	HDLCQ11
[High density lipoprotein cholesterol level QTL 12], 612797 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
[High density lipoprotein cholesterol level QTL 12], 612797 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HL
[High density lipoprotein cholesterol level QTL 12], 612797 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPH
[High density lipoprotein cholesterol level QTL 12], 612797 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HDLCQ12
[High density lipoprotein cholesterol level QTL 1] (2)	HDLCQ1	606613	9p	HDLCQ1
[High density lipoprotein cholesterol level QTL 2] (2)	HDLCQ2	607053	8q23	HDLCQ2
[High density lipoprotein cholesterol level QTL 4] (2)	HDLCQ4	610239	4q32.3	HDLCQ4
[High density lipoprotein cholesterol level QTL 5] (2)	HDLCQ5	610761	3q24-q26	HDLCQ5
[High density lipoprotein cholesterol level QTL 8] (3)	VNN1, HDLCQ8	603570	6q23.2	VNN1
[High density lipoprotein cholesterol level QTL 8] (3)	VNN1, HDLCQ8	603570	6q23.2	HDLCQ8
[High density lipoprotein cholesterol level QTL 9] (3)	PLTP, HDLCQ9	172425	20q13.12	PLTP
[High density lipoprotein cholesterol level QTL 9] (3)	PLTP, HDLCQ9	172425	20q13.12	HDLCQ9
[High density lipoprotein cholesterol level QTL6], 610762 (3)	SCARB1, CD36L1, CLA1, HDLQTL6	601040	12q24.31	SCARB1
[High density lipoprotein cholesterol level QTL6], 610762 (3)	SCARB1, CD36L1, CLA1, HDLQTL6	601040	12q24.31	CD36L1
[High density lipoprotein cholesterol level QTL6], 610762 (3)	SCARB1, CD36L1, CLA1, HDLQTL6	601040	12q24.31	CLA1
[High density lipoprotein cholesterol level QTL6], 610762 (3)	SCARB1, CD36L1, CLA1, HDLQTL6	601040	12q24.31	HDLQTL6
[High molecular weight kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG1
[High molecular weight kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG
[Histidinemia], 235800 (3)	HAL, HSTD	609457	12q23.1	HAL
[Histidinemia], 235800 (3)	HAL, HSTD	609457	12q23.1	HSTD
[Hyperphenylalaninemia, non-PKU mild], 261600 (3)	PAH, PKU1	612349	12q23.2	PAH
[Hyperphenylalaninemia, non-PKU mild], 261600 (3)	PAH, PKU1	612349	12q23.2	PKU1
[Hyperproreninemia] (3)	REN, HNFJ2	179820	1q32.1	REN
[Hyperproreninemia] (3)	REN, HNFJ2	179820	1q32.1	HNFJ2
[Hypoceruloplasminemia, hereditary], 604290 (3)	CP	117700	3q24-q25	CP
[Hypohaptoglobinemia], 614081 (3)	HP	140100	16q22.2	HP
[IMPDH2 enzyme activity, variation in] (3)	IMPDH2, IMPD2	146691	3p21.31	IMPDH2
[IMPDH2 enzyme activity, variation in] (3)	IMPDH2, IMPD2	146691	3p21.31	IMPD2
[IgE levels QTL], 147050 (3)	PHF11, NYREN34	607796	13q14.2	PHF11
[IgE levels QTL], 147050 (3)	PHF11, NYREN34	607796	13q14.2	NYREN34
[IgE, elevated level of], 147050 (3)	IL21R	605383	16p12.1	IL21R
[IgG receptor I, phagocytic, familial deficiency of] (3)	FCGR1A, IGFR1, CD64	146760	1q21.2	FCGR1A
[IgG receptor I, phagocytic, familial deficiency of] (3)	FCGR1A, IGFR1, CD64	146760	1q21.2	IGFR1
[IgG receptor I, phagocytic, familial deficiency of] (3)	FCGR1A, IGFR1, CD64	146760	1q21.2	CD64
[Inosine triphosphatase deficiency], 613850 (3)	ITPA, EIEE35	147520	20p13	ITPA
[Inosine triphosphatase deficiency], 613850 (3)	ITPA, EIEE35	147520	20p13	EIEE35
[Interleukin 6, serum level of, QTL], 614752 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6R
[Interleukin 6, serum level of, QTL], 614752 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6RQ
[Interleukin 6, serum level of, QTL], 614752 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6Q
[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6R
[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6RQ
[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3)	IL6R, IL6RQ, IL6Q	147880	1q21.3	IL6Q
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCG2
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	BCRP
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCP
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	UAQTL1
[Junior blood group system], 614490 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	GOUT1
[Kallikrein, decreased urinary activity of], 615953 (3)	KLK1, KLKR	147910	19q13.33	KLK1
[Kallikrein, decreased urinary activity of], 615953 (3)	KLK1, KLKR	147910	19q13.33	KLKR
[Kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG1
[Kininogen deficiency], 228960 (3)	KNG1, KNG	612358	3q27.3	KNG
[LPA deficiency, congenital] (3)	LPA	152200	6q25-q26	LPA
[Lactate dehydrogenase-B deficiency], 614128 (3)	LDHB, LDHBD	150100	12p12.1	LDHB
[Lactate dehydrogenase-B deficiency], 614128 (3)	LDHB, LDHBD	150100	12p12.1	LDHBD
[Lean body mass QTL 1] (2)	LBMQTL1	612729	8q23	LBMQTL1
[Leptin serum levels QTL1] (2)	LEPQTL1, LSL	601694	2p21	LEPQTL1
[Leptin serum levels QTL1] (2)	LEPQTL1, LSL	601694	2p21	LSL
[Longevity 1] (2)	LGV1	152430	4q25	LGV1
[Longevity 2] (2)	LGV2	606460	6q21	LGV2
[Low density lipoprotein cholesterol level QTL 3] (3)	HMGCR, LDLCQ3	142910	5q13.3	HMGCR
[Low density lipoprotein cholesterol level QTL 3] (3)	HMGCR, LDLCQ3	142910	5q13.3	LDLCQ3
[Low density lipoprotein cholesterol level QTL6], 613589 (3)	SORT1, NT3, LDLCQ6	602458	1p13.3	SORT1
[Low density lipoprotein cholesterol level QTL6], 613589 (3)	SORT1, NT3, LDLCQ6	602458	1p13.3	NT3
[Low density lipoprotein cholesterol level QTL6], 613589 (3)	SORT1, NT3, LDLCQ6	602458	1p13.3	LDLCQ6
[Macrothrombocytopenia] (1)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
[Macrothrombocytopenia] (1)	CD36, CHDS7, BDPLT10	173510	7q21.11	CHDS7
[Macrothrombocytopenia] (1)	CD36, CHDS7, BDPLT10	173510	7q21.11	BDPLT10
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SLC4A1
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	AE1
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	EPB3
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SPH4
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	SAO
[Malaria, resistance to], 611162 (3)	SLC4A1, AE1, EPB3, SPH4, SAO, CHC	109270	17q21.31	CHC
[Mean platelet volume QTL1] (2)	MPVQTL1	612573	12q24.31	MPVQTL1
[Mean platelet volume QTL2] (2)	MPVQTL2	612574	3p21-p13	MPVQTL2
[Mean platelet volume QTL3] (2)	MPVQTL3	612575	17q11.2	MPVQTL3
[Memory, enhanced, QTL], 615602 (3)	WWC1, KIBRA, KIAA0869, MEMRYQTL	610533	5q34	WWC1
[Memory, enhanced, QTL], 615602 (3)	WWC1, KIBRA, KIAA0869, MEMRYQTL	610533	5q34	KIBRA
[Memory, enhanced, QTL], 615602 (3)	WWC1, KIBRA, KIAA0869, MEMRYQTL	610533	5q34	KIAA0869
[Memory, enhanced, QTL], 615602 (3)	WWC1, KIBRA, KIAA0869, MEMRYQTL	610533	5q34	MEMRYQTL
[Musical aptitude QTL 1] (2)	MUSQTL1	612343	4q22	MUSQTL1
[Novelty seeking personality], 601696 (1)	DRD4	126452	11p15.5	DRD4
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
[Obesity, resistance to] (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
[Pentosuria], 260800 (3)	DCXR, P34H, PNTSU	608347	17q25.3	DCXR
[Pentosuria], 260800 (3)	DCXR, P34H, PNTSU	608347	17q25.3	P34H
[Pentosuria], 260800 (3)	DCXR, P34H, PNTSU	608347	17q25.3	PNTSU
[Phenylthiocarbamide tasting], 171200 (3)	TAS2R38, T2R61, PTC	607751	7q34	TAS2R38
[Phenylthiocarbamide tasting], 171200 (3)	TAS2R38, T2R61, PTC	607751	7q34	T2R61
[Phenylthiocarbamide tasting], 171200 (3)	TAS2R38, T2R61, PTC	607751	7q34	PTC
[Placental lactogen deficiency] (1)	CSH1, CSA, PL	150200	17q23.3	CSH1
[Placental lactogen deficiency] (1)	CSH1, CSA, PL	150200	17q23.3	CSA
[Placental lactogen deficiency] (1)	CSH1, CSA, PL	150200	17q23.3	PL
[Plasma glucose, 2-hour, QTL 1] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	FGQTL6
[Plasma glucose, 2-hour, QTL 1] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	BWQTL3
[Plasma glucose, 2-hour, QTL 1] (2)	FGQTL6, BWQTL3, PGQTL1	613460	3q21	PGQTL1
[Plasma glucose, 2-hour, QTL 2] (2)	GIPR, PGQTL2	137241	19q13.32	GIPR
[Plasma glucose, 2-hour, QTL 2] (2)	GIPR, PGQTL2	137241	19q13.32	PGQTL2
[Polyunsaturated fatty acids plasma level QTL1] (2)	PURAQTL1	612795	11q12-q13.1	PURAQTL1
[Premature chromatid separation trait], 176430 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUB1B
[Premature chromatid separation trait], 176430 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	BUBR1
[Premature chromatid separation trait], 176430 (3)	BUB1B, BUBR1, MVA1	602860	15q15.1	MVA1
[Protein Z deficiency], 614024 (3)	PROZ, PZ	176895	13q34	PROZ
[Protein Z deficiency], 614024 (3)	PROZ, PZ	176895	13q34	PZ
[QT interval, variation in] (2)	QTV	610141	1q23.3	QTV
[Respiratory rhythmicity in sleep] (2)	RRIS	609116	10q26	RRIS
[Resting heart rate], 607276 (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1
[Resting heart rate], 607276 (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1R
[Resting heart rate], 607276 (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	RHR
[Rh-negative blood type] (3)	RHD	111680	1p36.11	RHD
[Sarcosinemia], 268900 (3)	SARDH, SARD, SAR	604455	9q34.2	SARDH
[Sarcosinemia], 268900 (3)	SARDH, SARD, SAR	604455	9q34.2	SARD
[Sarcosinemia], 268900 (3)	SARDH, SARD, SAR	604455	9q34.2	SAR
[Sex hormone-binding globulin circulating level QTL 1] (2)	SXGQTL1	613498	17p13	SXGQTL1
[Short sleeper], 612975 (3)	BHLHE41, BHLHB3, DEC2, SHARP1	606200	12p12.1	BHLHE41
[Short sleeper], 612975 (3)	BHLHE41, BHLHB3, DEC2, SHARP1	606200	12p12.1	BHLHB3
[Short sleeper], 612975 (3)	BHLHE41, BHLHB3, DEC2, SHARP1	606200	12p12.1	DEC2
[Short sleeper], 612975 (3)	BHLHE41, BHLHB3, DEC2, SHARP1	606200	12p12.1	SHARP1
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	SHEP1
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	MRT38
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	P
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	PED
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	D15S12
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	BOCA
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	EYCL3
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	HCL3
[Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	SHEP1
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	HERC2
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	SHEP1
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	HERC2, SHEP1, MRT38	605837	15q13.1	MRT38
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	OCA2
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	P
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	PED
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	D15S12
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	BOCA
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	EYCL3
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	HCL3
[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3)	OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1	611409	15q12-q13	SHEP1
[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	TPCN2, TPC2, SHEP10	612163	11q13.3	TPCN2
[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	TPCN2, TPC2, SHEP10	612163	11q13.3	TPC2
[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)	TPCN2, TPC2, SHEP10	612163	11q13.3	SHEP10
[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
[Skin/hair/eye pigmentation 2, blond hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
[Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
[Skin/hair/eye pigmentation 3, blue/green eyes], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
[Skin/hair/eye pigmentation 3, light/dark/freckling skin], 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SLC24A5
[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	NCKX5
[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	SHEP4
[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)	SLC24A5, NCKX5, SHEP4, OCA6	609802	15q21.1	OCA6
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	MATP
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	AIM1
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SHEP5
[Skin/hair/eye pigmentation 5, black/nonblack hair], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	OCA4
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	MATP
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	AIM1
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SHEP5
[Skin/hair/eye pigmentation 5, dark/fair skin], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	OCA4
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SLC45A2
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	MATP
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	AIM1
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	SHEP5
[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3)	SLC45A2, MATP, AIM1, SHEP5, OCA4	606202	5p13.2	OCA4
[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	NCKX4
[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SHEP6
[Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	AI2A5
[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SLC24A4
[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	NCKX4
[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	SHEP6
[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3)	SLC24A4, NCKX4, SHEP6, AI2A5	609840	14q32.12	AI2A5
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	KITLG
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	MGF
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SF
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SCF
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	SHEP7
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	FPHH
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DCUA
[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3)	KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69	184745	12q21.32	DFNA69
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	ASIP
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	AGTIL
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	SHEP9
[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	ASIP
[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	AGTIL
[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3)	ASIP, AGTIL, SHEP9	600201	20q11.22	SHEP9
[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	TYRP1
[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	CAS2
[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	GP75
[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3)	TYRP1, CAS2, GP75, SHEP11	115501	9p23	SHEP11
[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	IRF4, LSIRF, SHEP8	601900	6p25.3	IRF4
[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	IRF4, LSIRF, SHEP8	601900	6p25.3	LSIRF
[Skin/hair/eye pigmentation, variation in, 8], 611724 (3)	IRF4, LSIRF, SHEP8	601900	6p25.3	SHEP8
[Social cognition] (2)	CGF1	300082	Xq	CGF1
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	TRPV4
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	VROAC
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	HMSN2C
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	CMT2C
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SPSMA
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SSQTL1
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	SMAL
[Sodium serum level QTL 1], 613508 (3)	TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3	605427	12q24.11	BCYM3
[Sprinting performance] (3)	ACTN3	102574	11q13.2	ACTN3
[Statins, attenuated cholesterol lowering by] (3)	HMGCR, LDLCQ3	142910	5q13.3	HMGCR
[Statins, attenuated cholesterol lowering by] (3)	HMGCR, LDLCQ3	142910	5q13.3	LDLCQ3
[Superoxide dismutase, elevated extracellular] (3)	SOD3	185490	4p15.2	SOD3
[Telomere length, mean leukocyte] (2)	TELM	609113	14q23.2	TELM
[Thyroid-stimulating hormone level QTL 1] (2)	TSHQTL1	612306	5q13	TSHQTL1
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
[Transferrin serum level QTL2], 614193 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
[Tuberculin skin test reactivity QTL] (2)	TST2	613637	5p15	TST2
[Tuberculin skin test reactivity, absence of] (2)	TST1	613636	11p14	TST1
[Urate oxidase deficiency] (1)	UOX	191540	1p22	UOX
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCG2
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	BCRP
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	ABCP
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	UAQTL1
[Uric acid concentration, serum, QTL1], 138900 (3)	ABCG2, BCRP, ABCP, UAQTL1, GOUT1	603756	4q22.1	GOUT1
[Uric acid concentration, serum, QTL4], 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	SLC17A3
[Uric acid concentration, serum, QTL4], 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	NPT4
[Uric acid concentration, serum, QTL4], 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	UAQTL4
[Uric acid concentration, serum, QTL4], 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	GOUT4
[Uric acid concentration, serum, QTL5] (2)	UAQTL5	614746	19q13	UAQTL5
[Uric acid concentration, serum, QTL6] (2)	UAQTL6	614747	1q21.1	UAQTL6
[Visuospatial/perceptual abilities] (2)	VSPA	313000	Xp22.33	VSPA
[White blood cell count QTL], 611862 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	DARC
[White blood cell count QTL], 611862 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	FY
[White blood cell count QTL], 611862 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	GPD
[White blood cell count QTL], 611862 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	WBCQ1
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
van Buchem disease, type 2, 607636 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	VWS
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	LPS
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PIT
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PPS1
van der Woude syndrome, 119300 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	OFC6
von Hippel-Lindau syndrome, 193300 (3)	VHL	608537	3p25.3	VHL
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BSS
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT1
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	VWDP
von Willebrand disease, platelet-type, 177820 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT3
von Willebrand disease, type 1, 193400 (3)	VWF, F8VWF	613160	12p13.31	VWF
von Willebrand disease, type 1, 193400 (3)	VWF, F8VWF	613160	12p13.31	F8VWF
von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)	VWF, F8VWF	613160	12p13.31	VWF
von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3)	VWF, F8VWF	613160	12p13.31	F8VWF
von Willibrand disease, type 3, 277480 (3)	VWF, F8VWF	613160	12p13.31	VWF
von Willibrand disease, type 3, 277480 (3)	VWF, F8VWF	613160	12p13.31	F8VWF
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	AKR1C4
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	CHDR
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	CDR
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	HAKRA
{46XY sex reversal 8, modifier of}, 614279 (3)	AKR1C4, CHDR, CDR, HAKRA, DD4	600451	10p15.1	DD4
{?Allergy and asthma susceptibility} (2)	IGES	147061	5q31.1	IGES
{?Amyloidosis, secondary, susceptibility to} (1)	APCS, SAP	104770	1q23.2	APCS
{?Amyloidosis, secondary, susceptibility to} (1)	APCS, SAP	104770	1q23.2	SAP
{?Breast cancer susceptibility}, 114480 (1)	NQO2, NMOR2	160998	6p25.2	NQO2
{?Breast cancer susceptibility}, 114480 (1)	NQO2, NMOR2	160998	6p25.2	NMOR2
{?Hearing loss, cisplatin-induced, susceptibility to} (2)	CIHL	613290	6p22.3	CIHL
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	TRAF3
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	CD40BP
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	LAP1
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	CAP1
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	CRAF1
{?Herpes simplex encephalitis, susceptibility to, 3}, 614849 (3)	TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5	601896	14q32.32	IIAE5
{?Herpes simplex encephalitis, susceptibility to, 7}, 616532 (3)	IRF3, IIAE7	603734	19q13.33	IRF3
{?Herpes simplex encephalitis, susceptibility to, 7}, 616532 (3)	IRF3, IIAE7	603734	19q13.33	IIAE7
{?Hypertension, essential} (1)	ACSM3, SAH	145505	16p12.3	ACSM3
{?Hypertension, essential} (1)	ACSM3, SAH	145505	16p12.3	SAH
{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	SPRY2, IGAN3	602466	13q31.1	SPRY2
{?IgA nephropathy, susceptibility to, 3}, 616818 (3)	SPRY2, IGAN3	602466	13q31.1	IGAN3
{?Macular degeneration, age-related}, 603075 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
{?Macular degeneration, age-related}, 603075 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
{?Macular degeneration, age-related}, 603075 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
{?Macular degeneration, age-related}, 603075 (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
{?Major affective disorder 2} (2)	MAFD2, MDX	309200	Xq28	MAFD2
{?Major affective disorder 2} (2)	MAFD2, MDX	309200	Xq28	MDX
{?Membranous nephropathy, susceptibility to} (2)	MBNP	614692	6p21.3	MBNP
{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	MRAP2, C6orf117, BMIQ18	615410	6q14.2	MRAP2
{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	MRAP2, C6orf117, BMIQ18	615410	6q14.2	C6orf117
{?Obesity, susceptibility to, BMIQ18}, 615457 (3)	MRAP2, C6orf117, BMIQ18	615410	6q14.2	BMIQ18
{?Obesity, susceptibility to}, 601665 (3)	CARTPT, CART	602606	5q13.2	CARTPT
{?Obesity, susceptibility to}, 601665 (3)	CARTPT, CART	602606	5q13.2	CART
{?SLE susceptibility} (1)	CR1, C3BR	120620	1q32.2	CR1
{?SLE susceptibility} (1)	CR1, C3BR	120620	1q32.2	C3BR
{?Schizophrenia susceptibility 18}, 615232 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SLC1A1
{?Schizophrenia susceptibility 18}, 615232 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	EAAC1
{?Schizophrenia susceptibility 18}, 615232 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	SCZD18
{?Schizophrenia susceptibility 18}, 615232 (3)	SLC1A1, EAAC1, SCZD18, DCBXA	133550	9p24.2	DCBXA
{?Schizophrenia, susceptibility to}, 603013 (1)	NRG1, HGL, HRGA, ARIA	142445	8p12	NRG1
{?Schizophrenia, susceptibility to}, 603013 (1)	NRG1, HGL, HRGA, ARIA	142445	8p12	HGL
{?Schizophrenia, susceptibility to}, 603013 (1)	NRG1, HGL, HRGA, ARIA	142445	8p12	HRGA
{?Schizophrenia, susceptibility to}, 603013 (1)	NRG1, HGL, HRGA, ARIA	142445	8p12	ARIA
{?Schizophrenia}, 181500 (2)	SCZD2	603342	11q14-q21	SCZD2
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HABP2
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	PHBP
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HGFAL
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	FSAP
{?Thyroid cancer, nonmedullary, 5}, 616535 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	NMTC5
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	KIR3DL1
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	NKAT3
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	NKB1
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	AMB11
{AIDS, delayed/rapid progression to}, 609423 (3)	KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1	604946	19q13.42	KIR3DS1
{AIDS, rapid progression to}, 609423 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{AIDS, rapid progression to}, 609423 (3)	IFNG, IFG, IFI	147570	12q15	IFG
{AIDS, rapid progression to}, 609423 (3)	IFNG, IFG, IFI	147570	12q15	IFI
{AIDS, resistance to}, 609423 (3)	CXCL12, SDF1	600835	10q11.21	CXCL12
{AIDS, resistance to}, 609423 (3)	CXCL12, SDF1	600835	10q11.21	SDF1
{AIDS, slow progression to}, 609423 (3)	CXCR1, IL8RA	146929	2q35	CXCR1
{AIDS, slow progression to}, 609423 (3)	CXCR1, IL8RA	146929	2q35	IL8RA
{AIDS, slow progression to}, 609423 (3)	IL4R, IL4RA	147781	16p12.1	IL4R
{AIDS, slow progression to}, 609423 (3)	IL4R, IL4RA	147781	16p12.1	IL4RA
{Abacavir hypersensitivity, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Abacavir hypersensitivity, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Abruptio placentae, susceptibility to} (3)	MTHFD, MTHFC	172460	14q23.3	MTHFD
{Abruptio placentae, susceptibility to} (3)	MTHFD, MTHFC	172460	14q23.3	MTHFC
{Accelerated tumor formation, susceptibility to}, 614401 (3)	MDM2, ACTFS	164785	12q15	MDM2
{Accelerated tumor formation, susceptibility to}, 614401 (3)	MDM2, ACTFS	164785	12q15	ACTFS
{Adiponectin, serum level of, QTL2} (2)	ADIPQTL2, CAQ5	606770	5p15.2-p14	ADIPQTL2
{Adiponectin, serum level of, QTL2} (2)	ADIPQTL2, CAQ5	606770	5p15.2-p14	CAQ5
{Adiponectin, serum level of, QTL3} (2)	ADIPQTL3, CAQ14	606771	14p11.2-q13	ADIPQTL3
{Adiponectin, serum level of, QTL3} (2)	ADIPQTL3, CAQ14	606771	14p11.2-q13	CAQ14
{Adiponectin, serum level of, QTL4} (2)	ADIPQTL4	612629	11q23-q24	ADIPQTL4
{Adiponectin, serum level of, QTL5] (2)	ADIPQTL5	613836	16q23.3	ADIPQTL5
{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	ADH1B, ADH2	103720	4q23	ADH1B
{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against} (3)	ADH1B, ADH2	103720	4q23	ADH2
{Age-related hearing impairment 1} (2)	ARHI1	612448	8q24.13-q24.22	ARHI1
{Age-related hearing impairment 2} (2)	ARHI2	612976	3p26.1-p25.1	ARHI2
{Albinism, oculocutaneous, type II, modifier of}, 203200 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{Albinism, oculocutaneous, type II, modifier of}, 203200 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
{Albinism, oculocutaneous, type II, modifier of}, 203200 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
{Alcohol dependence, protection against}, 103780 (3)	ADH1B, ADH2	103720	4q23	ADH1B
{Alcohol dependence, protection against}, 103780 (3)	ADH1B, ADH2	103720	4q23	ADH2
{Alcohol dependence, protection against}, 103780 (3)	ADH1C, ADH3	103730	4q23	ADH1C
{Alcohol dependence, protection against}, 103780 (3)	ADH1C, ADH3	103730	4q23	ADH3
{Alcohol dependence, susceptibility to}, 103780 (3)	GABRA2	137140	4p12	GABRA2
{Alcohol dependence, susceptibility to}, 103780 (3)	HTR2A	182135	13q14.2	HTR2A
{Alcohol dependence, susceptibility to}, 103780 (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	RCBTB1
{Alcohol dependence, susceptibility to}, 103780 (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	CLLD7
{Alcohol dependence, susceptibility to}, 103780 (3)	RCBTB1, CLLD7, GLP	607867	13q14.2	GLP
{Alcohol dependence}, 103780 (3)	TAS2R16, T2R16	604867	7q31.32	TAS2R16
{Alcohol dependence}, 103780 (3)	TAS2R16, T2R16	604867	7q31.32	T2R16
{Alkaline phosphatase, plasma level of, QTL 2} (2)	ALPQTL2	612367	1p36	ALPQTL2
{Alkaline phosphatase, plasma level of, QTL1} (2)	ALPQTL1	171720	9q34.13	ALPQTL1
{Alkaline phosphatase, plasma level of, QTL3} (2)	ALPQTL3	612368	6p22	ALPQTL3
{Alkaline phosphatase, plasma level of, QTL4} (2)	ALPQTL4	612369	10q21	ALPQTL4
{Allergic rhinitis, susceptibility to}, 607154 (3)	IL13, ALRH, BHR1	147683	5q31.1	IL13
{Allergic rhinitis, susceptibility to}, 607154 (3)	IL13, ALRH, BHR1	147683	5q31.1	ALRH
{Allergic rhinitis, susceptibility to}, 607154 (3)	IL13, ALRH, BHR1	147683	5q31.1	BHR1
{Alzheimer disease 12} (2)	AD12	611073	8p12-q22	AD12
{Alzheimer disease 16} (2)	AD16	300756	Xq21.3	AD16
{Alzheimer disease 18, susceptibility to}, 615590 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	ADAM10
{Alzheimer disease 18, susceptibility to}, 615590 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	MADM
{Alzheimer disease 18, susceptibility to}, 615590 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	RAK
{Alzheimer disease 18, susceptibility to}, 615590 (3)	ADAM10, MADM, RAK, AD18	602192	15q21.3	AD18
{Alzheimer disease 9, susceptibility to}, 608907 (3)	ABCA7, ABCX, AD9	605414	19p13.3	ABCA7
{Alzheimer disease 9, susceptibility to}, 608907 (3)	ABCA7, ABCX, AD9	605414	19p13.3	ABCX
{Alzheimer disease 9, susceptibility to}, 608907 (3)	ABCA7, ABCX, AD9	605414	19p13.3	AD9
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	NOS3	163729	7q36.1	NOS3
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	PLAU
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	URK
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	QPD
{Alzheimer disease, late-onset, susceptibility to}, 104300 (3)	PLAU, URK, QPD, BDPLT5	191840	10q22.2	BDPLT5
{Alzheimer disease, susceptibility to}, 104300 (3)	A2M , A2MD	103950	12p13.31	A2M
{Alzheimer disease, susceptibility to}, 104300 (3)	A2M , A2MD	103950	12p13.31	A2MD
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
{Alzheimer disease, susceptibility to}, 104300 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
{Alzheimer disease, susceptibility to}, 104300 (3)	MPO	606989	17q22	MPO
{Alzheimer disease-13} (2)	AD13	611152	1q21	AD13
{Alzheimer disease-14} (2)	AD14	611154	1q25	AD14
{Alzheimer disease-15} (2)	AD15	611155	3q22-q24	AD15
{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATX2
{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	SCA2
{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ASL13
{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	DCTN1, HMN7B	601143	2p13.1	DCTN1
{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	DCTN1, HMN7B	601143	2p13.1	HMN7B
{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)	PRPH	170710	12q13.12	PRPH
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	TRPM7, LTRPC7, CHAK, ALSPDC	605692	15q21.2	TRPM7
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	TRPM7, LTRPC7, CHAK, ALSPDC	605692	15q21.2	LTRPC7
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	TRPM7, LTRPC7, CHAK, ALSPDC	605692	15q21.2	CHAK
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3)	TRPM7, LTRPC7, CHAK, ALSPDC	605692	15q21.2	ALSPDC
{Aneurysm, familial abdominal 3} (2)	AAA3	611891	9p21	AAA3
{Aneurysm, intracranial berry, 10} (2)	ANIB10	612587	8q12.1	ANIB10
{Aneurysm, intracranial berry, 6} (2)	ANIB6	611892	9p21	ANIB6
{Aneurysm, intracranial berry, 9} (2)	ANIB9	612586	2q33.1	ANIB9
{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	XPNPEP2, AEACEI	300145	Xq26.1	XPNPEP2
{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3)	XPNPEP2, AEACEI	300145	Xq26.1	AEACEI
{Anorexia nervosa, susceptibility to, 1} (2)	ANON1	606788	1p	ANON1
{Anorexia nervosa, susceptibility to}, 606788 (3)	HTR2A	182135	13q14.2	HTR2A
{Anorexia nervosa, susceptibility to}, 610269 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Anorexia nervosa, susceptibility to}, 610269 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BULN2
{Anorexia nervosa, susceptibility to}, 610269 (3)	BDNF, BULN2, ANON2	113505	11p14.1	ANON2
{Antisocial behavior}, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	MAOA
{Antisocial behavior}, 300615 (3)	MAOA, BRNRS	309850	Xp11.3	BRNRS
{Anxiety-related personality traits}, 607834 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	SLC6A4
{Anxiety-related personality traits}, 607834 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	HTT
{Anxiety-related personality traits}, 607834 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	OCD1
{Aplastic anemia, susceptibility to}, 609135 (3)	SBDS, SDS	607444	7q11.21	SBDS
{Aplastic anemia, susceptibility to}, 609135 (3)	SBDS, SDS	607444	7q11.21	SDS
{Aplastic anemia}, 609135 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Aplastic anemia}, 609135 (3)	IFNG, IFG, IFI	147570	12q15	IFG
{Aplastic anemia}, 609135 (3)	IFNG, IFG, IFI	147570	12q15	IFI
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TRC3
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TR
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	DKCA1
{Aplastic anemia}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	PFBMFT2
{Asperger syndrome susceptibility 1} (2)	ASPG1	608638	3q25-q27	ASPG1
{Asperger syndrome susceptibility 2} (2)	ASPG2	608631	17p13	ASPG2
{Asperger syndrome susceptibility 3} (2)	ASPG3	608781	1q21-q22	ASPG3
{Asperger syndrome susceptibility 4} (2)	ASPG4	609954	3p24-p21	ASPG4
{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	NLGN3
{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	ASPGX1
{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	AUTSX1
{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	KIAA1260
{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	AUTSX2
{Asperger syndrome susceptibility, X-linked 2}, 300497 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	ASPGX2
{Aspergillosis, susceptibility to}, 614079 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLEC7A
{Aspergillosis, susceptibility to}, 614079 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CLECSF12
{Aspergillosis, susceptibility to}, 614079 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	DECTIN1
{Aspergillosis, susceptibility to}, 614079 (3)	CLEC7A, CLECSF12, DECTIN1, CANDF4	606264	12p13.2	CANDF4
{Asthma susceptibility 5}, 611064 (3)	IRAK3, IRAKM, ASRT5	604459	12q14.3	IRAK3
{Asthma susceptibility 5}, 611064 (3)	IRAK3, IRAKM, ASRT5	604459	12q14.3	IRAKM
{Asthma susceptibility 5}, 611064 (3)	IRAK3, IRAKM, ASRT5	604459	12q14.3	ASRT5
{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	PTGER2	176804	14q22.1	PTGER2
{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	TBX21, TBET	604895	17q21.32	TBX21
{Asthma, aspirin-induced, susceptibility to}, 208550 (3)	TBX21, TBET	604895	17q21.32	TBET
{Asthma, diminished response to antileukotriene treatment in}, 600807 (3)	ALOX5	152390	10q11.21	ALOX5
{Asthma, nocturnal, susceptibility to}, 600807 (3)	ADRB2	109690	5q32	ADRB2
{Asthma, protection against}, 600807 (3)	MUC7	158375	4q13.3	MUC7
{Asthma, susceptibility to, 1}, 607277 (3)	PTGDR, AS1, ASRT1	604687	14q22.1	PTGDR
{Asthma, susceptibility to, 1}, 607277 (3)	PTGDR, AS1, ASRT1	604687	14q22.1	AS1
{Asthma, susceptibility to, 1}, 607277 (3)	PTGDR, AS1, ASRT1	604687	14q22.1	ASRT1
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	NPSR1
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	GPR154
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	GPRA
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	VRR1
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	PGR14
{Asthma, susceptibility to, 2}, 608584 (3)	NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2	608595	7p14.3	ASRT2
{Asthma, susceptibility to}, 600807 (2)	HLA-G	142871	6p22.1	HLA-G
{Asthma, susceptibility to}, 600807 (3)	CCL11, SCYA11	601156	17q12	CCL11
{Asthma, susceptibility to}, 600807 (3)	CCL11, SCYA11	601156	17q12	SCYA11
{Asthma, susceptibility to}, 600807 (3)	HNMT, MRT51	605238	2q22.1	HNMT
{Asthma, susceptibility to}, 600807 (3)	HNMT, MRT51	605238	2q22.1	MRT51
{Asthma, susceptibility to}, 600807 (3)	IL13, ALRH, BHR1	147683	5q31.1	IL13
{Asthma, susceptibility to}, 600807 (3)	IL13, ALRH, BHR1	147683	5q31.1	ALRH
{Asthma, susceptibility to}, 600807 (3)	IL13, ALRH, BHR1	147683	5q31.1	BHR1
{Asthma, susceptibility to}, 600807 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
{Asthma, susceptibility to}, 600807 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAH
{Asthma, susceptibility to}, 600807 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAD
{Asthma, susceptibility to}, 600807 (3)	SCGB3A2, UGRP1	606531	5q32	SCGB3A2
{Asthma, susceptibility to}, 600807 (3)	SCGB3A2, UGRP1	606531	5q32	UGRP1
{Asthma, susceptibility to}, 600807 (3)	TNF, TNFA	191160	6p21.33	TNF
{Asthma, susceptibility to}, 600807 (3)	TNF, TNFA	191160	6p21.33	TNFA
{Asthma-related traits, susceptibility to, 3} (2)	ASRT3	609958	2p16	ASRT3
{Asthma-related traits, susceptibility to, 4} (2)	ASRT4	610906	1p31	ASRT4
{Asthma-related traits, susceptibility to, 6} (2)	ASRT6	611403	17q21	ASRT6
{Asthma-related traits, susceptibility to, 7}, 611960 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	CHI3L1
{Asthma-related traits, susceptibility to, 7}, 611960 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	GP39
{Asthma-related traits, susceptibility to, 7}, 611960 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	YKL40
{Asthma-related traits, susceptibility to, 7}, 611960 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	ASRT7
{Asthma-related traits, susceptibility to, 8} (2)	ASRT8	613207	9q33	ASRT8
{Asthma}, 600807 (3)	PHF11, NYREN34	607796	13q14.2	PHF11
{Asthma}, 600807 (3)	PHF11, NYREN34	607796	13q14.2	NYREN34
{Atherosclerosis, susceptibility to} (2)	ATHS, ALP	108725	19p13.3-p13.2	ATHS
{Atherosclerosis, susceptibility to} (2)	ATHS, ALP	108725	19p13.3-p13.2	ALP
{Atherosclerosis, susceptibility to} (3)	ALOX5	152390	10q11.21	ALOX5
{Atherosclerosis, susceptibility to} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Atherosclerosis, susceptibility to} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
{Atherosclerosis, susceptibility to} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
{Atopy, resistance to}, 147050 (3)	HAVCR1, HAVCR	606518	5q33.3	HAVCR1
{Atopy, resistance to}, 147050 (3)	HAVCR1, HAVCR	606518	5q33.3	HAVCR
{Atopy, susceptibility to}, 147050 (3)	IL4R, IL4RA	147781	16p12.1	IL4R
{Atopy, susceptibility to}, 147050 (3)	IL4R, IL4RA	147781	16p12.1	IL4RA
{Atopy, susceptibility to}, 147050 (3)	MS4A2, FCER1B	147138	11q12.1	MS4A2
{Atopy, susceptibility to}, 147050 (3)	MS4A2, FCER1B	147138	11q12.1	FCER1B
{Atopy, susceptibility to}, 147050 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PLA2G7
{Atopy, susceptibility to}, 147050 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAH
{Atopy, susceptibility to}, 147050 (3)	PLA2G7, PAFAH, PAFAD	601690	6p12.3	PAFAD
{Atopy, susceptibility to}, 147050 (3)	SELP, GRMP	173610	1q24.2	SELP
{Atopy, susceptibility to}, 147050 (3)	SELP, GRMP	173610	1q24.2	GRMP
{Atrial fibrillation, familial, 5} (2)	ATFB5	611494	4q25	ATFB5
{Atrioventricular septal defect, susceptibility to, 1} (2)	AVSD1, AVCD	606215	1p31-p21	AVSD1
{Atrioventricular septal defect, susceptibility to, 1} (2)	AVSD1, AVCD	606215	1p31-p21	AVCD
{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	CRELD1
{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3)	CRELD1, AVSD2	607170	3p25.3	AVSD2
{Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)	ADHD5	612311	2q21.1	ADHD5
{Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)	ADHD6	612312	13q12.11	ADHD6
{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	TPH2
{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	NTPH
{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	ADHD7
{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1B
{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1L2
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD1	608903	16p13	ADHD1
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD2	608904	17p11	ADHD2
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD3	608905	6q12	ADHD3
{Attention deficit-hyperactivity disorder}, 143465 (2)	ADHD4	608906	5p13	ADHD4
{Attention deficit-hyperactivity disorder}, 143465 (3)	DRD4	126452	11p15.5	DRD4
{Autism susceptibility 11} (2)	AUTS11	610836	1q41-q42	AUTS11
{Autism susceptibility 12} (2)	AUTS12	610838	21p13-q11	AUTS12
{Autism susceptibility 13} (2)	AUTS13	610908	12q14.2	AUTS13
{Autism susceptibility 14A} (2)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	DEL16p11.2
{Autism susceptibility 14A} (2)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	C16DELp11.2
{Autism susceptibility 14A} (2)	DEL16p11.2, C16DELp11.2, AUTS14A	611913	16p11.2	AUTS14A
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CNTNAP2
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CASPR2
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	NRXN4
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	CDFE
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	AUTS15
{Autism susceptibility 15}, 612100 (3)	CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1	604569	7q35-q36	PTHSL1
{Autism susceptibility 17}, 613436 (3)	SHANK2, CORTBP1, AUTS17	603290	11q13.3-q13.4	SHANK2
{Autism susceptibility 17}, 613436 (3)	SHANK2, CORTBP1, AUTS17	603290	11q13.3-q13.4	CORTBP1
{Autism susceptibility 17}, 613436 (3)	SHANK2, CORTBP1, AUTS17	603290	11q13.3-q13.4	AUTS17
{Autism susceptibility 1} (2)	AUTS1	209850	7q22	AUTS1
{Autism susceptibility 3} (2)	AUTS3	608049	13q14.2-q14.1	AUTS3
{Autism susceptibility 4} (2)	AUTS4	608636	15q11	AUTS4
{Autism susceptibility 5} (2)	AUTS5	606053	2q	AUTS5
{Autism susceptibility 6} (2)	AUTS6	609378	17q11	AUTS6
{Autism susceptibility 7} (2)	AUTS7	610676	17q21	AUTS7
{Autism susceptibility 8} (2)	AUTS8	607373	3q25-q27	AUTS8
{Autism susceptibility, X-linked 1}, 300425 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	NLGN3
{Autism susceptibility, X-linked 1}, 300425 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	ASPGX1
{Autism susceptibility, X-linked 1}, 300425 (3)	NLGN3, ASPGX1, AUTSX1	300336	Xq13.1	AUTSX1
{Autism susceptibility, X-linked 2}, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	NLGN4
{Autism susceptibility, X-linked 2}, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	KIAA1260
{Autism susceptibility, X-linked 2}, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	AUTSX2
{Autism susceptibility, X-linked 2}, 300495 (3)	NLGN4, KIAA1260, AUTSX2, ASPGX2	300427	Xp22.32-p22.31	ASPGX2
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MECP2
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	RTT
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	PPMX
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	AUTSX3
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXSL
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRXS13
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX79
{Autism susceptibility, X-linked 3}, 300496 (3)	MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16	300005	Xq28	MRX16
{Autism, susceptibility to, 10} (2)	AUTS10	611016	7q36	AUTS10
{Autism, susceptibility to, 14B} (2)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	DUP16p11.2
{Autism, susceptibility to, 14B} (2)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	C16DUPp11.2
{Autism, susceptibility to, 14B} (2)	DUP16p11.2, C16DUPp11.2, AUTS14B	614671	16p11.2	AUTS14B
{Autism, susceptibility to, 18}, 615032 (3)	CHD8, DUPLIN, KIAA1564, AUTS18	610528	14q11.2	CHD8
{Autism, susceptibility to, 18}, 615032 (3)	CHD8, DUPLIN, KIAA1564, AUTS18	610528	14q11.2	DUPLIN
{Autism, susceptibility to, 18}, 615032 (3)	CHD8, DUPLIN, KIAA1564, AUTS18	610528	14q11.2	KIAA1564
{Autism, susceptibility to, 18}, 615032 (3)	CHD8, DUPLIN, KIAA1564, AUTS18	610528	14q11.2	AUTS18
{Autism, susceptibility to, 19}, 615091 (3)	EIF4E, EIF4EL1, AUTS19	133440	4q23	EIF4E
{Autism, susceptibility to, 19}, 615091 (3)	EIF4E, EIF4EL1, AUTS19	133440	4q23	EIF4EL1
{Autism, susceptibility to, 19}, 615091 (3)	EIF4E, EIF4EL1, AUTS19	133440	4q23	AUTS19
{Autism, susceptibility to, 9} (2)	AUTS9	611015	7q31	AUTS9
{Autism, susceptibility to, X-linked 4}, 300830 (3)	PTCHD1, AUTSX4	300828	Xp22.11	PTCHD1
{Autism, susceptibility to, X-linked 4}, 300830 (3)	PTCHD1, AUTSX4	300828	Xp22.11	AUTSX4
{Autism, susceptibility to, X-linked 5}, 300847 (3)	RPL10, DXS648, QM, AUTSX5	312173	Xq28	RPL10
{Autism, susceptibility to, X-linked 5}, 300847 (3)	RPL10, DXS648, QM, AUTSX5	312173	Xq28	DXS648
{Autism, susceptibility to, X-linked 5}, 300847 (3)	RPL10, DXS648, QM, AUTSX5	312173	Xq28	QM
{Autism, susceptibility to, X-linked 5}, 300847 (3)	RPL10, DXS648, QM, AUTSX5	312173	Xq28	AUTSX5
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	TMLHE
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	BBOX2
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	TMLH
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	TMLHED
{Autism, susceptibility to, X-linked 6}, 300872 (3)	TMLHE, BBOX2, TMLH, TMLHED, AUTSX6	300777	Xq28	AUTSX6
{Autoimmune disease, susceptibility to, 1}, 607836 (3)	FOXD3, AIS1, VAMAS2	611539	1p31.3	FOXD3
{Autoimmune disease, susceptibility to, 1}, 607836 (3)	FOXD3, AIS1, VAMAS2	611539	1p31.3	AIS1
{Autoimmune disease, susceptibility to, 1}, 607836 (3)	FOXD3, AIS1, VAMAS2	611539	1p31.3	VAMAS2
{Autoimmune disease, susceptibility to, 2} (2)	AIS2, VAMAS3	608391	Chr.7	AIS2
{Autoimmune disease, susceptibility to, 2} (2)	AIS2, VAMAS3	608391	Chr.7	VAMAS3
{Autoimmune disease, susceptibility to, 3} (2)	AIS3, VAMAS4	608392	Chr.8	AIS3
{Autoimmune disease, susceptibility to, 3} (2)	AIS3, VAMAS4	608392	Chr.8	VAMAS4
{Autoimmune disease, susceptibility to, 4} (2)	AIS4, VAMAS5	609400	4q13-q21	AIS4
{Autoimmune disease, susceptibility to, 4} (2)	AIS4, VAMAS5	609400	4q13-q21	VAMAS5
{Autoimmune disease, susceptibility to, 5} (2)	CELIAC6, AIS5	611598	4q27	CELIAC6
{Autoimmune disease, susceptibility to, 5} (2)	CELIAC6, AIS5	611598	4q27	AIS5
{Autoimmune disease, susceptibility to, 6}, 613551 (3)	SIAE, AIS6	610079	11q24.2	SIAE
{Autoimmune disease, susceptibility to, 6}, 613551 (3)	SIAE, AIS6	610079	11q24.2	AIS6
{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	COPA, AILJK	601924	1q23.2	COPA
{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3)	COPA, AILJK	601924	1q23.2	AILJK
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	FAS
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	TNFRSF6
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	APT1
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	CD95
{Autoimmune lymphoproliferative syndrome}, 601859 (3)	FAS, TNFRSF6, APT1, CD95, ALPS1A	134637	10q23.31	ALPS1A
{Autoimmune thyroid disease, susceptibility to, 1} (2)	AITD1	608173	6p11	AITD1
{Autoimmune thyroid disease, susceptibility to, 2} (2)	AITD2	608174	5q31-q33	AITD2
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	TG, AITD3, TDH3	188450	8q24.22	TG
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	TG, AITD3, TDH3	188450	8q24.22	AITD3
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	TG, AITD3, TDH3	188450	8q24.22	TDH3
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	ZFAT1, ZNF406, AITD3	610931	8q24.22	ZFAT1
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	ZFAT1, ZNF406, AITD3	610931	8q24.22	ZNF406
{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)	ZFAT1, ZNF406, AITD3	610931	8q24.22	AITD3
{Autoimmune thyroid disease, susceptibility to, 4} (2)	AITD4	608176	10q	AITD4
{Bacteremia, protection against}, 614382 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Bacteremia, protection against}, 614382 (3)	TIRAP, BACTS1	606252	11q24.2	BACTS1
{Bacteremia, susceptibility to}, 614383 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Bacteremia, susceptibility to}, 614383 (3)	CISH, BACTS2	602441	3p21.2	BACTS2
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	ARL6, BBS3, RP55	608845	3q11.2	ARL6
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	ARL6, BBS3, RP55	608845	3q11.2	BBS3
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	ARL6, BBS3, RP55	608845	3q11.2	RP55
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	CCDC28B, MGC1203	610162	1p35.2	CCDC28B
{Bardet-Biedl syndrome 1, modifier of}, 209900 (3)	CCDC28B, MGC1203	610162	1p35.2	MGC1203
{Bardet-Biedl syndrome 14, modifier of}, 615991 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	TMEM67
{Bardet-Biedl syndrome 14, modifier of}, 615991 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	MKS3
{Bardet-Biedl syndrome 14, modifier of}, 615991 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	JBTS6
{Bardet-Biedl syndrome 14, modifier of}, 615991 (3)	TMEM67, MKS3, JBTS6, NPHP11	609884	8q22.1	NPHP11
{Basal cell carcinoma 7}, 614740 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
{Basal cell carcinoma 7}, 614740 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
{Basal cell carcinoma 7}, 614740 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
{Basal cell carcinoma 7}, 614740 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
{Basal cell carcinoma, susceptibility to, 1} (2)	BCC1	605462	1p36	BCC1
{Basal cell carcinoma, susceptibility to, 2} (2)	BCC2	613058	1q42	BCC2
{Basal cell carcinoma, susceptibility to, 3} (2)	BCC3	613059	5p15.33	BCC3
{Basal cell carcinoma, susceptibility to, 4} (2)	BCC4	613061	12q13	BCC4
{Basal cell carcinoma, susceptibility to, 5} (2)	BCC5	613062	9p21	BCC5
{Basal cell carcinoma, susceptibility to, 6} (2)	BCC6	613063	7q32	BCC6
{Benzene toxicity, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Benzene toxicity, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	DIA4
{Benzene toxicity, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NMOR1
{Beryllium disease, chronic, susceptibility to} (3)	HLA-DPB1	142858	6p21.32	HLA-DPB1
{Biliary cirrhosis, primary, 2} (2)	PBC2	613007	6p21.3	PBC2
{Biliary cirrhosis, primary, 3} (2)	PBC3	613008	1p31.2	PBC3
{Bladder cancer, somatic}, 109800 (3)	HRAS	190020	11p15.5	HRAS
{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	TBXA2R, BDPLT13	188070	19p13.3	TBXA2R
{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3)	TBXA2R, BDPLT13	188070	19p13.3	BDPLT13
{Blepharospasm, primary benign}, 606798 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD5
{Blepharospasm, primary benign}, 606798 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1B
{Blepharospasm, primary benign}, 606798 (3)	DRD5, DRD1B, DRD1L2	126453	4p16.1	DRD1L2
{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	UGT2B17, BMND12	601903	4q13.2	UGT2B17
{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	UGT2B17, BMND12	601903	4q13.2	BMND12
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	COL1A1
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI1
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI2
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI3
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	OI4
{Bone mineral density variation QTL, osteoporosis}, 166710 (3)	COL1A1, OI1, OI2, OI3, OI4, EDSC	120150	17q21.33	EDSC
{Bone mineral density, low, susceptibility to}, 615311 (3)	LGR4, GPR48, BNMD17	606666	11p14.1	LGR4
{Bone mineral density, low, susceptibility to}, 615311 (3)	LGR4, GPR48, BNMD17	606666	11p14.1	GPR48
{Bone mineral density, low, susceptibility to}, 615311 (3)	LGR4, GPR48, BNMD17	606666	11p14.1	BNMD17
{Bone size QTL} (2)	BSZQTL	609656	17q23	BSZQTL
{Bone size QTL} (2)	BSZQTL2	609657	5q	BSZQTL2
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	RAD53
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHK2
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CDS1
{Breast and colorectal cancer, susceptibility to} (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	LFS2
{Breast cancer, invasive ductal}, 114480 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	RAD54L
{Breast cancer, invasive ductal}, 114480 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HR54
{Breast cancer, invasive ductal}, 114480 (3)	RAD54L, HR54, HRAD54	603615	1p34.1	HRAD54
{Breast cancer, lobular}, 114480 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	CDH1
{Breast cancer, lobular}, 114480 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	UVO
{Breast cancer, lobular}, 114480 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	LCAM
{Breast cancer, lobular}, 114480 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	ECAD
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Breast cancer, male, susceptibility to}, 114480 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Breast cancer, poor survival after chemotherapy for} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Breast cancer, poor survival after chemotherapy for} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	DIA4
{Breast cancer, poor survival after chemotherapy for} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NMOR1
{Breast cancer, protection against}, 114480 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
{Breast cancer, protection against}, 114480 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	MCH5
{Breast cancer, protection against}, 114480 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	ALPS2B
{Breast cancer, susceptibility to}, 114480 (3)	ATM, ATA, AT1	607585	11q22.3	ATM
{Breast cancer, susceptibility to}, 114480 (3)	ATM, ATA, AT1	607585	11q22.3	ATA
{Breast cancer, susceptibility to}, 114480 (3)	ATM, ATA, AT1	607585	11q22.3	AT1
{Breast cancer, susceptibility to}, 114480 (3)	BARD1	601593	2q35	BARD1
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	RAD53
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHK2
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CDS1
{Breast cancer, susceptibility to}, 114480 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	LFS2
{Breast cancer, susceptibility to}, 114480 (3)	HMMR	600936	5q34	HMMR
{Breast cancer, susceptibility to}, 114480 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
{Breast cancer, susceptibility to}, 114480 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	FANCN
{Breast cancer, susceptibility to}, 114480 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PNCA3
{Breast cancer, susceptibility to}, 114480 (3)	PHB	176705	17q21.33	PHB
{Breast cancer, susceptibility to}, 114480 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	RAD51A
{Breast cancer, susceptibility to}, 114480 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	RECA
{Breast cancer, susceptibility to}, 114480 (3)	RAD51A, RECA, MRMV2	179617	15q15.1	MRMV2
{Breast cancer, susceptibility to}, 114480 (3)	XRCC3, CMM6	600675	14q32.33	XRCC3
{Breast cancer, susceptibility to}, 114480 (3)	XRCC3, CMM6	600675	14q32.33	CMM6
{Breast cancer}, 114480 (1)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Breast cancer}, 114480 (1)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
{Breast cancer}, 114480 (1)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
{Breast-ovarian cancer, familial, 1}, 604370 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BRCA1
{Breast-ovarian cancer, familial, 1}, 604370 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	PSCP
{Breast-ovarian cancer, familial, 1}, 604370 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BROVCA1
{Breast-ovarian cancer, familial, 1}, 604370 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	PNCA4
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Breast-ovarian cancer, familial, 2}, 612555 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	RAD51C
{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	FANCO
{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3)	RAD51C, FANCO, BROVCA3	602774	17q22	BROVCA3
{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	RAD51L3, RAD51D, BROVCA4	602954	17q12	RAD51L3
{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	RAD51L3, RAD51D, BROVCA4	602954	17q12	RAD51D
{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)	RAD51L3, RAD51D, BROVCA4	602954	17q12	BROVCA4
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
{Budd-Chiari syndrome, somatic}, 600800 (3)	JAK2, THCYT3	147796	9p24.1	JAK2
{Budd-Chiari syndrome, somatic}, 600800 (3)	JAK2, THCYT3	147796	9p24.1	THCYT3
{Budd-Chiari syndrome}, 600880 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Budd-Chiari syndrome}, 600880 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
{Budd-Chiari syndrome}, 600880 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
{Bulimia nervosa, age of onset of weight loss in}, 607499 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Bulimia nervosa, age of onset of weight loss in}, 607499 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BULN2
{Bulimia nervosa, age of onset of weight loss in}, 607499 (3)	BDNF, BULN2, ANON2	113505	11p14.1	ANON2
{Bulimia nervosa, susceptibility to} (2)	BULN	607499	10p	BULN
{Buruli ulcer, susceptibility to}, 610446 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP1
{Buruli ulcer, susceptibility to}, 610446 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP
{Buruli ulcer, susceptibility to}, 610446 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	SLC11A1
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
{Calcium, serum level of} (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
{Cancer progression/metastasis} (3)	FGFR4	134935	5q35.2	FGFR4
{Cardiac conduction defect, susceptibility to}, 115080 (3)	AKAP10	604694	17p11.2	AKAP10
{Cataract 28, age-related cortical, susceptibility to} (2)	CTRCT28, ARCC1	609026	6p12-q12	CTRCT28
{Cataract 28, age-related cortical, susceptibility to} (2)	CTRCT28, ARCC1	609026	6p12-q12	ARCC1
{Celiac disease, susceptibility to, 10} (2)	CELIAC10	612008	3q25-q26	CELIAC10
{Celiac disease, susceptibility to, 11} (2)	CELIAC11	612009	3q28	CELIAC11
{Celiac disease, susceptibility to, 12} (2)	CELIAC12	612010	6q25.3	CELIAC12
{Celiac disease, susceptibility to, 13} (2)	CELIAC13	612011	12q24	CELIAC13
{Celiac disease, susceptibility to, 2} (2)	CELIAC2	609754	5q31-q33	CELIAC2
{Celiac disease, susceptibility to, 3}, 609755 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Celiac disease, susceptibility to, 3}, 609755 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	IDDM12
{Celiac disease, susceptibility to, 3}, 609755 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CELIAC3
{Celiac disease, susceptibility to, 3}, 609755 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	ALPS5
{Celiac disease, susceptibility to, 4}, 609753 (3)	MYO9B, MYR5, CELIAC4	602129	19p13.11	MYO9B
{Celiac disease, susceptibility to, 4}, 609753 (3)	MYO9B, MYR5, CELIAC4	602129	19p13.11	MYR5
{Celiac disease, susceptibility to, 4}, 609753 (3)	MYO9B, MYR5, CELIAC4	602129	19p13.11	CELIAC4
{Celiac disease, susceptibility to, 5} (2)	CELIAC5, GSES	607202	15q11-q13	CELIAC5
{Celiac disease, susceptibility to, 5} (2)	CELIAC5, GSES	607202	15q11-q13	GSES
{Celiac disease, susceptibility to, 6} (2)	CELIAC6, AIS5	611598	4q27	CELIAC6
{Celiac disease, susceptibility to, 6} (2)	CELIAC6, AIS5	611598	4q27	AIS5
{Celiac disease, susceptibility to, 7} (2)	CELIAC7	612005	1q31	CELIAC7
{Celiac disease, susceptibility to, 8} (2)	CELIAC8	612006	2q11-q12	CELIAC8
{Celiac disease, susceptibility to, 9} (2)	CELIAC9	612007	3p21	CELIAC9
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQA1, CELIAC1	146880	6p21.32	HLA-DQA1
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQA1, CELIAC1	146880	6p21.32	CELIAC1
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Celiac disease, susceptibility to}, 212750 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	CELIAC1
{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	MTMR14, C3orf29, HJUMPY	611089	3p25.3	MTMR14
{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	MTMR14, C3orf29, HJUMPY	611089	3p25.3	C3orf29
{Centronuclear myopathy, autosomal, modifier of}, 160150 (3)	MTMR14, C3orf29, HJUMPY	611089	3p25.3	HJUMPY
{Cerebral infarction, susceptibility to}, 601367 (3)	PRKCH, PKCL, PRKCL	605437	14q23.1	PRKCH
{Cerebral infarction, susceptibility to}, 601367 (3)	PRKCH, PKCL, PRKCL	605437	14q23.1	PKCL
{Cerebral infarction, susceptibility to}, 601367 (3)	PRKCH, PKCL, PRKCL	605437	14q23.1	PRKCL
{Chordoma, susceptibility to} (4)	CHDM	215400	6q27	CHDM
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBL2
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBL
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBP1
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBL2D
{Chronic infections, due to MBL deficiency}, 614372 (3)	MBL2, MBL, MBP1, MBL2D, MBPD	154545	10q21.1	MBPD
{Chronic mountain sickness, susceptibility to} (2)	CMTS	616182	12q13	CMTS
{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	KRT18	148070	12q13.13	KRT18
{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3)	KRT8	148060	12q13.13	KRT8
{Codeine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CYP2D6
{Codeine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CPD6
{Codeine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	P450DB1
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	ABCB1
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	PGY1
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	MDR1
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	IBD13
{Colchicine resistance}, 120080 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	CLCs
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	AURKA
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	STK15
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	AURORA2
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	BTAK
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	ARK1
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	STK6
{Colon cancer, susceptibility to}, 114500 (3)	AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK	603072	20q13.2	AIK
{Colonic adenoma recurrence, reduced risk of}, 114500 (3)	ODC1	165640	2p25.1	ODC1
{Colorectal cancer, susceptibility to, 10}, 612591 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	POLD1
{Colorectal cancer, susceptibility to, 10}, 612591 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	CRCS10
{Colorectal cancer, susceptibility to, 10}, 612591 (3)	POLD1, CRCS10, MDPL	174761	19q13.33	MDPL
{Colorectal cancer, susceptibility to, 11} (2)	CRCS11	612592	20p12.3	CRCS11
{Colorectal cancer, susceptibility to, 12}, 615083 (3)	POLE1, CRCS12, FILS	174762	12q24.33	POLE1
{Colorectal cancer, susceptibility to, 12}, 615083 (3)	POLE1, CRCS12, FILS	174762	12q24.33	CRCS12
{Colorectal cancer, susceptibility to, 12}, 615083 (3)	POLE1, CRCS12, FILS	174762	12q24.33	FILS
{Colorectal cancer, susceptibility to, 1}, 608812 (3)	GALNT12, CRCS1	610290	9q22.33	GALNT12
{Colorectal cancer, susceptibility to, 1}, 608812 (3)	GALNT12, CRCS1	610290	9q22.33	CRCS1
{Colorectal cancer, susceptibility to, 2} (2)	CRCS2	611469	8q24	CRCS2
{Colorectal cancer, susceptibility to, 3}, 612229 (3)	SMAD7, MADH7, CRCS3	602932	18q21.1	SMAD7
{Colorectal cancer, susceptibility to, 3}, 612229 (3)	SMAD7, MADH7, CRCS3	602932	18q21.1	MADH7
{Colorectal cancer, susceptibility to, 3}, 612229 (3)	SMAD7, MADH7, CRCS3	602932	18q21.1	CRCS3
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	HMPS1
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	CRAC1
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	CRCS4
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	DUP15q
{Colorectal cancer, susceptibility to, 4} (4)	HMPS1, CRAC1, CRCS4, DUP15q, C15DUPq	601228	15q15.3-q22.1	C15DUPq
{Colorectal cancer, susceptibility to, 5} (2)	CRCS5	612230	10p14	CRCS5
{Colorectal cancer, susceptibility to, 6} (2)	CRCS6	612231	8q23	CRCS6
{Colorectal cancer, susceptibility to, 7} (2)	CRCS7	612232	11q23	CRCS7
{Colorectal cancer, susceptibility to, 8} (2)	CRCS8	612589	14q22.2	CRCS8
{Colorectal cancer, susceptibility to, 9} (2)	CRCS9	612590	16q22.1	CRCS9
{Colorectal cancer, susceptibility to}, 114500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
{Colorectal cancer, susceptibility to}, 114500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	PRAD1
{Colorectal cancer, susceptibility to}, 114500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	BCL1
{Colorectal cancer, susceptibility to}, 114500 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Colorectal cancer, susceptibility to}, 114500 (3)	TLR2, TIL4	603028	4q31.3	TIL4
{Colorectal cancer}, 114500 (3)	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p36.13	PLA2G2A
{Colorectal cancer}, 114500 (3)	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p36.13	PLA2B
{Colorectal cancer}, 114500 (3)	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p36.13	PLA2L
{Colorectal cancer}, 114500 (3)	PLA2G2A, PLA2B, PLA2L, MOM1	172411	1p36.13	MOM1
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	612666	1q32.1	DSTYK
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	612666	1q32.1	KIAA0472
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	612666	1q32.1	RIP5
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	612666	1q32.1	DUSTYPK
{Congenital anomalies of kidney and urinary tract, susceptibility to}, 610805 (3)	DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1	612666	1q32.1	CAKUT1
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRA2C, ADRA2L2	104250	4p16.3	ADRA2C
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRA2C, ADRA2L2	104250	4p16.3	ADRA2L2
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	ADRB1R
{Congestive heart failure and beta-blocker response, modifier of} (3)	ADRB1, ADRB1R, RHR	109630	10q25.3	RHR
{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABCA1
{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	ABC1
{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	HDLDT1
{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3)	ABCA1, ABC1, HDLDT1, TGD	600046	9q31.1	TGD
{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	MEF2A, ADCAD1	600660	15q26.3	MEF2A
{Coronary artery disease, autosomal dominant, 1}, 608320 (3)	MEF2A, ADCAD1	600660	15q26.3	ADCAD1
{Coronary artery disease, autosomal dominant, 2}, 610947 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	LRP6
{Coronary artery disease, autosomal dominant, 2}, 610947 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	ADCAD2
{Coronary artery disease, autosomal dominant, 2}, 610947 (3)	LRP6, ADCAD2, STHAG7	603507	12p13.2	STHAG7
{Coronary artery disease, modifier of} (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Coronary artery disease, modifier of} (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	SCYA2
{Coronary artery disease, modifier of} (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCP1
{Coronary artery disease, modifier of} (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCAF
{Coronary artery disease, resistance to}, 607339 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Coronary artery disease, resistance to}, 607339 (3)	CX3CR1, GPR13, V28	601470	3p22.2	GPR13
{Coronary artery disease, resistance to}, 607339 (3)	CX3CR1, GPR13, V28	601470	3p22.2	V28
{Coronary artery disease, susceptibility to} (1)	LPA	152200	6q25-q26	LPA
{Coronary artery disease, susceptibility to} (3)	IRS1	147545	2q36.3	IRS1
{Coronary artery disease, susceptibility to} (3)	KL, KLOTHO	604824	13q13.1	KL
{Coronary artery disease, susceptibility to} (3)	KL, KLOTHO	604824	13q13.1	KLOTHO
{Coronary artery disease, susceptibility to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Coronary artery disease, susceptibility to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON
{Coronary artery disease, susceptibility to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	ESA
{Coronary artery disease, susceptibility to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	MVCD5
{Coronary artery disease, susceptibility to} (3)	PON2	602447	7q21.3	PON2
{Coronary artery spasm 1, susceptibility to} (3)	NOS3	163729	7q36.1	NOS3
{Coronary artery spasm 2, susceptibility to (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Coronary artery spasm 2, susceptibility to (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON
{Coronary artery spasm 2, susceptibility to (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	ESA
{Coronary artery spasm 2, susceptibility to (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	MVCD5
{Coronary heart disease, susceptibility to, 2} (2)	CHDS2	608316	2q21.1-q22	CHDS2
{Coronary heart disease, susceptibility to, 3} (2)	CHDS3	300464	Xq23-q26	CHDS3
{Coronary heart disease, susceptibility to, 4} (2)	CHDS4	608318	14q32	CHDS4
{Coronary heart disease, susceptibility to, 5}, 608901 (3)	KALRN, HAPIP, DUO, CHDS5	604605	3q21.1-q21.2	KALRN
{Coronary heart disease, susceptibility to, 5}, 608901 (3)	KALRN, HAPIP, DUO, CHDS5	604605	3q21.1-q21.2	HAPIP
{Coronary heart disease, susceptibility to, 5}, 608901 (3)	KALRN, HAPIP, DUO, CHDS5	604605	3q21.1-q21.2	DUO
{Coronary heart disease, susceptibility to, 5}, 608901 (3)	KALRN, HAPIP, DUO, CHDS5	604605	3q21.1-q21.2	CHDS5
{Coronary heart disease, susceptibility to, 6}, 614466 (3)	MMP3, STMY1, CHDS6	185250	11q22.2	MMP3
{Coronary heart disease, susceptibility to, 6}, 614466 (3)	MMP3, STMY1, CHDS6	185250	11q22.2	STMY1
{Coronary heart disease, susceptibility to, 6}, 614466 (3)	MMP3, STMY1, CHDS6	185250	11q22.2	CHDS6
{Coronary heart disease, susceptibility to, 7}, 610938 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Coronary heart disease, susceptibility to, 7}, 610938 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CHDS7
{Coronary heart disease, susceptibility to, 7}, 610938 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	BDPLT10
{Coronary heart disease, susceptibility to, 8} (2)	CHDS8	611139	9p21	CHDS8
{Coronary heart disease, susceptibility to, 9} (2)	CHDS9	612030	8p22	CHDS9
{Coronary heart disease, susceptibility to} (2)	CHDS1	607339	16pter-p13	CHDS1
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	ALX4
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	PFM2
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FPP
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	FND2
{Craniosynostosis 5, susceptibility to}, 615529 (3)	ALX4, PFM2, FPP, FND2, CRS5	605420	11p11.2	CRS5
{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	CELIAC1
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IFNB2
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	BSF2
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HSF
{Crohn disease-associated growth failure}, 266600 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HGF
{Cystic fibrosis lung disease, modifier of}, 219700 (3)	TGFB1, DPD1, CED	190180	19q13.2	TGFB1
{Cystic fibrosis lung disease, modifier of}, 219700 (3)	TGFB1, DPD1, CED	190180	19q13.2	DPD1
{Cystic fibrosis lung disease, modifier of}, 219700 (3)	TGFB1, DPD1, CED	190180	19q13.2	CED
{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	ATP2B2, PMCA2	108733	3p25.3	ATP2B2
{Deafness, autosomal recessive 12, modifier of}, 601386 (3)	ATP2B2, PMCA2	108733	3p25.3	PMCA2
{Deafness, mitochondrial, modifier of}, 580000 (3)	TRMU, MTO2	610230	22q13.31	TRMU
{Deafness, mitochondrial, modifier of}, 580000 (3)	TRMU, MTO2	610230	22q13.31	MTO2
{Deafness, nonsyndromic, modifier 1} (2)	DFNM1	605429	1q24	DFNM1
{Debrisoquine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CYP2D6
{Debrisoquine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	CPD6
{Debrisoquine sensitivity}, 608902 (3)	CYP2D6, CPD6, P450DB1	124030	22q13.2	P450DB1
{Deep venous thrombosis, protection against}, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
{Deep venous thrombosis, protection against}, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	HEMB
{Deep venous thrombosis, protection against}, 300807 (3)	F9, HEMB, THPH8	300746	Xq27.1	THPH8
{Delayed sleep phase syndrome, susceptibility to} (2)	DSPS	614163	17q25	DSPS
{Dementia, vascular, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNF
{Dementia, vascular, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNFA
{Dengue fever, protection against}, 614371 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{Dengue fever, protection against}, 614371 (3)	CD209, CDSIGN	604672	19p13.2	CDSIGN
{Dermatitis, atopic, susceptibility to, 1} (2)	ATOD1	603165	3q21	ATOD1
{Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	FLG, ATOD2	135940	1q21.3	FLG
{Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	FLG, ATOD2	135940	1q21.3	ATOD2
{Dermatitis, atopic, susceptibility to, 3} (2)	ATOD3	605804	20p	ATOD3
{Dermatitis, atopic, susceptibility to, 4} (2)	ATOD4	605805	17q25.3	ATOD4
{Dermatitis, atopic, susceptibility to, 5} (2)	ATOD5	605844	13q12-q14	ATOD5
{Dermatitis, atopic, susceptibility to, 6} (2)	ATOD6	605845	5q31-q33	ATOD6
{Dermatitis, atopic, susceptibility to, 7} (2)	ATOD7	613064	11q13.5	ATOD7
{Dermatitis, atopic, susceptibility to, 8} (2)	ATOD8	613518	4q22.1	ATOD8
{Dermatitis, atopic, susceptibility to, 9} (2)	ATOD9	613519	3p24	ATOD9
{Diabetes mellitus, insulin-dependent, 11} (2)	IDDM11	601208	14q24.3-q31	IDDM11
{Diabetes mellitus, insulin-dependent, 12}, 601388 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Diabetes mellitus, insulin-dependent, 12}, 601388 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	IDDM12
{Diabetes mellitus, insulin-dependent, 12}, 601388 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CELIAC3
{Diabetes mellitus, insulin-dependent, 12}, 601388 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	ALPS5
{Diabetes mellitus, insulin-dependent, 13} (2)	IDDM13	601318	2q34	IDDM13
{Diabetes mellitus, insulin-dependent, 15} (2)	IDDM15	601666	6q21	IDDM15
{Diabetes mellitus, insulin-dependent, 17} (2)	IDDM17	603266	10q25	IDDM17
{Diabetes mellitus, insulin-dependent, 18} (2)	IDDM18	605598	5q31.1-q33.1	IDDM18
{Diabetes mellitus, insulin-dependent, 19} (2)	IDDM19	610155	2q24.3	IDDM19
{Diabetes mellitus, insulin-dependent, 21} (2)	IDDM21	612521	6q25	IDDM21
{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CMKBR5
{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCCKR5
{Diabetes mellitus, insulin-dependent, 22}, 612522 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	IDDM22
{Diabetes mellitus, insulin-dependent, 23} (2)	IDDM23	612622	4q27	IDDM23
{Diabetes mellitus, insulin-dependent, 24} (2)	IDDM24	613006	10q23.31	IDDM24
{Diabetes mellitus, insulin-dependent, 3} (2)	IDDM3	600318	15q26	IDDM3
{Diabetes mellitus, insulin-dependent, 4} (2)	IDDM4	600319	11q13	IDDM4
{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	SUMO4, IDDM5	608829	6q25.1	SUMO4
{Diabetes mellitus, insulin-dependent, 5}, 600320 (3)	SUMO4, IDDM5	608829	6q25.1	IDDM5
{Diabetes mellitus, insulin-dependent, 6} (2)	IDDM6	601941	18q21	IDDM6
{Diabetes mellitus, insulin-dependent, 7} (2)	IDDM7	600321	2q31	IDDM7
{Diabetes mellitus, insulin-dependent, 8} (2)	IDDM8	600883	6q25-q27	IDDM8
{Diabetes mellitus, insulin-dependent, X-linked} (2)	IDDMX	300136	Xp11	IDDMX
{Diabetes mellitus, insulin-dependent-1} (2)	IDDM1	222100	6p21.3	IDDM1
{Diabetes mellitus, insulin-dependent}, 222100 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
{Diabetes mellitus, insulin-dependent}, 222100 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
{Diabetes mellitus, insulin-dependent}, 222100 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
{Diabetes mellitus, insulin-dependent}, 222100 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	PAX4, MODY9, KPD	167413	7q32.1	PAX4
{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	PAX4, MODY9, KPD	167413	7q32.1	MODY9
{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3)	PAX4, MODY9, KPD	167413	7q32.1	KPD
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PDNP1
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	NPPS
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	M6S1
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PCA1
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ARHR2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}, 125853 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	COLED
{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	CAPN10, NIDDM1	605286	2q37.3	CAPN10
{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)	CAPN10, NIDDM1	605286	2q37.3	NIDDM1
{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	HNF1A
{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	TCF1
{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	MODY3
{Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3)	HNF1A, TCF1, MODY3, IDDM20	142410	12q24.31	IDDM20
{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	TBC1D4, AS160, KIAA0603, NIDDM5	612465	13q22.2	TBC1D4
{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	TBC1D4, AS160, KIAA0603, NIDDM5	612465	13q22.2	AS160
{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	TBC1D4, AS160, KIAA0603, NIDDM5	612465	13q22.2	KIAA0603
{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3)	TBC1D4, AS160, KIAA0603, NIDDM5	612465	13q22.2	NIDDM5
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS1
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFRS
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFS
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA6
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA14
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	DFNA38
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	WFSL
{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3)	WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41	606201	4p16.1	CTRCT41
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	CDKAL1	611259	6p22.3	CDKAL1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	HMGA1, HMGIY	600701	6p21.31	HMGA1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	HMGA1, HMGIY	600701	6p21.31	HMGIY
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	IGF2BP2, IMP2	608289	3q27.2	IGF2BP2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	IGF2BP2, IMP2	608289	3q27.2	IMP2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RETN
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RSTN
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	FIZZ3
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	SLC30A8, ZNT8	611145	8q24.11	SLC30A8
{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3)	SLC30A8, ZNT8	611145	8q24.11	ZNT8
{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	NIDDM3	603694	20q12-q13.1	NIDDM3
{Diabetes mellitus, noninsulin-dependent}, 125853 (2)	NIDDM4	608036	5q34-q35.2	NIDDM4
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	GCGR	138033	17q25.3	GCGR
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	HNF4A
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	TCF14
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	MODY1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	HNF4A, TCF14, MODY1, FRTS4	600281	20q13.12	FRTS4
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	IRS1	147545	2q36.3	IRS1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	IRS2	600797	13q34	IRS2
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPC
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HL
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	LIPH
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	LIPC, HL, LIPH, HDLCQ12	151670	15q21.3	HDLCQ12
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	MAPK8IP1, IB1	604641	11p11.2	MAPK8IP1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	MAPK8IP1, IB1	604641	11p11.2	IB1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	NEUROD1, NIDDM	601724	2q31.3	NEUROD1
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	NEUROD1, NIDDM	601724	2q31.3	NIDDM
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	SLC2A2, GLUT2	138160	3q26.2	SLC2A2
{Diabetes mellitus, noninsulin-dependent}, 125853 (3)	SLC2A2, GLUT2	138160	3q26.2	GLUT2
{Diabetes mellitus, transient neonatal}, 601410 (1)	PLAGL1, ZAC, LOT1	603044	6q24.2	PLAGL1
{Diabetes mellitus, transient neonatal}, 601410 (1)	PLAGL1, ZAC, LOT1	603044	6q24.2	ZAC
{Diabetes mellitus, transient neonatal}, 601410 (1)	PLAGL1, ZAC, LOT1	603044	6q24.2	LOT1
{Diabetes mellitus, type 1, susceptibility to}, 222100 (3)	OAS1, OIAS	164350	12q24.13	OAS1
{Diabetes mellitus, type 1, susceptibility to}, 222100 (3)	OAS1, OIAS	164350	12q24.13	OIAS
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	KCNJ11
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	BIR
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	PHHI
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	HHF2
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	TNDM3
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13	600937	11p15.1	MODY13
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	MTNR1B	600804	11q14.3	MTNR1B
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	TCF7L2, TCF4	602228	10q25.2-q25.3	TCF7L2
{Diabetes mellitus, type 2, susceptibility to}, 125853 (3)	TCF7L2, TCF4	602228	10q25.2-q25.3	TCF4
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	FOXP3
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	IPEX
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	AIID
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	XPID
{Diabetes mellitus, type I, susceptibility to}, 222100 (3)	FOXP3, IPEX, AIID, XPID, PIDX	300292	Xp11.23	PIDX
{Diabetes mellitus, type II, susceptibility to}, 125853 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	IPF1
{Diabetes mellitus, type II, susceptibility to}, 125853 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	MODY4
{Diabetes mellitus, type II, susceptibility to}, 125853 (3)	IPF1, MODY4, PAGEN1	600733	13q12.2	PAGEN1
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2RA
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	CD25
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IL2R
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IDDM10
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3)	IL2RA, CD25, IL2R, IDDM10, IMD41	147730	10p15.1	IMD41
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IFNB2
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	BSF2
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HSF
{Diabetes, susceptibility to}, 222100, 125853 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HGF
{Diabetes, type 1, susceptibility to}, 222100 (2)	ITPR3	147267	6p21.31	ITPR3
{Diabetes, type 1, susceptibility to}, 222100 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Diabetes, type 1, susceptibility to}, 222100 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PEP
{Diabetes, type 1, susceptibility to}, 222100 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN8
{Diabetes, type 1, susceptibility to}, 222100 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	LYP
{Diabetes, type 2, susceptibility to}, 125853 (3)	GPD2	138430	2q24.1	GPD2
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG1
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	PPARG2
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	CIMT1
{Diabetes, type 2}, 125853 (3)	PPARG, PPARG1, PPARG2, CIMT1, GLM1	601487	3p25.2	GLM1
{Diphtheria, susceptibility to} (1)	HBEGF, DTR, DTSF, HEGFL	126150	5q31.3	HBEGF
{Diphtheria, susceptibility to} (1)	HBEGF, DTR, DTSF, HEGFL	126150	5q31.3	DTR
{Diphtheria, susceptibility to} (1)	HBEGF, DTR, DTSF, HEGFL	126150	5q31.3	DTSF
{Diphtheria, susceptibility to} (1)	HBEGF, DTR, DTSF, HEGFL	126150	5q31.3	HEGFL
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SCN9A
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	NENA
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	PN1
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	FEB3B
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	GEFSP7
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	SFNP
{Dravet syndrome, modifier of}, 607208 (3)	SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D	603415	2q24.3	HSAN2D
{Drug addiction, susceptibility to}, 606581 (3)	FAAH	602935	1p33	FAAH
{Drug-induced liver injury due to flucloxacillin} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Drug-induced liver injury due to flucloxacillin} (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TCS1
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	EST2
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCA2
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCB4
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	PFBMFT1
{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	CMM9
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TCS1
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	EST2
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCA2
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCB4
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	PFBMFT1
{Dyskeratosis congenita, autosomal recessive 4}, 613989 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	CMM9
{Dyslexia, susceptibility to, 1}, 127700 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYX1C1
{Dyslexia, susceptibility to, 1}, 127700 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYXC1
{Dyslexia, susceptibility to, 1}, 127700 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	DYX1
{Dyslexia, susceptibility to, 1}, 127700 (3)	DYX1C1, DYXC1, DYX1, CILD25	608706	15q21.3	CILD25
{Dyslexia, susceptibility to, 2}, 600202 (3)	KIAA0319, DYX2, DYLX2, DLX2	609269	6p22.3	KIAA0319
{Dyslexia, susceptibility to, 2}, 600202 (3)	KIAA0319, DYX2, DYLX2, DLX2	609269	6p22.3	DYX2
{Dyslexia, susceptibility to, 2}, 600202 (3)	KIAA0319, DYX2, DYLX2, DLX2	609269	6p22.3	DYLX2
{Dyslexia, susceptibility to, 2}, 600202 (3)	KIAA0319, DYX2, DYLX2, DLX2	609269	6p22.3	DLX2
{Dyslexia, susceptibility to, 3} (2)	DYX3	604254	2p16-p15	DYX3
{Dyslexia, susceptibility to, 5} (2)	DYX5	606896	3p12-q13	DYX5
{Dyslexia, susceptibility to, 6} (2)	DYX6, DYXQTL18	606616	18p11.2	DYX6
{Dyslexia, susceptibility to, 6} (2)	DYX6, DYXQTL18	606616	18p11.2	DYXQTL18
{Dyslexia, susceptibility to, 8} (2)	DYX8	608995	1p36-p34	DYX8
{Dyslexia, susceptibility to, 9} (2)	DYX9	300509	Xq27.3	DYX9
{Dystonia-1, modifier of} (3)	DYT1, TOR1A	605204	9q34.11	DYT1
{Dystonia-1, modifier of} (3)	DYT1, TOR1A	605204	9q34.11	TOR1A
{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B6
{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	CYP2B
{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3)	CYP2B6, CYP2B, EFVM	123930	19q13.2	EFVM
{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	RANBP2, NUP358, ANE1, IIAE3	601181	2q13	RANBP2
{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	RANBP2, NUP358, ANE1, IIAE3	601181	2q13	NUP358
{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	RANBP2, NUP358, ANE1, IIAE3	601181	2q13	ANE1
{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3)	RANBP2, NUP358, ANE1, IIAE3	601181	2q13	IIAE3
{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	CPT2, IIAE4	600650	1p32.3	CPT2
{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3)	CPT2, IIAE4	600650	1p32.3	IIAE4
{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	APOL1
{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	FSGS4
{Endometrial cancer, susceptibility to}, 608089 (3)	MLH3, HNPCC7	604395	14q24.3	MLH3
{Endometrial cancer, susceptibility to}, 608089 (3)	MLH3, HNPCC7	604395	14q24.3	HNPCC7
{Endometriosis, susceptibility to, 1} (2)	ENDO1	131200	10q26	ENDO1
{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	MMP1, CLG	120353	11q22.2	MMP1
{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3)	MMP1, CLG	120353	11q22.2	CLG
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	CASR
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HHC1
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	PCAR1
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	FIH
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	EIG8
{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3)	CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1	601199	3q13.3-q21.1	HYPOC1
{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GABRG2
{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	GEFSP3
{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	CAE2
{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3)	GABRG2, GEFSP3, CAE2, ECA2	137164	5q34	ECA2
{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EJM5
{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	ECA4
{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EIEE19
{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3)	GABRB3, ECA5	137192	15q12	GABRB3
{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3)	GABRB3, ECA5	137192	15q12	ECA5
{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	EIG6
{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	ECA6
{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	HALD4
{Epilepsy, familial temporal lobe, 7}, 616436 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RELN
{Epilepsy, familial temporal lobe, 7}, 616436 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	RL
{Epilepsy, familial temporal lobe, 7}, 616436 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	LIS2
{Epilepsy, familial temporal lobe, 7}, 616436 (3)	RELN, RL, LIS2, ETL7	600514	7q22.1	ETL7
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GEFSP5
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EIG10
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EJM7
{Epilepsy, idiopathic generalized, 10}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Epilepsy, idiopathic generalized, 10}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GEFSP5
{Epilepsy, idiopathic generalized, 10}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EIG10
{Epilepsy, idiopathic generalized, 10}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EJM7
{Epilepsy, idiopathic generalized, susceptibility to 4} (2)	EIG4	609750	10q25-q26	EIG4
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGMA
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	ECA2
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGI11
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EJM8
{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	LKPAT
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SLC2A1
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT18
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	PED
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	GLUT1DS
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	EIG12
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	DYT9
{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3)	SLC2A1, GLUT1, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN	138140	1p34.2	SDCHCN
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	SLC12A5
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	KCC2
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	KIAA1176
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	EIEE34
{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3)	SLC12A5, KCC2, KIAA1176, EIEE34, EIG14	606726	20q13.12	EIG14
{Epilepsy, idiopathic generalized, susceptibility to, 1} (2)	EIG1	600669	8q24	EIG1
{Epilepsy, idiopathic generalized, susceptibility to, 2} (2)	EIG2	606972	14q23	EIG2
{Epilepsy, idiopathic generalized, susceptibility to, 3} (2)	EIG3	608762	9q32-q33	EIG3
{Epilepsy, idiopathic generalized, susceptibility to, 5} (2)	EIG5	611934	10p11.22	EIG5
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	CACNA1H
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	EIG6
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	ECA6
{Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3)	CACNA1H, EIG6, ECA6, HALD4	607904	16p13.3	HALD4
{Epilepsy, idiopathic generalized, susceptibility to, 7} (2)	EIG7, EJM2	604827	15q14	EIG7
{Epilepsy, idiopathic generalized, susceptibility to, 7} (2)	EIG7, EJM2	604827	15q14	EJM2
{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EJM6
{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EA5
{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EIG9
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EFHC1
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	FLJ10466
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EJM1
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	JAE
{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EJA1
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGMA
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	ECA2
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGI11
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EJM8
{Epilepsy, juvenile absence, susceptibility to, 2}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	LKPAT
{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	GABRA1
{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EJM5
{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	ECA4
{Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3)	GABRA1, EJM5, ECA4, EIEE19	137160	5q34	EIEE19
{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	CACNB4
{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EJM6
{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EA5
{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3)	CACNB4, EJM6, EA5, EIG9	601949	2q23.3	EIG9
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	CLCN2
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGMA
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	ECA2
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EGI11
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	EJM8
{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3)	CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT	600570	3q27.1	LKPAT
{Epilepsy, juvenile myoclonic, susceptibility to, 9} (2)	EJM9	614280	2q33-q36	EJM9
{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GABRD
{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	GEFSP5
{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EIG10
{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3)	GABRD, GEFSP5, EIG10, EJM7	137163	1p36.33	EJM7
{Esophageal cancer, alcohol-related, susceptibility to} (3)	ALDH2	100650	12q24.12	ALDH2
{Esophagitis, eosinophilic, 1} (2)	EOE1, EE	610247	7q11.2	EOE1
{Esophagitis, eosinophilic, 1} (2)	EOE1, EE	610247	7q11.2	EE
{Esophagitis, eosinophilic, 2} (2)	EOE2	613412	5q22	EOE2
{Essential tremor, susceptibility to}, 190300 (3)	DRD3, ETM1, FET1	126451	3q13.31	DRD3
{Essential tremor, susceptibility to}, 190300 (3)	DRD3, ETM1, FET1	126451	3q13.31	ETM1
{Essential tremor, susceptibility to}, 190300 (3)	DRD3, ETM1, FET1	126451	3q13.31	FET1
{Exfoliation syndrome, susceptibility to}, 177650 (3)	LOXL1, LOXL	153456	15q24.1	LOXL1
{Exfoliation syndrome, susceptibility to}, 177650 (3)	LOXL1, LOXL	153456	15q24.1	LOXL
{Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)	NAFLD1	613282	22q13	NAFLD1
{Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)	NAFLD2	613387	11q23	NAFLD2
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	SPINK1
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PSTI
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	PCTT
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TATI
{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3)	SPINK1, PSTI, PCTT, TATI, TCP	167790	5q32	TCP
{Follicular lymphoma, susceptibility to, 1} (2)	FL1	613024	6p21.33	FL1
{Gallbladder disease 4}, 611465 (3)	ABCG8, GBD4	605460	2p21	ABCG8
{Gallbladder disease 4}, 611465 (3)	ABCG8, GBD4	605460	2p21	GBD4
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1B	147720	2q14.1	IL1B
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	MVCD4
{Gastric cancer risk after H. pylori infection}, 137215 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	DIRA
{Gene expression, variation in, QTL} (2)	GEVQ1	608875	14q32	GEVQ1
{Gene expression, variation in, QTL} (2)	GEVQ2	608878	20q13	GEVQ2
{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3)	HDC	142704	15q21.2	HDC
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	OPA1
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NTG
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	NPG
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	BERHS
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPA1, NTG, NPG, BERHS, MTDPS14	605290	3q29	MTDPS14
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	OPTN
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	GLC1E
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	FIP2
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	HYPL
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	NRP
{Glaucoma, normal tension, susceptibility to}, 606657 (3)	OPTN, GLC1E, FIP2, HYPL, NRP, ALS12	602432	10p13	ALS12
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Glioblastoma 3}, 613029 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Glioma susceptibility 1}, 137800 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	TP53
{Glioma susceptibility 1}, 137800 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	P53
{Glioma susceptibility 1}, 137800 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	LFS1
{Glioma susceptibility 1}, 137800 (3)	TP53, P53, LFS1 , BCC7	191170	17p13.1	BCC7
{Glioma susceptibility 2}, 613028 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Glioma susceptibility 2}, 613028 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
{Glioma susceptibility 2}, 613028 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
{Glioma susceptibility 2}, 613028 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
{Glioma susceptibility 4} (2)	GLM4	607248	15q23-q26.3	GLM4
{Glioma susceptibility 5} (2)	GLM5	613030	9p21.3	GLM5
{Glioma susceptibility 6} (2)	GLM6	613031	20q13.33	GLM6
{Glioma susceptibility 7} (2)	GLM7	613032	8q24.21	GLM7
{Glioma susceptibility 8} (2)	GLM8	613033	5p15.33	GLM8
{Glioma susceptibility 9}, 616568 (3)	POT1, CMM10, GLM9	606478	7q31.33	POT1
{Glioma susceptibility 9}, 616568 (3)	POT1, CMM10, GLM9	606478	7q31.33	CMM10
{Glioma susceptibility 9}, 616568 (3)	POT1, CMM10, GLM9	606478	7q31.33	GLM9
{Glioma, susceptibility to, somatic}, 137800 (3)	IDH1	147700	2q34	IDH1
{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	APOL1
{Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3)	APOL1, FSGS4	603743	22q12.3	FSGS4
{Glucocorticoid therapy, response to}, 614400 (3)	GLCCI1, TSSN1, GCTR	614283	7p21.3	GLCCI1
{Glucocorticoid therapy, response to}, 614400 (3)	GLCCI1, TSSN1, GCTR	614283	7p21.3	TSSN1
{Glucocorticoid therapy, response to}, 614400 (3)	GLCCI1, TSSN1, GCTR	614283	7p21.3	GCTR
{Gout susceptibility 4}, 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	SLC17A3
{Gout susceptibility 4}, 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	NPT4
{Gout susceptibility 4}, 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	UAQTL4
{Gout susceptibility 4}, 612671 (3)	SLC17A3, NPT4, UAQTL4, GOUT4	611034	6p22.2	GOUT4
{Graft-versus-host disease, protection against}, 614395 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{Graft-versus-host disease, protection against}, 614395 (3)	IL10, CSIF, GVHDS	124092	1q32.1	CSIF
{Graft-versus-host disease, protection against}, 614395 (3)	IL10, CSIF, GVHDS	124092	1q32.1	GVHDS
{Graves disease, susceptibility to, 1} (2)	GRD1	275000	14q31	GRD1
{Graves disease, susceptibility to, 2} (2)	GRD2	603388	20q13.11	GRD2
{Graves disease, susceptibility to, X-linked} (2)	GRDX, GD3	300351	Xp11	GRDX
{Graves disease, susceptibility to, X-linked} (2)	GRDX, GD3	300351	Xp11	GD3
{H. pylori infection, susceptibility to}, 600263 (1)	PTPRZ1, PTP18	176891	7q31.32	PTPRZ1
{H. pylori infection, susceptibility to}, 600263 (1)	PTPRZ1, PTP18	176891	7q31.32	PTP18
{H. pylori infection, susceptibility to}, 600263 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{H. pylori infection, susceptibility to}, 600263 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
{H. pylori infection, susceptibility to}, 600263 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
{HDL response to hormone replacement, augmented} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{HDL response to hormone replacement, augmented} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
{HDL response to hormone replacement, augmented} (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
{HFE hemochromatosis, modifier of}, 235200 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2
{HFE hemochromatosis, modifier of}, 235200 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BMP2A
{HFE hemochromatosis, modifier of}, 235200 (3)	BMP2, BMP2A, BDA2	112261	20p12.3	BDA2
{HIV infection, resistance to}, 609423 (2)	CCL3, SCYA3, MIP1A	182283	17q12	CCL3
{HIV infection, resistance to}, 609423 (2)	CCL3, SCYA3, MIP1A	182283	17q12	SCYA3
{HIV infection, resistance to}, 609423 (2)	CCL3, SCYA3, MIP1A	182283	17q12	MIP1A
{HIV infection, susceptibility/resistance to} (3)	CCR2, CMKBR2	601267	3p21.31	CCR2
{HIV infection, susceptibility/resistance to} (3)	CCR2, CMKBR2	601267	3p21.31	CMKBR2
{HIV infection, susceptibility/resistance to} (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{HIV infection, susceptibility/resistance to} (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CMKBR5
{HIV infection, susceptibility/resistance to} (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCCKR5
{HIV infection, susceptibility/resistance to} (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	IDDM22
{HIV type 1, susceptibility to}, 609423 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{HIV type 1, susceptibility to}, 609423 (3)	CD209, CDSIGN	604672	19p13.2	CDSIGN
{HIV-1 disease, delayed progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	CCL5
{HIV-1 disease, delayed progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	SCYA5
{HIV-1 disease, delayed progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	D17S136E
{HIV-1 disease, delayed progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	TCP228
{HIV-1 disease, rapid progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	CCL5
{HIV-1 disease, rapid progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	SCYA5
{HIV-1 disease, rapid progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	D17S136E
{HIV-1 disease, rapid progression of} (3)	CCL5, SCYA5, D17S136E, TCP228	187011	17q12	TCP228
{HIV-1 viremia, susceptibility to}, 609423 (3)	HLA-C, PSORS1	142840	6p21.33	HLA-C
{HIV-1 viremia, susceptibility to}, 609423 (3)	HLA-C, PSORS1	142840	6p21.33	PSORS1
{HIV-1, resistance to}, 609423 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{HIV-1, resistance to}, 609423 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	SCYA2
{HIV-1, resistance to}, 609423 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCP1
{HIV-1, resistance to}, 609423 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCAF
{HIV-1, susceptibility to}, 609423 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{HIV-1, susceptibility to}, 609423 (3)	IL10, CSIF, GVHDS	124092	1q32.1	CSIF
{HIV-1, susceptibility to}, 609423 (3)	IL10, CSIF, GVHDS	124092	1q32.1	GVHDS
{HIV/AIDS, susceptibility to}, 609423 (3)	CCL3L1, SCYA3L1, LD78	601395	17q11.2	CCL3L1
{HIV/AIDS, susceptibility to}, 609423 (3)	CCL3L1, SCYA3L1, LD78	601395	17q11.2	SCYA3L1
{HIV/AIDS, susceptibility to}, 609423 (3)	CCL3L1, SCYA3L1, LD78	601395	17q11.2	LD78
{HIV1 infection, resistance to}, 609423 (3)	TLR3, IIAE2	603029	4q35.1	TLR3
{HIV1 infection, resistance to}, 609423 (3)	TLR3, IIAE2	603029	4q35.1	IIAE2
{HIV1, resistance to}, 609423 (3)	CCL11, SCYA11	601156	17q12	CCL11
{HIV1, resistance to}, 609423 (3)	CCL11, SCYA11	601156	17q12	SCYA11
{Hangover, susceptibility to}, 610251 (3)	ALDH2	100650	12q24.12	ALDH2
{Hashimoto thyroiditis}, 140300 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Hashimoto thyroiditis}, 140300 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	IDDM12
{Hashimoto thyroiditis}, 140300 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CELIAC3
{Hashimoto thyroiditis}, 140300 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	ALPS5
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ANTXR1
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	TEM8
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	ATR
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	ANTXR1, TEM8, ATR, GAPO	606410	2p13.3	GAPO
{Hemangioma, capillary infantile, susceptibility to}, 602089 (3)	KDR	191306	4q12	KDR
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HF1
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HUS
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	ARMD4
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	AHUS1
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	MCP, CD46, AHUS2	120920	1q32.2	MCP
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	MCP, CD46, AHUS2	120920	1q32.2	CD46
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3)	MCP, CD46, AHUS2	120920	1q32.2	AHUS2
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	FI
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	AHUS3
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	ARMD13
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	BF
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	GBG
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	AHUS4
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	ARMD14
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}, 612924 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFBD
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3)	C3, ARMD9, AHUS5	120700	19p13.3	ARMD9
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}, 612925 (3)	C3, ARMD9, AHUS5	120700	19p13.3	AHUS5
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THBD
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THRM
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	AHUS6
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3)	THBD, THRM, AHUS6, THPH12	188040	20p11.21	THPH12
{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	DGKE
{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	NPHS7
{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3)	DGKE, NPHS7, AHUS7	601440	17q22	AHUS7
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHR1
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	FHR1
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	HFL1
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHL1
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHR3
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	FHR3
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	HLF4
{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHL3
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	COL4A1
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	POREN1
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	HANAC
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	ICH
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	BSVD
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A1, POREN1, HANAC, ICH, BSVD, RATOR	120130	13q34	RATOR
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A2, POREN2, ICH	120090	13q34	COL4A2
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A2, POREN2, ICH	120090	13q34	POREN2
{Hemorrhage, intracerebral, susceptibility to}, 614519 (3)	COL4A2, POREN2, ICH	120090	13q34	ICH
{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection} (2)	SM2	604201	6q22-q23	SM2
{Hepatitic C virus, susceptibility to}, 609532 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	PTPRC
{Hepatitic C virus, susceptibility to}, 609532 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	CD45
{Hepatitic C virus, susceptibility to}, 609532 (3)	PTPRC, CD45, LCA	151460	1q31.3-q32.1	LCA
{Hepatitis B virus infection, susceptibility to}, 610424 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{Hepatitis B virus infection, susceptibility to}, 610424 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
{Hepatitis B virus infection, susceptibility to}, 610424 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
{Hepatitis B virus, susceptibility to}, 610424 (3)	CRFB4, IBD25	123889	21q22.11	CRFB4
{Hepatitis B virus, susceptibility to}, 610424 (3)	CRFB4, IBD25	123889	21q22.11	IBD25
{Hepatitis B virus, susceptibility to}, 610424 (3)	IFNAR2, IMD45	602376	21q22.11	IFNAR2
{Hepatitis B virus, susceptibility to}, 610424 (3)	IFNAR2, IMD45	602376	21q22.11	IMD45
{Hepatitis C virus infection, response to therapy of}, 609532 (3)	IFNL3, IL28B	607402	19q13.2	IFNL3
{Hepatitis C virus infection, response to therapy of}, 609532 (3)	IFNL3, IL28B	607402	19q13.2	IL28B
{Hepatitis C virus, resistance to}, 609532 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{Hepatitis C virus, resistance to}, 609532 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CMKBR5
{Hepatitis C virus, resistance to}, 609532 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCCKR5
{Hepatitis C virus, resistance to}, 609532 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	IDDM22
{Hepatitis C virus, response to therapy of}, 609532 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Hepatitis C virus, response to therapy of}, 609532 (3)	IFNG, IFG, IFI	147570	12q15	IFG
{Hepatitis C virus, response to therapy of}, 609532 (3)	IFNG, IFG, IFI	147570	12q15	IFI
{Herpes simplex encephalitic, susceptibility to, 6}, 614850 (3)	TICAM1, TRIF, IIAE6	607601	19p13.3	TICAM1
{Herpes simplex encephalitic, susceptibility to, 6}, 614850 (3)	TICAM1, TRIF, IIAE6	607601	19p13.3	TRIF
{Herpes simplex encephalitic, susceptibility to, 6}, 614850 (3)	TICAM1, TRIF, IIAE6	607601	19p13.3	IIAE6
{Herpes simplex encephalitis, susceptibility to, 1}, 610551 (3)	UNC93B1, IIAE1	608204	11q13.2	UNC93B1
{Herpes simplex encephalitis, susceptibility to, 1}, 610551 (3)	UNC93B1, IIAE1	608204	11q13.2	IIAE1
{Herpes simplex encephalitis, susceptibility to, 2} 613002 (3)	TLR3, IIAE2	603029	4q35.1	TLR3
{Herpes simplex encephalitis, susceptibility to, 2} 613002 (3)	TLR3, IIAE2	603029	4q35.1	IIAE2
{High density lipoprotein cholesterol level QTL 7} (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	EDN1
{High density lipoprotein cholesterol level QTL 7} (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	ARCND3
{High density lipoprotein cholesterol level QTL 7} (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	QME
{High density lipoprotein cholesterol level QTL 7} (3)	EDN1, ARCND3, QME, HDLCQ7	131240	6p24.1	HDLCQ7
{High density lipoprotein cholesterol, low serum, 3} (2)	HDLC3	607687	16q24.1	HDLC3
{Hirschsprung disease, susceptibility to, 1}, 142623 (3)	RET, MEN2A, HSCR1	164761	10q11.21	RET
{Hirschsprung disease, susceptibility to, 1}, 142623 (3)	RET, MEN2A, HSCR1	164761	10q11.21	MEN2A
{Hirschsprung disease, susceptibility to, 1}, 142623 (3)	RET, MEN2A, HSCR1	164761	10q11.21	HSCR1
{Hirschsprung disease, susceptibility to, 2}, 600155 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	EDNRB
{Hirschsprung disease, susceptibility to, 2}, 600155 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	HSCR2
{Hirschsprung disease, susceptibility to, 2}, 600155 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	ABCDS
{Hirschsprung disease, susceptibility to, 2}, 600155 (3)	EDNRB, HSCR2, ABCDS, WS4A	131244	13q22.3	WS4A
{Hirschsprung disease, susceptibility to, 3}, 613711 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
{Hirschsprung disease, susceptibility to, 3}, 613711 (3)	GDNF, HSCR3	600837	5p13.2	HSCR3
{Hirschsprung disease, susceptibility to, 4}, 613712 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	EDN3
{Hirschsprung disease, susceptibility to, 4}, 613712 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	WS4B
{Hirschsprung disease, susceptibility to, 4}, 613712 (3)	EDN3, WS4B, HSCR4	131242	20q13.32	HSCR4
{Hirschsprung disease, susceptibility to, 5} (2)	HSCR5	600156	9q31	HSCR5
{Hirschsprung disease, susceptibility to, 6} (2)	HSCR6	606874	3p21	HSCR6
{Hirschsprung disease, susceptibility to, 7} (2)	HSCR7	606875	19q12	HSCR7
{Hirschsprung disease, susceptibility to, 8} (2)	HSCR8	608462	16q23	HSCR8
{Hirschsprung disease, susceptibility to, 9} (2)	HSCR9	611644	4q31.3-q32.3	HSCR9
{Hodgkin disease susceptibility, pseudoautosomal} (2)	HDPA	300221	Xpter-p22.32	HDPA
{Hodgkin lymphoma, susceptibility to}, 236000 (3)	KLHDC8B, CHL	613169	3p21.31	KLHDC8B
{Hodgkin lymphoma, susceptibility to}, 236000 (3)	KLHDC8B, CHL	613169	3p21.31	CHL
{Human herpesvirus 8, susceptibility to} (2)	HHV8S	614836	3p22	HHV8S
{Hyperapobetalipoproteinemia, susceptibility to} (3)	PPARA, PPAR	170998	22q13.31	PPARA
{Hyperapobetalipoproteinemia, susceptibility to} (3)	PPARA, PPAR	170998	22q13.31	PPAR
{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	ADCY10, SAC, HCA2	605205	1q24.2	ADCY10
{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	ADCY10, SAC, HCA2	605205	1q24.2	SAC
{Hypercalciuria, absorptive, susceptibility to}, 143870 (3)	ADCY10, SAC, HCA2	605205	1q24.2	HCA2
{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3)	EPHX2	132811	8p21.2-p21.1	EPHX2
{Hypercholesterolemia, familial, modifier of}, 143890 (3)	APOA2	107670	1q23.3	APOA2
{Hypercholesterolemia, familial, modifier of}, 143890 (3)	GHR, GHIP	600946	5p13-p12	GHR
{Hypercholesterolemia, familial, modifier of}, 143890 (3)	GHR, GHIP	600946	5p13-p12	GHIP
{Hypercholesterolemia, susceptibility to}, 143890 (3)	GSBS	604088	7p14.3	GSBS
{Hypercholesterolemia, susceptibility to}, 143890 (3)	ITIH4, PK120, ITIHL1	600564	3p21.1	ITIH4
{Hypercholesterolemia, susceptibility to}, 143890 (3)	ITIH4, PK120, ITIHL1	600564	3p21.1	PK120
{Hypercholesterolemia, susceptibility to}, 143890 (3)	ITIH4, PK120, ITIHL1	600564	3p21.1	ITIHL1
{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	USF1, HYPLIP1	191523	1q23.3	USF1
{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)	USF1, HYPLIP1	191523	1q23.3	HYPLIP1
{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3)	HLA-A	142800	6p22.1	HLA-A
{Hypertension, diastolic, resistance to}, 608622 (3)	KCNMB1	603951	5q35.1	KCNMB1
{Hypertension, essential, salt-sensitive}, 145500 (3)	ADD1	102680	4p16.3	ADD1
{Hypertension, essential, susceptibility to, 1}, 145500 (2)	HYT1	603918	17q	HYT1
{Hypertension, essential, susceptibility to, 2}, 145500 (2)	HYT2	604329	15q	HYT2
{Hypertension, essential, susceptibility to, 3}, 145500 (2)	HYT3	607329	2p25-p24	HYT3
{Hypertension, essential, susceptibility to, 4}, 145500 (2)	HYT4	608742	12p12.2-p12.1	HYT4
{Hypertension, essential, susceptibility to, 5}, 145500 (2)	HYT5	610261	20q11-q13	HYT5
{Hypertension, essential, susceptibility to, 6}, 145500 (2)	HYT6	610262	5p13-q12	HYT6
{Hypertension, essential, susceptibility to, 7} (2)	HYT7	610948	3p14.1-q12.3	HYT7
{Hypertension, essential, susceptibility to, 8} (2)	HYT8	611014	18q21.2	HYT8
{Hypertension, essential, susceptibility to}, 145500 (3)	AGT, SERPINA8	106150	1q42.2	AGT
{Hypertension, essential, susceptibility to}, 145500 (3)	AGT, SERPINA8	106150	1q42.2	SERPINA8
{Hypertension, essential, susceptibility to}, 145500 (3)	ECE1	600423	1p36.12	ECE1
{Hypertension, essential, susceptibility to}, 145500 (3)	GNB3, CSNB1H	139130	12p13.31	GNB3
{Hypertension, essential, susceptibility to}, 145500 (3)	GNB3, CSNB1H	139130	12p13.31	CSNB1H
{Hypertension, essential}, 145500 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1
{Hypertension, essential}, 145500 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AGTR1A
{Hypertension, essential}, 145500 (3)	AGTR1, AGTR1A, AT2R1	106165	3q24	AT2R1
{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RETN
{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	RSTN
{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3)	RETN, RSTN, FIZZ3	605565	19p13.2	FIZZ3
{Hypertension, pregnancy-induced}, 189800 (3)	NOS3	163729	7q36.1	NOS3
{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	CYP3A5, P450PCN3	605325	7q22.1	CYP3A5
{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3)	CYP3A5, P450PCN3	605325	7q22.1	P450PCN3
{Hypertension, susceptibility to}, 145500 (2)	NOS2A, NOS2	163730	17q11.2	NOS2A
{Hypertension, susceptibility to}, 145500 (2)	NOS2A, NOS2	163730	17q11.2	NOS2
{Hypertension, susceptibility to}, 145500 (3)	NOS3	163729	7q36.1	NOS3
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	APOA5	606368	11q23.3	APOA5
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	LIPI, LPDL, PRED5	609252	21q11.2	LIPI
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	LIPI, LPDL, PRED5	609252	21q11.2	LPDL
{Hypertriglyceridemia, susceptibility to}, 145750 (3)	LIPI, LPDL, PRED5	609252	21q11.2	PRED5
{Hypertrypsinemia, neonatal} (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Hypertrypsinemia, neonatal} (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
{Hypertrypsinemia, neonatal} (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
{Hypertrypsinemia, neonatal} (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	HS6ST1, HS6ST, HH15	604846	2q14.3	HS6ST1
{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	HS6ST1, HS6ST, HH15	604846	2q14.3	HS6ST
{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3)	HS6ST1, HS6ST, HH15	604846	2q14.3	HH15
{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	SEMA3A, SEMAD, COLL1, HH16	603961	7q21.11	SEMA3A
{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	SEMA3A, SEMAD, COLL1, HH16	603961	7q21.11	SEMAD
{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	SEMA3A, SEMAD, COLL1, HH16	603961	7q21.11	COLL1
{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3)	SEMA3A, SEMAD, COLL1, HH16	603961	7q21.11	HH16
{Hypospadias 4, X-linked, susceptibility to} (2)	HYSP4	300856	Xp11.22	HYSP4
{Hypothalamic hamartomas, somatic}, 241800 (3)	GLI3, PAPA, PAPB	165240	7p14.1	GLI3
{Hypothalamic hamartomas, somatic}, 241800 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPA
{Hypothalamic hamartomas, somatic}, 241800 (3)	GLI3, PAPA, PAPB	165240	7p14.1	PAPB
{IgA nephropathy, susceptibility to, 1} (2)	IGAN1	161950	6q22-q23	IGAN1
{IgA nephropathy, susceptibility to, 2} (2)	IGAN2	613944	2q36	IGAN2
{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	ATG16L1, APG16L, IBD10	610767	2q37.1	ATG16L1
{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	ATG16L1, APG16L, IBD10	610767	2q37.1	APG16L
{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3)	ATG16L1, APG16L, IBD10	610767	2q37.1	IBD10
{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IRGM
{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	LRG47
{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IFI1
{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IBD19
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	NOD2
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CARD15
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	IBD1
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CD
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	ACUG
{Inflammatory bowel disease (Crohn disease) 1}, 266600 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	PSORAS1
{Inflammatory bowel disease 11} (2)	IBD11	191390	7q22	IBD11
{Inflammatory bowel disease 12} (2)	IBD12	612241	3p21.3	IBD12
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	ABCB1
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	PGY1
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	MDR1
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	IBD13
{Inflammatory bowel disease 13}, 612244 (3)	ABCB1, PGY1, MDR1, IBD13, CLCs	171050	7q21.12	CLCs
{Inflammatory bowel disease 14}, 612245 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IRF5
{Inflammatory bowel disease 14}, 612245 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IBD14
{Inflammatory bowel disease 14}, 612245 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	SLEB10
{Inflammatory bowel disease 15} (2)	IBD15	612255	10q21	IBD15
{Inflammatory bowel disease 16} (2)	IBD16	612259	9q32	IBD16
{Inflammatory bowel disease 17, protection against}, 612261 (3)	IL23R, IBD17	607562	1p31.3	IL23R
{Inflammatory bowel disease 17, protection against}, 612261 (3)	IL23R, IBD17	607562	1p31.3	IBD17
{Inflammatory bowel disease 18} (2)	IBD18	612262	5p13.1	IBD18
{Inflammatory bowel disease 20} (2)	IBD20	612288	10q23-q24	IBD20
{Inflammatory bowel disease 21} (2)	IBD21	612354	18p11	IBD21
{Inflammatory bowel disease 22} (2)	IBD22	612380	17q21.2	IBD22
{Inflammatory bowel disease 23} (2)	IBD23	612381	1q32.1	IBD23
{Inflammatory bowel disease 24} (2)	IBD24	612566	20q13	IBD24
{Inflammatory bowel disease 26} (2)	IBD26	612639	12q15	IBD26
{Inflammatory bowel disease 27} (2)	IBD27	612796	13q13.3	IBD27
{Inflammatory bowel disease 2} (2)	IBD2	601458	12p13.2-q24.1	IBD2
{Inflammatory bowel disease 3} (2)	IBD3	604519	6p21.3	IBD3
{Inflammatory bowel disease 4} (2)	IBD4	606675	14q11-q12	IBD4
{Inflammatory bowel disease 5} (2)	IBD5	606348	5q31	IBD5
{Inflammatory bowel disease 6} (2)	IBD6	606674	19p13	IBD6
{Inflammatory bowel disease 7} (2)	IBD7	605225	1p36	IBD7
{Inflammatory bowel disease 8} (2)	IBD8	606668	16p	IBD8
{Inflammatory bowel disease 9} (2)	IBD9	608448	3p26	IBD9
{Influenza, severe, susceptibility to}, 614680 (3)	IFITM3	605579	11p15.5	IFITM3
{Insulin resistance, susceptibility to}, 125853 (3)	PTPN1, PTP1B	176885	20q13.13	PTPN1
{Insulin resistance, susceptibility to}, 125853 (3)	PTPN1, PTP1B	176885	20q13.13	PTP1B
{Intelligence QTL1} (2)	INTLQ1	603783	4p16-q34	INTLQ1
{Intelligence QTL3} (2)	INTLQ2	610295	2q24.1-q31.1	INTLQ2
{Intelligence QTL3} (2)	INTLQ3	610294	6p25.3-p22.3	INTLQ3
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A2, EDM2, STL5	120260	1p34.2	COL9A2
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A2, EDM2, STL5	120260	1p34.2	EDM2
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A2, EDM2, STL5	120260	1p34.2	STL5
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A3, EDM3, IDD	120270	20q13.33	COL9A3
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A3, EDM3, IDD	120270	20q13.33	EDM3
{Intervertebral disc disease, susceptibility to}, 603932 (3)	COL9A3, EDM3, IDD	120270	20q13.33	IDD
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IFNB2
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	BSF2
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HSF
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}, 108010 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HGF
{Ischemic stroke, susceptibility to}, 601367 (3)	NOS3	163729	7q36.1	NOS3
{Kala-azar, susceptibility to, 1} (2)	KAZA1	608207	22q12	KAZA1
{Kala-azar, susceptibility to, 2} (2)	KAZA2	611381	1p22	KAZA2
{Kala-azar, susceptibility to, 3} (2)	KAZA3	611382	6q27	KAZA3
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IFNB2
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	BSF2
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HSF
{Kaposi sarcoma, susceptibility to}, 148000 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HGF
{Kawasaki disease, susceptibility to}, 611775 (3)	ITPKC	606476	19q13.2	ITPKC
{Kuru, susceptibility to}, 245300 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRNP
{Kuru, susceptibility to}, 245300 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	PRIP
{Kuru, susceptibility to}, 245300 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	KURU
{Kuru, susceptibility to}, 245300 (3)	PRNP, PRIP, KURU, CJD	176640	20p13	CJD
{Lead poisoning, susceptibility to}, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALAD
{Lead poisoning, susceptibility to}, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	ALADH
{Lead poisoning, susceptibility to}, 612740 (3)	ALAD, ALADH, PBGS	125270	9q32	PBGS
{Leanness, inherited} (3)	AGRP, ART, AGRT	602311	16q22.1	AGRP
{Leanness, inherited} (3)	AGRP, ART, AGRT	602311	16q22.1	ART
{Leanness, inherited} (3)	AGRP, ART, AGRT	602311	16q22.1	AGRT
{Leber optic atrophy, susceptibility to} (2)	LOAS	308905	Xp11	LOAS
{Legionaire disease, susceptibility to}, 608556 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Legionaire disease, susceptibility to}, 608556 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TIL3
{Legionaire disease, susceptibility to}, 608556 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	SLEB1
{Legionaire disease, susceptibility to}, 608556 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	MELIOS
{Leprosy, paucibacillary type, susceptibility to} (2)	LPRS	609888	10p13	LPRS
{Leprosy, protection against}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TLR1
{Leprosy, protection against}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TIL.LPRS5
{Leprosy, susceptibility to, 4}, 610988 (3)	LTA, TNFB	153440	6p21.33	LTA
{Leprosy, susceptibility to, 4}, 610988 (3)	LTA, TNFB	153440	6p21.33	TNFB
{Leprosy, susceptibility to, 5}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TLR1
{Leprosy, susceptibility to, 5}, 613223 (3)	TLR1, TIL. LPRS5	601194	4p14	TIL.LPRS5
{Leprosy, susceptibility to, 6} (2)	LPRS6	613407	13q14.11	LPRS6
{Leprosy, susceptibility to}, 246300 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Leprosy, susceptibility to}, 246300 (3)	TLR2, TIL4	603028	4q31.3	TIL4
{Leprosy, susceptibility to}, 607572 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PRKN
{Leprosy, susceptibility to}, 607572 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PARK2
{Leprosy, susceptibility to}, 607572 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	PDJ
{Leprosy, susceptibility to}, 607572 (3)	PRKN, PARK2, PDJ, LPRS2	602544	6q26	LPRS2
{Leukemia, acute lymphoblastic, susceptibility to, 2} (2)	ALL2	613067	7p12.2	ALL2
{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	PAX5, BSAP, ALL3	167414	9p13.2	PAX5
{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	PAX5, BSAP, ALL3	167414	9p13.2	BSAP
{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3)	PAX5, BSAP, ALL3	167414	9p13.2	ALL3
{Leukemia, acute lymphocytic, susceptibility to, 1} (2)	ALL1	613065	10q21	ALL1
{Leukemia, acute myeloid, susceptibility to}, 601626 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
{Leukemia, acute myeloid, susceptibility to}, 601626 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	DCML
{Leukemia, acute myeloid, susceptibility to}, 601626 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	MONOMAC
{Leukemia, acute myeloid, susceptibility to}, 601626 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	IMD21
{Leukemia, acute myeloid}, 601626 (3)	CHIC2, BTL	604332	4q12	CHIC2
{Leukemia, acute myeloid}, 601626 (3)	CHIC2, BTL	604332	4q12	BTL
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TCS1
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	EST2
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCA2
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCB4
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	PFBMFT1
{Leukemia, acute myeloid}, 601626 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	CMM9
{Leukemia, chronic lymphocytic susceptibility to, 4} (2)	CLLS4	612558	6p25	CLLS4
{Leukemia, chronic lymphocytic susceptibility to, 5} (2)	CLLS5	612559	11q24.1	CLLS5
{Leukemia, chronic lymphocytic, susceptibility to, 1} (2)	CLLS1	609630	11p11	CLLS1
{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	CLLS2, D13S25, DBM	109543	13q14	CLLS2
{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	CLLS2, D13S25, DBM	109543	13q14	D13S25
{Leukemia, chronic lymphocytic, susceptibility to, 2} (2)	CLLS2, D13S25, DBM	109543	13q14	DBM
{Leukemia, chronic lymphocytic, susceptibility to, 3} (2)	CLLS3	612557	9q34.1	CLLS3
{Leukemia, post-chemotherapy, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NQO1
{Leukemia, post-chemotherapy, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	DIA4
{Leukemia, post-chemotherapy, susceptibility to} (3)	NQO1, DIA4, NMOR1	125860	16q22.1	NMOR1
{Lewy body dementia, susceptibility to}, 127750 (3)	GBA	606463	1q22	GBA
{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMNB2
{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	LMN2
{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)	LMNB2, LMN2, EPM9	150341	19p13.3	EPM9
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNQ1
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KCNA9
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	LQT1
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	KVLQT1
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	ATFB3
{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3)	KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2	607542	11p15.5-p15.4	SQT2
{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	KCNH2
{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	LQT2
{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	HERG
{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3)	KCNH2, LQT2, HERG, SQT1	152427	7q36.1	SQT1
{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	ALG10, KCR1	603313	12p11.1	ALG10
{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3)	ALG10, KCR1	603313	12p11.1	KCR1
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	PCSK9
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	NARC1
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	HCHOLA3
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	FH3
{Low density lipoprotein cholesterol level QTL 1}, 603776 (3)	PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1	607786	1p32.3	LDLCQ1
{Low renin hypertension, susceptibility to} (3)	CYP11B2	124080	8q24.3	CYP11B2
{Lumbar disc degeneration}, 603932 (3)	ASPN, PLAP1, OS3	608135	9q22.31	ASPN
{Lumbar disc degeneration}, 603932 (3)	ASPN, PLAP1, OS3	608135	9q22.31	PLAP1
{Lumbar disc degeneration}, 603932 (3)	ASPN, PLAP1, OS3	608135	9q22.31	OS3
{Lumbar disc disease, susceptibility to}, 603932 (3)	CILP	603489	15q22.31	CILP
{Lumbar disc herniation, susceptibility to}, 603932 (3)	COL11A1, STL2	120280	1p21.1	COL11A1
{Lumbar disc herniation, susceptibility to}, 603932 (3)	COL11A1, STL2	120280	1p21.1	STL2
{Lumbar disc herniation, susceptibility to}, 603932 (3)	THBS2	188061	6q27	THBS2
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA3, LNCR2, PAOD2	118503	15q25.1	CHRNA3
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA3, LNCR2, PAOD2	118503	15q25.1	LNCR2
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA3, LNCR2, PAOD2	118503	15q25.1	PAOD2
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	CHRNA5
{Lung cancer susceptibility 2}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	LNCR2
{Lung cancer susceptibility 3} (2)	LNCR3	612571	5p15.33	LNCR3
{Lung cancer susceptibility 4} (2)	LNCR4	612593	6p21.33	LNCR4
{Lung cancer susceptibility 5} (2)	LNCR5	614210	3q28	LNCR5
{Lung cancer susceptibility} (2)	LNCR1	608935	6q23-q25	LNCR1
{Lung cancer, protection against, in smokers} (3)	MPO	606989	17q22	MPO
{Lung cancer, protection against}, 211980 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	CASP8
{Lung cancer, protection against}, 211980 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	MCH5
{Lung cancer, protection against}, 211980 (3)	CASP8, MCH5, ALPS2B	601763	2q33.1	ALPS2B
{Lung cancer, resistance to}, 211980 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
{Lung cancer, resistance to}, 211980 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A3
{Lung cancer, resistance to}, 211980 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A
{Lung cancer, resistance to}, 211980 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	P450C2A
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
{Lung cancer, susceptibility to}, 211980 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASLG
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	TNFSF6
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	APT1LG1
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	FASL
{Lung cancer, susceptibility to}, 211980 (3)	FASLG, TNFSF6, APT1LG1, FASL, ALPS1B	134638	1q24.3	ALPS1B
{Lupus nephritis, susceptibility to}, 152700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Lupus nephritis, susceptibility to}, 152700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	IGFR2
{Lupus nephritis, susceptibility to}, 152700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	CD32
{Lymphoma, follicular, somatic}, 605027 (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Lymphoma, follicular, somatic}, 605027 (3)	BCL10, IMD37	603517	1p22.3	IMD37
{Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)	WM1	153600	6p21.3	WM1
{Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)	WM2	610430	4q	WM2
{Macular degeneration, age-related, 11}, 611953 (3)	CST3, ARMD11	604312	20p11.21	CST3
{Macular degeneration, age-related, 11}, 611953 (3)	CST3, ARMD11	604312	20p11.21	ARMD11
{Macular degeneration, age-related, 12}, 613784 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Macular degeneration, age-related, 12}, 613784 (3)	CX3CR1, GPR13, V28	601470	3p22.2	GPR13
{Macular degeneration, age-related, 12}, 613784 (3)	CX3CR1, GPR13, V28	601470	3p22.2	V28
{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	CFI
{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	FI
{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	AHUS3
{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3)	CFI, FI, AHUS3, ARMD13	217030	4q25	ARMD13
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	C2, ARMD14	613927	6p21.33	C2
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	C2, ARMD14	613927	6p21.33	ARMD14
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFB
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	BF
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	GBG
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	AHUS4
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	ARMD14
{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3)	CFB, BF, GBG, AHUS4, ARMD14, CFBD	138470	6p21.33	CFBD
{Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	C9, C9D, ARMD15	120940	5p13.1	C9
{Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	C9, C9D, ARMD15	120940	5p13.1	C9D
{Macular degeneration, age-related, 15, susceptibility to}, 615591 (3)	C9, C9D, ARMD15	120940	5p13.1	ARMD15
{Macular degeneration, age-related, 1}, 603075 (3)	HMCN1, FBLN6, FIBL6, ARMD1	608548	1q25.3-q31.1	HMCN1
{Macular degeneration, age-related, 1}, 603075 (3)	HMCN1, FBLN6, FIBL6, ARMD1	608548	1q25.3-q31.1	FBLN6
{Macular degeneration, age-related, 1}, 603075 (3)	HMCN1, FBLN6, FIBL6, ARMD1	608548	1q25.3-q31.1	FIBL6
{Macular degeneration, age-related, 1}, 603075 (3)	HMCN1, FBLN6, FIBL6, ARMD1	608548	1q25.3-q31.1	ARMD1
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCA4
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ABCR
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	STGD1
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	FFM
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	RP19
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	CORD3
{Macular degeneration, age-related, 2}, 153800 (3)	ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2	601691	1p22.1	ARMD2
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	CFH
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HF1
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	HUS
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	ARMD4
{Macular degeneration, age-related, 4}, 610698 (3)	CFH, HF1, HUS, ARMD4, AHUS1	134370	1q31.3	AHUS1
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	PRSS11
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	ARMD7
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CARASIL
{Macular degeneration, age-related, 7}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CADASIL2
{Macular degeneration, age-related, 8}, 613778 (3)	LOC387715, ARMD8	611313	10q26.13	LOC387715
{Macular degeneration, age-related, 8}, 613778 (3)	LOC387715, ARMD8	611313	10q26.13	ARMD8
{Macular degeneration, age-related, 9}, 611378 (3)	C3, ARMD9, AHUS5	120700	19p13.3	C3
{Macular degeneration, age-related, 9}, 611378 (3)	C3, ARMD9, AHUS5	120700	19p13.3	ARMD9
{Macular degeneration, age-related, 9}, 611378 (3)	C3, ARMD9, AHUS5	120700	19p13.3	AHUS5
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	HTRA1
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	PRSS11
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	ARMD7
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CARASIL
{Macular degeneration, age-related, neovascular type}, 610149 (3)	HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2	602194	10q26.13	CADASIL2
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHR1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	FHR1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	HFL1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR1, FHR1, HFL1, CFHL1	134371	1q31.3	CFHL1
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHR3
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	FHR3
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	HLF4
{Macular degeneration, age-related, reduced risk of}, 603075 (3)	CFHR3, FHR3, HLF4, CFHL3	605336	1q31.3	CFHL3
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ERCC6
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CKN2
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	COFS1
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	CSB
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	ARMD5
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	UVSS1
{Macular degeneration, age-related, susceptibility to 5}, 613761 (3)	ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11	609413	10q11.23	POF11
{Major affective disorder 1} (2)	MAFD1, BPAD, MD1	125480	18p	MAFD1
{Major affective disorder 1} (2)	MAFD1, BPAD, MD1	125480	18p	BPAD
{Major affective disorder 1} (2)	MAFD1, BPAD, MD1	125480	18p	MD1
{Major affective disorder 3, early onset} (2)	MAFD3, BPEO	609633	21q22.13	MAFD3
{Major affective disorder 3, early onset} (2)	MAFD3, BPEO	609633	21q22.13	BPEO
{Major affective disorder 5} (2)	MAFD5	611535	2q22-q24	MAFD5
{Major affective disorder 6} (2)	MAFD6, BPAD	611536	6q23-q24	MAFD6
{Major affective disorder 6} (2)	MAFD6, BPAD	611536	6q23-q24	BPAD
{Major affective disorder-7, susceptibility to}, 612371 (3)	XBP1, XBP2	194355	22q12.1	XBP1
{Major affective disorder-7, susceptibility to}, 612371 (3)	XBP1, XBP2	194355	22q12.1	XBP2
{Major affective disorder-8, susceptibility to} (2)	MAFD8	612357	10q21	MAFD8
{Major affective disorder-9, susceptibility to} (2)	MAFD9	612372	12p13.3	MAFD9
{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	FKBP5, FKBP51	602623	6p21.31	FKBP5
{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3)	FKBP5, FKBP51	602623	6p21.31	FKBP51
{Major depressive disorder, response to citalopram therapy in}, 608516 (3)	HTR2A	182135	13q14.2	HTR2A
{Malaria, cerebral, reduced risk of}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Malaria, cerebral, reduced risk of}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CHDS7
{Malaria, cerebral, reduced risk of}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	BDPLT10
{Malaria, cerebral, susceptibility to}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CD36
{Malaria, cerebral, susceptibility to}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	CHDS7
{Malaria, cerebral, susceptibility to}, 611162 (3)	CD36, CHDS7, BDPLT10	173510	7q21.11	BDPLT10
{Malaria, cerebral, susceptibility to}, 611162 (3)	ICAM1	147840	19p13.2	ICAM1
{Malaria, cerebral, susceptibility to}, 611162 (3)	TNF, TNFA	191160	6p21.33	TNF
{Malaria, cerebral, susceptibility to}, 611162 (3)	TNF, TNFA	191160	6p21.33	TNFA
{Malaria, intensity of infection} (2)	PFBI	248310	5q31-q33	PFBI
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	NCR3
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	1C7
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	NKP30
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	CD337
{Malaria, mild, susceptibility to}, 609148 (3)	NCR3, 1C7, NKP30, CD337, MALS	611550	6p21.33	MALS
{Malaria, protection against}, 611162 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Malaria, protection against}, 611162 (3)	TIRAP, BACTS1	606252	11q24.2	BACTS1
{Malaria, resistance to}, 611162 (3)	FCGR2B, CD32	604590	1q23.3	FCGR2B
{Malaria, resistance to}, 611162 (3)	FCGR2B, CD32	604590	1q23.3	CD32
{Malaria, resistance to}, 611162 (3)	GYPA, MN, GPA	111300	4q31.21	GYPA
{Malaria, resistance to}, 611162 (3)	GYPA, MN, GPA	111300	4q31.21	MN
{Malaria, resistance to}, 611162 (3)	GYPA, MN, GPA	111300	4q31.21	GPA
{Malaria, resistance to}, 611162 (3)	GYPB, SS, MNS	111740	4q31.21	GYPB
{Malaria, resistance to}, 611162 (3)	GYPB, SS, MNS	111740	4q31.21	SS
{Malaria, resistance to}, 611162 (3)	GYPB, SS, MNS	111740	4q31.21	MNS
{Malaria, resistance to}, 611162 (3)	GYPC, GE, GPC	110750	2q14.3	GYPC
{Malaria, resistance to}, 611162 (3)	GYPC, GE, GPC	110750	2q14.3	GE
{Malaria, resistance to}, 611162 (3)	GYPC, GE, GPC	110750	2q14.3	GPC
{Malaria, resistance to}, 611162 (3)	HBB	141900	11p15.4	HBB
{Malaria, resistance to}, 611162 (3)	NOS2A, NOS2	163730	17q11.2	NOS2A
{Malaria, resistance to}, 611162 (3)	NOS2A, NOS2	163730	17q11.2	NOS2
{Malaria, severe, resistance to}, 611162 (3)	CR1, C3BR	120620	1q32.2	CR1
{Malaria, severe, resistance to}, 611162 (3)	CR1, C3BR	120620	1q32.2	C3BR
{Malaria, severe, susceptibility to}, 611162 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Malaria, severe, susceptibility to}, 611162 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	IGFR2
{Malaria, severe, susceptibility to}, 611162 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	CD32
{Malaria, susceptibility to}, 611162 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Malaria, susceptibility to}, 611162 (3)	CISH, BACTS2	602441	3p21.2	BACTS2
{Malaria, vivax, protection against}, 611162 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	DARC
{Malaria, vivax, protection against}, 611162 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	FY
{Malaria, vivax, protection against}, 611162 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	GPD
{Malaria, vivax, protection against}, 611162 (3)	DARC, FY, GPD, WBCQ1	613665	1q23.2	WBCQ1
{Male germ cell tumor, somatic}, 273300, (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Male germ cell tumor, somatic}, 273300, (3)	BCL10, IMD37	603517	1p22.3	IMD37
{Malignant hyperthermia susceptibility 1}, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	RYR1
{Malignant hyperthermia susceptibility 1}, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	MHS
{Malignant hyperthermia susceptibility 1}, 145600 (3)	RYR1, MHS, CCO	180901	19q13.2	CCO
{Malignant hyperthermia susceptibility 2} (2)	MHS2	154275	17q11.2-q24	MHS2
{Malignant hyperthermia susceptibility 3} (2)	MHS3	154276	7q21-q22	MHS3
{Malignant hyperthermia susceptibility 4} (2)	MHS4	600467	3q13.1	MHS4
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNL1A3
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CCHL1A3
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	TTPP1
{Malignant hyperthermia susceptibility 5}, 601887 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	HOKPP1
{Malignant hyperthermia susceptibility 6} (2)	MHS6	601888	5p	MHS6
{Maturity-onset diabetes of the young, type 14}, 616511 (3)	APPL1, APPL, MODY14	604299	3p14.3	APPL1
{Maturity-onset diabetes of the young, type 14}, 616511 (3)	APPL1, APPL, MODY14	604299	3p14.3	APPL
{Maturity-onset diabetes of the young, type 14}, 616511 (3)	APPL1, APPL, MODY14	604299	3p14.3	MODY14
{Meconium ileus in cystic fibrosis, susceptibility to} (2)	CFM1	603855	19q13.2-q13.4	CFM1
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Medulloblastoma}, 155255 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Melanoma, cutaneous malignant, 1} (2)	CMM, MLM, DNS	155600	1p36	CMM
{Melanoma, cutaneous malignant, 1} (2)	CMM, MLM, DNS	155600	1p36	MLM
{Melanoma, cutaneous malignant, 1} (2)	CMM, MLM, DNS	155600	1p36	DNS
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CDKN2A
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MTS1
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	P16
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	MLM
{Melanoma, cutaneous malignant, 2}, 155601 (3)	CDKN2A, MTS1, P16, MLM, CMM2	600160	9p21.3	CMM2
{Melanoma, cutaneous malignant, 3}, 609048 (3)	CDK4, CMM3	123829	12q14.1	CDK4
{Melanoma, cutaneous malignant, 3}, 609048 (3)	CDK4, CMM3	123829	12q14.1	CMM3
{Melanoma, cutaneous malignant, 4} (2)	CMM4	608035	1p22	CMM4
{Melanoma, cutaneous malignant, 5}, 613099 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{Melanoma, cutaneous malignant, 5}, 613099 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
{Melanoma, cutaneous malignant, 5}, 613099 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
{Melanoma, cutaneous malignant, 6}, 613972 (3)	XRCC3, CMM6	600675	14q32.33	XRCC3
{Melanoma, cutaneous malignant, 6}, 613972 (3)	XRCC3, CMM6	600675	14q32.33	CMM6
{Melanoma, cutaneous malignant, 7} (2)	CMM7	612263	20q11.2	CMM7
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TCS1
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	EST2
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCA2
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCB4
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	PFBMFT1
{Melanoma, cutaneous malignant, 9}, 615134 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	CMM9
{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3)	POT1, CMM10, GLM9	606478	7q31.33	POT1
{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3)	POT1, CMM10, GLM9	606478	7q31.33	CMM10
{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3)	POT1, CMM10, GLM9	606478	7q31.33	GLM9
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	TYR
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	SHEP3
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	CMM8
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	OCA1A
{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3)	TYR, SHEP3, CMM8, OCA1A, ATN	606933	11q14.3	ATN
{Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	MITF, WS2A, CMM8	156845	3p13	MITF
{Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	MITF, WS2A, CMM8	156845	3p13	WS2A
{Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3)	MITF, WS2A, CMM8	156845	3p13	CMM8
{Melanoma, uveal, susceptibility to, 1} (2)	UVM1	606660	3q24-q26	UVM1
{Melanoma, uveal, susceptibility to, 2} (2)	UVM2	606661	3p25.2-p25.1	UVM2
{Melioidosis, susceptibility to}, 615557 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Melioidosis, susceptibility to}, 615557 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TIL3
{Melioidosis, susceptibility to}, 615557 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	SLEB1
{Melioidosis, susceptibility to}, 615557 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	MELIOS
{Memory impairment, susceptibility to} (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Memory impairment, susceptibility to} (3)	BDNF, BULN2, ANON2	113505	11p14.1	BULN2
{Memory impairment, susceptibility to} (3)	BDNF, BULN2, ANON2	113505	11p14.1	ANON2
{Menarche, age at, QTL2} (2)	MENAQ2	612882	6q21	MENAQ2
{Menarche, age at, QTL3} (2)	MENAQ3	612883	9q31.2	MENAQ3
{Menarche, age at, QTL} (2)	MENAQ1	610873	22q13	MENAQ1
{Meningioma, familial, susceptibility to}, 607174 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	SMARCE1
{Meningioma, familial, susceptibility to}, 607174 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	BAF57
{Meningioma, familial, susceptibility to}, 607174 (3)	SMARCE1, BAF57, CSS5	603111	17q21.2	CSS5
{Meningioma, familial, susceptibility to}, 607174 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFU
{Meningioma, familial, susceptibility to}, 607174 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUXL
{Meningioma, familial, susceptibility to}, 607174 (3)	SUFU, SUFUXL, SUFUH	607035	10q24.32	SUFUH
{Meningioma}, 607174 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Meningioma}, 607174 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
{Meningioma}, 607174 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
{Meningioma}, 607174 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
{Menopause, natural, age at, QTL1} (2)	MENOQ1	300488	Xp21.3	MENOQ1
{Menopause, natural, age at, QTL2} (2)	MENOQ2	612884	19q13.4	MENOQ2
{Menopause, natural, age at, QTL4} (2)	MENOQ4	612886	5q35.2	MENOQ4
{Mental health wellness-1} (2)	MHW1	603663	4p	MHW1
{Mental health wellness-2} (2)	MHW2	603664	4q	MHW2
{Mesothelioma, somatic}, 156240 (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Mesothelioma, somatic}, 156240 (3)	BCL10, IMD37	603517	1p22.3	IMD37
{Metabolic syndrome, protection against}, 605552 (3)	MTP	157147	4q23	MTP
{Microvascular complications of diabetes 1}, 603933 (3)	VEGF, MVCD1	192240	6p21.1	VEGF
{Microvascular complications of diabetes 1}, 603933 (3)	VEGF, MVCD1	192240	6p21.1	MVCD1
{Microvascular complications of diabetes 2}, 612623 (3)	EPO, MVCD2	133170	7q22.1	EPO
{Microvascular complications of diabetes 2}, 612623 (3)	EPO, MVCD2	133170	7q22.1	MVCD2
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
{Microvascular complications of diabetes 3}, 612624 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
{Microvascular complications of diabetes 4}, 612628 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	IL1RN
{Microvascular complications of diabetes 4}, 612628 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	MVCD4
{Microvascular complications of diabetes 4}, 612628 (3)	IL1RN, MVCD4, DIRA	147679	2q14.1	DIRA
{Microvascular complications of diabetes 5}, 612633 (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Microvascular complications of diabetes 5}, 612633 (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON
{Microvascular complications of diabetes 5}, 612633 (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	ESA
{Microvascular complications of diabetes 5}, 612633 (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	MVCD5
{Microvascular complications of diabetes 6}, 612634 (3)	SOD2, MNSOD, MVCD6	147460	6q25.3	SOD2
{Microvascular complications of diabetes 6}, 612634 (3)	SOD2, MNSOD, MVCD6	147460	6q25.3	MNSOD
{Microvascular complications of diabetes 6}, 612634 (3)	SOD2, MNSOD, MVCD6	147460	6q25.3	MVCD6
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
{Microvascular complications of diabetes 7}, 612635 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
{Migraine with aura, susceptibility to, 7} (2)	MGR7	609179	15q11.2-q12	MGR7
{Migraine with aura, susceptibility to, 9} (2)	MGR9	609670	11q24	MGR9
{Migraine with or without aura, susceptibility to, 1} (2)	MGR1, MA	157300	4q24	MGR1
{Migraine with or without aura, susceptibility to, 1} (2)	MGR1, MA	157300	4q24	MA
{Migraine with or without aura, susceptibility to, 3} (2)	MGR3	607498	6p21.1-p12.2	MGR3
{Migraine with or without aura, susceptibility to, 5} (2)	MGR5	607508	19p13	MGR5
{Migraine with or without aura, susceptibility to, 6} (2)	MGR6, FHM3	607516	1q31	MGR6
{Migraine with or without aura, susceptibility to, 6} (2)	MGR6, FHM3	607516	1q31	FHM3
{Migraine without aura, susceptibility to, 4} (2)	MGR4, MGOA	607501	14q21.2-q22.3	MGR4
{Migraine without aura, susceptibility to, 4} (2)	MGR4, MGOA	607501	14q21.2-q22.3	MGOA
{Migraine without aura, susceptibility to}, 157300 (3)	TNF, TNFA	191160	6p21.33	TNF
{Migraine without aura, susceptibility to}, 157300 (3)	TNF, TNFA	191160	6p21.33	TNFA
{Migraine, familial hemiplegic, 4} (2)	MGR6, FHM3	607516	1q31	MGR6
{Migraine, familial hemiplegic, 4} (2)	MGR6, FHM3	607516	1q31	FHM3
{Migraine, familial typical, susceptibility to, 2} (2)	MGR2	300125	Xq	MGR2
{Migraine, resistance to}, 157300 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	EDNRA
{Migraine, resistance to}, 157300 (3)	EDNRA, MFDA	131243	4q31.22-q31.23	MFDA
{Migraine, susceptibility to, 8} (2)	MGR8	609570	5q21	MGR8
{Migraine, susceptibility to}, 157300 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Migraine, susceptibility to}, 157300 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
{Migraine, susceptibility to}, 157300 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
{Migraine, with or without aura, susceptibility to, 12} (2)	MGR12	611706	10q22-q23	MGR12
{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	KCNK18, TRESK, TRIK, MGR13	613655	10q25.3	KCNK18
{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	KCNK18, TRESK, TRIK, MGR13	613655	10q25.3	TRESK
{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	KCNK18, TRESK, TRIK, MGR13	613655	10q25.3	TRIK
{Migraine, with or without aura, susceptibility to, 13}, 613656 (3)	KCNK18, TRESK, TRIK, MGR13	613655	10q25.3	MGR13
{Moyamoya disease 2, susceptibility to}, 607151 (3)	RNF213, ALO17, KIAA1618, MYMY2	613768	17q25.3	RNF213
{Moyamoya disease 2, susceptibility to}, 607151 (3)	RNF213, ALO17, KIAA1618, MYMY2	613768	17q25.3	ALO17
{Moyamoya disease 2, susceptibility to}, 607151 (3)	RNF213, ALO17, KIAA1618, MYMY2	613768	17q25.3	KIAA1618
{Moyamoya disease 2, susceptibility to}, 607151 (3)	RNF213, ALO17, KIAA1618, MYMY2	613768	17q25.3	MYMY2
{Multiple myeloma, resistance to}, 254500 (3)	LIG4, LIG4S	601837	13q33.3	LIG4
{Multiple myeloma, resistance to}, 254500 (3)	LIG4, LIG4S	601837	13q33.3	LIG4S
{Multiple myeloma, susceptibility to}, 254500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
{Multiple myeloma, susceptibility to}, 254500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	PRAD1
{Multiple myeloma, susceptibility to}, 254500 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	BCL1
{Multiple sclerosis, disease progression, modifier of}, 126200 (3)	PDCD1, SLEB2	600244	2q37.3	PDCD1
{Multiple sclerosis, disease progression, modifier of}, 126200 (3)	PDCD1, SLEB2	600244	2q37.3	SLEB2
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	HLA-DQB1
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DQB1, CELIAC1	604305	6p21.32	CELIAC1
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Multiple sclerosis, susceptibility to, 1}, 126200 (3)	HLA-DRB1, SS1	142857	6p21.32	SS1
{Multiple sclerosis, susceptibility to, 2} (2)	MS2	612594	10p15.1	MS2
{Multiple sclerosis, susceptibility to, 3} (2)	MS3	612595	5p13.2	MS3
{Multiple sclerosis, susceptibility to, 4} (2)	MS4	612596	1p36	MS4
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFRSF1A
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFR1
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	TNFAR
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	FPF
{Multiple sclerosis, susceptibility to, 5}, 614810 (3)	TNFRSF1A, TNFR1, TNFAR, FPF, MS5	191190	12p13.31	MS5
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	TGFBR1
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	ALK5
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	AAT5
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	LDS1
{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3)	TGFBR1, ALK5, AAT5, LDS1, MSSE	190181	9q22.33	MSSE
{Multiple system atrophy, susceptibility to}, 146500 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ2
{Multiple system atrophy, susceptibility to}, 146500 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	COQ10D1
{Multiple system atrophy, susceptibility to}, 146500 (3)	COQ2, COQ10D1, MSA1	609825	4q21.22-q21.23	MSA1
{Mycobacerium tuberculosis, susceptibility, X-linked} (2)	MTBSX	300259	Xq	MTBSX
{Mycobacterium tuberculosis, protection against}, 607948 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IRGM
{Mycobacterium tuberculosis, protection against}, 607948 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	LRG47
{Mycobacterium tuberculosis, protection against}, 607948 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IFI1
{Mycobacterium tuberculosis, protection against}, 607948 (3)	IRGM, LRG47, IFI1, IBD19	608212	5q33.1	IBD19
{Mycobacterium tuberculosis, protection against}, 607948 (3)	MC3R, BMIQ9	155540	20q13.2	MC3R
{Mycobacterium tuberculosis, protection against}, 607948 (3)	MC3R, BMIQ9	155540	20q13.2	BMIQ9
{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP1
{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	NRAMP
{Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3)	NRAMP1, NRAMP, SLC11A1	600266	2q35	SLC11A1
{Mycobacterium tuberculosis, susceptibility to, 2} (2)	MTBS2	611046	8q12-q13	MTBS2
{Mycobacterium tuberculosis, susceptibility to, 3} (2)	MTBS3	612929	20q13.31-q13.33	MTBS3
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	SCYA2
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCP1
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCAF
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CD209, CDSIGN	604672	19p13.2	CD209
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	CD209, CDSIGN	604672	19p13.2	CDSIGN
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	SP110
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	IFI41
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	IFI75
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	SP110, IFI41, IFI75, VODI	604457	2q37.1	VODI
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	TLR2, TIL4	603028	4q31.3	TLR2
{Mycobacterium tuberculosis, susceptibility to}, 607948 (3)	TLR2, TIL4	603028	4q31.3	TIL4
{Myelodysplastic syndrome, susceptibility to}, 614286 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	GATA2
{Myelodysplastic syndrome, susceptibility to}, 614286 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	DCML
{Myelodysplastic syndrome, susceptibility to}, 614286 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	MONOMAC
{Myelodysplastic syndrome, susceptibility to}, 614286 (3)	GATA2, DCML, MONOMAC, IMD21	137295	3q21.3	IMD21
{Myeloproliferative neoplasms, familial, susceptibility to} (4)	DUP14q32, C14DUPq32	616604	14q32	DUP14q32
{Myeloproliferative neoplasms, familial, susceptibility to} (4)	DUP14q32, C14DUPq32	616604	14q32	C14DUPq32
{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	DDX41, ABS, MPLPF	608170	5q35.3	DDX41
{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	DDX41, ABS, MPLPF	608170	5q35.3	ABS
{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3)	DDX41, ABS, MPLPF	608170	5q35.3	MPLPF
{Myocardial infarcation, susceptibility to}, 608446 (3)	PSMA6, PROS27, P27K	602855	14q13.2	PSMA6
{Myocardial infarcation, susceptibility to}, 608446 (3)	PSMA6, PROS27, P27K	602855	14q13.2	PROS27
{Myocardial infarcation, susceptibility to}, 608446 (3)	PSMA6, PROS27, P27K	602855	14q13.2	P27K
{Myocardial infarction susceptibility} (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	APOE
{Myocardial infarction susceptibility} (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	AD2
{Myocardial infarction susceptibility} (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LPG
{Myocardial infarction susceptibility} (3)	APOE, AD2, LPG, LDLCQ5	107741	19q13.32	LDLCQ5
{Myocardial infarction, decreased susceptibility to}, 608446 (3)	F7	613878	13q34	F7
{Myocardial infarction, protection against}, 608446 (3)	F13A1, F13A	134570	6p25.1	F13A1
{Myocardial infarction, protection against}, 608446 (3)	F13A1, F13A	134570	6p25.1	F13A
{Myocardial infarction, susceptibility to, 2} (2)	MCI2	608557	13q12	MCI2
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
{Myocardial infarction, susceptibility to} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
{Myocardial infarction, susceptibility to}, 608446 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR1
{Myocardial infarction, susceptibility to}, 608446 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESR
{Myocardial infarction, susceptibility to}, 608446 (3)	ESR1, ESR, ESTRR	133430	6q25.1-q25.2	ESTRR
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLC, GLCLC	606857	6p12.1	GCLC
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLC, GLCLC	606857	6p12.1	GLCLC
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLM, GLCLR	601176	1p22.1	GCLM
{Myocardial infarction, susceptibility to}, 608446 (3)	GCLM, GLCLR	601176	1p22.1	GLCLR
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	ITGB3
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GP3A
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	GT
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT2
{Myocardial infarction, susceptibility to}, 608446 (3)	ITGB3, GP3A, GT, BDPLT2, BDPLT16	173470	17q21.32	BDPLT16
{Myocardial infarction, susceptibility to}, 608446 (3)	LGALS2	150571	22q13.1	LGALS2
{Myocardial infarction, susceptibility to}, 608446 (3)	LRP8, APOER2, MCI1	602600	1p32.3	LRP8
{Myocardial infarction, susceptibility to}, 608446 (3)	LRP8, APOER2, MCI1	602600	1p32.3	APOER2
{Myocardial infarction, susceptibility to}, 608446 (3)	LRP8, APOER2, MCI1	602600	1p32.3	MCI1
{Myocardial infarction, susceptibility to}, 608446 (3)	LTA, TNFB	153440	6p21.33	LTA
{Myocardial infarction, susceptibility to}, 608446 (3)	LTA, TNFB	153440	6p21.33	TNFB
{Myocardial infarction, susceptibility to}, 608446 (3)	MIAT, C22orf35	611082	22q12.1	MIAT
{Myocardial infarction, susceptibility to}, 608446 (3)	MIAT, C22orf35	611082	22q12.1	C22orf35
{Myocardial infarction, susceptibility to}, 608446 (3)	OLR1, LOX1	602601	12p13.2	OLR1
{Myocardial infarction, susceptibility to}, 608446 (3)	OLR1, LOX1	602601	12p13.2	LOX1
{Myocardial infarction, susceptibility to}, 608446 (3)	TNFSF4, GP34, OX4OL	603594	1q25.1	TNFSF4
{Myocardial infarction, susceptibility to}, 608446 (3)	TNFSF4, GP34, OX4OL	603594	1q25.1	GP34
{Myocardial infarction, susceptibility to}, 608446 (3)	TNFSF4, GP34, OX4OL	603594	1q25.1	OX4OL
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EFHC1
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	FLJ10466
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EJM1
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	JAE
{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3)	EFHC1, FLJ10466, EJM1, JAE, EJA1	608815	6p12.2	EJA1
{Narcolepsy 4} (2)	NRCLP4	612417	22q13	NRCLP4
{Narcolepsy 5} (2)	NRCLP5	612851	14q11.2	NRCLP5
{Nasopharyngeal carcinoma 1} (2)	NPC1, NPCA1	607107	4p15.1-q12	NPC1
{Nasopharyngeal carcinoma 1} (2)	NPC1, NPCA1	607107	4p15.1-q12	NPCA1
{Nasopharyngeal carcinoma, susceptibility to, 2} (2)	NPCA2	161550	6p21.3	NPCA2
{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	ZNF365, UAN	607818	10q21.2	ZNF365
{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)	ZNF365, UAN	607818	10q21.2	UAN
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTR, HMAG	156570	1q43	MTR
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTR, HMAG	156570	1q43	HMAG
{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3)	MTRR	602568	5p15.31	MTRR
{Neural tube defects, susceptibility to}, 182940 (3)	T, TFT, SAVA	601397	6q27	T
{Neural tube defects, susceptibility to}, 182940 (3)	T, TFT, SAVA	601397	6q27	TFT
{Neural tube defects, susceptibility to}, 182940 (3)	T, TFT, SAVA	601397	6q27	SAVA
{Neural tube defects, susceptibility to}, 182940 (3)	VANGL1, STBM2	610132	1p13.1	VANGL1
{Neural tube defects, susceptibility to}, 182940 (3)	VANGL1, STBM2	610132	1p13.1	STBM2
{Neural tube defects, susceptibility to}, 601634 (3)	MTHFR	607093	1p36.22	MTHFR
{Neuroblastoma, susceptibility to, 1}, 256700 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	KIF1B
{Neuroblastoma, susceptibility to, 1}, 256700 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A
{Neuroblastoma, susceptibility to, 1}, 256700 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	CMT2A1
{Neuroblastoma, susceptibility to, 1}, 256700 (3)	KIF1B, CMT2A, CMT2A1, NBLST1	605995	1p36.22	NBLST1
{Neuroblastoma, susceptibility to, 2}, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PMX2B
{Neuroblastoma, susceptibility to, 2}, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBPHOX
{Neuroblastoma, susceptibility to, 2}, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	PHOX2B
{Neuroblastoma, susceptibility to, 2}, 613013 (3)	PMX2B, NBPHOX, PHOX2B, NBLST2	603851	4p13	NBLST2
{Neuroblastoma, susceptibility to, 3}, 613014 (3)	ALK, NBLST3	105590	2p23.2-p23.1	ALK
{Neuroblastoma, susceptibility to, 3}, 613014 (3)	ALK, NBLST3	105590	2p23.2-p23.1	NBLST3
{Neuroblastoma, susceptibility to, 4} (2)	NBLST4	613015	6p22	NBLST4
{Neuroblastoma, susceptibility to, 5} (2)	NBLST5	613016	2q35	NBLST5
{Neuroblastoma, susceptibility to, 6} (2)	NBLST6	613017	1q21.1	NBLST6
{Neuroblastoma, susceptibility to, 7} (2)	NBLST7	616792	11p15	NBLST7
{Nevus sebaceous or woolly hair nevus, somatic}, 162900 (3)	HRAS	190020	11p15.5	HRAS
{Nicotine addiction, protection from}, 188890 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A6
{Nicotine addiction, protection from}, 188890 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A3
{Nicotine addiction, protection from}, 188890 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	CYP2A
{Nicotine addiction, protection from}, 188890 (3)	CYP2A6, CYP2A3, CYP2A, P450C2A	122720	19q13.2	P450C2A
{Nicotine addiction, susceptibility to}, 188890 (3)	CHRNA4, ENFL1	118504	20q13.33	CHRNA4
{Nicotine addiction, susceptibility to}, 188890 (3)	CHRNA4, ENFL1	118504	20q13.33	ENFL1
{Nicotine dependence, protection against}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GPR51
{Nicotine dependence, protection against}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GABBR2
{Nicotine dependence, protection against}, 188890 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	SLC6A3
{Nicotine dependence, protection against}, 188890 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	DAT1
{Nicotine dependence, protection against}, 188890 (3)	SLC6A3, DAT1, PKDYS	126455	5p15.33	PKDYS
{Nicotine dependence, susceptibility to}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GPR51
{Nicotine dependence, susceptibility to}, 188890 (3)	GPR51, GABBR2	607340	9q22.33	GABBR2
{Nicotine dependence, susceptibility to}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	CHRNA5
{Nicotine dependence, susceptibility to}, 612052 (3)	CHRNA5, LNCR2	118505	15q25.1	LNCR2
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	GP1BA
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BSS
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT1
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	VWDP
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3)	GP1BA, BSS, BDPLT1, VWDP, BDPLT3	606672	17p13.2	BDPLT3
{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)	EGFR, NISBD2	131550	7p11.2	EGFR
{Nonsmall cell lung cancer, susceptibility to}, 211980 (3)	EGFR, NISBD2	131550	7p11.2	NISBD2
{Nonsmall cell lung cancer} (2)	TSG11	603040	11q23	TSG11
{Norwalk virus infection, resistance to} (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
{Norwalk virus infection, resistance to} (3)	FUT2, SE, B12QTL1	182100	19q13.33	SE
{Norwalk virus infection, resistance to} (3)	FUT2, SE, B12QTL1	182100	19q13.33	B12QTL1
{Obesity, association with}, 601665 (3)	SDC3, SYND3, SDCN	186357	1p35.2	SDC3
{Obesity, association with}, 601665 (3)	SDC3, SYND3, SDCN	186357	1p35.2	SYND3
{Obesity, association with}, 601665 (3)	SDC3, SYND3, SDCN	186357	1p35.2	SDCN
{Obesity, early-onset, susceptibility to}, 601665 (3)	POMC	176830	2p23.3	POMC
{Obesity, late-onset}, 601665 (3)	AGRP, ART, AGRT	602311	16q22.1	AGRP
{Obesity, late-onset}, 601665 (3)	AGRP, ART, AGRT	602311	16q22.1	ART
{Obesity, late-onset}, 601665 (3)	AGRP, ART, AGRT	602311	16q22.1	AGRT
{Obesity, severe, and type II diabetes}, 601665 (3)	UCP3	602044	11q13.4	UCP3
{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)	MC3R, BMIQ9	155540	20q13.2	MC3R
{Obesity, severe, susceptibility to, BMIQ9}, 602025 (3)	MC3R, BMIQ9	155540	20q13.2	BMIQ9
{Obesity, susceptibility to, BMIQ11}, 300306 (3)	SLC6A14, OBX, BMIQ11	300444	Xq23	SLC6A14
{Obesity, susceptibility to, BMIQ11}, 300306 (3)	SLC6A14, OBX, BMIQ11	300444	Xq23	OBX
{Obesity, susceptibility to, BMIQ11}, 300306 (3)	SLC6A14, OBX, BMIQ11	300444	Xq23	BMIQ11
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PCSK1
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	NEC1
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PC1
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	PC3
{Obesity, susceptibility to, BMIQ12}, 612362 (3)	PCSK1, NEC1, PC1, PC3, BMIQ12	162150	5q15	BMIQ12
{Obesity, susceptibility to, BMIQ14}, 612460 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	FTO
{Obesity, susceptibility to, BMIQ14}, 612460 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	GDFD
{Obesity, susceptibility to, BMIQ14}, 612460 (3)	FTO, GDFD, BMIQ14	610966	16q12.2	BMIQ14
{Obesity, susceptibility to, BMIQ4}, 607447 (3)	UCP2, BMIQ4	601693	11q13.4	UCP2
{Obesity, susceptibility to, BMIQ4}, 607447 (3)	UCP2, BMIQ4	601693	11q13.4	BMIQ4
{Obesity, susceptibility to, BMIQ7} (2)	BMIQ7	608410	4p15-p14	BMIQ7
{Obesity, susceptibility to, BMIQ8} (2)	BMIQ8	603188	10p	BMIQ8
{Obesity, susceptibility to}, 601665 (3)	ADRB2	109690	5q32	ADRB2
{Obesity, susceptibility to}, 601665 (3)	ADRB3	109691	8p11.23	ADRB3
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ENPP1
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PDNP1
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	NPPS
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	M6S1
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	PCA1
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	ARHR2
{Obesity, susceptibility to}, 601665 (3)	ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED	173335	6q23.2	COLED
{Obesity, susceptibility to}, 601665 (3)	GHRL	605353	3p25.3	GHRL
{Obesity, susceptibility to}, 601665 (3)	UCP1	113730	4q31.1	UCP1
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	FFAR4
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	O3FAR1
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	GPR120
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	PGR4
{Obesity, susceptibility to}, 607514 (3)	FFAR4, O3FAR1, GPR120, PGR4, BMIQ10	609044	10q23.33	BMIQ10
{Obesity, variation in}, 601665 (3)	PPARGC1B, PGC1B, PERC	608886	5q32	PPARGC1B
{Obesity, variation in}, 601665 (3)	PPARGC1B, PGC1B, PERC	608886	5q32	PGC1B
{Obesity, variation in}, 601665 (3)	PPARGC1B, PGC1B, PERC	608886	5q32	PERC
{Obsessive-compulsive disorder, protection against}, 164230 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BDNF
{Obsessive-compulsive disorder, protection against}, 164230 (3)	BDNF, BULN2, ANON2	113505	11p14.1	BULN2
{Obsessive-compulsive disorder, protection against}, 164230 (3)	BDNF, BULN2, ANON2	113505	11p14.1	ANON2
{Obsessive-compulsive disorder, susceptibility to}, 164230 (3)	HTR2A	182135	13q14.2	HTR2A
{Obsessive-compulsive disorder}, 164230 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	SLC6A4
{Obsessive-compulsive disorder}, 164230 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	HTT
{Obsessive-compulsive disorder}, 164230 (3)	SLC6A4, HTT, OCD1	182138	17q11.2	OCD1
{Opioid dependence, susceptibility to, 1} (2)	ODS1	610064	Chr.17	ODS1
{Organophosphate poisoning, sensitivity to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON1
{Organophosphate poisoning, sensitivity to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	PON
{Organophosphate poisoning, sensitivity to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	ESA
{Organophosphate poisoning, sensitivity to} (3)	PON1, PON, ESA, MVCD5	168820	7q21.3	MVCD5
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	IRF6
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	VWS
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	LPS
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PIT
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	PPS1
{Orofacial cleft 6}, 608864 (3)	IRF6, VWS, LPS, PIT, PPS1, OFC6	607199	1q32.2	OFC6
{Osteoarthritis susceptibility 1}, 165720 (3)	FRZB, FRZB1, SRFP3, OS1	605083	2q32.1	FRZB
{Osteoarthritis susceptibility 1}, 165720 (3)	FRZB, FRZB1, SRFP3, OS1	605083	2q32.1	FRZB1
{Osteoarthritis susceptibility 1}, 165720 (3)	FRZB, FRZB1, SRFP3, OS1	605083	2q32.1	SRFP3
{Osteoarthritis susceptibility 1}, 165720 (3)	FRZB, FRZB1, SRFP3, OS1	605083	2q32.1	OS1
{Osteoarthritis susceptibility 2}, 140600 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	MATN3
{Osteoarthritis susceptibility 2}, 140600 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	EDM5
{Osteoarthritis susceptibility 2}, 140600 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	HOA
{Osteoarthritis susceptibility 2}, 140600 (3)	MATN3, EDM5, HOA, OS2	602109	2p24.1	OS2
{Osteoarthritis susceptibility 3}, 607850 (3)	ASPN, PLAP1, OS3	608135	9q22.31	ASPN
{Osteoarthritis susceptibility 3}, 607850 (3)	ASPN, PLAP1, OS3	608135	9q22.31	PLAP1
{Osteoarthritis susceptibility 3}, 607850 (3)	ASPN, PLAP1, OS3	608135	9q22.31	OS3
{Osteoarthritis susceptibility 4} (2)	OS4, GOA1	610839	2q33.3	OS4
{Osteoarthritis susceptibility 4} (2)	OS4, GOA1	610839	2q33.3	GOA1
{Osteoarthritis susceptibility 6} (2)	OS6	612401	3p24.3	OS6
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	GDF5
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	CDMP1
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYNS2
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	OS5
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	BDA1C
{Osteoarthritis-5}, 612400 (3)	GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B	601146	20q11.22	SYM1B
{Osteofibrous dysplasia, susceptibility to}, 607278 (3)	MET, DFNB97, OSFD	164860	7q31.2	MET
{Osteofibrous dysplasia, susceptibility to}, 607278 (3)	MET, DFNB97, OSFD	164860	7q31.2	DFNB97
{Osteofibrous dysplasia, susceptibility to}, 607278 (3)	MET, DFNB97, OSFD	164860	7q31.2	OSFD
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	WNT1
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	INT1
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	OI15
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3)	WNT1, INT1, OI15, BMND16	164820	12q13.12	BMND16
{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	CALCR, CRT	114131	7q21.3	CALCR
{Osteoporosis, postmenopausal, susceptibility}, 166710 (3)	CALCR, CRT	114131	7q21.3	CRT
{Osteoporosis, postmenopausal}, 166710 (3)	COL1A2	120160	7q21.3	COL1A2
{Osteoporosis, susceptibility to}, 166710 (3)	RIL	603422	5q31.1	RIL
{Osteoporosis}, 166710 (2)	BMND7	611738	20p12.3	BMND7
{Osteoporosis}, 166710 (2)	BMND8	611739	11p12	BMND8
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP5
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	BMND1
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LRP7
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	LR3
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPPG
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	VBCH2
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	OPTA1
{Osteoporosis}, 166710 (3)	LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4	603506	11q13.2	EVR4
{Otitis media, susceptibility to} (2)	OMS	166760	10q26.3	OMS
{Otosclerosis 4} (2)	OTSC4	611571	16q22.1-q23.1	OTSC4
{Ovarian cancer, somatic}, 167000 (3)	OPCML	600632	11q25	OPCML
{Ovarian cancer, susceptibility to} (2)	OVCAS1	607893	3p25-p22	OVCAS1
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	TNFRSF11A
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	RANK
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	ODFR
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	FEO
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	OPTB7
{Paget disease of bone 2, early-onset}, 602080 (3)	TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2	603499	18q21.33	PDB2
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Pancreatic cancer 2}, 613347 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	PALLD, KIAA0992, PNCA1	608092	4q32.3	PALLD
{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	PALLD, KIAA0992, PNCA1	608092	4q32.3	KIAA0992
{Pancreatic cancer, susceptibility to, 1}, 606856 (3)	PALLD, KIAA0992, PNCA1	608092	4q32.3	PNCA1
{Pancreatic cancer, susceptibility to, 3}, 613348 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PALB2
{Pancreatic cancer, susceptibility to, 3}, 613348 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	FANCN
{Pancreatic cancer, susceptibility to, 3}, 613348 (3)	PALB2, FANCN, PNCA3	610355	16p12.2	PNCA3
{Pancreatic cancer, susceptibility to, 4}, 614320 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BRCA1
{Pancreatic cancer, susceptibility to, 4}, 614320 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	PSCP
{Pancreatic cancer, susceptibility to, 4}, 614320 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	BROVCA1
{Pancreatic cancer, susceptibility to, 4}, 614320 (3)	BRCA1, PSCP, BROVCA1, PNCA4	113705	17q21.31	PNCA4
{Pancreatitis, chronic, protection against}, 167800 (3)	PRSS2, TRY2	601564	7q34	PRSS2
{Pancreatitis, chronic, protection against}, 167800 (3)	PRSS2, TRY2	601564	7q34	TRY2
{Pancreatitis, chronic, susceptibility to}, 167800 (3)	CTRC, CLCR	601405	1p36.21	CTRC
{Pancreatitis, chronic, susceptibility to}, 167800 (3)	CTRC, CLCR	601405	1p36.21	CLCR
{Pancreatitis, idiopathic}, 167800 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CFTR
{Pancreatitis, idiopathic}, 167800 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	ABCC7
{Pancreatitis, idiopathic}, 167800 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	CF
{Pancreatitis, idiopathic}, 167800 (3)	CFTR, ABCC7, CF, MRP7	602421	7q31.2	MRP7
{Panic disorder, susceptibility to}, 167870 (3)	COMT	116790	22q11.21	COMT
{Parkinson disease 10} (2)	PARK10, AAOPD	606852	1p32	PARK10
{Parkinson disease 10} (2)	PARK10, AAOPD	606852	1p32	AAOPD
{Parkinson disease 11}, 607688 (3)	GIGYF2, KIAA0642, PARK11	612003	2q37.1	GIGYF2
{Parkinson disease 11}, 607688 (3)	GIGYF2, KIAA0642, PARK11	612003	2q37.1	KIAA0642
{Parkinson disease 11}, 607688 (3)	GIGYF2, KIAA0642, PARK11	612003	2q37.1	PARK11
{Parkinson disease 12} (2)	PARK12	300557	Xq21-q25	PARK12
{Parkinson disease 13}, 610297 (3)	HTRA2, OMI, PARK13, PRSS25	606441	2p13.1	HTRA2
{Parkinson disease 13}, 610297 (3)	HTRA2, OMI, PARK13, PRSS25	606441	2p13.1	OMI
{Parkinson disease 13}, 610297 (3)	HTRA2, OMI, PARK13, PRSS25	606441	2p13.1	PARK13
{Parkinson disease 13}, 610297 (3)	HTRA2, OMI, PARK13, PRSS25	606441	2p13.1	PRSS25
{Parkinson disease 16} (2)	PARK16	613164	1q32	PARK16
{Parkinson disease 17}, 614203 (3)	VPS35, MEM3, PARK17	601501	16q11.2	VPS35
{Parkinson disease 17}, 614203 (3)	VPS35, MEM3, PARK17	601501	16q11.2	MEM3
{Parkinson disease 17}, 614203 (3)	VPS35, MEM3, PARK17	601501	16q11.2	PARK17
{Parkinson disease 18}, 614251 (3)	EIF4G1, EIF4G, PARK18	600495	3q27.1	EIF4G1
{Parkinson disease 18}, 614251 (3)	EIF4G1, EIF4G, PARK18	600495	3q27.1	EIF4G
{Parkinson disease 18}, 614251 (3)	EIF4G1, EIF4G, PARK18	600495	3q27.1	PARK18
{Parkinson disease 3} (2)	PARK3	602404	2p13	PARK3
{Parkinson disease 8}, 607060 (3)	LRRK2, PARK8	609007	12q12	LRRK2
{Parkinson disease 8}, 607060 (3)	LRRK2, PARK8	609007	12q12	PARK8
{Parkinson disease, age of onset, modifier}, 168600 (3)	GLUD2	300144	Xq24	GLUD2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATXN2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ATX2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	SCA2
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	ATXN2, ATX2, SCA2, ASL13	601517	12q24.12	ASL13
{Parkinson disease, late-onset, susceptibility to}, 168600 (3)	GBA	606463	1q22	GBA
{Parkinson disease, susceptibility to}, 168600 (3)	ADH1C, ADH3	103730	4q23	ADH1C
{Parkinson disease, susceptibility to}, 168600 (3)	ADH1C, ADH3	103730	4q23	ADH3
{Parkinson disease, susceptibility to}, 168600 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MAPT
{Parkinson disease, susceptibility to}, 168600 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MTBT1
{Parkinson disease, susceptibility to}, 168600 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	DDPAC
{Parkinson disease, susceptibility to}, 168600 (3)	MAPT, MTBT1, DDPAC, MSTD	157140	17q21.31	MSTD
{Parkinson disease, susceptibility to}, 168600 (3)	TBP, SCA17, HDL4	600075	6q27	TBP
{Parkinson disease, susceptibility to}, 168600 (3)	TBP, SCA17, HDL4	600075	6q27	SCA17
{Parkinson disease, susceptibility to}, 168600 (3)	TBP, SCA17, HDL4	600075	6q27	HDL4
{Patent ductus arteriosus, susceptibility to} (2)	PDA1	607411	12q24	PDA1
{Pelvic organ prolapse, susceptibility to, 1} (2)	PVOP1	176780	1q31	PVOP1
{Pelvic organ prolapse, susceptibility to, 2} (2)	PVOP2	613088	9q21	PVOP2
{Pemphigoid, susceptibility to} (2)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Pemphigoid, susceptibility to} (2)	HLA-DRB1, SS1	142857	6p21.32	SS1
{Pheochromocytoma, modifier of}, 171300 (3)	GDNF, HSCR3	600837	5p13.2	GDNF
{Pheochromocytoma, modifier of}, 171300 (3)	GDNF, HSCR3	600837	5p13.2	HSCR3
{Pheochromocytoma, susceptibility to}, 171300 (3)	MAX	154950	14q23.3	MAX
{Pheochromocytoma, susceptibility to}, 171300 (3)	TMEM127	613403	2q11.2	TMEM127
{Placental abruption} (3)	NOS3	163729	7q36.1	NOS3
{Plasmodium falciparum fever episodes QTL1} (2)	PFFE1	611384	10p15	PFFE1
{Pneumococcal disease, invasive, protection against}, 610799 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Pneumococcal disease, invasive, protection against}, 610799 (3)	TIRAP, BACTS1	606252	11q24.2	BACTS1
{Podoconiosis, susceptibility to} (2)	PDCOS	614590	6p21.3	PDCOS
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
{Porphyria cutanea tarda, susceptibility to}, 176100 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HLA-H
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	HFE1
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	MVCD7
{Porphyria variegata, susceptibility to}, 176200 (3)	HFE, HLA-H, HFE1, MVCD7, TFQTL2	613609	6p22.2	TFQTL2
{Preeclampsia, susceptibility to} (3)	AGT, SERPINA8	106150	1q42.2	AGT
{Preeclampsia, susceptibility to} (3)	AGT, SERPINA8	106150	1q42.2	SERPINA8
{Preeclampsia, susceptibility to}, 189800 (3)	EPHX1	132810	1q42.12	EPHX1
{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
{Pregnancy loss, recurrent, susceptibility to, 1}, 614389 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	F2, THPH1, RPRGL2	176930	11p11.2	THPH1
{Pregnancy loss, recurrent, susceptibility to, 2}, 614390 (3)	F2, THPH1, RPRGL2	176930	11p11.2	RPRGL2
{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	ANXA5, ENX2, RPRGL3	131230	4q27	ANXA5
{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	ANXA5, ENX2, RPRGL3	131230	4q27	ENX2
{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3)	ANXA5, ENX2, RPRGL3	131230	4q27	RPRGL3
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH1
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	SERPINH2
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	PPROM
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	CBP2
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	CBP1
{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3)	SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10	600943	11q13.5	OI10
{Prostate cancer aggressiveness QTL}, 176807 (2)	HPCQTL19	607592	19q	HPCQTL19
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHEK2
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	RAD53
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CHK2
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	CDS1
{Prostate cancer, familial, susceptibility to}, 176807 (3)	CHEK2, RAD53, CHK2, CDS1, LFS2	604373	22q12.1	LFS2
{Prostate cancer, hereditary, 10} (2)	HPC10	611100	8q24	HPC10
{Prostate cancer, hereditary, 11} (2)	HPC11	611955	17q12	HPC11
{Prostate cancer, hereditary, 12}, 611868 (3)	EHBP1, KIAA0903, HPC12	609922	2p15	EHBP1
{Prostate cancer, hereditary, 12}, 611868 (3)	EHBP1, KIAA0903, HPC12	609922	2p15	KIAA0903
{Prostate cancer, hereditary, 12}, 611868 (3)	EHBP1, KIAA0903, HPC12	609922	2p15	HPC12
{Prostate cancer, hereditary, 13}, 611928 (3)	MSMB, HPC13	157145	10q11.22	MSMB
{Prostate cancer, hereditary, 13}, 611928 (3)	MSMB, HPC13	157145	10q11.22	HPC13
{Prostate cancer, hereditary, 14} (2)	HPC14	611958	11q13	HPC14
{Prostate cancer, hereditary, 15} (2)	HPC15	611959	19q13.4	HPC15
{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3)	ELAC2, HPC2, COXPD17	605367	17p12	ELAC2
{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3)	ELAC2, HPC2, COXPD17	605367	17p12	HPC2
{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3)	ELAC2, HPC2, COXPD17	605367	17p12	COXPD17
{Prostate cancer, hereditary, 5}, 176807 (2)	HPC5	609299	3p26	HPC5
{Prostate cancer, hereditary, 7} (2)	HPC7	610321	15q12	HPC7
{Prostate cancer, hereditary, 9} (2)	HPC9	610997	17q21-q22	HPC9
{Prostate cancer, hereditary, X-linked 1} (2)	HPCX1	300147	Xq27-q28	HPCX1
{Prostate cancer, hereditary, X-linked 2} (2)	HPCX2	300704	Xp11.22	HPCX2
{Prostate cancer, progression of}, 176807 (1)	HIP1	601767	7q11.23	HIP1
{Prostate cancer, somatic}, 176807 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	PTEN
{Prostate cancer, somatic}, 176807 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	MMAC1
{Prostate cancer, somatic}, 176807 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	GLM2
{Prostate cancer, somatic}, 176807 (3)	PTEN, MMAC1, GLM2, CWS1	601728	10q23.31	CWS1
{Prostate cancer, susceptibility to, 3}, 176807 (2)	HPC3	608656	20q13	HPC3
{Prostate cancer, susceptibility to, 4}, 176807 (2)	HPC4	608658	7p11-q21	HPC4
{Prostate cancer, susceptibility to, somatic}, 176807 (3)	ZFHX3, ATBF1	104155	16q22.2-q22.3	ZFHX3
{Prostate cancer, susceptibility to, somatic}, 176807 (3)	ZFHX3, ATBF1	104155	16q22.2-q22.3	ATBF1
{Prostate cancer, susceptibility to}, 176807 (2)	CD82, SAR2, KAI1, ST6	600623	11p11.2	CD82
{Prostate cancer, susceptibility to}, 176807 (2)	CD82, SAR2, KAI1, ST6	600623	11p11.2	SAR2
{Prostate cancer, susceptibility to}, 176807 (2)	CD82, SAR2, KAI1, ST6	600623	11p11.2	KAI1
{Prostate cancer, susceptibility to}, 176807 (2)	CD82, SAR2, KAI1, ST6	600623	11p11.2	ST6
{Prostate cancer, susceptibility to}, 176807 (2)	HPC6	609558	22q12.3	HPC6
{Prostate cancer, susceptibility to}, 176807 (2)	PCAP	602759	1q42.2-q43	PCAP
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	AR
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	DHTR
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	TFM
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SBMA
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	KD
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	SMAX1
{Prostate cancer, susceptibility to}, 176807 (3)	AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1	313700	Xq12	HYSP1
{Prostate cancer, susceptibility to}, 176807 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	CDH1
{Prostate cancer, susceptibility to}, 176807 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	UVO
{Prostate cancer, susceptibility to}, 176807 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	LCAM
{Prostate cancer, susceptibility to}, 176807 (3)	CDH1, UVO, LCAM, ECAD	192090	16q22.1	ECAD
{Prostate cancer, susceptibility to}, 176807 (3)	MXI1	600020	10q25.2	MXI1
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	EPHB2
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	EPHT3
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	DRT
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	ERK
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	PCBC
{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3)	EPHB2, EPHT3, DRT, ERK, PCBC, CAPB	600997	1p36.12	CAPB
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BRCA2
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	FANCD1
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	BROVCA2
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	GLM3
{Prostate cancer}, 176807 (3)	BRCA2, FANCD1, BROVCA2, GLM3, PNCA2	600185	13q13.1	PNCA2
{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	KRT75, K6HF, PFB	609025	12q13.13	KRT75
{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	KRT75, K6HF, PFB	609025	12q13.13	K6HF
{Pseudofolliculitis barbae, susceptibility to}, 612318 (3)	KRT75, K6HF, PFB	609025	12q13.13	PFB
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	FCGR2A
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	IGFR2
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3)	FCGR2A, IGFR2, CD32	146790	1q23.3	CD32
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XYLT1
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	XT1
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT1, XT1, DBQD2	608124	16p12.3	DBQD2
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT2, XT2, SOS	608125	17q21.33	XYLT2
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT2, XT2, SOS	608125	17q21.33	XT2
{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)	XYLT2, XT2, SOS	608125	17q21.33	SOS
{Psoraisis susceptibility 9} (2)	PSORS9	607857	4q31-q34	PSORS9
{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	AP1S3, PSORS15	615781	2q36.1	AP1S3
{Psoriasis 15, pustular, susceptibility to}, 616106 (3)	AP1S3, PSORS15	615781	2q36.1	PSORS15
{Psoriasis susceptibility 10} (2)	PSORS10	612410	18p11.23	PSORS10
{Psoriasis susceptibility 11} (2)	PSORS11	612599	5q31.1-q33.1	PSORS11
{Psoriasis susceptibility 12} (2)	PSORS12	612950	20q13	PSORS12
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	TRAF3IP2
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf5
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	ACT1
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	CIKS
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf4
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	C6orf6
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	PSORS13
{Psoriasis susceptibility 13}, 614070 (3)	TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8	607043	6q21	CANDF8
{Psoriasis susceptibility 1}, 177900 (3)	HLA-C, PSORS1	142840	6p21.33	HLA-C
{Psoriasis susceptibility 1}, 177900 (3)	HLA-C, PSORS1	142840	6p21.33	PSORS1
{Psoriasis susceptibility 3} (2)	PSORS3	601454	4q	PSORS3
{Psoriasis susceptibility 4} (2)	PSORS4	603935	1q21	PSORS4
{Psoriasis susceptibility 5} (2)	PSORS5	604316	3q21	PSORS5
{Psoriasis susceptibility 6} (2)	PSORS6	605364	19p13	PSORS6
{Psoriasis susceptibility 7} (2)	PSORS7	605606	1p	PSORS7
{Psoriasis susceptibility 8} (2)	PSORS8	610707	16q	PSORS8
{Psoriasis, protection against}, 605606 (3)	IL23R, IBD17	607562	1p31.3	IL23R
{Psoriasis, protection against}, 605606 (3)	IL23R, IBD17	607562	1p31.3	IBD17
{Psoriatic arthritis, susceptibility to}, 607507 (3)	LTA, TNFB	153440	6p21.33	LTA
{Psoriatic arthritis, susceptibility to}, 607507 (3)	LTA, TNFB	153440	6p21.33	TNFB
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	NOD2
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CARD15
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	IBD1
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	CD
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	ACUG
{Psoriatic arthritis, susceptibility to}, 607507 (3)	NOD2, CARD15, IBD1, CD, ACUG, PSORAS1	605956	16q12.1	PSORAS1
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	SERPINA1, PI, AAT	107400	14q32.13	SERPINA1
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	SERPINA1, PI, AAT	107400	14q32.13	PI
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1)	SERPINA1, PI, AAT	107400	14q32.13	AAT
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1
{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3)	HMOX1, HMOX1D	141250	22q12.3	HMOX1D
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TERT
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	TCS1
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	EST2
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCA2
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	DKCB4
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	PFBMFT1
{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3)	TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9	187270	5p15.33	CMM9
{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	MUC5B	600770	11p15.5	MUC5B
{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	SFTPA1, SFTP1	178630	10q22.3	SFTPA1
{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)	SFTPA1, SFTP1	178630	10q22.3	SFTP1
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TERC
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TRC3
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	TR
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	DKCA1
{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3)	TERC, TRC3, TR, DKCA1, PFBMFT2	602322	3q26.2	PFBMFT2
{Pulmonary function} (2)	PLF	608852	6q21-q22	PLF
{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to} (2)	CTEPH1	612862	6p21.3	CTEPH1
{Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)	CPS1, PHN	608307	2q34	CPS1
{Pulmonary hypertension, neonatal, susceptibility to}, 615371 (3)	CPS1, PHN	608307	2q34	PHN
{Rapid progression to AIDS from HIV1 infection}, 609423 (3)	CX3CR1, GPR13, V28	601470	3p22.2	CX3CR1
{Rapid progression to AIDS from HIV1 infection}, 609423 (3)	CX3CR1, GPR13, V28	601470	3p22.2	GPR13
{Rapid progression to AIDS from HIV1 infection}, 609423 (3)	CX3CR1, GPR13, V28	601470	3p22.2	V28
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF1B
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	TCF2
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HNF2
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	MODY5
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	FJHN
{Renal cell carcinoma}, 144700 (3)	HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11	189907	17q12	HPC11
{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	BICC1, BICC, CYSRD	614295	10q21.1	BICC1
{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	BICC1, BICC, CYSRD	614295	10q21.1	BICC
{Renal dysplasia, cystic, susceptibility to}, 601331 (3)	BICC1, BICC, CYSRD	614295	10q21.1	CYSRD
{Resistance to malaria due to G6PD deficiency}, 611162 (3)	G6PD, G6PD1	305900	Xq28	G6PD
{Resistance to malaria due to G6PD deficiency}, 611162 (3)	G6PD, G6PD1	305900	Xq28	G6PD1
{Restless legs syndrome 1} (2)	RLS1	102300	12q12-q21	RLS1
{Restless legs syndrome 2} (2)	RLS2	608831	14q13-q21	RLS2
{Restless legs syndrome 3} (2)	RLS3	610438	9p24-p22	RLS3
{Restless legs syndrome 4} (2)	RLS4	610439	2q33	RLS4
{Restless legs syndrome 5} (2)	RLS5	611242	20p13	RLS5
{Restless legs syndrome 6} (2)	RLS6	611185	6p21	RLS6
{Restless legs syndrome 7} (2)	RLS7	612853	2p14-p13	RLS7
{Restless legs syndrome 8} (2)	RLS8	615197	5q31	RLS8
{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3)	PDZD7	612971	10q24.31	PDZD7
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SNF5
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	INI1
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RDT
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RTPS1
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	MRD15
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SWNTS1
{Rhabdoid predisposition syndrome 1}, 609322 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	CSS3
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	SMARCA4
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	BRG1
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	RTPS2
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	MRD16
{Rhabdoid tumor predisposition syndrome 2}, 613325 (3)	SMARCA4, BRG1, RTPS2, MRD16, CSS4	603254	19p13.2	CSS4
{Rheumatoid arthritis, progression of}, 180300 (3)	IL10, CSIF, GVHDS	124092	1q32.1	IL10
{Rheumatoid arthritis, progression of}, 180300 (3)	IL10, CSIF, GVHDS	124092	1q32.1	CSIF
{Rheumatoid arthritis, progression of}, 180300 (3)	IL10, CSIF, GVHDS	124092	1q32.1	GVHDS
{Rheumatoid arthritis, susceptibility to} (2)	RA	180300	6q23	RA
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CD244, NAIL, NKR2B4, SLAMF4	605554	1q23.3	CD244
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CD244, NAIL, NKR2B4, SLAMF4	605554	1q23.3	NAIL
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CD244, NAIL, NKR2B4, SLAMF4	605554	1q23.3	NKR2B4
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	CD244, NAIL, NKR2B4, SLAMF4	605554	1q23.3	SLAMF4
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	HLA-DRB1, SS1	142857	6p21.32	SS1
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	MHC2TA, C2TA	600005	16p13.13	MHC2TA
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	MHC2TA, C2TA	600005	16p13.13	C2TA
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	NFKBIL1	601022	6p21.33	NFKBIL1
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PADI4, PADI5, PAD	605347	1p36.13	PADI4
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PADI4, PADI5, PAD	605347	1p36.13	PADI5
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PADI4, PADI5, PAD	605347	1p36.13	PAD
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PEP
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN8
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	LYP
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	SLC22A4, OCTN1	604190	5q31.1	SLC22A4
{Rheumatoid arthritis, susceptibility to}, 180300 (3)	SLC22A4, OCTN1	604190	5q31.1	OCTN1
{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3)	MIF	153620	22q11.23	MIF
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IL6
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	IFNB2
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	BSF2
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HSF
{Rheumatoid arthritis, systemic juvenile}, 604302 (3)	IL6, IFNB2, BSF2, HSF, HGF	147620	7p15.3	HGF
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
{SARS, progression of} (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
{Sarcoidosis, susceptibility to, 1}, 181000 (3)	HLA-DRB1, SS1	142857	6p21.32	HLA-DRB1
{Sarcoidosis, susceptibility to, 1}, 181000 (3)	HLA-DRB1, SS1	142857	6p21.32	SS1
{Sarcoidosis, susceptibility to, 2}, 612387 (3)	BTNL2, SS2	606000	6p21.32	BTNL2
{Sarcoidosis, susceptibility to, 2}, 612387 (3)	BTNL2, SS2	606000	6p21.32	SS2
{Sarcoidosis, susceptibility to, 3} (2)	SS3	612388	10q22.3	SS3
{Schistosoma mansoni infection, susceptibility/resistance to} (2)	SM1	181460	5q31-q33	SM1
{Schizoaffective disorder, susceptibility to}, 181500 (3)	DISC1, SCZD9	605210	1q42.2	DISC1
{Schizoaffective disorder, susceptibility to}, 181500 (3)	DISC1, SCZD9	605210	1q42.2	SCZD9
{Schizophrenia 10} (2)	SCZD10	605419	15q15	SCZD10
{Schizophrenia 12}, 181500 (2)	SCZD12	608543	1p36.2	SCZD12
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SHANK3
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	PSAP2
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	PROSAP2
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	KIAA1650
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	DEL22q13.3
{Schizophrenia 15}, 613950 (3)	SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15	606230	22q13.33	SCZD15
{Schizophrenia, susceptibility to, 13} (2)	SCZD13	613025	15q13	SCZD13
{Schizophrenia, susceptibility to, 14} (2)	SCZD14	612361	2q32.1	SCZD14
{Schizophrenia, susceptibility to, 17}, 614332 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	NRXN1
{Schizophrenia, susceptibility to, 17}, 614332 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	PTHSL2
{Schizophrenia, susceptibility to, 17}, 614332 (3)	NRXN1, PTHSL2, SCZD17	600565	2p16.3	SCZD17
{Schizophrenia, susceptibility to, 4}, 600850 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH
{Schizophrenia, susceptibility to, 4}, 600850 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	PRODH2
{Schizophrenia, susceptibility to, 4}, 600850 (3)	PRODH, PRODH2, SCZD4	606810	22q11.21	SCZD4
{Schizophrenia, susceptibility to}, 181500 (2)	AKT1, CWS6	164730	14q32.33	AKT1
{Schizophrenia, susceptibility to}, 181500 (2)	AKT1, CWS6	164730	14q32.33	CWS6
{Schizophrenia, susceptibility to}, 181500 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	CHI3L1
{Schizophrenia, susceptibility to}, 181500 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	GP39
{Schizophrenia, susceptibility to}, 181500 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	YKL40
{Schizophrenia, susceptibility to}, 181500 (3)	CHI3L1, GP39, YKL40, ASRT7	601525	1q32.1	ASRT7
{Schizophrenia, susceptibility to}, 181500 (3)	COMT	116790	22q11.21	COMT
{Schizophrenia, susceptibility to}, 181500 (3)	DRD3, ETM1, FET1	126451	3q13.31	DRD3
{Schizophrenia, susceptibility to}, 181500 (3)	DRD3, ETM1, FET1	126451	3q13.31	ETM1
{Schizophrenia, susceptibility to}, 181500 (3)	DRD3, ETM1, FET1	126451	3q13.31	FET1
{Schizophrenia, susceptibility to}, 181500 (3)	HTR2A	182135	13q14.2	HTR2A
{Schizophrenia, susceptibility to}, 181500 (3)	MTHFR	607093	1p36.22	MTHFR
{Schizophrenia, susceptibility to}, 181500 (3)	RTN4R, NOGOR	605566	22q11.21	RTN4R
{Schizophrenia, susceptibility to}, 181500 (3)	RTN4R, NOGOR	605566	22q11.21	NOGOR
{Schizophrenia, susceptibility to}, 181500 (3)	SYN2	600755	3p25.2	SYN2
{Schizophrenia, susceptibility to}, 604906 (3)	DISC1, SCZD9	605210	1q42.2	DISC1
{Schizophrenia, susceptibility to}, 604906 (3)	DISC1, SCZD9	605210	1q42.2	SCZD9
{Schizophrenia}, 181500 (1)	APOL2	607252	22q12.3	APOL2
{Schizophrenia}, 181500 (1)	APOL4	607254	22q12.3	APOL4
{Schizophrenia}, 181500 (2)	DAO, DAMOX	124050	12q24.11	DAO
{Schizophrenia}, 181500 (2)	DAO, DAMOX	124050	12q24.11	DAMOX
{Schizophrenia}, 181500 (2)	DAOA, G72	607408	13q33.2	DAOA
{Schizophrenia}, 181500 (2)	DAOA, G72	607408	13q33.2	G72
{Schizophrenia}, 181500 (2)	SCZD1	181510	5q23-q35	SCZD1
{Schizophrenia}, 181500 (2)	SCZD11	608078	10q22.3	SCZD11
{Schizophrenia}, 181500 (2)	SCZD3	600511	6p23	SCZD3
{Schizophrenia}, 181500 (2)	SCZD5	603175	6q13-q26	SCZD5
{Schizophrenia}, 181500 (2)	SCZD6	603013	8p21	SCZD6
{Schizophrenia}, 181500 (2)	SCZD7	603176	13q32	SCZD7
{Schizophrenia}, 181500 (2)	SCZD8	603206	18p	SCZD8
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SMARCB1
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SNF5
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	INI1
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RDT
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	RTPS1
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	MRD15
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	SWNTS1
{Schwannomatosis-1, susceptibility to}, 162091 (3)	SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3	601607	22q11.23	CSS3
{Schwannomatosis-2, susceptibility to}, 615670 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	LZTR1
{Schwannomatosis-2, susceptibility to}, 615670 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	SWNTS2
{Schwannomatosis-2, susceptibility to}, 615670 (3)	LZTR1, SWNTS2, NS10	600574	22q11.21	NS10
{Scoliosis, idiopathic, susceptibility to, 4} (2)	IS4	612238	9q31.2-q34.2	IS4
{Scoliosis, idiopathic, susceptibility to, 5} (2)	IS5	612239	17q25.3	IS5
{Scoliosis, isolated, susceptibility to, 3} (2)	IS3	608765	8q12	IS3
{Seasonal affective disorder, susceptibility to}, 608516 (3)	HTR2A	182135	13q14.2	HTR2A
{Sepsis, susceptibility to} (3)	CASP12, CASP12P1	608633	11q22.3	CASP12
{Sepsis, susceptibility to} (3)	CASP12, CASP12P1	608633	11q22.3	CASP12P1
{Septic shock, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNF
{Septic shock, susceptibility to} (3)	TNF, TNFA	191160	6p21.33	TNFA
{Sezary syndrome, somatic}, (3)	BCL10, IMD37	603517	1p22.3	BCL10
{Sezary syndrome, somatic}, (3)	BCL10, IMD37	603517	1p22.3	IMD37
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYH6
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	ASD3
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	MYHCA
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMD1EE
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	CMH14
{Sick sinus syndrome 3}, 614090 (3)	MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3	160710	14q11.2	SSS3
{Smoking as a quantitative trait locus 1} (2)	SQTL1	611003	10q22	SQTL1
{Smoking as a quantitative trait locus 2} (2)	SQTL2	611004	22q12	SQTL2
{Specific language impairment 4} (2)	SLI4	612514	7q35-q36	SLI4
{Specific language impairment 5}, 615432 (3)	TM4SF20, SLI5	615404	2q36.3	TM4SF20
{Specific language impairment 5}, 615432 (3)	TM4SF20, SLI5	615404	2q36.3	SLI5
{Speech-sound disorder} (2)	SSD	608445	3p12-q13	SSD
{Spermatogenic failure, susceptibility to} (3)	DAZL, DAZH, SPGYLA	601486	3p24.3	DAZL
{Spermatogenic failure, susceptibility to} (3)	DAZL, DAZH, SPGYLA	601486	3p24.3	DAZH
{Spermatogenic failure, susceptibility to} (3)	DAZL, DAZH, SPGYLA	601486	3p24.3	SPGYLA
{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)	MTHFD, MTHFC	172460	14q23.3	MTHFD
{Spina bifida, folate-sensitive, susceptibility to}, 601634 (3)	MTHFD, MTHFC	172460	14q23.3	MTHFC
{Spina bifida, susceptibility to}, 182940 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	CCL2
{Spina bifida, susceptibility to}, 182940 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	SCYA2
{Spina bifida, susceptibility to}, 182940 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCP1
{Spina bifida, susceptibility to}, 182940 (3)	CCL2, SCYA2, MCP1, MCAF	158105	17q12	MCAF
{Spinal muscular atrophy, type III, modifier of}, 253400 (3)	SMN2	601627	5q13.2	SMN2
{Spitz nevus or nevus spilus, somatic}, 137550 (3)	HRAS	190020	11p15.5	HRAS
{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Spondyloarthropathy, susceptibility to, 1}, 106300 (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Spondyloarthropathy, susceptibility to, 2} (2)	SPDA2	183840	9q31-q34	SPDA2
{Spondyloarthropathy, susceptibility to, 3} (2)	SPDA3	613238	2q36.1-q36.3	SPDA3
{Stature QTL 10} (2)	STQTL10	612221	3q23	STQTL10
{Stature QTL 11} (2)	STQTL11	612223	7q21	STQTL11
{Stature QTL 12} (2)	STQTL12	612224	4q31	STQTL12
{Stature QTL 13} (2)	STQTL13	612226	4p15.3	STQTL13
{Stature QTL 14} (2)	STQTL14	612228	20q11.22	STQTL14
{Stature QTL 15} (2)	STQTL15	612578	8q21.13	STQTL15
{Stature QTL 16} (2)	STQTL16	612579	15q22.32	STQTL16
{Stature QTL 17} (2)	STQTL17	612737	7p15	STQTL17
{Stature QTL 18} (2)	STQTL18	612892	6p22.1	STQTL18
{Stature QTL 19} (2)	STQTL19	612893	6p21.31	STQTL19
{Stature QTL 1} (2)	STQTL1	606255	6q24-q25	STQTL1
{Stature QTL 20} (2)	STQTL20	612894	13q14.3	STQTL20
{Stature QTL 21} (2)	STQTL21	613440	2q37.1	STQTL21
{Stature QTL 22} (2)	STQTL22	613547	16q24	STQTL22
{Stature QTL 23} (2)	STQTL23	613548	1p32	STQTL23
{Stature QTL 24} (2)	STQTL24	613549	2p16	STQTL24
{Stature QTL 2} (2)	STQTL2	606256	7q31.3	STQTL2
{Stature QTL 3} (2)	STQTL3	606257	12p11.2-q14	STQTL3
{Stature QTL 4} (2)	STQTL4	606258	13q32-q33	STQTL4
{Stature QTL 5} (2)	STQTL5	608982	3p26	STQTL5
{Stature QTL 6} (2)	STQTL6	300591	Xq24-q25	STQTL6
{Stature QTL 7} (2)	STQTL7	609822	1p21	STQTL7
{Stature QTL 8} (2)	STQTL8	610114	9q22	STQTL8
{Stature QTL 9} (2)	STQTL9	611547	12q14.3	STQTL9
{Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Stevens-Johnson syndrome, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Strabismus, susceptibility to, 1} (2)	STBMS1	185100	7p22.1	STBMS1
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	DCP1
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ACE1
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	MVCD3
{Stroke, hemorrhagic}, 614519 (3)	ACE, DCP1, ACE1, MVCD3, ICH	106180	17q23.3	ICH
{Stroke, ischemic, susceptibility to}, 601367 (3)	F2, THPH1, RPRGL2	176930	11p11.2	F2
{Stroke, ischemic, susceptibility to}, 601367 (3)	F2, THPH1, RPRGL2	176930	11p11.2	THPH1
{Stroke, ischemic, susceptibility to}, 601367 (3)	F2, THPH1, RPRGL2	176930	11p11.2	RPRGL2
{Stroke, ischemic, susceptibility to}, 601367 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Stroke, ischemic, susceptibility to}, 601367 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
{Stroke, ischemic, susceptibility to}, 601367 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
{Stroke, susceptibility to, 1}, 606799 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	PDE4D
{Stroke, susceptibility to, 1}, 606799 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	DPDE3
{Stroke, susceptibility to, 1}, 606799 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	STRK1
{Stroke, susceptibility to, 1}, 606799 (3)	PDE4D, DPDE3, STRK1, ACRDYS2	600129	5q11.2-q12.1	ACRDYS2
{Stroke, susceptibility to}, 601367 (3)	ALOX5AP, FLAP	603700	13q12.3	ALOX5AP
{Stroke, susceptibility to}, 601367 (3)	ALOX5AP, FLAP	603700	13q12.3	FLAP
{Sublingual nitroglycerin, susceptibility to poor response to} (3)	ALDH2	100650	12q24.12	ALDH2
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SCN5A
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	LQT3
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	VF1
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	HB1
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	SSS1
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CMD1E
{Sudden infant death syndrome, susceptibility to}, 272120 (3)	SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2	600163	3p22.2	CDCD2
{Synovitis, chronic, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Synovitis, chronic, susceptibility to} (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Systemic lupus erthematosus, susceptibility to, 15} (2)	SLEB15	300809	Xq28	SLEB15
{Systemic lupus erythematosus susceptibility to}, 152700 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN22
{Systemic lupus erythematosus susceptibility to}, 152700 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PEP
{Systemic lupus erythematosus susceptibility to}, 152700 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	PTPN8
{Systemic lupus erythematosus susceptibility to}, 152700 (3)	PTPN22, PEP, PTPN8, LYP	600716	1p13.2	LYP
{Systemic lupus erythematosus with hemolytic anemia} (2)	SLEH1	607279	11q14	SLEH1
{Systemic lupus erythematosus with nephritis, susceptibility to, 1} (2)	SLEN1	607965	10q22.3	SLEN1
{Systemic lupus erythematosus with nephritis, susceptibility to, 2} (2)	SLEN2	607966	2q34-q35	SLEN2
{Systemic lupus erythematosus with nephritis, susceptibility to, 3} (2)	SLEN3	607967	11p15.5	SLEN3
{Systemic lupus erythematosus, resistance to}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Systemic lupus erythematosus, resistance to}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TIL3
{Systemic lupus erythematosus, resistance to}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	SLEB1
{Systemic lupus erythematosus, resistance to}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	MELIOS
{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IRF5
{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	IBD14
{Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3)	IRF5, IBD14, SLEB10	607218	7q32.1	SLEB10
{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	STAT4, SLEB11	600558	2q32.2-q32.3	STAT4
{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3)	STAT4, SLEB11	600558	2q32.2-q32.3	SLEB11
{Systemic lupus erythematosus, susceptibility to, 12} (2)	SLEB12	612254	8p23.1	SLEB12
{Systemic lupus erythematosus, susceptibility to, 13} (2)	SLEB13	612378	6q23	SLEB13
{Systemic lupus erythematosus, susceptibility to, 14} (2)	SLEB14	613145	1q21-q23	SLEB14
{Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TLR5
{Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	TIL3
{Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	SLEB1
{Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3)	TLR5, TIL3, SLEB1, MELIOS	603031	1q41	MELIOS
{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)	PDCD1, SLEB2	600244	2q37.3	PDCD1
{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3)	PDCD1, SLEB2	600244	2q37.3	SLEB2
{Systemic lupus erythematosus, susceptibility to, 3} (2)	SLEB3	605480	4p16-p15.2	SLEB3
{Systemic lupus erythematosus, susceptibility to, 4} (2)	SLEB4	608437	12q24	SLEB4
{Systemic lupus erythematosus, susceptibility to, 5} (2)	SLEB5	609903	13q32	SLEB5
{Systemic lupus erythematosus, susceptibility to, 7} (2)	SLEB7	610065	20p12	SLEB7
{Systemic lupus erythematosus, susceptibility to, 8} (2)	SLEB8	610066	20q13	SLEB8
{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CR2
{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	C3DR
{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	SLEB9
{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)	CR2, C3DR, SLEB9, CVID7	120650	1q32.2	CVID7
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CTLA4
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	IDDM12
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	CELIAC3
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	CTLA4, IDDM12, CELIAC3, ALPS5	123890	2q33.2	ALPS5
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	DNASE1, DNL1	125505	16p13.3	DNASE1
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	DNASE1, DNL1	125505	16p13.3	DNL1
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	FCGR2B, CD32	604590	1q23.3	FCGR2B
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	FCGR2B, CD32	604590	1q23.3	CD32
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	TREX1
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	AGS1
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	CRV
{Systemic lupus erythematosus, susceptibility to}, 152700 (3)	TREX1, AGS1, CRV, HERNS	606609	3p21.31	HERNS
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	ITGAM
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	CR3A
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	CD11B
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	MAC1A
{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3)	ITGAM, CR3A, CD11B, MAC1A, SLEB6	120980	16p11.2	SLEB6
{T-cell acute lymphoblastic leukemia} (3)	MYB	189990	6q23.3	MYB
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	IFNG, IFG, IFI	147570	12q15	IFG
{TSC2 angiomyolipomas, renal, modifier of}, 613254 (3)	IFNG, IFG, IFI	147570	12q15	IFI
{Thiopurines, poor metabolism of, 1}, 610460 (3)	TPMT, TPMTD	187680	6p22.3	TPMT
{Thiopurines, poor metabolism of, 1}, 610460 (3)	TPMT, TPMTD	187680	6p22.3	TPMTD
{Thiopurines, poor metabolism of, 2}, 616903 (3)	NUDT15, MTH2, NUDT15D	615792	13q14.2	NUDT15
{Thiopurines, poor metabolism of, 2}, 616903 (3)	NUDT15, MTH2, NUDT15D	615792	13q14.2	MTH2
{Thiopurines, poor metabolism of, 2}, 616903 (3)	NUDT15, MTH2, NUDT15D	615792	13q14.2	NUDT15D
{Thromboembolism, susceptibility to}, 188050 (3)	MTHFR	607093	1p36.22	MTHFR
{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	F5
{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	THPH2
{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3)	F5, THPH2, RPRGL1	612309	1q24.2	RPRGL1
{Thyroid cancer, monmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2-1
{Thyroid cancer, monmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TITF1
{Thyroid cancer, monmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NKX2A
{Thyroid cancer, monmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	TTF1
{Thyroid cancer, monmedullary, 1}, 188550 (3)	NKX2-1, TITF1, NKX2A, TTF1, NMTC1	600635	14q13.3	NMTC1
{Thyroid cancer, nonmedullary, 2}, 188470 (3)	SRGAP1, KIAA1304, NMTC2	606523	12q14.2	SRGAP1
{Thyroid cancer, nonmedullary, 2}, 188470 (3)	SRGAP1, KIAA1304, NMTC2	606523	12q14.2	KIAA1304
{Thyroid cancer, nonmedullary, 2}, 188470 (3)	SRGAP1, KIAA1304, NMTC2	606523	12q14.2	NMTC2
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FOXE1
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	FKHL15
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	TITF2
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	TTF2
{Thyroid cancer, nonmedullary, 4}, 616534 (3)	FOXE1, FKHL15, TITF2, TTF2, NMTC4	602617	9q22.33	NMTC4
{Thyroid carcinoma, Hurthle cell}, 607464 (3)	NDUFA13, GRIM19	609435	19p13.11	NDUFA13
{Thyroid carcinoma, Hurthle cell}, 607464 (3)	NDUFA13, GRIM19	609435	19p13.11	GRIM19
{Thyroid carcinoma, follicular, somatic}, 188470 (3)	HRAS	190020	11p15.5	HRAS
{Thyroid carcinoma, nonmedullary, 3} (2)	NMTC3	606240	2q21	NMTC3
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNA1S
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CACNL1A3
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	CCHL1A3
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	TTPP1
{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3)	CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1	114208	1q32.1	HOKPP1
{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	KCNJ18, KIR2.6, TTPP2	613236	17p11.2	KCNJ18
{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	KCNJ18, KIR2.6, TTPP2	613236	17p11.2	KIR2.6
{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)	KCNJ18, KIR2.6, TTPP2	613236	17p11.2	TTPP2
{Toxic epidermal necrolysis, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	HLA-B
{Toxic epidermal necrolysis, susceptibility to}, 608579 (3)	HLA-B, SPDA1	142830	6p21.33	SPDA1
{Transcription of plasminogen activator inhibitor, modulator of} (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PAI1
{Transcription of plasminogen activator inhibitor, modulator of} (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	PLANH1
{Transcription of plasminogen activator inhibitor, modulator of} (3)	PAI1, PLANH1, SERPINE1	173360	7q22.1	SERPINE1
{Tuberculosis infection, protection against}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{Tuberculosis infection, protection against}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
{Tuberculosis infection, protection against}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
{Tuberculosis, protection against}, 607948 (3)	IFNG, IFG, IFI	147570	12q15	IFNG
{Tuberculosis, protection against}, 607948 (3)	IFNG, IFG, IFI	147570	12q15	IFG
{Tuberculosis, protection against}, 607948 (3)	IFNG, IFG, IFI	147570	12q15	IFI
{Tuberculosis, protection against}, 607948 (3)	TIRAP, BACTS1	606252	11q24.2	TIRAP
{Tuberculosis, protection against}, 607948 (3)	TIRAP, BACTS1	606252	11q24.2	BACTS1
{Tuberculosis, susceptibility to} (2)	MTBS1	607949	2q35	MTBS1
{Tuberculosis, susceptibility to}, 607948 (3)	CISH, BACTS2	602441	3p21.2	CISH
{Tuberculosis, susceptibility to}, 607948 (3)	CISH, BACTS2	602441	3p21.2	BACTS2
{Tuberculosis, susceptibility to}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IFNGR1
{Tuberculosis, susceptibility to}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27A
{Tuberculosis, susceptibility to}, 607948 (3)	IFNGR1, IMD27A, IMD27B	107470	6q23.3	IMD27B
{UV-induced skin damage}, 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	MC1R
{UV-induced skin damage}, 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	SHEP2
{UV-induced skin damage}, 266300 (3)	MC1R, SHEP2, CMM5	155555	16q24.3	CMM5
{Unipolar depression, susceptibility to}, 608516 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	TPH2
{Unipolar depression, susceptibility to}, 608516 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	NTPH
{Unipolar depression, susceptibility to}, 608516 (3)	TPH2, NTPH, ADHD7	607478	12q21.1	ADHD7
{Uric acid concentration, serum, QTL 2}, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	SLC2A9
{Uric acid concentration, serum, QTL 2}, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	GLUT9
{Uric acid concentration, serum, QTL 2}, 612076 (3)	SLC2A9, GLUT9, UAQTL2	606142	4p16.1	UAQTL2
{Vascular disease, susceptibility to} (3)	MTHFR	607093	1p36.22	MTHFR
{Venoocclusive disease after bone marrow transplantation} (3)	CPS1, PHN	608307	2q34	CPS1
{Venoocclusive disease after bone marrow transplantation} (3)	CPS1, PHN	608307	2q34	PHN
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HABP2
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	PHBP
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	HGFAL
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	FSAP
{Venous thromboembolism, susceptibility to}, 188050 (3)	HABP2, PHBP, HGFAL, FSAP, NMTC5	603924	10q25.3	NMTC5
{Venous thrombosis, protection against}, 188050 (3)	F13A1, F13A	134570	6p25.1	F13A1
{Venous thrombosis, protection against}, 188050 (3)	F13A1, F13A	134570	6p25.1	F13A
{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3)	DPP6, VF2, MRD33	126141	7q36.2	DPP6
{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3)	DPP6, VF2, MRD33	126141	7q36.2	VF2
{Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3)	DPP6, VF2, MRD33	126141	7q36.2	MRD33
{Viral infection, susceptibility to} (3)	OAS1, OIAS	164350	12q24.13	OAS1
{Viral infection, susceptibility to} (3)	OAS1, OIAS	164350	12q24.13	OIAS
{Vitamin B12 plasma level QTL1}, 612542 (3)	FUT2, SE, B12QTL1	182100	19q13.33	FUT2
{Vitamin B12 plasma level QTL1}, 612542 (3)	FUT2, SE, B12QTL1	182100	19q13.33	SE
{Vitamin B12 plasma level QTL1}, 612542 (3)	FUT2, SE, B12QTL1	182100	19q13.33	B12QTL1
{Vitamin B6 plasma level QTL 1} (2)	B6QTL1	612957	1p36.12	B6QTL1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	NLRP1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	NALP1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	KIAA0926
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	DEFCAP
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	CARD7
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	SLEV1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	VAMAS1
{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3)	NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, CIDED	606636	17p13.2	CIDED
{Vitiligo-associated multiple autoimmune disease susceptibility 6} (2)	VAMAS6	193200	6p21.3	VAMAS6
{Warfarin sensitivity}, 122700 (3)	F9, HEMB, THPH8	300746	Xq27.1	F9
{Warfarin sensitivity}, 122700 (3)	F9, HEMB, THPH8	300746	Xq27.1	HEMB
{Warfarin sensitivity}, 122700 (3)	F9, HEMB, THPH8	300746	Xq27.1	THPH8
{West nile virus, susceptibility to}, 610379 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCR5
{West nile virus, susceptibility to}, 610379 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CMKBR5
{West nile virus, susceptibility to}, 610379 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	CCCKR5
{West nile virus, susceptibility to}, 610379 (3)	CCR5, CMKBR5, CCCKR5, IDDM22	601373	3p21.31	IDDM22
{Wilms tumor 6, susceptibility to}, 616806 (3)	REST, NRSF, WT6	600571	4q12	REST
{Wilms tumor 6, susceptibility to}, 616806 (3)	REST, NRSF, WT6	600571	4q12	NRSF
{Wilms tumor 6, susceptibility to}, 616806 (3)	REST, NRSF, WT6	600571	4q12	WT6
{Wilms tumor susceptibility-5}, 601583 (3)	POU6F2, WTSL, WT5	609062	7p14.1	POU6F2
{Wilms tumor susceptibility-5}, 601583 (3)	POU6F2, WTSL, WT5	609062	7p14.1	WTSL
{Wilms tumor susceptibility-5}, 601583 (3)	POU6F2, WTSL, WT5	609062	7p14.1	WT5
{von Hippel-Lindau syndrome, modifier of}, 193300 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	CCND1
{von Hippel-Lindau syndrome, modifier of}, 193300 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	PRAD1
{von Hippel-Lindau syndrome, modifier of}, 193300 (3)	CCND1, PRAD1, BCL1	168461	11q13.3	BCL1
